<SEC-DOCUMENT>0000950123-11-075098.txt : 20110809
<SEC-HEADER>0000950123-11-075098.hdr.sgml : 20110809
<ACCEPTANCE-DATETIME>20110809161633
ACCESSION NUMBER:		0000950123-11-075098
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		10
CONFORMED PERIOD OF REPORT:	20110703
FILED AS OF DATE:		20110809
DATE AS OF CHANGE:		20110809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0209

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		111020994

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>y91358e10vq.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
<TITLE>e10vq</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 10-Q</B>
</DIV>


<DIV align="center">
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%" style="font-size: 12pt">
<TR style="font-size: 6pt">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center"><FONT style="font-family: Wingdings">&#254;</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD><B>Quarterly Report Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
<br><BR style="font-size: 6pt">
<!-- xbrl,dc -->
for the quarterly period ended July&nbsp;3, 2011</b>
<!-- /xbrl,dc -->
</TD>
</TR>
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>or</B></DIV>


<DIV align="center">
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%" style="font-size: 12pt">
<TR style="font-size: 6pt">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center"><FONT style="font-family: Wingdings">&#111;</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD><B>Transition Report Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 <br><BR style="font-size: 6pt">for the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>
Commission file number 1-3215</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><IMG src="y91358y9135800.gif" alt="(JOHNSON &#038; JOHNSON LOGO)"></DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">NEW JERSEY<BR>
(State or other jurisdiction of <BR>
incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">22-1024240<BR>
(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">One Johnson &#038; Johnson Plaza<BR>
New Brunswick, New Jersey 08933<BR>
(Address of principal executive offices)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code (732)&nbsp;524-0400</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed
by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&nbsp;months (or
for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been
subject to such filing requirements for the past 90&nbsp;days. <FONT style="font-family: Wingdings">&#254;</FONT> Yes <FONT style="font-family: Wingdings">&#111;</FONT> No
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T during the preceding 12&nbsp;months (or for such shorter period
that the registrant was required to submit and post such files). <FONT style="font-family: Wingdings">&#254;</FONT> Yes <FONT style="font-family: Wingdings">&#111;</FONT> No
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See definitions of &#147;large
accelerated filer&#148;, &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the
Exchange Act.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="22%"></TD>
    <TD width="3%"></TD>
    <TD width="22%"></TD>
    <TD width="3%"></TD>
    <TD width="22%"></TD>
    <TD width="3%"></TD>
    <TD width="22%"></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">Large accelerated filer <FONT style="font-family: Wingdings">&#254;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Accelerated filer <FONT style="font-family: Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Non-accelerated filer <FONT style="font-family: Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">Smaller reporting company <FONT style="font-family: Wingdings">&#111;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of
the Exchange Act). <FONT style="font-family: Wingdings">&#111;</FONT> Yes <FONT style="font-family: Wingdings">&#254;</FONT> No
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate the number of shares outstanding of each of the issuer&#146;s classes of common stock, as
of the latest practicable date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On July&nbsp;29, 2011 2,740,354,114 shares of Common Stock, $1.00 par value, were outstanding.
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="Y91358tocpage"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">TABLE OF CONTENTS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Page</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">No.</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358101">Part I &#151; Financial Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358102">Item&nbsp;1. Financial Statements (unaudited)</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358103">Consolidated Balance Sheets &#151; July&nbsp;3, 2011 and January&nbsp;2, 2011</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358104">Consolidated Statements of Earnings for the Fiscal Second Quarters Ended July&nbsp;3, 2011 and July&nbsp;4, 2010</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358105">Consolidated Statements of Earnings for the Fiscal Six Months Ended July&nbsp;3, 2011 and July&nbsp;4, 2010</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358106">Consolidated Statements of Cash Flows for the Fiscal Six Months Ended July&nbsp;3, 2011 and July&nbsp;4, 2010</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358107">Notes to Consolidated Financial Statements</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358108">Item&nbsp;2. Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358109">Item&nbsp;3. Quantitative and Qualitative Disclosures About Market Risk</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358110">Item&nbsp;4. Controls and Procedures</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358111">Part II &#151; Other Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358112">Item&nbsp;1 - Legal Proceedings</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358113">Item&nbsp;2 &#151; Unregistered Sales of Equity Securities and Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358114">Item&nbsp;5 - Other Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358115">Item&nbsp;6 - Exhibits</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#Y91358116">Signatures</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y91358exv31w1.htm">EX-31.1</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="y91358exv32w1.htm">EX-32.1</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703.xml">EX-101 INSTANCE DOCUMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703.xsd">EX-101 SCHEMA DOCUMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703_cal.xml">EX-101 CALCULATION LINKBASE DOCUMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703_lab.xml">EX-101 LABELS LINKBASE DOCUMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703_pre.xml">EX-101 PRESENTATION LINKBASE DOCUMENT</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="jnj-20110703_def.xml">EX-101 DEFINITION LINKBASE DOCUMENT</A></FONT></TD></TR>
</TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<A name="Y91358101"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Part&nbsp;I &#151; FINANCIAL INFORMATION
</DIV>

<DIV align="left">
<A name="Y91358102"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;1 &#151; FINANCIAL STATEMENTS
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES
</DIV>

<DIV align="left">
<A name="Y91358103"></A>
</DIV>

<!-- xbrl,bs -->
<DIV align="center" style="font-size: 10pt">CONSOLIDATED BALANCE SHEETS</DIV>
<!-- xbrl,body -->


<DIV align="center" style="font-size: 10pt">(Unaudited; Dollars in Millions Except Share and Per Share Data)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ASSETS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3, 2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">January 2, 2011</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current assets:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,974</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">19,355</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Marketable securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14,708</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,303</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accounts receivable, trade, less
allowances for doubtful accounts $327
(2010, $340)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,982</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,774</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Inventories (Note 2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,413</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,378</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deferred taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,306</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,224</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Prepaid expenses and other receivables</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,290</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,273</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52,673</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47,307</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Property, plant and equipment at cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32,435</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30,426</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less: accumulated depreciation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(17,461</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(15,873</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Property, plant and equipment, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14,974</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14,553</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intangible assets, net (Note 3)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18,378</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,716</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goodwill, net (Note 3)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,243</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,294</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deferred taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,653</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,096</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,193</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,942</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">112,114</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">102,908</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">See Notes to Consolidated Financial Statements
</DIV>

<!-- /xbrl,bs -->
<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES<BR>

<!-- xbrl,bs -->
CONSOLIDATED BALANCE SHEETS<BR>
<!-- xbrl,body -->
(Unaudited; Dollars in Millions Except Share and Per Share Data)
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">LIABILITIES AND SHAREHOLDERS&#146; EQUITY
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3, 2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">January 2, 2011</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current liabilities:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Loans and notes payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">5,046</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,617</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accounts payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,689</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,623</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accrued liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,405</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,100</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accrued rebates, returns and promotions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,933</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,512</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accrued compensation and employee related obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,104</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,642</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accrued taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">808</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">578</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20,985</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23,072</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Long-term debt (Note 4)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13,680</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,156</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deferred taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,888</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,447</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Employee related obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,202</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,087</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,227</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,567</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49,982</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46,329</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shareholders&#146; equity:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Common stock &#151; par value $1.00 per share (authorized
4,320,000,000 shares; issued 3,119,843,000 shares)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,120</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,120</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accumulated other comprehensive income (Note 7)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,192</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3,531</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Retained earnings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80,836</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77,773</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less: common stock held in treasury, at cost
(379,263,000 and 381,746,000 shares)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20,632</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20,783</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total shareholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62,132</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56,579</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total liabilities and shareholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">112,114</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">102,908</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">See Notes to Consolidated Financial Statements
</DIV>


<!-- /xbrl,bs -->

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES
</DIV>

<DIV align="left">
<A name="Y91358104"></A>
</DIV>


<!-- xbrl,in -->
<DIV align="center" style="font-size: 10pt">CONSOLIDATED STATEMENTS OF EARNINGS</DIV>
<!-- xbrl,body -->

<DIV align="center" style="font-size: 10pt">(Unaudited; Dollars &#038; Shares in Millions Except Per Share Amounts)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="52%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="15" style="border-bottom: 1px solid #ffffff">Fiscal Second Quarters Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">to Sales</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">to Sales</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sales to customers (Note 9)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">16,597</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">100.0</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,330</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">100.0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost of products sold</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,172</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31.2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,630</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Gross profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11,425</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,700</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Selling, marketing and
administrative expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,215</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,756</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Research and development expense</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,882</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,648</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(18</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(43</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.3</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest expense, net of portion capitalized</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">129</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">101</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other (income)expense, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">206</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Restructuring expense</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">589</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Earnings before provision for taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,422</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,220</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27.5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Provision for taxes on income (Note 5)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">646</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.9</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">771</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET EARNINGS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,776</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">16.7</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,449</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">22.5</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET EARNINGS PER SHARE (Note 8)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.01</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.25</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.23</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH DIVIDENDS PER SHARE</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.57</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.54</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">AVG. SHARES OUTSTANDING</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,740.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,756.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,781.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,796.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">See Notes to Consolidated Financial Statements
</DIV>


<!-- /xbrl,in -->

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES
</DIV>

<DIV align="left">
<A name="Y91358105"></A>
</DIV>

<!-- xbrl,in -->
<DIV align="center" style="font-size: 10pt">CONSOLIDATED STATEMENTS OF EARNINGS</DIV>
<!-- xbrl,body -->

<DIV align="center" style="font-size: 10pt; margin-top: 0pt">(Unaudited; Dollars &#038; Shares in Millions Except Per Share Amounts)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="52%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="15" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">to Sales</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">to Sales</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sales to customers (Note 9)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">32,770</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">100.0</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">30,961</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">100.0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost of products sold</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,950</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,158</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Gross profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,820</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21,803</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Selling, marketing and administrative expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,271</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,535</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Research and development expense</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,620</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,205</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(39</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(70</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.2</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest expense, net of portion capitalized</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">254</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">209</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other (income)expense, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">193</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,576</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5.1</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Restructuring expense</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">589</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Earnings before provision for taxes on income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,932</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24.2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33.9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Provision for taxes on income (Note 5)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,680</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,525</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET EARNINGS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,252</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">19.1</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,975</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">25.8</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET EARNINGS PER SHARE (Note 8)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.89</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.25</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.85</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH DIVIDENDS PER SHARE</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.11</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.03</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">AVG. SHARES OUTSTANDING</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,739.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,755.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,778.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,796.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">See Notes to Consolidated Financial Statements
</DIV>


<!-- /xbrl,in -->



<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">JOHNSON &#038; JOHNSON AND SUBSIDIARIES
</DIV>

<DIV align="left">
<A name="Y91358106"></A>
</DIV>


<!-- xbrl,cf -->
<DIV align="center" style="font-size: 10pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</DIV>
<!-- xbrl,body -->


<DIV align="center" style="font-size: 10pt">(Unaudited; Dollars in Millions)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH FLOW FROM OPERATING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net earnings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,252</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,975</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Adjustments to reconcile net earnings to cash flows from operating activities:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Depreciation and amortization of property and intangibles</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,532</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,445</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Stock based compensation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">339</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">305</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deferred tax provision</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(504</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">604</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accounts receivable allowances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(33</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Changes in assets and liabilities, net of effects from acquisitions:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Increase in accounts receivable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(576</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(555</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Increase in inventories</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(620</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(88</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Decrease in accounts payable and accrued liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(444</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,719</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Increase in other current and non-current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(920</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(704</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Increase in other current and non-current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,199</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">218</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET CASH FLOWS FROM OPERATING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,225</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,527</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH FLOWS FROM INVESTING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Additions to property, plant and equipment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,054</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(897</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proceeds from the disposal of assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">143</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">109</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisitions, net of cash acquired</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,049</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(871</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchases of investments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(16,820</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(6,695</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sales of investments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,582</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,800</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(62</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(21</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET CASH USED BY INVESTING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(9,260</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(4,575</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH FLOWS FROM FINANCING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dividends to shareholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3,043</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,839</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Repurchase of common stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(929</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(780</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proceeds from short-term debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,586</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">956</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Retirement of short-term debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(6,194</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3,598</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proceeds from long-term debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Retirement of long-term debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(12</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proceeds from the exercise of stock options/excess tax benefits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">717</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">386</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET CASH USED BY FINANCING ACTIVITIES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,464</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5,887</TD>
    <TD nowrap>)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<!-- /xbrl,cf -->
<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->
<!-- XBRL,cf -->
<DIV style="display: none">CONSOLIDATED STATEMENTS OF CASH FLOWS</DIV>
<!-- XBRL,body -->

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Effect of exchange rate changes on cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">118</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(162</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Decrease in cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(4,381</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3,097</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash and Cash equivalents, beginning of period</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19,355</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,810</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CASH AND CASH EQUIVALENTS, END OF PERIOD</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,974</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,713</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fair value of assets acquired</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,248</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">909</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fair value of liabilities assumed and non-controlling interests</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(199</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(38</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net cash paid for acquisitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,049</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">871</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">See Notes to Consolidated Financial Statements
</DIV>



<!-- /xbrl,cf -->

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl,ns -->
<DIV align="left">
<A name="Y91358107"></A>
</DIV>





<DIV align="left" style="font-size: 10pt; margin-top: 6pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
</DIV>



<!-- XBRL,n -->
<DIV style="display: none">NOTE 1 &#151; SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES</DIV>
<!-- XBRL,body -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">NOTE 1 &#151;
The accompanying unaudited interim consolidated financial statements and related notes
should be read in conjunction with the audited Consolidated Financial Statements of Johnson &#038;
Johnson and its subsidiaries (the &#147;Company&#148;) and related notes as contained in the Company&#146;s Annual
Report on Form 10-K for the fiscal year ended January&nbsp;2, 2011. The unaudited interim financial
statements include all adjustments (consisting only of normal recurring adjustments) and accruals
necessary in the judgment of management for a fair statement of the results for the periods
presented.
</DIV>


<!-- xbrl,dnap,"Requirements For Presentation Of Comprehensive Income Policy" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
amendments to the disclosure requirements for presentation of comprehensive income. The amendment
requires that all non-owner changes in stockholders&#146; equity be presented either in a single
continuous statement of comprehensive income or in two separate but consecutive statements. This
guidance is effective retrospectively for the interim periods and annual periods beginning after
December&nbsp;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
material impact on the Company&#146;s results of operations, cash flows or financial position.
</DIV>
<!-- /xbrl,dnap -->

<!-- xbrl,dnap,"Fair Value Of Financial Instruments Policy" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
common fair value measurement. These amendments result in convergence of fair value measurement and
disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
the interim periods and annual periods beginning after December&nbsp;15, 2011. Early adoption is
prohibited. The adoption of this standard is not expected to have a material impact on the
Company&#146;s results of operations, cash flows or financial position.
</DIV>
<!-- /xbrl,dnap -->

<!-- xbrl,dnap,"Revenue Recognition Policy" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance and amendments
issued related to revenue recognition under the milestone method. The objective of the accounting
standard update is to provide guidance on defining a milestone and determining when it may be
appropriate to apply the milestone method of revenue recognition for research or development
transactions. This update is effective on a prospective basis for milestones achieved in fiscal
years, and interim periods within those years, beginning on or after June&nbsp;15, 2010. The adoption of
this standard did not have a material impact on the Company&#146;s results of operations, cash flows or
financial position.
</DIV>
<!-- /xbrl,dnap -->

<!-- xbrl,dnap,"Pharmaceutical Fees Paid To Government Policy" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
pharmaceutical companies should recognize and classify in the Company&#146;s financial statements, the
non-deductible annual fee paid to the Government in accordance with the Patient Protection and
Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
based on an allocation of a company&#146;s market share of total branded prescription drug sales from
the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
in the Company&#146;s financial statement and will be amortized on a straight-line basis for the year as
per the FASB guidance. The adoption of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">this standard did not have a material impact on the
Company&#146;s results of operations, cash flows or financial position.
</DIV>
<!-- /xbrl,dnap -->

<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 2 &#151; INVENTORIES
</DIV>
<!-- xbrl,body -->

<!-- xbrl,dn,"Schedule Of Inventory Current Table" -->
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">July 3, 2011</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">January 2, 2011</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Raw materials and supplies</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">1,383</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,073</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goods in process</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,897</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,460</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Finished goods</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,133</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,845</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total inventories</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">6,413</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,378</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 3 &#151; INTANGIBLE ASSETS AND GOODWILL
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Intangible assets that have finite useful lives are amortized over their estimated useful lives.
The latest impairment assessment of goodwill and indefinite lived intangible assets was completed
in the fiscal fourth quarter of 2010. Future impairment tests for goodwill and indefinite lived
intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted.
</DIV>

<!-- xbrl,dn,"Schedule Of Intangible Assets And Goodwill Table" -->
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">January 2,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intangible assets with definite lives:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Patents and trademarks &#151; gross</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,520</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,660</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less accumulated amortization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,819</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,629</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Patents and trademarks &#151; net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,701</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,031</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="top"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other intangibles &#151; gross</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,609</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,674</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less accumulated amortization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,048</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,880</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other intangibles &#151; net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,561</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,794</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="top"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intangible assets with indefinite lives:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Trademarks</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,080</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,954</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchased in-process research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,036</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,937</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total intangible assets with indefinite lives</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,116</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,891</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="top"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total intangible assets &#151; net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">18,378</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,716</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company reclassified $971&nbsp;million from purchased
in-process research and development to amortizable other intangibles to reflect the
commercialization of ZYTIGA&#174;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Goodwill as of July&nbsp;3, 2011 was allocated by segment of business as follows:
</DIV>
<!-- xbrl,dn,"Schedule Of Goodwill" -->
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Med Dev</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Consumer</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Pharm</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&#038; Diag</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goodwill, net at January&nbsp;2, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">8,144</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,225</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,925</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,294</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">538</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">538</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Currency translation/Other</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">320</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">411</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goodwill, net as of July&nbsp;3, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">8,464</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,815</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,964</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,243</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The weighted average amortization periods for patents and trademarks and other intangible assets
are 17&nbsp;years and 27&nbsp;years, respectively. The amortization expense of amortizable intangible assets
for the fiscal six months ended July&nbsp;3, 2011 was $402&nbsp;million, and the estimated amortization
expense for the five succeeding years approximates $840&nbsp;million, per year.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 4 &#151; FAIR VALUE MEASUREMENTS
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company uses forward exchange contracts to manage its exposure to the variability of cash
flows, primarily related to the foreign exchange rate changes of future intercompany product and
third- party purchases of raw materials denominated in foreign currency. The Company also uses
cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both
types of derivatives are designated as cash flow hedges. The Company also uses forward exchange
contracts to manage its exposure to the variability of cash flows for repatriation of foreign
dividends. These contracts are designated as net investment hedges. Additionally, the Company
uses forward exchange contracts to offset its exposure to certain foreign currency assets and
liabilities. These forward exchange contracts are not designated as hedges, and therefore, changes
in the fair values of these derivatives are recognized in earnings, thereby offsetting the current
earnings effect of the related foreign currency assets and liabilities. The Company does not enter
into derivative financial instruments for trading or speculative
purposes, or that contain credit risk
related contingent features or requirements to post collateral. On an ongoing basis, the Company
monitors counterparty credit ratings. The Company considers credit non-performance risk to be low,
because the Company enters into agreements with commercial institutions that have at least an A (or
equivalent) credit rating. As of July&nbsp;3, 2011, the Company had notional amounts outstanding for
forward foreign exchange contracts and cross currency interest rate swaps of $23&nbsp;billion and $3
billion, respectively.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair
value of derivatives are recorded each period in current earnings or other comprehensive income,
depending on whether the derivative is designated as part of a hedge transaction, and if so, the
type of hedge transaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company entered into an option to hedge the currency
risk associated with the cash portion of the payment for the planned acquisition of Synthes, Inc.
The option was not designated as a hedge, and therefore, the change in the fair value of the option
of $102&nbsp;million was recognized as Other Income in the fiscal second quarter of 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The
designation as a cash flow hedge is made at the entrance date of the derivative contract. At
inception, all derivatives are expected to be highly effective. Changes in the fair value of a
derivative that is designated as a cash flow hedge and is highly effective are recorded in
accumulated other comprehensive income
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">until the underlying transaction affects earnings, and are
then reclassified to earnings in the same account as the hedged transaction. Gains/losses on net
investment hedges are accounted for through the currency translation account and are insignificant.
On an ongoing basis, the Company assesses whether each derivative continues to be highly effective
in offsetting changes in the cash flows of hedged items. If and when a derivative is no longer
expected to be highly effective, hedge accounting is discontinued. Hedge ineffectiveness, if any,
is included in current period earnings in other (income)/expense, net, and was not material for the
fiscal quarters ended July&nbsp;3, 2011 and July
4, 2010. Refer to Note 7 for disclosures of movements in Accumulated Other Comprehensive Income.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">As of July&nbsp;3, 2011, the balance of deferred net gains on derivatives included in accumulated other
comprehensive income was $228&nbsp;million after-tax. For additional information, see Note 7. The
Company expects that substantially all of the amounts related to foreign exchange contracts will be
reclassified into earnings over the next 12&nbsp;months as a result of transactions that are expected to
occur over that period. The maximum length of time over which the Company is hedging transaction
exposure is 18&nbsp;months excluding interest rate swaps. The amount ultimately realized in earnings
will differ as foreign exchange rates change. Realized gains and losses are ultimately determined
by actual exchange rates at maturity of the derivative.
</DIV>

<!-- xbrl,dn,"Schedule Of Derivative Instruments Gain Loss In Statement Of Financial Performance" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
the fiscal second quarters in 2011 and 2010:
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="28%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>reclassified</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>recognized in</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>from</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>recognized in</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Accumulated</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Accumulated OCI</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>other</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>OCI</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>into income</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>income/expense</B><SUP style="FONT-size: 85%; vertical-align: text-top">(2)</SUP></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">second</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">quarter</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Cash Flow Hedges</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(53</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(9</TD>
    <TD nowrap>)<SUB style="FONT-size: 85%; vertical-align: text-bottom">(A)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(20</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(102</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(44</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(76</TD>
    <TD nowrap>)<SUB style="FONT-size: 85%; vertical-align: text-bottom">(B)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(149</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">20</TD>
    <TD nowrap>&nbsp;<SUB style="FONT-size: 85%; vertical-align: text-bottom">(C)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(31</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(82</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(16</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">11</TD>
    <TD nowrap>&nbsp;<SUB style="FONT-size: 85%; vertical-align: text-bottom">(D)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>&nbsp;<SUB style="FONT-size: 85%; vertical-align: text-bottom">(E)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(158</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(40</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(54</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(133</TD>
    <TD nowrap>)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All amounts shown in the table above are net of tax.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
the first fiscal six months in 2011 and 2010:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="28%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>reclassified</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Gain/ (Loss)</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>recognized in</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>from</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>recognized in</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Accumulated</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>Accumulated OCI</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7"><B>other</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>OCI</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>into income</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><B>income/expense</B><SUP style="FONT-size: 85%; vertical-align: text-top">(2)</SUP></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Fiscal</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">six</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">months</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Cash Flow Hedges</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(84</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(10</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(29</TD>
    <TD nowrap>)<SUB style="FONT-size: 85%; vertical-align: text-bottom">(A)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(21</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">92</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(206</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(106</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(98</TD>
    <TD nowrap>)<SUB style="FONT-size: 85%; vertical-align: text-bottom">(B)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(154</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(8</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">21</TD>
    <TD nowrap>&nbsp;<SUB style="FONT-size: 85%; vertical-align: text-bottom">(C)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(40</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(49</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(18</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">11</TD>
    <TD nowrap>&nbsp;<SUB style="FONT-size: 85%; vertical-align: text-bottom">(D)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(59</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)<SUB style="FONT-size: 85%; vertical-align: text-bottom">(E)</SUB></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(185</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(118</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(96</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(139</TD>
    <TD nowrap>)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All amounts shown in the table above are net of tax.
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Effective portion</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Ineffective portion</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(A)</TD>
    <TD>&nbsp;</TD>
    <TD>Included in Sales to customers</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(B)</TD>
    <TD>&nbsp;</TD>
    <TD>Included in Cost of products sold</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(C)</TD>
    <TD>&nbsp;</TD>
    <TD>Included in Research and development expense</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(D)</TD>
    <TD>&nbsp;</TD>
    <TD>Included in Interest (income)/Interest expense, net</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(E)</TD>
    <TD>&nbsp;</TD>
    <TD>Included in Other (income)/expense, net</TD>
</TR>

</TABLE>
<!-- /xbrl,dn -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For the fiscal second quarters ended July&nbsp;3, 2011 and July&nbsp;4, 2010, a loss of $7&nbsp;million and $21
million, respectively, were recognized in Other (income)/expense, net, relating to foreign exchange
contracts not designated as hedging instruments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For the
first fiscal six months ended July&nbsp;3, 2011 and July&nbsp;4, 2010, a gain of $8&nbsp;million and a
loss of $69&nbsp;million, respectively, were recognized in Other (income)/expense, net, relating to
foreign exchange contracts not designated as hedging instruments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fair value is the exit price that would be received to sell an asset or paid to transfer a
liability. Fair value is a market-based measurement that is determined using assumptions that
market participants would use in pricing an asset or liability. The authoritative literature
establishes a three-level hierarchy to
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">prioritize the inputs used in measuring fair value. The
levels within the hierarchy are described below with Level 1 having the highest priority and Level
3 having the lowest.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The fair value of a derivative financial instrument (i.e. forward exchange contract or currency
swap) is the aggregation by currency of all future cash flows discounted to its present value at
the prevailing market interest rates and subsequently converted to the U.S. dollar at the current
spot foreign exchange rate. The Company does not believe that fair values of these derivative
instruments materially differ from the amounts that could be realized upon settlement or maturity,
or that the changes in fair value will have a material effect on the Company&#146;s results of
operations, cash flows or financial position. The Company also holds equity investments which are
classified as Level 1 because they are traded in an active exchange market. The Company did not
have any other significant financial assets or liabilities which would require revised valuations
under this standard that are recognized at fair value.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following three levels of inputs are used to measure fair value:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Level 1 &#151; Quoted prices in active markets for identical assets and liabilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Level 2 &#151; Significant other observable inputs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Level 3 &#151; Significant unobservable inputs.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->

<!-- xbrl,dn,"Schedule Of Derivative Instruments In Statement Of Financial Position Fair Value" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s significant financial assets and liabilities measured at fair value as of July&nbsp;3,
2011 and January&nbsp;2, 2011 were as follows:
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 0px solid #000000"><B>July 3, 2011</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>January 2, 2011</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 0px solid #000000">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Level 1</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Level 2</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Level 3</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Total</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Total</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Derivatives designated as hedging instruments:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Assets:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">487</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">487</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">321</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<SUP style="FONT-size: 85%; vertical-align: text-top">(2)</SUP></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Total</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">489</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">489</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">338</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Liabilities:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">646</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">646</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">586</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">502</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Total</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,050</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,050</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,088</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Derivatives not designated as hedging instruments:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Assets:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Swiss Franc Option*</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">569</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">569</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">597</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">597</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Liabilities:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign exchange contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Other Investments</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(4)</B></SUP></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,371</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,371</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,165</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Currency option related to the planned acquisition of Synthes, Inc.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>As of January&nbsp;2, 2011, these assets and liabilities are classified as Level 2 with the exception
of Other Investments of $1,165 which are classified as Level 1.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes $2&nbsp;million and $14&nbsp;million of non-current assets for July&nbsp;3, 2011 and January&nbsp;2, 2011,
respectively.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes $404&nbsp;million and $502&nbsp;million of non-current liabilities for July&nbsp;3, 2011 and January
2, 2011, respectively.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Classified as non-current other assets.</TD>
</TR>

</TABLE>
<!-- /xbrl,dn -->

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<!-- xbrl -->

<!-- xbrl,dn,"Fair Value By Balance Sheet Grouping" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Financial Instruments not measured at Fair Value:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following financial assets and liabilities are held at carrying amount on the consolidated
balance sheet as of July&nbsp;3, 2011:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">Carrying</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">Estimated</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">Amount</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" colspan="2">Fair Value</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Financial Assets</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Current Investments</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,299</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,299</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Government securities and obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23,951</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23,951</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Corporate debt securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">515</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">515</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Money market funds</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,820</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,820</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Time deposits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,097</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,097</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total cash, cash equivalents and current marketable securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">29,682</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29,682</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD colspan="9" align="left">Fair value of government securities and
obligations and non-current marketable
securities was estimated using quoted broker prices
in active
markets.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Financial Liabilities</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Current Debt</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">5,046</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,046</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Non-Current Debt</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2012</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">599</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">632</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">0.70% Notes due 2013</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">503</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3.80% Debentures due 2013</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">527</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3&nbsp;month LIBOR&#043;0% FRN due 2013</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3&nbsp;month LIBOR&#043;0.09% FRN due 2014</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">750</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">1.20% Notes due 2014</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">999</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,006</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2.15% Notes due 2016</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">898</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">903</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.55% Debentures due 2017</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,161</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2018</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">898</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,015</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">4.75% Notes due 2019 (1B Euro 1.4476)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,440</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,569</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3% Zero Coupon Convertible Subordinated Debentures due in 2020</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">197</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">246</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2.95% Debentures due 2020</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">541</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">522</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3.55% Notes due 2021</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">446</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">456</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6.73% Debentures due 2023</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">250</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">323</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.50% Notes due 2024 (500 GBP1.6025)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">795</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">856</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6.95% Notes due 2029</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">294</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">375</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">4.95% Debentures due 2033</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">523</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.95% Notes due 2037</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">995</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,120</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">5.86% Debentures due 2038</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">700</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">773</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">4.50% Debentures due 2040</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">539</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">489</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">4.85% Notes due 2041</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">298</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">291</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other (Includes Industrial Revenue Bonds)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total Non-Current Debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">13,680</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14,581</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The weighted average effective rate on non-current debt is 4.08%.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fair value of the non-current debt was estimated using market prices, which were corroborated by
quoted broker prices in active markets.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 5 &#151; INCOME TAXES
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The worldwide effective income tax rates for the first fiscal six months of 2011 and 2010 were
21.2% and 24.0%, respectively. The lower effective tax rate was due to higher income in lower tax
jurisdictions and the U.S. Research and Development tax credit, which was not in effect for the
first fiscal six months of 2010. Additionally, in 2010 the Company had litigation gains in high tax
jurisdictions.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->


<!-- xbrl,n -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">NOTE 6 &#151; PENSIONS AND OTHER POSTRETIREMENT BENEFITS
</DIV>
<!-- xbrl,body -->

<!-- xbrl,dn,"Schedule Of Net Benefit Costs Table" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Components of Net Periodic Benefit Cost
Net periodic benefit cost for the Company&#146;s defined benefit retirement plans and other benefit
plans for the fiscal second quarters of 2011 and 2010 include the following components:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="52%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Service cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">144</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">121</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">214</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">194</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expected return on plan assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(277</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(248</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Recognized actuarial losses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net periodic benefit cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">181</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">130</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">94</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">94</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Net periodic benefit cost for the Company&#146;s defined benefit retirement plans and other benefit
plans for the first fiscal six months of 2011 and 2010 include the following components:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="52%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Service cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">287</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">247</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">74</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">427</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">394</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">94</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expected return on plan assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(555</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(500</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Recognized actuarial losses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">194</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">117</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net periodic benefit cost</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">358</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">265</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">189</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">189</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company Contributions<BR>
For the fiscal six months ended July&nbsp;3, 2011, the Company contributed $119&nbsp;million and $16&nbsp;million
to its U.S. and international retirement plans, respectively. The Company plans to continue to fund
its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International
plans are funded in accordance with local regulations.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 7 &#151; ACCUMULATED OTHER COMPREHENSIVE INCOME
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Total comprehensive income for the fiscal six months ended July&nbsp;3, 2011 was $8.6&nbsp;billion, compared
with $5.3&nbsp;billion for the same period a year ago. Total comprehensive income for the fiscal second
quarter ended July&nbsp;3, 2011 was $3.6&nbsp;billion, compared with $1.6&nbsp;billion for the same period a year
ago. Total comprehensive income included net earnings, net unrealized currency gains and losses on
translation, net unrealized gains and losses on securities available for sale, adjustments related
to employee benefit plans, and net gains and losses on derivative instruments qualifying and
designated as cash flow hedges. The following table sets forth the components of accumulated other
comprehensive income.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<!-- xbrl,dn,"Schedule Of Accumulated Other Comprehensive Income Loss Table" -->
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Accum</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Other</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Foreign</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Securities</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Deriv.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Comp.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Gains/(Losses)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Available</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Benefit</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&#038;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Income/</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Translation</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">for sale</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Plans</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Hedges</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">(Loss)</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">January&nbsp;2, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">(969</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,686</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3,531</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">2011 six months change</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Unrealized gain (loss)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">435</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Net amount reclassed to net earnings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(139</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">116</TD>
    <TD nowrap>*</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net six months change</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,787</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">296</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">128</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">128</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,339</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">July&nbsp;3, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">818</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">320</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,558</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">228</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,192</TD>
    <TD nowrap>)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Substantially offset in net earnings by changes in value of the underlying transactions.</TD>
</TR>

</TABLE>
<!-- /xbrl,dn -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Amounts in accumulated other comprehensive income are presented net of the related tax impact.
Foreign currency translation adjustments are not currently adjusted for income taxes as they relate
to permanent investments in international subsidiaries.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 8 &#151; EARNINGS PER SHARE
</DIV>

<!-- xbrl,body -->

<!-- xbrl,dn,"Schedule Of Earnings Per Share Reconciliation Table_#1" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
for the fiscal second quarters ended July&nbsp;3, 2011 and July&nbsp;4, 2010.
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic net earnings per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.01</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Average shares outstanding &#151; basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,740.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,756.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">168.9</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">175.5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(131.7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(139.7</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Convertible debt shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Average shares outstanding &#151; diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,781.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,796.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diluted earnings per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1.23</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for both fiscal second quarters ended July&nbsp;3, 2011 and
July&nbsp;4, 2010 included the dilutive effect of convertible debt that was offset by the related
reduction in interest expense.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for the fiscal second quarters ended July&nbsp;3, 2011 and
July&nbsp;4, 2010, excluded 51&nbsp;million and 68&nbsp;million shares, respectively, related to stock options,
as the exercise price of these options was greater than their average market value, which would
result in an anti-dilutive effect on diluted earnings per share.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->


<!-- xbrl,dn,"Schedule Of Earnings Per Share Reconciliation Table_#2" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
for the fiscal six months ended July&nbsp;3, 2011 and July&nbsp;4, 2010.
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic net earnings per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.89</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Average shares outstanding &#151; basic</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,739.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,755.7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">168.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">175.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(133.9</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(138.6</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Convertible debt shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Average shares outstanding &#151; diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,778.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,796.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diluted earnings per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.25</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2.85</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for both the fiscal six months ended July&nbsp;3, 2011 and
July&nbsp;4, 2010 included the dilutive effect of convertible debt that was offset by the related
reduction in interest expense.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for the fiscal six months ended July&nbsp;3, 2011 and July&nbsp;4,
2010 excluded 52&nbsp;million and 68&nbsp;million shares related to stock options, as the exercise price of
these options was greater than their average market value, which would result in an anti-dilutive
effect on diluted earnings per share.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 9 &#151; SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS
</DIV>

<!-- xbrl,body -->

<!-- xbrl,dn,"Sales By Segment Of Business Table" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">SALES BY SEGMENT OF BUSINESS
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consumer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,339</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,463</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(8.5</TD>
    <TD nowrap>)%</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,454</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,184</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,793</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,647</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Pharmaceutical</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,239</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,110</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,994</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,443</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,233</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,553</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,869</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,865</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,702</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,265</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,571</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,130</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Worldwide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,447</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,438</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,150</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,892</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15.9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">16,597</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,330</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">8.3</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consumer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,684</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,023</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(11.2</TD>
    <TD nowrap>)%</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,791</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,390</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,475</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,413</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Pharmaceutical</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,630</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,316</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,662</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,875</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,292</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11,191</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,741</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,751</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.2</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,262</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,606</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13,003</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,357</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Worldwide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,055</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,090</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.2</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">International</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,715</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,871</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">32,770</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">30,961</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.8</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<!-- xbrl,dn,"Schedule Of Segment Reporting Information By Segment" -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">OPERATING PROFIT BY SEGMENT OF BUSINESS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consumer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">549</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">669</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(17.9</TD>
    <TD nowrap>)%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,714</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,833</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(6.5</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,275</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,876</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(32.0</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Segments operating profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,538</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,378</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(19.2</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(116</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(158</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Worldwide income before taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,422</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">4,220</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(18.9</TD>
    <TD nowrap>)%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Consumer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,122</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,454</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(22.8</TD>
    <TD nowrap>)%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,923</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,803</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,219</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,578</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(42.3</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Segments operating profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,264</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,835</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(23.7</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(332</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(335</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Worldwide income before taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,932</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">10,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(24.5</TD>
    <TD nowrap>)%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes litigation expense of $290&nbsp;million and $540&nbsp;million recorded in the fiscal second
quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011
includes a gain related to the Company&#146;s earlier investment in Crucell recorded in the fiscal first
quarter of 2011. The fiscal second quarter and the first fiscal six
months of 2010, includes net litigation expense of $115&nbsp;million and $202&nbsp;million, respectively.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes restructuring expense of $676&nbsp;million recorded in the fiscal second quarter and first
fiscal six months of 2011. Includes litigation expense and additional DePuy ASR&#153; Hip recall costs
of $127&nbsp;million recorded in the fiscal second quarter of 2011. Includes litigation expense and
additional DePuy ASR&#153; Hip recall costs of $223&nbsp;million recorded in the first fiscal six months of
2011. Includes net litigation expense of $42&nbsp;million and income of $1,542&nbsp;million recorded in the
fiscal second quarter and the first fiscal six months of 2010, respectively.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Amounts not allocated to segments include interest income/(expense), non-controlling interests
and general corporate income/(expense).</TD>
</TR>

</TABLE>
<!-- /xbrl,dn -->

<!-- xbrl,dn,"Sale By Geographic Area Table" -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">SALES BY GEOGRAPHIC AREA
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,447</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,438</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Europe</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,543</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,832</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,543</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,375</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,064</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,685</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">16,597</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,330</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">8.3</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Percent</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,055</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,090</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(0.2</TD>
    <TD nowrap>)%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Europe</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,726</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,934</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,979</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,655</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,010</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,282</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">32,770</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">30,961</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.8</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<!-- /xbrl,dn -->

<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 10&#151; BUSINESS COMBINATIONS AND DIVESTITURES
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company entered into a definitive agreement to
acquire Synthes, Inc. for approximately
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">$21.3&nbsp;billion, approximately $19.3&nbsp;billion net of cash
acquired, subject to the terms of the merger agreement and currency values at the time of closing.
Under the terms of the agreement, each share of Synthes common stock, subject to certain
conditions, will be exchanged for approximately 35% in cash and 65%
in Johnson &#38; Johnson common
stock. Synthes, Inc. is a premier global developer and manufacturer of orthopaedics devices.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company acquired substantially all of the outstanding
equity of Crucell N.V. that it did not already own. Crucell is a global biopharmaceutical company
focused on the research and development, production and marketing of vaccines and antibodies
against infectious disease worldwide. The net purchase price of $2.0&nbsp;billion was allocated
primarily to non-amortizable intangible assets for $1.0&nbsp;billion, amortizable intangible assets for
$0.7&nbsp;billion and goodwill for $0.5&nbsp;billion.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2010, the Company acquired RespiVert Ltd., a privately held
drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of
pulmonary diseases.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2010, the Company acquired Acclarent, Inc., a medical technology
company dedicated to designing, developing and commercializing devices that address conditions
affecting the ear, nose and throat, for a net purchase price of $0.8&nbsp;billion. The purchase price
for the acquisition was allocated primarily to amortizable intangible assets for $0.7&nbsp;billion.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 11 &#151; LEGAL PROCEEDINGS
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Johnson &#038; Johnson (the Company) and certain of its subsidiaries are involved in various lawsuits
and claims regarding product liability, intellectual property, commercial and other matters;
governmental investigations; and other legal proceedings that arise from time to time in the
ordinary course of their business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company records accruals for such contingencies when it is probable that a liability will be
incurred and the amount of the loss can be reasonably estimated. Through the period ended July&nbsp;3,
2011, the Company has determined that the liabilities associated with certain litigation matters
are probable and can be reasonably estimated. The Company has accrued for these matters and will
continue to monitor each related legal issue and adjust accruals for new information and further
developments in accordance with ASC 450-20-25. For these and other litigation and regulatory
matters currently disclosed for which a loss is probable or reasonably possible, the Company is
unable to determine an estimate of the possible loss or range of loss beyond the amounts already
accrued. These matters can be affected by various factors, including damages sought in the
proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced
or is not complete; proceedings are in early stages; matters present legal uncertainties; there are
significant facts in dispute; there are numerous parties involved.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In the Company&#146;s opinion, based on its examination of these matters, its experience to date and
discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in
the Company&#146;s balance sheet, is not expected to have a material adverse effect on the Company&#146;s
financial position, although the resolution in any reporting period of one or more of these
matters, either alone or in the aggregate, may have a material adverse effect on the Company&#146;s
results of operations, and cash flows for that period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>PRODUCT LIABILITY</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s subsidiaries are involved in numerous product liability cases in the United States,
many of which concern alleged adverse reactions to drugs and medical devices. The damages claimed
are substantial, and while the Company&#146;s subsidiaries are confident of the adequacy of the warnings
and instructions for use that accompany such products, it is not feasible to predict the ultimate
outcome of litigation. The Company has established product liability reserves based on currently
available information, which in some cases may be limited, and changes to the reserves may be
required in the future as additional information becomes available.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Multiple products of the Company&#146;s subsidiaries are subject to numerous product liability claims
and lawsuits. There are a significant number of claimants who have pending lawsuits or claims
regarding injuries allegedly due to ORTHO EVRA&#174;, RISPERDAL&#174;, LEVAQUIN&#174;, DURAGESIC&#174;/fentanyl
patches, pelvic meshes, the CHARIT&#201;&#153; Artificial Disc, CYPHER&#174; Stent, and ASR&#153; Hip. These claimants
seek substantial compensatory and, where available, punitive damages.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In August&nbsp;2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR&#153;
XL Acetabular System and DePuy ASR&#153; Hip Resurfacing System used in hip replacement surgery. Claims
for personal injury have been made against DePuy and the Company. The Company has received limited
information to date with respect to potential claims and other costs associated with this recall.
The Company&#146;s product liability reserve has been increased in part due to an increase in
anticipated product liability litigation expense and costs associated with the DePuy ASR&#153; Hip
recall program. Changes to the reserve may be required in the future as additional information
becomes available. The ultimate resolution of these matters is not
expected to have a material adverse effect on the Company&#146;s
financial position, although  the resolution in any reporting period
could have a material impact on the Company&#146;s results of
operations and cash flows for that period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>INTELLECTUAL PROPERTY</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Certain of the Company&#146;s subsidiaries are subject, from time to time, to legal proceedings and
claims related to patent, trademark and other intellectual property matters arising out of their
business. The most significant of these matters are described below.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="FONT-variant: SMALL-CAPS"><U>PATENT INFRINGEMENT</U></FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Certain of the Company&#146;s subsidiaries are involved in lawsuits challenging the coverage and/or
validity of the patents on their products. Although the Company&#146;s subsidiaries believe that they
have substantial defenses to these challenges with respect to all material patents, there can be no
assurance as to the outcome of these matters, and a loss in any of these cases could potentially
adversely affect the ability of the Company&#146;s subsidiaries to sell their products, or require the
payment of past damages and future royalties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">MEDICAL DEVICES &#038; DIAGNOSTICS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In October&nbsp;2004, Tyco Healthcare Group, LP, (Tyco) and U.S. Surgical Corporation filed a lawsuit
against Ethicon Endo-Surgery, Inc. (EES)&nbsp;in the United States District Court for the District of
Connecticut alleging that several features of EES&#146;s HARMONIC&#174; scalpel infringed four
Tyco patents. In October&nbsp;2007, on motions for summary judgment prior to the initial trial, a number
of claims were found invalid and a number were found infringed. However, no claim was found both
valid and infringed. Trial commenced in December&nbsp;2007, and the court dismissed the case without
prejudice on grounds that Tyco did not own the patents in suit. The dismissal without prejudice was
affirmed on appeal. In January&nbsp;2010, Tyco filed another complaint in the United States District
Court for the District of Connecticut asserting infringement of three of the four patents from the
previous lawsuit and adding new products. Tyco is seeking monetary damages and injunctive relief.
This case is scheduled to be tried in October&nbsp;2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in March&nbsp;2006, Cordis Corporation (Cordis) filed patent infringement lawsuits in the
United States District Courts for the Districts of New Jersey and Delaware, against Guidant
Corporation (Guidant), Abbott Laboratories, Inc. (Abbott), Boston Scientific Corporation (Boston
Scientific) and Medtronic Ave, Inc. (Medtronic) alleging that the Xience V&#153; (Abbott), Promus&#153;
(Boston Scientific) and Endeavor&#174; (Medtronic) drug eluting stents infringe several of Cordis&#146;s
Wright/Falotico patents. Cordis is seeking monetary relief. In January&nbsp;2010, in one of the cases
against Boston Scientific, the United States District Court for the District of Delaware found the
Wright/Falotico patents invalid for lack of written description and/or lack of enablement. In June
2011, the Court of Appeals for the Federal Circuit affirmed the ruling, and Cordis moved for the
Court to reconsider that decision.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In October&nbsp;2007, Bruce Saffran (Saffran) filed a patent infringement lawsuit against the Company
and Cordis in the United States District Court for the Eastern District of Texas alleging
infringement on U.S. Patent No.&nbsp;5,653,760. In January&nbsp;2011, a jury returned a verdict finding that
Cordis&#146;s sales of its CYPHER&#174; stent willfully infringed a patent issued to Saffran. The jury
awarded Saffran $482&nbsp;million. In March&nbsp;2011, the Court entered judgment against Cordis in the
amount of $593&nbsp;million, representing the jury verdict, plus $111&nbsp;million in pre-judgment
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">interest.
Cordis has moved for the District Court to overturn the jury verdict and to vacate the judgment.
If that motion is denied, Cordis will appeal the judgment. Because the Company believes that the
potential for an unfavorable outcome is not probable, it has not established a reserve with respect
to the case.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In November&nbsp;2007, Roche Diagnostics Operations, Inc., et al. (Roche) filed a patent infringement
lawsuit against LifeScan, Inc. (LifeScan) in the United States District Court for the District of
Delaware, accusing LifeScan&#146;s entire OneTouch&#174; line of blood glucose monitoring systems of
infringement of two patents related to the use of microelectrode sensors. In September&nbsp;2009,
LifeScan obtained a favorable ruling on claim construction that precluded a finding of
infringement. The Court entered judgment against Roche in July&nbsp;2010 and Roche appealed. Briefing
on appeal issues has been completed. Oral argument will be held in
fall 2011. Roche is seeking
monetary damages and injunctive relief.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in February&nbsp;2008, Cordis filed patent infringement lawsuits in the United States District
Court for the District of New Jersey against Guidant, Abbott, Boston Scientific and Medtronic
alleging that the Xience V&#153; (Abbott), Promus&#153; (Boston Scientific) and Endeavor&#174; (Medtronic) drug
eluting stents infringe several of Wyeth&#146;s (now Pfizer Inc.) Morris patents, which have been
licensed to Cordis. Cordis is seeking monetary relief. Trial is scheduled for September&nbsp;2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In June&nbsp;2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit
against Johnson &#038; Johnson Vision Care, Inc. (JJVC)&nbsp;in the United States District Court for the
Eastern District of Texas alleging that JJVC&#146;s manufacture and sale of its ACUVUE ADVANCE&#174; and
ACUVUE&#174; OASYS&#153; HYDROGEL contact lenses infringe their U.S. Patent No.&nbsp;5,712,327 (the Chang patent).
Rembrandt is seeking monetary relief. The case is scheduled for trial in May&nbsp;2012.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">PHARMACEUTICAL
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In
April&nbsp;2007, Centocor, Inc. (Centocor) (now Janssen Biotech, Inc. (JBI)) filed a patent infringement lawsuit against Abbott Laboratories,
Inc. (Abbott) in the United States District Court for the Eastern District of Texas alleging that
Abbott&#146;s HUMIRA&#174; anti-TNF alpha product infringes Centocor&#146;s U.S. Patent 7,070,775. In June&nbsp;2009,
a jury returned a verdict finding the patent valid and infringed, and awarded JBI damages of
approximately $1.7&nbsp;billion. In February&nbsp;2011, the Court of Appeals reversed the June&nbsp;2009 decision
and the judgment of the District Court. JBI will file a petition for
review of the decision in the United
States Supreme Court.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In May&nbsp;2009, Abbott Biotechnology Ltd. (Abbott) filed a patent infringement lawsuit against
 Centocor (now JBI) in the United States District Court for
the District of Massachusetts alleging that SIMPONI&#174; infringes Abbott&#146;s U.S. Patent Nos. 7,223,394
and 7,451,031 (the Salfeld patents). Abbott is seeking monetary damages and injunctive relief. No
trial date has been set.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In August&nbsp;2009, Abbott GmbH &#038; Co. (Abbott GmbH) and Abbott Bioresearch Center filed a patent
infringement lawsuit against Centocor (now JBI) in the United States District Court for the
District of Massachusetts alleging that STELARA&#174; infringes two United States patents assigned to
Abbott GmbH. JBI filed a complaint in the United States District Court for the District of Columbia
for a declaratory judgment of non-infringement and invalidity of the Abbott GmbH patents, as well
as a Complaint for Review of a Patent Interference Decision that granted priority of invention on
one of the two asserted patents to Abbott GmbH. The
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">cases have been transferred from the District
of Columbia to the District of Massachusetts. Discovery in these cases is ongoing. No trial date
has been set. Also in August&nbsp;2009, Abbott GmbH and Abbott Laboratories Limited brought a patent
infringement lawsuit in The Federal Court of Canada alleging that STELARA&#174; infringes Abbott GmbH&#146;s
Canadian patent. The Canadian case is scheduled to be tried in October&nbsp;2012. In each of these
cases, Abbott is seeking monetary damages and injunctive relief.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In August&nbsp;2009, Bayer HealthCare LLC (Bayer) filed a patent infringement lawsuit against Centocor
Ortho Biotech Inc. (now JBI) in United States District Court for the District of Massachusetts
alleging that the manufacture and sale by JBI of SIMPONI&#174; infringes a Bayer patent relating to
human anti-TNF antibodies. In January&nbsp;2011, the court issued judgment dismissing Bayer&#146;s
infringement claims. Bayer appealed this ruling. In addition, in November&nbsp;2009, Bayer filed a
lawsuit under its European counterpart to these patents in Germany and the Netherlands. The court
in the Netherlands held the Dutch patent invalid and entered judgment in favor of JBI&#146;s European
affiliate, Janssen Biologics B.V. Bayer appealed that judgment in the Netherlands. In addition,
in March&nbsp;2010, Janssen-Cilag NV filed a revocation action in the High Court in London seeking to
invalidate Bayer&#146;s UK patent relating to human anti-TNF antibodies. In May&nbsp;2011, JBI settled all
of these cases and received a paid-up, royalty-free license to the family of patents in suit.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>LITIGATION AGAINST FILERS OF ABBREVIATED NEW DRUG APPLICATIONS (ANDAs)</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following summarizes lawsuits pending against generic companies that filed Abbreviated New Drug
Applications (ANDAs) seeking to market generic forms of products sold by various subsidiaries of
the Company prior to expiration of the applicable patents covering those products. These ANDAs
typically include allegations of non-infringement, invalidity and unenforceability of these
patents. In the event the Company&#146;s subsidiaries are not successful in these actions, or the
statutory 30-month stays expire before the District Court rulings are obtained, the third-party
companies involved will have the ability, upon approval of the United States Food and Drug
Administration (FDA), to introduce generic versions of the products at issue resulting in very
substantial market share and revenue losses for those products.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">CONCERTA&#174;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In January&nbsp;2010, ALZA Corporation (ALZA)&nbsp;and Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI)
(now Janssen Pharmaceuticals, Inc. (JPI)) filed a patent infringement lawsuit in the United States
District Court for the District of Delaware against Kremers-Urban, LLC and KUDCO Ireland, Ltd.
(collectively, KUDCO) in response to KUDCO&#146;s ANDA seeking approval to market a generic version of
CONCERTA&#174; before the expiration of two of ALZA and JPI&#146;s patents relating to CONCERTA&#174;. KUDCO filed
counterclaims alleging non-infringement and invalidity. ALZA and JPI subsequently removed one of
the patents from the lawsuit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In November&nbsp;2010, ALZA and OMJPI (now JPI) filed a patent infringement lawsuit in the United States
District Court for the District of Delaware against Impax Laboratories, Inc. (Impax), Teva
Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. (collectively, Teva) in response
to Impax and Teva&#146;s filing of a major amendment to its ANDA seeking approval to market a generic
version of CONCERTA&#174; before the expiration of ALZA and JPI&#146;s patent relating to CONCERTA&#174;. Impax
and Teva filed counterclaims alleging non-infringement and invalidity. In May&nbsp;2011, Alza and JPI
filed a second lawsuit against Teva in response to Teva&#146;s filing of a second major amendment to its
ANDA seeking approval to market additional dosage strengths of its generic CONCERTA&#174; product before
the expiration of Alza and JPI&#146;s patent relating to CONCERTA&#174;. In each of the above cases, ALZA and
JPI are seeking an Order enjoining the defendants from marketing its generic version of CONCERTA&#174;
prior to the expiration of ALZA and JPI&#146;s CONCERTA&#174; patent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">ORTHO TRI-CYLEN&#174;LO
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In October&nbsp;2008, OMJPI (now JPI) and Johnson &#038; Johnson Pharmaceutical Research &#038; Development,
L.L.C. (JJPRD)&nbsp;filed a patent infringement lawsuit against Watson Laboratories, Inc. and Watson
Pharmaceuticals, Inc. (collectively, Watson) in the United States District Court for the District
of New Jersey in response to Watson&#146;s ANDA seeking approval to market a generic version of JPI&#146;s
product prior to the expiration of JPI&#146;s patent relating to ORTHO TRI-CYCLEN&#174; LO (the OTCLO
patent). Watson filed a counterclaim alleging invalidity of the patent. In addition, in January
2010, JPI filed a patent infringement lawsuit against Lupin Ltd. and Lupin Pharmaceuticals, Inc.
(collectively, Lupin) in the United States District Court for the District of New Jersey in
response to Lupin&#146;s ANDA seeking approval to market a generic version of ORTHO TRI-CYCLEN&#174; LO prior
to the expiration of the OTCLO patent. Lupin filed a counterclaim alleging invalidity of the
patent. The Lupin and Watson cases have been consolidated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In November&nbsp;2010, OMJPI (now JPI) filed a patent infringement lawsuit against Mylan Inc. and Mylan
Pharmaceuticals, Inc. (collectively, Mylan), and Famy Care, Ltd. (Famy Care) in the United States
District Court for the District of New Jersey in response to Famy Care&#146;s ANDA seeking approval to
market a generic version of ORTHO TRI-CYCLEN&#174; LO prior to the expiration of the OTCLO patent.
Mylan and Famy Care filed counterclaims alleging
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">invalidity of the patent. In each of the above
cases, JJPRD and/or JPI are seeking an Order enjoining the defendants from marketing their generic
versions of ORTHO TRI-CYLCEN&#174; LO before the expiration of the OTCLO patent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">PREZISTA&#174;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In November&nbsp;2010, Tibotec, Inc. and Tibotec Pharmaceuticals, Inc. (collectively, Tibotec) filed a
patent infringement lawsuit against Lupin, Ltd., Lupin Pharmaceuticals, Inc. (collectively, Lupin),
Mylan, Inc. and Mylan Pharmaceuticals, Inc. (collectively, Mylan) in the United States District
Court for the District of New Jersey in response to Lupin&#146;s and Mylan&#146;s respective ANDA&#146;s seeking
approval to market generic versions of Tibotec&#146;s PREZISTA&#174; product before the expiration of
Tibotec&#146;s patent relating to PREZISTA&#174;. Lupin and Mylan each filed counterclaims alleging
non-infringement and invalidity.

In July&nbsp;2011,
Tibotec filed another patent infringement lawsuit against Lupin in the United States
District Court for the District of New Jersey in response to Lupin&#146;s supplement to its ANDA to add
new dosage strengths for its proposed product.

In August&nbsp;2011, Tibotec and G.D. Searle &#038; Company (G.D. Searle)
filed a patent infringement lawsuit against Lupin and Mylan in response to their notice letters
advising that their ANDAs are seeking approval to market generic versions of Tibotec&#146;s PREZISTA&#174;
product before the expiration of two patents relating to PREZISTA&#174; that Tibotec exclusively
licenses from G.D. Searle.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In March&nbsp;2011, Tibotec and G.D. Searle  filed a patent infringement lawsuit
against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Ltd. (collectively, Teva) in the
United States District Court for the District of New Jersey in response to Teva&#146;s ANDA seeking
approval to market a generic version of PREZISTA&#174; before the expiration of certain patents relating
to PREZISTA&#174; that Tibotec either owns or exclusively licenses from G.D. Searle.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In March&nbsp;2011, Tibotec filed a patent infringement lawsuit against Hetero Drugs, Ltd. Unit III and
Hetero USA Inc. (collectively, Hetero) in the United States District Court for the District of New
Jersey in response to Hetero&#146;s ANDA seeking approval to market a generic version of PREZISTA&#174;
before the expiration of certain patents relating to PREZISTA&#174; that Tibotec exclusively licenses
from G.D. Searle.
In July 2011, upon agreement by the parties, the Court entered a stay of the lawsuit pending a final decision
in the lawsuit  against Teva with respect to the validity and/or enforceability
of the patents that Tibotec licenses from G.D. Searle, with Hetero agreeing to be bound by such final decision.


 In each of the above lawsuits, Tibotec is seeking an Order enjoining the
defendants from marketing their generic versions of PREZISTA&#174; before the expiration of the relevant
patents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>OTHER INTELLECTUAL PROPERTY MATTERS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In September&nbsp;2009, Centocor Ortho Biotech Products, L.P. (now Janssen Products, LP (JPLP))
intervened in an inventorship lawsuit filed by the University of Kansas Center for Research, Inc.
(KUCR)&nbsp;against the United States of America (USA)&nbsp;in the United States District Court for the
District of Kansas. KUCR alleges that two KUCR scientists should be added as inventors on two
USA-owned patents relating to VELCADE&#174;. The USA licensed the patents
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(and their foreign
counterparts) to Millennium Pharmaceuticals, Inc. (MPI), who in turn sublicensed the patents (and
their foreign counterparts) to JPLP for commercial marketing outside the United States. In July
2010, the parties reached a settlement agreement to resolve the disputes in this case and will
submit the inventorship issue to arbitration. The case has been stayed pending the arbitration. As
a result of the settlement agreement, the outcome of the arbitration regarding inventorship will
determine whether pre-specified payments will be made to KUCR, but will not affect JPLP&#146;s right to
market VELCADE&#174;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In December&nbsp;2009, the State of Israel filed a lawsuit in the District Court in Tel Aviv Jaffa
against various affiliates of Omrix Biopharmaceuticals, Inc. (Omrix). In the lawsuit, the State
claims that an employee of a government-owned hospital was the inventor on several patents related
to fibrin glue technology that the employee developed while he was a government employee. The State
claims that he had no right to transfer any intellectual property to Omrix because it belongs to
the State. The State is seeking damages plus royalties on QUIXIL&#153; and EVICEL&#153; or, alternatively,
transfer of the patents to the State.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In January&nbsp;2011, Genentech, Inc. (Genentech) initiated an arbitration against UCB Celltech
(Celltech) seeking damages for allegedly cooperating with Centocor (now JBI) to improperly
terminate a prior agreement in which JBI was sublicensed under Genentech&#146;s Cabilly patents. JBI
has an indemnity agreement with Celltech, and Celltech has asserted that JBI is liable for any
damages Celltech may be required to pay Genentech in that arbitration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>GOVERNMENT PROCEEDINGS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Like other companies in the pharmaceutical and medical devices and diagnostics industries, the
Company and certain of its subsidiaries are subject to extensive regulation by national, state and
local government agencies in the United States and other countries in which they operate. As a
result, interaction with government agencies is ongoing. The most significant litigation brought
by, and investigations conducted by, government agencies are listed below. It is possible that
criminal charges and substantial fines and/or civil penalties or damages could result from
government investigations or litigation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>AVERAGE WHOLESALE PRICE (AWP)&nbsp;LITIGATION</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company and several of its pharmaceutical subsidiaries (the J&#038;J AWP defendants), along with
numerous other pharmaceutical companies, are defendants in a series of lawsuits in state and
federal courts involving allegations that the pricing and marketing of certain pharmaceutical
products amounted to fraudulent and otherwise actionable conduct because, among other things, the
companies allegedly reported an inflated Average Wholesale Price (AWP)&nbsp;for the drugs at issue.
Payors alleged that they used those AWPs in calculating provider reimbursement levels.
Many of these cases, both federal actions and state actions
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">removed to federal court, were
consolidated for pre-trial purposes in a Multi-District Litigation (MDL)&nbsp;in the United States
District Court for the District of Massachusetts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The plaintiffs in these cases included three classes of private persons or entities that paid for
any portion of the purchase of the drugs at issue based on AWP, and state government entities that
made Medicaid payments for the drugs at issue based on AWP. In June&nbsp;2007, after a trial on the
merits, the MDL Court dismissed the claims of two of the plaintiff classes against the J&#038;J AWP
defendants from the case regarding all claims of Classes 2 and 3. In March&nbsp;2011, the Court
dismissed the claims of the third class against the J&#038;J AWP defendants without prejudice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AWP cases brought by various Attorneys General have proceeded to trial against other manufacturers.
Three state cases against certain of the Company&#146;s subsidiaries have been set for trial: Idaho in
October&nbsp;2011, Kentucky in January&nbsp;2012 and Kansas in March&nbsp;2013. Other state cases are likely to
be set for trial. In addition, an AWP case against the J&#038;J AWP defendants brought by the
Commonwealth of Pennsylvania was tried in Commonwealth Court in October and November&nbsp;2010. The
Court found in the Commonwealth&#146;s favor with regard to certain of its claims under the Pennsylvania
Unfair Trade Practices and Consumer Protection Law, entered an injunction, and awarded $45&nbsp;million
in restitution and $6.5&nbsp;million in civil penalties. The Court found in the J&#038;J AWP defendants&#146;
favor on the Commonwealth&#146;s claims of unjust enrichment, misrepresentation/fraud, civil conspiracy,
and on certain of the Commonwealth&#146;s claims under the Pennsylvania Unfair Trade Practices and
Consumer Protection Law. The parties are currently awaiting a ruling on post trial motions, which,
if necessary, will be followed by an appeal to the Pennsylvania Supreme Court. The Company
believes that it has strong arguments supporting an appeal. Because the Company believes that the
potential for an unfavorable outcome is not probable, it has not established a reserve with respect
to the verdict.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>RISPERDAL&#174;</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In January&nbsp;2004, Janssen Pharmaceutica Inc. (Janssen) (now Janssen Pharmaceuticals, Inc. (JPI))
received a subpoena from the Office of the Inspector General of the United States Office of
Personnel Management seeking documents concerning sales and marketing of, any and all payments to
physicians in connection with sales and marketing of, and clinical trials for, RISPERDAL&#174; from 1997
to 2002. Documents subsequent to 2002 have also been requested by the Department of Justice. An
additional subpoena seeking information about marketing of, and adverse reactions to, RISPERDAL&#174;
was received from the United States Attorney&#146;s Office for the Eastern District of Pennsylvania in
November&nbsp;2005. Numerous subpoenas seeking testimony from various witnesses before a grand jury were
also received. JPI cooperated in responding to these requests for documents and witnesses. The
United States Department of Justice and the United States Attorney&#146;s Office for the Eastern
District of Pennsylvania (the Government) are continuing to actively pursue both criminal and civil
actions. In February&nbsp;2010, the Government served Civil Investigative Demands seeking additional
information
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">relating to sales and marketing of RISPERDAL&#174; and sales and marketing of INVEGA&#174;. The
focus of these matters is the alleged promotion of RISPERDAL&#174; and INVEGA&#174; for off-label uses. The
Government has notified JPI that there are also pending qui tam actions alleging off-label
promotion of RISPERDAL&#174;. The Government informed JPI that it will intervene in these qui tam
actions and file a superseding complaint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Discussions have been ongoing in an effort to resolve criminal penalties under the Food Drug and
Cosmetic Act related to the promotion of RISPERDAL&#174;. An
agreement in principal on key issues relevant
to a disposition of criminal charges pursuant to a single misdemeanor violation of the Food Drug
and Cosmetic Act has been reached, but certain issues remain open
before a settlement can be
finalized. The Company has adjusted the accrued amount in the second
quarter of 2011 to cover the financial component of the
proposed criminal settlement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In
addition, discussions with state and federal government representatives to resolve the separate
civil claims related to the marketing of RISPERDAL&#174; and INVEGA&#174;, including
those under the False Claims Act (the qui
tam actions), have been ongoing. The Company believes there are meritorious defenses to these
claims, and it remains unclear whether a settlement can be reached as discovery is not complete,
there are significant facts in dispute, the damages sought in the claims are unsubstantiated and
indeterminate, there are numerous parties involved, and possible outcomes are uncertain. For these
reasons, the Company is unable to estimate a range of loss. However, future negotiations may lead
to a narrowing of the areas of disagreement and the liability may then become reasonably estimable
in accordance with applicable accounting principles. If a negotiated resolution cannot be reached,
civil litigation relating to the allegations of off-label promotion of RISPERDAL&#174; and/or INVEGA&#174; is
likely. The ultimate resolution of the above criminal and these civil matters is not expected to
have a material adverse effect on the Company&#146;s financial position, although the resolution in any
reporting period could have a material impact on the Company&#146;s results of operations and cash flows
for that period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The
Attorneys General of multiple states, including Alaska, Arkansas,
Louisiana, Massachusetts, Mississippi, Montana, New Mexico,
Pennsylvania, South Carolina, Texas and Utah, have pending actions against Janssen (now JPI) seeking
one or more of the following remedies:
reimbursement of Medicaid or other
public funds for RISPERDAL&#174; prescriptions written for off-label use, compensation for treating
their citizens for alleged adverse reactions to RISPERDAL&#174;, civil fines or penalties, damages for
&#147;overpayments&#148; by the state and others, punitive damages,
or other relief relating to alleged unfair business practices.
Certain of these actions also seek injunctive relief relating to the
promotion of RISPERDAL&#174;. In the Texas matter, the Attorney General of
Texas has joined a qui tam action in that state seeking similar
relief, and the trial is scheduled to commence in late November&nbsp;2011.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Attorney General of West Virginia commenced suit in 2004 against Janssen (now JPI) based on
claims of alleged consumer fraud as to DURAGESIC&#174;, as well as RISPERDAL&#174;. JPI was found liable and
damages were assessed at $4.5&nbsp;million. JPI filed an appeal, and in November&nbsp;2010, the West
Virginia Supreme Court reversed the trial court&#146;s decision. In December&nbsp;2010, the Attorney General
of West Virginia dismissed the case as it related to RISPERDAL&#174; without any payment. Thereafter,
JPI settled the case insofar as it related to DURAGESIC&#174;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In 2004, the Attorney General of Louisiana filed a multi-count Complaint against Janssen (now JPI).
The Company was later added as a defendant. The case was tried in October&nbsp;2010. The issue tried
to the jury was whether the Company or JPI had violated the State&#146;s Medicaid Fraud Act (the Act)
through misrepresentations allegedly made in the mailing of a November&nbsp;2003 Dear Health Care
Provider letter. The jury returned a verdict that JPI and the Company had violated the Act and
awarded $257.7&nbsp;million in damages. The trial judge subsequently awarded the Attorney General
counsel fees and expenses in the amount of $73&nbsp;million. The Company and JPI&#146;s motion for a new
trial was denied. The Company and JPI have filed an appeal and believe that they have strong
arguments supporting the appeal. The Company believes that the potential for an unfavorable outcome
is not probable, and therefore, the Company has not established a reserve with respect to the
verdict.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In 2007, The Office of General Counsel of the Commonwealth of Pennsylvania filed a lawsuit against
Janssen (now JPI) on a multi-Count Complaint related to Janssen&#146;s sale of RISPERDAL&#174; to the
Commonwealth&#146;s Medicaid program. The trial occurred in June&nbsp;2010. The trial judge dismissed the
case after the close of the plaintiff&#146;s evidence. The Commonwealth&#146;s post-trial motions were
denied. The Commonwealth filed an appeal in April&nbsp;2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In 2007, the Attorney General of South Carolina filed a lawsuit against the Company and Janssen
(now JPI) on several counts. In March&nbsp;2011, the matter was tried on liability only, at which time
the lawsuit was limited to claims of violation of the South Carolina Unfair Trade Practice Act,
including, among others, questions of whether the Company or JPI engaged in unfair or deceptive
acts or practices in the conduct of any trade or commerce by distributing the November&nbsp;2003 &#147;Dear
Doctor&#148; letter or in their use of the FDA-approved label. The jury found in favor of the Company
and against JPI. In June&nbsp;2011, the Court awarded civil penalties of approximately $327.1&nbsp;million.
Post-trial briefing is underway, and if relief is not granted, JPI intends to appeal this judgment.
The Company and JPI believe that JPI has strong arguments supporting an appeal and that the
potential for an unfavorable outcome is not probable. Therefore, the Company has not established a
reserve with respect to the verdict.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Attorneys
General of approximately 40 other states have indicated a potential interest in pursuing similar
litigation against JPI, and have obtained a tolling agreement staying the running of the statute of
limitations while they pursue a coordinated civil investigation of JPI regarding potential consumer
fraud actions in connection with the marketing of
RISPERDAL&#174;.</div>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>MCNEIL CONSUMER HEALTHCARE</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in June&nbsp;2010, McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (McNeil Consumer
Healthcare), and certain
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> affiliates, including the Company (the Companies), received grand jury
subpoenas from the United States Attorney&#146;s Office for the Eastern District of Pennsylvania
requesting documents broadly relating to recent recalls of various products of McNeil Consumer
Healthcare, and the FDA inspections of the Fort Washington, Pennsylvania and Lancaster,
Pennsylvania manufacturing facilities. In addition, in February&nbsp;2011, the government served
McNEIL-PPC, Inc. (McNEIL-PPC) with a Civil Investigative Demand seeking records relevant to its
investigation to determine if there was a violation of the False Claims Act. The Companies are
cooperating with the United States Attorney&#146;s Office in responding to these subpoenas.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Companies have also received Civil Investigative Demands from multiple State Attorneys General
Offices broadly relating to the McNeil recall issues. The Companies continue to cooperate with
these inquiries. In January&nbsp;2011, the Oregon Attorney General filed a civil complaint against the
Company, McNEIL-PPC and McNeil Healthcare LLC in state court alleging civil violations of the
Oregon unlawful trade practices act relating to an earlier recall of a McNeil OTC product. The
Companies removed this case to federal court and have sought transfer of the case to the United
States District Court for the Eastern District of Pennsylvania. The Judicial Panel on
Multidistrict Litigation denied the transfer request, and the Companies moved for reconsideration
of the Panel&#146;s decision. Currently, the case has been stayed pending a final decision on transfer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In March&nbsp;2011, the United States filed a complaint for injunctive relief in the United States
District Court for the Eastern District of Pennsylvania against McNEIL-PPC and two of its
employees, alleging that McNEIL-PPC is in violation of FDA regulations regarding the manufacture of
drugs at the facilities it operates in Lancaster, Pennsylvania, Fort Washington, Pennsylvania, and
Las Piedras, Puerto Rico. On the same day, the parties filed a consent decree of permanent
injunction resolving the claims set forth in the complaint. The Court approved and entered the
consent decree on March&nbsp;16, 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The consent decree, which is subject to ongoing enforcement by the court, requires McNEIL-PPC to
take enhanced measures to remediate the three facilities. The Fort Washington facility, which the
company voluntarily shut down in April&nbsp;2010, will remain shut down until a third-party consultant
certifies that its operations will be in compliance with applicable law, and the FDA concurs with
the third party certification. The Lancaster and Las Piedras facilities may continue to
manufacture and distribute drugs, provided that a third party reviews manufacturing records for
selected batches of drugs released from the facilities, and certifies that any deviations reviewed
do not adversely affect the quality of the selected batches.
McNEIL-PPC must further submit a workplan (with deadlines) to the FDA for remediation of the
Lancaster and Las Piedras facilities; that plan is subject to FDA approval. After completion of
the workplan, third-party batch record review may cease if the FDA has stated that the facilities
appear to be in compliance with applicable law. Each facility is
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">subject to a five-year audit
period by a third party after the facility has been deemed by the FDA to be in apparent compliance
with applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>OMNICARE</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In September&nbsp;2005, the Company received a subpoena from the United States Attorney&#146;s Office,
District of Massachusetts, seeking documents related to the sales and marketing of eight drugs to
Omnicare, Inc. (Omnicare), a manager of pharmaceutical benefits for long-term care facilities. In
April&nbsp;2009, the Company and certain of its pharmaceutical subsidiaries were served in two civil qui
tam cases asserting claims under the Federal False Claims Act and related state law claims alleging
that the defendants provided Omnicare with rebates and other alleged kickbacks, causing Omnicare to
file false claims with Medicaid and other government programs. In January&nbsp;2010, the government
intervened in both of these cases, naming the Company, Ortho-McNeil-Janssen Pharmaceuticals, Inc.
(now Janssen Pharmaceuticals, Inc. (JPI)), and Johnson &#038; Johnson Health Care Systems Inc. as
defendants. Subsequently, the Commonwealth of Massachusetts, Virginia, and Kentucky, and the
States of California and Indiana intervened in the action. The defendants moved to dismiss the
Complaints, and in February&nbsp;2011, the United States District Court for the District of
Massachusetts dismissed one qui tam case entirely and dismissed the other case in part, rejecting
allegations that the defendants had violated its obligation to report its &#147;best price&#148; to health
care program officials. The defendants subsequently moved the Court to reconsider its decision not
to dismiss the second case in its entirety, which the Court denied in May&nbsp;2011. The claims of the
United States and individual states remain pending.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In November&nbsp;2005, a lawsuit was filed under seal by Scott Bartz, a former employee, in the United
States District Court for the Eastern District of Pennsylvania against the Company and certain of
its pharmaceutical subsidiaries (the J&#038;J Defendants), along with co-defendants McKesson Corporation
and Omnicare, Inc. The Bartz complaint raises many issues in common with the Omnicare-related
litigation discussed above already pending before the United States District Court for the District
of Massachusetts, such as best price and a number of kickback allegations. After investigation, the
United States declined to intervene. The case was subsequently unsealed in January&nbsp;2011. In
February&nbsp;2011, the plaintiff filed an amended complaint, which was placed under seal. Thereafter,
on the J&#038;J Defendants&#146; motion, the case was transferred to the United States District Court for the
District of Massachusetts, where it is currently pending. In April&nbsp;2011, the amended complaint was
ordered unsealed and alleges a variety of causes of action under the federal False Claims Act and
corresponding state and local statutes, including that the J&#038;J Defendants engaged in various
improper transactions that were allegedly designed to report false prescription drug prices to the
federal government in order to reduce the J&#038;J Defendant&#146;s Medicaid rebate obligations. The
complaint further alleges that the J&#038;J Defendants improperly retaliated against the plaintiff for
having raised these allegations internally. Bartz seeks multiple forms of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">relief, including damages
and reinstatement to a position with the same seniority status. The J&#038;J Defendants subsequently
moved to dismiss the complaint in May&nbsp;2011, which is currently scheduled for argument in August
2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>OTHER</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In July&nbsp;2003, Centocor, Inc. (now Janssen Biotech, Inc. (JBI)), received a request that it
voluntarily provide documents and information to the criminal division of the United States
Attorney&#146;s Office, District of New Jersey, in connection with its investigation into various JBI
marketing practices. Subsequent requests for documents have been received from the United States
Attorney&#146;s Office. Both the Company and JBI have responded to these requests for documents and
information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In July&nbsp;2005, Scios Inc. (Scios) received a subpoena from the United States Attorney&#146;s Office
for the District of Massachusetts, seeking documents related to the sales and marketing of NATRECOR&#174;. In
August&nbsp;2005, Scios was advised that the investigation would be handled by the United States
Attorney&#146;s Office for the Northern District of California in San Francisco. In February&nbsp;2009, two
qui tam complaints were unsealed in the United States District Court for the Northern District of
California, alleging, among other things, improper activities in the promotion of NATRECOR&#174;. In
June&nbsp;2009, the United States government intervened in one of the qui tam actions, and filed a
complaint against Scios and the Company seeking relief under the False Claims Act and asserting a
claim of unjust enrichment. The civil case is proceeding and discovery is ongoing. An
Information charging Scios with a misdemeanor violation of the Food Drug and Cosmetic Act has been filed by the government.
It is expected that a proposed settlement of that charge will be submitted to the court for approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In February&nbsp;2007, the Company voluntarily disclosed to the United States Department of Justice
(DOJ)&nbsp;and the United States Securities &#038; Exchange Commission (SEC)&nbsp;that subsidiaries outside the
United States are believed to have made improper payments in connection with the sale of medical
devices in two small-market countries, which payments may fall within the jurisdiction of the
Foreign Corrupt Practices Act (FCPA). In the course of continuing dialogues with the agencies,
other issues potentially rising to the level of FCPA violations in additional markets were brought
to the attention of the agencies by the Company. Law enforcement agencies of a number of other
countries are pursuing investigations of matters voluntarily disclosed by the Company to the DOJ
and SEC. In addition, in February&nbsp;2006, the Company received a subpoena from the SEC requesting
documents relating to the participation by several Company subsidiaries in the United Nations Iraq
Oil for Food Program. On April&nbsp;8, 2011, the Company resolved the FCPA
and Oil for Food matters through settlements with the DOJ, SEC and United Kingdom Serious Fraud
Office. These settlements required payments of approximately $78&nbsp;million in financial penalties. As
part of the settlement with the DOJ, the Company entered into a Deferred Prosecution Agreement that
requires the Company to complete a three-year term of enhanced compliance practices.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In April&nbsp;2007, the Company received two subpoenas from the Office of the Attorney General of the
State of Delaware. The subpoenas seek documents and information relating to nominal pricing
agreements. For purposes of the subpoenas, nominal pricing agreements are defined as agreements
under which the Company agreed to provide a pharmaceutical product for less than ten percent of the
Average Manufacturer Price for the product. The Company responded to these requests.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In May&nbsp;2007, the New York State Attorney General issued a subpoena to the Company seeking
information relating to the marketing, sale, reimbursement and safety of PROCRIT&#174;. The Company has
responded to the subpoena.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In June&nbsp;2008, the Company received a subpoena from the United States Attorney&#146;s Office for the
District of Massachusetts relating to the marketing of biliary stents by Cordis Corporation
(Cordis). Cordis is currently cooperating in responding to the subpoena. In addition, in January
2010, a complaint was unsealed in the United States District Court for the Northern District of
Texas seeking damages against Cordis for alleged violations of the federal False Claims Act and
several similar state laws in connection with the marketing of biliary stents. The United States
Department of Justice and several states have declined to intervene at this time. In April&nbsp;2011,
the District Court for the Northern District of Texas dismissed the complaint without prejudice.
</DIV>




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In May&nbsp;2009, the New Jersey Attorney General issued a subpoena to DePuy Orthopaedics, Inc., seeking
information regarding the financial interest of clinical investigators who performed clinical
studies for DePuy Orthopaedics, Inc. and DePuy Spine, Inc. DePuy Orthopaedics, Inc. has responded
to these requests.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In recent years the Company has received numerous requests from a variety of United States
Congressional Committees to produce information relevant to ongoing congressional inquiries. It is
the Company&#146;s policy to cooperate with these inquiries by producing the requested information.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>GENERAL LITIGATION</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In September&nbsp;2004, Plaintiffs, in an employment discrimination litigation initiated against the
Company in 2001 in the United States District Court for the District of New Jersey, moved to
certify a class of all African American and Hispanic salaried employees of the Company and its
affiliates in the United States, who were employed at any time from November&nbsp;1997 to the present.
Plaintiffs seek monetary damages for the period 1997 through the present (including punitive
damages) and equitable relief. The Court denied Plaintiffs&#146; class certification motion in December
2006 and their motion for reconsideration in April&nbsp;2007. Plaintiffs sought to appeal these
decisions and, in April&nbsp;2008, the Court of Appeals ruled that Plaintiffs&#146; appeal of the denial of
class certification was untimely. In July&nbsp;2009, Plaintiffs filed a motion for certification of a
modified class, which the Company opposed. The District Court denied Plaintiffs&#146; motion in July
2010, and the Court of Appeals denied Plaintiffs&#146; request for leave to appeal the denial of
certification of the modified class. In May&nbsp;2011, the case was dismissed with prejudice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in July&nbsp;2006, five lawsuits were filed in United States District Court for the District of
New Jersey by various employers and employee benefit plans and funds seeking to recover amounts
they paid for RISPERDAL&#174; for plan participants. In general, Plaintiffs allege that the Company and
certain of its pharmaceutical subsidiaries engaged in off-label marketing of RISPERDAL&#174; in
violation of the federal and New Jersey RICO statutes. In addition, Plaintiffs asserted various
state law claims. All of the cases were consolidated into one case seeking class action status, but
shortly thereafter, one action was voluntarily dismissed. In December&nbsp;2008, the Court dismissed the
actions of the four remaining plaintiffs. In April&nbsp;2010, those plaintiffs filed a new consolidated
class action against the Company and Janssen, L.P. (now Janssen Pharmaceuticals, Inc. (JPI)); and
in March&nbsp;2011, that action was dismissed. In April&nbsp;2011, one of those plaintiffs filed a notice of
appeal with the United States Court of Appeals for the Third Circuit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In April&nbsp;2009, Ortho-Clinical Diagnostics, Inc. (OCD)&nbsp;received a grand jury subpoena from the
United States Department of Justice, Antitrust Division, requesting documents and information for
the period beginning September&nbsp;1, 2000 through the present, pertaining to an investigation of
alleged violations of the antitrust laws in the blood reagents industry. OCD complied with the
subpoena. In February&nbsp;2011, OCD received a letter from the Antitrust Division indicating that it
had closed its investigation in November&nbsp;2010. In June&nbsp;2009, following the public announcement
that OCD had received a grand jury subpoena, multiple class action complaints seeking damages for
alleged price fixing were filed against OCD. The various cases were consolidated for pre-trial
purposes in the United States District Court for the Eastern District of Pennsylvania. Discovery
is ongoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In
May&nbsp;2009, Centocor Ortho Biotech Inc. (now Janssen Biotech, Inc.
(JBI)) commenced an arbitration
proceeding before the American Arbitration Association against Schering-Plough Corporation and its
subsidiary Schering-Plough (Ireland) Company (collectively, Schering-Plough). JBI and
Schering-Plough are parties to a series of agreements (Distribution
Agreements) that grant Schering-Plough the exclusive right to distribute the drugs REMICADE&#174; and
SIMPONI&#174; worldwide, except within the United States, Japan, Taiwan, Indonesia, and the People&#146;s
Republic of China (including Hong Kong). JBI distributes REMICADE&#174; and SIMPONI&#174;, the next
generation treatment, within the United States. In the arbitration, JBI sought a declaration that
the agreement and merger between Merck &#038; Co., Inc. (Merck) and Schering-Plough constituted a change
of control under the terms of the Distribution Agreements that permitted JBI to terminate the
Agreements. On April&nbsp;15, 2011, the Company, JBI and Merck announced an agreement to amend the
Distribution Agreements. This agreement concluded the arbitration proceeding.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Under the terms of the amended Distribution Agreements, effective July&nbsp;1, 2011, Merck&#146;s subsidiary,
Schering-Plough (Ireland) will relinquish exclusive marketing rights for REMICADE&#174; and SIMPONI&#174; to
the Company&#146;s Janssen pharmaceutical companies in territories including Canada, Central and South
America, the Middle East, Africa and Asia Pacific (relinquished territories). Note, in Japan,
Indonesia, and Taiwan, JBI will continue to license distribution rights to REMICADE&#174; and SIMPONI&#174;
to Mitsubishi Tanabe Pharma Corporation. Merck will retain exclusive marketing rights throughout
Europe, Russia and Turkey (retained territories). The retained territories represent approximately
70&nbsp;percent of Merck&#146;s 2010 revenue of approximately $2.8&nbsp;billion from REMICADE&#174; and SIMPONI&#174;, while
the relinquished territories represent approximately 30&nbsp;percent. In addition, beginning July&nbsp;1,
2011, all profit derived from Merck&#146;s exclusive distribution of the two products in the retained
territories will be equally divided between Merck and JBI. Under the prior terms of the
Distribution Agreements, the contribution income (profit)&nbsp;split, which was at 58&nbsp;percent to Merck
and 42&nbsp;percent to JBI, would have declined for Merck and increased for JBI each year until 2014,
when it would have been equally divided. JBI also received a one-time payment of $500&nbsp;million in
April&nbsp;2011, which will be amortized over the period of the agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In April&nbsp;2010, a putative class action lawsuit was filed in the United States District Court for
the Northern District of California by representatives of nursing home residents or their estates
against the Company, Omnicare, Inc. (Omnicare), and other unidentified companies or individuals.
In February&nbsp;2011, plaintiffs filed a second amended complaint asserting that certain rebate
agreements between the Company and Omnicare increased the amount of money spent on pharmaceuticals
by the nursing home residents and violated the Sherman Act and the California Business &#038;
Professions Code. The second amended complaint also asserts a claim of unjust enrichment.
Plaintiffs seek multiple forms of monetary and injunctive relief. The Company moved to dismiss the
second amended complaint in March&nbsp;2011. A hearing is set on the motion to dismiss for August&nbsp;2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in April&nbsp;2010, a number of shareholder derivative lawsuits were filed in the United States
District Court for the District of New Jersey against certain current and former directors and
officers of the Company. The Company is named as a nominal defendant. These actions were
consolidated on August&nbsp;17, 2010 into one lawsuit: <I>In re Johnson &#038; Johnson Shareholder Derivative
Litigation</I>. An amended consolidated complaint was filed on December&nbsp;17, 2010. Additionally, in
September&nbsp;2010, another shareholder derivative lawsuit was filed in New Jersey Superior Court
against certain current and former directors and officers of the Company. The Company is named as a
nominal defendant in this action as well. The parties to this action have stipulated that it shall
be stayed until the <I>In re Johnson &#038; Johnson Shareholder Derivative Litigation </I>is completely
resolved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">These shareholder derivative actions are similar in their claims and collectively they assert a
variety of alleged breaches of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">fiduciary duties, including, among other things, that the defendants
allegedly engaged in, approved of, or failed to remedy or prevent defective medical devices,
improper pharmaceutical rebates, improper off-label marketing of pharmaceutical and medical device
products, violations of current good manufacturing practice regulations that resulted in product
recalls, and failed to disclose the aforementioned alleged misconduct in the Company&#146;s filings
under the Securities Exchange Act of 1934. Each complaint seeks a variety of relief, including
monetary damages and corporate governance reforms. In February&nbsp;2011, the Company moved to dismiss
these actions on the grounds, <I>inter alia</I>, that the plaintiffs failed to make a demand upon the
Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In May&nbsp;2011, two additional shareholder derivative lawsuits were filed in the United States
District Court for the District of New Jersey and another shareholder derivative lawsuit was filed
in New Jersey Superior Court, all naming the Company&#146;s current directors as defendants and the
Company as the nominal defendant. The complaints allege breaches of fiduciary duties related to
the Company&#146;s compliance with the Foreign Corrupt Practices Act and participation in the United
Nations Iraq Oil For Food Program, that the Company has suffered damages as a result of those
alleged breaches, and that the defendants failed to disclose the alleged misconduct in the
Company&#146;s filings under the Securities Exchange Act of 1934. Plaintiffs seek monetary damages, and
one plaintiff also seeks corporate governance reforms. The Company intends to move to dismiss the
federal lawsuits on the grounds, <I>inter alia</I>, that the plaintiffs failed to make a demand upon the
Board of Directors. The Company intends to move to dismiss or stay the state lawsuit pending
resolution of the federal lawsuits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In July&nbsp; 2011, in the <I>In re Johnson &#038; Johnson Shareholder Derivative
Litigation </I>matter, the Company filed a report prepared by a Special Committee of the Board of Directors, which investigated
the allegations contained in the derivative actions and in a series of shareholder letters that the
Board received in 2010 raising similar issues. The Special Committee was assisted in its
investigation by independent counsel. The Special Committee&#146;s report recommended: i) that the
Company reject the shareholder demands and take whatever steps are necessary or appropriate to
secure dismissal of the derivative litigation and ii) that the Board of Directors create a new
Regulatory and Compliance Committee charged with responsibility
for monitoring and oversight of the Company&#146;s Health Care Compliance and Quality &#038; Compliance
systems and issues. The Company&#146;s Board of Directors  unanimously adopted the Special Committee&#146;s recommendations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Starting in May&nbsp;2010, multiple complaints seeking class action certification related to the McNeil
recalls have been filed against McNeil Consumer Healthcare and certain affiliates, including the
Company, in the United States District Court for the Eastern District of Pennsylvania, the Northern
District of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Illinois, the Central District of California, the Southern District of
Ohio and the
Eastern District of Missouri. These consumer complaints allege generally that purchasers of various
McNeil medicines are owed monetary damages and penalties because they paid premium prices for
defective medications rather than less expensive alternative medications. All but one complaint
seeks certification of a nation-wide class of purchasers of these medicines, whereas one complaint,
the Harvey case, seeks certification of a class of Motrin&#174; IB purchasers in Missouri. In October
2010, the Judicial Panel on Multidistrict Litigation (JPML)&nbsp;consolidated all of the consumer
complaints, except for the Harvey case, which was consolidated in March&nbsp;2011, for pretrial
proceedings in the United States District Court for the Eastern District of Pennsylvania. In
January&nbsp;2011, the plaintiffs in all of the cases except the Harvey case filed a &#147;Consolidated
Amended Civil Consumer Class&nbsp;Action Complaint&#148; (CAC)&nbsp;naming additional parties and claims. In July
2011, the Court granted the Company&#146;s motion to dismiss the CAC without prejudice, but permitted
the plaintiffs to file an amended complaint within thirty days of the dismissal order.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In September&nbsp;2010, a shareholder, Ronald Monk, filed a lawsuit in the United States District Court
for the District of New Jersey seeking class certification and alleging that the Company and
certain individuals, including executive officers and employees of the Company, failed to disclose
that a number of manufacturing facilities were failing to maintain current good manufacturing
practices, and that as a result, the price of the Company&#146;s stock has declined significantly.
Plaintiff seeks to pursue remedies under the Securities Exchange Act of 1934 to recover his alleged
economic losses. In May&nbsp;2011, the Company filed a motion to dismiss, which is pending before the
Court.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In April&nbsp;2011, OMJ Pharmaceuticals, Inc. (OMJ PR) filed a lawsuit against the United States in
United States District Court for the District of Puerto Rico alleging overpayment of federal income
taxes for the tax years ended November&nbsp;30, 1999 and November&nbsp;30, 2000. OMJ PR alleges that the
Internal Revenue Service erroneously calculated OMJ PR&#146;s tax credits under Section&nbsp;936 of the Tax
Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In August
2011, an arbitration panel ruled that Mitsubishi Tanabe Pharma
Corporation (Tanabe), JBI&#146;s distributor of REMICADE<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP> in
Japan, could seek to modify the proportion of net sales revenue that
Tanabe must remit to JBI in exchange for distribution rights and
commercial supply of REMICADE<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP> (the Supply Price). Tanabe
commenced the arbitration against JBI in 2009 pursuant to the
parties&#146; distribution agreement, which grants Tanabe the right
to distribute REMICADE<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP> in Japan and certain other parts of
Asia. JBI has counterclaimed for an increase in the Supply Price. The
arbitration hearing to determine the appropriate split of revenue is
scheduled for November 2011, and a decision is anticipated in 2012.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company or its subsidiaries are also parties to a number of proceedings brought under the
Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund,
and comparable state, local or foreign laws in which the primary relief sought is the cost of past
and/or future remediation.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 12 &#151; RESTRUCTURING
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In the fiscal second quarter of 2011, Cordis Corporation, a subsidiary of Johnson &#038; Johnson,
announced the discontinuation of its clinical development program for the NEVO&#153; Sirolimus-Eluting
Coronary Stent and cessation of the manufacture and marketing of CYPHER&#174; and CYPHER
SELECT<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP>Plus Sirolimus-Eluting Coronary Stents by the end of 2011. This will allow the
Company to focus on other cardiovascular therapies where significant patient needs exist.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- xbrl -->



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">As a
result of the above mentioned restructuring plan announced by Cordis
Corporation, the Company recorded $676&nbsp;million in related pre-tax charges, of which approximately
$164&nbsp;million of the pre-tax restructuring charges require cash payments. The $676&nbsp;million of
restructuring charges consists of asset write-offs of $512&nbsp;million and $164&nbsp;million related to
leasehold and contract obligations and other expenses. The $512&nbsp;million of asset write-offs relate
to property, plant and equipment of $265&nbsp;million, intangible assets of $160&nbsp;million and inventory
of $87&nbsp;million (recorded in cost of products sold).
</DIV>

<!-- xbrl,dn,"Schedule Of Restructuring Reserve By Type Of Cost" -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following table summarizes the severance reserves associated with the restructuring plan
recorded in the fourth quarter of 2009.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Severance</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Reserve balance as of:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">January&nbsp;2, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">345</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash outlays</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(77</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">July&nbsp;3, 2011*</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">268</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Remaining cash outlays for severance are expected to be paid out in accordance with the Company&#146;s
plans and local laws.</TD>
</TR>

</TABLE>
<!-- /xbrl,dn -->


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Of the 7,500 positions the Company planned to eliminate in the 2009 restructuring plan,
approximately 5,700 positions have been eliminated as of July&nbsp;3, 2011.
</DIV>


<!-- xbrl,n -->
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 13 &#151; SUBSEQUENT EVENTS
</DIV>

<!-- xbrl,body -->
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On July&nbsp;7, 2011, the Company completed the divestiture of its Animal Health business to Elanco, a
Division of Eli Lilly.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On July&nbsp;14, 2011, the Company completed the acquisition of several over-the-counter cough and cold
brands in Russia from J.B. Chemicals and Pharmaceuticals Ltd.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On July&nbsp;15, 2011, the Company announced the definitive agreement to divest the assets of its Ortho
Dermatologics division in the U.S. to subsidiaries of Valeant Pharmaceuticals International, Inc.
</DIV>

<!-- /xbrl,ns -->

<DIV align="left">
<A name="Y91358108"></A>
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">Item&nbsp;2</TD>
    <TD>&nbsp;</TD>
    <TD> &#151; MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">RESULTS OF OPERATIONS

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Analysis of Consolidated Sales

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For the first fiscal six months of 2011, worldwide sales were $32.8&nbsp;billion, an increase of 5.8%,
including an operational increase of 2.2% as compared to 2010 first fiscal six months sales of
$31.0&nbsp;billion. Currency fluctuations had a positive impact of 3.6% for the first fiscal six months
of 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sales by U.S. companies were $15.1&nbsp;billion in the first fiscal six months of 2011, which
represented a decrease of 0.2% as compared to the same period last year. Sales by international
companies
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">were $17.7&nbsp;billion, which represented a total increase of 11.6% including an operational
increase of 4.6%, and a positive impact from currency of 7.0% as compared to the first fiscal six
months sales of 2010.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sales by companies in Europe achieved growth of 10.0%, including operational growth of 3.6% and a
positive impact from currency of 6.4%. Sales by companies in the Western Hemisphere, excluding the
U.S., achieved growth of 12.2% including operational growth of 6.2% and a positive impact from
currency of 6.0%. Sales by companies in the Asia-Pacific, Africa region achieved sales growth of
13.8%, including operational growth of 5.2% and an increase of 8.6% related to the positive impact
of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For the fiscal second quarter of 2011, worldwide sales were $16.6&nbsp;billion, an increase of 8.3%,
including an operational increase of 2.6% as compared to 2010 fiscal second quarter sales of $15.3
billion. Currency fluctuations had a positive impact of 5.7% for the fiscal second quarter of 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sales by U.S. companies were $7.4&nbsp;billion in the fiscal second quarter of 2011, which represented
an increase of 0.1% as compared to the same period last year. Sales by international companies were
$9.2&nbsp;billion, which represented a total increase of 15.9%, including an operational increase of
4.9%, and a positive impact from currency of 11.0% as compared to the fiscal second quarter sales
of 2010.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sales by companies in Europe achieved growth of 18.6%, including operational growth of 5.4% and a
positive impact from currency of 13.2%. Sales by companies in the Western Hemisphere, excluding the
U.S., achieved growth of 12.2%, including operational growth of 5.3%, and a positive impact from
currency of 6.9%. Sales by companies in the Asia-Pacific, Africa region achieved sales growth of
14.1%, including operational growth of 4.2%, and an increase of 9.9% related to the positive impact
of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">U.S. Health Care Reform
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act
of 2010 were signed into law during March&nbsp;2010. The health care reform legislation included an
increase in the minimum Medicaid rebate rate from 15.1% to 23.1% and also extended the rebate to
drugs provided through Medicaid managed care organizations. The 2011 full year impact to sales
rebates, thereby reducing sales revenue, is estimated to be $400 &#151; $500&nbsp;million of which
approximately $230&nbsp;million and $110&nbsp;million impacted the Company&#146;s fiscal first six months and
second quarter of 2011, respectively. The impact to the Company&#146;s fiscal first six months and fiscal
second quarter of 2010 were approximately $150&nbsp;million and $90&nbsp;million, respectively.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Beginning in 2011, companies that sell branded prescription drugs to specified U.S. Government
programs pay an annual non-tax deductible fee based on an allocation of the company&#146;s market
share of total branded prescription drug sales from the prior
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">year. The 2011 full year impact to
selling, marketing and administrative expenses is estimated to be $150 &#151; $175&nbsp;million.
Additionally, in 2011, discounts are provided on the Company&#146;s brand-name drugs to patients who
fall within the Medicare Part&nbsp;D coverage gap &#147;donut
hole&#148;. Beginning in 2013, the Company will be
required to pay a tax deductible 2.3% excise tax imposed on the sale of certain medical devices.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ANALYSIS OF SALES BY BUSINESS SEGMENTS

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consumer

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consumer segment sales in the fiscal first six months of 2011 were $7.5&nbsp;billion, an increase of
0.8% as compared to the same period a year ago, including an operational decline of 3.0% and a
positive currency impact of 3.8%. U.S. Consumer segment sales declined by 11.2% while international
sales growth of 9.1%, included operational growth of 2.6% and a positive currency impact of 6.5%.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Consumer Franchise Sales &#151; Fiscal Six Months
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">OTC Pharm &#038; Nutr</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,212</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,348</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5.8</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(9.8</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">4.0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Skin Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,828</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,763</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Baby Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,159</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,066</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Women&#146;s Health</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">936</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">935</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(4.0</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Oral Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">790</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">753</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.9</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Wound Care/Other</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">550</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">548</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2.7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,475</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,413</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">0.8</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(3.0</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">3.8</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consumer segment sales in the fiscal second quarter of 2011 were $3.8&nbsp;billion, an increase of 4.0%
as compared to the same period a year ago, including an operational decline of 1.8%, and a positive
currency impact of 5.8%. U.S. Consumer segment sales declined by 8.5% while international sales
achieved sales growth of 12.4%, including operational growth of 2.8%, and a positive currency
impact of 9.6%.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Consumer Franchise Sales &#151; Fiscal Second Quarters
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">OTC Pharm &#038; Nutr</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,083</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,141</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5.1</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(11.5</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">6.4</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Skin Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">929</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">843</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Baby Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">598</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">537</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Women&#146;s Health</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">477</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">466</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(4.0</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Oral Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">399</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">372</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Wound Care/Other</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">307</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">288</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,793</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,647</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">4.0</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1.8</TD>
    <TD nowrap>)%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.8</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The OTC Pharmaceuticals and Nutritionals franchise experienced an operational decline of 11.5% as
compared to the prior year fiscal second quarter. Sales in the U.S. were negatively impacted by the
suspension of production at McNeil Consumer Healthcare&#146;s Fort Washington, Pennsylvania facility as
well as the impact on
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">production volumes related to ongoing efforts to enhance quality and
manufacturing systems.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, a consent decree was signed with the U.S. Food and Drug
Administration (FDA), which will govern certain McNeil Consumer Healthcare manufacturing
operations. The consent decree identifies procedures that will help provide additional assurance of
product quality to the FDA. The consent decree recognizes the work already initiated by McNeil
under the Comprehensive Action Plan (CAP).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Production volumes from the Las Piedras and Lancaster facilities have been impacted due to the
additional review and approval processes. However, shipments of key selected products will ship
during the latter part of 2011. A limited amount of certain products previously produced at the Fort
Washington facility are in the process of being re-sited and are expected to ship in late 2011. The
balance of the portfolio of key products will continue to be reintroduced throughout 2012.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Skin Care franchise achieved operational growth of 5.3% as compared to the prior year primarily
due to the success of new product launches in the NEUTROGENA&#174;, LE PETIT
MARSEILLAIS&#174; and AVEENO&#174; product lines.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Baby Care franchise achieved operational growth of 5.2% as compared to the prior year primarily
due to growth in cleansers, wipes and oils.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Women&#146;s Health Franchise experienced an operational decline of 4.0% as compared to the prior
year primarily due to lower sales of sanitary protection and K-Y&#174; products.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Oral Care franchise achieved operational growth of 1.5% as compared to the prior year primarily
due to increased sales of LISTERINE<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP>and toothbrushes in the U.S.<SUP style="FONT-size: 85%; vertical-align: text-top"> </SUP>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Pharmaceutical
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pharmaceutical segment sales in the first fiscal six months of 2011 were $12.3&nbsp;billion, a total
increase of 9.8% as compared to the same period a year ago with an operational increase of 6.7% and
an increase of 3.1% related to the positive impact of currency. U.S. Pharmaceutical sales increased
by 5.0% as compared to the same period a year ago and international Pharmaceutical sales achieved growth of
16.1%, including operational growth of 8.9%, and an increase of 7.2% related to the positive
impact of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Pharmaceutical Product Revenues &#151; Fiscal Six Months*
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">REMICADE&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,656</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,316</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">14.7</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">14.7</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">0.0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PROCRIT&#174;/EPREX&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">872</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,049</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(16.9</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(19.3</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">RISPERDAL<FONT style="font-family: Symbol">&#226;</FONT> CONSTA<FONT style="font-family: Symbol">&#226;</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">808</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">734</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CONCERTA<FONT style="font-family: Symbol">&#226;</FONT>/methylphenidate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">711</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">652</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">VELCADE&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">627</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">547</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.9</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LEVAQUIN&#174;/FLOXIN&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">593</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">671</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(11.6</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(11.7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ACIPHEX&#174;/PARIET<FONT style="font-family: Symbol">&#226;</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">486</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">514</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(5.4</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(8.9</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other Pharmaceuticals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,539</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,708</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,292</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">11,191</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">9.8</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">6.7</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">3.1</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Prior year amounts have been reclassified to conform to current year presentation.</TD>
</TR>

</TABLE>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pharmaceutical segment sales in the fiscal second quarter of 2011 were $6.2&nbsp;billion, a total
increase of 12.2% as compared to the same period a year ago with an operational increase of 7.0%
and an increase of 5.2% related to the positive impact of currency. U.S. Pharmaceutical sales
increased by 4.1% as compared to the same period a year ago and international Pharmaceutical sales
achieved sales growth of 22.6%, including operational growth of 10.7%, and an increase of 11.9%
related to the positive impact of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Pharmaceutical Product Revenues &#151; Fiscal Second Quarters*
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">REMICADE&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,371</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,130</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">21.3</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">21.3</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">0.0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PROCRIT&#174;/EPREX&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">475</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">526</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(9.7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(14.0</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">RISPERDAL<FONT style="font-family: Symbol">&#226;</FONT> CONSTA<FONT style="font-family: Symbol">&#226;</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">355</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CONCERTA<FONT style="font-family: Symbol">&#226;</FONT>/methylphenidate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">349</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">323</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">VELCADE&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">347</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">286</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ACIPHEX&#174;/PARIET<FONT style="font-family: Symbol">&#226;</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">247</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">254</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2.8</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(9.4</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LEVAQUIN&#174;/FLOXIN&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">159</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">300</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(47.0</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(47.2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other Pharmaceuticals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,881</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,379</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,233</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">5,553</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">12.2</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">7.0</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.2</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Prior year amounts have been reclassified to conform to current year presentation.</TD>
</TR>

</TABLE>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">REMICADE&#174; (infliximab), a biologic approved for the treatment of a number of
immune-mediated inflammatory diseases, achieved operational growth of 21.3% as compared to the
prior year fiscal second quarter. Growth was primarily driven by an increase in U.S. export sales
due to customer inventory planning<FONT style="FONT-variant: SMALL-CAPS"> </FONT>and the impact of the agreement with Merck &#038; Co., Inc.
(Merck). On April&nbsp;15, 2011, the Company announced it reached an agreement with Merck which includes
distribution rights to REMICADE&#174; and SIMPONI<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP>whereby, effective July&nbsp;1,
2011, certain territories were transferred to the Company. On July&nbsp;1, 2011, the Company began to
record sales of product from certain territories, including Canada, Brazil, Australia and Mexico,
which were previously supplied by Merck.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PROCRIT<FONT style="font-family: Symbol">&#226;</FONT> (Epoetin alfa)/EPREX<FONT style="font-family: Symbol">&#226;</FONT> (Epoetin alfa), experienced an operational sales decline
of 14.0%, as compared to the prior year fiscal second quarter. The decline was primarily due to
softening of the market for Erythropoiesis Stimulating Agents (ESAs) and increased competition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">RISPERDAL&#174; CONSTA&#174; (risperidone), a long-acting injectable antipsychotic, achieved operational
growth of 4.5% as compared to the prior year fiscal second quarter. Sales of RISPERDAL&#174; CONSTA&#174;
outside the U.S. increased while sales in the U.S. declined.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">However, the total U.S. sales of the
Company&#146;s long-acting injectables, including INVEGA&#174; SUSTENNA&#153; (paliperidone palmitate), increased
by double digits versus a year ago due to an increase in combined market share.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">CONCERTA<FONT style="font-family: Symbol">&#226;</FONT>/methylphenidate, a product for the treatment of attention deficit hyperactivity
disorder, achieved operational sales growth of 4.5% as compared to the prior year fiscal second
quarter. On November&nbsp;1, 2010, the Company entered into a U.S. Supply and Distribution Agreement
with Watson Laboratories, Inc. to distribute an authorized generic version of CONCERTA<FONT style="font-family: Symbol">&#226;</FONT>
beginning May&nbsp;1, 2011. The fiscal second quarter sales growth reflects the shipments
to Watson Laboratories, Inc., including the initial stocking of the authorized generic, partially
offset by lower sales of the branded product.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">VELCADE&#174; (bortezomib), a product for the treatment for multiple myeloma, for which the Company has
commercial rights in Europe and the rest of the world outside the U.S., achieved operational sales
growth of 10.0% as compared to the prior year fiscal second quarter primarily due to strong growth
in Asia and Latin America.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ACIPHEX<FONT style="font-family: Symbol">&#226;</FONT>/PARIET<FONT style="font-family: Symbol">&#226;</FONT> experienced an operational decline of 9.4% as compared to the prior
year fiscal second quarter primarily due to increased generic competition in the category.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">LEVAQUIN&#174; (levofloxacin)/FLOXIN<SUP style="FONT-size: 85%; vertical-align: text-top"><FONT style="font-family: Symbol">&#226;</FONT></SUP>(ofloxacin), an anti-infective,
experienced an operational decline of 47.2% as compared to the prior year fiscal second quarter due
to the loss of market exclusivity in the U.S. in June&nbsp;2011. In 2010, full year U.S. sales of
LEVAQUIN&#174; were $1.3&nbsp;billion. U.S. sales of LEVAQUIN&#174; in the fiscal second
quarter and the fiscal six months of 2010 were $0.3&nbsp;billion and $0.7&nbsp;billion, respectively. U.S.
sales of LEVAQUIN&#174; in the fiscal second quarter and the fiscal six months of 2011 were
$0.1&nbsp;billion and $0.6&nbsp;billion, respectively. Due to the loss of market exclusivity in the U.S., year
over year sales growth of LEVAQUIN<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP>will continue to decline in the second half of 2011.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In the fiscal second quarter of 2011, Other Pharmaceutical sales achieved operational growth of
13.8% as compared to the prior year fiscal second quarter. Contributors to the increase were sales
of <FONT style="FONT-variant: SMALL-CAPS"> </FONT>STELARA&#174; (ustekinumab), PREZISTA&#174; (darunavir), INVEGA&#174; SUSTENNA&#153;
(paliperidone palmitate), ZYTIGA&#174;(abiraterone acetate),<SUP style="FONT-size: 85%; vertical-align: text-top"> </SUP>CAELYX&#174;(pegylated
liposomal doxorubicin hydrochloride), INTELENCE&#174; (etravirine), NUCYNTA&#174; (tapentadol), SIMPONI&#174;
(golimumab)&nbsp;and newly acquired products from Crucell. This growth was partially offset by lower
sales of DURAGESIC&#174;/Fentanyl Transdermal (fentanyl transdermal system), and TOPAMAX&#174; (topiramate)
due to continued generic competition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Medical Devices and Diagnostics
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Medical Devices and Diagnostics segment sales in the first fiscal six months of 2011 were $13.0
billion, an increase of 5.2% as compared to the same period a year ago, with 1.3% of this change
due to an operational increase and an increase of 3.9% related to the positive impact of currency.
U.S. Medical Devices and
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Diagnostics sales decreased 0.2% as compared to the prior year.
The international Medical Devices and Diagnostics sales increase of 9.9% included an operational
increase of 2.5% and an increase of 7.4% related to the positive impact of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Medical Devices and Diagnostics Franchise Sales &#151; Fiscal Six Months
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">DEPUY&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,972</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,829</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.1</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">1.5</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">3.6</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ETHICON ENDO-SURGERY&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,516</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,364</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ETHICON&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,450</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,279</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.5</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Vision Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,454</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,326</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diabetes Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,318</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,213</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.7</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cardiovascular Care*</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,222</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,327</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(7.9</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(11.7</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ORTHO-CLINICAL DIAGNOSTICS&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,071</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,019</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">13,003</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,357</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.2</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">1.3</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">3.9</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Previously referred to as CORDIS&#174;</TD>
</TR>

</TABLE>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Medical Devices and Diagnostics segment sales in the fiscal second quarter of 2011 were $6.6
billion, an increase of 7.2% as compared to the same period a year ago, including an operational
increase of 1.3% and a positive currency impact of 5.9%. U.S. Medical Devices and Diagnostics sales
increased 0.1%. The international Medical Devices and Diagnostics sales increase of 13.4% included an
operational increase of 2.2% and an increase of 11.2% related to the positive impact of currency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Major Medical Devices and Diagnostics Franchise Sales &#151; Fiscal Second Quarters
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 3,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">July 4,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Total</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Operations</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Currency</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">(Dollars in Millions)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2011</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2010</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Change</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">DEPUY&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,469</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,375</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">6.8</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">1.3</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.5</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ETHICON ENDO-SURGERY&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,295</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,196</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.8</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ETHICON&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,257</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,132</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.0</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Vision Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">732</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">662</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diabetes Care</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">681</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">616</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10.6</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cardiovascular Care*</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">587</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">655</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(10.4</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(16.1</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ORTHO-CLINICAL DIAGNOSTICS&#174;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">550</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">494</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,571</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,130</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">7.2</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">1.3</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">5.9</TD>
    <TD nowrap>%</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96%"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Previously referred to as CORDIS&#174;</TD>
</TR>

</TABLE>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The DePuy franchise achieved operational growth of 1.3% as compared to the same period a year ago.
This growth was primarily due to sales of newly acquired products from Micrus, Mitek sports
medicine products and the trauma product line. The growth was partially offset by lower sales volume of
both hips and knees due in part to continued pricing pressure and lost market share in hips due to
the Depuy ASR&#153; hip recall.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Ethicon Endo-Surgery franchise achieved operational growth of 1.8% as compared to the prior
year fiscal second quarter. Growth was attributable to the Advanced Sterilization products and
outside the U.S., the HARMONIC&#174; and Endo mechanical product lines were contributors to the growth.
Total growth was impacted by the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">divestiture of the breast care business in the third quarter of
2010.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Ethicon franchise achieved operational growth of 5.0% as compared to the prior year fiscal
second quarter. The primary drivers of the growth include the emerging market growth in sutures,
newly launched products; PHYSIOMESH&#153; and SECURESTRAP&#153; and growth in the Acclarent product line.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Vision Care franchise achieved operational sales growth of 3.3% as compared to the prior year
fiscal second quarter. ACUVUE&#174; MOIST&#174; and the astigmatism lenses were strong contributors to the
growth in the quarter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Diabetes Care franchise achieved operational sales growth of 5.3% as compared to the prior year
fiscal second quarter. The growth was primarily due to sales of the OneTouch&#174; product line.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Cardiovascular Care franchise experienced an operational sales decline of 16.1% as compared to
the prior year fiscal second quarter. Sales were impacted by the Company&#146;s decision to exit the
drug-eluting stent market. The decline was partially offset by strong growth in Biosense Webster,
the Company&#146;s electrophysiology business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Ortho-Clinical Diagnostics franchise achieved operational sales growth of 6.4% as compared to
the prior year fiscal second quarter. The growth was primarily attributable to the continued growth
in clinical labs due to the strength of the VITROS&#174; 5600 and 3600 analyzers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Cost of Products Sold and Selling, Marketing and Administrative Expenses
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consolidated costs of products sold for the first fiscal six months of 2011 increased to 30.4% from
29.6% of sales in the same period a year ago. Consolidated costs of products sold for the fiscal
second quarter of 2011 increased to 31.2% from 30.2% of sales as compared to the same period a year
ago. The increase in both the fiscal six months and fiscal second quarter was primarily due to
restructuring charges related to the Cardiovascular Care business and ongoing remediation costs in
the Consumer OTC business. In addition, lower margins and integration costs including inventory
step-up associated with the acquisition of Crucell negatively impacted cost of products sold.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consolidated selling, marketing and administrative expenses for the first fiscal six months of 2011
increased to 31.3% from 30.8% of sales as compared to the same period a year ago. Consolidated
selling, marketing and administrative expenses for the fiscal second quarter of 2011 increased to
31.4% from 31.0% of sales as compared to the same period a year ago. The increase in both periods
was primarily due to investment spending in the Medical Devices and Diagnostics business as well as
the fee on branded pharmaceutical products incurred due to the U.S. health care reform legislation.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Research &#038; Development Expense
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Research &#038; development activities represent a significant part of the Company&#146;s business. These
expenditures relate to the processes of discovering, testing and developing new products, improving
existing products, as well as ensuring product efficacy and regulatory compliance prior to launch.
The Company remains committed to investing in research &#038; development with the aim of delivering
high quality and innovative products. Worldwide costs of research and development activities for
the first fiscal six months of 2011 were $3.6&nbsp;billion, an increase of 12.9% compared to the prior
fiscal period. Worldwide costs of research and development activities for the fiscal second quarter
of 2011 were $1.9&nbsp;billion, an increase of 14.2% as compared to the prior fiscal period. The
increases in both periods were primarily due to higher levels of spending to advance the Company&#146;s
Pharmaceutical pipeline.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Restructuring Expense
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, Cordis Corporation, a subsidiary of Johnson &#038; Johnson,
announced the discontinuation of its clinical development program for the NEVO&#153; Sirolimus-Eluting
Coronary Stent and cessation of the manufacture and marketing of CYPHER&#174; and CYPHER
SELECT<SUP style="FONT-size: 85%; vertical-align: text-top">&#174; </SUP>Plus Sirolimus-Eluting Coronary Stents by the end of 2011. This will allow the
Company to focus on other cardiovascular therapies where significant patient needs exist.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company recorded a pre-tax charge of $676&nbsp;million, of
which $87&nbsp;million is included in cost of products sold. See Note 12 to the Consolidated Financial
Statements for additional details related to the restructuring.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Other (Income) Expense, Net
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Other (income)&nbsp;expense, net is the account where the Company records gains and losses related to
the sale and write-down of certain equity securities of the Johnson &#038; Johnson Development
Corporation, gains and losses on the disposal of assets, currency gains and losses, gains and
losses relating to non-controlling interests, litigation settlements, as well as royalty income.
The change in other (income)&nbsp;expense, net for the first fiscal six months of 2011 was unfavorable
by $1.8&nbsp;billion as compared to the same period a year ago.
The first fiscal six months of 2011 included $0.8 billion of
litigation expense and DePuy
ASR<SUP style="font-size: 85%; vertical-align: text-top">TM</SUP> Hip recall costs versus
a net gain of $1.3 billion from litigation matters recorded in the first fiscal six months of 2010. The first fiscal
six months of 2011 also included a gain related to the Company&#146;s earlier investment in Crucell and a
mark-to-market gain associated with a currency option related to the planned acquisition of Synthes, Inc. The
change in other (income) expense, net for the fiscal second quarter of 2011, was unfavorable by $0.2 billion
as compared to the same period a year ago. The fiscal second quarter of 2011 included $0.4 billion of litigation
expense and additional DePuy ASR<SUP style="font-size: 85%; vertical-align: text-top">TM</SUP> Hip recall costs versus $0.2 billion related to litigation matters recorded in
the fiscal second quarter of 2010. The fiscal second quarter of 2011 included a mark-to-market gain associated
with a currency option related to the planned acquisition of Synthes, Inc.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 12pt">OPERATING PROFIT BY SEGMENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consumer Segment

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Operating profit for the Consumer segment as a percent to sales in the first fiscal six months of
2011 was 15.0% versus 19.6% for the same period a year ago. Operating profit for the Consumer
segment as a percent to sales in the fiscal second quarter of 2011 was 14.5% versus 18.3% for the
same period a year ago. The primary drivers of the decline in operating profit for both periods
were unfavorable product mix and remediation costs associated with the recall of certain OTC
products.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Pharmaceutical Segment
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Operating profit for the Pharmaceutical segment as a percent to sales in the first fiscal six
months of 2011 was 31.9% versus 34.0% for the same period a year ago. The primary drivers of the
decrease in the operating profit margin were higher litigation expense recorded in 2011, the impact
of the health care reform fee and integration costs including inventory step-up associated with the
Crucell acquisition. This was partially offset by the gain related to the Company&#146;s earlier investment in
Crucell and lower manufacturing costs. Operating profit for the Pharmaceutical segment as a percent
to sales in the fiscal second quarter of 2011 was 27.5% versus 33.0% for the same period a year
ago. The primary drivers of the decrease in the operating profit margin were higher litigation
expense recorded in 2011, the impact of the health care reform fee and integration costs including
inventory step-up associated with the Crucell acquisition. This was partially offset by lower
manufacturing costs and favorable product mix.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Medical Devices and Diagnostics Segment
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Operating profit for the Medical Devices and Diagnostics segment as a percent to sales in the first
fiscal six months of 2011 was 24.8% versus 45.1% for the same period a year ago. Operating profit
for the Medical Devices and Diagnostics segment as a percent to sales in the fiscal second quarter
of 2011 was 19.4% versus 30.6% for the same period a year ago. The primary drivers of the decline
in the operating profit margin in the Medical Devices and Diagnostics
segment for both periods were
 restructuring expense of $676&nbsp;million, higher litigation expense and additional DePuy ASR&#153;
Hip recall costs and investment spending. The fiscal six months of 2010 included a $1.5&nbsp;billion gain from net litigation
matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Interest (Income) Expense
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Interest income decreased in both the first fiscal six months and fiscal second quarter of 2011 as
compared to the same periods a year ago, due to lower rates of interest earned despite higher
average cash balances. The ending balance of cash, cash equivalents and marketable securities, was
$29.7&nbsp;billion at the end of the fiscal second quarter of 2011. This is an increase of $10.8&nbsp;billion
from the same period a year ago. The increase was primarily due to cash generated from operating
activities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Interest expense increased in both the first fiscal six months and the fiscal second quarter of
2011 as compared to the same periods a year ago due to a higher average debt balance. At the end of
the fiscal second quarter of 2011, the Company&#146;s debt position was $18.7&nbsp;billion compared to $11.7
billion from the same period a
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">year ago. The Company increased borrowings, capitalizing on
favorable terms in the capital markets. The proceeds of the debt were used for general corporate
purposes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Provision for Taxes on Income
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The worldwide effective income tax rates for the first fiscal six months of 2011 and 2010 were
21.2% and 24.0%, respectively. The lower effective tax rate was due to higher income in lower tax
jurisdictions and the U.S. Research and Development tax credit, which was not in effect for the
first fiscal six months of 2010. Additionally, in 2010 the Company had litigation gains in high tax
jurisdictions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">As of July&nbsp;3, 2011, the Company had approximately $2.5&nbsp;billion of liabilities from unrecognized tax
benefits. The Company does not expect that the total amount of unrecognized tax benefits will
change significantly during the next twelve months.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">See Note 8 to the Consolidated Financial Statements in the Annual Report on Form 10-K for the
fiscal year ended January&nbsp;2, 2011 for more detailed information regarding unrecognized tax
benefits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">LIQUIDITY AND CAPITAL RESOURCES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cash Flows
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cash and cash equivalents were $15.0&nbsp;billion at the end of the fiscal second quarter of 2011 as
compared with $19.4&nbsp;billion at the fiscal year end of 2010. The primary uses of cash that
contributed to the $4.4&nbsp;billion decrease were approximately $9.3&nbsp;billion net cash used by investing activities
and $1.5&nbsp;billion used by financing activities partially offset by approximately $6.2&nbsp;billion generated from
operating activities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cash flow
from operations of $6.2&nbsp;billion was the result of $6.3&nbsp;billion of net earnings and $1.3
billion of non cash charges primarily  related to depreciation and amortization, stock based compensation, and deferred tax provision reduced by $1.4&nbsp;billion related to changes in assets and liabilities, net of effects from
acquisitions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cash used by investing activities of $9.3&nbsp;billion was primarily due to net purchases of investments in
marketable securities of $6.2&nbsp;billion, acquisitions of $2.0&nbsp;billion and $1.1&nbsp;billion used for
additions to property, plant and equipment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Financing activities use of $1.5&nbsp;billion was primarily for dividends to shareholders of $3.0
billion and $0.2&nbsp;billion for repurchase of common stock net of proceeds from stock options
exercised partially offset by $1.8&nbsp;billion net proceeds from short and long-term debt.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In the fiscal second quarter of 2011, the Company continued to have access to liquidity through
the commercial paper market. The Company anticipates that operating cash flows, existing credit
facilities and access to the commercial paper markets will continue to provide sufficient
resources to fund operating needs. However, the Company monitors the global capital markets on an
ongoing basis and from time to time may raise capital when market conditions are favorable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dividends
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On April&nbsp;28, 2011, the Board of Directors declared a regular cash dividend of $0.570 per share,
payable on June&nbsp;14, 2011 to shareholders of record as of May&nbsp;31, 2011. This represented an increase
of 5.6% in the quarterly dividend rate and was the 49th consecutive year of cash dividend
increases.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On July&nbsp;18, 2011, the Board of Directors declared a regular cash dividend of $0.570 per share,
payable on September&nbsp;13, 2011 to shareholders of record as of August&nbsp;30, 2011. The Company expects
to continue the practice of paying regular quarterly cash dividends.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">OTHER INFORMATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">New Accounting Standards
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the
fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
amendments to the disclosure requirements for presentation of comprehensive income. The amendment
requires that all non-owner changes in stockholders&#146; equity be presented either in a single
continuous statement of comprehensive income or in two separate but consecutive statements. This
guidance is effective retrospectively for the interim periods and annual periods beginning after
December&nbsp;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
material impact on the Company&#146;s results of operations, cash flows or financial position.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
common fair value measurement. These amendments result in convergence of fair value measurement and
disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
the interim periods and annual periods beginning after December&nbsp;15, 2011. Early adoption is
prohibited. The adoption of this standard is not expected to have a material impact on the
Company&#146;s results of operations, cash flows or financial position.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the Financial Accounting Standards
Board (FASB)&nbsp;guidance and amendments issued related to revenue recognition under the milestone
method. The objective of the accounting standard update is to provide guidance on defining a
milestone and determining when it may be appropriate to apply the milestone method of revenue
recognition for research or development transactions. This update is effective on a prospective
basis for milestones achieved
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in fiscal years, and interim periods within those years, beginning on
or after June&nbsp;15, 2010. The adoption of this standard did not have a material impact on the
Company&#146;s results of operations, cash flows or financial position.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
pharmaceutical companies should recognize and classify in the Company&#146;s financial statements, the
non-deductible annual fee paid to the Government in accordance with the Patient Protection and
Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
based on an allocation of a company&#146;s market share of total branded prescription drug sales from
the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
in the Company&#146;s financial statement and will be amortized on a straight-line basis for the year as
per the FASB guidance. The adoption of this standard did not have a material impact on the
Company&#146;s results of operations, cash flows or financial position.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Economic and Market Factors
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Johnson &#038; Johnson is aware that its products are used in an environment where, for more than a
decade, policymakers, consumers and businesses have expressed concern about the rising cost of
health care. Johnson &#038; Johnson has a long-standing policy of pricing products responsibly. For the
period 2000 through 2010 in the United States, the weighted average compound annual growth rate of
Johnson &#038; Johnson price increases for health care products (prescription and over-the-counter
drugs, hospital and professional products) was below the U.S. Consumer Price Index (CPI).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company operates in certain countries where the economic conditions continue to present
significant challenges. The Company continues to monitor these situations and take appropriate
actions. Inflation rates continue to have an effect on worldwide economies and, consequently, on
the way companies operate. In the face of increasing costs, the Company strives to maintain its
profit margins through cost reduction programs, productivity improvements and periodic price
increases. The Company faces various worldwide health care changes that may continue to result in
pricing pressures that include health care cost containment and government legislation relating to
sales, promotions and reimbursement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Changes in the behavior and spending patterns of consumers of health care products and services,
including delaying medical procedures, rationing prescription medications, reducing the frequency
of physician visits and foregoing health care insurance coverage, as a result of a prolonged
global economic downturn will continue to impact the Company&#146;s businesses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company also operates in an environment increasingly hostile to intellectual property rights.
Generic drug firms have filed Abbreviated New Drug Applications seeking to market generic forms of
most of the Company&#146;s key pharmaceutical products, prior to expiration of the applicable patents
covering those products. In the event the Company is not successful in defending a lawsuit
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">resulting from an Abbreviated New Drug Application filing, the generic firms will then introduce
generic versions of the product at issue, resulting in very substantial market share and revenue
losses. For further information see the discussion on &#147;Litigation Against Filers of Abbreviated New
Drug Applications&#148; included in Item&nbsp;1. Financial Statements (unaudited)- Notes to Consolidated
Financial Statements, Note 11.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Form 10-Q contains forward-looking statements. Forward- looking statements do not relate
strictly to historical or current facts and anticipate results based on management&#146;s plans that are
subject to uncertainty. Forward-looking statements may be identified by the use of words like
&#147;plans,&#148; &#147;expects,&#148; &#147;will,&#148; &#147;anticipates,&#148; &#147;estimates&#148; and other words of similar meaning in
conjunction with, among other things, discussions of future operations, financial performance, the
Company&#146;s strategy for growth, product development, regulatory approval, market position and
expenditures.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Forward-looking statements are based on current expectations of future events. The Company cannot
guarantee that any forward- looking statement will be accurate, although the Company believes that
it has been reasonable in its expectations and assumptions. Investors should realize that if
underlying assumptions prove inaccurate or that unknown risks or uncertainties materialize, actual
results could vary materially from the Company&#146;s expectations and projections. Investors are
therefore cautioned not to place undue reliance on any forward-looking statements. The Company does
not undertake to update any forward-looking&nbsp;statements as a result of new information or future
events or developments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Risks and uncertainties include, but are not limited to, general industry conditions and
competition; economic factors, such as interest rate and currency exchange rate fluctuations;
technological advances, new products and patents attained by competitors; challenges inherent in
new product development, including obtaining regulatory approvals; challenges to patents;
significant litigation adverse to the Company; impact of business combinations; financial distress
and bankruptcies experienced by significant customers and suppliers; changes to governmental laws
and regulations and U.S. and foreign health care reforms; trends toward healthcare cost
containment; increased scrutiny of the health care industry by government agencies; changes in
behavior and spending patterns of healthcare products and services; manufacturing difficulties or
delays; product efficacy or safety concerns resulting in product recalls or regulatory action.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#146;s Annual Report on Form 10-K for the fiscal year ended January&nbsp;2, 2011 contains, as an
Exhibit, a discussion of additional factors that could cause actual results to differ from
expectations. The Company notes these factors as permitted by the Private Securities Litigation
Reform Act of 1995.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="Y91358109"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;3  &#151; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">There has been no material change in the Company&#146;s assessment of
its sensitivity to market risk since its presentation set forth in
Item&nbsp;7A, &#147;Quantitative and Qualitative Disclosures About Market
Risk,&#148; in its Annual Report on Form 10-K for the fiscal year ended
January&nbsp;2, 2011.
</DIV>

<DIV align="left">
<A name="Y91358110"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;4  &#151; CONTROLS AND PROCEDURES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Disclosure controls and procedures. At the end of the period covered by this report, the Company
evaluated the effectiveness of the design and operation of its disclosure controls and procedures.
The Company&#146;s disclosure controls and procedures are designed to ensure that information required
to be disclosed by the Company in the reports that it files or submits under the Securities
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in
the SEC&#146;s rules and forms. Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by the Company in the
reports that it files or submits under the Securities Exchange Act is accumulated and communicated
to the Company&#146;s management, including its principal executive and principal financial officers, or
persons performing similar functions, as appropriate, to allow timely decisions regarding required
disclosure. William C. Weldon, Chairman and Chief Executive Officer, and Dominic J. Caruso, Vice
President, Finance and Chief Financial Officer, reviewed and participated in this evaluation.
Based on this evaluation, Messrs.&nbsp;Weldon and Caruso concluded that, as of the end of the period
covered by this report, the Company&#146;s disclosure controls and procedures were effective.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Internal control. During the period covered by this report, there were no changes in the Company&#146;s
internal control over financial reporting that have materially affected, or are reasonably likely
to materially affect, the Company&#146;s internal control over financial reporting.
</DIV>

<DIV align="left">
<A name="Y91358111"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Part II &#151; OTHER INFORMATION
</DIV>

<DIV align="left">
<A name="Y91358112"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;1  &#151; LEGAL PROCEEDINGS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The information called for by this item is incorporated herein by reference to Note 11 included in
Part&nbsp;I, Item&nbsp;1, Financial Statements (unaudited) &#151; Notes to Consolidated Financial Statements.
</DIV>

<DIV align="left">
<A name="Y91358113"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;2  &#151; UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(c)&nbsp;Purchases of Equity Securities by the Issuer and Affiliated Purchasers.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following table provides information with respect to Common Stock purchases by the Company
during the fiscal second quarter of 2011. Common Stock purchases on the open market are made as
part of a systematic plan to meet the needs of the Company&#146;s compensation programs.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">Total Number</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">Average</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">of Shares</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">Price Paid</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Fiscal Month</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">Purchased</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" colspan="3">per Share</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">April&nbsp;4, 2011 through May&nbsp;1, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">454,009</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">59.48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">May&nbsp;2, 2011 through May&nbsp;29, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,967,992</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">65.80</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">May&nbsp;30, 2011 through July&nbsp;3, 2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,111,639</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">66.07</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,533,640</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left">
<A name="Y91358114"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;5  &#151; OTHER INFORMATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On April&nbsp;29, 2011, the Company filed a Current Report on Form 8-K disclosing the final voting
results in connection with the Company&#146;s Annual Meeting of Shareholders held on April&nbsp;28, 2011.
The Board of Directors has decided, in light of such vote, to include in the Company&#146;s proxy
materials for each Annual Meeting of Shareholders, a shareholder advisory vote on the compensation
of the executive officers named in the Company&#146;s proxy statement.
</DIV>

<DIV align="left">
<A name="Y91358115"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Item&nbsp;6  &#151; EXHIBITS
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Exhibit&nbsp;31.1 Certifications under Rule&nbsp;13a-14(a) of the
Securities Exchange Act pursuant to Section&nbsp;302 of the
Sarbanes-Oxley Act of 2002 &#151; Filed with this document.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Exhibit&nbsp;32.1 Certifications pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 &#151;
Furnished with this document.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Exhibit&nbsp;101 XBRL (Extensible Business Reporting Language)
The following materials from Johnson &#038; Johnson&#146;s Quarterly Report on Form 10-Q for the
quarter ended July&nbsp;3, 2011, formatted in Extensive Business Reporting Language (XBRL),
(i) consolidated balance sheets, (ii)&nbsp;consolidated statements of earnings, (iii)
consolidated statements of cash flows, and (iv)&nbsp;the notes to the consolidated financial
statements.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#Y91358tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left">
<A name="Y91358116"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SIGNATURES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">JOHNSON &#038; JOHNSON<BR>
(Registrant)<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Date:  August 9, 2011&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 0px solid #000000" align="left">By /s/ D. J. CARUSO
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">D. J. CARUSO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Vice President, Finance;
Chief Financial Officer
(Principal Financial Officer)&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Date:  August 9, 2011&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 0px solid #000000" align="left">By /s/ S. J. COSGROVE
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">S. J. COSGROVE&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Controller
(Principal Accounting Officer)&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->57<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>y91358exv31w1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv31w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Exhibit&nbsp;31.1</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">CERTIFICATION OF CHIEF EXECUTIVE OFFICER<BR>
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">I, William C. Weldon, certify that:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended July
3, 2011 (the &#147;report&#148;) of Johnson &#038; Johnson (the &#147;Company&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Company as of, and for, the periods presented in this report;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The Company&#146;s other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rule&nbsp;13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule&nbsp;13a-15(f)
and 15d-15(f)) for the Company and have:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the Company, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">c) Evaluated the effectiveness of the Company&#146;s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">d) Disclosed in this report any change in the Company&#146;s internal control over financial
reporting that occurred during the Company&#146;s most recent fiscal quarter (the Company&#146;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the Company&#146;s internal control over financial
reporting; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;The Company&#146;s other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Company&#146;s auditors and the audit
committee of the Company&#146;s board of directors (or persons performing the equivalent functions):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(a)&nbsp;All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the Company&#146;s ability to record, process, summarize and report financial information; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Any fraud, whether or not material, that involves management or other employees who
have a significant role in the Company&#146;s internal control over financial reporting.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">                                                         /s/ William C. Weldon
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">William C. Weldon&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Date: August&nbsp;8, 2011
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">CERTIFICATION OF CHIEF FINANCIAL OFFICER<BR>
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">I, Dominic J. Caruso, certify that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended July
3, 2011 (the &#147;report&#148;) of Johnson &#038; Johnson (the &#147;Company&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Company as of, and for, the periods presented in this report;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The Company&#146;s other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rule&nbsp;13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule&nbsp;13a-15(f)
and 15d-15(f)) for the Company and have:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the Company, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">c) Evaluated the effectiveness of the Company&#146;s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">d) Disclosed in this report any change in the Company&#146;s internal control over financial
reporting that occurred during the Company&#146;s most recent fiscal quarter (the Company&#146;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the Company&#146;s internal control over financial
reporting; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;The Company&#146;s other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Company&#146;s auditors and the audit
committee of the Company&#146;s board of directors (or persons performing the equivalent functions):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(a)&nbsp;All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the Company&#146;s ability to record, process, summarize and report financial information; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Any fraud, whether or not material, that involves management or other employees who
have a significant role in the Company&#146;s internal control over financial reporting.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">                                                                  /s/ Dominic J. Caruso
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Dominic J. Caruso&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Date: August&nbsp;8, 2011
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>y91358exv32w1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv32w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;32.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, William C. Weldon, the Chief Executive Officer of Johnson &#038; Johnson, a New
Jersey corporation (the &#147;Company&#148;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&nbsp;906
of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Company&#146;s Quarterly Report on Form
10-Q for the quarterly period ended
July&nbsp;3, 2011 (the &#147;Report&#148;) fully
complies with the requirements of
Section 13(a) of the Securities
Exchange Act of 1934; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the information contained in the
Report fairly presents, in all
material respects, the financial
condition and results of operations of
the Company.</TD>
</TR>

</TABLE>
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">                                    /s/ William C. Weldon
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">William C. Weldon&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: August&nbsp;8, 2011
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This certification is being furnished to the SEC with this Report pursuant to Section&nbsp;906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed
filed by the Company for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to liability of that section.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, Dominic J. Caruso, the Chief Financial Officer of Johnson &#038; Johnson, a New
Jersey corporation (the &#147;Company&#148;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&nbsp;906
of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Company&#146;s Quarterly Report on Form
10-Q for the quarterly period ended
July&nbsp;3, 2011 (the &#147;Report&#148;) fully
complies with the requirements of
Section 13(a) of the Securities
Exchange Act of 1934; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the information contained in the
Report fairly presents, in all
material respects, the financial
condition and results of operations of
the Company.</TD>
</TR>

</TABLE>
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">                                    /s/ Dominic J. Caruso
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Dominic J. Caruso&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: August&nbsp;8, 2011
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This certification is being furnished to the SEC with this Report pursuant to Section&nbsp;906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed
filed by the Company for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to liability of that section.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>4
<FILENAME>jnj-20110703.xml
<DESCRIPTION>EX-101 INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created by RR Donnelley Tagger version 10.0.0.149; Copyright (C) RR Donnelley-->
<!--Based on XBRL 2.1-->
<!--Created on: 8/9/2011 12:04:53 PM-->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:jnj="http://jnj.com/2011-07-03" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31">
  <link:schemaRef xlink:type="simple" xlink:href="jnj-20110703.xsd" />
  <!--Context Section-->
  <context id="ThreeMonthsEnded_04Jul2010_Consumer_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Consumer_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Europe_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Consumer_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Pharmaceutical_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Consumer_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Pharmaceutical_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Europe_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Employee_Severance_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Employee_Severance_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Employee_Severance_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Restructuring_Plan_Of2009_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:RestructuringPlanOf2009Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="TwentyOneMonthsEnded_03Jul2011_Restructuring_Plan_Of2009_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:RestructuringPlanOf2009Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-09-28</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_United_States_Pension_Plans_Of_U_S_Entity_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Pension_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Nine_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodNineMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Sixteen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Two_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Eighteen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodEighteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Nineteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodNineteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Three_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Two_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Nineteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodNineteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Twelve_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwelveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Eighteen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodEighteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Eight_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Ten_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Nine_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodNineMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Seven_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Seventeen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Eight_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Fourteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFourteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Five_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Four_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Three_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_One_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Fourteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFourteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Ten_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Fifteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Eleven_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodElevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Thirteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodThirteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Sixteen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_One_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Six_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSixMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Eleven_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodElevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Seven_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Twelve_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodTwelveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Five_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Six_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSixMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Thirteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodThirteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Notes_Due_Period_Seventeen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Fifteen_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Four_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">jnj:NotesDuePeriodFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Swiss_Franc_Option_Member_Fair_Value_Inputs_Level2_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jnj:SwissFrancOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Swiss_Franc_Option_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jnj:SwissFrancOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeFourNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeThreeNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeTwoNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeSixNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeThreeNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeFourNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeSixNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeThreeNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeTwoNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeFourNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeFourNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeTwoNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeThreeNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseTypeSixNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Cross_Currency_Interest_Rate_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Foreign_Exchange_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Foreign_Exchange_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Foreign_Exchange_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Cross_Currency_Interest_Rate_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Cross_Currency_Interest_Rate_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_2">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member_2">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Foreign_Exchange_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:ResearchExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:ResearchExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:ResearchExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:ResearchExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">jnj:OtherInterestIncomeExpenseNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member_2">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jan2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2010-01-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_03Apr2011_Crucell_Nv_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CrucellNvMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-04-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_04Apr2010_Acclarent_Inc_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AcclarentIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-04-04</instant>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Cordis_Restructuring_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:CordisRestructuringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Centocor_Ortho_Biotech_Inc_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="jnj:LitigationSettlementByCompaniesAxis">jnj:CentocorOrthoBiotechIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Consumer_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Consumer_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Consumer_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Consumer_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_International_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:InternationalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Europe_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_U_S_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:USMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Europe_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jnj:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Consumer_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Civil_Penalties_Member_Risperdal_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jnj:CivilPenaltiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="jnj:LitigationSettlementByCompaniesAxis">jnj:RisperdalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Civil_Penalties_Member_Average_Wholesale_Price_Litigation_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jnj:CivilPenaltiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="jnj:LitigationSettlementByCompaniesAxis">jnj:AverageWholesalePriceLitigationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Restitution_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jnj:RestitutionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010_Pharmaceutical_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesAndDiagnosticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Jul2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <startDate>2010-04-05</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="SixMonthsEnded_04Jul2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-07-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Cordis_Restructuring_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:CordisRestructuringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Apr2011_Crucell_Nv_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CrucellNvMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-04-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_04Apr2010_Acclarent_Inc_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AcclarentIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-04</startDate>
      <endDate>2010-04-04</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Jul2011_Synthes_Inc_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:SynthesIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-04-04</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_28Jun2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2009-06-28</instant>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011_Merck_Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
      <segment>
        <xbrldi:explicitMember dimension="jnj:LitigationSettlementByCompaniesAxis">jnj:MerckMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <context id="ThreeMonthsEnded_03Apr2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-04-03</endDate>
    </period>
  </context>
  <context id="BalanceAsOf_03Jul2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2011-07-03</instant>
    </period>
  </context>
  <context id="BalanceAsOf_02Jan2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2011-01-02</instant>
    </period>
  </context>
  <context id="BalanceAsOf_04Jul2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2010-07-04</instant>
    </period>
  </context>
  <context id="BalanceAsOf_29Jul2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <instant>2011-07-29</instant>
    </period>
  </context>
  <context id="SixMonthsEnded_03Jul2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
    </entity>
    <period>
      <startDate>2011-01-03</startDate>
      <endDate>2011-07-03</endDate>
    </period>
  </context>
  <!--Unit Section-->
  <unit id="Positions">
    <measure>jnj:Positions</measure>
  </unit>
  <unit id="USDEPS">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Pure">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="Shares">
    <measure>xbrli:shares</measure>
  </unit>
  <!--Tuple Section-->
  <!-- Begin Block Tagged Note -->
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 1 - us-gaap:SignificantAccountingPoliciesTextBlock--&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;!-- xbrl,ns --&gt;
    &lt;!-- xbrl,nx --&gt;
    &lt;div align="left"&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 0pt"&gt;
    &lt;/div&gt;
    &lt;div style="display: none"&gt;NOTE 1 &amp;#8212; SUMMARY OF SIGNIFICANT
    ACCOUNTING POLICIES
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;NOTE 1 &amp;#8212;
    The accompanying unaudited interim consolidated financial statements and related notes
    should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp;#038;
    Johnson and its subsidiaries (the &amp;#8220;Company&amp;#8221;) and related notes as contained in the Company&amp;#8217;s Annual
    Report on Form 10-K for the fiscal year ended January&amp;#160;2, 2011. The unaudited interim financial
    statements include all adjustments (consisting only of normal recurring adjustments) and accruals
    necessary in the judgment of management for a fair statement of the results for the periods
    presented.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
    amendments to the disclosure requirements for presentation of comprehensive income. The amendment
    requires that all non-owner changes in stockholders&amp;#8217; equity be presented either in a single
    continuous statement of comprehensive income or in two separate but consecutive statements. This
    guidance is effective retrospectively for the interim periods and annual periods beginning after
    December&amp;#160;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
    material impact on the Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
    common fair value measurement. These amendments result in convergence of fair value measurement and
    disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
    the interim periods and annual periods beginning after December&amp;#160;15, 2011. Early adoption is
    prohibited. The adoption of this standard is not expected to have a material impact on the
    Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2011, the Company adopted the FASB guidance and amendments
    issued related to revenue recognition under the milestone method. The objective of the accounting
    standard update is to provide guidance on defining a milestone and determining when it may be
    appropriate to apply the milestone method of revenue recognition for research or development
    transactions. This update is effective on a prospective basis for milestones achieved in fiscal
    years, and interim periods within those years, beginning on or after June&amp;#160;15, 2010. The adoption of
    this standard did not have a material impact on the Company&amp;#8217;s results of operations, cash flows or
    financial position.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
    pharmaceutical companies should recognize and classify in the Company&amp;#8217;s financial statements, the
    non-deductible annual fee paid to the Government in accordance with the Patient Protection and
    Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
    based on an allocation of a company&amp;#8217;s market share of total branded prescription drug sales from
    the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
    in the Company&amp;#8217;s financial statement and will be amortized on a straight-line basis for the year as
    per the FASB guidance. The adoption of
    this standard did not have a material impact on the
    Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SignificantAccountingPoliciesTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:InventoryDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 2 - us-gaap:InventoryDisclosureTextBlock--&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 2 &amp;#8212; INVENTORIES
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;July 3, 2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;January 2, 2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Raw materials and supplies
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,383&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,073&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goods in process
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,897&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,460&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Finished goods
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,133&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,845&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total inventories
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;6,413&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:InventoryDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 3 - us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock--&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 3 &amp;#8212; INTANGIBLE ASSETS AND GOODWILL
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Intangible assets that have finite useful lives are amortized over their estimated useful lives.
    The latest impairment assessment of goodwill and indefinite lived intangible assets was completed
    in the fiscal fourth quarter of 2010. Future impairment tests for goodwill and indefinite lived
    intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;January 2,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Intangible assets with definite lives:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Patents and trademarks &amp;#8212; gross
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,520&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,660&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less accumulated amortization
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,819&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,629&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Patents and trademarks &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,701&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,031&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other intangibles &amp;#8212; gross
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,609&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,674&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less accumulated amortization
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,048&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,880&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other intangibles &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,561&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,794&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Intangible assets with indefinite lives:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Trademarks
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,080&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,954&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Purchased in-process research and development
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,036&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,937&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total intangible assets with indefinite lives
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,116&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,891&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total intangible assets &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;18,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16,716&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the Company reclassified $971&amp;#160;million from purchased
    in-process research and development to amortizable other intangibles to reflect the
    commercialization of ZYTIGA&amp;#174;.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Goodwill as of July&amp;#160;3, 2011 was allocated by segment of business as follows:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Med Dev&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Consumer&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Pharm&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#038; Diag&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Total&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goodwill, net at January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;8,144&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,225&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,925&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,294&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Acquisitions
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Currency translation/Other
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;320&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;52&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;39&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;411&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goodwill, net as of July&amp;#160;3, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;8,464&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,815&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,964&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16,243&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The weighted average amortization periods for patents and trademarks and other intangible assets
    are 17&amp;#160;years and 27&amp;#160;years, respectively. The amortization expense of amortizable intangible assets
    for the fiscal six months ended July&amp;#160;3, 2011 was $402&amp;#160;million, and the estimated amortization
    expense for the five succeeding years approximates $840&amp;#160;million, per year.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:FairValueDisclosuresTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 4 - us-gaap:FairValueDisclosuresTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 4 &amp;#8212; FAIR VALUE MEASUREMENTS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company uses forward exchange contracts to manage its exposure to the variability of cash
    flows, primarily related to the foreign exchange rate changes of future intercompany product and
    third- party purchases of raw materials denominated in foreign currency. The Company also uses
    cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both
    types of derivatives are designated as cash flow hedges. The Company also uses forward exchange
    contracts to manage its exposure to the variability of cash flows for repatriation of foreign
    dividends. These contracts are designated as net investment hedges. Additionally, the Company
    uses forward exchange contracts to offset its exposure to certain foreign currency assets and
    liabilities. These forward exchange contracts are not designated as hedges, and therefore, changes
    in the fair values of these derivatives are recognized in earnings, thereby offsetting the current
    earnings effect of the related foreign currency assets and liabilities. The Company does not enter
    into derivative financial instruments for trading or speculative
    purposes, or that contain credit risk
    related contingent features or requirements to post collateral. On an ongoing basis, the Company
    monitors counterparty credit ratings. The Company considers credit non-performance risk to be low,
    because the Company enters into agreements with commercial institutions that have at least an A (or
    equivalent) credit rating. As of July&amp;#160;3, 2011, the Company had notional amounts outstanding for
    forward foreign exchange contracts and cross currency interest rate swaps of $23&amp;#160;billion and $3
    billion, respectively.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair
    value of derivatives are recorded each period in current earnings or other comprehensive income,
    depending on whether the derivative is designated as part of a hedge transaction, and if so, the
    type of hedge transaction.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the Company entered into an option to hedge the currency
    risk associated with the cash portion of the payment for the planned acquisition of Synthes, Inc.
    The option was not designated as a hedge, and therefore, the change in the fair value of the option
    of $102&amp;#160;million was recognized as Other Income in the fiscal second quarter of 2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
    designation as a cash flow hedge is made at the entrance date of the derivative contract. At
    inception, all derivatives are expected to be highly effective. Changes in the fair value of a
    derivative that is designated as a cash flow hedge and is highly effective are recorded in
    accumulated other comprehensive income
    until the underlying transaction affects earnings, and are
    then reclassified to earnings in the same account as the hedged transaction. Gains/losses on net
    investment hedges are accounted for through the currency translation account and are insignificant.
    On an ongoing basis, the Company assesses whether each derivative continues to be highly effective
    in offsetting changes in the cash flows of hedged items. If and when a derivative is no longer
    expected to be highly effective, hedge accounting is discontinued. Hedge ineffectiveness, if any,
    is included in current period earnings in other (income)/expense, net, and was not material for the
    fiscal quarters ended July&amp;#160;3, 2011 and July
    4, 2010. Refer to Note 7 for disclosures of movements in Accumulated Other Comprehensive Income.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;As of July&amp;#160;3, 2011, the balance of deferred net gains on derivatives included in accumulated other
    comprehensive income was $228&amp;#160;million after-tax. For additional information, see Note 7. The
    Company expects that substantially all of the amounts related to foreign exchange contracts will be
    reclassified into earnings over the next 12&amp;#160;months as a result of transactions that are expected to
    occur over that period. The maximum length of time over which the Company is hedging transaction
    exposure is 18&amp;#160;months excluding interest rate swaps. The amount ultimately realized in earnings
    will differ as foreign exchange rates change. Realized gains and losses are ultimately determined
    by actual exchange rates at maturity of the derivative.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table is a summary of the activity related to derivatives designated as hedges for
    the fiscal second quarters in 2011 and 2010:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="28%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;reclassified&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;from&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;OCI&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;into income&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;income/expense&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;Cash Flow Hedges&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(53&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(A)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(20&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(102&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(44&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(76&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(B)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(149&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;44&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;18&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(C)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(31&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(82&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(16&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(D)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;35&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(E)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(158&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(40&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(54&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(133&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)
    &lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 0pt"&gt;
    All amounts shown in the table above are net of tax.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table is a summary of the activity related to derivatives designated as hedges for
    the first fiscal six months in 2011 and 2010:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="28%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;reclassified&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;from&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;OCI&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;into income&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;income/expense&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;Cash Flow Hedges&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(84&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(10&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(29&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(A)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(21&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;92&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(206&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(106&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(98&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(B)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(154&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;73&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;21&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(C)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(40&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(49&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(18&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(D)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(59&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;81&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(E)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(185&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(118&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(96&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(139&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;All amounts shown in the table above are net of tax.
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Effective portion&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Ineffective portion&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(A)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Sales to customers&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(B)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Cost of products sold&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(C)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Research and development expense&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(D)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Interest (income)/Interest expense, net&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(E)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Other (income)/expense, net&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;For the fiscal second quarters ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010, a loss of $7&amp;#160;million and $21
    million, respectively, were recognized in Other (income)/expense, net, relating to foreign exchange
    contracts not designated as hedging instruments.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;For the
    first fiscal six months ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010, a gain of $8&amp;#160;million and a
    loss of $69&amp;#160;million, respectively, were recognized in Other (income)/expense, net, relating to
    foreign exchange contracts not designated as hedging instruments.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Fair value is the exit price that would be received to sell an asset or paid to transfer a
    liability. Fair value is a market-based measurement that is determined using assumptions that
    market participants would use in pricing an asset or liability. The authoritative literature
    establishes a three-level hierarchy to
    prioritize the inputs used in measuring fair value. The
    levels within the hierarchy are described below with Level 1 having the highest priority and Level
    3 having the lowest.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The fair value of a derivative financial instrument (i.e. forward exchange contract or currency
    swap) is the aggregation by currency of all future cash flows discounted to its present value at
    the prevailing market interest rates and subsequently converted to the U.S. dollar at the current
    spot foreign exchange rate. The Company does not believe that fair values of these derivative
    instruments materially differ from the amounts that could be realized upon settlement or maturity,
    or that the changes in fair value will have a material effect on the Company&amp;#8217;s results of
    operations, cash flows or financial position. The Company also holds equity investments which are
    classified as Level 1 because they are traded in an active exchange market. The Company did not
    have any other significant financial assets or liabilities which would require revised valuations
    under this standard that are recognized at fair value.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following three levels of inputs are used to measure fair value:
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Level 1 &amp;#8212; Quoted prices in active markets for identical assets and liabilities.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Level 2 &amp;#8212; Significant other observable inputs.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Level 3 &amp;#8212; Significant unobservable inputs.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company&amp;#8217;s significant financial assets and liabilities measured at fair value as of July&amp;#160;3,
    2011 and January&amp;#160;2, 2011 were as follows:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="40%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 0px solid #000000"&gt;&lt;b&gt;July 3, 2011&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&lt;b&gt;January 2, 2011&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Derivatives designated as hedging instruments:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Assets:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;487&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;487&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;321&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;17&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Total&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;338&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Liabilities:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;646&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;646&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;586&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(3)&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;404&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;404&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;502&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Total&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,050&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,050&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,088&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Derivatives not designated as hedging instruments:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Assets:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Swiss Franc Option*
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Liabilities:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;39&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Other Investments&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(4)&lt;/b&gt;&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,371&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,371&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,165&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Currency option related to the planned acquisition of Synthes, Inc.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;As of January&amp;#160;2, 2011, these assets and liabilities are classified as Level 2 with the exception
    of Other Investments of $1,165 which are classified as Level 1.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes $2&amp;#160;million and $14&amp;#160;million of non-current assets for July&amp;#160;3, 2011 and January&amp;#160;2, 2011,
    respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(3)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes $404&amp;#160;million and $502&amp;#160;million of non-current liabilities for July&amp;#160;3, 2011 and January
    2, 2011, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(4)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Classified as non-current other assets.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Financial Instruments not measured at Fair Value:
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following financial assets and liabilities are held at carrying amount on the consolidated
    balance sheet as of July&amp;#160;3, 2011:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Carrying&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Estimated&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Amount&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Fair Value&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Financial Assets&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Current Investments&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cash
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2,299&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,299&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Government securities and obligations
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23,951&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23,951&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Corporate debt securities
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;515&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;515&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Money market funds
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,820&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,820&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Time deposits
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,097&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,097&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total cash, cash equivalents and current marketable securities
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;29,682&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;29,682&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td colspan="9" align="left"&gt;Fair value of government securities and
    obligations and non-current marketable
    securities was estimated using quoted broker prices
    in active
    markets.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Current Debt&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;5,046&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,046&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Non-Current Debt&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.15% Debentures due 2012
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;599&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;632&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;0.70% Notes due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;503&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3.80% Debentures due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;527&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3&amp;#160;month LIBOR&amp;#043;0% FRN due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3&amp;#160;month LIBOR&amp;#043;0.09% FRN due 2014
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;750&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;750&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;1.20% Notes due 2014
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;999&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,006&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2.15% Notes due 2016
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;898&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;903&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.55% Debentures due 2017
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,000&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,161&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.15% Debentures due 2018
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;898&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,015&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.75% Notes due 2019 (1B Euro 1.4476)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,440&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3% Zero Coupon Convertible Subordinated Debentures due in 2020
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;197&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;246&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2.95% Debentures due 2020
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;541&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;522&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3.55% Notes due 2021
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;446&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;456&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;6.73% Debentures due 2023
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;250&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;323&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.50% Notes due 2024 (500 GBP1.6025)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;795&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;856&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;6.95% Notes due 2029
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;294&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;375&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.95% Debentures due 2033
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;523&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.95% Notes due 2037
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;995&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,120&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.86% Debentures due 2038
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;700&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;773&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.50% Debentures due 2040
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;539&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.85% Notes due 2041
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;298&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;291&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other (Includes Industrial Revenue Bonds)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;41&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;41&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total Non-Current Debt
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;13,680&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;14,581&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The weighted average effective rate on non-current debt is 4.08%.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Fair value of the non-current debt was estimated using market prices, which were corroborated by
    quoted broker prices in active markets.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:FairValueDisclosuresTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 5 - us-gaap:IncomeTaxDisclosureTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 5 &amp;#8212; INCOME TAXES
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The worldwide effective income tax rates for the first fiscal six months of 2011 and 2010 were
    21.2% and 24.0%, respectively. The lower effective tax rate was due to higher income in lower tax
    jurisdictions and the U.S. Research and Development tax credit, which was not in effect for the
    first fiscal six months of 2010. Additionally, in 2010 the Company had litigation gains in high tax
    jurisdictions.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;/div&gt;
  </us-gaap:IncomeTaxDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 6 - us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;NOTE 6 &amp;#8212; PENSIONS AND OTHER POSTRETIREMENT BENEFITS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Components of Net Periodic Benefit Cost
    Net periodic benefit cost for the Company&amp;#8217;s defined benefit retirement plans and other benefit
    plans for the fiscal second quarters of 2011 and 2010 include the following components:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="52%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Retirement Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Other Benefit Plans&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Service cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;144&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;121&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;37&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;33&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Interest cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;214&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;194&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;46&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;50&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expected return on plan assets
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(277&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(248&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of prior service cost/(credit)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of net transition obligation
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Recognized actuarial losses
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;98&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;59&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net periodic benefit cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;181&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;130&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Net periodic benefit cost for the Company&amp;#8217;s defined benefit retirement plans and other benefit
    plans for the first fiscal six months of 2011 and 2010 include the following components:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="52%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Retirement Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Other Benefit Plans&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Service cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;287&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;247&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;74&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;67&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Interest cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;427&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;394&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;100&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expected return on plan assets
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(555&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(500&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of prior service cost/(credit)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of net transition obligation
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Recognized actuarial losses
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;194&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;117&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net periodic benefit cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;358&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;265&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;189&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;189&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Company Contributions&lt;br /&gt;
    For the fiscal six months ended July&amp;#160;3, 2011, the Company contributed $119&amp;#160;million and $16&amp;#160;million
    to its U.S. and international retirement plans, respectively. The Company plans to continue to fund
    its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International
    plans are funded in accordance with local regulations.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 7 - us-gaap:ComprehensiveIncomeNoteTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 7 &amp;#8212; ACCUMULATED OTHER COMPREHENSIVE INCOME
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Total comprehensive income for the fiscal six months ended July&amp;#160;3, 2011 was $8.6&amp;#160;billion, compared
    with $5.3&amp;#160;billion for the same period a year ago. Total comprehensive income for the fiscal second
    quarter ended July&amp;#160;3, 2011 was $3.6&amp;#160;billion, compared with $1.6&amp;#160;billion for the same period a year
    ago. Total comprehensive income included net earnings, net unrealized currency gains and losses on
    translation, net unrealized gains and losses on securities available for sale, adjustments related
    to employee benefit plans, and net gains and losses on derivative instruments qualifying and
    designated as cash flow hedges. The following table sets forth the components of accumulated other
    comprehensive income.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="40%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Total&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Accum&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Other&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Foreign&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Securities&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Employee&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Deriv.&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Comp.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;Gains/(Losses)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Currency&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Available&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Benefit&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#038;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Income/&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Translation&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;for sale&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Hedges&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;(Loss)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(969&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;24&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2,686&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;100&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(3,531&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2011 six months change
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:30px; text-indent:-15px"&gt;Unrealized gain (loss)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;435&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:30px; text-indent:-15px"&gt;Net amount reclassed to net earnings
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(139&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;116&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net six months change
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,787&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;296&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;128&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;128&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,339&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;July&amp;#160;3, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;818&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;320&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2,558&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;228&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1,192&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Substantially offset in net earnings by changes in value of the underlying transactions.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Amounts in accumulated other comprehensive income are presented net of the related tax impact.
    Foreign currency translation adjustments are not currently adjusted for income taxes as they relate
    to permanent investments in international subsidiaries.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ComprehensiveIncomeNoteTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:EarningsPerShareTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 8 - us-gaap:EarningsPerShareTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 8 &amp;#8212; EARNINGS PER SHARE
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal second quarters ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Shares in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Basic net earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.01&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; basic
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,740.5&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,756.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Potential shares exercisable under stock option plans
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;168.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;175.5&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less: shares which could be repurchased under treasury stock method
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(131.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(139.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Convertible debt shares
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; diluted
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,781.3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,796.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Diluted earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.00&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.23&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The diluted earnings per share calculation for both fiscal second quarters ended July&amp;#160;3, 2011 and
    July&amp;#160;4, 2010 included the dilutive effect of convertible debt that was offset by the related
    reduction in interest expense.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The diluted earnings per share calculation for the fiscal second quarters ended July&amp;#160;3, 2011 and
    July&amp;#160;4, 2010, excluded 51&amp;#160;million and 68&amp;#160;million shares, respectively, related to stock options,
    as the exercise price of these options was greater than their average market value, which would
    result in an anti-dilutive effect on diluted earnings per share.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal six months ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Shares in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Basic net earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.89&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; basic
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,739.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,755.7&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Potential shares exercisable under stock option plans
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;168.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;175.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less: shares which could be repurchased under treasury stock method
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(133.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(138.6&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Convertible debt shares
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; diluted
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,778.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,796.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Diluted earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.85&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The diluted earnings per share calculation for both the fiscal six months ended July&amp;#160;3, 2011 and
    July&amp;#160;4, 2010 included the dilutive effect of convertible debt that was offset by the related
    reduction in interest expense.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The diluted earnings per share calculation for the fiscal six months ended July&amp;#160;3, 2011 and July&amp;#160;4,
    2010 excluded 52&amp;#160;million and 68&amp;#160;million shares related to stock options, as the exercise price of
    these options was greater than their average market value, which would result in an anti-dilutive
    effect on diluted earnings per share.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;/div&gt;
  </us-gaap:EarningsPerShareTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 9 - us-gaap:SegmentReportingDisclosureTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 9 &amp;#8212; SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;SALES BY SEGMENT OF BUSINESS
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,339&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,463&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(8.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,454&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,184&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,793&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,647&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,239&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,110&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,994&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,443&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;22.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,233&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,553&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,869&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,865&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,702&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,265&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,571&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,130&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,447&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,438&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9,150&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,892&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;16,597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,330&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2,684&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;3,023&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(11.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,791&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,390&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,475&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,413&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,630&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,316&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,662&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,875&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12,292&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11,191&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,741&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,751&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,262&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,606&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13,003&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12,357&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,055&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,090&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;17,715&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,871&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;32,770&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;30,961&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;OPERATING PROFIT BY SEGMENT OF BUSINESS
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;549&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;669&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(17.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical (1)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,714&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,833&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(6.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics (2)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,275&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,876&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(32.0&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Segments operating profit
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(19.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expense not allocated to segments (3)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(116&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(158&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide income before taxes
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;3,422&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;4,220&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(18.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,122&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,454&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(22.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical (1)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,923&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,803&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics (2)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,219&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,578&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(42.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Segments operating profit
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,264&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;10,835&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(23.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expense not allocated to segments (3)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(332&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(335&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide income before taxes
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,932&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;10,500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(24.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes litigation expense of $290&amp;#160;million and $540&amp;#160;million recorded in the fiscal second
    quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011
    includes a gain related to the Company&amp;#8217;s earlier investment in Crucell recorded in the fiscal first
    quarter of 2011. The fiscal second quarter and the first fiscal six
    months of 2010, includes net litigation expense of $115&amp;#160;million and $202&amp;#160;million, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes restructuring expense of $676&amp;#160;million recorded in the fiscal second quarter and first
    fiscal six months of 2011. Includes litigation expense and additional DePuy ASR&amp;#8482; Hip recall costs
    of $127&amp;#160;million recorded in the fiscal second quarter of 2011. Includes litigation expense and
    additional DePuy ASR&amp;#8482; Hip recall costs of $223&amp;#160;million recorded in the first fiscal six months of
    2011. Includes net litigation expense of $42&amp;#160;million and income of $1,542&amp;#160;million recorded in the
    fiscal second quarter and the first fiscal six months of 2010, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(3)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Amounts not allocated to segments include interest income/(expense), non-controlling interests
    and general corporate income/(expense).&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;SALES BY GEOGRAPHIC AREA
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,447&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,438&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Europe
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,543&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,832&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;18.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Western Hemisphere, excluding U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,543&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,375&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Asia-Pacific, Africa
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,064&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,685&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;14.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;16,597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,330&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,055&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,090&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Europe
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,726&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,934&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;10.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Western Hemisphere, excluding U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,979&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,655&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Asia-Pacific, Africa
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,282&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;32,770&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;30,961&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SegmentReportingDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 10 - us-gaap:BusinessCombinationDisclosureTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 10&amp;#8212; BUSINESS COMBINATIONS AND DIVESTITURES
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the Company entered into a definitive agreement to
    acquire Synthes, Inc. for approximately
    $21.3&amp;#160;billion, approximately $19.3&amp;#160;billion net of cash
    acquired, subject to the terms of the merger agreement and currency values at the time of closing.
    Under the terms of the agreement, each share of Synthes common stock, subject to certain
    conditions, will be exchanged for approximately 35% in cash and 65%
    in Johnson &amp;#38; Johnson common
    stock. Synthes, Inc. is a premier global developer and manufacturer of orthopaedics devices.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2011, the Company acquired substantially all of the outstanding
    equity of Crucell N.V. that it did not already own. Crucell is a global biopharmaceutical company
    focused on the research and development, production and marketing of vaccines and antibodies
    against infectious disease worldwide. The net purchase price of $2.0&amp;#160;billion was allocated
    primarily to non-amortizable intangible assets for $1.0&amp;#160;billion, amortizable intangible assets for
    $0.7&amp;#160;billion and goodwill for $0.5&amp;#160;billion.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2010, the Company acquired RespiVert Ltd., a privately held
    drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of
    pulmonary diseases.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2010, the Company acquired Acclarent, Inc., a medical technology
    company dedicated to designing, developing and commercializing devices that address conditions
    affecting the ear, nose and throat, for a net purchase price of $0.8&amp;#160;billion. The purchase price
    for the acquisition was allocated primarily to amortizable intangible assets for $0.7&amp;#160;billion.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:BusinessCombinationDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 11 - us-gaap:LegalMattersAndContingenciesTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 11 &amp;#8212; LEGAL PROCEEDINGS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Johnson &amp;#038; Johnson (the Company) and certain of its subsidiaries are involved in various lawsuits
    and claims regarding product liability, intellectual property, commercial and other matters;
    governmental investigations; and other legal proceedings that arise from time to time in the
    ordinary course of their business.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company records accruals for such contingencies when it is probable that a liability will be
    incurred and the amount of the loss can be reasonably estimated. Through the period ended July&amp;#160;3,
    2011, the Company has determined that the liabilities associated with certain litigation matters
    are probable and can be reasonably estimated. The Company has accrued for these matters and will
    continue to monitor each related legal issue and adjust accruals for new information and further
    developments in accordance with ASC 450-20-25. For these and other litigation and regulatory
    matters currently disclosed for which a loss is probable or reasonably possible, the Company is
    unable to determine an estimate of the possible loss or range of loss beyond the amounts already
    accrued. These matters can be affected by various factors, including damages sought in the
    proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced
    or is not complete; proceedings are in early stages; matters present legal uncertainties; there are
    significant facts in dispute; there are numerous parties involved.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In the Company&amp;#8217;s opinion, based on its examination of these matters, its experience to date and
    discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in
    the Company&amp;#8217;s balance sheet, is not expected to have a material adverse effect on the Company&amp;#8217;s
    financial position, although the resolution in any reporting period of one or more of these
    matters, either alone or in the aggregate, may have a material adverse effect on the Company&amp;#8217;s
    results of operations, and cash flows for that period.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;&lt;b&gt;PRODUCT LIABILITY&lt;/b&gt;&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company&amp;#8217;s subsidiaries are involved in numerous product liability cases in the United States,
    many of which concern alleged adverse reactions to drugs and medical devices. The damages claimed
    are substantial, and while the Company&amp;#8217;s subsidiaries are confident of the adequacy of the warnings
    and instructions for use that accompany such products, it is not feasible to predict the ultimate
    outcome of litigation. The Company has established product liability reserves based on currently
    available information, which in some cases may be limited, and changes to the reserves may be
    required in the future as additional information becomes available.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Multiple products of the Company&amp;#8217;s subsidiaries are subject to numerous product liability claims
    and lawsuits. There are a significant number of claimants who have pending lawsuits or claims
    regarding injuries allegedly due to ORTHO EVRA&amp;#174;, RISPERDAL&amp;#174;, LEVAQUIN&amp;#174;, DURAGESIC&amp;#174;/fentanyl
    patches, pelvic meshes, the CHARIT&amp;#201;&amp;#8482; Artificial Disc, CYPHER&amp;#174; Stent, and ASR&amp;#8482; Hip. These claimants
    seek substantial compensatory and, where available, punitive damages.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In August&amp;#160;2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR&amp;#8482;
    XL Acetabular System and DePuy ASR&amp;#8482; Hip Resurfacing System used in hip replacement surgery. Claims
    for personal injury have been made against DePuy and the Company. The Company has received limited
    information to date with respect to potential claims and other costs associated with this recall.
    The Company&amp;#8217;s product liability reserve has been increased in part due to an increase in
    anticipated product liability litigation expense and costs associated with the DePuy ASR&amp;#8482; Hip
    recall program. Changes to the reserve may be required in the future as additional information
    becomes available. The ultimate resolution of these matters is not
    expected to have a material adverse effect on the Company&amp;#8217;s
    financial position, although  the resolution in any reporting period
    could have a material impact on the Company&amp;#8217;s results of
    operations and cash flows for that period.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;&lt;b&gt;INTELLECTUAL PROPERTY&lt;/b&gt;&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Certain of the Company&amp;#8217;s subsidiaries are subject, from time to time, to legal proceedings and
    claims related to patent, trademark and other intellectual property matters arising out of their
    business. The most significant of these matters are described below.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;&lt;font style="font-variant: small-caps"&gt;&lt;u&gt;PATENT INFRINGEMENT&lt;/u&gt;&lt;/font&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Certain of the Company&amp;#8217;s subsidiaries are involved in lawsuits challenging the coverage and/or
    validity of the patents on their products. Although the Company&amp;#8217;s subsidiaries believe that they
    have substantial defenses to these challenges with respect to all material patents, there can be no
    assurance as to the outcome of these matters, and a loss in any of these cases could potentially
    adversely affect the ability of the Company&amp;#8217;s subsidiaries to sell their products, or require the
    payment of past damages and future royalties.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;MEDICAL DEVICES &amp;#038; DIAGNOSTICS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In October&amp;#160;2004, Tyco Healthcare Group, LP, (Tyco) and U.S. Surgical Corporation filed a lawsuit
    against Ethicon Endo-Surgery, Inc. (EES)&amp;#160;in the United States District Court for the District of
    Connecticut alleging that several features of EES&amp;#8217;s HARMONIC&amp;#174; scalpel infringed four
    Tyco patents. In October&amp;#160;2007, on motions for summary judgment prior to the initial trial, a number
    of claims were found invalid and a number were found infringed. However, no claim was found both
    valid and infringed. Trial commenced in December&amp;#160;2007, and the court dismissed the case without
    prejudice on grounds that Tyco did not own the patents in suit. The dismissal without prejudice was
    affirmed on appeal. In January&amp;#160;2010, Tyco filed another complaint in the United States District
    Court for the District of Connecticut asserting infringement of three of the four patents from the
    previous lawsuit and adding new products. Tyco is seeking monetary damages and injunctive relief.
    This case is scheduled to be tried in October&amp;#160;2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in March&amp;#160;2006, Cordis Corporation (Cordis) filed patent infringement lawsuits in the
    United States District Courts for the Districts of New Jersey and Delaware, against Guidant
    Corporation (Guidant), Abbott Laboratories, Inc. (Abbott), Boston Scientific Corporation (Boston
    Scientific) and Medtronic Ave, Inc. (Medtronic) alleging that the Xience V&amp;#8482; (Abbott), Promus&amp;#8482;
    (Boston Scientific) and Endeavor&amp;#174; (Medtronic) drug eluting stents infringe several of Cordis&amp;#8217;s
    Wright/Falotico patents. Cordis is seeking monetary relief. In January&amp;#160;2010, in one of the cases
    against Boston Scientific, the United States District Court for the District of Delaware found the
    Wright/Falotico patents invalid for lack of written description and/or lack of enablement. In June
    2011, the Court of Appeals for the Federal Circuit affirmed the ruling, and Cordis moved for the
    Court to reconsider that decision.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In October&amp;#160;2007, Bruce Saffran (Saffran) filed a patent infringement lawsuit against the Company
    and Cordis in the United States District Court for the Eastern District of Texas alleging
    infringement on U.S. Patent No.&amp;#160;5,653,760. In January&amp;#160;2011, a jury returned a verdict finding that
    Cordis&amp;#8217;s sales of its CYPHER&amp;#174; stent willfully infringed a patent issued to Saffran. The jury
    awarded Saffran $482&amp;#160;million. In March&amp;#160;2011, the Court entered judgment against Cordis in the
    amount of $593&amp;#160;million, representing the jury verdict, plus $111&amp;#160;million in pre-judgment
    interest.
    Cordis has moved for the District Court to overturn the jury verdict and to vacate the judgment.
    If that motion is denied, Cordis will appeal the judgment. Because the Company believes that the
    potential for an unfavorable outcome is not probable, it has not established a reserve with respect
    to the case.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In November&amp;#160;2007, Roche Diagnostics Operations, Inc., et al. (Roche) filed a patent infringement
    lawsuit against LifeScan, Inc. (LifeScan) in the United States District Court for the District of
    Delaware, accusing LifeScan&amp;#8217;s entire OneTouch&amp;#174; line of blood glucose monitoring systems of
    infringement of two patents related to the use of microelectrode sensors. In September&amp;#160;2009,
    LifeScan obtained a favorable ruling on claim construction that precluded a finding of
    infringement. The Court entered judgment against Roche in July&amp;#160;2010 and Roche appealed. Briefing
    on appeal issues has been completed. Oral argument will be held in
    fall 2011. Roche is seeking
    monetary damages and injunctive relief.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in February&amp;#160;2008, Cordis filed patent infringement lawsuits in the United States District
    Court for the District of New Jersey against Guidant, Abbott, Boston Scientific and Medtronic
    alleging that the Xience V&amp;#8482; (Abbott), Promus&amp;#8482; (Boston Scientific) and Endeavor&amp;#174; (Medtronic) drug
    eluting stents infringe several of Wyeth&amp;#8217;s (now Pfizer Inc.) Morris patents, which have been
    licensed to Cordis. Cordis is seeking monetary relief. Trial is scheduled for September&amp;#160;2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In June&amp;#160;2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit
    against Johnson &amp;#038; Johnson Vision Care, Inc. (JJVC)&amp;#160;in the United States District Court for the
    Eastern District of Texas alleging that JJVC&amp;#8217;s manufacture and sale of its ACUVUE ADVANCE&amp;#174; and
    ACUVUE&amp;#174; OASYS&amp;#8482; HYDROGEL contact lenses infringe their U.S. Patent No.&amp;#160;5,712,327 (the Chang patent).
    Rembrandt is seeking monetary relief. The case is scheduled for trial in May&amp;#160;2012.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;PHARMACEUTICAL
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
    April&amp;#160;2007, Centocor, Inc. (Centocor) (now Janssen Biotech, Inc. (JBI)) filed a patent infringement lawsuit against Abbott Laboratories,
    Inc. (Abbott) in the United States District Court for the Eastern District of Texas alleging that
    Abbott&amp;#8217;s HUMIRA&amp;#174; anti-TNF alpha product infringes Centocor&amp;#8217;s U.S. Patent 7,070,775. In June&amp;#160;2009,
    a jury returned a verdict finding the patent valid and infringed, and awarded JBI damages of
    approximately $1.7&amp;#160;billion. In February&amp;#160;2011, the Court of Appeals reversed the June&amp;#160;2009 decision
    and the judgment of the District Court. JBI will file a petition for
    review of the decision in the United
    States Supreme Court.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In May&amp;#160;2009, Abbott Biotechnology Ltd. (Abbott) filed a patent infringement lawsuit against
    Centocor (now JBI) in the United States District Court for
    the District of Massachusetts alleging that SIMPONI&amp;#174; infringes Abbott&amp;#8217;s U.S. Patent Nos. 7,223,394
    and 7,451,031 (the Salfeld patents). Abbott is seeking monetary damages and injunctive relief. No
    trial date has been set.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In August&amp;#160;2009, Abbott GmbH &amp;#038; Co. (Abbott GmbH) and Abbott Bioresearch Center filed a patent
    infringement lawsuit against Centocor (now JBI) in the United States District Court for the
    District of Massachusetts alleging that STELARA&amp;#174; infringes two United States patents assigned to
    Abbott GmbH. JBI filed a complaint in the United States District Court for the District of Columbia
    for a declaratory judgment of non-infringement and invalidity of the Abbott GmbH patents, as well
    as a Complaint for Review of a Patent Interference Decision that granted priority of invention on
    one of the two asserted patents to Abbott GmbH. The
    cases have been transferred from the District
    of Columbia to the District of Massachusetts. Discovery in these cases is ongoing. No trial date
    has been set. Also in August&amp;#160;2009, Abbott GmbH and Abbott Laboratories Limited brought a patent
    infringement lawsuit in The Federal Court of Canada alleging that STELARA&amp;#174; infringes Abbott GmbH&amp;#8217;s
    Canadian patent. The Canadian case is scheduled to be tried in October&amp;#160;2012. In each of these
    cases, Abbott is seeking monetary damages and injunctive relief.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In August&amp;#160;2009, Bayer HealthCare LLC (Bayer) filed a patent infringement lawsuit against Centocor
    Ortho Biotech Inc. (now JBI) in United States District Court for the District of Massachusetts
    alleging that the manufacture and sale by JBI of SIMPONI&amp;#174; infringes a Bayer patent relating to
    human anti-TNF antibodies. In January&amp;#160;2011, the court issued judgment dismissing Bayer&amp;#8217;s
    infringement claims. Bayer appealed this ruling. In addition, in November&amp;#160;2009, Bayer filed a
    lawsuit under its European counterpart to these patents in Germany and the Netherlands. The court
    in the Netherlands held the Dutch patent invalid and entered judgment in favor of JBI&amp;#8217;s European
    affiliate, Janssen Biologics B.V. Bayer appealed that judgment in the Netherlands. In addition,
    in March&amp;#160;2010, Janssen-Cilag NV filed a revocation action in the High Court in London seeking to
    invalidate Bayer&amp;#8217;s UK patent relating to human anti-TNF antibodies. In May&amp;#160;2011, JBI settled all
    of these cases and received a paid-up, royalty-free license to the family of patents in suit.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;LITIGATION AGAINST FILERS OF ABBREVIATED NEW DRUG APPLICATIONS (ANDAs)&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following summarizes lawsuits pending against generic companies that filed Abbreviated New Drug
    Applications (ANDAs) seeking to market generic forms of products sold by various subsidiaries of
    the Company prior to expiration of the applicable patents covering those products. These ANDAs
    typically include allegations of non-infringement, invalidity and unenforceability of these
    patents. In the event the Company&amp;#8217;s subsidiaries are not successful in these actions, or the
    statutory 30-month stays expire before the District Court rulings are obtained, the third-party
    companies involved will have the ability, upon approval of the United States Food and Drug
    Administration (FDA), to introduce generic versions of the products at issue resulting in very
    substantial market share and revenue losses for those products.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;CONCERTA&amp;#174;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In January&amp;#160;2010, ALZA Corporation (ALZA)&amp;#160;and Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI)
    (now Janssen Pharmaceuticals, Inc. (JPI)) filed a patent infringement lawsuit in the United States
    District Court for the District of Delaware against Kremers-Urban, LLC and KUDCO Ireland, Ltd.
    (collectively, KUDCO) in response to KUDCO&amp;#8217;s ANDA seeking approval to market a generic version of
    CONCERTA&amp;#174; before the expiration of two of ALZA and JPI&amp;#8217;s patents relating to CONCERTA&amp;#174;. KUDCO filed
    counterclaims alleging non-infringement and invalidity. ALZA and JPI subsequently removed one of
    the patents from the lawsuit.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In November&amp;#160;2010, ALZA and OMJPI (now JPI) filed a patent infringement lawsuit in the United States
    District Court for the District of Delaware against Impax Laboratories, Inc. (Impax), Teva
    Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. (collectively, Teva) in response
    to Impax and Teva&amp;#8217;s filing of a major amendment to its ANDA seeking approval to market a generic
    version of CONCERTA&amp;#174; before the expiration of ALZA and JPI&amp;#8217;s patent relating to CONCERTA&amp;#174;. Impax
    and Teva filed counterclaims alleging non-infringement and invalidity. In May&amp;#160;2011, Alza and JPI
    filed a second lawsuit against Teva in response to Teva&amp;#8217;s filing of a second major amendment to its
    ANDA seeking approval to market additional dosage strengths of its generic CONCERTA&amp;#174; product before
    the expiration of Alza and JPI&amp;#8217;s patent relating to CONCERTA&amp;#174;. In each of the above cases, ALZA and
    JPI are seeking an Order enjoining the defendants from marketing its generic version of CONCERTA&amp;#174;
    prior to the expiration of ALZA and JPI&amp;#8217;s CONCERTA&amp;#174; patent.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;ORTHO TRI-CYLEN&amp;#174;LO
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In October&amp;#160;2008, OMJPI (now JPI) and Johnson &amp;#038; Johnson Pharmaceutical Research &amp;#038; Development,
    L.L.C. (JJPRD)&amp;#160;filed a patent infringement lawsuit against Watson Laboratories, Inc. and Watson
    Pharmaceuticals, Inc. (collectively, Watson) in the United States District Court for the District
    of New Jersey in response to Watson&amp;#8217;s ANDA seeking approval to market a generic version of JPI&amp;#8217;s
    product prior to the expiration of JPI&amp;#8217;s patent relating to ORTHO TRI-CYCLEN&amp;#174; LO (the OTCLO
    patent). Watson filed a counterclaim alleging invalidity of the patent. In addition, in January
    2010, JPI filed a patent infringement lawsuit against Lupin Ltd. and Lupin Pharmaceuticals, Inc.
    (collectively, Lupin) in the United States District Court for the District of New Jersey in
    response to Lupin&amp;#8217;s ANDA seeking approval to market a generic version of ORTHO TRI-CYCLEN&amp;#174; LO prior
    to the expiration of the OTCLO patent. Lupin filed a counterclaim alleging invalidity of the
    patent. The Lupin and Watson cases have been consolidated.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In November&amp;#160;2010, OMJPI (now JPI) filed a patent infringement lawsuit against Mylan Inc. and Mylan
    Pharmaceuticals, Inc. (collectively, Mylan), and Famy Care, Ltd. (Famy Care) in the United States
    District Court for the District of New Jersey in response to Famy Care&amp;#8217;s ANDA seeking approval to
    market a generic version of ORTHO TRI-CYCLEN&amp;#174; LO prior to the expiration of the OTCLO patent.
    Mylan and Famy Care filed counterclaims alleging
    invalidity of the patent. In each of the above
    cases, JJPRD and/or JPI are seeking an Order enjoining the defendants from marketing their generic
    versions of ORTHO TRI-CYLCEN&amp;#174; LO before the expiration of the OTCLO patent.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;PREZISTA&amp;#174;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In November&amp;#160;2010, Tibotec, Inc. and Tibotec Pharmaceuticals, Inc. (collectively, Tibotec) filed a
    patent infringement lawsuit against Lupin, Ltd., Lupin Pharmaceuticals, Inc. (collectively, Lupin),
    Mylan, Inc. and Mylan Pharmaceuticals, Inc. (collectively, Mylan) in the United States District
    Court for the District of New Jersey in response to Lupin&amp;#8217;s and Mylan&amp;#8217;s respective ANDA&amp;#8217;s seeking
    approval to market generic versions of Tibotec&amp;#8217;s PREZISTA&amp;#174; product before the expiration of
    Tibotec&amp;#8217;s patent relating to PREZISTA&amp;#174;. Lupin and Mylan each filed counterclaims alleging
    non-infringement and invalidity.
    In July&amp;#160;2011,
    Tibotec filed another patent infringement lawsuit against Lupin in the United States
    District Court for the District of New Jersey in response to Lupin&amp;#8217;s supplement to its ANDA to add
    new dosage strengths for its proposed product.
    In August&amp;#160;2011, Tibotec and G.D. Searle &amp;#038; Company (G.D. Searle)
    filed a patent infringement lawsuit against Lupin and Mylan in response to their notice letters
    advising that their ANDAs are seeking approval to market generic versions of Tibotec&amp;#8217;s PREZISTA&amp;#174;
    product before the expiration of two patents relating to PREZISTA&amp;#174; that Tibotec exclusively
    licenses from G.D. Searle.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In March&amp;#160;2011, Tibotec and G.D. Searle  filed a patent infringement lawsuit
    against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Ltd. (collectively, Teva) in the
    United States District Court for the District of New Jersey in response to Teva&amp;#8217;s ANDA seeking
    approval to market a generic version of PREZISTA&amp;#174; before the expiration of certain patents relating
    to PREZISTA&amp;#174; that Tibotec either owns or exclusively licenses from G.D. Searle.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In March&amp;#160;2011, Tibotec filed a patent infringement lawsuit against Hetero Drugs, Ltd. Unit III and
    Hetero USA Inc. (collectively, Hetero) in the United States District Court for the District of New
    Jersey in response to Hetero&amp;#8217;s ANDA seeking approval to market a generic version of PREZISTA&amp;#174;
    before the expiration of certain patents relating to PREZISTA&amp;#174; that Tibotec exclusively licenses
    from G.D. Searle.
    In July 2011, upon agreement by the parties, the Court entered a stay of the lawsuit pending a final decision
    in the lawsuit  against Teva with respect to the validity and/or enforceability
    of the patents that Tibotec licenses from G.D. Searle, with Hetero agreeing to be bound by such final decision.
    In each of the above lawsuits, Tibotec is seeking an Order enjoining the
    defendants from marketing their generic versions of PREZISTA&amp;#174; before the expiration of the relevant
    patents.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;OTHER INTELLECTUAL PROPERTY MATTERS&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In September&amp;#160;2009, Centocor Ortho Biotech Products, L.P. (now Janssen Products, LP (JPLP))
    intervened in an inventorship lawsuit filed by the University of Kansas Center for Research, Inc.
    (KUCR)&amp;#160;against the United States of America (USA)&amp;#160;in the United States District Court for the
    District of Kansas. KUCR alleges that two KUCR scientists should be added as inventors on two
    USA-owned patents relating to VELCADE&amp;#174;. The USA licensed the patents
    (and their foreign
    counterparts) to Millennium Pharmaceuticals, Inc. (MPI), who in turn sublicensed the patents (and
    their foreign counterparts) to JPLP for commercial marketing outside the United States. In July
    2010, the parties reached a settlement agreement to resolve the disputes in this case and will
    submit the inventorship issue to arbitration. The case has been stayed pending the arbitration. As
    a result of the settlement agreement, the outcome of the arbitration regarding inventorship will
    determine whether pre-specified payments will be made to KUCR, but will not affect JPLP&amp;#8217;s right to
    market VELCADE&amp;#174;.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In December&amp;#160;2009, the State of Israel filed a lawsuit in the District Court in Tel Aviv Jaffa
    against various affiliates of Omrix Biopharmaceuticals, Inc. (Omrix). In the lawsuit, the State
    claims that an employee of a government-owned hospital was the inventor on several patents related
    to fibrin glue technology that the employee developed while he was a government employee. The State
    claims that he had no right to transfer any intellectual property to Omrix because it belongs to
    the State. The State is seeking damages plus royalties on QUIXIL&amp;#8482; and EVICEL&amp;#8482; or, alternatively,
    transfer of the patents to the State.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In January&amp;#160;2011, Genentech, Inc. (Genentech) initiated an arbitration against UCB Celltech
    (Celltech) seeking damages for allegedly cooperating with Centocor (now JBI) to improperly
    terminate a prior agreement in which JBI was sublicensed under Genentech&amp;#8217;s Cabilly patents. JBI
    has an indemnity agreement with Celltech, and Celltech has asserted that JBI is liable for any
    damages Celltech may be required to pay Genentech in that arbitration.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;&lt;b&gt;GOVERNMENT PROCEEDINGS&lt;/b&gt;&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Like other companies in the pharmaceutical and medical devices and diagnostics industries, the
    Company and certain of its subsidiaries are subject to extensive regulation by national, state and
    local government agencies in the United States and other countries in which they operate. As a
    result, interaction with government agencies is ongoing. The most significant litigation brought
    by, and investigations conducted by, government agencies are listed below. It is possible that
    criminal charges and substantial fines and/or civil penalties or damages could result from
    government investigations or litigation.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;AVERAGE WHOLESALE PRICE (AWP)&amp;#160;LITIGATION&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company and several of its pharmaceutical subsidiaries (the J&amp;#038;J AWP defendants), along with
    numerous other pharmaceutical companies, are defendants in a series of lawsuits in state and
    federal courts involving allegations that the pricing and marketing of certain pharmaceutical
    products amounted to fraudulent and otherwise actionable conduct because, among other things, the
    companies allegedly reported an inflated Average Wholesale Price (AWP)&amp;#160;for the drugs at issue.
    Payors alleged that they used those AWPs in calculating provider reimbursement levels.
    Many of these cases, both federal actions and state actions
    removed to federal court, were
    consolidated for pre-trial purposes in a Multi-District Litigation (MDL)&amp;#160;in the United States
    District Court for the District of Massachusetts.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The plaintiffs in these cases included three classes of private persons or entities that paid for
    any portion of the purchase of the drugs at issue based on AWP, and state government entities that
    made Medicaid payments for the drugs at issue based on AWP. In June&amp;#160;2007, after a trial on the
    merits, the MDL Court dismissed the claims of two of the plaintiff classes against the J&amp;#038;J AWP
    defendants from the case regarding all claims of Classes 2 and 3. In March&amp;#160;2011, the Court
    dismissed the claims of the third class against the J&amp;#038;J AWP defendants without prejudice.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;AWP cases brought by various Attorneys General have proceeded to trial against other manufacturers.
    Three state cases against certain of the Company&amp;#8217;s subsidiaries have been set for trial: Idaho in
    October&amp;#160;2011, Kentucky in January&amp;#160;2012 and Kansas in March&amp;#160;2013. Other state cases are likely to
    be set for trial. In addition, an AWP case against the J&amp;#038;J AWP defendants brought by the
    Commonwealth of Pennsylvania was tried in Commonwealth Court in October and November&amp;#160;2010. The
    Court found in the Commonwealth&amp;#8217;s favor with regard to certain of its claims under the Pennsylvania
    Unfair Trade Practices and Consumer Protection Law, entered an injunction, and awarded $45&amp;#160;million
    in restitution and $6.5&amp;#160;million in civil penalties. The Court found in the J&amp;#038;J AWP defendants&amp;#8217;
    favor on the Commonwealth&amp;#8217;s claims of unjust enrichment, misrepresentation/fraud, civil conspiracy,
    and on certain of the Commonwealth&amp;#8217;s claims under the Pennsylvania Unfair Trade Practices and
    Consumer Protection Law. The parties are currently awaiting a ruling on post trial motions, which,
    if necessary, will be followed by an appeal to the Pennsylvania Supreme Court. The Company
    believes that it has strong arguments supporting an appeal. Because the Company believes that the
    potential for an unfavorable outcome is not probable, it has not established a reserve with respect
    to the verdict.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;RISPERDAL&amp;#174;&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In January&amp;#160;2004, Janssen Pharmaceutica Inc. (Janssen) (now Janssen Pharmaceuticals, Inc. (JPI))
    received a subpoena from the Office of the Inspector General of the United States Office of
    Personnel Management seeking documents concerning sales and marketing of, any and all payments to
    physicians in connection with sales and marketing of, and clinical trials for, RISPERDAL&amp;#174; from 1997
    to 2002. Documents subsequent to 2002 have also been requested by the Department of Justice. An
    additional subpoena seeking information about marketing of, and adverse reactions to, RISPERDAL&amp;#174;
    was received from the United States Attorney&amp;#8217;s Office for the Eastern District of Pennsylvania in
    November&amp;#160;2005. Numerous subpoenas seeking testimony from various witnesses before a grand jury were
    also received. JPI cooperated in responding to these requests for documents and witnesses. The
    United States Department of Justice and the United States Attorney&amp;#8217;s Office for the Eastern
    District of Pennsylvania (the Government) are continuing to actively pursue both criminal and civil
    actions. In February&amp;#160;2010, the Government served Civil Investigative Demands seeking additional
    information
    relating to sales and marketing of RISPERDAL&amp;#174; and sales and marketing of INVEGA&amp;#174;. The
    focus of these matters is the alleged promotion of RISPERDAL&amp;#174; and INVEGA&amp;#174; for off-label uses. The
    Government has notified JPI that there are also pending qui tam actions alleging off-label
    promotion of RISPERDAL&amp;#174;. The Government informed JPI that it will intervene in these qui tam
    actions and file a superseding complaint.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Discussions have been ongoing in an effort to resolve criminal penalties under the Food Drug and
    Cosmetic Act related to the promotion of RISPERDAL&amp;#174;. An
    agreement in principal on key issues relevant
    to a disposition of criminal charges pursuant to a single misdemeanor violation of the Food Drug
    and Cosmetic Act has been reached, but certain issues remain open
    before a settlement can be
    finalized. The Company has adjusted the accrued amount in the second
    quarter of 2011 to cover the financial component of the
    proposed criminal settlement.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
    addition, discussions with state and federal government representatives to resolve the separate
    civil claims related to the marketing of RISPERDAL&amp;#174; and INVEGA&amp;#174;, including
    those under the False Claims Act (the qui
    tam actions), have been ongoing. The Company believes there are meritorious defenses to these
    claims, and it remains unclear whether a settlement can be reached as discovery is not complete,
    there are significant facts in dispute, the damages sought in the claims are unsubstantiated and
    indeterminate, there are numerous parties involved, and possible outcomes are uncertain. For these
    reasons, the Company is unable to estimate a range of loss. However, future negotiations may lead
    to a narrowing of the areas of disagreement and the liability may then become reasonably estimable
    in accordance with applicable accounting principles. If a negotiated resolution cannot be reached,
    civil litigation relating to the allegations of off-label promotion of RISPERDAL&amp;#174; and/or INVEGA&amp;#174; is
    likely. The ultimate resolution of the above criminal and these civil matters is not expected to
    have a material adverse effect on the Company&amp;#8217;s financial position, although the resolution in any
    reporting period could have a material impact on the Company&amp;#8217;s results of operations and cash flows
    for that period.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The
    Attorneys General of multiple states, including Alaska, Arkansas,
    Louisiana, Massachusetts, Mississippi, Montana, New Mexico,
    Pennsylvania, South Carolina, Texas and Utah, have pending actions against Janssen (now JPI) seeking
    one or more of the following remedies:
    reimbursement of Medicaid or other
    public funds for RISPERDAL&amp;#174; prescriptions written for off-label use, compensation for treating
    their citizens for alleged adverse reactions to RISPERDAL&amp;#174;, civil fines or penalties, damages for
    &amp;#8220;overpayments&amp;#8221; by the state and others, punitive damages,
    or other relief relating to alleged unfair business practices.
    Certain of these actions also seek injunctive relief relating to the
    promotion of RISPERDAL&amp;#174;. In the Texas matter, the Attorney General of
    Texas has joined a qui tam action in that state seeking similar
    relief, and the trial is scheduled to commence in late November&amp;#160;2011.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Attorney General of West Virginia commenced suit in 2004 against Janssen (now JPI) based on
    claims of alleged consumer fraud as to DURAGESIC&amp;#174;, as well as RISPERDAL&amp;#174;. JPI was found liable and
    damages were assessed at $4.5&amp;#160;million. JPI filed an appeal, and in November&amp;#160;2010, the West
    Virginia Supreme Court reversed the trial court&amp;#8217;s decision. In December&amp;#160;2010, the Attorney General
    of West Virginia dismissed the case as it related to RISPERDAL&amp;#174; without any payment. Thereafter,
    JPI settled the case insofar as it related to DURAGESIC&amp;#174;.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In 2004, the Attorney General of Louisiana filed a multi-count Complaint against Janssen (now JPI).
    The Company was later added as a defendant. The case was tried in October&amp;#160;2010. The issue tried
    to the jury was whether the Company or JPI had violated the State&amp;#8217;s Medicaid Fraud Act (the Act)
    through misrepresentations allegedly made in the mailing of a November&amp;#160;2003 Dear Health Care
    Provider letter. The jury returned a verdict that JPI and the Company had violated the Act and
    awarded $257.7&amp;#160;million in damages. The trial judge subsequently awarded the Attorney General
    counsel fees and expenses in the amount of $73&amp;#160;million. The Company and JPI&amp;#8217;s motion for a new
    trial was denied. The Company and JPI have filed an appeal and believe that they have strong
    arguments supporting the appeal. The Company believes that the potential for an unfavorable outcome
    is not probable, and therefore, the Company has not established a reserve with respect to the
    verdict.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In 2007, The Office of General Counsel of the Commonwealth of Pennsylvania filed a lawsuit against
    Janssen (now JPI) on a multi-Count Complaint related to Janssen&amp;#8217;s sale of RISPERDAL&amp;#174; to the
    Commonwealth&amp;#8217;s Medicaid program. The trial occurred in June&amp;#160;2010. The trial judge dismissed the
    case after the close of the plaintiff&amp;#8217;s evidence. The Commonwealth&amp;#8217;s post-trial motions were
    denied. The Commonwealth filed an appeal in April&amp;#160;2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In 2007, the Attorney General of South Carolina filed a lawsuit against the Company and Janssen
    (now JPI) on several counts. In March&amp;#160;2011, the matter was tried on liability only, at which time
    the lawsuit was limited to claims of violation of the South Carolina Unfair Trade Practice Act,
    including, among others, questions of whether the Company or JPI engaged in unfair or deceptive
    acts or practices in the conduct of any trade or commerce by distributing the November&amp;#160;2003 &amp;#8220;Dear
    Doctor&amp;#8221; letter or in their use of the FDA-approved label. The jury found in favor of the Company
    and against JPI. In June&amp;#160;2011, the Court awarded civil penalties of approximately $327.1&amp;#160;million.
    Post-trial briefing is underway, and if relief is not granted, JPI intends to appeal this judgment.
    The Company and JPI believe that JPI has strong arguments supporting an appeal and that the
    potential for an unfavorable outcome is not probable. Therefore, the Company has not established a
    reserve with respect to the verdict.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Attorneys
    General of approximately 40 other states have indicated a potential interest in pursuing similar
    litigation against JPI, and have obtained a tolling agreement staying the running of the statute of
    limitations while they pursue a coordinated civil investigation of JPI regarding potential consumer
    fraud actions in connection with the marketing of
    RISPERDAL&amp;#174;.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;&lt;u&gt;MCNEIL CONSUMER HEALTHCARE&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in June&amp;#160;2010, McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (McNeil Consumer
    Healthcare), and certain
    affiliates, including the Company (the Companies), received grand jury
    subpoenas from the United States Attorney&amp;#8217;s Office for the Eastern District of Pennsylvania
    requesting documents broadly relating to recent recalls of various products of McNeil Consumer
    Healthcare, and the FDA inspections of the Fort Washington, Pennsylvania and Lancaster,
    Pennsylvania manufacturing facilities. In addition, in February&amp;#160;2011, the government served
    McNEIL-PPC, Inc. (McNEIL-PPC) with a Civil Investigative Demand seeking records relevant to its
    investigation to determine if there was a violation of the False Claims Act. The Companies are
    cooperating with the United States Attorney&amp;#8217;s Office in responding to these subpoenas.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Companies have also received Civil Investigative Demands from multiple State Attorneys General
    Offices broadly relating to the McNeil recall issues. The Companies continue to cooperate with
    these inquiries. In January&amp;#160;2011, the Oregon Attorney General filed a civil complaint against the
    Company, McNEIL-PPC and McNeil Healthcare LLC in state court alleging civil violations of the
    Oregon unlawful trade practices act relating to an earlier recall of a McNeil OTC product. The
    Companies removed this case to federal court and have sought transfer of the case to the United
    States District Court for the Eastern District of Pennsylvania. The Judicial Panel on
    Multidistrict Litigation denied the transfer request, and the Companies moved for reconsideration
    of the Panel&amp;#8217;s decision. Currently, the case has been stayed pending a final decision on transfer.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In March&amp;#160;2011, the United States filed a complaint for injunctive relief in the United States
    District Court for the Eastern District of Pennsylvania against McNEIL-PPC and two of its
    employees, alleging that McNEIL-PPC is in violation of FDA regulations regarding the manufacture of
    drugs at the facilities it operates in Lancaster, Pennsylvania, Fort Washington, Pennsylvania, and
    Las Piedras, Puerto Rico. On the same day, the parties filed a consent decree of permanent
    injunction resolving the claims set forth in the complaint. The Court approved and entered the
    consent decree on March&amp;#160;16, 2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The consent decree, which is subject to ongoing enforcement by the court, requires McNEIL-PPC to
    take enhanced measures to remediate the three facilities. The Fort Washington facility, which the
    company voluntarily shut down in April&amp;#160;2010, will remain shut down until a third-party consultant
    certifies that its operations will be in compliance with applicable law, and the FDA concurs with
    the third party certification. The Lancaster and Las Piedras facilities may continue to
    manufacture and distribute drugs, provided that a third party reviews manufacturing records for
    selected batches of drugs released from the facilities, and certifies that any deviations reviewed
    do not adversely affect the quality of the selected batches.
    McNEIL-PPC must further submit a workplan (with deadlines) to the FDA for remediation of the
    Lancaster and Las Piedras facilities; that plan is subject to FDA approval. After completion of
    the workplan, third-party batch record review may cease if the FDA has stated that the facilities
    appear to be in compliance with applicable law. Each facility is
    subject to a five-year audit
    period by a third party after the facility has been deemed by the FDA to be in apparent compliance
    with applicable law.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;OMNICARE&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In September&amp;#160;2005, the Company received a subpoena from the United States Attorney&amp;#8217;s Office,
    District of Massachusetts, seeking documents related to the sales and marketing of eight drugs to
    Omnicare, Inc. (Omnicare), a manager of pharmaceutical benefits for long-term care facilities. In
    April&amp;#160;2009, the Company and certain of its pharmaceutical subsidiaries were served in two civil qui
    tam cases asserting claims under the Federal False Claims Act and related state law claims alleging
    that the defendants provided Omnicare with rebates and other alleged kickbacks, causing Omnicare to
    file false claims with Medicaid and other government programs. In January&amp;#160;2010, the government
    intervened in both of these cases, naming the Company, Ortho-McNeil-Janssen Pharmaceuticals, Inc.
    (now Janssen Pharmaceuticals, Inc. (JPI)), and Johnson &amp;#038; Johnson Health Care Systems Inc. as
    defendants. Subsequently, the Commonwealth of Massachusetts, Virginia, and Kentucky, and the
    States of California and Indiana intervened in the action. The defendants moved to dismiss the
    Complaints, and in February&amp;#160;2011, the United States District Court for the District of
    Massachusetts dismissed one qui tam case entirely and dismissed the other case in part, rejecting
    allegations that the defendants had violated its obligation to report its &amp;#8220;best price&amp;#8221; to health
    care program officials. The defendants subsequently moved the Court to reconsider its decision not
    to dismiss the second case in its entirety, which the Court denied in May&amp;#160;2011. The claims of the
    United States and individual states remain pending.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In November&amp;#160;2005, a lawsuit was filed under seal by Scott Bartz, a former employee, in the United
    States District Court for the Eastern District of Pennsylvania against the Company and certain of
    its pharmaceutical subsidiaries (the J&amp;#038;J Defendants), along with co-defendants McKesson Corporation
    and Omnicare, Inc. The Bartz complaint raises many issues in common with the Omnicare-related
    litigation discussed above already pending before the United States District Court for the District
    of Massachusetts, such as best price and a number of kickback allegations. After investigation, the
    United States declined to intervene. The case was subsequently unsealed in January&amp;#160;2011. In
    February&amp;#160;2011, the plaintiff filed an amended complaint, which was placed under seal. Thereafter,
    on the J&amp;#038;J Defendants&amp;#8217; motion, the case was transferred to the United States District Court for the
    District of Massachusetts, where it is currently pending. In April&amp;#160;2011, the amended complaint was
    ordered unsealed and alleges a variety of causes of action under the federal False Claims Act and
    corresponding state and local statutes, including that the J&amp;#038;J Defendants engaged in various
    improper transactions that were allegedly designed to report false prescription drug prices to the
    federal government in order to reduce the J&amp;#038;J Defendant&amp;#8217;s Medicaid rebate obligations. The
    complaint further alleges that the J&amp;#038;J Defendants improperly retaliated against the plaintiff for
    having raised these allegations internally. Bartz seeks multiple forms of
    relief, including damages
    and reinstatement to a position with the same seniority status. The J&amp;#038;J Defendants subsequently
    moved to dismiss the complaint in May&amp;#160;2011, which is currently scheduled for argument in August
    2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;OTHER&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In July&amp;#160;2003, Centocor, Inc. (now Janssen Biotech, Inc. (JBI)), received a request that it
    voluntarily provide documents and information to the criminal division of the United States
    Attorney&amp;#8217;s Office, District of New Jersey, in connection with its investigation into various JBI
    marketing practices. Subsequent requests for documents have been received from the United States
    Attorney&amp;#8217;s Office. Both the Company and JBI have responded to these requests for documents and
    information.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In July&amp;#160;2005, Scios Inc. (Scios) received a subpoena from the United States Attorney&amp;#8217;s Office
    for the District of Massachusetts, seeking documents related to the sales and marketing of NATRECOR&amp;#174;. In
    August&amp;#160;2005, Scios was advised that the investigation would be handled by the United States
    Attorney&amp;#8217;s Office for the Northern District of California in San Francisco. In February&amp;#160;2009, two
    qui tam complaints were unsealed in the United States District Court for the Northern District of
    California, alleging, among other things, improper activities in the promotion of NATRECOR&amp;#174;. In
    June&amp;#160;2009, the United States government intervened in one of the qui tam actions, and filed a
    complaint against Scios and the Company seeking relief under the False Claims Act and asserting a
    claim of unjust enrichment. The civil case is proceeding and discovery is ongoing. An
    Information charging Scios with a misdemeanor violation of the Food Drug and Cosmetic Act has been filed by the government.
    It is expected that a proposed settlement of that charge will be submitted to the court for approval.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In February&amp;#160;2007, the Company voluntarily disclosed to the United States Department of Justice
    (DOJ)&amp;#160;and the United States Securities &amp;#038; Exchange Commission (SEC)&amp;#160;that subsidiaries outside the
    United States are believed to have made improper payments in connection with the sale of medical
    devices in two small-market countries, which payments may fall within the jurisdiction of the
    Foreign Corrupt Practices Act (FCPA). In the course of continuing dialogues with the agencies,
    other issues potentially rising to the level of FCPA violations in additional markets were brought
    to the attention of the agencies by the Company. Law enforcement agencies of a number of other
    countries are pursuing investigations of matters voluntarily disclosed by the Company to the DOJ
    and SEC. In addition, in February&amp;#160;2006, the Company received a subpoena from the SEC requesting
    documents relating to the participation by several Company subsidiaries in the United Nations Iraq
    Oil for Food Program. On April&amp;#160;8, 2011, the Company resolved the FCPA
    and Oil for Food matters through settlements with the DOJ, SEC and United Kingdom Serious Fraud
    Office. These settlements required payments of approximately $78&amp;#160;million in financial penalties. As
    part of the settlement with the DOJ, the Company entered into a Deferred Prosecution Agreement that
    requires the Company to complete a three-year term of enhanced compliance practices.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In April&amp;#160;2007, the Company received two subpoenas from the Office of the Attorney General of the
    State of Delaware. The subpoenas seek documents and information relating to nominal pricing
    agreements. For purposes of the subpoenas, nominal pricing agreements are defined as agreements
    under which the Company agreed to provide a pharmaceutical product for less than ten percent of the
    Average Manufacturer Price for the product. The Company responded to these requests.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In May&amp;#160;2007, the New York State Attorney General issued a subpoena to the Company seeking
    information relating to the marketing, sale, reimbursement and safety of PROCRIT&amp;#174;. The Company has
    responded to the subpoena.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In June&amp;#160;2008, the Company received a subpoena from the United States Attorney&amp;#8217;s Office for the
    District of Massachusetts relating to the marketing of biliary stents by Cordis Corporation
    (Cordis). Cordis is currently cooperating in responding to the subpoena. In addition, in January
    2010, a complaint was unsealed in the United States District Court for the Northern District of
    Texas seeking damages against Cordis for alleged violations of the federal False Claims Act and
    several similar state laws in connection with the marketing of biliary stents. The United States
    Department of Justice and several states have declined to intervene at this time. In April&amp;#160;2011,
    the District Court for the Northern District of Texas dismissed the complaint without prejudice.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In May&amp;#160;2009, the New Jersey Attorney General issued a subpoena to DePuy Orthopaedics, Inc., seeking
    information regarding the financial interest of clinical investigators who performed clinical
    studies for DePuy Orthopaedics, Inc. and DePuy Spine, Inc. DePuy Orthopaedics, Inc. has responded
    to these requests.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In recent years the Company has received numerous requests from a variety of United States
    Congressional Committees to produce information relevant to ongoing congressional inquiries. It is
    the Company&amp;#8217;s policy to cooperate with these inquiries by producing the requested information.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;&lt;u&gt;&lt;b&gt;GENERAL LITIGATION&lt;/b&gt;&lt;/u&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In September&amp;#160;2004, Plaintiffs, in an employment discrimination litigation initiated against the
    Company in 2001 in the United States District Court for the District of New Jersey, moved to
    certify a class of all African American and Hispanic salaried employees of the Company and its
    affiliates in the United States, who were employed at any time from November&amp;#160;1997 to the present.
    Plaintiffs seek monetary damages for the period 1997 through the present (including punitive
    damages) and equitable relief. The Court denied Plaintiffs&amp;#8217; class certification motion in December
    2006 and their motion for reconsideration in April&amp;#160;2007. Plaintiffs sought to appeal these
    decisions and, in April&amp;#160;2008, the Court of Appeals ruled that Plaintiffs&amp;#8217; appeal of the denial of
    class certification was untimely. In July&amp;#160;2009, Plaintiffs filed a motion for certification of a
    modified class, which the Company opposed. The District Court denied Plaintiffs&amp;#8217; motion in July
    2010, and the Court of Appeals denied Plaintiffs&amp;#8217; request for leave to appeal the denial of
    certification of the modified class. In May&amp;#160;2011, the case was dismissed with prejudice.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in July&amp;#160;2006, five lawsuits were filed in United States District Court for the District of
    New Jersey by various employers and employee benefit plans and funds seeking to recover amounts
    they paid for RISPERDAL&amp;#174; for plan participants. In general, Plaintiffs allege that the Company and
    certain of its pharmaceutical subsidiaries engaged in off-label marketing of RISPERDAL&amp;#174; in
    violation of the federal and New Jersey RICO statutes. In addition, Plaintiffs asserted various
    state law claims. All of the cases were consolidated into one case seeking class action status, but
    shortly thereafter, one action was voluntarily dismissed. In December&amp;#160;2008, the Court dismissed the
    actions of the four remaining plaintiffs. In April&amp;#160;2010, those plaintiffs filed a new consolidated
    class action against the Company and Janssen, L.P. (now Janssen Pharmaceuticals, Inc. (JPI)); and
    in March&amp;#160;2011, that action was dismissed. In April&amp;#160;2011, one of those plaintiffs filed a notice of
    appeal with the United States Court of Appeals for the Third Circuit.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In April&amp;#160;2009, Ortho-Clinical Diagnostics, Inc. (OCD)&amp;#160;received a grand jury subpoena from the
    United States Department of Justice, Antitrust Division, requesting documents and information for
    the period beginning September&amp;#160;1, 2000 through the present, pertaining to an investigation of
    alleged violations of the antitrust laws in the blood reagents industry. OCD complied with the
    subpoena. In February&amp;#160;2011, OCD received a letter from the Antitrust Division indicating that it
    had closed its investigation in November&amp;#160;2010. In June&amp;#160;2009, following the public announcement
    that OCD had received a grand jury subpoena, multiple class action complaints seeking damages for
    alleged price fixing were filed against OCD. The various cases were consolidated for pre-trial
    purposes in the United States District Court for the Eastern District of Pennsylvania. Discovery
    is ongoing.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In
    May&amp;#160;2009, Centocor Ortho Biotech Inc. (now Janssen Biotech, Inc.
    (JBI)) commenced an arbitration
    proceeding before the American Arbitration Association against Schering-Plough Corporation and its
    subsidiary Schering-Plough (Ireland) Company (collectively, Schering-Plough). JBI and
    Schering-Plough are parties to a series of agreements (Distribution
    Agreements) that grant Schering-Plough the exclusive right to distribute the drugs REMICADE&amp;#174; and
    SIMPONI&amp;#174; worldwide, except within the United States, Japan, Taiwan, Indonesia, and the People&amp;#8217;s
    Republic of China (including Hong Kong). JBI distributes REMICADE&amp;#174; and SIMPONI&amp;#174;, the next
    generation treatment, within the United States. In the arbitration, JBI sought a declaration that
    the agreement and merger between Merck &amp;#038; Co., Inc. (Merck) and Schering-Plough constituted a change
    of control under the terms of the Distribution Agreements that permitted JBI to terminate the
    Agreements. On April&amp;#160;15, 2011, the Company, JBI and Merck announced an agreement to amend the
    Distribution Agreements. This agreement concluded the arbitration proceeding.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Under the terms of the amended Distribution Agreements, effective July&amp;#160;1, 2011, Merck&amp;#8217;s subsidiary,
    Schering-Plough (Ireland) will relinquish exclusive marketing rights for REMICADE&amp;#174; and SIMPONI&amp;#174; to
    the Company&amp;#8217;s Janssen pharmaceutical companies in territories including Canada, Central and South
    America, the Middle East, Africa and Asia Pacific (relinquished territories). Note, in Japan,
    Indonesia, and Taiwan, JBI will continue to license distribution rights to REMICADE&amp;#174; and SIMPONI&amp;#174;
    to Mitsubishi Tanabe Pharma Corporation. Merck will retain exclusive marketing rights throughout
    Europe, Russia and Turkey (retained territories). The retained territories represent approximately
    70&amp;#160;percent of Merck&amp;#8217;s 2010 revenue of approximately $2.8&amp;#160;billion from REMICADE&amp;#174; and SIMPONI&amp;#174;, while
    the relinquished territories represent approximately 30&amp;#160;percent. In addition, beginning July&amp;#160;1,
    2011, all profit derived from Merck&amp;#8217;s exclusive distribution of the two products in the retained
    territories will be equally divided between Merck and JBI. Under the prior terms of the
    Distribution Agreements, the contribution income (profit)&amp;#160;split, which was at 58&amp;#160;percent to Merck
    and 42&amp;#160;percent to JBI, would have declined for Merck and increased for JBI each year until 2014,
    when it would have been equally divided. JBI also received a one-time payment of $500&amp;#160;million in
    April&amp;#160;2011, which will be amortized over the period of the agreement.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In April&amp;#160;2010, a putative class action lawsuit was filed in the United States District Court for
    the Northern District of California by representatives of nursing home residents or their estates
    against the Company, Omnicare, Inc. (Omnicare), and other unidentified companies or individuals.
    In February&amp;#160;2011, plaintiffs filed a second amended complaint asserting that certain rebate
    agreements between the Company and Omnicare increased the amount of money spent on pharmaceuticals
    by the nursing home residents and violated the Sherman Act and the California Business &amp;#038;
    Professions Code. The second amended complaint also asserts a claim of unjust enrichment.
    Plaintiffs seek multiple forms of monetary and injunctive relief. The Company moved to dismiss the
    second amended complaint in March&amp;#160;2011. A hearing is set on the motion to dismiss for August&amp;#160;2011.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in April&amp;#160;2010, a number of shareholder derivative lawsuits were filed in the United States
    District Court for the District of New Jersey against certain current and former directors and
    officers of the Company. The Company is named as a nominal defendant. These actions were
    consolidated on August&amp;#160;17, 2010 into one lawsuit: &lt;i&gt;In re Johnson &amp;#038; Johnson Shareholder Derivative
    Litigation&lt;/i&gt;. An amended consolidated complaint was filed on December&amp;#160;17, 2010. Additionally, in
    September&amp;#160;2010, another shareholder derivative lawsuit was filed in New Jersey Superior Court
    against certain current and former directors and officers of the Company. The Company is named as a
    nominal defendant in this action as well. The parties to this action have stipulated that it shall
    be stayed until the &lt;i&gt;In re Johnson &amp;#038; Johnson Shareholder Derivative Litigation &lt;/i&gt;is completely
    resolved.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;These shareholder derivative actions are similar in their claims and collectively they assert a
    variety of alleged breaches of
    fiduciary duties, including, among other things, that the defendants
    allegedly engaged in, approved of, or failed to remedy or prevent defective medical devices,
    improper pharmaceutical rebates, improper off-label marketing of pharmaceutical and medical device
    products, violations of current good manufacturing practice regulations that resulted in product
    recalls, and failed to disclose the aforementioned alleged misconduct in the Company&amp;#8217;s filings
    under the Securities Exchange Act of 1934. Each complaint seeks a variety of relief, including
    monetary damages and corporate governance reforms. In February&amp;#160;2011, the Company moved to dismiss
    these actions on the grounds, &lt;i&gt;inter alia&lt;/i&gt;, that the plaintiffs failed to make a demand upon the
    Board of Directors.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In May&amp;#160;2011, two additional shareholder derivative lawsuits were filed in the United States
    District Court for the District of New Jersey and another shareholder derivative lawsuit was filed
    in New Jersey Superior Court, all naming the Company&amp;#8217;s current directors as defendants and the
    Company as the nominal defendant. The complaints allege breaches of fiduciary duties related to
    the Company&amp;#8217;s compliance with the Foreign Corrupt Practices Act and participation in the United
    Nations Iraq Oil For Food Program, that the Company has suffered damages as a result of those
    alleged breaches, and that the defendants failed to disclose the alleged misconduct in the
    Company&amp;#8217;s filings under the Securities Exchange Act of 1934. Plaintiffs seek monetary damages, and
    one plaintiff also seeks corporate governance reforms. The Company intends to move to dismiss the
    federal lawsuits on the grounds, &lt;i&gt;inter alia&lt;/i&gt;, that the plaintiffs failed to make a demand upon the
    Board of Directors. The Company intends to move to dismiss or stay the state lawsuit pending
    resolution of the federal lawsuits.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In July&amp;#160; 2011, in the &lt;i&gt;In re Johnson &amp;#038; Johnson Shareholder Derivative
    Litigation &lt;/i&gt;matter, the Company filed a report prepared by a Special Committee of the Board of Directors, which investigated
    the allegations contained in the derivative actions and in a series of shareholder letters that the
    Board received in 2010 raising similar issues. The Special Committee was assisted in its
    investigation by independent counsel. The Special Committee&amp;#8217;s report recommended: i) that the
    Company reject the shareholder demands and take whatever steps are necessary or appropriate to
    secure dismissal of the derivative litigation and ii) that the Board of Directors create a new
    Regulatory and Compliance Committee charged with responsibility
    for monitoring and oversight of the Company&amp;#8217;s Health Care Compliance and Quality &amp;#038; Compliance
    systems and issues. The Company&amp;#8217;s Board of Directors  unanimously adopted the Special Committee&amp;#8217;s recommendations.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Starting in May&amp;#160;2010, multiple complaints seeking class action certification related to the McNeil
    recalls have been filed against McNeil Consumer Healthcare and certain affiliates, including the
    Company, in the United States District Court for the Eastern District of Pennsylvania, the Northern
    District of
    Illinois, the Central District of California, the Southern District of
    Ohio and the
    Eastern District of Missouri. These consumer complaints allege generally that purchasers of various
    McNeil medicines are owed monetary damages and penalties because they paid premium prices for
    defective medications rather than less expensive alternative medications. All but one complaint
    seeks certification of a nation-wide class of purchasers of these medicines, whereas one complaint,
    the Harvey case, seeks certification of a class of Motrin&amp;#174; IB purchasers in Missouri. In October
    2010, the Judicial Panel on Multidistrict Litigation (JPML)&amp;#160;consolidated all of the consumer
    complaints, except for the Harvey case, which was consolidated in March&amp;#160;2011, for pretrial
    proceedings in the United States District Court for the Eastern District of Pennsylvania. In
    January&amp;#160;2011, the plaintiffs in all of the cases except the Harvey case filed a &amp;#8220;Consolidated
    Amended Civil Consumer Class&amp;#160;Action Complaint&amp;#8221; (CAC)&amp;#160;naming additional parties and claims. In July
    2011, the Court granted the Company&amp;#8217;s motion to dismiss the CAC without prejudice, but permitted
    the plaintiffs to file an amended complaint within thirty days of the dismissal order.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In September&amp;#160;2010, a shareholder, Ronald Monk, filed a lawsuit in the United States District Court
    for the District of New Jersey seeking class certification and alleging that the Company and
    certain individuals, including executive officers and employees of the Company, failed to disclose
    that a number of manufacturing facilities were failing to maintain current good manufacturing
    practices, and that as a result, the price of the Company&amp;#8217;s stock has declined significantly.
    Plaintiff seeks to pursue remedies under the Securities Exchange Act of 1934 to recover his alleged
    economic losses. In May&amp;#160;2011, the Company filed a motion to dismiss, which is pending before the
    Court.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In April&amp;#160;2011, OMJ Pharmaceuticals, Inc. (OMJ PR) filed a lawsuit against the United States in
    United States District Court for the District of Puerto Rico alleging overpayment of federal income
    taxes for the tax years ended November&amp;#160;30, 1999 and November&amp;#160;30, 2000. OMJ PR alleges that the
    Internal Revenue Service erroneously calculated OMJ PR&amp;#8217;s tax credits under Section&amp;#160;936 of the Tax
    Code.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In August
    2011, an arbitration panel ruled that Mitsubishi Tanabe Pharma
    Corporation (Tanabe), JBI&amp;#8217;s distributor of REMICADE&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&amp;#174; &lt;/sup&gt; in
    Japan, could seek to modify the proportion of net sales revenue that
    Tanabe must remit to JBI in exchange for distribution rights and
    commercial supply of REMICADE&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&amp;#174; &lt;/sup&gt; (the Supply Price). Tanabe
    commenced the arbitration against JBI in 2009 pursuant to the
    parties&amp;#8217; distribution agreement, which grants Tanabe the right
    to distribute REMICADE&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&amp;#174; &lt;/sup&gt; in Japan and certain other parts of
    Asia. JBI has counterclaimed for an increase in the Supply Price. The
    arbitration hearing to determine the appropriate split of revenue is
    scheduled for November 2011, and a decision is anticipated in 2012.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company or its subsidiaries are also parties to a number of proceedings brought under the
    Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund,
    and comparable state, local or foreign laws in which the primary relief sought is the cost of past
    and/or future remediation.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:LegalMattersAndContingenciesTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 12 - us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 12 &amp;#8212; RESTRUCTURING
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;In the fiscal second quarter of 2011, Cordis Corporation, a subsidiary of Johnson &amp;#038; Johnson,
    announced the discontinuation of its clinical development program for the NEVO&amp;#8482; Sirolimus-Eluting
    Coronary Stent and cessation of the manufacture and marketing of CYPHER&amp;#174; and CYPHER
    SELECT&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&amp;#174; &lt;/sup&gt;Plus Sirolimus-Eluting Coronary Stents by the end of 2011. This will allow the
    Company to focus on other cardiovascular therapies where significant patient needs exist.
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;As a
    result of the above mentioned restructuring plan announced by Cordis
    Corporation, the Company recorded $676&amp;#160;million in related pre-tax charges, of which approximately
    $164&amp;#160;million of the pre-tax restructuring charges require cash payments. The $676&amp;#160;million of
    restructuring charges consists of asset write-offs of $512&amp;#160;million and $164&amp;#160;million related to
    leasehold and contract obligations and other expenses. The $512&amp;#160;million of asset write-offs relate
    to property, plant and equipment of $265&amp;#160;million, intangible assets of $160&amp;#160;million and inventory
    of $87&amp;#160;million (recorded in cost of products sold).
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table summarizes the severance reserves associated with the restructuring plan
    recorded in the fourth quarter of 2009.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="88%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #000000"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;Severance&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Reserve balance as of:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;345&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cash outlays
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(77&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;July&amp;#160;3, 2011*
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;268&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Remaining cash outlays for severance are expected to be paid out in accordance with the Company&amp;#8217;s
    plans and local laws.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Of the 7,500 positions the Company planned to eliminate in the 2009 restructuring plan,
    approximately 5,700 positions have been eliminated as of July&amp;#160;3, 2011.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Note -->
  <us-gaap:SubsequentEventsTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note 13 - us-gaap:SubsequentEventsTextBlock--&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;NOTE 13 &amp;#8212; SUBSEQUENT EVENTS
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;On July&amp;#160;7, 2011, the Company completed the divestiture of its Animal Health business to Elanco, a
    Division of Eli Lilly.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;On July&amp;#160;14, 2011, the Company completed the acquisition of several over-the-counter cough and cold
    brands in Russia from J.B. Chemicals and Pharmaceuticals Ltd.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;On July&amp;#160;15, 2011, the Company announced the definitive agreement to divest the assets of its Ortho
    Dermatologics division in the U.S. to subsidiaries of Valeant Pharmaceuticals International, Inc.
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SubsequentEventsTextBlock>
  <!-- End Block Tagged Note -->
  <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table1-->
  <jnj:RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table1 - jnj:RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
    amendments to the disclosure requirements for presentation of comprehensive income. The amendment
    requires that all non-owner changes in stockholders&amp;#8217; equity be presented either in a single
    continuous statement of comprehensive income or in two separate but consecutive statements. This
    guidance is effective retrospectively for the interim periods and annual periods beginning after
    December&amp;#160;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
    material impact on the Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </jnj:RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock>
  <!-- End Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table1-->
  <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table2-->
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table2 - us-gaap:FairValueOfFinancialInstrumentsPolicy--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
    common fair value measurement. These amendments result in convergence of fair value measurement and
    disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
    the interim periods and annual periods beginning after December&amp;#160;15, 2011. Early adoption is
    prohibited. The adoption of this standard is not expected to have a material impact on the
    Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <!-- End Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table2-->
  <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table3-->
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table3 - us-gaap:RevenueRecognitionPolicyTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2011, the Company adopted the FASB guidance and amendments
    issued related to revenue recognition under the milestone method. The objective of the accounting
    standard update is to provide guidance on defining a milestone and determining when it may be
    appropriate to apply the milestone method of revenue recognition for research or development
    transactions. This update is effective on a prospective basis for milestones achieved in fiscal
    years, and interim periods within those years, beginning on or after June&amp;#160;15, 2010. The adoption of
    this standard did not have a material impact on the Company&amp;#8217;s results of operations, cash flows or
    financial position.
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:RevenueRecognitionPolicyTextBlock>
  <!-- End Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table3-->
  <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table4-->
  <jnj:PharmaceuticalFeesPaidToGovernmentPolicyTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table4 - jnj:PharmaceuticalFeesPaidToGovernmentPolicyTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
    pharmaceutical companies should recognize and classify in the Company&amp;#8217;s financial statements, the
    non-deductible annual fee paid to the Government in accordance with the Patient Protection and
    Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
    based on an allocation of a company&amp;#8217;s market share of total branded prescription drug sales from
    the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
    in the Company&amp;#8217;s financial statement and will be amortized on a straight-line basis for the year as
    per the FASB guidance. The adoption of
    this standard did not have a material impact on the
    Company&amp;#8217;s results of operations, cash flows or financial position.
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </jnj:PharmaceuticalFeesPaidToGovernmentPolicyTextBlock>
  <!-- End Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table4-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note2_table1-->
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note2_table1 - us-gaap:ScheduleOfInventoryCurrentTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;July 3, 2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;January 2, 2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Raw materials and supplies
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,383&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,073&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goods in process
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,897&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,460&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Finished goods
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,133&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,845&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total inventories
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;6,413&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note2_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table1-->
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table1 - us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;January 2,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Intangible assets with definite lives:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Patents and trademarks &amp;#8212; gross
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,520&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,660&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less accumulated amortization
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,819&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,629&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Patents and trademarks &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,701&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,031&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other intangibles &amp;#8212; gross
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,609&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,674&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less accumulated amortization
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,048&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,880&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other intangibles &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,561&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,794&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Intangible assets with indefinite lives:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Trademarks
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,080&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,954&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Purchased in-process research and development
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,036&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,937&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total intangible assets with indefinite lives
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,116&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,891&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total intangible assets &amp;#8212; net
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;18,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16,716&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note3_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table2-->
  <us-gaap:ScheduleOfGoodwillTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table2 - us-gaap:ScheduleOfGoodwillTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Med Dev&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Consumer&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Pharm&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#038; Diag&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Total&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goodwill, net at January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;8,144&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,225&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,925&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,294&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Acquisitions
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Currency translation/Other
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;320&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;52&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;39&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;411&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Goodwill, net as of July&amp;#160;3, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;8,464&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,815&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,964&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16,243&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfGoodwillTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note3_table2-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table1-->
  <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table1 - us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table is a summary of the activity related to derivatives designated as hedges for
    the fiscal second quarters in 2011 and 2010:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="28%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;reclassified&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;from&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;OCI&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;into income&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;income/expense&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;second&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;quarter&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;Cash Flow Hedges&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(53&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(A)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(20&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(102&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(44&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(76&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(B)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(149&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;44&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;18&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(C)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(31&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(82&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(16&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(D)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;35&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(E)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(158&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(40&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(54&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(133&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)
    &lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 0pt"&gt;
    All amounts shown in the table above are net of tax.
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table is a summary of the activity related to derivatives designated as hedges for
    the first fiscal six months in 2011 and 2010:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="28%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;reclassified&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Gain/ (Loss)&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;from&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;recognized in&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;Accumulated OCI&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;OCI&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;into income&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;&lt;b&gt;income/expense&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Fiscal&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;six&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;months&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;&lt;b&gt;Cash Flow Hedges&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(84&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(10&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(29&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(A)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(21&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;92&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(206&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(106&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(98&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(B)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(154&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;73&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;21&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(C)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(40&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(49&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(18&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(D)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(59&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;81&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;sub style="font-size: 85%; vertical-align: text-bottom"&gt;(E)&lt;/sub&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;20&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(185&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(118&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(96&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(139&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;All amounts shown in the table above are net of tax.
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Effective portion&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Ineffective portion&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(A)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Sales to customers&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(B)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Cost of products sold&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(C)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Research and development expense&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(D)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Interest (income)/Interest expense, net&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(E)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Included in Other (income)/expense, net&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note4_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table2-->
  <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table2 - us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The Company&amp;#8217;s significant financial assets and liabilities measured at fair value as of July&amp;#160;3,
    2011 and January&amp;#160;2, 2011 were as follows:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="40%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 0px solid #000000"&gt;&lt;b&gt;July 3, 2011&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&lt;b&gt;January 2, 2011&lt;/b&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/sup&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Derivatives designated as hedging instruments:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Assets:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;487&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;487&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;321&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(2)&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;17&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Total&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;338&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Liabilities:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;646&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;646&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;586&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cross currency interest rate swaps&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;(3)&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;404&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;404&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;502&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Total&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,050&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,050&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,088&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Derivatives not designated as hedging instruments:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Assets:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Swiss Franc Option*
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;19&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Liabilities:&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Foreign exchange contracts
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;27&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;39&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Other Investments&lt;/b&gt;&lt;sup style="font-size: 85%; vertical-align: text-top"&gt;&lt;b&gt;(4)&lt;/b&gt;&lt;/sup&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,371&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,371&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,165&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Currency option related to the planned acquisition of Synthes, Inc.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;As of January&amp;#160;2, 2011, these assets and liabilities are classified as Level 2 with the exception
    of Other Investments of $1,165 which are classified as Level 1.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes $2&amp;#160;million and $14&amp;#160;million of non-current assets for July&amp;#160;3, 2011 and January&amp;#160;2, 2011,
    respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(3)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes $404&amp;#160;million and $502&amp;#160;million of non-current liabilities for July&amp;#160;3, 2011 and January
    2, 2011, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(4)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Classified as non-current other assets.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note4_table2-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table3-->
  <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table3 - us-gaap:FairValueByBalanceSheetGroupingTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Financial Instruments not measured at Fair Value:
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following financial assets and liabilities are held at carrying amount on the consolidated
    balance sheet as of July&amp;#160;3, 2011:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Carrying&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Estimated&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Amount&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right" colspan="2"&gt;Fair Value&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Financial Assets&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Current Investments&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cash
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2,299&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,299&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Government securities and obligations
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23,951&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23,951&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Corporate debt securities
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;515&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;515&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Money market funds
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,820&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,820&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Time deposits
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,097&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,097&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total cash, cash equivalents and current marketable securities
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;29,682&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;29,682&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td colspan="9" align="left"&gt;Fair value of government securities and
    obligations and non-current marketable
    securities was estimated using quoted broker prices
    in active
    markets.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Current Debt&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;5,046&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,046&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&lt;b&gt;Non-Current Debt&lt;/b&gt;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.15% Debentures due 2012
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;599&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;632&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;0.70% Notes due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;503&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3.80% Debentures due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;527&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3&amp;#160;month LIBOR&amp;#043;0% FRN due 2013
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3&amp;#160;month LIBOR&amp;#043;0.09% FRN due 2014
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;750&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;750&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;1.20% Notes due 2014
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;999&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,006&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2.15% Notes due 2016
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;898&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;903&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.55% Debentures due 2017
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,000&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,161&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.15% Debentures due 2018
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;898&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,015&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.75% Notes due 2019 (1B Euro 1.4476)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,440&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,569&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3% Zero Coupon Convertible Subordinated Debentures due in 2020
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;197&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;246&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2.95% Debentures due 2020
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;541&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;522&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;3.55% Notes due 2021
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;446&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;456&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;6.73% Debentures due 2023
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;250&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;323&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.50% Notes due 2024 (500 GBP1.6025)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;795&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;856&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;6.95% Notes due 2029
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;294&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;375&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.95% Debentures due 2033
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;523&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.95% Notes due 2037
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;995&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,120&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;5.86% Debentures due 2038
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;700&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;773&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.50% Debentures due 2040
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;539&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;489&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;4.85% Notes due 2041
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;298&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;291&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Other (Includes Industrial Revenue Bonds)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;41&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;41&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total Non-Current Debt
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="left"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;13,680&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;14,581&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:FairValueByBalanceSheetGroupingTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note4_table3-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note6_table1-->
  <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note6_table1 - us-gaap:ScheduleOfNetBenefitCostsTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Components of Net Periodic Benefit Cost
    Net periodic benefit cost for the Company&amp;#8217;s defined benefit retirement plans and other benefit
    plans for the fiscal second quarters of 2011 and 2010 include the following components:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="52%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Retirement Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Other Benefit Plans&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Service cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;144&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;121&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;37&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;33&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Interest cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;214&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;194&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;46&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;50&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expected return on plan assets
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(277&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(248&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of prior service cost/(credit)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of net transition obligation
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Recognized actuarial losses
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;98&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;59&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net periodic benefit cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;181&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;130&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;Net periodic benefit cost for the Company&amp;#8217;s defined benefit retirement plans and other benefit
    plans for the first fiscal six months of 2011 and 2010 include the following components:
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="52%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Retirement Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Other Benefit Plans&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Service cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;287&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;247&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;74&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;67&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Interest cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;427&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;394&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;94&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;100&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expected return on plan assets
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(555&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(500&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of prior service cost/(credit)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Amortization of net transition obligation
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Recognized actuarial losses
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;194&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;117&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;23&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net periodic benefit cost
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;358&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;265&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;189&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;189&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note6_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note7_table1-->
  <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note7_table1 - us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="40%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Total&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Accum&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Other&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Foreign&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Securities&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Employee&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Deriv.&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Comp.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;Gains/(Losses)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Currency&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Available&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Benefit&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;&amp;#038;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Income/&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Translation&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;for sale&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Plans&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Hedges&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;(Loss)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;(969&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;24&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2,686&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;100&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(3,531&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;2011 six months change
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:30px; text-indent:-15px"&gt;Unrealized gain (loss)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;435&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:30px; text-indent:-15px"&gt;Net amount reclassed to net earnings
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(139&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;&amp;#8212;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;116&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Net six months change
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,787&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;296&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;128&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;128&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,339&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;July&amp;#160;3, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;818&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;320&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(2,558&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;228&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(1,192&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Substantially offset in net earnings by changes in value of the underlying transactions.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note7_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note8_table1-->
  <us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note8_table1 - us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal second quarters ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Shares in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Basic net earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.01&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; basic
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,740.5&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,756.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Potential shares exercisable under stock option plans
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;168.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;175.5&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less: shares which could be repurchased under treasury stock method
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(131.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(139.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Convertible debt shares
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; diluted
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,781.3&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,796.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Diluted earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.00&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1.23&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    <!-- next part of non-contiguous block - from filename JNJ-20110703_note8_table2.htm -->
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note8_table2 - jnj:ScheduleOfEarningsPerShareReconciliationTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal six months ended July&amp;#160;3, 2011 and July&amp;#160;4, 2010.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="76%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff"&gt;(Shares in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Basic net earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.28&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.89&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; basic
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,739.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,755.7&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Potential shares exercisable under stock option plans
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;168.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;175.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Less: shares which could be repurchased under treasury stock method
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(133.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(138.6&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Convertible debt shares
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Average shares outstanding &amp;#8212; diluted
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,778.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,796.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Diluted earnings per share
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.25&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2.85&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note8_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table1-->
  <jnj:SalesBySegmentOfBusinessTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table1 - jnj:SalesBySegmentOfBusinessTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;SALES BY SEGMENT OF BUSINESS
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,339&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,463&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(8.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,454&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,184&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,793&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,647&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,239&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,110&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,994&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,443&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;22.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,233&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,553&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,869&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,865&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,702&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,265&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13.4&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,571&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,130&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,447&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,438&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9,150&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,892&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;16,597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,330&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;2,684&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;3,023&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(11.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,791&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,390&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,475&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,413&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,630&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,316&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,662&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,875&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;16.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12,292&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11,191&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,741&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,751&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,262&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,606&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;9.9&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13,003&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12,357&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,055&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,090&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;International
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;17,715&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;15,871&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;11.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;32,770&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;30,961&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </jnj:SalesBySegmentOfBusinessTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note9_table1-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table2-->
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table2 - us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock--&gt;
    &lt;div align="right" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;OPERATING PROFIT BY SEGMENT OF BUSINESS
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;549&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;669&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(17.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical (1)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,714&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,833&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(6.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics (2)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,275&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,876&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(32.0&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Segments operating profit
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,538&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,378&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(19.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expense not allocated to segments (3)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(116&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(158&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide income before taxes
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;3,422&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;4,220&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(18.9&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Consumer
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,122&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;1,454&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(22.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Pharmaceutical (1)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,923&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,803&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Medical Devices &amp;#038; Diagnostics (2)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,219&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,578&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(42.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Segments operating profit
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,264&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;10,835&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(23.7&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Expense not allocated to segments (3)
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(332&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(335&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Worldwide income before taxes
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,932&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;10,500&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(24.5&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;!-- Folio --&gt;
    &lt;!-- /Folio --&gt;
    &lt;/div&gt;
    &lt;!-- PAGEBREAK --&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(1)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes litigation expense of $290&amp;#160;million and $540&amp;#160;million recorded in the fiscal second
    quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011
    includes a gain related to the Company&amp;#8217;s earlier investment in Crucell recorded in the fiscal first
    quarter of 2011. The fiscal second quarter and the first fiscal six
    months of 2010, includes net litigation expense of $115&amp;#160;million and $202&amp;#160;million, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(2)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Includes restructuring expense of $676&amp;#160;million recorded in the fiscal second quarter and first
    fiscal six months of 2011. Includes litigation expense and additional DePuy ASR&amp;#8482; Hip recall costs
    of $127&amp;#160;million recorded in the fiscal second quarter of 2011. Includes litigation expense and
    additional DePuy ASR&amp;#8482; Hip recall costs of $223&amp;#160;million recorded in the first fiscal six months of
    2011. Includes net litigation expense of $42&amp;#160;million and income of $1,542&amp;#160;million recorded in the
    fiscal second quarter and the first fiscal six months of 2010, respectively.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 3pt"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(3)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Amounts not allocated to segments include interest income/(expense), non-controlling interests
    and general corporate income/(expense).&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note9_table2-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table3-->
  <jnj:SaleByGeographicAreaTableTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table3 - jnj:SaleByGeographicAreaTableTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 12pt"&gt;SALES BY GEOGRAPHIC AREA
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Quarters Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,447&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;7,438&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;0.1&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Europe
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;4,543&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,832&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;18.6&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Western Hemisphere, excluding U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,543&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;1,375&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Asia-Pacific, Africa
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;3,064&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,685&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;14.1&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;16,597&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,330&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8.3&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="64%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff"&gt;Fiscal Six Months Ended&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 3,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;July 4,&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Percent&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2011&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;2010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3"&gt;Change&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,055&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;15,090&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(0.2&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Europe
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;8,726&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;7,934&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;10.0&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Western Hemisphere, excluding U.S.
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,979&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;2,655&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;12.2&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Asia-Pacific, Africa
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;6,010&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5,282&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;13.8&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;&lt;!-- Blank Space --&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;&amp;#160;
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Total
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;32,770&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;30,961&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;5.8&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </jnj:SaleByGeographicAreaTableTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note9_table3-->
  <!-- Begin Block Tagged Note Table: JNJ-20110703_note12_table1-->
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="SixMonthsEnded_03Jul2011">
    &lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
    &lt;!-- Begin Block Tagged Note Table: JNJ-20110703_note12_table1 - us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock--&gt;
    &lt;div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div style="font-family: 'Times New Roman',Times,serif"&gt;
    &lt;div align="left" style="font-size: 10pt; margin-top: 6pt"&gt;The following table summarizes the severance reserves associated with the restructuring plan
    recorded in the fourth quarter of 2009.
    &lt;/div&gt;
    &lt;div align="center"&gt;
    &lt;table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%"&gt;
    &lt;!-- Begin Table Head --&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td width="88%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="5%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td width="3%"&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr style="font-size: 8pt" valign="bottom"&gt;
    &lt;td nowrap="nowrap" align="left" style="border-bottom: 1px solid #000000"&gt;(Dollars in Millions)&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"&gt;Severance&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Head --&gt;
    &lt;!-- Begin Table Body --&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Reserve balance as of:
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;January&amp;#160;2, 2011
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;345&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom" style="background: #cceeff"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;Cash outlays
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td nowrap="nowrap" align="right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;(77&lt;/td&gt;
    &lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="bottom"&gt;
    &lt;td&gt;
    &lt;div style="margin-left:15px; text-indent:-15px"&gt;July&amp;#160;3, 2011*
    &lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td align="right"&gt;$&lt;/td&gt;
    &lt;td align="right"&gt;268&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;!-- End Table Body --&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;div align="left"&gt;
    &lt;div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000"&gt;&amp;#160;
    &lt;/div&gt;
    &lt;/div&gt;
    &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left"&gt;
    &lt;tr&gt;
    &lt;td width="3%"&gt;&lt;/td&gt;
    &lt;td width="1%"&gt;&lt;/td&gt;
    &lt;td width="96%"&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr valign="top"&gt;
    &lt;td nowrap="nowrap" align="left"&gt;*&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;Remaining cash outlays for severance are expected to be paid out in accordance with the Company&amp;#8217;s
    plans and local laws.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;/table&gt;
    &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <!-- End Block Tagged Note Table: JNJ-20110703_note12_table1-->
  <!--Element Section-->
  <dei:AmendmentFlag contextRef="SixMonthsEnded_03Jul2011">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="SixMonthsEnded_03Jul2011">--01-01</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="SixMonthsEnded_03Jul2011">Q2</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="SixMonthsEnded_03Jul2011">2011</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate contextRef="SixMonthsEnded_03Jul2011">2011-07-03</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="SixMonthsEnded_03Jul2011">10-Q</dei:DocumentType>
  <dei:EntityCentralIndexKey contextRef="SixMonthsEnded_03Jul2011">0000200406</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding contextRef="BalanceAsOf_29Jul2011" unitRef="Shares" decimals="INF">2740354114</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="SixMonthsEnded_03Jul2011">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="SixMonthsEnded_03Jul2011">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityPublicFloat contextRef="BalanceAsOf_04Jul2010" unitRef="USD" decimals="-9">163000000000</dei:EntityPublicFloat>
  <dei:EntityRegistrantName contextRef="SixMonthsEnded_03Jul2011">JOHNSON &amp; JOHNSON</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers contextRef="SixMonthsEnded_03Jul2011">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer contextRef="SixMonthsEnded_03Jul2011">Yes</dei:EntityWellKnownSeasonedIssuer>
  <jnj:AccruedRebatesReturnsAndPromotions contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2512000000</jnj:AccruedRebatesReturnsAndPromotions>
  <jnj:AccruedRebatesReturnsAndPromotions contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2933000000</jnj:AccruedRebatesReturnsAndPromotions>
  <jnj:AmountGivenToPlaintiffByJury contextRef="ThreeMonthsEnded_03Apr2011" unitRef="USD" decimals="-6">482000000</jnj:AmountGivenToPlaintiffByJury>
  <jnj:AmountOfRevenueRepresentedByRetainedTerritories contextRef="SixMonthsEnded_03Jul2011_Merck_Member" unitRef="USD" decimals="-8">2800000000</jnj:AmountOfRevenueRepresentedByRetainedTerritories>
  <jnj:AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-5">4500000</jnj:AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs>
  <jnj:AwardedDamagesReversed contextRef="BalanceAsOf_28Jun2009" unitRef="USD" decimals="-8">1700000000</jnj:AwardedDamagesReversed>
  <jnj:BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage contextRef="ThreeMonthsEnded_03Jul2011_Synthes_Inc_Member" unitRef="Pure" decimals="2">0.35</jnj:BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage>
  <jnj:BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage contextRef="ThreeMonthsEnded_03Jul2011_Synthes_Inc_Member" unitRef="Pure" decimals="2">0.65</jnj:BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage>
  <jnj:BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice contextRef="ThreeMonthsEnded_04Apr2010_Acclarent_Inc_Member" unitRef="USD" decimals="-8">800000000</jnj:BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice>
  <jnj:BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice contextRef="ThreeMonthsEnded_03Apr2011_Crucell_Nv_Member" unitRef="USD" decimals="-8">2000000000</jnj:BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice>
  <jnj:CashPaymentsForRestructuring contextRef="ThreeMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">164000000</jnj:CashPaymentsForRestructuring>
  <jnj:CostOfGoodsSoldPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.296</jnj:CostOfGoodsSoldPercentageIncreaseDecrease>
  <jnj:CostOfGoodsSoldPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.302</jnj:CostOfGoodsSoldPercentageIncreaseDecrease>
  <jnj:CostOfGoodsSoldPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.304</jnj:CostOfGoodsSoldPercentageIncreaseDecrease>
  <jnj:CostOfGoodsSoldPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.312</jnj:CostOfGoodsSoldPercentageIncreaseDecrease>
  <jnj:ExpenseNotAllocatedToSegments contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">335000000</jnj:ExpenseNotAllocatedToSegments>
  <jnj:ExpenseNotAllocatedToSegments contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">158000000</jnj:ExpenseNotAllocatedToSegments>
  <jnj:ExpenseNotAllocatedToSegments contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">332000000</jnj:ExpenseNotAllocatedToSegments>
  <jnj:ExpenseNotAllocatedToSegments contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">116000000</jnj:ExpenseNotAllocatedToSegments>
  <jnj:FiniteLivedPatentsAndTrademarksAccumulatedAmortization contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2629000000</jnj:FiniteLivedPatentsAndTrademarksAccumulatedAmortization>
  <jnj:FiniteLivedPatentsAndTrademarksAccumulatedAmortization contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2819000000</jnj:FiniteLivedPatentsAndTrademarksAccumulatedAmortization>
  <jnj:FiniteLivedPatentsAndTrademarksGross contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">6660000000</jnj:FiniteLivedPatentsAndTrademarksGross>
  <jnj:FiniteLivedPatentsAndTrademarksGross contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">7520000000</jnj:FiniteLivedPatentsAndTrademarksGross>
  <jnj:FiniteLivedPatentsAndTrademarksNet contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">4031000000</jnj:FiniteLivedPatentsAndTrademarksNet>
  <jnj:FiniteLivedPatentsAndTrademarksNet contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">4701000000</jnj:FiniteLivedPatentsAndTrademarksNet>
  <jnj:GrossProfitPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.704</jnj:GrossProfitPercentageIncreaseDecrease>
  <jnj:GrossProfitPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.698</jnj:GrossProfitPercentageIncreaseDecrease>
  <jnj:GrossProfitPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.696</jnj:GrossProfitPercentageIncreaseDecrease>
  <jnj:GrossProfitPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.688</jnj:GrossProfitPercentageIncreaseDecrease>
  <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.339</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease>
  <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.275</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease>
  <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.242</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease>
  <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.206</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease>
  <jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.081</jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease>
  <jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.050</jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease>
  <jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.051</jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease>
  <jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.039</jnj:IncomeTaxExpenseBenefitPercentageIncreaseDecrease>
  <jnj:InterestExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.006</jnj:InterestExpensePercentageIncreaseDecrease>
  <jnj:InterestExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.007</jnj:InterestExpensePercentageIncreaseDecrease>
  <jnj:InterestExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.008</jnj:InterestExpensePercentageIncreaseDecrease>
  <jnj:InterestExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.008</jnj:InterestExpensePercentageIncreaseDecrease>
  <jnj:InvestmentIncomeInterestPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">-0.002</jnj:InvestmentIncomeInterestPercentageIncreaseDecrease>
  <jnj:InvestmentIncomeInterestPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">-0.003</jnj:InvestmentIncomeInterestPercentageIncreaseDecrease>
  <jnj:InvestmentIncomeInterestPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.001</jnj:InvestmentIncomeInterestPercentageIncreaseDecrease>
  <jnj:InvestmentIncomeInterestPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.001</jnj:InvestmentIncomeInterestPercentageIncreaseDecrease>
  <jnj:LitigationAndRecallExpense contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">223000000</jnj:LitigationAndRecallExpense>
  <jnj:LitigationAndRecallExpense contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">127000000</jnj:LitigationAndRecallExpense>
  <jnj:LitigationExpense contextRef="SixMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">202000000</jnj:LitigationExpense>
  <jnj:LitigationExpense contextRef="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">1542000000</jnj:LitigationExpense>
  <jnj:LitigationExpense contextRef="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">115000000</jnj:LitigationExpense>
  <jnj:LitigationExpense contextRef="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">42000000</jnj:LitigationExpense>
  <jnj:LitigationExpense contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">540000000</jnj:LitigationExpense>
  <jnj:LitigationExpense contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">290000000</jnj:LitigationExpense>
  <jnj:LitigationLoss contextRef="ThreeMonthsEnded_03Apr2011" unitRef="USD" decimals="-6">593000000</jnj:LitigationLoss>
  <jnj:LitigationLoss contextRef="SixMonthsEnded_03Jul2011_Restitution_Member" unitRef="USD" decimals="-6">45000000</jnj:LitigationLoss>
  <jnj:LitigationLoss contextRef="SixMonthsEnded_03Jul2011_Civil_Penalties_Member_Average_Wholesale_Price_Litigation_Member" unitRef="USD" decimals="-5">6500000</jnj:LitigationLoss>
  <jnj:LitigationLoss contextRef="SixMonthsEnded_03Jul2011_Civil_Penalties_Member_Risperdal_Member" unitRef="USD" decimals="-5">327100000</jnj:LitigationLoss>
  <jnj:LitigationSettlementPreJudgmentInterest contextRef="ThreeMonthsEnded_03Apr2011" unitRef="USD" decimals="-6">111000000</jnj:LitigationSettlementPreJudgmentInterest>
  <jnj:OneTimePaymentReceivedByCompany contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">500000000</jnj:OneTimePaymentReceivedByCompany>
  <jnj:OtherFiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2880000000</jnj:OtherFiniteLivedIntangibleAssetsAccumulatedAmortization>
  <jnj:OtherFiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">3048000000</jnj:OtherFiniteLivedIntangibleAssetsAccumulatedAmortization>
  <jnj:OtherFiniteLivedIntangibleAssetsNet contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">4794000000</jnj:OtherFiniteLivedIntangibleAssetsNet>
  <jnj:OtherFiniteLivedIntangibleAssetsNet contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">5561000000</jnj:OtherFiniteLivedIntangibleAssetsNet>
  <jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">-0.051</jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease>
  <jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.001</jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease>
  <jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.006</jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease>
  <jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.013</jnj:OtherNonOperatingIncomeExpensePercentageIncreaseDecrease>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.237</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="Pure" decimals="3">0.032</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Consumer_Member" unitRef="Pure" decimals="3">-0.228</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="Pure" decimals="3">-0.423</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.192</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="Pure" decimals="3">-0.065</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="Pure" decimals="3">-0.320</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member" unitRef="Pure" decimals="3">-0.179</jnj:PercentageChangeInOperatingIncomeLoss>
  <jnj:PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.245</jnj:PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments>
  <jnj:PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">-0.189</jnj:PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.058</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="Pure" decimals="3">0.122</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="Pure" decimals="3">0.138</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="SixMonthsEnded_03Jul2011_Europe_Member" unitRef="Pure" decimals="3">0.100</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="SixMonthsEnded_03Jul2011_U_S_Member" unitRef="Pure" decimals="3">-0.002</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.083</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="Pure" decimals="3">0.122</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="ThreeMonthsEnded_03Jul2011_U_S_Member" unitRef="Pure" decimals="3">0.001</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="ThreeMonthsEnded_03Jul2011_Europe_Member" unitRef="Pure" decimals="3">0.186</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesByGeographicArea contextRef="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="Pure" decimals="3">0.141</jnj:PercentageChangeInSalesByGeographicArea>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.058</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Consumer_Member" unitRef="Pure" decimals="3">0.008</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_International_Member" unitRef="Pure" decimals="3">0.116</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="Pure" decimals="3">0.052</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_U_S_Member" unitRef="Pure" decimals="3">-0.002</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="Pure" decimals="3">0.098</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member" unitRef="Pure" decimals="3">0.050</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="Pure" decimals="3">-0.002</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Consumer_Member_U_S_Member" unitRef="Pure" decimals="3">-0.112</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="Pure" decimals="3">0.099</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Consumer_Member_International_Member" unitRef="Pure" decimals="3">0.091</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member" unitRef="Pure" decimals="3">0.161</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.083</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_U_S_Member" unitRef="Pure" decimals="3">0.001</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_International_Member" unitRef="Pure" decimals="3">0.159</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member" unitRef="Pure" decimals="2">0.04</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="Pure" decimals="3">0.072</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="Pure" decimals="3">0.122</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member_International_Member" unitRef="Pure" decimals="3">0.124</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="Pure" decimals="3">0.134</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member_U_S_Member" unitRef="Pure" decimals="3">-0.085</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member" unitRef="Pure" decimals="3">0.226</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member" unitRef="Pure" decimals="3">0.041</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageChangeInSalesBySegmentOfBusiness contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="Pure" decimals="3">0.001</jnj:PercentageChangeInSalesBySegmentOfBusiness>
  <jnj:PercentageOfContributionToIncomeProfitSplit contextRef="SixMonthsEnded_03Jul2011_Merck_Member" unitRef="Pure" decimals="2">0.58</jnj:PercentageOfContributionToIncomeProfitSplit>
  <jnj:PercentageOfContributionToIncomeProfitSplit contextRef="SixMonthsEnded_03Jul2011_Centocor_Ortho_Biotech_Inc_Member" unitRef="Pure" decimals="2">0.42</jnj:PercentageOfContributionToIncomeProfitSplit>
  <jnj:PercentageOfRevenueRepresentedByRelinquishedTerritories contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="2">0.30</jnj:PercentageOfRevenueRepresentedByRelinquishedTerritories>
  <jnj:PercentageOfRevenueRepresentedByRetainedTerritories contextRef="SixMonthsEnded_03Jul2011_Merck_Member" unitRef="Pure" decimals="2">0.70</jnj:PercentageOfRevenueRepresentedByRetainedTerritories>
  <jnj:ProfitLossPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.258</jnj:ProfitLossPercentageIncreaseDecrease>
  <jnj:ProfitLossPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.225</jnj:ProfitLossPercentageIncreaseDecrease>
  <jnj:ProfitLossPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.191</jnj:ProfitLossPercentageIncreaseDecrease>
  <jnj:ProfitLossPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.167</jnj:ProfitLossPercentageIncreaseDecrease>
  <jnj:RealizedGainOnOptionNotDesignatedAsHedge contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">102000000</jnj:RealizedGainOnOptionNotDesignatedAsHedge>
  <jnj:ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">971000000</jnj:ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets>
  <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.104</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease>
  <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.108</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease>
  <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.110</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease>
  <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.113</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease>
  <jnj:RestructuringAndRelatedCostIntangibleAssets contextRef="SixMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">160000000</jnj:RestructuringAndRelatedCostIntangibleAssets>
  <jnj:RestructuringAndRelatedCostInventory contextRef="SixMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">87000000</jnj:RestructuringAndRelatedCostInventory>
  <jnj:RestructuringExpensesIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.018</jnj:RestructuringExpensesIncreaseDecrease>
  <jnj:RestructuringExpensesIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.035</jnj:RestructuringExpensesIncreaseDecrease>
  <jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="INF">1</jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease>
  <jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="INF">1</jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease>
  <jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="INF">1</jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease>
  <jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="INF">1</jnj:SalesRevenueGoodsNetPercentageIncreaseDecrease>
  <jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.308</jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease>
  <jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.310</jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease>
  <jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.313</jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease>
  <jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.314</jnj:SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease>
  <jnj:SettlementPaymentRelatedFinesDisgorgementAndInterest contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">78000000</jnj:SettlementPaymentRelatedFinesDisgorgementAndInterest>
  <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">138600000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
  <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">139700000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
  <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">133900000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
  <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">131700000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
  <jnj:VerdictAgainstCompany contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-5">257700000</jnj:VerdictAgainstCompany>
  <jnj:WeightedAverageAmortizationPeriodsForOtherIntangibleAssets contextRef="SixMonthsEnded_03Jul2011">P27Y</jnj:WeightedAverageAmortizationPeriodsForOtherIntangibleAssets>
  <jnj:WeightedAverageAmortizationPeriodsForPatentsAndTrademarks contextRef="SixMonthsEnded_03Jul2011">P17Y</jnj:WeightedAverageAmortizationPeriodsForPatentsAndTrademarks>
  <us-gaap:AccountsPayableCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">5623000000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">5689000000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">9774000000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">10982000000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">578000000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">808000000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">4100000000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">4405000000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">15873000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">17461000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">24000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">320000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">100000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">228000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2686000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2558000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">-969000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">818000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">-3531000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">-1192000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">340000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">327000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-6">68000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-6">68000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-6">52000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-6">51000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:Assets contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">102908000000</us-gaap:Assets>
  <us-gaap:Assets contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">112114000000</us-gaap:Assets>
  <us-gaap:AssetsCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">47307000000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">52673000000</us-gaap:AssetsCurrent>
  <us-gaap:AvailableForSaleSecuritiesCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">8303000000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">14708000000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-8">19300000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-8">21300000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets contextRef="BalanceAsOf_04Apr2010_Acclarent_Inc_Member" unitRef="USD" decimals="-8">700000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets contextRef="BalanceAsOf_03Apr2011_Crucell_Nv_Member" unitRef="USD" decimals="-8">700000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount contextRef="BalanceAsOf_03Apr2011_Crucell_Nv_Member" unitRef="USD" decimals="-8">500000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable contextRef="BalanceAsOf_03Apr2011_Crucell_Nv_Member" unitRef="USD" decimals="-8">1000000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable>
  <us-gaap:BusinessExitCosts contextRef="ThreeMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">164000000</us-gaap:BusinessExitCosts>
  <us-gaap:Cash contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">2299000000</us-gaap:Cash>
  <us-gaap:Cash contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">2299000000</us-gaap:Cash>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_03Jan2010" unitRef="USD" decimals="-6">15810000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_04Jul2010" unitRef="USD" decimals="-6">12713000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">19355000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">14974000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-3097000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-4381000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">29682000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">29682000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="SixMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="INF">1.03</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="INF">0.54</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="SixMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="INF">1.11</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="INF">0.57</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="BalanceAsOf_02Jan2011" unitRef="USDEPS" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="BalanceAsOf_03Jul2011" unitRef="USDEPS" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="BalanceAsOf_02Jan2011" unitRef="Shares" decimals="INF">4320000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="BalanceAsOf_03Jul2011" unitRef="Shares" decimals="INF">4320000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="BalanceAsOf_02Jan2011" unitRef="Shares" decimals="INF">3119843000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="BalanceAsOf_03Jul2011" unitRef="Shares" decimals="INF">3119843000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">3120000000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">3120000000</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-8">5300000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-8">1600000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-8">8600000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-8">3600000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:CostOfGoodsSold contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">9158000000</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">4630000000</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">9950000000</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">5172000000</us-gaap:CostOfGoodsSold>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="4">0.0408</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">604000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-504000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2224000000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2306000000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">5096000000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">5653000000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1447000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">1888000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-25000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-117000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-59000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-194000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-98000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-12000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">6000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAmortizationOfTransitionObligationsAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">500000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">248000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">555000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">277000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">394000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">100000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">50000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">194000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">427000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">94000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">46000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanInterestCost contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">214000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">189000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">265000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">94000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">130000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">189000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">358000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">181000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">94000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="SixMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">247000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="SixMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">67000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="ThreeMonthsEnded_04Jul2010_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">121000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="ThreeMonthsEnded_04Jul2010_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">33000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="SixMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">74000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="SixMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">287000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="ThreeMonthsEnded_03Jul2011_Other_Postretirement_Benefit_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">37000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanServiceCost contextRef="ThreeMonthsEnded_03Jul2011_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">144000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">1445000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1532000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DerivativeAssetsNoncurrent contextRef="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member_2" unitRef="USD" decimals="-6">14000000</us-gaap:DerivativeAssetsNoncurrent>
  <us-gaap:DerivativeAssetsNoncurrent contextRef="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeAssetsNoncurrent>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-96000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">11000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-98000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">21000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">-29000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-54000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">20000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-76000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">11000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">-9000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-118000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-3000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-18000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">19000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-106000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">-10000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-40000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">18000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-44000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-16000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-185000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">81000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-206000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">73000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">-84000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-49000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-158000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-82000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">44000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">-102000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">-53000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">35000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">12000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-59000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">92000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">-8000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-40000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Sales_Member" unitRef="USD" decimals="-6">27000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-7000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Research_Expense_Member" unitRef="USD" decimals="-6">28000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_Interest_Income_Expense_Net_Member" unitRef="USD" decimals="-6">-31000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Cost_Of_Sales_Member" unitRef="USD" decimals="-6">12000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">338000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_02Jan2011_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">321000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">17000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">489000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member" unitRef="USD" decimals="-6">489000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member_2" unitRef="USD" decimals="-6">487000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_2" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">487000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1088000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">502000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_02Jan2011_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">586000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">1050000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member_2" unitRef="USD" decimals="-6">404000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member" unitRef="USD" decimals="-6">1050000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member_2" unitRef="USD" decimals="-6">646000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">646000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">404000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
  <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="BalanceAsOf_02Jan2011_Cross_Currency_Interest_Rate_Contract_Member_2" unitRef="USD" decimals="-6">502000000</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-6">404000000</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-139000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member" unitRef="USD" decimals="-6">20000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member" unitRef="USD" decimals="-6">-154000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member" unitRef="USD" decimals="-6">-21000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member" unitRef="USD" decimals="-6">16000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-133000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member" unitRef="USD" decimals="-6">16000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member" unitRef="USD" decimals="-6">-20000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member" unitRef="USD" decimals="-6">-149000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_04Jul2010_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member" unitRef="USD" decimals="-6">20000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member" unitRef="USD" decimals="-6">-2000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member" unitRef="USD" decimals="-6">3000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Six_Net_Member" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="SixMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Two_Net_Member" unitRef="USD" decimals="-6">-2000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">4000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Three_Net_Member" unitRef="USD" decimals="-6">6000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="ThreeMonthsEnded_03Jul2011_Foreign_Exchange_Contract_Member_Other_Interest_Income_Expense_Type_Four_Net_Member" unitRef="USD" decimals="-6">-2000000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss contextRef="SixMonthsEnded_03Jul2011">Next 12 months</us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss>
  <us-gaap:EarningsPerShareBasic contextRef="SixMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="2">2.89</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="2">1.25</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic contextRef="SixMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="2">2.28</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="2">1.01</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="SixMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="2">2.85</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USDEPS" decimals="2">1.23</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted contextRef="SixMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="2">2.25</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USDEPS" decimals="2">1.00</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="SixMonthsEnded_04Jul2010" unitRef="Pure" decimals="3">0.240</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="SixMonthsEnded_03Jul2011" unitRef="Pure" decimals="3">0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-162000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">118000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2642000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2104000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1165000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
  <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">1371000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
  <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member" unitRef="USD" decimals="-6">0</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
  <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member" unitRef="USD" decimals="-6">1371000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
  <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member" unitRef="USD" decimals="-6">0</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">402000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense>
  <us-gaap:FiniteLivedIntangibleAssetsFutureAmortizationExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">840000000</us-gaap:FiniteLivedIntangibleAssetsFutureAmortizationExpense>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">19000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_02Jan2011_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">19000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">597000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Swiss_Franc_Option_Member" unitRef="USD" decimals="-6">569000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member" unitRef="USD" decimals="-6">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member_2" unitRef="USD" decimals="-6">28000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member" unitRef="USD" decimals="-6">597000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Swiss_Franc_Option_Member_Fair_Value_Inputs_Level2_Member" unitRef="USD" decimals="-6">569000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">28000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue contextRef="BalanceAsOf_02Jan2011_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">39000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue contextRef="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member_2" unitRef="USD" decimals="-6">27000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level1_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level2_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">27000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue contextRef="BalanceAsOf_03Jul2011_Fair_Value_Inputs_Level3_Member_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-6">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
  <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-69000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
  <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-21000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
  <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">8000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
  <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-7000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
  <us-gaap:Goodwill contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">15294000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_02Jan2011_Consumer_Member" unitRef="USD" decimals="-6">8144000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_02Jan2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">5925000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_02Jan2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">1225000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">16243000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">8464000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">1815000000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="BalanceAsOf_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">5964000000</us-gaap:Goodwill>
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">538000000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">538000000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillOtherChanges contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">411000000</us-gaap:GoodwillOtherChanges>
  <us-gaap:GoodwillOtherChanges contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">39000000</us-gaap:GoodwillOtherChanges>
  <us-gaap:GoodwillOtherChanges contextRef="SixMonthsEnded_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">320000000</us-gaap:GoodwillOtherChanges>
  <us-gaap:GoodwillOtherChanges contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">52000000</us-gaap:GoodwillOtherChanges>
  <us-gaap:GrossProfit contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">21803000000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">10700000000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">22820000000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">11425000000</us-gaap:GrossProfit>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">10500000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">4220000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">7932000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">3422000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">2525000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">771000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1680000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">646000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-1719000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-444000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">555000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">576000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInInventories contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">88000000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInInventories contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">620000000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">704000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">920000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">218000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1199000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">3600000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
  <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">3600000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
  <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">3600000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
  <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">3600000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">175400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">175500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">168800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">168900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">7891000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">8116000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedTrademarks contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">5954000000</us-gaap:IndefiniteLivedTrademarks>
  <us-gaap:IndefiniteLivedTrademarks contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">6080000000</us-gaap:IndefiniteLivedTrademarks>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">16716000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">18378000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:InterestExpense contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">209000000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">101000000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">254000000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">129000000</us-gaap:InterestExpense>
  <us-gaap:InventoryFinishedGoods contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2845000000</us-gaap:InventoryFinishedGoods>
  <us-gaap:InventoryFinishedGoods contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">3133000000</us-gaap:InventoryFinishedGoods>
  <us-gaap:InventoryNet contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">5378000000</us-gaap:InventoryNet>
  <us-gaap:InventoryNet contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">6413000000</us-gaap:InventoryNet>
  <us-gaap:InventoryRawMaterialsAndSupplies contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1073000000</us-gaap:InventoryRawMaterialsAndSupplies>
  <us-gaap:InventoryRawMaterialsAndSupplies contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">1383000000</us-gaap:InventoryRawMaterialsAndSupplies>
  <us-gaap:InventoryWorkInProcess contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1460000000</us-gaap:InventoryWorkInProcess>
  <us-gaap:InventoryWorkInProcess contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">1897000000</us-gaap:InventoryWorkInProcess>
  <us-gaap:InvestmentIncomeInterest contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">70000000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">43000000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">39000000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">18000000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:Liabilities contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">46329000000</us-gaap:Liabilities>
  <us-gaap:Liabilities contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">49982000000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">102908000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">112114000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">23072000000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">20985000000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LitigationSettlementExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">73000000</us-gaap:LitigationSettlementExpense>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">9156000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">13680000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">13680000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">14581000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Four_Member" unitRef="USD" decimals="-6">1569000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Fifteen_Member" unitRef="USD" decimals="-6">41000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Seventeen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Thirteen_Member" unitRef="USD" decimals="-6">489000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Six_Member" unitRef="USD" decimals="-6">541000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Five_Member" unitRef="USD" decimals="-6">197000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Twelve_Member" unitRef="USD" decimals="-6">773000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Seven_Member" unitRef="USD" decimals="-6">323000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Eleven_Member" unitRef="USD" decimals="-6">1120000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">903000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Six_Member" unitRef="USD" decimals="-6">522000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_One_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">446000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Two_Member" unitRef="USD" decimals="-6">527000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_One_Member" unitRef="USD" decimals="-6">599000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Sixteen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">503000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Thirteen_Member" unitRef="USD" decimals="-6">539000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Eleven_Member" unitRef="USD" decimals="-6">995000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Fifteen_Member" unitRef="USD" decimals="-6">41000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Ten_Member" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Fourteen_Member" unitRef="USD" decimals="-6">898000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_One_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">456000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_One_Member" unitRef="USD" decimals="-6">632000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Three_Member" unitRef="USD" decimals="-6">1000000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Four_Member" unitRef="USD" decimals="-6">1440000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Five_Member" unitRef="USD" decimals="-6">246000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Fourteen_Member" unitRef="USD" decimals="-6">1015000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Eight_Member" unitRef="USD" decimals="-6">856000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Seventeen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Seven_Member" unitRef="USD" decimals="-6">250000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Nine_Member" unitRef="USD" decimals="-6">375000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Ten_Member" unitRef="USD" decimals="-6">523000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">898000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Eight_Member" unitRef="USD" decimals="-6">795000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Two_Member" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Eighteen_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">750000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Twelve_Member" unitRef="USD" decimals="-6">700000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Nineteen_Member" unitRef="USD" decimals="-6">1006000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Two_Member_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">291000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member_Notes_Due_Period_Three_Member" unitRef="USD" decimals="-6">1161000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Nineteen_Member" unitRef="USD" decimals="-6">999000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Eighteen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">750000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Twenty_Two_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">298000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Notes_Due_Period_Sixteen_Member_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member_Notes_Due_Period_Nine_Member" unitRef="USD" decimals="-6">294000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge contextRef="SixMonthsEnded_03Jul2011">18 Months</us-gaap:MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">1820000000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">1820000000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-5887000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-1464000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-4575000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-9260000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">7527000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">6225000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">871000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
  <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2049000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">909000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2248000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">38000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">199000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
  <us-gaap:NotionalAmountOfForeignCurrencyDerivatives contextRef="BalanceAsOf_03Jul2011_Foreign_Exchange_Contract_Member" unitRef="USD" decimals="-9">23000000000</us-gaap:NotionalAmountOfForeignCurrencyDerivatives>
  <us-gaap:NotionalAmountOfInterestRateDerivatives contextRef="BalanceAsOf_03Jul2011_Cross_Currency_Interest_Rate_Contract_Member" unitRef="USD" decimals="-9">3000000000</us-gaap:NotionalAmountOfInterestRateDerivatives>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">10835000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">5578000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_04Jul2010_Consumer_Member" unitRef="USD" decimals="-6">1454000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">3803000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">4378000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">1876000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">1833000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_04Jul2010_Consumer_Member" unitRef="USD" decimals="-6">669000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">8264000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">3219000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">1122000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">3923000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">3538000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">549000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">1275000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">1714000000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherAssetsNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">3942000000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">4193000000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">515000000</us-gaap:OtherCashEquivalentsAtCarryingValue>
  <us-gaap:OtherCashEquivalentsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">515000000</us-gaap:OtherCashEquivalentsAtCarryingValue>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">296000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">128000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">128000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1787000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2339000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">139000000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-116000000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">12000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">435000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">7674000000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
  <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">8609000000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
  <us-gaap:OtherIndefiniteLivedIntangibleAssets contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">1937000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
  <us-gaap:OtherIndefiniteLivedIntangibleAssets contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">2036000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">6567000000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">7227000000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">1576000000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">-18000000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-193000000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-206000000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherRestructuringCosts contextRef="ThreeMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">512000000</us-gaap:OtherRestructuringCosts>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">21000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">62000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">780000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">929000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">2839000000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">3043000000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">871000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2049000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireInvestments contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">6695000000</us-gaap:PaymentsToAcquireInvestments>
  <us-gaap:PaymentsToAcquireInvestments contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">16820000000</us-gaap:PaymentsToAcquireInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">897000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1054000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">6087000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">6202000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:PensionContributions contextRef="SixMonthsEnded_03Jul2011_Foreign_Pension_Plans_Defined_Benefit_Member" unitRef="USD" decimals="-6">16000000</us-gaap:PensionContributions>
  <us-gaap:PensionContributions contextRef="SixMonthsEnded_03Jul2011_United_States_Pension_Plans_Of_U_S_Entity_Defined_Benefit_Member" unitRef="USD" decimals="-6">119000000</us-gaap:PensionContributions>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">2273000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">3290000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">4404000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">3800000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">10582000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">109000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">143000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:ProceedsFromShortTermDebt contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">956000000</us-gaap:ProceedsFromShortTermDebt>
  <us-gaap:ProceedsFromShortTermDebt contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">3586000000</us-gaap:ProceedsFromShortTermDebt>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">386000000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">717000000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProfitLoss contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">7975000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">3449000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">6252000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">2776000000</us-gaap:ProfitLoss>
  <us-gaap:PropertyPlantAndEquipmentDisposals contextRef="SixMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">265000000</us-gaap:PropertyPlantAndEquipmentDisposals>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">30426000000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">32435000000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">14553000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">14974000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">46000000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">-33000000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">12000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">5000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RepaymentsOfShortTermDebt contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">3598000000</us-gaap:RepaymentsOfShortTermDebt>
  <us-gaap:RepaymentsOfShortTermDebt contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">6194000000</us-gaap:RepaymentsOfShortTermDebt>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">3205000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">1648000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">3620000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">1882000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated contextRef="TwentyOneMonthsEnded_03Jul2011_Restructuring_Plan_Of2009_Member" unitRef="Positions" decimals="INF">7500</us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated>
  <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate contextRef="BalanceAsOf_03Jul2011_Restructuring_Plan_Of2009_Member" unitRef="Positions" decimals="INF">5700</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate>
  <us-gaap:RestructuringCharges contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">589000000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">676000000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">589000000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges contextRef="ThreeMonthsEnded_03Jul2011_Cordis_Restructuring_Member" unitRef="USD" decimals="-6">676000000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">676000000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringReserve contextRef="BalanceAsOf_02Jan2011_Employee_Severance_Member" unitRef="USD" decimals="-6">345000000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="BalanceAsOf_03Jul2011_Employee_Severance_Member" unitRef="USD" decimals="-6">268000000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="SixMonthsEnded_03Jul2011_Employee_Severance_Member" unitRef="USD" decimals="-6">77000000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">77773000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">80836000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">30961000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Europe_Member" unitRef="USD" decimals="-6">7934000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_International_Member" unitRef="USD" decimals="-6">15871000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="USD" decimals="-6">2655000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_U_S_Member" unitRef="USD" decimals="-6">15090000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Consumer_Member" unitRef="USD" decimals="-6">7413000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">11191000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="USD" decimals="-6">5282000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">12357000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Pharmaceutical_Member_International_Member" unitRef="USD" decimals="-6">4875000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Consumer_Member_International_Member" unitRef="USD" decimals="-6">4390000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Pharmaceutical_Member_U_S_Member" unitRef="USD" decimals="-6">6316000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="USD" decimals="-6">6606000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="USD" decimals="-6">5751000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_04Jul2010_Consumer_Member_U_S_Member" unitRef="USD" decimals="-6">3023000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">15330000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">6130000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_International_Member" unitRef="USD" decimals="-6">7892000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Europe_Member" unitRef="USD" decimals="-6">3832000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="USD" decimals="-6">1375000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_U_S_Member" unitRef="USD" decimals="-6">7438000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member" unitRef="USD" decimals="-6">5553000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Consumer_Member" unitRef="USD" decimals="-6">3647000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="USD" decimals="-6">2685000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member_U_S_Member" unitRef="USD" decimals="-6">3110000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Consumer_Member_U_S_Member" unitRef="USD" decimals="-6">1463000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="USD" decimals="-6">2865000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Pharmaceutical_Member_International_Member" unitRef="USD" decimals="-6">2443000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="USD" decimals="-6">3265000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_04Jul2010_Consumer_Member_International_Member" unitRef="USD" decimals="-6">2184000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">32770000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">13003000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">7475000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_U_S_Member" unitRef="USD" decimals="-6">15055000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Europe_Member" unitRef="USD" decimals="-6">8726000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">12292000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_International_Member" unitRef="USD" decimals="-6">17715000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="USD" decimals="-6">6010000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="USD" decimals="-6">2979000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="USD" decimals="-6">7262000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="USD" decimals="-6">5741000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member" unitRef="USD" decimals="-6">5662000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Consumer_Member_International_Member" unitRef="USD" decimals="-6">4791000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Consumer_Member_U_S_Member" unitRef="USD" decimals="-6">2684000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="SixMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member" unitRef="USD" decimals="-6">6630000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">16597000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member" unitRef="USD" decimals="-6">6233000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_U_S_Member" unitRef="USD" decimals="-6">7447000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_One_Member" unitRef="USD" decimals="-6">1543000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Europe_Member" unitRef="USD" decimals="-6">4543000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member" unitRef="USD" decimals="-6">3793000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Segment_Geographical_Groups_Of_Countries_Group_Two_Member" unitRef="USD" decimals="-6">3064000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_International_Member" unitRef="USD" decimals="-6">9150000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member" unitRef="USD" decimals="-6">6571000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member_International_Member" unitRef="USD" decimals="-6">2454000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_International_Member" unitRef="USD" decimals="-6">2994000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Consumer_Member_U_S_Member" unitRef="USD" decimals="-6">1339000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_International_Member" unitRef="USD" decimals="-6">3702000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Pharmaceutical_Member_U_S_Member" unitRef="USD" decimals="-6">3239000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="ThreeMonthsEnded_03Jul2011_Medical_Devices_And_Diagnostics_Member_U_S_Member" unitRef="USD" decimals="-6">2869000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">9535000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="ThreeMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">4756000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">10271000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="ThreeMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">5215000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ShareBasedCompensation contextRef="SixMonthsEnded_04Jul2010" unitRef="USD" decimals="-6">305000000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="SixMonthsEnded_03Jul2011" unitRef="USD" decimals="-6">339000000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShortTermBorrowings contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">7617000000</us-gaap:ShortTermBorrowings>
  <us-gaap:ShortTermBorrowings contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">5046000000</us-gaap:ShortTermBorrowings>
  <us-gaap:ShortTermBorrowings contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">5046000000</us-gaap:ShortTermBorrowings>
  <us-gaap:ShortTermBorrowings contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">5046000000</us-gaap:ShortTermBorrowings>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">56579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">62132000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:TimeDepositsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">1097000000</us-gaap:TimeDepositsAtCarryingValue>
  <us-gaap:TimeDepositsAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">1097000000</us-gaap:TimeDepositsAtCarryingValue>
  <us-gaap:TreasuryStockShares contextRef="BalanceAsOf_02Jan2011" unitRef="Shares" decimals="INF">381746000</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockShares contextRef="BalanceAsOf_03Jul2011" unitRef="Shares" decimals="INF">379263000</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockValue contextRef="BalanceAsOf_02Jan2011" unitRef="USD" decimals="-6">20783000000</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValue contextRef="BalanceAsOf_03Jul2011" unitRef="USD" decimals="-6">20632000000</us-gaap:TreasuryStockValue>
  <us-gaap:USGovernmentSecuritiesAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Carrying_Reported_Amount_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">23951000000</us-gaap:USGovernmentSecuritiesAtCarryingValue>
  <us-gaap:USGovernmentSecuritiesAtCarryingValue contextRef="BalanceAsOf_03Jul2011_Estimate_Of_Fair_Value_Fair_Value_Disclosure_Member" unitRef="USD" decimals="-6">23951000000</us-gaap:USGovernmentSecuritiesAtCarryingValue>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">2796100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">2796000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">2778100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">2781300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="SixMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">2755700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="ThreeMonthsEnded_04Jul2010" unitRef="Shares" decimals="-5">2756600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="SixMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">2739600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="ThreeMonthsEnded_03Jul2011" unitRef="Shares" decimals="-5">2740500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Footnote Section-->
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>jnj-20110703.xsd
<DESCRIPTION>EX-101 SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Bowne Tagger XBRL Enabler by Bowne Software version 10.0.0.56-->
<!--Based on XBRL 2.1-->
<!--Modified on: 8/9/2011 12:05:36 PM-->
<schema targetNamespace="http://jnj.com/2011-07-03" attributeFormDefault="unqualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:jnj="http://jnj.com/2011-07-03" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals" id="AccumulatedOtherComprehensiveIncomeDetailsTextuals">
        <link:definition>06071 - Disclosure - Accumulated Other Comprehensive Income (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/RestructuringDetailsTextuals" id="RestructuringDetailsTextuals">
        <link:definition>06121 - Disclosure - Restructuring (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/EarningsPerShareDetailsTextuals" id="EarningsPerShareDetailsTextuals">
        <link:definition>06081 - Disclosure - Earnings Per Share (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurementsDetails1" id="FairValueMeasurementsDetails1">
        <link:definition>06041 - Disclosure - Fair Value Measurements (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals" id="IntangibleAssetsAndGoodwillDetailsTextuals">
        <link:definition>06031 - Disclosure - Intangible Assets and Goodwill (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" id="SegmentsOfBusinessAndGeographicAreasDetails2">
        <link:definition>06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurementsDetails2" id="FairValueMeasurementsDetails2">
        <link:definition>06042 - Disclosure - Fair Value Measurements (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IncomeStatementPercentageToSales" id="IncomeStatementPercentageToSales">
        <link:definition>0121 - Statement - Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IncomeTaxesDetailsTextuals" id="IncomeTaxesDetailsTextuals">
        <link:definition>0605 - Disclosure - Income Taxes (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" id="FairValueMeasurementsDetailsTextuals">
        <link:definition>06043 - Disclosure - Fair Value Measurements (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" id="PensionsAndOtherBenefitPlansDetailsTextuals">
        <link:definition>06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" id="SegmentsOfBusinessAndGeographicAreasDetailsTextuals">
        <link:definition>06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" id="SegmentsOfBusinessAndGeographicAreasDetails1">
        <link:definition>06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" id="PensionsAndOtherBenefitPlansDetails">
        <link:definition>0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansTables" id="PensionsAndOtherBenefitPlansTables">
        <link:definition>0506 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlans" id="PensionsAndOtherBenefitPlans">
        <link:definition>0206 - Disclosure - Pensions and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0213 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurementsDetails" id="FairValueMeasurementsDetails">
        <link:definition>0604 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
        <link:definition>0504 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/Restructuring" id="Restructuring">
        <link:definition>0212 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/LegalProceedings" id="LegalProceedings">
        <link:definition>0211 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/BusinessCombinationsAndDivestitures" id="BusinessCombinationsAndDivestitures">
        <link:definition>0210 - Disclosure - Business Combinations and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas" id="SegmentsOfBusinessAndGeographicAreas">
        <link:definition>0209 - Disclosure - Segments of Business and Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>0208 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncome" id="AccumulatedOtherComprehensiveIncome">
        <link:definition>0207 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0205 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/FairValueMeasurements" id="FairValueMeasurements">
        <link:definition>0204 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwill" id="IntangibleAssetsAndGoodwill">
        <link:definition>0203 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/Inventories" id="Inventories">
        <link:definition>0202 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>0201 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
        <link:definition>0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/StatementsOfEarnings" id="StatementsOfEarnings">
        <link:definition>0120 - Statement - Consolidated Statements of Earnings (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>0111 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/BalanceSheets" id="BalanceSheets">
        <link:definition>0110 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/LegalProceedingDetails" id="LegalProceedingDetails">
        <link:definition>0611 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" id="BusinessCombinationsAndDivestituresDetails">
        <link:definition>0610 - Disclosure - Business Combinations and Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" id="AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0607 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" id="AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>0507 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <link:definition>0608 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <link:definition>0508 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" id="SegmentsOfBusinessAndGeographicAreasDetails">
        <link:definition>0609 - Disclosure - Segments of Business and Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables" id="SegmentsOfBusinessAndGeographicAreasTables">
        <link:definition>0509 - Disclosure - Segments of Business and Geographic Areas (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/RestructuringDetails" id="RestructuringDetails">
        <link:definition>0612 - Disclosure - Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/RestructuringTables" id="RestructuringTables">
        <link:definition>0512 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>0401 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" id="IntangibleAssetsAndGoodwillDetails">
        <link:definition>0603 - Disclosure - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillTables" id="IntangibleAssetsAndGoodwillTables">
        <link:definition>0503 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/InventoriesDetails" id="InventoriesDetails">
        <link:definition>0602 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/InventoriesTables" id="InventoriesTables">
        <link:definition>0502 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://jnj.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>00 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="jnj-20110703_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links, all" />
      <link:linkbaseRef xlink:type="simple" xlink:href="jnj-20110703_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links, all" />
      <link:linkbaseRef xlink:type="simple" xlink:href="jnj-20110703_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links, all" />
      <link:linkbaseRef xlink:type="simple" xlink:href="jnj-20110703_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links, all" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2011-01-31" schemaLocation="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd" />
  <import namespace="http://fasb.org/us-gaap/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2011-01-31" schemaLocation="http://xbrl.sec.gov/currency/2011/currency-2011-01-31.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2011-01-31" schemaLocation="http://xbrl.sec.gov/exch/2011/exch-2011-01-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <element name="ConsumerMember" id="jnj_ConsumerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PharmaceuticalMember" name="PharmaceuticalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="MedicalDevicesAndDiagnosticsMember" id="jnj_MedicalDevicesAndDiagnosticsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" name="WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" name="WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="FiniteLivedPatentsAndTrademarksGross" id="jnj_FiniteLivedPatentsAndTrademarksGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <element name="FiniteLivedPatentsAndTrademarksAccumulatedAmortization" id="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <element name="OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" id="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <element name="OtherFiniteLivedIntangibleAssetsNet" id="jnj_OtherFiniteLivedIntangibleAssetsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <element name="DocumentAndEntityInformationAbstract" id="jnj_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="InterestIncomeExpenseNetMember" id="jnj_InterestIncomeExpenseNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="ResearchExpenseMember" id="jnj_ResearchExpenseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="OtherInterestIncomeExpenseTypeThreeNetMember" id="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="OtherInterestIncomeExpenseTypeTwoNetMember" id="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="OtherInterestIncomeExpenseTypeSixNetMember" id="jnj_OtherInterestIncomeExpenseTypeSixNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_USMember" name="USMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="InternationalMember" id="jnj_InternationalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="EuropeMember" id="jnj_EuropeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element name="EarningsPerShareTextualsAbstract" id="jnj_EarningsPerShareTextualsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="LegalProceedingTextualsAbstract" id="jnj_LegalProceedingTextualsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="AccruedRebatesReturnsAndPromotions" id="jnj_AccruedRebatesReturnsAndPromotions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <element name="AcquisitionsAbstract" id="jnj_AcquisitionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="IncomeTaxTextualsAbstract" id="jnj_IncomeTaxTextualsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="FairValueMeasurementsTextualsAbstract" id="jnj_FairValueMeasurementsTextualsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element name="IntangibleAssetsAndGoodwillTextualsAbstract" id="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" name="SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_CashPaymentsForRestructuring" name="CashPaymentsForRestructuring" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_OtherInterestIncomeExpenseNetMember" name="OtherInterestIncomeExpenseNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" name="SegmentOfBusinessAndGeographicAreasTextualsAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_FiniteLivedPatentsAndTrademarksNet" name="FiniteLivedPatentsAndTrademarksNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" />
  <element id="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" name="PensionsAndOtherBenefitPlansTextualsAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" name="BusinessCombinationsAndDivestituresTextualsAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_ExpenseNotAllocatedToSegments" name="ExpenseNotAllocatedToSegments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" name="AccumulatedOtherComprehensiveIncomeTextualsAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_VerdictAgainstCompany" name="VerdictAgainstCompany" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_RestitutionMember" name="RestitutionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_CivilPenaltiesMember" name="CivilPenaltiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_AmountGivenToPlaintiffByJury" name="AmountGivenToPlaintiffByJury" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" name="SalesRevenueGoodsNetPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" name="CostOfGoodsSoldPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_GrossProfitPercentageIncreaseDecrease" name="GrossProfitPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" name="SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" name="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" name="InvestmentIncomeInterestPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_InterestExpensePercentageIncreaseDecrease" name="InterestExpensePercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" name="OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" name="IncomeTaxExpenseBenefitPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_ProfitLossPercentageIncreaseDecrease" name="ProfitLossPercentageIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" name="FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodOneMember" name="NotesDuePeriodOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTwoMember" name="NotesDuePeriodTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodThreeMember" name="NotesDuePeriodThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodFourteenMember" name="NotesDuePeriodFourteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodFourMember" name="NotesDuePeriodFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodFiveMember" name="NotesDuePeriodFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodSixMember" name="NotesDuePeriodSixMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodSevenMember" name="NotesDuePeriodSevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodEightMember" name="NotesDuePeriodEightMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodNineMember" name="NotesDuePeriodNineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTenMember" name="NotesDuePeriodTenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodElevenMember" name="NotesDuePeriodElevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTwelveMember" name="NotesDuePeriodTwelveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodThirteenMember" name="NotesDuePeriodThirteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodFifteenMember" name="NotesDuePeriodFifteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PercentageChangeInSalesBySegmentOfBusiness" name="PercentageChangeInSalesBySegmentOfBusiness" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" name="BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" name="SettlementPaymentRelatedFinesDisgorgementAndInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" name="PercentageOfRevenueRepresentedByRetainedTerritories" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_AmountOfRevenueRepresentedByRetainedTerritories" name="AmountOfRevenueRepresentedByRetainedTerritories" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" name="PercentageOfRevenueRepresentedByRelinquishedTerritories" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PercentageOfContributionToIncomeProfitSplit" name="PercentageOfContributionToIncomeProfitSplit" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_LitigationSettlementByCompaniesAxis" name="LitigationSettlementByCompaniesAxis" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_LitigationSettlementByCompaniesDomain" name="LitigationSettlementByCompaniesDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_MerckMember" name="MerckMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_CentocorOrthoBiotechIncMember" name="CentocorOrthoBiotechIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_OneTimePaymentReceivedByCompany" name="OneTimePaymentReceivedByCompany" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_CrucellNvMember" name="CrucellNvMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_AcclarentIncMember" name="AcclarentIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" name="PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_LitigationSettlementPreJudgmentInterest" name="LitigationSettlementPreJudgmentInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" name="AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_OtherInterestIncomeExpenseTypeFourNetMember" name="OtherInterestIncomeExpenseTypeFourNetMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" name="DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" abstract="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SaleByGeographicAreaTableTextBlock" name="SaleByGeographicAreaTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PercentageChangeInSalesByGeographicArea" name="PercentageChangeInSalesByGeographicArea" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SalesBySegmentOfBusinessTableTextBlock" name="SalesBySegmentOfBusinessTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PercentageChangeInOperatingIncomeLoss" name="PercentageChangeInOperatingIncomeLoss" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" name="PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" name="RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_SwissFrancOptionMember" name="SwissFrancOptionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodSixteenMember" name="NotesDuePeriodSixteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodSeventeenMember" name="NotesDuePeriodSeventeenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodEighteenMember" name="NotesDuePeriodEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTwentyMember" name="NotesDuePeriodTwentyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTwentyOneMember" name="NotesDuePeriodTwentyOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodTwentyTwoMember" name="NotesDuePeriodTwentyTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_RestructuringExpensesIncreaseDecrease" name="RestructuringExpensesIncreaseDecrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_AverageWholesalePriceLitigationMember" name="AverageWholesalePriceLitigationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_RisperdalMember" name="RisperdalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_NotesDuePeriodNineteenMember" name="NotesDuePeriodNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_LitigationAndRecallExpense" name="LitigationAndRecallExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_SynthesIncMember" name="SynthesIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" name="BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" name="BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_RestructuringAndRelatedCostIntangibleAssets" name="RestructuringAndRelatedCostIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_RestructuringAndRelatedCostInventory" name="RestructuringAndRelatedCostInventory" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" name="BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_RealizedGainOnOptionNotDesignatedAsHedge" name="RealizedGainOnOptionNotDesignatedAsHedge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" />
  <element id="jnj_LitigationExpense" name="LitigationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_LitigationLoss" name="LitigationLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_CordisRestructuringMember" name="CordisRestructuringMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <element id="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" name="ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" />
  <element id="jnj_AwardedDamagesReversed" name="AwardedDamagesReversed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <element id="jnj_RestructuringPlanOf2009Member" name="RestructuringPlanOf2009Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>jnj-20110703_cal.xml
<DESCRIPTION>EX-101 CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Bowne Tagger XBRL Enabler by Bowne Software version 10.0.0.56-->
<!--Based on XBRL 2.1-->
<!--Modified on: 8/9/2011 12:05:36 PM-->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://jnj.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="jnj-20110703.xsd#DocumentAndEntityInformation" />
  <roleRef roleURI="http://jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#InventoriesTables" />
  <roleRef roleURI="http://jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#InventoriesDetails" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillTables" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillDetails" />
  <roleRef roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20110703.xsd#SummaryOfSignificantAccountingPoliciesPolicies" />
  <roleRef roleURI="http://jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringTables" />
  <roleRef roleURI="http://jnj.com/role/RestructuringDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetails" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasTables" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareTables" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareDetails" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeTables" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeDetails" />
  <roleRef roleURI="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#BusinessCombinationsAndDivestituresDetails" />
  <roleRef roleURI="http://jnj.com/role/LegalProceedingDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#LegalProceedingDetails" />
  <roleRef roleURI="http://jnj.com/role/BalanceSheets" xlink:type="simple" xlink:href="jnj-20110703.xsd#BalanceSheets" />
  <roleRef roleURI="http://jnj.com/role/BalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20110703.xsd#BalanceSheetsParenthetical" />
  <roleRef roleURI="http://jnj.com/role/StatementsOfEarnings" xlink:type="simple" xlink:href="jnj-20110703.xsd#StatementsOfEarnings" />
  <roleRef roleURI="http://jnj.com/role/StatementsOfCashFlows" xlink:type="simple" xlink:href="jnj-20110703.xsd#StatementsOfCashFlows" />
  <roleRef roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20110703.xsd#SummaryOfSignificantAccountingPolicies" />
  <roleRef roleURI="http://jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20110703.xsd#Inventories" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwill" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwill" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurements" />
  <roleRef roleURI="http://jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeTaxes" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncome" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShare" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreas" />
  <roleRef roleURI="http://jnj.com/role/BusinessCombinationsAndDivestitures" xlink:type="simple" xlink:href="jnj-20110703.xsd#BusinessCombinationsAndDivestitures" />
  <roleRef roleURI="http://jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20110703.xsd#LegalProceedings" />
  <roleRef roleURI="http://jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20110703.xsd#Restructuring" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsTables" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SubsequentEvents" roleURI="http://jnj.com/role/SubsequentEvents" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlans" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlans" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansTables" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansTables" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetails" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails1" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetailsTextuals" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetailsTextuals" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetailsTextuals" roleURI="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeTaxesDetailsTextuals" roleURI="http://jnj.com/role/IncomeTaxesDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeStatementPercentageToSales" roleURI="http://jnj.com/role/IncomeStatementPercentageToSales" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails2" roleURI="http://jnj.com/role/FairValueMeasurementsDetails2" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails2" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillDetailsTextuals" roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails1" roleURI="http://jnj.com/role/FairValueMeasurementsDetails1" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareDetailsTextuals" roleURI="http://jnj.com/role/EarningsPerShareDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetailsTextuals" roleURI="http://jnj.com/role/RestructuringDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeDetailsTextuals" roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/DocumentAndEntityInformation" xlink:title="00 - Document - Document and Entity Information" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/InventoriesTables" xlink:title="0502 - Disclosure - Inventories (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/InventoriesDetails" xlink:title="0602 - Disclosure - Inventories (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_InventoryNet" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_InventoryFinishedGoods" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_InventoryNet" xlink:to="loc_InventoryFinishedGoods" use="optional" order="60" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_InventoryWorkInProcess" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_InventoryNet" xlink:to="loc_InventoryWorkInProcess" use="optional" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="loc_InventoryRawMaterialsAndSupplies" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_InventoryNet" xlink:to="loc_InventoryRawMaterialsAndSupplies" use="optional" order="20" weight="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillTables" xlink:title="0503 - Disclosure - Intangible Assets and Goodwill (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_IntangibleAssetsNetExcludingGoodwill" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IntangibleAssetsNetExcludingGoodwill" xlink:to="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="loc_IndefiniteLivedTrademarks" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="loc_IndefiniteLivedTrademarks" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:label="loc_OtherIndefiniteLivedIntangibleAssets" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="loc_OtherIndefiniteLivedIntangibleAssets" order="40" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksNet" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IntangibleAssetsNetExcludingGoodwill" xlink:to="jnj_FiniteLivedPatentsAndTrademarksNet" order="5" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_FiniteLivedPatentsAndTrademarksNet" xlink:to="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" order="20" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksGross" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_FiniteLivedPatentsAndTrademarksNet" xlink:to="jnj_FiniteLivedPatentsAndTrademarksGross" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IntangibleAssetsNetExcludingGoodwill" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsNet" order="7.5" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_OtherFiniteLivedIntangibleAssetsGross" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:to="loc_OtherFiniteLivedIntangibleAssetsGross" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" order="40" use="optional" weight="-1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="0401 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringTables" xlink:title="0512 - Disclosure - Restructuring (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables" xlink:title="0509 - Disclosure - Segments of Business and Geographic Areas (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareTables" xlink:title="0508 - Disclosure - Earnings Per Share (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareDetails" xlink:title="0608 - Disclosure - Earnings Per Share (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" use="optional" priority="1" order="80" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" use="optional" priority="1" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_WeightedAverageNumberOfSharesOutstandingBasic" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_WeightedAverageNumberOfSharesOutstandingBasic" use="optional" priority="1" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" order="60" use="optional" weight="-1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:title="0507 - Disclosure - Accumulated Other Comprehensive Income (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:title="0607 - Disclosure - Accumulated Other Comprehensive Income (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" use="optional" priority="1" order="10" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" use="optional" priority="1" order="20" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" use="optional" priority="1" order="30" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" use="optional" priority="1" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" order="10" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" order="30" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" order="10" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xlink:label="loc_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" order="20" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="15" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" xlink:label="loc_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="loc_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" order="40" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/BalanceSheets" xlink:title="0110 - Statement - Consolidated Balance Sheets (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_Assets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_AssetsCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="loc_AssetsCurrent" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_CashAndCashEquivalentsAtCarryingValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_AvailableForSaleSecuritiesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_AvailableForSaleSecuritiesCurrent" order="40" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_AccountsReceivableNetCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_AccountsReceivableNetCurrent" order="60" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_InventoryNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_InventoryNet" order="80" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="loc_DeferredTaxAssetsNetCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_DeferredTaxAssetsNetCurrent" order="100" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_PropertyPlantAndEquipmentNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="loc_PropertyPlantAndEquipmentNet" order="40" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_IntangibleAssetsNetExcludingGoodwill" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="loc_IntangibleAssetsNetExcludingGoodwill" order="60" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_2" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="us-gaap_Goodwill_2" order="80" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="loc_DeferredTaxAssetsNetNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="loc_DeferredTaxAssetsNetNoncurrent" order="100" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_OtherAssetsNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Assets" xlink:to="loc_OtherAssetsNoncurrent" order="120" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_LiabilitiesAndStockholdersEquity" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_Liabilities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesAndStockholdersEquity" xlink:to="loc_Liabilities" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_LiabilitiesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Liabilities" xlink:to="loc_LiabilitiesCurrent" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_ShortTermBorrowings" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="loc_ShortTermBorrowings" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_AccountsPayableCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="loc_AccountsPayableCurrent" order="40" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_AccruedLiabilitiesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="loc_AccruedLiabilitiesCurrent" order="60" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AccruedRebatesReturnsAndPromotions" xlink:label="jnj_AccruedRebatesReturnsAndPromotions" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="jnj_AccruedRebatesReturnsAndPromotions" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_EmployeeRelatedLiabilitiesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="loc_EmployeeRelatedLiabilitiesCurrent" order="100" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_AccruedIncomeTaxesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesCurrent" xlink:to="loc_AccruedIncomeTaxesCurrent" order="120" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_LongTermDebtNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Liabilities" xlink:to="loc_LongTermDebtNoncurrent" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_DeferredTaxLiabilitiesNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Liabilities" xlink:to="loc_DeferredTaxLiabilitiesNoncurrent" order="60" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Liabilities" xlink:to="loc_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" order="80" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_OtherLiabilitiesNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_Liabilities" xlink:to="loc_OtherLiabilitiesNoncurrent" order="100" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LiabilitiesAndStockholdersEquity" xlink:to="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_TreasuryStockValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_TreasuryStockValue" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_PropertyPlantAndEquipmentGross" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_PropertyPlantAndEquipmentNet" xlink:to="loc_PropertyPlantAndEquipmentGross" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_PropertyPlantAndEquipmentNet" xlink:to="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_CommonStockValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_CommonStockValue" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_RetainedEarningsAccumulatedDeficit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_RetainedEarningsAccumulatedDeficit" order="15" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_AssetsCurrent" xlink:to="loc_PrepaidExpenseAndOtherAssetsCurrent" order="110" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/BalanceSheetsParenthetical" xlink:title="0111 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/StatementsOfEarnings" xlink:title="0120 - Statement - Consolidated Statements of Earnings (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_ProfitLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_IncomeTaxExpenseBenefit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ProfitLoss" xlink:to="loc_IncomeTaxExpenseBenefit" use="optional" order="40" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ProfitLoss" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" use="optional" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_OtherNonoperatingIncomeExpense" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_OtherNonoperatingIncomeExpense" use="optional" order="160" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_InterestExpense" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_InterestExpense" use="optional" order="120" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_InvestmentIncomeInterest" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_InvestmentIncomeInterest" use="optional" order="100" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" use="optional" order="80" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_SellingGeneralAndAdministrativeExpense" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_SellingGeneralAndAdministrativeExpense" use="optional" order="40" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_GrossProfit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_GrossProfit" use="optional" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_CostOfGoodsSold" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GrossProfit" xlink:to="loc_CostOfGoodsSold" use="optional" order="40" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_SalesRevenueGoodsNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GrossProfit" xlink:to="loc_SalesRevenueGoodsNet" use="optional" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_RestructuringCharges" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_RestructuringCharges" order="10" use="optional" weight="-1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/StatementsOfCashFlows" xlink:title="0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_EffectOfExchangeRateOnCashAndCashEquivalents" use="optional" order="80" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_NetCashProvidedByUsedInFinancingActivities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities" use="optional" order="60" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_ProceedsFromStockOptionsExercised" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ProceedsFromStockOptionsExercised" use="optional" order="140" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_RepaymentsOfLongTermDebt" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RepaymentsOfLongTermDebt" use="optional" order="120" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_RepaymentsOfShortTermDebt" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RepaymentsOfShortTermDebt" use="optional" order="100" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_ProceedsFromShortTermDebt" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ProceedsFromShortTermDebt" use="optional" priority="1" order="80" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_PaymentsForRepurchaseOfCommonStock" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_PaymentsForRepurchaseOfCommonStock" use="optional" order="60" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends" xlink:label="loc_PaymentsOfOrdinaryDividends" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_PaymentsOfOrdinaryDividends" use="optional" order="40" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_ProceedsFromIssuanceOfLongTermDebt" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ProceedsFromIssuanceOfLongTermDebt" use="optional" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_NetCashProvidedByUsedInInvestingActivities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities" use="optional" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_PaymentsForProceedsFromOtherInvestingActivities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_PaymentsForProceedsFromOtherInvestingActivities" use="optional" order="120" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments" use="optional" order="100" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_PaymentsToAcquireInvestments" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_PaymentsToAcquireInvestments" use="optional" order="80" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" use="optional" order="60" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_ProceedsFromSaleOfProductiveAssets" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ProceedsFromSaleOfProductiveAssets" use="optional" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="20" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_NetCashProvidedByUsedInOperatingActivities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities" use="optional" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_IncreaseDecreaseInOtherOperatingLiabilities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" order="240" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_IncreaseDecreaseInOtherOperatingAssets" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IncreaseDecreaseInOtherOperatingAssets" use="optional" order="220" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" order="200" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_IncreaseDecreaseInInventories" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IncreaseDecreaseInInventories" use="optional" order="180" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_IncreaseDecreaseInAccountsReceivable" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IncreaseDecreaseInAccountsReceivable" use="optional" order="160" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_ProvisionForDoubtfulAccounts" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ProvisionForDoubtfulAccounts" use="optional" order="140" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_DeferredIncomeTaxExpenseBenefit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_DeferredIncomeTaxExpenseBenefit" use="optional" order="120" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_ShareBasedCompensation" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ShareBasedCompensation" use="optional" order="60" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_DepreciationDepletionAndAmortization" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_DepreciationDepletionAndAmortization" use="optional" order="40" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_ProfitLoss" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ProfitLoss" use="optional" priority="1" order="20" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="loc_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="loc_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="loc_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" order="20" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:label="loc_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="loc_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" order="10" use="optional" weight="1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="0201 - Disclosure - Summary of Significant Accounting Policies" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/Inventories" xlink:title="0202 - Disclosure - Inventories" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwill" xlink:title="0203 - Disclosure - Intangible Assets and Goodwill" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurements" xlink:title="0204 - Disclosure - Fair Value Measurements" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeTaxes" xlink:title="0205 - Disclosure - Income Taxes" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:title="0207 - Disclosure - Accumulated Other Comprehensive Income" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShare" xlink:title="0208 - Disclosure - Earnings Per Share" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas" xlink:title="0209 - Disclosure - Segments of Business and Geographic Areas" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestitures" xlink:title="0210 - Disclosure - Business Combinations and Divestitures" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedings" xlink:title="0211 - Disclosure - Legal Proceedings" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/Restructuring" xlink:title="0212 - Disclosure - Restructuring" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsTables" xlink:title="0504 - Disclosure - Fair Value Measurements (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SubsequentEvents" xlink:title="0213 - Disclosure - Subsequent Events" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlans" xlink:title="0206 - Disclosure - Pensions and Other Postretirement Benefits" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansTables" xlink:title="0506 - Disclosure - Pensions and Other Postretirement Benefits (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_DefinedBenefitPlanNetPeriodicBenefitCost" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_DefinedBenefitPlanServiceCost" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanServiceCost" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_DefinedBenefitPlanInterestCost" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanInterestCost" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanExpectedReturnOnPlanAssets" order="60" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:label="loc_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_DefinedBenefitPlanAmortizationOfGainsLosses" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanAmortizationOfGainsLosses" order="120" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xlink:label="loc_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" order="50" use="optional" weight="1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeTaxesDetailsTextuals" xlink:title="0605 - Disclosure - Income Taxes (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeStatementPercentageToSales" xlink:title="0121 - Statement - Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)">
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ProfitLossPercentageIncreaseDecrease" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_ProfitLossPercentageIncreaseDecrease" xlink:to="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" order="10" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_ProfitLossPercentageIncreaseDecrease" xlink:to="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" order="10" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" order="20" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestExpensePercentageIncreaseDecrease" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_InterestExpensePercentageIncreaseDecrease" order="30" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringExpensesIncreaseDecrease" xlink:label="jnj_RestructuringExpensesIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_RestructuringExpensesIncreaseDecrease" order="50" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" order="5" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_GrossProfitPercentageIncreaseDecrease" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_GrossProfitPercentageIncreaseDecrease" order="1" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_GrossProfitPercentageIncreaseDecrease" xlink:to="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" order="10" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CostOfGoodsSoldPercentageIncreaseDecrease" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jnj_GrossProfitPercentageIncreaseDecrease" xlink:to="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" order="20" use="optional" weight="-1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_CashCashEquivalentsAndShortTermInvestments" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_Cash" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashCashEquivalentsAndShortTermInvestments" xlink:to="loc_Cash" order="10" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="loc_USGovernmentSecuritiesAtCarryingValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashCashEquivalentsAndShortTermInvestments" xlink:to="loc_USGovernmentSecuritiesAtCarryingValue" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherCashEquivalentsAtCarryingValue" xlink:label="loc_OtherCashEquivalentsAtCarryingValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashCashEquivalentsAndShortTermInvestments" xlink:to="loc_OtherCashEquivalentsAtCarryingValue" order="30" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_MoneyMarketFundsAtCarryingValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashCashEquivalentsAndShortTermInvestments" xlink:to="loc_MoneyMarketFundsAtCarryingValue" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="loc_TimeDepositsAtCarryingValue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CashCashEquivalentsAndShortTermInvestments" xlink:to="loc_TimeDepositsAtCarryingValue" order="50" use="optional" weight="1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals" xlink:title="06031 - Disclosure - Intangible Assets and Goodwill (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareDetailsTextuals" xlink:title="06081 - Disclosure - Earnings Per Share (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)" />
  <calculationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals" xlink:title="06071 - Disclosure - Accumulated Other Comprehensive Income (Details Textuals)" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>jnj-20110703_lab.xml
<DESCRIPTION>EX-101 LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Bowne Tagger XBRL Enabler by Bowne Software version 10.0.0.56-->
<!--Based on XBRL 2.1-->
<!--Modified on: 8/9/2011 12:05:36 PM-->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <label xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory, Net</label>
    <label xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total inventories</label>
    <label xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Inventories (Note 2)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total intangible assets - net</label>
    <label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible assets, net (Note 3)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" />
    <label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Goodwill, net</label>
    <label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Goodwill, Ending Balance</label>
    <label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Goodwill, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Goodwill, net (Note 3)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="us-gaap_InventoryNetAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryNetAbstract_lbl" />
    <label xlink:type="resource" xlink:label="us-gaap_InventoryNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory Net [Abstract]</label>
    <label xlink:type="resource" xlink:label="us-gaap_InventoryNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Summary of Inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
    <label xlink:type="resource" xlink:label="lab_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Goods in process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="lab_InventoryWorkInProcess" />
    <label xlink:type="resource" xlink:label="lab_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory, Work in Process</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="lab_InventoryFinishedGoods" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible assets with indefinite lives:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedTrademarks" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Trademarks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTrademarks" xlink:to="lab_IndefiniteLivedTrademarks" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedTrademarks" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Indefinite-Lived Trademarks</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_OtherIndefiniteLivedIntangibleAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:to="lab_OtherIndefiniteLivedIntangibleAssets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total intangible assets with indefinite lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <label xlink:type="resource" xlink:label="lab_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_OtherFiniteLivedIntangibleAssetsGross" />
    <label xlink:type="resource" xlink:label="lab_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Other intangibles - gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="lab_OtherFiniteLivedIntangibleAssetsGross" />
    <label xlink:type="resource" xlink:label="lab_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Finite-Lived Intangible Assets, Gross</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ConsumerMember" xlink:to="jnj_ConsumerMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ConsumerMember_lbl" xml:lang="en-US">Consumer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_ConsumerMember_lbl" xml:lang="en-US">Consumer [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_ConsumerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Consumer.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PharmaceuticalMember" xlink:to="jnj_PharmaceuticalMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PharmaceuticalMember_lbl" xml:lang="en-US">Pharmaceutical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PharmaceuticalMember_lbl" xml:lang="en-US">Pharmaceutical [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_PharmaceuticalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Pharmaceutical.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_MedicalDevicesAndDiagnosticsMember" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember_lbl" xml:lang="en-US">Medical Devices and Diagnostics [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember_lbl" xml:lang="en-US">Medical Devices and Diagnostics [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Medical Devices and Diagnostics.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense" xlink:to="lab_FiniteLivedIntangibleAssetsFutureAmortizationExpense" />
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsFutureAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Future Amortization Expense</label>
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsFutureAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Estimated amortization expense per year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_IntangibleAssetsNetExcludingGoodwillAbstract" />
    <label xlink:type="resource" xlink:label="lab_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <label xlink:type="resource" xlink:label="lab_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement, Business Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_StatementBusinessSegmentsAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_EffectiveIncomeTaxRateContinuingOperations" />
    <label xlink:type="resource" xlink:label="lab_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations</label>
    <label xlink:type="resource" xlink:label="lab_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Effective tax rates</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_InventoryRawMaterialsAndSupplies" />
    <label xlink:type="resource" xlink:label="lab_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory, Raw Materials and Supplies</label>
    <label xlink:type="resource" xlink:label="lab_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Raw materials and supplies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" />
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible assets with definite lives:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_FiniteLivedIntangibleAssetsNetAbstract" />
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
    <label xlink:type="resource" xlink:label="lab_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_GoodwillAcquiredDuringPeriod" />
    <label xlink:type="resource" xlink:label="lab_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Goodwill, Acquired During Period</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" xlink:label="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" xlink:to="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_lbl" xml:lang="en-US">Weighted average amortization periods for patents and trademarks</label>
    <label xlink:type="resource" xlink:label="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Weighted average amortization periods for patents and trademarks</label>
    <label xlink:type="resource" xlink:label="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Weighted average amortization periods for patents and trademarks.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" xlink:label="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" xlink:to="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_lbl" xml:lang="en-US">Weighted average amortization periods for other Intangible assets</label>
    <label xlink:type="resource" xlink:label="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Weighted average amortization periods for other Intangible assets</label>
    <label xlink:type="resource" xlink:label="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Weighted average amortization periods for other Intangible assets.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense" xlink:to="lab_FiniteLivedIntangibleAssetsAmortizationExpense" />
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense</label>
    <label xlink:type="resource" xlink:label="lab_FiniteLivedIntangibleAssetsAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Amortization expense of amortizable intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <label xlink:type="resource" xlink:label="lab_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="lab_DocumentFiscalYearFocus" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <label xlink:type="resource" xlink:label="lab_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="lab_DocumentFiscalPeriodFocus" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksGross" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross" />
    <label xlink:type="resource" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Patents and trademarks - gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_FiniteLivedPatentsAndTrademarksGross" xlink:to="jnj_FiniteLivedPatentsAndTrademarksGross_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross_lbl" xml:lang="en-US">Finite Lived Patents And Trademarks Gross</label>
    <label xlink:type="resource" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Finite Lived Patents And Trademarks Gross</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" xlink:to="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization_lbl" xml:lang="en-US">Finite Lived Patents And Trademarks Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization_lbl" xml:lang="en-US">Less accumulated amortization</label>
    <label xlink:type="resource" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Finite Lived Patents And Trademarks Accumulated Amortization.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Other Finite Lived Intangible Assets Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less accumulated amortization</label>
    <label xlink:type="resource" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Other Finite Lived Intangible Assets Accumulated Amortization.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet" />
    <label xlink:type="resource" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Other intangibles - net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsNet_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Other Finite Lived Intangible Assets Net</label>
    <label xlink:type="resource" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Other Finite Lived Intangible Assets Net.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Financial assets and liabilities at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeContractMember" xlink:to="lab_ForeignExchangeContractMember" />
    <label xlink:type="resource" xlink:label="lab_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Foreign exchange contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ForeignExchangeContractMember" xml:lang="en-US">Foreign exchange contracts [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="us-gaap_CrossCurrencyInterestRateContractMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_CrossCurrencyInterestRateContractMember" />
    <label xlink:type="resource" xlink:label="lab_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cross currency interest rate swaps [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_CrossCurrencyInterestRateContractMember" xml:lang="en-US">Cross currency interest rate swaps [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="lab_LongTermDebtNoncurrent" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Summary of designated derivatives</label>
    <label xlink:type="resource" xlink:label="lab_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="lab_FairValueInputsLevel1Member" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="lab_FairValueInputsLevel2Member" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="lab_FairValueInputsLevel3Member" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:to="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion, Net</label>
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Gain/ (Loss) recognized in Accumulated OCI</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:label="us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" />
    <label xlink:type="resource" xlink:label="lab_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Reclassification of foreign exchange contracts into earnings, period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:to="lab_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" />
    <label xlink:type="resource" xlink:label="lab_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Description of Reclassification of Cash Flow Hedge Gain (Loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" xlink:label="us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" />
    <label xlink:type="resource" xlink:label="lab_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Maximum length of time for hedging transaction exposure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" xlink:to="lab_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" />
    <label xlink:type="resource" xlink:label="lab_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Maximum Length of Time Hedged in Foreign Currency Cash Flow Hedge</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" />
    <label xlink:type="resource" xlink:label="lab_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xml:lang="en-US">Other income/(expense), net, related to foreign exchange contracts, non hedging</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:label="us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_DerivativeInstrumentsInHedgesAssetsAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</label>
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Derivatives designated as hedging instruments : Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:label="us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</label>
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Derivatives designated as hedging instruments : Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Derivatives not designated as hedging instruments : Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
    <label xlink:type="resource" xlink:label="lab_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Derivatives not designated as hedging instruments : Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="lab_ShortTermBorrowings" />
    <label xlink:type="resource" xlink:label="lab_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Short-term Borrowings</label>
    <label xlink:type="resource" xlink:label="lab_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Loans and notes payable</label>
    <label xlink:type="resource" xlink:label="lab_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current Debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfForeignCurrencyDerivatives" xlink:label="us-gaap_NotionalAmountOfForeignCurrencyDerivatives" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotionalAmountOfForeignCurrencyDerivatives" xlink:to="lab_NotionalAmountOfForeignCurrencyDerivatives" />
    <label xlink:type="resource" xlink:label="lab_NotionalAmountOfForeignCurrencyDerivatives" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Notional amounts outstanding for forward foreign exchange contracts</label>
    <label xlink:type="resource" xlink:label="lab_NotionalAmountOfForeignCurrencyDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Notional Amount of Foreign Currency Derivatives</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfInterestRateDerivatives" xlink:label="us-gaap_NotionalAmountOfInterestRateDerivatives" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotionalAmountOfInterestRateDerivatives" xlink:to="lab_NotionalAmountOfInterestRateDerivatives" />
    <label xlink:type="resource" xlink:label="lab_NotionalAmountOfInterestRateDerivatives" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Notional amounts outstanding for cross currency interest rate swaps</label>
    <label xlink:type="resource" xlink:label="lab_NotionalAmountOfInterestRateDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Notional Amount of Interest Rate Derivatives</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_DocumentAndEntityInformationAbstract" xlink:label="jnj_DocumentAndEntityInformationAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="jnj_DocumentAndEntityInformationAbstract_lbl" />
    <label xlink:type="resource" xlink:label="jnj_DocumentAndEntityInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_DocumentAndEntityInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Document And Entity Information.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestIncomeExpenseNetMember" xlink:label="jnj_InterestIncomeExpenseNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_InterestIncomeExpenseNetMember" xlink:to="jnj_InterestIncomeExpenseNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_InterestIncomeExpenseNetMember_lbl" xml:lang="en-US">Interest Income Expense Net Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_InterestIncomeExpenseNetMember_lbl" xml:lang="en-US">Included in Interest (income)/Interest expense, net [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_InterestIncomeExpenseNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Interest Income Expense Net Member.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchExpenseMember" xlink:label="jnj_ResearchExpenseMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ResearchExpenseMember" xlink:to="jnj_ResearchExpenseMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ResearchExpenseMember_lbl" xml:lang="en-US">Research Expense Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_ResearchExpenseMember_lbl" xml:lang="en-US">Included in Research and development expense [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_ResearchExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Research Expense Member.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="lab_SalesMember" />
    <label xlink:type="resource" xlink:label="lab_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Sales [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SalesMember" xml:lang="en-US">Included in Sales to customer [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="lab_CostOfSalesMember" />
    <label xlink:type="resource" xlink:label="lab_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cost Of Sales [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_CostOfSalesMember" xml:lang="en-US">Included in Cost of products sold [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" />
    <label xlink:type="resource" xlink:label="lab_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Hedging Relationship [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="lab_HedgingRelationshipDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <label xlink:type="resource" xlink:label="lab_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:to="lab_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:label="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" />
    <label xlink:type="resource" xlink:label="lab_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Statement and Other Comprehensive Income Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="lab_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeThreeNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" xlink:to="jnj_OtherInterestIncomeExpenseTypeThreeNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Type Three Net Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember_lbl" xml:lang="en-US">Included in Other (Income)/Expense Type Three, net [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Other Interest Income Expense Type Three Net Member.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeTwoNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" xlink:to="jnj_OtherInterestIncomeExpenseTypeTwoNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Type Two Net Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember_lbl" xml:lang="en-US">Included in Other (Income)/Expense Type Two, net [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Other Interest Income Expense Type Two Net Member.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeSixNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherInterestIncomeExpenseTypeSixNetMember" xlink:to="jnj_OtherInterestIncomeExpenseTypeSixNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Type Six Net Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Type Six Net [Member]</label>
    <label xlink:type="resource" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Other Interest Income Expense Type Six Net Member.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="us-gaap_DefinedBenefitPlanServiceCost" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_DefinedBenefitPlanServiceCost" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plan, Service Cost</label>
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Service cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="us-gaap_DefinedBenefitPlanInterestCost" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plan, Interest Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_DefinedBenefitPlanInterestCost" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Interest cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plan, Expected Return on Plan Assets</label>
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US">Expected return on plan assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_DefinedBenefitPlanNetPeriodicBenefitCost" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="us-gaap_PensionPlansDefinedBenefitMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_PensionPlansDefinedBenefitMember" />
    <label xlink:type="resource" xlink:label="lab_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Pension Plans Defined Benefit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_PensionPlansDefinedBenefitMember" xml:lang="en-US">Retirement Plans [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:label="us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_OtherPostretirementBenefitPlansDefinedBenefitMember" />
    <label xlink:type="resource" xlink:label="lab_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Postretirement Benefit Plans Defined Benefit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OtherPostretirementBenefitPlansDefinedBenefitMember" xml:lang="en-US">Other Benefit Plans [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionContributions" xlink:label="us-gaap_PensionContributions" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionContributions" xlink:to="lab_PensionContributions" />
    <label xlink:type="resource" xlink:label="lab_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Pension Contributions</label>
    <label xlink:type="resource" xlink:label="lab_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Contribution to pension plans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xlink:label="us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xlink:to="lab_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" />
    <label xlink:type="resource" xlink:label="lab_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">United States Pension Plans Of U S Entity Defined Benefit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xml:lang="en-US">U.S. retirement plans [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignPensionPlansDefinedBenefitMember" xlink:label="us-gaap_ForeignPensionPlansDefinedBenefitMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignPensionPlansDefinedBenefitMember" xlink:to="lab_ForeignPensionPlansDefinedBenefitMember" />
    <label xlink:type="resource" xlink:label="lab_ForeignPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Foreign Pension Plans Defined Benefit Member [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ForeignPensionPlansDefinedBenefitMember" xml:lang="en-US">International retirement plans [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="us-gaap_RestructuringReserveRollForward" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveRollForward" xlink:to="lab_RestructuringReserveRollForward" />
    <label xlink:type="resource" xlink:label="lab_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring Reserve [Roll Forward]</label>
    <label xlink:type="resource" xlink:label="lab_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Severance Reserve balance as of:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="lab_RestructuringReserve" />
    <label xlink:type="resource" xlink:label="lab_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring Reserve</label>
    <label xlink:type="resource" xlink:label="lab_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:label="lab_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Beginning Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveSettledWithCash" xlink:label="us-gaap_RestructuringReserveSettledWithCash" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveSettledWithCash" xlink:to="lab_RestructuringReserveSettledWithCash" />
    <label xlink:type="resource" xlink:label="lab_RestructuringReserveSettledWithCash" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring Reserve, Settled with Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_RestructuringReserveSettledWithCash" xml:lang="en-US">Current year activity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plans Disclosures, Defined Benefit Plans [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="lab_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="us-gaap_DefinedBenefitPlansDomain" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plans [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDomain" xlink:to="lab_DefinedBenefitPlansDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="lab_RestructuringCharges" />
    <label xlink:type="resource" xlink:label="lab_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_RestructuringCharges" xml:lang="en-US">Restructuring charges, pre tax</label>
    <label xlink:type="resource" xlink:label="lab_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Restructuring expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessExitCosts" xlink:label="us-gaap_BusinessExitCosts" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessExitCosts" xlink:to="lab_BusinessExitCosts" />
    <label xlink:type="resource" xlink:label="lab_BusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Business Exit Costs</label>
    <label xlink:type="resource" xlink:label="lab_BusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Leasehold and contract obligations included in restructuring charges</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="lab_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Components of net periodic benefit cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_RestructuringAndRelatedActivitiesDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:label="lab_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">RESTRUCTURING</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Operating profit by segment of business</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_USMember" xlink:label="jnj_USMember" />
    <label xlink:type="resource" xlink:label="jnj_USMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">U.S. Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_USMember" xlink:to="jnj_USMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_USMember_lbl" xml:lang="en-US">U S [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_USMember_lbl" xml:lang="en-US">U.S. [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InternationalMember" xlink:label="jnj_InternationalMember" />
    <label xlink:type="resource" xlink:label="jnj_InternationalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">International Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_InternationalMember" xlink:to="jnj_InternationalMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_InternationalMember_lbl" xml:lang="en-US">International [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_InternationalMember_lbl" xml:lang="en-US">International [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_EuropeMember" xlink:label="jnj_EuropeMember" />
    <label xlink:type="resource" xlink:label="jnj_EuropeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Europe Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_EuropeMember" xlink:to="jnj_EuropeMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xlink:label="us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xlink:to="lab_SegmentGeographicalGroupsOfCountriesGroupTwoMember" />
    <label xlink:type="resource" xlink:label="lab_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Segment Geographical Groups Of Countries Group Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xml:lang="en-US">Asia-Pacific, Africa [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" xlink:label="us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" xlink:to="label_SegmentGeographicalGroupsOfCountriesGroupOneMember" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_EarningsPerShareReconciliationAbstract" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Reconciliation of basic net earnings per share to diluted net earnings per share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="lab_EarningsPerShareDiluted" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_EarningsPerShareDiluted" xml:lang="en-US">Diluted net earnings per share</label>
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Diluted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="lab_EarningsPerShareBasic" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_EarningsPerShareBasic" xml:lang="en-US">Basic net earnings per share</label>
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Basic</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_WeightedAverageNumberOfSharesOutstandingBasic" />
    <label xlink:type="resource" xlink:label="lab_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:label="lab_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Average shares outstanding - basic</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
    <label xlink:type="resource" xlink:label="lab_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Incremental Common Shares Attributable to Conversion of Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
    <label xlink:type="resource" xlink:label="lab_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Convertible debt shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <label xlink:type="resource" xlink:label="lab_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Incremental Common Shares Attributable to Share-based Payment Arrangements</label>
    <label xlink:type="resource" xlink:label="lab_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Potential shares exercisable under stock option plans</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_EarningsPerShareTextualsAbstract" xlink:label="jnj_EarningsPerShareTextualsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_EarningsPerShareTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Earnings Per Share Textuals Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_EarningsPerShareTextualsAbstract" xlink:to="jnj_EarningsPerShareTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_EarningsPerShareTextualsAbstract_lbl" xml:lang="en-US">Earnings Per Share (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_EarningsPerShareTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Earnings Per Share (Textuals) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <label xlink:type="resource" xlink:label="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <label xlink:type="resource" xlink:label="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Antidilutive shares excluded from computation of earnings per share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <label xlink:type="resource" xlink:label="lab_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Segment, Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="lab_SegmentGeographicalDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_ComprehensiveIncomeNoteTextBlock" />
    <label xlink:type="resource" xlink:label="lab_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Comprehensive Income Note [Text Block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xlink:to="lab_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Comprehensive Income, Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xml:lang="en-US">Net amount reclassified to net earnings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Comprehensive Income, Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Unrealized gain (loss)</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LegalProceedingTextualsAbstract" xlink:label="jnj_LegalProceedingTextualsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_LegalProceedingTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Legal Proceeding Textuals Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_LegalProceedingTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LegalProceedingTextualsAbstract_lbl" xml:lang="en-US">Legal Proceeding (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_LegalProceedingTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Legal Proceedings (Textuals) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Comprehensive Income, Available-for-sale Securities Adjustment, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xml:lang="en-US">Net six months change</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Comprehensive Income, Defined Benefit Plans Adjustment, Net of Tax</label>
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net six months change</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="AccumulatedTranslationAdjustmentMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedTranslationAdjustmentMember" xlink:to="label_AccumulatedTranslationAdjustmentMember" xlink:title="label: AccumulatedTranslationAdjustmentMember to label_AccumulatedTranslationAdjustmentMember" />
    <label xlink:type="resource" xlink:label="label_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_AccumulatedTranslationAdjustmentMember">Accumulated Translation Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_AccumulatedTranslationAdjustmentMember" xml:lang="en-US">Foreign Currency Translation [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PartnerCapitalComponentsAxis" xlink:label="PartnerCapitalComponentsAxis" />
    <label xlink:type="resource" xlink:label="label_PartnerCapitalComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_PartnerCapitalComponentsAxis">Statement, Partner Capital Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnerCapitalComponentsAxis" xlink:to="label_PartnerCapitalComponentsAxis" xlink:title="label: PartnerCapitalComponentsAxis to label_PartnerCapitalComponentsAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PartnerCapitalComponentsDomain" xlink:label="PartnerCapitalComponentsDomain" />
    <label xlink:type="resource" xlink:label="label_PartnerCapitalComponentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_PartnerCapitalComponentsDomain">Partner Capital Components [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnerCapitalComponentsDomain" xlink:to="label_PartnerCapitalComponentsDomain" xlink:title="label: PartnerCapitalComponentsDomain to label_PartnerCapitalComponentsDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" />
    <label xlink:type="resource" xlink:label="label_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_StatementEquityComponentsAxis">Statement, Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="label_StatementEquityComponentsAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" />
    <label xlink:type="resource" xlink:label="label_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_EquityComponentDomain">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="label_EquityComponentDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" />
    <label xlink:type="resource" xlink:label="label_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="label_SubsequentEventTypeDomain" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SettlementOfLitigationMember" xlink:label="SettlementOfLitigationMember" />
    <label xlink:type="resource" xlink:label="label_SettlementOfLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_SettlementOfLitigationMember">Settlement of Litigation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SettlementOfLitigationMember" xlink:to="label_SettlementOfLitigationMember" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" />
    <label xlink:type="resource" xlink:label="label_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_LegalEntityAxis">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="label_LegalEntityAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="LossContingenciesByNatureOfContingencyAxis" />
    <label xlink:type="resource" xlink:label="label_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_LossContingenciesByNatureOfContingencyAxis">Loss Contingencies by Nature of Contingency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesByNatureOfContingencyAxis" xlink:to="label_LossContingenciesByNatureOfContingencyAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" />
    <label xlink:type="resource" xlink:label="label_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="label_SubsequentEventTypeAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:label="OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:to="label_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" />
    <label xlink:type="resource" xlink:label="label_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease">Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xml:lang="en-US">Net Six months change</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xml:lang="en-US">Gains/(Losses) on derivatives &amp; hedges</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Comprehensive Income, Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</label>
    <label xlink:type="resource" xlink:label="lab_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net six months change</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <label xlink:type="resource" xlink:label="lab_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Consolidated Balance Sheets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <label xlink:type="resource" xlink:label="lab_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="lab_AssetsAbstract" />
    <label xlink:type="resource" xlink:label="lab_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="lab_AssetsCurrentAbstract" />
    <label xlink:type="resource" xlink:label="lab_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_LiabilitiesCurrentAbstract" />
    <label xlink:type="resource" xlink:label="lab_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="lab_StockholdersEquityAbstract" />
    <label xlink:type="resource" xlink:label="lab_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Shareholders' equity:</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AccruedRebatesReturnsAndPromotions" xlink:label="jnj_AccruedRebatesReturnsAndPromotions" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AccruedRebatesReturnsAndPromotions" xlink:to="jnj_AccruedRebatesReturnsAndPromotions_lbl" />
    <label xlink:type="resource" xlink:label="jnj_AccruedRebatesReturnsAndPromotions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accrued Rebates Returns And Promotions</label>
    <label xlink:type="resource" xlink:label="jnj_AccruedRebatesReturnsAndPromotions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accrued rebates, returns and promotions</label>
    <label xlink:type="resource" xlink:label="jnj_AccruedRebatesReturnsAndPromotions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue" />
    <label xlink:type="resource" xlink:label="lab_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:label="lab_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">CASH AND CASH EQUIVALENTS, END OF PERIOD</label>
    <label xlink:type="resource" xlink:label="lab_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Cash and Cash equivalents, beginning of period</label>
    <label xlink:type="resource" xlink:label="lab_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesCurrent" xlink:to="lab_AvailableForSaleSecuritiesCurrent" />
    <label xlink:type="resource" xlink:label="lab_AvailableForSaleSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Available-for-sale Securities, Current</label>
    <label xlink:type="resource" xlink:label="lab_AvailableForSaleSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Marketable securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_AccountsReceivableNetCurrent" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetCurrent" xlink:to="lab_DeferredTaxAssetsNetCurrent" />
    <label xlink:type="resource" xlink:label="lab_DeferredTaxAssetsNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Tax Assets, Net, Current</label>
    <label xlink:type="resource" xlink:label="lab_DeferredTaxAssetsNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deferred taxes on income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="lab_AssetsCurrent" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_PropertyPlantAndEquipmentGross" />
    <label xlink:type="resource" xlink:label="lab_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:label="lab_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Property, plant and equipment at cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <label xlink:type="resource" xlink:label="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less: accumulated depreciation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_PropertyPlantAndEquipmentNet" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:to="lab_DeferredTaxAssetsNetNoncurrent" />
    <label xlink:type="resource" xlink:label="lab_DeferredTaxAssetsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Tax Assets, Net, Noncurrent</label>
    <label xlink:type="resource" xlink:label="lab_DeferredTaxAssetsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deferred taxes on income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="lab_OtherAssetsNoncurrent" />
    <label xlink:type="resource" xlink:label="lab_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OtherAssetsNoncurrent" xml:lang="en-US">Other assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="lab_Assets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="lab_AccountsPayableCurrent" />
    <label xlink:type="resource" xlink:label="lab_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:label="lab_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounts payable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_AccruedLiabilitiesCurrent" />
    <label xlink:type="resource" xlink:label="lab_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:label="lab_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accrued liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_EmployeeRelatedLiabilitiesCurrent" />
    <label xlink:type="resource" xlink:label="lab_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <label xlink:type="resource" xlink:label="lab_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accrued compensation and employee related obligations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_AccruedIncomeTaxesCurrent" />
    <label xlink:type="resource" xlink:label="lab_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accrued Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_AccruedIncomeTaxesCurrent" xml:lang="en-US">Accrued taxes on income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="lab_LiabilitiesCurrent" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="lab_DeferredTaxLiabilitiesNoncurrent" />
    <label xlink:type="resource" xlink:label="lab_DeferredTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Tax Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:label="lab_DeferredTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deferred taxes on income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <label xlink:type="resource" xlink:label="lab_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:label="lab_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Employee related obligations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_OtherLiabilitiesNoncurrent" />
    <label xlink:type="resource" xlink:label="lab_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OtherLiabilitiesNoncurrent" xml:lang="en-US">Other liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="lab_Liabilities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="lab_CommonStockValue" />
    <label xlink:type="resource" xlink:label="lab_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:label="lab_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock - par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <label xlink:type="resource" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">July 3, 2011</label>
    <label xlink:type="resource" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">January 2, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Deferred net gains on derivatives included in accumulated other comprehensive income</label>
    <label xlink:type="resource" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated other comprehensive income (Note 7)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_RetainedEarningsAccumulatedDeficit" />
    <label xlink:type="resource" xlink:label="lab_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Retained Earnings Accumulated Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained earnings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="lab_TreasuryStockValue" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <label xlink:type="resource" xlink:label="lab_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_CommonStockParOrStatedValuePerShare" />
    <label xlink:type="resource" xlink:label="lab_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, par value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <label xlink:type="resource" xlink:label="lab_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="lab_CommonStockSharesAuthorized" />
    <label xlink:type="resource" xlink:label="lab_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="lab_CommonStockSharesIssued" />
    <label xlink:type="resource" xlink:label="lab_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:label="lab_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, shares issued</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="lab_TreasuryStockShares" />
    <label xlink:type="resource" xlink:label="lab_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:label="lab_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Treasury stock, shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <label xlink:type="resource" xlink:label="lab_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</label>
    <label xlink:type="resource" xlink:label="lab_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Allowances for doubtful accounts</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <label xlink:type="resource" xlink:label="lab_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Consolidated Statements of Earnings [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="lab_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="lab_EarningsPerShareAbstract" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">NET EARNINGS PER SHARE (Note 8)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="lab_SalesRevenueGoodsNet" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="lab_CostOfGoodsSold" />
    <label xlink:type="resource" xlink:label="lab_CostOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cost of Goods Sold</label>
    <label xlink:type="resource" xlink:label="lab_CostOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cost of products sold</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="lab_GrossProfit" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_SellingGeneralAndAdministrativeExpense" />
    <label xlink:type="resource" xlink:label="lab_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Selling, General and Administrative Expense</label>
    <label xlink:type="resource" xlink:label="lab_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Selling, marketing and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <label xlink:type="resource" xlink:label="lab_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <label xlink:type="resource" xlink:label="lab_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Research and development expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="lab_InvestmentIncomeInterest" />
    <label xlink:type="resource" xlink:label="lab_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Investment Income, Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_InvestmentIncomeInterest" xml:lang="en-US">Interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="lab_InterestExpense" />
    <label xlink:type="resource" xlink:label="lab_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Interest Expense</label>
    <label xlink:type="resource" xlink:label="lab_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Interest expense, net of portion capitalized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_OtherNonoperatingIncomeExpense" />
    <label xlink:type="resource" xlink:label="lab_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other (income) expense, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_IncomeTaxExpenseBenefit" />
    <label xlink:type="resource" xlink:label="lab_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for taxes on income (Note 5)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="lab_ProfitLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <label xlink:type="resource" xlink:label="lab_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Consolidated Statements of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AcquisitionsAbstract" xlink:label="jnj_AcquisitionsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_AcquisitionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Acquisitions Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AcquisitionsAbstract" xlink:to="jnj_AcquisitionsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AcquisitionsAbstract_lbl" xml:lang="en-US">Acquisitions [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_AcquisitionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Acquisitions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CASH FLOW FROM OPERATING ACTIVITIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xlink:type="resource" xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xlink:type="resource" xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Adjustments to reconcile net earnings to cash flows from operating activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_DepreciationDepletionAndAmortization" />
    <label xlink:type="resource" xlink:label="lab_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:label="lab_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Depreciation and amortization of property and intangibles</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="lab_ShareBasedCompensation" />
    <label xlink:type="resource" xlink:label="lab_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Share-based Compensation</label>
    <label xlink:type="resource" xlink:label="lab_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Stock based compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_DeferredIncomeTaxExpenseBenefit" />
    <label xlink:type="resource" xlink:label="lab_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:label="lab_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deferred tax provision</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
    <label xlink:type="resource" xlink:label="lab_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Provision for Doubtful Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_ProvisionForDoubtfulAccounts" />
    <label xlink:type="resource" xlink:label="lab_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounts receivable allowances</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_IncreaseDecreaseInOperatingCapitalAbstract" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Changes in assets and liabilities, net of effects from acquisitions:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_IncreaseDecreaseInAccountsReceivable" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase in accounts receivable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_IncreaseDecreaseInInventories" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_IncreaseDecreaseInInventories" xml:lang="en-US">Increase in inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Decrease in accounts payable and accrued liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_IncreaseDecreaseInOtherOperatingAssets" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US">Increase in other current and non-current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_IncreaseDecreaseInOtherOperatingLiabilities" />
    <label xlink:type="resource" xlink:label="lab_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US">Increase in other current and non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_PaymentsToAcquirePropertyPlantAndEquipment" />
    <label xlink:type="resource" xlink:label="lab_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Additions to property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_ProceedsFromSaleOfProductiveAssets" />
    <label xlink:type="resource" xlink:label="lab_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Sale of Productive Assets</label>
    <label xlink:type="resource" xlink:label="lab_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Proceeds from the disposal of assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <label xlink:type="resource" xlink:label="lab_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsToAcquireBusinessesNetOfCashAcquired" xml:lang="en-US">Acquisitions, net of cash acquired</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_PaymentsToAcquireInvestments" />
    <label xlink:type="resource" xlink:label="lab_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments to Acquire Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsToAcquireInvestments" xml:lang="en-US">Purchases of investments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <label xlink:type="resource" xlink:label="lab_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Sale, Maturity and Collections of Investments</label>
    <label xlink:type="resource" xlink:label="lab_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Sales of investments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_PaymentsForProceedsFromOtherInvestingActivities" />
    <label xlink:type="resource" xlink:label="lab_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsForProceedsFromOtherInvestingActivities" xml:lang="en-US">Other</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_NetCashProvidedByUsedInInvestingActivities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends" xlink:label="us-gaap_PaymentsOfOrdinaryDividends" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_PaymentsOfOrdinaryDividends" />
    <label xlink:type="resource" xlink:label="lab_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments of Ordinary Dividends</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsOfOrdinaryDividends" xml:lang="en-US">Dividends to shareholders</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_PaymentsForRepurchaseOfCommonStock" />
    <label xlink:type="resource" xlink:label="lab_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payments for Repurchase of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_PaymentsForRepurchaseOfCommonStock" xml:lang="en-US">Repurchase of common stock</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_ProceedsFromShortTermDebt" />
    <label xlink:type="resource" xlink:label="lab_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Short-term Debt</label>
    <label xlink:type="resource" xlink:label="lab_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Proceeds from short-term debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="us-gaap_RepaymentsOfShortTermDebt" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_RepaymentsOfShortTermDebt" />
    <label xlink:type="resource" xlink:label="lab_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Repayments of Short-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_RepaymentsOfShortTermDebt" xml:lang="en-US">Retirement of short-term debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_ProceedsFromIssuanceOfLongTermDebt" />
    <label xlink:type="resource" xlink:label="lab_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</label>
    <label xlink:type="resource" xlink:label="lab_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Proceeds from long-term debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_RepaymentsOfLongTermDebt" />
    <label xlink:type="resource" xlink:label="lab_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Repayments of Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_RepaymentsOfLongTermDebt" xml:lang="en-US">Retirement of long-term debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_ProceedsFromStockOptionsExercised" />
    <label xlink:type="resource" xlink:label="lab_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from the exercise of stock options/ excess tax benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_NetCashProvidedByUsedInFinancingActivities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <label xlink:type="resource" xlink:label="lab_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_EffectOfExchangeRateOnCashAndCashEquivalents" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="us-gaap_CommonStockDividendsPerShareCashPaid" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_CommonStockDividendsPerShareCashPaid" />
    <label xlink:type="resource" xlink:label="lab_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</label>
    <label xlink:type="resource" xlink:label="lab_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CASH DIVIDENDS PER SHARE</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <label xlink:type="resource" xlink:label="lab_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_SignificantAccountingPoliciesTextBlock" />
    <label xlink:type="resource" xlink:label="lab_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_InventoryDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:label="lab_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">INVENTORIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:label="lab_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">INTANGIBLE ASSETS AND GOODWILL</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_FairValueDisclosuresTextBlock" />
    <label xlink:type="resource" xlink:label="lab_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:label="lab_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">FAIR VALUE MEASUREMENTS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_IncomeTaxDisclosureTextBlock" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="lab_EarningsPerShareTextBlock" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_SegmentReportingDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_BusinessCombinationDisclosureTextBlock" />
    <label xlink:type="resource" xlink:label="lab_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Business Combination Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:label="lab_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">BUSINESS COMBINATIONS AND DIVESTITURES</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeTaxTextualsAbstract" xlink:label="jnj_IncomeTaxTextualsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_IncomeTaxTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Income Tax Textuals Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_IncomeTaxTextualsAbstract" xlink:to="jnj_IncomeTaxTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_IncomeTaxTextualsAbstract_lbl" xml:lang="en-US">Income Tax (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_IncomeTaxTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Income Tax (Textuals) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FairValueMeasurementsTextualsAbstract" xlink:label="jnj_FairValueMeasurementsTextualsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_FairValueMeasurementsTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Fair Value Measurements Textuals Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="jnj_FairValueMeasurementsTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_FairValueMeasurementsTextualsAbstract_lbl" xml:lang="en-US">Fair Value Measurements Textuals [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_FairValueMeasurementsTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Fair Value Measurements (Textuals)</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:label="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" />
    <label xlink:type="resource" xlink:label="jnj_IntangibleAssetsAndGoodwillTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Intangible Assets and Goodwill Textuals Abstract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="jnj_IntangibleAssetsAndGoodwillTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_IntangibleAssetsAndGoodwillTextualsAbstract_lbl" xml:lang="en-US">Intangible Assets and Goodwill (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:label="jnj_IntangibleAssetsAndGoodwillTextualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible Assets and Goodwill (Textuals)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <label xlink:type="resource" xlink:label="LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_DefinedBenefitPlanAmortizationOfGainsLosses" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DefinedBenefitPlanAmortizationOfGainsLosses" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_DefinedBenefitPlanAmortizationOfGainsLosses" xml:lang="en-US">Recognized actuarial losses</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:to="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_lbl" xml:lang="en-US">Shares Which Could Be Repurchased Under Treasury Stock Method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_lbl" xml:lang="en-US">Less: shares which could be repurchased under treasury stock method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_lbl" xml:lang="en-US">Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xml:lang="en-US">Severance reserve and the associated spending</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xlink:to="lab_DerivativeInstrumentsGainLossRecognizedInIncomeNet" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xml:lang="en-US">Gain/ (Loss) reclassified from Accumulated OCI into income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:label="us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:to="lab_DerivativeNetHedgeIneffectivenessGainLoss" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeNetHedgeIneffectivenessGainLoss" xml:lang="en-US">Derivative, Net Hedge Ineffectiveness Gain (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DerivativeNetHedgeIneffectivenessGainLoss" xml:lang="en-US">Gain/ (Loss) recognized in Other income/expense</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CashPaymentsForRestructuring" xlink:label="jnj_CashPaymentsForRestructuring" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CashPaymentsForRestructuring" xlink:to="jnj_CashPaymentsForRestructuring_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CashPaymentsForRestructuring_lbl" xml:lang="en-US">Cash payments for Restructuring</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_CashPaymentsForRestructuring_lbl" xml:lang="en-US">Restructuring charges required to be paid in cash, pre tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_CashPaymentsForRestructuring_lbl" xml:lang="en-US">Aggregate amount of cash expected to be paid associated with the restructuring.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseNetMember" xlink:label="jnj_OtherInterestIncomeExpenseNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherInterestIncomeExpenseNetMember" xlink:to="jnj_OtherInterestIncomeExpenseNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherInterestIncomeExpenseNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherInterestIncomeExpenseNetMember_lbl" xml:lang="en-US">Included in Other (income)/expense, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_OtherInterestIncomeExpenseNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Net.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:to="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract_lbl" xml:lang="en-US">Segment Of Business And Geographic Areas (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract_lbl" xml:lang="en-US">Segment of Business and Geographic Areas (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract_lbl" xml:lang="en-US">Segment Of Business And Geographic Areas.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="lab_LitigationSettlementExpense" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LitigationSettlementExpense" xml:lang="en-US">Litigation Settlement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_LitigationSettlementExpense" xml:lang="en-US">Net litigation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_LitigationSettlementExpense" xml:lang="en-US">Litigation Expense</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksNet" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_FiniteLivedPatentsAndTrademarksNet" xlink:to="jnj_FiniteLivedPatentsAndTrademarksNet_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet_lbl" xml:lang="en-US">Finite Lived Patents And Trademarks Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet_lbl" xml:lang="en-US">Patents and trademarks - net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet_lbl" xml:lang="en-US">Finite lived patents and trademarks net.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xml:lang="en-US">Schedule of Goodwill [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillLineItems_lbl" xml:lang="en-US">Goodwill [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US">Goodwill [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US">Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativesFairValueLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesFairValueLineItems_lbl" xml:lang="en-US">Derivatives, Fair Value [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US">Derivative Contract Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PensionsAndOtherBenefitPlansTextualsAbstract" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" xlink:to="jnj_PensionsAndOtherBenefitPlansTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract_lbl" xml:lang="en-US">Pensions and Other Benefit Plans (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract_lbl" xml:lang="en-US">Pensions and Other Benefit Plans (Textuals)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract_lbl" xml:lang="en-US">Pensions and Other Benefit Plans Textuals Abstract.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_LiabilitiesAndStockholdersEquityAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities And Stockholders Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Shareholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="lab_EntityPublicFloat" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_EntityPublicFloat" xml:lang="en-US">Entity Public Float</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="jnj_BusinessCombinationsAndDivestituresTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract_lbl" xml:lang="en-US">Business Combinations And Divestitures (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract_lbl" xml:lang="en-US">Business Combinations and Divestitures (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract_lbl" xml:lang="en-US">Business Combinations And Divestitures Textuals Abstract.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:label="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_lbl" xml:lang="en-US">Segment Reporting Information Operating Income Loss [Abstract]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ExpenseNotAllocatedToSegments" xlink:label="jnj_ExpenseNotAllocatedToSegments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ExpenseNotAllocatedToSegments" xlink:to="jnj_ExpenseNotAllocatedToSegments_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ExpenseNotAllocatedToSegments_lbl" xml:lang="en-US">Expense Not Allocated To Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_ExpenseNotAllocatedToSegments_lbl" xml:lang="en-US">Expense not allocated to segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="jnj_ExpenseNotAllocatedToSegments_lbl" xml:lang="en-US">Expense not allocated to segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_ExpenseNotAllocatedToSegments_lbl" xml:lang="en-US">Expense not allocated to segments.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_DebtInstrumentInterestRateDuringPeriod" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DebtInstrumentInterestRateDuringPeriod" xml:lang="en-US">Debt Instrument, Interest Rate During Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_DebtInstrumentInterestRateDuringPeriod" xml:lang="en-US">Weighted average rate on non-current debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease_lbl" xml:lang="en-US">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net Six months change</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" xlink:label="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" xlink:to="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Textuals) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract_lbl" xml:lang="en-US">Accumulated other comprehensive income loss.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedIncomeTaxesPayable" xlink:label="us-gaap_AccruedIncomeTaxesPayable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedIncomeTaxesPayable" xlink:label="us-gaap_AccruedIncomeTaxesPayable" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_VerdictAgainstCompany" xlink:label="jnj_VerdictAgainstCompany" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_VerdictAgainstCompany" xlink:to="jnj_VerdictAgainstCompany_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_VerdictAgainstCompany_lbl" xml:lang="en-US">Verdict Against Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_VerdictAgainstCompany_lbl" xml:lang="en-US">Verdict in favor of the State's Attorney General and against Janssen and the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_VerdictAgainstCompany_lbl" xml:lang="en-US">Verdict in favor of the State's Attorney General and against Janssen and the Company.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:label="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:to="lab_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_FairValueDisclosureItemAmountsDomain" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueDisclosureItemAmountsDomain" xml:lang="en-US">Fair Value, Disclosure Item Amounts [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="lab_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_CashCashEquivalentsAndShortTermInvestmentsAbstract" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_CashCashEquivalentsAndShortTermInvestmentsAbstract" xml:lang="en-US">Current Investments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="lab_Cash" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_Cash" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_Cash" xml:lang="en-US">Cash</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:to="lab_USGovernmentSecuritiesAtCarryingValue" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_USGovernmentSecuritiesAtCarryingValue" xml:lang="en-US">US Government Securities, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_USGovernmentSecuritiesAtCarryingValue" xml:lang="en-US">Government securities and obligations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherCashEquivalentsAtCarryingValue" xlink:label="us-gaap_OtherCashEquivalentsAtCarryingValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCashEquivalentsAtCarryingValue" xlink:to="lab_OtherCashEquivalentsAtCarryingValue" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_OtherCashEquivalentsAtCarryingValue" xml:lang="en-US">Other Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OtherCashEquivalentsAtCarryingValue" xml:lang="en-US">Corporate debt securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_MoneyMarketFundsAtCarryingValue" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_MoneyMarketFundsAtCarryingValue" xml:lang="en-US">Money Market Funds, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_MoneyMarketFundsAtCarryingValue" xml:lang="en-US">Money market funds</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="us-gaap_TimeDepositsAtCarryingValue" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimeDepositsAtCarryingValue" xlink:to="lab_TimeDepositsAtCarryingValue" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_TimeDepositsAtCarryingValue" xml:lang="en-US">Time Deposits, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_TimeDepositsAtCarryingValue" xml:lang="en-US">Time deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_CashCashEquivalentsAndShortTermInvestments" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_CashCashEquivalentsAndShortTermInvestments" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_CashCashEquivalentsAndShortTermInvestments" xml:lang="en-US">Total cash, cash equivalents and current marketable securities</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestitutionMember" xlink:label="jnj_RestitutionMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RestitutionMember" xlink:to="jnj_RestitutionMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RestitutionMember_lbl" xml:lang="en-US">Restitution [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RestitutionMember_lbl" xml:lang="en-US">Restitution [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RestitutionMember_lbl" xml:lang="en-US">Restitution.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CivilPenaltiesMember" xlink:label="jnj_CivilPenaltiesMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CivilPenaltiesMember" xlink:to="jnj_CivilPenaltiesMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CivilPenaltiesMember_lbl" xml:lang="en-US">Civil penalties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_CivilPenaltiesMember_lbl" xml:lang="en-US">Civil penalties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_CivilPenaltiesMember_lbl" xml:lang="en-US">Civil penalties.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AmountGivenToPlaintiffByJury" xlink:label="jnj_AmountGivenToPlaintiffByJury" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AmountGivenToPlaintiffByJury" xlink:to="jnj_AmountGivenToPlaintiffByJury_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AmountGivenToPlaintiffByJury_lbl" xml:lang="en-US">Amount Given To Plaintiff By Jury</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AmountGivenToPlaintiffByJury_lbl" xml:lang="en-US">Amount given to plaintiff by jury.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AmountGivenToPlaintiffByJury_lbl" xml:lang="en-US">Amount given to plaintiff by jury</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="lab_LossContingenciesTable" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LossContingenciesTable" xml:lang="en-US">Loss Contingencies [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="lab_LossContingencyNatureDomain" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LossContingencyNatureDomain" xml:lang="en-US">Loss Contingency, Nature [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="lab_LossContingenciesLineItems" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LossContingenciesLineItems" xml:lang="en-US">Loss Contingencies [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xml:lang="en-US">July 3, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xml:lang="en-US">January 2, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xml:lang="en-US">Deferred net gains on derivatives included in accumulated other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" xlink:to="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease_lbl" xml:lang="en-US">Sales Revenue Goods Net Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease_lbl" xml:lang="en-US">Sales to customers (Note 9)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease_lbl" xml:lang="en-US">Sales revenue goods net percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CostOfGoodsSoldPercentageIncreaseDecrease" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" xlink:to="jnj_CostOfGoodsSoldPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease_lbl" xml:lang="en-US">Cost Of Goods Sold Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease_lbl" xml:lang="en-US">Cost of products sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease_lbl" xml:lang="en-US">Cost of goods sold percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_GrossProfitPercentageIncreaseDecrease" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_GrossProfitPercentageIncreaseDecrease" xlink:to="jnj_GrossProfitPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Gross Profit Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Gross profit percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" xlink:to="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Selling General And Administrative Expense Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Selling, marketing and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Selling general and administrative expense percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" xlink:to="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease_lbl" xml:lang="en-US">Research And Development Expense Excluding Acquired In Process Cost Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease_lbl" xml:lang="en-US">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease_lbl" xml:lang="en-US">Research and development expense excluding acquired in process cost percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" xlink:to="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease_lbl" xml:lang="en-US">Investment Income Interest Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease_lbl" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease_lbl" xml:lang="en-US">Investment income interest percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestExpensePercentageIncreaseDecrease" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_InterestExpensePercentageIncreaseDecrease" xlink:to="jnj_InterestExpensePercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Interest Expense Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Interest expense, net of portion capitalized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Interest expense percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" xlink:to="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Other Non Operating Income Expense Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Other (income) expense, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease_lbl" xml:lang="en-US">Other non operating income expense percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:to="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease_lbl" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease_lbl" xml:lang="en-US">Earnings before provision for taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease_lbl" xml:lang="en-US">Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" xlink:to="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Income Tax Expense Benefit Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Provision for taxes on income (Note 5)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease_lbl" xml:lang="en-US">Income tax expense benefit percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ProfitLossPercentageIncreaseDecrease" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ProfitLossPercentageIncreaseDecrease" xlink:to="jnj_ProfitLossPercentageIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease_lbl" xml:lang="en-US">Profit Loss Percentage Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease_lbl" xml:lang="en-US">NET EARNINGS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease_lbl" xml:lang="en-US">Profit loss percentage increase decrease.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">AVG. SHARES OUTSTANDING</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Financial assets and liabilities not measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Financial assets and liabilities not measured at fair value</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:to="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Financial Assets And Liabilities Not Measured At Fair Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Financial assets and liabilities not measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Financial assets and liabilities not measured at fair value.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Financial Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Financial Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Financial Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LongTermDebtNoncurrentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_LongTermDebtNoncurrentAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LongTermDebtNoncurrentAbstract" xml:lang="en-US">Long-term Debt, Excluding Current Maturities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_LongTermDebtNoncurrentAbstract" xml:lang="en-US">Non-Current Debt</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodOneMember" xlink:label="jnj_NotesDuePeriodOneMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodOneMember" xlink:to="jnj_NotesDuePeriodOneMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodOneMember_lbl" xml:lang="en-US">Notes Due Period One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodOneMember_lbl" xml:lang="en-US">5.15% Debentures due 2012 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodOneMember_lbl" xml:lang="en-US">Notes due period one.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwoMember" xlink:label="jnj_NotesDuePeriodTwoMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTwoMember" xlink:to="jnj_NotesDuePeriodTwoMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTwoMember_lbl" xml:lang="en-US">Notes Due Period Two Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTwoMember_lbl" xml:lang="en-US">3.80% Debentures due 2013 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTwoMember_lbl" xml:lang="en-US">Notes due period two.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThreeMember" xlink:label="jnj_NotesDuePeriodThreeMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodThreeMember" xlink:to="jnj_NotesDuePeriodThreeMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodThreeMember_lbl" xml:lang="en-US">Notes Due Period Three Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodThreeMember_lbl" xml:lang="en-US">5.55% Debentures due 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodThreeMember_lbl" xml:lang="en-US">Notes due period three.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourteenMember" xlink:label="jnj_NotesDuePeriodFourteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodFourteenMember" xlink:to="jnj_NotesDuePeriodFourteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodFourteenMember_lbl" xml:lang="en-US">Notes Due Period Fourteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodFourteenMember_lbl" xml:lang="en-US">5.15% Debentures due 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodFourteenMember_lbl" xml:lang="en-US">Notes due period fourteen.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourMember" xlink:label="jnj_NotesDuePeriodFourMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodFourMember" xlink:to="jnj_NotesDuePeriodFourMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodFourMember_lbl" xml:lang="en-US">Notes Due Period Four Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodFourMember_lbl" xml:lang="en-US">4.75% Notes due 2019 (1B Euro 1.4476) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodFourMember_lbl" xml:lang="en-US">Notes due period four.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFiveMember" xlink:label="jnj_NotesDuePeriodFiveMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodFiveMember" xlink:to="jnj_NotesDuePeriodFiveMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodFiveMember_lbl" xml:lang="en-US">Notes Due Period Five Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodFiveMember_lbl" xml:lang="en-US">3% Zero Coupon Convertible Subordinated Debentures due in 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodFiveMember_lbl" xml:lang="en-US">Notes due period five.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixMember" xlink:label="jnj_NotesDuePeriodSixMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodSixMember" xlink:to="jnj_NotesDuePeriodSixMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodSixMember_lbl" xml:lang="en-US">Notes Due Period Six Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodSixMember_lbl" xml:lang="en-US">2.95% Debentures due 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodSixMember_lbl" xml:lang="en-US">Notes due period six.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSevenMember" xlink:label="jnj_NotesDuePeriodSevenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodSevenMember" xlink:to="jnj_NotesDuePeriodSevenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodSevenMember_lbl" xml:lang="en-US">Notes Due Period Seven Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodSevenMember_lbl" xml:lang="en-US">6.73% Debentures due 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodSevenMember_lbl" xml:lang="en-US">Notes due period seven.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEightMember" xlink:label="jnj_NotesDuePeriodEightMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodEightMember" xlink:to="jnj_NotesDuePeriodEightMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodEightMember_lbl" xml:lang="en-US">Notes Due Period Eight Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodEightMember_lbl" xml:lang="en-US">5.50% Notes due 2024 (500 GBP 1.6025) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodEightMember_lbl" xml:lang="en-US">Notes due period eight.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineMember" xlink:label="jnj_NotesDuePeriodNineMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodNineMember" xlink:to="jnj_NotesDuePeriodNineMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodNineMember_lbl" xml:lang="en-US">Notes Due Period Nine Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodNineMember_lbl" xml:lang="en-US">6.95% Notes due 2029 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodNineMember_lbl" xml:lang="en-US">Notes due period nine.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTenMember" xlink:label="jnj_NotesDuePeriodTenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTenMember" xlink:to="jnj_NotesDuePeriodTenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTenMember_lbl" xml:lang="en-US">Notes Due Period Ten Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTenMember_lbl" xml:lang="en-US">4.95% Debentures due 2033 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTenMember_lbl" xml:lang="en-US">Notes due period ten.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodElevenMember" xlink:label="jnj_NotesDuePeriodElevenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodElevenMember" xlink:to="jnj_NotesDuePeriodElevenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodElevenMember_lbl" xml:lang="en-US">Notes Due Period Eleven Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodElevenMember_lbl" xml:lang="en-US">5.95% Notes due 2037 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodElevenMember_lbl" xml:lang="en-US">Notes due period eleven.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwelveMember" xlink:label="jnj_NotesDuePeriodTwelveMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTwelveMember" xlink:to="jnj_NotesDuePeriodTwelveMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTwelveMember_lbl" xml:lang="en-US">Notes Due Period Twelve Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTwelveMember_lbl" xml:lang="en-US">5.86% Debentures due 2038 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTwelveMember_lbl" xml:lang="en-US">Notes due period twelve.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThirteenMember" xlink:label="jnj_NotesDuePeriodThirteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodThirteenMember" xlink:to="jnj_NotesDuePeriodThirteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodThirteenMember_lbl" xml:lang="en-US">Notes Due Period Thirteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodThirteenMember_lbl" xml:lang="en-US">4.50% Debentures due 2040 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodThirteenMember_lbl" xml:lang="en-US">Notes due period thirteen.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFifteenMember" xlink:label="jnj_NotesDuePeriodFifteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodFifteenMember" xlink:to="jnj_NotesDuePeriodFifteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodFifteenMember_lbl" xml:lang="en-US">Notes Due Period Fifteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodFifteenMember_lbl" xml:lang="en-US">Other (Includes Industrial Revenue Bonds) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodFifteenMember_lbl" xml:lang="en-US">Notes due period fifteen.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_CarryingReportedAmountFairValueDisclosureMember" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_EstimateOfFairValueFairValueDisclosureMember" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_FairValueByBalanceSheetGroupingTable" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueByBalanceSheetGroupingTable" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="lab_LongtermDebtTypeAxis" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LongtermDebtTypeAxis" xml:lang="en-US">Long-term Debt, Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="lab_LongtermDebtTypeDomain" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LongtermDebtTypeDomain" xml:lang="en-US">Long-term Debt, Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:to="jnj_PercentageChangeInSalesBySegmentOfBusiness_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness_lbl" xml:lang="en-US">Percentage Change In Sales By Segment Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness_lbl" xml:lang="en-US">Percentage Change</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness_lbl" xml:lang="en-US">Percentage change in sales by segment of business.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" xlink:to="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice_lbl" xml:lang="en-US">Business Acquisition Costs Of Acquired Entity Purchase Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice_lbl" xml:lang="en-US">Business acquisition cost of acquired entity purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice_lbl" xml:lang="en-US">Business acquisition costs of acquired entity purchase price.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" xlink:label="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" xlink:to="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest_lbl" xml:lang="en-US">Settlement Payment Related Fines Disgorgement And Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest_lbl" xml:lang="en-US">Settlement payment related fines disgorgement and interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest_lbl" xml:lang="en-US">Settlement payment related fines disgorgement and interest</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" xlink:to="jnj_PercentageOfRevenueRepresentedByRetainedTerritories_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Percentage Of Revenue Represented By Retained Territories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Percentage of revenue represented by retained territories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Percentage of revenue represented by retained territories</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AmountOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AmountOfRevenueRepresentedByRetainedTerritories" xlink:to="jnj_AmountOfRevenueRepresentedByRetainedTerritories_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Amount Of Revenue Represented By Retained Territories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Amount of revenue represented by retained territories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories_lbl" xml:lang="en-US">Amount of revenue represented by retained territories</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" xlink:label="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" xlink:to="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories_lbl" xml:lang="en-US">Percentage Of Revenue Represented By Relinquished Territories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories_lbl" xml:lang="en-US">Percentage of revenue represented by relinquished territories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories_lbl" xml:lang="en-US">Percentage of revenue represented by relinquished territories</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfContributionToIncomeProfitSplit" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageOfContributionToIncomeProfitSplit" xlink:to="jnj_PercentageOfContributionToIncomeProfitSplit_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit_lbl" xml:lang="en-US">Percentage Of Contribution To Income Profit Split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit_lbl" xml:lang="en-US">Percentage of contribution to income profit split.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit_lbl" xml:lang="en-US">Percentage of contribution to income profit split</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesAxis" xlink:label="jnj_LitigationSettlementByCompaniesAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationSettlementByCompaniesAxis" xlink:to="jnj_LitigationSettlementByCompaniesAxis_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationSettlementByCompaniesAxis_lbl" xml:lang="en-US">Litigation Settlement By Companies [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationSettlementByCompaniesAxis_lbl" xml:lang="en-US">Litigation settlement by companies.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesDomain" xlink:label="jnj_LitigationSettlementByCompaniesDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_LitigationSettlementByCompaniesDomain_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationSettlementByCompaniesDomain_lbl" xml:lang="en-US">Litigation Settlement By Companies [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationSettlementByCompaniesDomain_lbl" xml:lang="en-US">Litigation settlement by companies.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MerckMember" xlink:label="jnj_MerckMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_MerckMember" xlink:to="jnj_MerckMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_MerckMember_lbl" xml:lang="en-US">Merck [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_MerckMember_lbl" xml:lang="en-US">Merck.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_MerckMember_lbl" xml:lang="en-US">Merck [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CentocorOrthoBiotechIncMember" xlink:label="jnj_CentocorOrthoBiotechIncMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CentocorOrthoBiotechIncMember" xlink:to="jnj_CentocorOrthoBiotechIncMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CentocorOrthoBiotechIncMember_lbl" xml:lang="en-US">Centocor Ortho Biotech Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_CentocorOrthoBiotechIncMember_lbl" xml:lang="en-US">COBI [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_CentocorOrthoBiotechIncMember_lbl" xml:lang="en-US">Centocor Ortho Biotech Inc.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OneTimePaymentReceivedByCompany" xlink:label="jnj_OneTimePaymentReceivedByCompany" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OneTimePaymentReceivedByCompany" xlink:to="jnj_OneTimePaymentReceivedByCompany_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OneTimePaymentReceivedByCompany_lbl" xml:lang="en-US">One Time Payment Received By Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_OneTimePaymentReceivedByCompany_lbl" xml:lang="en-US">One time payment received by Company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OneTimePaymentReceivedByCompany_lbl" xml:lang="en-US">One time payment received by Company</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="us-gaap_OtherRestructuringCosts" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherRestructuringCosts" xlink:to="us-gaap_OtherRestructuringCosts_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherRestructuringCosts_lbl" xml:lang="en-US">Other Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherRestructuringCosts_lbl" xml:lang="en-US">Asset write-offs included in restructuring charges</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xlink:to="lab_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xlink:to="lab_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xml:lang="en-US">Business Acquisition, Purchase Price Allocation, Intangible Assets Not Amortizable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xml:lang="en-US">Non amortizable intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions By Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition Acquiree Domain]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CrucellNvMember" xlink:label="jnj_CrucellNvMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CrucellNvMember" xlink:to="jnj_CrucellNvMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CrucellNvMember_lbl" xml:lang="en-US">Crucell Nv Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_CrucellNvMember_lbl" xml:lang="en-US">Crucell .N. V [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AcclarentIncMember" xlink:label="jnj_AcclarentIncMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AcclarentIncMember" xlink:to="jnj_AcclarentIncMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AcclarentIncMember_lbl" xml:lang="en-US">Acclarent Inc Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AcclarentIncMember_lbl" xml:lang="en-US">Acclarent Inc [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" xlink:label="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" xlink:to="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock_lbl" xml:lang="en-US">Pharmaceutical Fees Paid To Government [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock_lbl" xml:lang="en-US">Pharmaceutical fees paid to the government</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock_lbl" xml:lang="en-US">Pharmaceutical fees paid to government.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementPreJudgmentInterest" xlink:label="jnj_LitigationSettlementPreJudgmentInterest" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationSettlementPreJudgmentInterest" xlink:to="jnj_LitigationSettlementPreJudgmentInterest_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationSettlementPreJudgmentInterest_lbl" xml:lang="en-US">Litigation Settlement Pre Judgment Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationSettlementPreJudgmentInterest_lbl" xml:lang="en-US">Litigation settlement pre judgment interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_LitigationSettlementPreJudgmentInterest_lbl" xml:lang="en-US">Litigation settlement pre judgment interest</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" xlink:label="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" xlink:to="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs_lbl" xml:lang="en-US">Assessed Damages For Alleged Consumer Fraud Related To Certain Drugs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs_lbl" xml:lang="en-US">Assessed damages for alleged consumer fraud as to DURAGESIC and RISPERDAL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs_lbl" xml:lang="en-US">Assessed Damages for Alleged Consumer Fraud as to DURAGESIC and RISPERDAL.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xml:lang="en-US">Fair value of assets acquired</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xml:lang="en-US">Fair value of liabilities assumed and non-controlling interests</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xml:lang="en-US">Net cash paid for acquisitions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="us-gaap_EquityMethodInvestmentsFairValueDisclosure" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_EquityMethodInvestmentsFairValueDisclosure" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_EquityMethodInvestmentsFairValueDisclosure" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_EquityMethodInvestmentsFairValueDisclosure" xml:lang="en-US">Derivatives not designated as hedging instruments : Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_EquityMethodInvestmentsFairValueDisclosure" xml:lang="en-US">Other investments</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeFourNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_OtherInterestIncomeExpenseTypeFourNetMember" xlink:to="jnj_OtherInterestIncomeExpenseTypeFourNetMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember_lbl" xml:lang="en-US">Other Interest Income Expense Type Four Net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember_lbl" xml:lang="en-US">Included in Other (Income)/Expense Type Four, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember_lbl" xml:lang="en-US">Other interest income expense type four net.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_DerivativeInstrumentRiskAxis" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeInstrumentRiskAxis" xml:lang="en-US">Derivative Instrument Risk [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_FairValueByFairValueHierarchyLevelAxis" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_FairValueMeasurementsFairValueHierarchyDomain" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xlink:to="lab_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xml:lang="en-US">Defined Benefit Plan, Amortization of Transition Obligations (Assets)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xml:lang="en-US">Amortization of net transition obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="lab_SegmentDomain" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SegmentDomain" xml:lang="en-US">Segment [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="lab_OperatingIncomeLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="lab_StatementGeographicalAxis" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_StatementGeographicalAxis" xml:lang="en-US">Statement, Geographical [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <label xlink:type="resource" xlink:label="lab_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_AssetsCurrent" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:label="lab_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:label="lab_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_Assets" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:label="lab_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:label="lab_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_Liabilities" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities And Stockholders Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">NET CASH USED BY FINANCING ACTIVITIES</label>
    <label xlink:type="resource" xlink:label="lab_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Inventory, Finished Goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_InventoryFinishedGoods" xml:lang="en-US">Finished goods</label>
    <label xlink:type="resource" xlink:label="lab_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Indefinite-lived Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OtherIndefiniteLivedIntangibleAssets" xml:lang="en-US">Purchased in-process research and development</label>
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_DefinedBenefitPlanNetPeriodicBenefitCost" xml:lang="en-US">Net periodic benefit cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="us-gaap_SegmentsGeographicalAreasAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentsGeographicalAreasAbstract" xlink:to="lab_SegmentsGeographicalAreasAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SegmentsGeographicalAreasAbstract" xml:lang="en-US">Segments, Geographical Areas [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SegmentsGeographicalAreasAbstract" xml:lang="en-US">Sales by geographic area</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_lbl" xml:lang="en-US">Derivative Instruments Gain Loss On Statement Of Financial Performance Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_lbl" xml:lang="en-US">Summary of designated derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_lbl" xml:lang="en-US">Derivative instruments gain loss on statement of financial performance.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract" xlink:label="us-gaap_DerivativeInstrumentDetailAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_DerivativeInstrumentDetailAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeInstrumentDetailAbstract" xml:lang="en-US">Derivative Instrument Detail [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DerivativeInstrumentDetailAbstract" xml:lang="en-US">Financial assets and liabilities at fair value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="lab_AccountingPoliciesAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_AccountingPoliciesAbstract" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="lab_InventoryDisclosureAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_InventoryDisclosureAbstract" xml:lang="en-US">Inventories [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US">Intangible Assets and Goodwill [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_FairValueDisclosuresAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Measurements [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_IncomeTaxDisclosureAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Taxes [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_CompensationAndRetirementDisclosureAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US">Pensions and Other Benefit Plans [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="lab_EquityAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_EquityAbstract" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="lab_SegmentReportingAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SegmentReportingAbstract" xml:lang="en-US">Segments of Business and Geographic Areas [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_LegalMattersAndContingenciesTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_LegalMattersAndContingenciesTextBlock" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_LegalMattersAndContingenciesTextBlock" xml:lang="en-US">LEGAL PROCEEDINGS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="lab_SubsequentEventsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="lab_SubsequentEventsTextBlock" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_RestructuringAndRelatedActivitiesAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_RestructuringAndRelatedActivitiesAbstract" xml:lang="en-US">Restructuring and Related Activities [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_RevenueRecognitionPolicyTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Adoption of standard update related to revenue recognition under the milestone method and its impact</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_ScheduleOfInventoryCurrentTableTextBlock" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xml:lang="en-US">Components of Accumulated Other Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="lab_BusinessCombinationsAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_BusinessCombinationsAbstract" xml:lang="en-US">Business Combinations and Divestitures [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock" xlink:to="lab_ScheduleOfEarningsPerShareReconciliationTableTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfEarningsPerShareReconciliationTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfEarningsPerShareReconciliationTableTextBlock" xml:lang="en-US">Reconciliation of basic net earnings per share to diluted net earnings per share</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SaleByGeographicAreaTableTextBlock" xlink:label="jnj_SaleByGeographicAreaTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SaleByGeographicAreaTableTextBlock" xlink:to="jnj_SaleByGeographicAreaTableTextBlock_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SaleByGeographicAreaTableTextBlock_lbl" xml:lang="en-US">Sale By Geographic Area Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SaleByGeographicAreaTableTextBlock_lbl" xml:lang="en-US">Sales by geographic area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SaleByGeographicAreaTableTextBlock_lbl" xml:lang="en-US">Tabular disclosure of sale by geographic area.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_SegmentReportingInformationRevenueAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SegmentReportingInformationRevenueAbstract" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesByGeographicArea" xlink:label="jnj_PercentageChangeInSalesByGeographicArea" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageChangeInSalesByGeographicArea" xlink:to="jnj_PercentageChangeInSalesByGeographicArea_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageChangeInSalesByGeographicArea_lbl" xml:lang="en-US">Percentage Change In Sales By Geographic Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageChangeInSalesByGeographicArea_lbl" xml:lang="en-US">Percentage change in sales by geographic area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageChangeInSalesByGeographicArea_lbl" xml:lang="en-US">Percent Change</label>
    <label xlink:type="resource" xlink:label="lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Stockholders Equity Including Portion Attributable To Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:label="lab_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Quoted prices in active markets for identical assets and liabilities Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_FairValueInputsLevel1Member" xml:lang="en-US">Quoted prices in active markets for identical assets and liabilities Level 1 [Member]</label>
    <label xlink:type="resource" xlink:label="lab_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Significant other observable inputs Level 2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_FairValueInputsLevel2Member" xml:lang="en-US">Significant other observable inputs Level 2 [Member]</label>
    <label xlink:type="resource" xlink:label="lab_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Significant unobservable inputs Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_FairValueInputsLevel3Member" xml:lang="en-US">Significant unobservable inputs Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US">Carrying Amount [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US">Carrying Amount [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US">Estimated Fair Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US">Estimated Fair Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xml:lang="en-US">Business Acquisition, Purchase Price Allocation, Goodwill Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xml:lang="en-US">Business Acquisition, Purchase Price Allocation, Goodwill Amount</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_PrepaidExpenseAndOtherAssetsCurrent" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent" xlink:label="us-gaap_DerivativeAssetsNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_DerivativeAssetsNoncurrent" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeAssetsNoncurrent" xml:lang="en-US">Derivative Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DerivativeAssetsNoncurrent" xml:lang="en-US">Non-current assets included into cross currency interest rate swaps</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_DerivativeLiabilitiesNoncurrent" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeLiabilitiesNoncurrent" xml:lang="en-US">Derivative Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_DerivativeLiabilitiesNoncurrent" xml:lang="en-US">Non-current liabilities included into cross currency interest rate swaps</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xml:lang="en-US">Expected number of positions to be eliminated</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xlink:to="lab_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xml:lang="en-US">Number of positions eliminated to date</label>
    <label xlink:type="resource" xlink:label="lab_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:label="lab_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Average shares outstanding - diluted</label>
    <label xlink:type="resource" xlink:label="lab_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:label="lab_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US">Net earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ProfitLoss" xml:lang="en-US">NET EARNINGS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ProfitLoss" xml:lang="en-US">NET EARNINGS</label>
    <label xlink:type="resource" xlink:label="lab_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Gross Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_GrossProfit" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:label="lab_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:label="lab_SalesRevenueGoodsNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Sales Revenue, Goods, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_SalesRevenueGoodsNet" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_SalesRevenueGoodsNet" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SalesRevenueGoodsNet" xml:lang="en-US">Sales to customers (Note 9)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillOtherChanges" xlink:label="us-gaap_GoodwillOtherChanges" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillOtherChanges" xlink:to="lab_GoodwillOtherChanges" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_GoodwillOtherChanges" xml:lang="en-US">Goodwill, Other Changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_GoodwillOtherChanges" xml:lang="en-US">Currency translation/other</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US">Intangible assets and Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_ScheduleOfNetBenefitCostsTableTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfNetBenefitCostsTableTextBlock" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfNetBenefitCostsTableTextBlock" xml:lang="en-US">Components of net periodic benefit cost</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:label="jnj_SalesBySegmentOfBusinessTableTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:to="jnj_SalesBySegmentOfBusinessTableTextBlock_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SalesBySegmentOfBusinessTableTextBlock_lbl" xml:lang="en-US">Sales By Segment Of Business [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SalesBySegmentOfBusinessTableTextBlock_lbl" xml:lang="en-US">Sales by segment of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SalesBySegmentOfBusinessTableTextBlock_lbl" xml:lang="en-US">Sales by segment of business.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_CommitmentsAndContingenciesDisclosureAbstract" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Legal Proceedings [Abstract]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLoss" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageChangeInOperatingIncomeLoss" xlink:to="jnj_PercentageChangeInOperatingIncomeLoss_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss_lbl" xml:lang="en-US">Percentage Change in Operating Income Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss_lbl" xml:lang="en-US">Percent Change</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss_lbl" xml:lang="en-US">Percentage change in operating income loss.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" xlink:to="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments_lbl" xml:lang="en-US">Percentage Change in Operating Income Loss Excluding Expenses Not Allocated to Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments_lbl" xml:lang="en-US">Worldwide total, percent total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments_lbl" xml:lang="en-US">Percentage change in operating income loss excluding expenses not allocated to segments.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTable" xlink:to="lab_DerivativeTable" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeTable" xml:lang="en-US">Derivative [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="lab_DerivativeLineItems" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_DerivativeLineItems" xml:lang="en-US">Derivative [Line Items]</label>
    <label xlink:type="resource" xlink:label="lab_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Receivable, Net, Current</label>
    <label xlink:type="resource" xlink:label="lab_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounts receivable, trade, less allowances for doubtful accounts $327 (2010, $340)</label>
    <label xlink:type="resource" xlink:label="lab_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Treasury Stock, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_TreasuryStockValue" xml:lang="en-US">Less: common stock held in treasury, at cost (379,263,000 and 381,746,000 shares)</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" xlink:label="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" xlink:to="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock_lbl" xml:lang="en-US">Requirements For Presentation Of Comprehensive Income [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock_lbl" xml:lang="en-US">Presentation of comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock_lbl" xml:lang="en-US">Requirements for presentation of comprehensive income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfInventoryCurrentTableTextBlock" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfInventoryCurrentTableTextBlock" xml:lang="en-US">Summary of Inventories</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_ScheduleOfGoodwillTextBlock" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Goodwill</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SwissFrancOptionMember" xlink:label="jnj_SwissFrancOptionMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SwissFrancOptionMember" xlink:to="jnj_SwissFrancOptionMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SwissFrancOptionMember_lbl" xml:lang="en-US">Swiss Franc Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SwissFrancOptionMember_lbl" xml:lang="en-US">Swiss Franc option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_SwissFrancOptionMember_lbl" xml:lang="en-US">Swiss Franc Option [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixteenMember" xlink:label="jnj_NotesDuePeriodSixteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodSixteenMember" xlink:to="jnj_NotesDuePeriodSixteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodSixteenMember_lbl" xml:lang="en-US">Notes Due Period Sixteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodSixteenMember_lbl" xml:lang="en-US">0.70% Notes due 2013 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodSixteenMember_lbl" xml:lang="en-US">Notes due period fourteen.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSeventeenMember" xlink:label="jnj_NotesDuePeriodSeventeenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodSeventeenMember" xlink:to="jnj_NotesDuePeriodSeventeenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodSeventeenMember_lbl" xml:lang="en-US">Notes Due Period Seventeen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodSeventeenMember_lbl" xml:lang="en-US">3 month LIBOR+0% FRN due 2013 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodSeventeenMember_lbl" xml:lang="en-US">Notes Due Period Seventeen.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEighteenMember" xlink:label="jnj_NotesDuePeriodEighteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodEighteenMember" xlink:to="jnj_NotesDuePeriodEighteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodEighteenMember_lbl" xml:lang="en-US">Notes Due Period Eighteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodEighteenMember_lbl" xml:lang="en-US">3 month LIBOR+0.09% FRN due 2014 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodEighteenMember_lbl" xml:lang="en-US">Notes due period eighteen.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyMember" xlink:label="jnj_NotesDuePeriodTwentyMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTwentyMember" xlink:to="jnj_NotesDuePeriodTwentyMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTwentyMember_lbl" xml:lang="en-US">Notes Due Period Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTwentyMember_lbl" xml:lang="en-US">2.15% Notes due 2016 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTwentyMember_lbl" xml:lang="en-US">Notes due period twenty.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyOneMember" xlink:label="jnj_NotesDuePeriodTwentyOneMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTwentyOneMember" xlink:to="jnj_NotesDuePeriodTwentyOneMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTwentyOneMember_lbl" xml:lang="en-US">Notes Due Period Twenty One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTwentyOneMember_lbl" xml:lang="en-US">3.55% Notes due 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTwentyOneMember_lbl" xml:lang="en-US">Notes due period twenty one.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyTwoMember" xlink:label="jnj_NotesDuePeriodTwentyTwoMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodTwentyTwoMember" xlink:to="jnj_NotesDuePeriodTwentyTwoMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodTwentyTwoMember_lbl" xml:lang="en-US">Notes Due Period Twenty Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodTwentyTwoMember_lbl" xml:lang="en-US">4.85% Notes due 2041 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodTwentyTwoMember_lbl" xml:lang="en-US">Note due period twenty two.</label>
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</label>
    <label xlink:type="resource" xlink:label="lab_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Amortization of prior service cost/ (credit)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid" xlink:to="lab_BusinessAcquisitionCostOfAcquiredEntityCashPaid" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_BusinessAcquisitionCostOfAcquiredEntityCashPaid" xml:lang="en-US">Business Acquisition, Cost of Acquired Entity, Cash Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_BusinessAcquisitionCostOfAcquiredEntityCashPaid" xml:lang="en-US">Acquisition cash paid</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="lab_PropertyPlantAndEquipmentDisposals" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_PropertyPlantAndEquipmentDisposals" xml:lang="en-US">Property, Plant and Equipment, Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_PropertyPlantAndEquipmentDisposals" xml:lang="en-US">Asset write-offs related to property, plant and equipment</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">NET CASH FLOWS FROM OPERATING ACTIVITIES</label>
    <label xlink:type="resource" xlink:label="lab_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">NET CASH USED BY INVESTING ACTIVITIES</label>
    <label xlink:type="resource" xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Decrease in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringExpensesIncreaseDecrease" xlink:label="jnj_RestructuringExpensesIncreaseDecrease" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RestructuringExpensesIncreaseDecrease" xlink:to="jnj_RestructuringExpensesIncreaseDecrease_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RestructuringExpensesIncreaseDecrease_lbl" xml:lang="en-US">Restructuring Expenses Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RestructuringExpensesIncreaseDecrease_lbl" xml:lang="en-US">Restructuring expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RestructuringExpensesIncreaseDecrease_lbl" xml:lang="en-US">Restructuring expenses increase decrease.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_FairValueOfFinancialInstrumentsPolicy" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Requirements for common fair value measurement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" xlink:to="lab_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" xml:lang="en-US">Business Acquisition, Cost of Acquired Entity, Purchase Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" xml:lang="en-US">Agreement to Acquire Synthesis</label>
    <label xlink:type="resource" xlink:label="lab_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:label="lab_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">PENSIONS AND OTHER POSTRETIREMENT BENEFITS</label>
    <label xlink:type="resource" xlink:label="lab_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</label>
    <label xlink:type="resource" xlink:label="lab_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">EARNINGS PER SHARE</label>
    <label xlink:type="resource" xlink:label="lab_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS</label>
    <label xlink:type="resource" xlink:label="lab_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible assets and Goodwill</label>
    <label xlink:type="resource" xlink:label="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xml:lang="en-US">Derivatives &amp; Hedges [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SegmentReportingInformationRevenueAbstract" xml:lang="en-US">Sales by segment of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_lbl" xml:lang="en-US">Operating profit by segment of business</label>
    <label xlink:type="resource" xlink:label="label_SegmentGeographicalGroupsOfCountriesGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="label_SegmentGeographicalGroupsOfCountriesGroupOneMember">Segment Geographical Groups Of Countries Group [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_SegmentGeographicalGroupsOfCountriesGroupOneMember" xml:lang="en-US">Western Hemisphere, excluding U.S. [Member]</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AverageWholesalePriceLitigationMember" xlink:label="jnj_AverageWholesalePriceLitigationMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AverageWholesalePriceLitigationMember" xlink:to="jnj_AverageWholesalePriceLitigationMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AverageWholesalePriceLitigationMember_lbl" xml:lang="en-US">Average Wholesale Price Litigation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AverageWholesalePriceLitigationMember_lbl" xml:lang="en-US">Average Wholesale Price Litigation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AverageWholesalePriceLitigationMember_lbl" xml:lang="en-US">Average Wholesale Price (Awp) Litigation.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RisperdalMember" xlink:label="jnj_RisperdalMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RisperdalMember" xlink:to="jnj_RisperdalMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RisperdalMember_lbl" xml:lang="en-US">Risperdal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RisperdalMember_lbl" xml:lang="en-US">Risperdal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RisperdalMember_lbl" xml:lang="en-US">Risperdal.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineteenMember" xlink:label="jnj_NotesDuePeriodNineteenMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_NotesDuePeriodNineteenMember" xlink:to="jnj_NotesDuePeriodNineteenMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_NotesDuePeriodNineteenMember_lbl" xml:lang="en-US">Notes Due Period Nineteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_NotesDuePeriodNineteenMember_lbl" xml:lang="en-US">1.20% notes due 2014 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_NotesDuePeriodNineteenMember_lbl" xml:lang="en-US">f</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US">Type of Restructuring [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeSeveranceMember" xlink:to="us-gaap_EmployeeSeveranceMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xml:lang="en-US">Employee Severance [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xml:lang="en-US">Severance [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_SubsequentEventsTextBlock" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:label="lab_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_LongTermDebtNoncurrent" xml:lang="en-US">Long-term debt (Note 4)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_LongTermDebtNoncurrent" xml:lang="en-US">Long-term debt</label>
    <label xlink:type="resource" xlink:label="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xml:lang="en-US">Earnings before provision for taxes on income</label>
    <label xlink:type="resource" xlink:label="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Worldwide income before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_OperatingIncomeLoss" xml:lang="en-US">Segments operating profit</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationAndRecallExpense" xlink:label="jnj_LitigationAndRecallExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationAndRecallExpense" xlink:to="jnj_LitigationAndRecallExpense_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationAndRecallExpense_lbl" xml:lang="en-US">Litigation And Recall Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_LitigationAndRecallExpense_lbl" xml:lang="en-US">Litigation and additional DePuy ASR Hip recall costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationAndRecallExpense_lbl" xml:lang="en-US">Litigation And Recall Expense.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SynthesIncMember" xlink:label="jnj_SynthesIncMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_SynthesIncMember" xlink:to="jnj_SynthesIncMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_SynthesIncMember_lbl" xml:lang="en-US">Synthes, Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_SynthesIncMember_lbl" xml:lang="en-US">Synthes, Inc.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage_lbl" xml:lang="en-US">Business Acquisition Cost Of Acquired Entity Cash Paid Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage_lbl" xml:lang="en-US">Business Acquisition Cost of Acquired Entity Cash Paid Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage_lbl" xml:lang="en-US">Business Acquisition Cost Of Acquired Entity Cash Paid Percentage.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage_lbl" xml:lang="en-US">Business Acquisition Cost Of Acquired Entity Equity Interest Issued And Issuable Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage_lbl" xml:lang="en-US">Business Acquisition Cost of Acquired Entity Equity Interest Issued and Issuable Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage_lbl" xml:lang="en-US">Business Acquisition Cost Of Acquired Entity Equity Interest Issued And Issuable Percentage.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostIntangibleAssets" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RestructuringAndRelatedCostIntangibleAssets" xlink:to="jnj_RestructuringAndRelatedCostIntangibleAssets_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets_lbl" xml:lang="en-US">Restructuring and related cost, intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets_lbl" xml:lang="en-US">Asset write-offs related to intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets_lbl" xml:lang="en-US">Restructuring and related cost, intangible assets</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostInventory" xlink:label="jnj_RestructuringAndRelatedCostInventory" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RestructuringAndRelatedCostInventory" xlink:to="jnj_RestructuringAndRelatedCostInventory_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RestructuringAndRelatedCostInventory_lbl" xml:lang="en-US">Restructuring and related cost, inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RestructuringAndRelatedCostInventory_lbl" xml:lang="en-US">Asset write-offs related to inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RestructuringAndRelatedCostInventory_lbl" xml:lang="en-US">Restructuring and related cost, inventory</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage_lbl" xml:lang="en-US">Business acquisition cost of acquired entity stock issued percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage_lbl" xml:lang="en-US">Business acquisition cost of acquired entity stock issued percentage.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">July 3, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">January 2, 2011</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US">July 3, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US">January 2, 2011</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" xml:lang="en-US">July 3, 2011</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" xml:lang="en-US">January 2, 2011</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_lbl" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RealizedGainOnOptionNotDesignatedAsHedge" xlink:label="jnj_RealizedGainOnOptionNotDesignatedAsHedge" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RealizedGainOnOptionNotDesignatedAsHedge" xlink:to="jnj_RealizedGainOnOptionNotDesignatedAsHedge_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RealizedGainOnOptionNotDesignatedAsHedge_lbl" xml:lang="en-US">Realized Gain On Option Not Designated As Hedge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RealizedGainOnOptionNotDesignatedAsHedge_lbl" xml:lang="en-US">Realized gain on option not designated as hedge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RealizedGainOnOptionNotDesignatedAsHedge_lbl" xml:lang="en-US">Realized gain on option not designated as hedge.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Foreign Currency Translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Securities Available for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Employee Benefit Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Derivatives &amp; Hedges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Total Accumulated Other Comprehensive Income/(Loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized gain (loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax_lbl" xml:lang="en-US">Net amount reclassed to net earnings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets_lbl" xml:lang="en-US">Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets_lbl" xml:lang="en-US">Acquisition price allocated to amortizable intangible assets</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationExpense" xlink:label="jnj_LitigationExpense" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationExpense" xlink:to="jnj_LitigationExpense_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationExpense_lbl" xml:lang="en-US">Litigation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationExpense_lbl" xml:lang="en-US">Litigation expense.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationLoss" xlink:label="jnj_LitigationLoss" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_LitigationLoss" xlink:to="jnj_LitigationLoss_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_LitigationLoss_lbl" xml:lang="en-US">Litigation Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_LitigationLoss_lbl" xml:lang="en-US">Litigation loss.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CordisRestructuringMember" xlink:label="jnj_CordisRestructuringMember" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_CordisRestructuringMember" xlink:to="jnj_CordisRestructuringMember_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_CordisRestructuringMember_lbl" xml:lang="en-US">Cordis Restructuring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_CordisRestructuringMember_lbl" xml:lang="en-US">Cordis restructuring.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" xlink:label="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" xlink:to="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets_lbl" xml:lang="en-US">Reclassifed In Process Research And Development to Amortizable Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets_lbl" xml:lang="en-US">Purchased in process research and development to amortizable intangibles to reflect commercialization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets_lbl" xml:lang="en-US">Reclassifed in process research and development to amortizable assets.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AwardedDamagesReversed" xlink:label="jnj_AwardedDamagesReversed" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_AwardedDamagesReversed" xlink:to="jnj_AwardedDamagesReversed_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_AwardedDamagesReversed_lbl" xml:lang="en-US">Awarded Damages Reversed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_AwardedDamagesReversed_lbl" xml:lang="en-US">Approximate damages initially awarded to Centocor, then subsequently reversed by the Court of Appeals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_AwardedDamagesReversed_lbl" xml:lang="en-US">Awarded damages reversed.</label>
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringPlanOf2009Member" xlink:label="jnj_RestructuringPlanOf2009Member" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jnj_RestructuringPlanOf2009Member" xlink:to="jnj_RestructuringPlanOf2009Member_lbl" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jnj_RestructuringPlanOf2009Member_lbl" xml:lang="en-US">Restructuring Plan of 2009 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jnj_RestructuringPlanOf2009Member_lbl" xml:lang="en-US">2009 Restructuring Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jnj_RestructuringPlanOf2009Member_lbl" xml:lang="en-US">Restructuring Plan of 2009 [Member]</label>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>jnj-20110703_pre.xml
<DESCRIPTION>EX-101 PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Bowne Tagger XBRL Enabler by Bowne Software version 10.0.0.56-->
<!--Based on XBRL 2.1-->
<!--Modified on: 8/9/2011 12:05:36 PM-->
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://jnj.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="jnj-20110703.xsd#DocumentAndEntityInformation" />
  <roleRef roleURI="http://jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#InventoriesTables" />
  <roleRef roleURI="http://jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#InventoriesDetails" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillTables" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillDetails" />
  <roleRef roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20110703.xsd#SummaryOfSignificantAccountingPoliciesPolicies" />
  <roleRef roleURI="http://jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringTables" />
  <roleRef roleURI="http://jnj.com/role/RestructuringDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetails" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasTables" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareTables" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareDetails" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeTables" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeDetails" />
  <roleRef roleURI="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#BusinessCombinationsAndDivestituresDetails" />
  <roleRef roleURI="http://jnj.com/role/LegalProceedingDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#LegalProceedingDetails" />
  <roleRef roleURI="http://jnj.com/role/BalanceSheets" xlink:type="simple" xlink:href="jnj-20110703.xsd#BalanceSheets" />
  <roleRef roleURI="http://jnj.com/role/BalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20110703.xsd#BalanceSheetsParenthetical" />
  <roleRef roleURI="http://jnj.com/role/StatementsOfEarnings" xlink:type="simple" xlink:href="jnj-20110703.xsd#StatementsOfEarnings" />
  <roleRef roleURI="http://jnj.com/role/StatementsOfCashFlows" xlink:type="simple" xlink:href="jnj-20110703.xsd#StatementsOfCashFlows" />
  <roleRef roleURI="http://jnj.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20110703.xsd#SummaryOfSignificantAccountingPolicies" />
  <roleRef roleURI="http://jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20110703.xsd#Inventories" />
  <roleRef roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwill" xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwill" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurements" />
  <roleRef roleURI="http://jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeTaxes" />
  <roleRef roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncome" />
  <roleRef roleURI="http://jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShare" />
  <roleRef roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas" xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreas" />
  <roleRef roleURI="http://jnj.com/role/BusinessCombinationsAndDivestitures" xlink:type="simple" xlink:href="jnj-20110703.xsd#BusinessCombinationsAndDivestitures" />
  <roleRef roleURI="http://jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20110703.xsd#LegalProceedings" />
  <roleRef roleURI="http://jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20110703.xsd#Restructuring" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsTables" />
  <roleRef roleURI="http://jnj.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SubsequentEvents" roleURI="http://jnj.com/role/SubsequentEvents" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlans" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlans" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansTables" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansTables" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetails" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails1" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetailsTextuals" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetailsTextuals" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetailsTextuals" roleURI="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeTaxesDetailsTextuals" roleURI="http://jnj.com/role/IncomeTaxesDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IncomeStatementPercentageToSales" roleURI="http://jnj.com/role/IncomeStatementPercentageToSales" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails2" roleURI="http://jnj.com/role/FairValueMeasurementsDetails2" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails2" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillDetailsTextuals" roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails1" roleURI="http://jnj.com/role/FairValueMeasurementsDetails1" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#EarningsPerShareDetailsTextuals" roleURI="http://jnj.com/role/EarningsPerShareDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetailsTextuals" roleURI="http://jnj.com/role/RestructuringDetailsTextuals" />
  <roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#AccumulatedOtherComprehensiveIncomeDetailsTextuals" roleURI="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals" />
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/DocumentAndEntityInformation" xlink:title="00 - Document - Document and Entity Information">
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_DocumentAndEntityInformationAbstract" xlink:label="jnj_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_633653622982031250" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_633653622982031250" use="optional" priority="1" order="280" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_633653624786562500" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus_633653624786562500" use="optional" priority="2" order="240" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_633653624498437500" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory_633653624498437500" use="optional" priority="2" order="220" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_633653624983750000" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers_633653624983750000" use="optional" priority="2" order="200" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_633653625215937500" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer_633653625215937500" use="optional" priority="2" order="180" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_633653625418281250" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate_633653625418281250" use="optional" priority="1" order="160" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_DocumentFiscalPeriodFocus" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="loc_DocumentFiscalPeriodFocus" use="optional" order="140" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_DocumentFiscalYearFocus" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="loc_DocumentFiscalYearFocus" use="optional" order="120" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_633653625674375000" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_633653625674375000" use="optional" priority="1" order="100" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_633653625785156250" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_633653625785156250" use="optional" priority="1" order="80" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_633653625855468750" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_633653625855468750" use="optional" priority="1" order="60" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_633653625998281250" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_633653625998281250" use="optional" priority="1" order="40" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_633653626079062500" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_633653626079062500" use="optional" priority="1" order="20" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_EntityPublicFloat" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DocumentAndEntityInformationAbstract" xlink:to="loc_EntityPublicFloat" order="260" use="optional" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/InventoriesTables" xlink:title="0502 - Disclosure - Inventories (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_ScheduleOfInventoryCurrentTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryDisclosureAbstract" xlink:to="loc_ScheduleOfInventoryCurrentTableTextBlock" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/InventoriesDetails" xlink:title="0602 - Disclosure - Inventories (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="loc_InventoryNetAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryDisclosureAbstract" xlink:to="loc_InventoryNetAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="loc_InventoryRawMaterialsAndSupplies" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryNetAbstract" xlink:to="loc_InventoryRawMaterialsAndSupplies" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_InventoryWorkInProcess" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryNetAbstract" xlink:to="loc_InventoryWorkInProcess" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_InventoryFinishedGoods" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryNetAbstract" xlink:to="loc_InventoryFinishedGoods" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_InventoryNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryNetAbstract" xlink:to="loc_InventoryNet" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillTables" xlink:title="0503 - Disclosure - Intangible Assets and Goodwill (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_ScheduleOfGoodwillTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_ScheduleOfGoodwillTextBlock" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_ScheduleOfGoodwillTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_ScheduleOfGoodwillTable" order="2.5" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_StatementBusinessSegmentsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfGoodwillTable" xlink:to="loc_StatementBusinessSegmentsAxis" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_SegmentDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementBusinessSegmentsAxis" xlink:to="loc_SegmentDomain" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_GoodwillLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfGoodwillTable" xlink:to="loc_GoodwillLineItems" order="40" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_GoodwillRollForward" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillLineItems" xlink:to="loc_GoodwillRollForward" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillRollForward" xlink:to="us-gaap_Goodwill_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_GoodwillAcquiredDuringPeriod" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillRollForward" xlink:to="loc_GoodwillAcquiredDuringPeriod" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillOtherChanges" xlink:label="loc_GoodwillOtherChanges" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillRollForward" xlink:to="loc_GoodwillOtherChanges" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_Goodwill" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillRollForward" xlink:to="loc_Goodwill" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_ConsumerMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_IntangibleAssetsNetExcludingGoodwillAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_IntangibleAssetsNetExcludingGoodwillAbstract" order="1.25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_FiniteLivedIntangibleAssetsNetAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="loc_FiniteLivedIntangibleAssetsNetAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksGross" xlink:label="jnj_FiniteLivedPatentsAndTrademarksGross" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="jnj_FiniteLivedPatentsAndTrademarksGross" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" xlink:label="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FiniteLivedPatentsAndTrademarksNet" xlink:label="jnj_FiniteLivedPatentsAndTrademarksNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="jnj_FiniteLivedPatentsAndTrademarksNet" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_OtherFiniteLivedIntangibleAssetsGross" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="loc_OtherFiniteLivedIntangibleAssetsGross" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherFiniteLivedIntangibleAssetsNet" xlink:label="jnj_OtherFiniteLivedIntangibleAssetsNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="jnj_OtherFiniteLivedIntangibleAssetsNet" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="loc_IndefiniteLivedTrademarks" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="loc_IndefiniteLivedTrademarks" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:label="loc_OtherIndefiniteLivedIntangibleAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="loc_OtherIndefiniteLivedIntangibleAssets" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_IntangibleAssetsNetExcludingGoodwill" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="loc_IntangibleAssetsNetExcludingGoodwill" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="0401 - Disclosure - Summary of Significant Accounting Policies (Policies)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" xlink:label="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AccountingPoliciesAbstract" xlink:to="jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_RevenueRecognitionPolicyTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AccountingPoliciesAbstract" xlink:to="loc_RevenueRecognitionPolicyTextBlock" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" xlink:label="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AccountingPoliciesAbstract" xlink:to="jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_FairValueOfFinancialInstrumentsPolicy" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AccountingPoliciesAbstract" xlink:to="loc_FairValueOfFinancialInstrumentsPolicy" order="7.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringTables" xlink:title="0512 - Disclosure - Restructuring (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_RestructuringAndRelatedActivitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringAndRelatedActivitiesAbstract" xlink:to="loc_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_RestructuringAndRelatedActivitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_ScheduleOfRestructuringAndRelatedCostsTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringAndRelatedActivitiesAbstract" xlink:to="loc_ScheduleOfRestructuringAndRelatedCostsTable" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_RestructuringCostAndReserveAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_RestructuringCostAndReserveAxis" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_TypeOfRestructuringDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveAxis" xlink:to="loc_TypeOfRestructuringDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_EmployeeSeveranceMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TypeOfRestructuringDomain" xlink:to="loc_EmployeeSeveranceMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_RestructuringCostAndReserveLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_RestructuringCostAndReserveLineItems" order="40" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_RestructuringReserveRollForward" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_RestructuringReserveRollForward" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_RestructuringReserve_1" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringReserveRollForward" xlink:to="loc_RestructuringReserve_1" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveSettledWithCash" xlink:label="loc_RestructuringReserveSettledWithCash" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringReserveRollForward" xlink:to="loc_RestructuringReserveSettledWithCash" order="15" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_RestructuringReserve" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringReserveRollForward" xlink:to="loc_RestructuringReserve" order="17.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables" xlink:title="0509 - Disclosure - Segments of Business and Geographic Areas (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SaleByGeographicAreaTableTextBlock" xlink:label="jnj_SaleByGeographicAreaTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="jnj_SaleByGeographicAreaTableTextBlock" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:label="jnj_SalesBySegmentOfBusinessTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="jnj_SalesBySegmentOfBusinessTableTextBlock" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_ScheduleOfSegmentReportingInformationBySegmentTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_StatementBusinessSegmentsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_StatementBusinessSegmentsAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_SegmentDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementBusinessSegmentsAxis" xlink:to="loc_SegmentDomain" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_ConsumerMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_StatementGeographicalAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_StatementGeographicalAxis" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_SegmentGeographicalDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementGeographicalAxis" xlink:to="loc_SegmentGeographicalDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_USMember" xlink:label="jnj_USMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="jnj_USMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InternationalMember" xlink:label="jnj_InternationalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="jnj_InternationalMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_SegmentReportingInformationLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_SegmentReportingInformationLineItems" order="60" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract" xlink:label="loc_SegmentReportingInformationRevenueAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationLineItems" xlink:to="loc_SegmentReportingInformationRevenueAbstract" order="2.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_SalesRevenueGoodsNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationRevenueAbstract" xlink:to="loc_SalesRevenueGoodsNet" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationRevenueAbstract" xlink:to="jnj_PercentageChangeInSalesBySegmentOfBusiness" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareTables" xlink:title="0508 - Disclosure - Earnings Per Share (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock" xlink:label="loc_ScheduleOfEarningsPerShareReconciliationTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="loc_ScheduleOfEarningsPerShareReconciliationTableTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareDetails" xlink:title="0608 - Disclosure - Earnings Per Share (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_EarningsPerShareReconciliationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="loc_EarningsPerShareReconciliationAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_EarningsPerShareBasic" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_EarningsPerShareBasic" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_WeightedAverageNumberOfSharesOutstandingBasic" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_WeightedAverageNumberOfSharesOutstandingBasic" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:label="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_WeightedAverageNumberOfDilutedSharesOutstanding" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_EarningsPerShareDiluted" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareReconciliationAbstract" xlink:to="loc_EarningsPerShareDiluted" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:title="0507 - Disclosure - Accumulated Other Comprehensive Income (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:title="0607 - Disclosure - Accumulated Other Comprehensive Income (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" order="37.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" order="38.75" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" xlink:label="loc_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax" order="35" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease" order="37.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="39.375" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_2" order="57.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="45" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" xlink:label="loc_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax" order="65" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessCombinationsAbstract" xlink:to="loc_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_BusinessAcquisitionAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_BusinessAcquisitionAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_BusinessAcquisitionAcquireeDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessAcquisitionAxis" xlink:to="loc_BusinessAcquisitionAcquireeDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CrucellNvMember" xlink:label="jnj_CrucellNvMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_CrucellNvMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AcclarentIncMember" xlink:label="jnj_AcclarentIncMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_AcclarentIncMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_BusinessAcquisitionLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_BusinessAcquisitionLineItems" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessAcquisitionLineItems" xlink:to="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xlink:label="loc_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="loc_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xlink:label="loc_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="loc_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SynthesIncMember" xlink:label="jnj_SynthesIncMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_SynthesIncMember" order="60" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" xlink:label="loc_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessCombinationsAbstract" xlink:to="loc_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid" xlink:label="loc_BusinessAcquisitionCostOfAcquiredEntityCashPaid" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessCombinationsAbstract" xlink:to="loc_BusinessAcquisitionCostOfAcquiredEntityCashPaid" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" order="110" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" order="140" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" order="160" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" xlink:label="loc_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:to="loc_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_LossContingenciesTable" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesAxis" xlink:label="jnj_LitigationSettlementByCompaniesAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesTable" xlink:to="jnj_LitigationSettlementByCompaniesAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesDomain" xlink:label="jnj_LitigationSettlementByCompaniesDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LitigationSettlementByCompaniesAxis" xlink:to="jnj_LitigationSettlementByCompaniesDomain" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MerckMember" xlink:label="jnj_MerckMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_MerckMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CentocorOrthoBiotechIncMember" xlink:label="jnj_CentocorOrthoBiotechIncMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_CentocorOrthoBiotechIncMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_LossContingenciesByNatureOfContingencyAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesTable" xlink:to="loc_LossContingenciesByNatureOfContingencyAxis" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_LossContingencyNatureDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesByNatureOfContingencyAxis" xlink:to="loc_LossContingencyNatureDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestitutionMember" xlink:label="jnj_RestitutionMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingencyNatureDomain" xlink:to="jnj_RestitutionMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CivilPenaltiesMember" xlink:label="jnj_CivilPenaltiesMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingencyNatureDomain" xlink:to="jnj_CivilPenaltiesMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_LossContingenciesLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesTable" xlink:to="loc_LossContingenciesLineItems" order="60" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfContributionToIncomeProfitSplit" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesLineItems" xlink:to="jnj_PercentageOfContributionToIncomeProfitSplit" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesLineItems" xlink:to="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AmountOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesLineItems" xlink:to="jnj_AmountOfRevenueRepresentedByRetainedTerritories" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LegalProceedingTextualsAbstract" xlink:label="jnj_LegalProceedingTextualsAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AmountGivenToPlaintiffByJury" xlink:label="jnj_AmountGivenToPlaintiffByJury" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_AmountGivenToPlaintiffByJury" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementPreJudgmentInterest" xlink:label="jnj_LitigationSettlementPreJudgmentInterest" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_LitigationSettlementPreJudgmentInterest" order="31.5625" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" xlink:label="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs" order="35.07813" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" xlink:label="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest" order="35.95703" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" xlink:label="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories" order="113.0762" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OneTimePaymentReceivedByCompany" xlink:label="jnj_OneTimePaymentReceivedByCompany" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_OneTimePaymentReceivedByCompany" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_LossContingenciesTable" order="20" use="optional" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="jnj_LegalProceedingTextualsAbstract" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RisperdalMember" xlink:label="jnj_RisperdalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_RisperdalMember" order="50" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AverageWholesalePriceLitigationMember" xlink:label="jnj_AverageWholesalePriceLitigationMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_AverageWholesalePriceLitigationMember" order="45" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_StatementBusinessSegmentsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesTable" xlink:to="loc_StatementBusinessSegmentsAxis" order="50" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_SegmentDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementBusinessSegmentsAxis" xlink:to="loc_SegmentDomain" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_VerdictAgainstCompany" xlink:label="jnj_VerdictAgainstCompany" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_VerdictAgainstCompany" order="20.78125" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_LitigationSettlementExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesLineItems" xlink:to="loc_LitigationSettlementExpense" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationLoss" xlink:label="jnj_LitigationLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LossContingenciesLineItems" xlink:to="jnj_LitigationLoss" order="30" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AwardedDamagesReversed" xlink:label="jnj_AwardedDamagesReversed" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_LegalProceedingTextualsAbstract" xlink:to="jnj_AwardedDamagesReversed" order="34.101565" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/BalanceSheets" xlink:title="0110 - Statement - Consolidated Balance Sheets (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_AssetsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfFinancialPositionAbstract" xlink:to="loc_AssetsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_AssetsCurrentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_AssetsCurrentAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_CashAndCashEquivalentsAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_AvailableForSaleSecuritiesCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_AvailableForSaleSecuritiesCurrent" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_AccountsReceivableNetCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_AccountsReceivableNetCurrent" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_InventoryNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_InventoryNet" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="loc_DeferredTaxAssetsNetCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_DeferredTaxAssetsNetCurrent" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_AssetsCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_AssetsCurrent" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_PropertyPlantAndEquipmentNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_PropertyPlantAndEquipmentNet" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_IntangibleAssetsNetExcludingGoodwill" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_IntangibleAssetsNetExcludingGoodwill" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="us-gaap_Goodwill_2" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="loc_DeferredTaxAssetsNetNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_DeferredTaxAssetsNetNoncurrent" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_OtherAssetsNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_OtherAssetsNoncurrent" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_Assets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_Assets" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfFinancialPositionAbstract" xlink:to="loc_LiabilitiesAndStockholdersEquityAbstract" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_LiabilitiesAndStockholdersEquity" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_LiabilitiesAndStockholdersEquity" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_StockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_StockholdersEquityAbstract" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_Liabilities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_Liabilities" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_OtherLiabilitiesNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_OtherLiabilitiesNoncurrent" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_DeferredTaxLiabilitiesNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_DeferredTaxLiabilitiesNoncurrent" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_LongTermDebtNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_LongTermDebtNoncurrent" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_LiabilitiesCurrentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_LiabilitiesCurrentAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_ShortTermBorrowings" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_ShortTermBorrowings" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_AccountsPayableCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_AccountsPayableCurrent" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_AccruedLiabilitiesCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_AccruedLiabilitiesCurrent" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AccruedRebatesReturnsAndPromotions" xlink:label="jnj_AccruedRebatesReturnsAndPromotions" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="jnj_AccruedRebatesReturnsAndPromotions" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_EmployeeRelatedLiabilitiesCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_EmployeeRelatedLiabilitiesCurrent" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_AccruedIncomeTaxesCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_AccruedIncomeTaxesCurrent" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_LiabilitiesCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="loc_LiabilitiesCurrent" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_TreasuryStockValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_TreasuryStockValue" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_PropertyPlantAndEquipmentGross" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_PropertyPlantAndEquipmentGross" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsAbstract" xlink:to="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="35" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_CommonStockValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_CommonStockValue" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_RetainedEarningsAccumulatedDeficit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_RetainedEarningsAccumulatedDeficit" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_PrepaidExpenseAndOtherAssetsCurrent" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/BalanceSheetsParenthetical" xlink:title="0111 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_AssetsCurrentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AssetsCurrentAbstract" xlink:to="loc_AllowanceForDoubtfulAccountsReceivableCurrent" use="optional" priority="1" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_StockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfFinancialPositionAbstract" xlink:to="loc_StockholdersEquityAbstract" use="optional" priority="1" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_CommonStockParOrStatedValuePerShare" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_CommonStockParOrStatedValuePerShare" use="optional" priority="1" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_CommonStockSharesAuthorized" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_CommonStockSharesAuthorized" use="optional" priority="1" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_CommonStockSharesIssued" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_CommonStockSharesIssued" use="optional" priority="1" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_TreasuryStockShares" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StockholdersEquityAbstract" xlink:to="loc_TreasuryStockShares" use="optional" priority="1" order="120" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfFinancialPositionAbstract" xlink:to="loc_AssetsCurrentAbstract" use="optional" priority="1" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/StatementsOfEarnings" xlink:title="0120 - Statement - Consolidated Statements of Earnings (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="loc_CommonStockDividendsPerShareCashPaid" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_CommonStockDividendsPerShareCashPaid" use="optional" order="300" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_ProfitLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_ProfitLoss" use="optional" priority="1" order="260" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_IncomeTaxExpenseBenefit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_IncomeTaxExpenseBenefit" use="optional" priority="1" order="240" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" use="optional" priority="1" order="220" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_OtherNonoperatingIncomeExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_OtherNonoperatingIncomeExpense" use="optional" priority="1" order="180" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_InterestExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_InterestExpense" use="optional" priority="1" order="160" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_InvestmentIncomeInterest" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_InvestmentIncomeInterest" use="optional" priority="1" order="140" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" use="optional" priority="1" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_SellingGeneralAndAdministrativeExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_SellingGeneralAndAdministrativeExpense" use="optional" priority="1" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_GrossProfit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_GrossProfit" use="optional" priority="1" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_CostOfGoodsSold" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_CostOfGoodsSold" use="optional" priority="1" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_SalesRevenueGoodsNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_SalesRevenueGoodsNet" use="optional" priority="1" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_EarningsPerShareAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_EarningsPerShareAbstract" order="262.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_EarningsPerShareBasic" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="loc_EarningsPerShareBasic" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_EarningsPerShareDiluted" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="loc_EarningsPerShareDiluted" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_WeightedAverageNumberOfSharesOutstandingAbstract" order="305" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_WeightedAverageNumberOfSharesOutstandingBasic" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_WeightedAverageNumberOfSharesOutstandingBasic" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_WeightedAverageNumberOfDilutedSharesOutstanding" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_RestructuringCharges" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="loc_RestructuringCharges" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/StatementsOfCashFlows" xlink:title="0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_ProvisionForDoubtfulAccounts" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ProvisionForDoubtfulAccounts" use="optional" order="120" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_DeferredIncomeTaxExpenseBenefit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_DeferredIncomeTaxExpenseBenefit" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_ShareBasedCompensation" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ShareBasedCompensation" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_DepreciationDepletionAndAmortization" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_DepreciationDepletionAndAmortization" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_IncreaseDecreaseInOtherOperatingLiabilities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_IncreaseDecreaseInOtherOperatingLiabilities" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_IncreaseDecreaseInOtherOperatingAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_IncreaseDecreaseInOtherOperatingAssets" use="optional" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" priority="1" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_IncreaseDecreaseInInventories" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_IncreaseDecreaseInInventories" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_IncreaseDecreaseInAccountsReceivable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_IncreaseDecreaseInAccountsReceivable" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_NetCashProvidedByUsedInOperatingActivities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_ProfitLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ProfitLoss" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_NetCashProvidedByUsedInInvestingActivities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities" use="optional" order="140" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_PaymentsForProceedsFromOtherInvestingActivities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_PaymentsForProceedsFromOtherInvestingActivities" use="optional" order="120" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_PaymentsToAcquireInvestments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_PaymentsToAcquireInvestments" use="optional" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" use="optional" order="60" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_ProceedsFromSaleOfProductiveAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_ProceedsFromSaleOfProductiveAssets" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_NetCashProvidedByUsedInFinancingActivities" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities" use="optional" order="160" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_ProceedsFromStockOptionsExercised" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ProceedsFromStockOptionsExercised" use="optional" order="140" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_RepaymentsOfLongTermDebt" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RepaymentsOfLongTermDebt" use="optional" order="120" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_RepaymentsOfShortTermDebt" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RepaymentsOfShortTermDebt" use="optional" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_ProceedsFromShortTermDebt" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ProceedsFromShortTermDebt" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_PaymentsForRepurchaseOfCommonStock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_PaymentsForRepurchaseOfCommonStock" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends" xlink:label="loc_PaymentsOfOrdinaryDividends" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_PaymentsOfOrdinaryDividends" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_ProceedsFromIssuanceOfLongTermDebt" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ProceedsFromIssuanceOfLongTermDebt" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AcquisitionsAbstract" xlink:label="jnj_AcquisitionsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="jnj_AcquisitionsAbstract" use="optional" priority="1" order="200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_CashAndCashEquivalentsAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="1" order="140" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_CashAndCashEquivalentsPeriodIncreaseDecrease" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="loc_EffectOfExchangeRateOnCashAndCashEquivalents" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="loc_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_AcquisitionsAbstract" xlink:to="loc_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" order="16.25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="loc_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_AcquisitionsAbstract" xlink:to="loc_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" order="12.5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:label="loc_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_AcquisitionsAbstract" xlink:to="loc_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" order="11.25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="0201 - Disclosure - Summary of Significant Accounting Policies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_SignificantAccountingPoliciesTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_AccountingPoliciesAbstract" xlink:to="loc_SignificantAccountingPoliciesTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/Inventories" xlink:title="0202 - Disclosure - Inventories">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_InventoryDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_InventoryDisclosureAbstract" xlink:to="loc_InventoryDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwill" xlink:title="0203 - Disclosure - Intangible Assets and Goodwill">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurements" xlink:title="0204 - Disclosure - Fair Value Measurements">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_FairValueDisclosuresTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_FairValueDisclosuresTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeTaxes" xlink:title="0205 - Disclosure - Income Taxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_IncomeTaxDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeTaxDisclosureAbstract" xlink:to="loc_IncomeTaxDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:title="0207 - Disclosure - Accumulated Other Comprehensive Income">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_ComprehensiveIncomeNoteTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="loc_ComprehensiveIncomeNoteTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShare" xlink:title="0208 - Disclosure - Earnings Per Share">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_EarningsPerShareTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="loc_EarningsPerShareTextBlock" use="optional" priority="1" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas" xlink:title="0209 - Disclosure - Segments of Business and Geographic Areas">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_SegmentReportingDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_SegmentReportingDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestitures" xlink:title="0210 - Disclosure - Business Combinations and Divestitures">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_BusinessCombinationDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_BusinessCombinationsAbstract" xlink:to="loc_BusinessCombinationDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedings" xlink:title="0211 - Disclosure - Legal Proceedings">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_LegalMattersAndContingenciesTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_LegalMattersAndContingenciesTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/Restructuring" xlink:title="0212 - Disclosure - Restructuring">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_RestructuringAndRelatedActivitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_RestructuringAndRelatedActivitiesDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringAndRelatedActivitiesAbstract" xlink:to="loc_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsTables" xlink:title="0504 - Disclosure - Fair Value Measurements (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_FairValueByBalanceSheetGroupingTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_FairValueByBalanceSheetGroupingTextBlock" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_DerivativeInstrumentsGainLossLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_DerivativeInstrumentsGainLossLineItems" use="optional" order="60" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:label="loc_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" use="optional" order="40" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:label="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:to="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" use="optional" order="20" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_SalesMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="loc_SalesMember" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_CostOfSalesMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="loc_CostOfSalesMember" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchExpenseMember" xlink:label="jnj_ResearchExpenseMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_ResearchExpenseMember" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestIncomeExpenseNetMember" xlink:label="jnj_InterestIncomeExpenseNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_InterestIncomeExpenseNetMember" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeTwoNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" use="optional" order="120" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeThreeNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" use="optional" order="140" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeSixNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeSixNetMember" use="optional" order="180" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseNetMember" xlink:label="jnj_OtherInterestIncomeExpenseNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseNetMember" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeFourNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeFourNetMember" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_DerivativeInstrumentRiskAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_DerivativeInstrumentRiskAxis" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_DerivativeContractTypeDomain_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentRiskAxis" xlink:to="loc_DerivativeContractTypeDomain_2" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_ForeignExchangeContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeContractTypeDomain_2" xlink:to="loc_ForeignExchangeContractMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_CrossCurrencyInterestRateContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeContractTypeDomain_2" xlink:to="loc_CrossCurrencyInterestRateContractMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossLineItems" xlink:to="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInIncomeNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="loc_DerivativeInstrumentsGainLossRecognizedInIncomeNet" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:label="loc_DerivativeNetHedgeIneffectivenessGainLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="loc_DerivativeNetHedgeIneffectivenessGainLoss" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="20" use="optional" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SubsequentEvents" xlink:title="0213 - Disclosure - Subsequent Events">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_SubsequentEventsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_SubsequentEventsTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SubsequentEventsAbstract" xlink:to="loc_SubsequentEventsTextBlock" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlans" xlink:title="0206 - Disclosure - Pensions and Other Postretirement Benefits">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CompensationAndRetirementDisclosureAbstract" xlink:to="loc_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansTables" xlink:title="0506 - Disclosure - Pensions and Other Postretirement Benefits (Tables)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_ScheduleOfNetBenefitCostsTableTextBlock" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CompensationAndRetirementDisclosureAbstract" xlink:to="loc_ScheduleOfNetBenefitCostsTableTextBlock" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CompensationAndRetirementDisclosureAbstract" xlink:to="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_DefinedBenefitPlansDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_DefinedBenefitPlansDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="loc_PensionPlansDefinedBenefitMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDomain" xlink:to="loc_PensionPlansDefinedBenefitMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:label="loc_OtherPostretirementBenefitPlansDefinedBenefitMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDomain" xlink:to="loc_OtherPostretirementBenefitPlansDefinedBenefitMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_DefinedBenefitPlanDisclosureLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_DefinedBenefitPlanDisclosureLineItems" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlanDisclosureLineItems" xlink:to="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_DefinedBenefitPlanServiceCost" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanServiceCost" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_DefinedBenefitPlanInterestCost" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanInterestCost" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanExpectedReturnOnPlanAssets" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:label="loc_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xlink:label="loc_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_DefinedBenefitPlanAmortizationOfGainsLosses" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanAmortizationOfGainsLosses" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_DefinedBenefitPlanNetPeriodicBenefitCost" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_DefinedBenefitPlanNetPeriodicBenefitCost" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_ScheduleOfSegmentReportingInformationBySegmentTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_StatementBusinessSegmentsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_StatementBusinessSegmentsAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_SegmentDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementBusinessSegmentsAxis" xlink:to="loc_SegmentDomain" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_ConsumerMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_SegmentReportingInformationLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_SegmentReportingInformationLineItems" order="60" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:label="loc_SegmentReportingInformationOperatingIncomeLossAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationLineItems" xlink:to="loc_SegmentReportingInformationOperatingIncomeLossAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_OperatingIncomeLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="loc_OperatingIncomeLoss" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLoss" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="jnj_PercentageChangeInOperatingIncomeLoss" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ExpenseNotAllocatedToSegments" xlink:label="jnj_ExpenseNotAllocatedToSegments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="jnj_ExpenseNotAllocatedToSegments" order="45" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="65" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" order="85" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_ScheduleOfSegmentReportingInformationBySegmentTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_StatementBusinessSegmentsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_StatementBusinessSegmentsAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_SegmentDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementBusinessSegmentsAxis" xlink:to="loc_SegmentDomain" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_SegmentReportingInformationLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_SegmentReportingInformationLineItems" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingInformationLineItems" xlink:to="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_RestructuringCharges" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:to="loc_RestructuringCharges" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationAndRecallExpense" xlink:label="jnj_LitigationAndRecallExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:to="jnj_LitigationAndRecallExpense" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationExpense" xlink:label="jnj_LitigationExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:to="jnj_LitigationExpense" order="55" use="optional" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CompensationAndRetirementDisclosureAbstract" xlink:to="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_DefinedBenefitPlansDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_DefinedBenefitPlansDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xlink:label="loc_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDomain" xlink:to="loc_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignPensionPlansDefinedBenefitMember" xlink:label="loc_ForeignPensionPlansDefinedBenefitMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlansDomain" xlink:to="loc_ForeignPensionPlansDefinedBenefitMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_DefinedBenefitPlanDisclosureLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_DefinedBenefitPlanDisclosureLineItems" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PensionsAndOtherBenefitPlansTextualsAbstract" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DefinedBenefitPlanDisclosureLineItems" xlink:to="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionContributions" xlink:label="loc_PensionContributions" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" xlink:to="loc_PensionContributions" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_HedgingRelationshipDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="loc_HedgingRelationshipDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_ForeignExchangeContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_HedgingRelationshipDomain" xlink:to="loc_ForeignExchangeContractMember" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_CrossCurrencyInterestRateContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_HedgingRelationshipDomain" xlink:to="loc_CrossCurrencyInterestRateContractMember" order="40" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FairValueMeasurementsTextualsAbstract" xlink:label="jnj_FairValueMeasurementsTextualsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" order="7.5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:label="loc_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" order="11.25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" xlink:label="loc_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge" order="13.125" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" order="14.0625" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_DebtInstrumentInterestRateDuringPeriod" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_DebtInstrumentInterestRateDuringPeriod" order="14.76563" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="loc_EquityMethodInvestmentsFairValueDisclosure" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="loc_EquityMethodInvestmentsFairValueDisclosure" order="14.29688" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="jnj_FairValueMeasurementsTextualsAbstract" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_DerivativeTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_DerivativeTable" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_DerivativeLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeTable" xlink:to="loc_DerivativeLineItems" order="20" use="optional" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeTable" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfForeignCurrencyDerivatives" xlink:label="loc_NotionalAmountOfForeignCurrencyDerivatives" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeLineItems" xlink:to="loc_NotionalAmountOfForeignCurrencyDerivatives" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfInterestRateDerivatives" xlink:label="loc_NotionalAmountOfInterestRateDerivatives" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeLineItems" xlink:to="loc_NotionalAmountOfInterestRateDerivatives" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent" xlink:label="loc_DerivativeAssetsNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeLineItems" xlink:to="loc_DerivativeAssetsNoncurrent" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_DerivativeLiabilitiesNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeLineItems" xlink:to="loc_DerivativeLiabilitiesNoncurrent" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RealizedGainOnOptionNotDesignatedAsHedge" xlink:label="jnj_RealizedGainOnOptionNotDesignatedAsHedge" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FairValueMeasurementsTextualsAbstract" xlink:to="jnj_RealizedGainOnOptionNotDesignatedAsHedge" order="3.75" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeTaxesDetailsTextuals" xlink:title="0605 - Disclosure - Income Taxes (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeTaxTextualsAbstract" xlink:label="jnj_IncomeTaxTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeTaxDisclosureAbstract" xlink:to="jnj_IncomeTaxTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_EffectiveIncomeTaxRateContinuingOperations" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IncomeTaxTextualsAbstract" xlink:to="loc_EffectiveIncomeTaxRateContinuingOperations" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IncomeStatementPercentageToSales" xlink:title="0121 - Statement - Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" xlink:label="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease" order="20" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CostOfGoodsSoldPercentageIncreaseDecrease" xlink:label="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_CostOfGoodsSoldPercentageIncreaseDecrease" order="40" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_GrossProfitPercentageIncreaseDecrease" xlink:label="jnj_GrossProfitPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_GrossProfitPercentageIncreaseDecrease" order="60" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" xlink:label="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease" order="80" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" xlink:label="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease" order="100" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" xlink:label="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_InvestmentIncomeInterestPercentageIncreaseDecrease" order="120" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestExpensePercentageIncreaseDecrease" xlink:label="jnj_InterestExpensePercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_InterestExpensePercentageIncreaseDecrease" order="140" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" xlink:label="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease" order="160" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" xlink:label="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease" order="180" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" xlink:label="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease" order="200" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ProfitLossPercentageIncreaseDecrease" xlink:label="jnj_ProfitLossPercentageIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_ProfitLossPercentageIncreaseDecrease" order="220" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringExpensesIncreaseDecrease" xlink:label="jnj_RestructuringExpensesIncreaseDecrease" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_IncomeStatementAbstract" xlink:to="jnj_RestructuringExpensesIncreaseDecrease" order="175" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_FairValueByBalanceSheetGroupingTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:label="loc_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueByBalanceSheetGroupingTable" xlink:to="loc_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_FairValueDisclosureItemAmountsDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:to="loc_FairValueDisclosureItemAmountsDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_CarryingReportedAmountFairValueDisclosureMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosureItemAmountsDomain" xlink:to="loc_CarryingReportedAmountFairValueDisclosureMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_EstimateOfFairValueFairValueDisclosureMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosureItemAmountsDomain" xlink:to="loc_EstimateOfFairValueFairValueDisclosureMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueByBalanceSheetGroupingTable" xlink:to="loc_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="40" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="loc_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:to="loc_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_Cash" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_Cash" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="loc_USGovernmentSecuritiesAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_USGovernmentSecuritiesAtCarryingValue" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherCashEquivalentsAtCarryingValue" xlink:label="loc_OtherCashEquivalentsAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_OtherCashEquivalentsAtCarryingValue" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_MoneyMarketFundsAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_MoneyMarketFundsAtCarryingValue" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="loc_TimeDepositsAtCarryingValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_TimeDepositsAtCarryingValue" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_CashCashEquivalentsAndShortTermInvestments" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="loc_CashCashEquivalentsAndShortTermInvestments" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="loc_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:to="loc_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_ShortTermBorrowings" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_ShortTermBorrowings" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_LongtermDebtTypeAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueByBalanceSheetGroupingTable" xlink:to="loc_LongtermDebtTypeAxis" order="30" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_LongtermDebtTypeDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeAxis" xlink:to="loc_LongtermDebtTypeDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodOneMember" xlink:label="jnj_NotesDuePeriodOneMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodOneMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwoMember" xlink:label="jnj_NotesDuePeriodTwoMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwoMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThreeMember" xlink:label="jnj_NotesDuePeriodThreeMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodThreeMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourteenMember" xlink:label="jnj_NotesDuePeriodFourteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFourteenMember" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourMember" xlink:label="jnj_NotesDuePeriodFourMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFourMember" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFiveMember" xlink:label="jnj_NotesDuePeriodFiveMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFiveMember" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixMember" xlink:label="jnj_NotesDuePeriodSixMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSixMember" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSevenMember" xlink:label="jnj_NotesDuePeriodSevenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSevenMember" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEightMember" xlink:label="jnj_NotesDuePeriodEightMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodEightMember" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineMember" xlink:label="jnj_NotesDuePeriodNineMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodNineMember" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTenMember" xlink:label="jnj_NotesDuePeriodTenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTenMember" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodElevenMember" xlink:label="jnj_NotesDuePeriodElevenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodElevenMember" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwelveMember" xlink:label="jnj_NotesDuePeriodTwelveMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwelveMember" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThirteenMember" xlink:label="jnj_NotesDuePeriodThirteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodThirteenMember" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFifteenMember" xlink:label="jnj_NotesDuePeriodFifteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFifteenMember" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="loc_LongTermDebtNoncurrentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="loc_LongTermDebtNoncurrentAbstract" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_LongTermDebtNoncurrent" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongTermDebtNoncurrentAbstract" xlink:to="loc_LongTermDebtNoncurrent" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_FairValueByBalanceSheetGroupingTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixteenMember" xlink:label="jnj_NotesDuePeriodSixteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSixteenMember" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSeventeenMember" xlink:label="jnj_NotesDuePeriodSeventeenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSeventeenMember" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEighteenMember" xlink:label="jnj_NotesDuePeriodEighteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodEighteenMember" order="51.25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyMember" xlink:label="jnj_NotesDuePeriodTwentyMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyMember" order="53.75" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyOneMember" xlink:label="jnj_NotesDuePeriodTwentyOneMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyOneMember" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyTwoMember" xlink:label="jnj_NotesDuePeriodTwentyTwoMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyTwoMember" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineteenMember" xlink:label="jnj_NotesDuePeriodNineteenMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodNineteenMember" order="53.125" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentReportingAbstract" xlink:to="loc_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_StatementGeographicalAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_StatementGeographicalAxis" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_SegmentGeographicalDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_StatementGeographicalAxis" xlink:to="loc_SegmentGeographicalDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_USMember" xlink:label="jnj_USMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="jnj_USMember" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_EuropeMember" xlink:label="jnj_EuropeMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="jnj_EuropeMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" xlink:label="loc_SegmentGeographicalGroupsOfCountriesGroupOneMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="loc_SegmentGeographicalGroupsOfCountriesGroupOneMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xlink:label="loc_SegmentGeographicalGroupsOfCountriesGroupTwoMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentGeographicalDomain" xlink:to="loc_SegmentGeographicalGroupsOfCountriesGroupTwoMember" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="loc_SegmentsGeographicalAreasAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_SegmentsGeographicalAreasAbstract" order="20" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesByGeographicArea" xlink:label="jnj_PercentageChangeInSalesByGeographicArea" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentsGeographicalAreasAbstract" xlink:to="jnj_PercentageChangeInSalesByGeographicArea" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_SalesRevenueGoodsNet" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SegmentsGeographicalAreasAbstract" xlink:to="loc_SalesRevenueGoodsNet" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals" xlink:title="06031 - Disclosure - Intangible Assets and Goodwill (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:label="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks" xlink:label="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks_2" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets" xlink:label="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets_2" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense" xlink:label="loc_FiniteLivedIntangibleAssetsAmortizationExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="loc_FiniteLivedIntangibleAssetsAmortizationExpense" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense" xlink:label="loc_FiniteLivedIntangibleAssetsFutureAmortizationExpense" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="loc_FiniteLivedIntangibleAssetsFutureAmortizationExpense" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" xlink:label="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets" order="2.5" use="optional" priority="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_DerivativesFairValueLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="loc_DerivativesFairValueLineItems" order="60" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_DerivativeInstrumentRiskAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="loc_DerivativeInstrumentRiskAxis" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_DerivativeContractTypeDomain_2" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentRiskAxis" xlink:to="loc_DerivativeContractTypeDomain_2" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_ForeignExchangeContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeContractTypeDomain_2" xlink:to="loc_ForeignExchangeContractMember" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_CrossCurrencyInterestRateContractMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeContractTypeDomain_2" xlink:to="loc_CrossCurrencyInterestRateContractMember" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_FairValueByFairValueHierarchyLevelAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis" order="25" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueByFairValueHierarchyLevelAxis" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_FairValueInputsLevel1Member" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_FairValueInputsLevel1Member" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_FairValueInputsLevel2Member" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_FairValueInputsLevel2Member" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_FairValueInputsLevel3Member" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_FairValueInputsLevel3Member" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract" xlink:label="loc_DerivativeInstrumentDetailAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativesFairValueLineItems" xlink:to="loc_DerivativeInstrumentDetailAbstract" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:label="loc_DerivativeInstrumentsInHedgesAssetsAtFairValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentDetailAbstract" xlink:to="loc_DerivativeInstrumentsInHedgesAssetsAtFairValue" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:label="loc_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentDetailAbstract" xlink:to="loc_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="loc_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentDetailAbstract" xlink:to="loc_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="loc_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentDetailAbstract" xlink:to="loc_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="loc_EquityMethodInvestmentsFairValueDisclosure" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeInstrumentDetailAbstract" xlink:to="loc_EquityMethodInvestmentsFairValueDisclosure" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FairValueDisclosuresAbstract" xlink:to="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SwissFrancOptionMember" xlink:label="jnj_SwissFrancOptionMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_DerivativeContractTypeDomain_2" xlink:to="jnj_SwissFrancOptionMember" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/EarningsPerShareDetailsTextuals" xlink:title="06081 - Disclosure - Earnings Per Share (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_EarningsPerShareTextualsAbstract" xlink:label="jnj_EarningsPerShareTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EarningsPerShareAbstract" xlink:to="jnj_EarningsPerShareTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_EarningsPerShareTextualsAbstract" xlink:to="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_RestructuringAndRelatedActivitiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_ScheduleOfRestructuringAndRelatedCostsTable" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringAndRelatedActivitiesAbstract" xlink:to="loc_ScheduleOfRestructuringAndRelatedCostsTable" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_RestructuringCostAndReserveAxis" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_RestructuringCostAndReserveAxis" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_TypeOfRestructuringDomain" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveAxis" xlink:to="loc_TypeOfRestructuringDomain" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_RestructuringCostAndReserveLineItems" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_RestructuringCostAndReserveLineItems" order="40" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_RestructuringCharges" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_RestructuringCharges" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CashPaymentsForRestructuring" xlink:label="jnj_CashPaymentsForRestructuring" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="jnj_CashPaymentsForRestructuring" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="loc_OtherRestructuringCosts" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_OtherRestructuringCosts" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessExitCosts" xlink:label="loc_BusinessExitCosts" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_BusinessExitCosts" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_PropertyPlantAndEquipmentDisposals" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_PropertyPlantAndEquipmentDisposals" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostIntangibleAssets" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="jnj_RestructuringAndRelatedCostIntangibleAssets" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostInventory" xlink:label="jnj_RestructuringAndRelatedCostInventory" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="jnj_RestructuringAndRelatedCostInventory" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:label="loc_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xlink:label="loc_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RestructuringCostAndReserveLineItems" xlink:to="loc_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CordisRestructuringMember" xlink:label="jnj_CordisRestructuringMember" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TypeOfRestructuringDomain" xlink:to="jnj_CordisRestructuringMember" order="40" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringPlanOf2009Member" xlink:label="jnj_RestructuringPlanOf2009Member" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TypeOfRestructuringDomain" xlink:to="jnj_RestructuringPlanOf2009Member" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals" xlink:title="06071 - Disclosure - Accumulated Other Comprehensive Income (Details Textuals)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_EquityAbstract" />
    <loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" xlink:label="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_EquityAbstract" xlink:to="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract" xlink:to="loc_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>jnj-20110703_def.xml
<DESCRIPTION>EX-101 DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created by RR Donnelley Tagger version 10.0.0.149; Copyright (C) RR Donnelley-->
<!--Based on XBRL 2.1-->
<link:linkbase xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#IntangibleAssetsAndGoodwillDetails" roleURI="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails" roleURI="http://jnj.com/role/FairValueMeasurementsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails1" roleURI="http://jnj.com/role/FairValueMeasurementsDetails1" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetails2" roleURI="http://jnj.com/role/FairValueMeasurementsDetails2" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#FairValueMeasurementsDetailsTextuals" roleURI="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetails" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#PensionsAndOtherBenefitPlansDetailsTextuals" roleURI="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails1" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetails2" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#SegmentsOfBusinessAndGeographicAreasDetailsTextuals" roleURI="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#BusinessCombinationsAndDivestituresDetails" roleURI="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#LegalProceedingDetails" roleURI="http://jnj.com/role/LegalProceedingDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetails" roleURI="http://jnj.com/role/RestructuringDetails" />
  <link:roleRef xlink:type="simple" xlink:href="jnj-20110703.xsd#RestructuringDetailsTextuals" roleURI="http://jnj.com/role/RestructuringDetailsTextuals" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_ConsumerMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:GoodwillLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GoodwillOtherChanges" xlink:label="us-gaap_GoodwillOtherChanges" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillOtherChanges" order="4" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/IntangibleAssetsAndGoodwillDetails" xlink:title="0603 - Disclosure - Intangible Assets and Goodwill (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="us-gaap_CrossCurrencyInterestRateContractMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeContractMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_CrossCurrencyInterestRateContractMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" order="2" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:label="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ResearchExpenseMember" xlink:label="jnj_ResearchExpenseMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InterestIncomeExpenseNetMember" xlink:label="jnj_InterestIncomeExpenseNetMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseNetMember" xlink:label="jnj_OtherInterestIncomeExpenseNetMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeTwoNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeThreeNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeFourNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeFourNetMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_OtherInterestIncomeExpenseTypeSixNetMember" xlink:label="jnj_OtherInterestIncomeExpenseTypeSixNetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="us-gaap_SalesMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_ResearchExpenseMember" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_InterestIncomeExpenseNetMember" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseNetMember" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeTwoNetMember" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeThreeNetMember" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeFourNetMember" order="8" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:to="jnj_OtherInterestIncomeExpenseTypeSixNetMember" order="9" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:DerivativeInstrumentsGainLossLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:label="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:label="us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" order="4" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" xlink:label="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentsGainLossByIncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementAndOtherComprehensiveIncomeLocationDomain" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="us-gaap_CrossCurrencyInterestRateContractMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SwissFrancOptionMember" xlink:label="jnj_SwissFrancOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeContractMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_CrossCurrencyInterestRateContractMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="jnj_SwissFrancOptionMember" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:DerivativesFairValueLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract" xlink:label="us-gaap_DerivativeInstrumentDetailAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:label="us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:label="us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:label="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="us-gaap_EquityMethodInvestmentsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_EquityMethodInvestmentsFairValueDisclosure" order="6" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails1" xlink:title="06041 - Disclosure - Fair Value Measurements (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:label="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:label="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodOneMember" xlink:label="jnj_NotesDuePeriodOneMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixteenMember" xlink:label="jnj_NotesDuePeriodSixteenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwoMember" xlink:label="jnj_NotesDuePeriodTwoMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSeventeenMember" xlink:label="jnj_NotesDuePeriodSeventeenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEighteenMember" xlink:label="jnj_NotesDuePeriodEighteenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineteenMember" xlink:label="jnj_NotesDuePeriodNineteenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyMember" xlink:label="jnj_NotesDuePeriodTwentyMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThreeMember" xlink:label="jnj_NotesDuePeriodThreeMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourteenMember" xlink:label="jnj_NotesDuePeriodFourteenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFourMember" xlink:label="jnj_NotesDuePeriodFourMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFiveMember" xlink:label="jnj_NotesDuePeriodFiveMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSixMember" xlink:label="jnj_NotesDuePeriodSixMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyOneMember" xlink:label="jnj_NotesDuePeriodTwentyOneMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodSevenMember" xlink:label="jnj_NotesDuePeriodSevenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodEightMember" xlink:label="jnj_NotesDuePeriodEightMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodNineMember" xlink:label="jnj_NotesDuePeriodNineMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTenMember" xlink:label="jnj_NotesDuePeriodTenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodElevenMember" xlink:label="jnj_NotesDuePeriodElevenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwelveMember" xlink:label="jnj_NotesDuePeriodTwelveMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodThirteenMember" xlink:label="jnj_NotesDuePeriodThirteenMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodTwentyTwoMember" xlink:label="jnj_NotesDuePeriodTwentyTwoMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_NotesDuePeriodFifteenMember" xlink:label="jnj_NotesDuePeriodFifteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodOneMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSixteenMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwoMember" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSeventeenMember" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodEighteenMember" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodNineteenMember" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyMember" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodThreeMember" order="8" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFourteenMember" order="9" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFourMember" order="10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFiveMember" order="11" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSixMember" order="12" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyOneMember" order="13" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodSevenMember" order="14" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodEightMember" order="15" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodNineMember" order="16" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTenMember" order="17" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodElevenMember" order="18" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwelveMember" order="19" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodThirteenMember" order="20" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodTwentyTwoMember" order="21" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="jnj_NotesDuePeriodFifteenMember" order="22" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" xlink:label="jnj_FinancialAssetsAndLiabilitiesNotMeasuredAtFairValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherCashEquivalentsAtCarryingValue" xlink:label="us-gaap_OtherCashEquivalentsAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TimeDepositsAtCarryingValue" xlink:label="us-gaap_TimeDepositsAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LongTermDebtNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_Cash" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_OtherCashEquivalentsAtCarryingValue" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_TimeDepositsAtCarryingValue" order="8" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="9" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_ShortTermBorrowings" order="11" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" order="13" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:label="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="1" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetails2" xlink:title="06042 - Disclosure - Fair Value Measurements (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="us-gaap_CrossCurrencyInterestRateContractMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="us-gaap_HedgingRelationshipDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="us-gaap_ForeignExchangeContractMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="us-gaap_CrossCurrencyInterestRateContractMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:DerivativeLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfForeignCurrencyDerivatives" xlink:label="us-gaap_NotionalAmountOfForeignCurrencyDerivatives" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotionalAmountOfInterestRateDerivatives" xlink:label="us-gaap_NotionalAmountOfInterestRateDerivatives" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent" xlink:label="us-gaap_DerivativeAssetsNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_NotionalAmountOfForeignCurrencyDerivatives" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_NotionalAmountOfInterestRateDerivatives" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeAssetsNoncurrent" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="4" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/FairValueMeasurementsDetailsTextuals" xlink:title="06043 - Disclosure - Fair Value Measurements (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="us-gaap_HedgingRelationshipDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="us-gaap_DefinedBenefitPlansDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="us-gaap_PensionPlansDefinedBenefitMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:label="us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansDomain" xlink:to="us-gaap_PensionPlansDefinedBenefitMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansDomain" xlink:to="us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:DefinedBenefitPlanDisclosureLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="us-gaap_DefinedBenefitPlanServiceCost" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="us-gaap_DefinedBenefitPlanInterestCost" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanServiceCost" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanInterestCost" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" order="8" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetails" xlink:title="0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="us-gaap_DefinedBenefitPlansDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="us-gaap_DefinedBenefitPlansDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" xlink:label="us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ForeignPensionPlansDefinedBenefitMember" xlink:label="us-gaap_ForeignPensionPlansDefinedBenefitMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansDomain" xlink:to="us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansDomain" xlink:to="us-gaap_ForeignPensionPlansDefinedBenefitMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:DefinedBenefitPlanDisclosureLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PensionsAndOtherBenefitPlansTextualsAbstract" xlink:label="jnj_PensionsAndOtherBenefitPlansTextualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PensionContributions" xlink:label="us-gaap_PensionContributions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_PensionContributions" order="2" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals" xlink:title="06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="us-gaap_DefinedBenefitPlansDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_ConsumerMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementGeographicalAxis" order="2" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_USMember" xlink:label="jnj_USMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_InternationalMember" xlink:label="jnj_InternationalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jnj_USMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jnj_InternationalMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="3" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:SegmentReportingInformationLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:label="jnj_PercentageChangeInSalesBySegmentOfBusiness" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_PercentageChangeInSalesBySegmentOfBusiness" order="3" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails" xlink:title="0609 - Disclosure - Segments of Business and Geographic Areas (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ConsumerMember" xlink:label="jnj_ConsumerMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_ConsumerMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:SegmentReportingInformationLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:label="us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLoss" xlink:label="jnj_PercentageChangeInOperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_ExpenseNotAllocatedToSegments" xlink:label="jnj_ExpenseNotAllocatedToSegments" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" xlink:label="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_PercentageChangeInOperatingIncomeLoss" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_ExpenseNotAllocatedToSegments" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments" order="6" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1" xlink:title="06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_StatementGeographicalAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_USMember" xlink:label="jnj_USMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_EuropeMember" xlink:label="jnj_EuropeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" xlink:label="us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" xlink:label="us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jnj_USMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jnj_EuropeMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalGroupsOfCountriesGroupOneMember" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalGroupsOfCountriesGroupTwoMember" order="4" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:RevenuesFromExternalCustomersAndLongLivedAssetsLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="us-gaap_SegmentsGeographicalAreasAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageChangeInSalesByGeographicArea" xlink:label="jnj_PercentageChangeInSalesByGeographicArea" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="jnj_PercentageChangeInSalesByGeographicArea" order="3" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2" xlink:title="06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MedicalDevicesAndDiagnosticsMember" xlink:label="jnj_MedicalDevicesAndDiagnosticsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_MedicalDevicesAndDiagnosticsMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:SegmentReportingInformationLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" xlink:label="jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationExpense" xlink:label="jnj_LitigationExpense" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationAndRecallExpense" xlink:label="jnj_LitigationAndRecallExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_LitigationExpense" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RestructuringCharges" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="jnj_LitigationAndRecallExpense" order="4" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals" xlink:title="06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CrucellNvMember" xlink:label="jnj_CrucellNvMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AcclarentIncMember" xlink:label="jnj_AcclarentIncMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_SynthesIncMember" xlink:label="jnj_SynthesIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_CrucellNvMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_AcclarentIncMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jnj_SynthesIncMember" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:BusinessAcquisitionLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessCombinationsAndDivestituresTextualsAbstract" xlink:label="jnj_BusinessCombinationsAndDivestituresTextualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" xlink:label="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" xlink:label="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityEquityInterestIssuedAndIssuablePercentage" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage" order="8" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/BusinessCombinationsAndDivestituresDetails" xlink:title="0610 - Disclosure - Business Combinations and Divestitures (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesAxis" xlink:label="jnj_LitigationSettlementByCompaniesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="jnj_LitigationSettlementByCompaniesAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesAxis" xlink:label="jnj_LitigationSettlementByCompaniesAxis" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesDomain" xlink:label="jnj_LitigationSettlementByCompaniesDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_MerckMember" xlink:label="jnj_MerckMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CentocorOrthoBiotechIncMember" xlink:label="jnj_CentocorOrthoBiotechIncMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AverageWholesalePriceLitigationMember" xlink:label="jnj_AverageWholesalePriceLitigationMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RisperdalMember" xlink:label="jnj_RisperdalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="jnj_LitigationSettlementByCompaniesAxis" xlink:to="jnj_LitigationSettlementByCompaniesDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_MerckMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_CentocorOrthoBiotechIncMember" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_AverageWholesalePriceLitigationMember" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jnj_LitigationSettlementByCompaniesDomain" xlink:to="jnj_RisperdalMember" order="4" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="2" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestitutionMember" xlink:label="jnj_RestitutionMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CivilPenaltiesMember" xlink:label="jnj_CivilPenaltiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="jnj_RestitutionMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="jnj_CivilPenaltiesMember" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="3" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PharmaceuticalMember" xlink:label="jnj_PharmaceuticalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jnj_PharmaceuticalMember" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" order="4" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:LossContingenciesLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationLoss" xlink:label="jnj_LitigationLoss" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfContributionToIncomeProfitSplit" xlink:label="jnj_PercentageOfContributionToIncomeProfitSplit" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_PercentageOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_AmountOfRevenueRepresentedByRetainedTerritories" xlink:label="jnj_AmountOfRevenueRepresentedByRetainedTerritories" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="jnj_LitigationLoss" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="jnj_PercentageOfContributionToIncomeProfitSplit" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="jnj_PercentageOfRevenueRepresentedByRetainedTerritories" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="jnj_AmountOfRevenueRepresentedByRetainedTerritories" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementExpense" order="5" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesAxis" xlink:label="jnj_LitigationSettlementByCompaniesAxis" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_LitigationSettlementByCompaniesDomain" xlink:label="jnj_LitigationSettlementByCompaniesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="jnj_LitigationSettlementByCompaniesAxis" xlink:to="jnj_LitigationSettlementByCompaniesDomain" order="1" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="2" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/LegalProceedingDetails" xlink:title="0611 - Disclosure - Legal Proceedings (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="3" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_EmployeeSeveranceMember" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:RestructuringCostAndReserveLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="us-gaap_RestructuringReserveRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringReserveSettledWithCash" xlink:label="us-gaap_RestructuringReserveSettledWithCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserveSettledWithCash" order="3" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetails" xlink:title="0612 - Disclosure - Restructuring (Details)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1" />
  </link:definitionLink>
  <!-- Hypercube Definition (Line Items to Hypercube)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="1" />
  </link:definitionLink>
  <!-- Domain Members -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CordisRestructuringMember" xlink:label="jnj_CordisRestructuringMember" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringPlanOf2009Member" xlink:label="jnj_RestructuringPlanOf2009Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="jnj_CordisRestructuringMember" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="jnj_RestructuringPlanOf2009Member" order="2" />
  </link:definitionLink>
  <!-- Hypercube Definition (All)-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="2" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <!-- Inheritance for Line Items:  us-gaap:RestructuringCostAndReserveLineItems-->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_CashPaymentsForRestructuring" xlink:label="jnj_CashPaymentsForRestructuring" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="us-gaap_OtherRestructuringCosts" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_BusinessExitCosts" xlink:label="us-gaap_BusinessExitCosts" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostIntangibleAssets" xlink:label="jnj_RestructuringAndRelatedCostIntangibleAssets" />
    <link:loc xlink:type="locator" xlink:href="jnj-20110703.xsd#jnj_RestructuringAndRelatedCostInventory" xlink:label="jnj_RestructuringAndRelatedCostInventory" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCharges" order="1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="jnj_CashPaymentsForRestructuring" order="2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_OtherRestructuringCosts" order="3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_BusinessExitCosts" order="4" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="5" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="jnj_RestructuringAndRelatedCostIntangibleAssets" order="6" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="jnj_RestructuringAndRelatedCostInventory" order="7" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" order="8" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate" order="9" />
  </link:definitionLink>
  <!-- Dimension Defaults -->
  <link:definitionLink xlink:type="extended" xlink:role="http://jnj.com/role/RestructuringDetailsTextuals" xlink:title="06121 - Disclosure - Restructuring (Details Textuals)">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>y91358y9135800.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 y91358y9135800.gif
M1TE&.#EAK0`D`.8``/[UYOWK\M%+6,XF-OBZRKM/5OW]^>MG<-&/D>E2:?O7
MX^H$"]$U1]!F<O[^_N<V2_K)U_[X^O[U^-$6,+0'$/K`S_WKZ_>UONA#5OWE
M[K(J./:8I-=99O[Z_/G\^_O]_.22EOSBV?FION-W@?S@Y__\_-D!!;,6(N:I
MJN*$E-!V??[P]?2%E?[Y]K(Y2?[T]/W]]N`L-<8!!_[^^^N:H>X2(?:'HNNT
MNO7Z]-.IKOO1W/.II_[P[_S<W_72V]"`A/"DL_7[^?S]^_G\]O9G@.F'B<,(
M&/C$O/WJX=@'%O[U\/:;L?2(A?[Y\/O/TOO5S/20G?S]_<E!1OS[^?)VA-N8
MHO+.T?KZ]/_]_OS^^N1J@9TL.O'4UN=[CN(3%/S7U_[]\LH1'._$R:($#?>Y
ML?W\_?=VD?G\[?3<WI\3(?OZ^]B@G>JHH?7VY[QB9O/(T?GY\?&7B?5MC?GR
M\?OV[_#Y\>2OKO7:T/:-K>:?KO-::+TD*OOEY]L=)NTC0/___R'Y!```````
M+`````"M`"0```?_@`Z"@PY_6"4=41Y!'D*#?Y"1D8,?'I8>486$DIR=GI^@
MH0Z'95$?64*-6%B/?X*FF:<S,XM!'QT1A:&[O+V$):R9:E@S0U,&)<FK@JRN
M@D)"!EDP0T,?CLZ"O=O<GZ-E'1TSTK,=B!$E#D(?[)G1,S`P<+81N=WWVX3!
M[!XS<"TM)`A,EBP<EFS0#``$>.S@)GP0>WU04V\AP'H1)$0H4^E#)@<&8#1I
MHD3)%0_U=$5<*4G;GUB+/,"@$T!'%01<T"4KT\R!J80OOMRXP0?=*E8J9[!<
MZLI2!PDK>MA!D&.%!'!JV'GDB26D$CX7\O"9$J&#2J9+'5BJ%&3(%0LB_U0T
M<''CA;)7KZ#-:/$E!8<"=@+H3"=)*=J(:HWQ$).B00$W`3HXZN@`4;B0/*HD
M$(!@3@0UAUEJ4^OA5+P5*0J,6*)!3-E$CDQ]$#2C!.H]'%PT\+&B`Y:/D0R'
MQF?@"H\W`AK0:/`CPU72'[#@*JM0Q``!1+:@D0!Z.,2/6"S-@O%BB>X*74[T
M4)C.H^S*]70(F&"F`(<WO15E\L[2P`LQ!0AP014%5,&#!.%T%$4X'91A``\)
M&$$%"VGX($$0_.&#21DE9#+."PH,P,`13SRP1P"SS*`((Q[A`E4>#/3!0@$-
M6"'!#)1!TDR&V^RE`P=[T%"!%AK8T<054S3H7O\4X7U@0`\#)`$%$UOX$($0
M/':SH6]_E!!!!B,8H4<(1X0QP`NS9%')6@X\!=4/)\1@A@L_C&7`FK,=<I8S
M2#T$BDNM<+)G918`,<$`7UR`P0!DG''&$+BP`HTB'S1101\F;.!8#Q%$L9^@
M>V;IH0&9=+!"!2<8(4(/.\@0PPM"S""$IQQA,@5`%C1P`@-$,)"'55-D40<C
M9<'C$SP&M!F.$$'@$$ZI9HURT#@M)%+)$%D,(8T'@DR!0W1E"(*+%1P8D4``
M2_@10Z./XA)..ED9`,`.F&Z@01$!E!$$([[-D(4@R3B0A0$S+!.P)8-\!+!O
MA#SSAUG^SM)E5S"T&`#_"Q2<H(`.9I@0`QUD@8-@!U-,`4\3%A1`P0,8<%"!
M51)<@8,M`K4`@R`M@`%#DAIYBT,]TFGD8ADSC!3!"A%\@(.V,\$011D2&&`-
M.H*4P8,=)TQ@0P90)+$N&#J?$\$4)8"C!`!QA+$`$1K@U\$'^R(84@M>2C`'
M#&`@PV"#0=0Q3#TNHN-;"<_-<,4,N,!:C5+`A)3)EPF,P0`)$.AA0A\\"%'/
M"RV05%(+>Z5,01\Q`$$"#TJT<*<'$@20`>B$\J"Z&J;2\6@)%ZWP`@\6!(`@
M0"MD(!CM*ZR0>EGUS#`%3P88P'H58PP@0@9%R,!H$\<`]((2350;00L\0.'%
M_P)]=,''"A98);(%+UB5$?=*O,#@"H+A\#-4`>0?`.<&"&25S>1IW0JDUHB)
M$6P4$2`!!L8@@`Q`(`$F\`(/GK("'R```3M0`0B^T+X,"$`&)A"`$WK`!C?8
MX04>F,(*9F2'.70@`!MPPQHRUP$KK.$.3:`#^"!0!!FBX`<HX$/K+M``%5@A
M`*=2@1L4((%SR*I+-L/!"U(PACU<@'K6V\$+!&(!.P`1`3^P@E4"8(,:+.`!
M3B"!"!HP`J1U(`-`<(,*G+,",;@!`21`4`#RD(,7N&4%$(!"`T``!0V&0`D!
M@(`2R0"`%I`@-1=`H26<,8M#=(`$#Z"`%"SPP`B>+_\#%Q```]PP`A%I@0`9
MJ,`#7`6%$$"!`2?@``FLMH$]4,`-:%C!!09@!!=8H`4!J,(65,`')?0`!`+H
M@Q144``I"(`&$$@!+$\``A)D(`$3,`(>`G"(D`Q!"!W8GG&Z0($]D(%ZEXL#
M_8:TA09H@0$,$,`-,J``(IB1!3P@``/"T`<+0$4$#S#"%@AP'`%H\@)6N8`4
M&O"$,U@`"AC8PQZ0R0`I%,$)&Q#`"2B0@!!8P`;93``)%.&!X-2F;!G`@`Q\
MZ80#1+`")``"`[RV@10,X`%]$$`7]FF"!VS@"!A(0D\A(($OG,`$)F#`&Q0@
M!:'NH0<\4``#*,``$=R@`0+_B,$"#L"&9F(@!O%,0!@H<(`*I$NH<L@`/.(!
M@PY88`<_^`(?J&A.='J!"3$5:QA`8`8_F$@`6IC/`A9P@1YP(`D+,$(/7G!-
MH1IA`TZ@P@1DT`<H\(`$8>H#$YZ@`@'XP008((,`6#8`*3`@`4+MPQ$@$*4%
MQ$`!G_F`,V2K#![(00;JZ0$3(@B%+FC@`29(`!]TT(4!9(P#>)""#!ZP`PYP
M(`8F\$,%`M"`!'QV``0P`\M,\%02;,`($?0#`[JP`9QN@`\W2&88.$``Z\C@
M`")@@!;Z(`,B6&`(,&A!\&HR@C2,H`=K2,,>-A"`KB5!#]+T0Q*D<`3BPC(-
M`F`!_Q&\8((=L,$%<O""#`ZYA`$D0`9A8`$(&'``RK(`+'X8;!\>T``@8,`$
M!T`"`9X;!@8``0*86L`.M)``#+A6!R-["3O:5`(AO.`"1J!`!4(0!Q,L@`$N
MZ((>%J`'WRF`#`V0P@[DXRHB"``*4H@N`8!0`#*D.`:L6<*']Z"#"@@@`0]8
M0`VH``$09&T)KK,"%`90!`M48``R2``1,+"$/<B`"D@`@Q*<,!<WI"`%81``
MJV(0!B*@B\)]D*_E'G`$"RC@""/0P`:9,+X-;($&-O!"$N3J`A:0,PQRT,,!
MJB<C"(R``3Y>``;:J](1-"&1%R!Q&@=@@AJ800,B>'$,OO_P&B&7AD/P",$'
MS=`#,CB9`30XPI0Q$`)3A8"91T#"!]4U`C<;P0\BH%,(XER#!'"@!WJ0P1X(
M(`<I7(`*Q6;!,<-0`QL@\07Q!0$/6"L##(R7`(;6`PE>@(8&A,$/>7BNU]I,
MA3/&E+YA*((.\+TN`)PM#E)@`Q)(K6LI*``/XWN#"ES`A2)0`+0"`L'HS)`:
M&E"A!B:0)0%>'..CD6"A/B`!L6OP@`3H0*4Q"$$34B*K9Y<`'@!`,@8@<(3!
M$N$+(=AM#*:7`2>XP0T>_6`2I*>``IR[94=8]V`G<($06&X/K-D`&QBP@"10
M@0\H(#812+`"'M#@`30(P)]-D`3_!ES@"88F0@7<(`8M&&$"2UC"BRO-`0:8
M8`)``*@,I/`$/K#`"V&@@064@`0W2,$.(=B`&3'/M?'A80MB"`$-9$#9+GR!
M!J-+0`(:0(8$+$`&(OQ13YVP3@VDH`="=S*:Y>.Q(ZPA!U,0V+\H"8,S`$`$
M:1"TDZD0`!Z00:A^D`,>&+"'/GN0]@?(P/E-T!HE\.#%24B`!2P0;^M54PL>
M#D,7+/`$EX)V`U2P!P)P!`-G:#)0!#R`>-%E!')P.AF5!F-``34&!4[`!S2@
M`0(@!S@G!200`)KG!7J`!WIP`BG`=V6D:WRW`>.C34W@2K0W`"1P3""4!`(`
M`0@P6K<4_P)(<``+T%,V8`,QH%H2D`$#,%@'@'P05`-^L`5\``-_D`7_`@Q_
M``]G``8!H`4G8$9)T$818%@RD`1)8`0GT``0X#HJ@V;JUP!)E@)\\`(6(`!5
MA%`90`0R8`2;1'\W944OT`1D`&A&D&1[P`8\P`-?H`$4L&LM@`0:(`,U,`$0
MP`--@`0]``%O<`$'4``90`=M\%9J\WM2H`,!\$AA4(<;]0`$@$1+,`%)@`<:
ML0%A`%H*`#XT,`:5%@`6@`(4(`-5E0$((`52L`<_````<`3*%8840`$C@`0O
M$``:$(87H`0DH`5"I34OX(0')(54"`8MH$]^@`%&,`(9H#M.$/\F%#``^N8_
M"$`G)%`/:^`"'`!D$?`"IH8`%O`4%[`'4E`!WY,'6Z`!7;`"<``'`$`&4I`Q
M\L0#9),!!;`%@2$!2@`"&C!O$I`S8),^(8``:[`"RB,!/7``#\`!%%``3"0!
M)+!GY?2.$H`%*T``4:8`A],#OT@``\0#-[`%`J``N@,@4K`$PD,`"TE,`+%H
M_94&#``"(=`&0R`!*7`"2V`!VJ@#&N"/`0`#./`',#`#TD(,(0$#*P`$`B`"
M1$`!#8!$#AD"5B`&;T`"+>`!9:`&?,`%;8@,%N`#.#DVEV4%%C`%'U`&%O`&
M/B`8)?"6<-DI0C`%`/`%:*D`%I`5<(/_!F@@&-]C`5Q@(6H0$F=`'IUC`3R0
M"U"#'$RPE)\H`1-A`6=I!3UP(4&@!BN`!GQ`!TOS`CY@!6B"*W0)F7,0`G<@
M1/3C`SY0%"5C`$W`!V\@!CZ`!$VP-$/X!J]SE2_`!5Q``N*@%%?)#$\W"RV0
M`<RA`RPP!EW@'$+@%G!`!R\0`>$1!`I1,Y=Y-%:A!H49CFM9&B5Q(&;Q/4?R
M-.APGOF#(*S@)A(P!=@"//6@"-^$"%<9+E,PA'G@!D]``WL@DA%0&J:".N,9
M$U,P$F>``[6A$8<S`YP#.&7@`3@@$F!P#L4C#NN`"5#A/OZI$+B@D;,P!U#1
M1&4`";/`#ARB_Y6GX@)W@`10D`8I(!C,4@?#X@@.`#?:D@Y#<`8&@!$?V@^F
MHB^E$0\&P`IJ4`(&D`J6D`RTP)8980[)`!4=L#A/^#`E<`DXL`HJ$@4/LP)O
M($-(D`<:@(EO,PH.,`O)8`E7@#=@\"@.T)9%6@G*,QF,X`%)>B=1T#RH("NS
MPB0-P@Q8H#I8Z0I3``F$DPZZD`X0&BWDL7M\@`0;D`8(50:344"0$"A3F`TM
MX1(TV@F`<A:;\`B!`JN>\$;\J``\@`*Z(1A14!:J6A@2PPN$(!QH8:KML2`=
M\@$SD`%[@`<`@`2^I0!]V@&N<!!94JV1T`$ZH`4%H%]5X`(_J@91D/\,'F&M
MPS$:R7"H+U`!:0`!S:H%4K`"JY`.JT"NUKJ-'^F&"%``!"`_XZ`FH4*O$9$%
M6*D,0I`%2@`$::```'`'`F`#3=0GO0JPH6$X!#``<F!,S-1MQ``#=_*O$GL/
M!7M2ZC`#/``"8P`!2&`'6P`!Z#"M+ONQPS$#2G`#$V!?-\`!(-`$6+E6LP&S
M+"&P!2,I#Y('%(`'-.`&/P"=SC"C$>NS++$7-/L`1.0&/9`W=3H.V."T$)$B
MNE"P+5`!1I`$$^`")'"5J*JU$_NU#Q"&AJ<$,%`:3"*L:-L-6`DH\"`!<I"!
M$``ZSE"J'CNW='N=2U``IU2-:N(>2`&XW0!4'DGA'\#RJXH;&@*C$"]`!QRK
M%(?@*4Q"K9'+"QY!IX.0(@3T*9T[K-!0#4NC%-+R-!SRMZ4;"4,F+<DPA;5Q
7"`'SNDQ1I)71`023#:,0,*Z+NX$``#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EQ4AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Restructuring (Details Textuals) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">21 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011
</div>
          <div>Cordis Restructuring [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011
</div>
          <div>Cordis Restructuring [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011
</div>
          <div>2009 Restructuring Plan [Member]
</div>
          <div>Positions</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges, pre tax</a></td>
        <td class="nump">$ 589<span></span></td>
        <td class="nump">$ 589<span></span></td>
        <td class="nump">$ 676<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashPaymentsForRestructuring', window );">Restructuring charges required to be paid in cash, pre tax</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">164<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Asset write-offs included in restructuring charges</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">512<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts', window );">Leasehold and contract obligations included in restructuring charges</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">164<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Asset write-offs related to property, plant and equipment</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">265<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringAndRelatedCostIntangibleAssets', window );">Asset write-offs related to intangible assets</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">160<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringAndRelatedCostInventory', window );">Asset write-offs related to inventory</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 87<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated', window );">Expected number of positions to be eliminated</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">7,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate', window );">Number of positions eliminated to date</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">5,700<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashPaymentsForRestructuring">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of cash expected to be paid associated with the restructuring.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_CashPaymentsForRestructuring</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringAndRelatedCostIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Restructuring and related cost, intangible assets</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_RestructuringAndRelatedCostIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringAndRelatedCostInventory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Restructuring and related cost, inventory</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_RestructuringAndRelatedCostInventory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The charge against earnings in the period, comprised of costs incurred associated with an exit or disposal activity other than for a discontinued operations as defined under generally accepted accounting principles. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 146<br> -Paragraph 2-6, 8-17, 20<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessExitCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy pursuant to a duly authorized plan, excluding a discontinued operation as defined by generally accepted accounting principles. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, but excludes costs associated with the retirement of a long-lived asset and severance costs associated with established compensation plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 146<br> -Paragraph 20<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherRestructuringCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Current year divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisposals</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The expected number of positions to be eliminated as a result of restructuring activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of positions eliminated as of the balance sheet date since inception of the restructuring plan(s).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCostAndReserveLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E5OAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)<br>In Millions, except Share data</strong></div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for doubtful accounts</a></td>
        <td class="nump">$ 327<span></span></td>
        <td class="nump">$ 340<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">4,320,000,000<span></span></td>
        <td class="nump">4,320,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">3,119,843,000<span></span></td>
        <td class="nump">3,119,843,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
        <td class="nump">379,263,000<span></span></td>
        <td class="nump">381,746,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6965416&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 129<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28,29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TreasuryStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6YAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Earnings (Unaudited) (USD $)<br>In Millions, except Per Share data</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statements of Earnings [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Sales to customers (Note 9)</a></td>
        <td class="nump">$ 16,597<span></span></td>
        <td class="nump">$ 15,330<span></span></td>
        <td class="nump">$ 32,770<span></span></td>
        <td class="nump">$ 30,961<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of products sold</a></td>
        <td class="nump">5,172<span></span></td>
        <td class="nump">4,630<span></span></td>
        <td class="nump">9,950<span></span></td>
        <td class="nump">9,158<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
        <td class="nump">11,425<span></span></td>
        <td class="nump">10,700<span></span></td>
        <td class="nump">22,820<span></span></td>
        <td class="nump">21,803<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, marketing and administrative expenses</a></td>
        <td class="nump">5,215<span></span></td>
        <td class="nump">4,756<span></span></td>
        <td class="nump">10,271<span></span></td>
        <td class="nump">9,535<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
        <td class="nump">1,882<span></span></td>
        <td class="nump">1,648<span></span></td>
        <td class="nump">3,620<span></span></td>
        <td class="nump">3,205<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="num">(18)<span></span></td>
        <td class="num">(43)<span></span></td>
        <td class="num">(39)<span></span></td>
        <td class="num">(70)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of portion capitalized</a></td>
        <td class="nump">129<span></span></td>
        <td class="nump">101<span></span></td>
        <td class="nump">254<span></span></td>
        <td class="nump">209<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
        <td class="nump">206<span></span></td>
        <td class="nump">18<span></span></td>
        <td class="nump">193<span></span></td>
        <td class="num">(1,576)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expense</a></td>
        <td class="nump">589<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">589<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before provision for taxes on income</a></td>
        <td class="nump">3,422<span></span></td>
        <td class="nump">4,220<span></span></td>
        <td class="nump">7,932<span></span></td>
        <td class="nump">10,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for taxes on income (Note 5)</a></td>
        <td class="nump">646<span></span></td>
        <td class="nump">771<span></span></td>
        <td class="nump">1,680<span></span></td>
        <td class="nump">2,525<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET EARNINGS</a></td>
        <td class="nump">$ 2,776<span></span></td>
        <td class="nump">$ 3,449<span></span></td>
        <td class="nump">$ 6,252<span></span></td>
        <td class="nump">$ 7,975<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET EARNINGS PER SHARE (Note 8)</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
        <td class="nump">$ 1.01<span></span></td>
        <td class="nump">$ 1.25<span></span></td>
        <td class="nump">$ 2.28<span></span></td>
        <td class="nump">$ 2.89<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="nump">$ 1.23<span></span></td>
        <td class="nump">$ 2.25<span></span></td>
        <td class="nump">$ 2.85<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">CASH DIVIDENDS PER SHARE</a></td>
        <td class="nump">$ 0.57<span></span></td>
        <td class="nump">$ 0.54<span></span></td>
        <td class="nump">$ 1.11<span></span></td>
        <td class="nump">$ 1.03<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>AVG. SHARES OUTSTANDING</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
        <td class="nump">2,740.5<span></span></td>
        <td class="nump">2,756.6<span></span></td>
        <td class="nump">2,739.6<span></span></td>
        <td class="nump">2,755.7<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
        <td class="nump">2,781.3<span></span></td>
        <td class="nump">2,796.0<span></span></td>
        <td class="nump">2,778.1<span></span></td>
        <td class="nump">2,796.1<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate dividends paid during the period for each share of common stock outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockDividendsPerShareCashPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs related to goods produced and sold during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostOfGoodsSold</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=6945512&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 20<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 7<br> -Paragraph 18<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 36, 37, 38<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 21<br> -Article 9<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 11, 12, 36<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 20<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 7<br> -Paragraph 18<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 21<br> -Article 9<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrossProfit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 4<br> -Section 08<br> -Paragraph h<br> -Subparagraph 1(i)<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph h<br> -Article 4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 45<br> -Subparagraph a, b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 34<br> -Paragraph 21<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 9<br> -Article 9<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher OTS<br> -Name Federal Regulation (FR)<br> -Number Title 12<br> -Chapter V<br> -Section 563c.102<br> -Paragraph 9<br> -Subsection II<br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 7<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 14<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 9<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A1, A4, A5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 5<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 86<br> -Paragraph 11<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 86<br> -Paragraph 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 2<br> -Paragraph 8, 12, 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueGoodsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Chapter 4<br> -Paragraph 5A<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 4<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6386349&amp;loc=d3e3636-108311<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SellingGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 171<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EBEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of designated derivatives</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table1 - us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
    the fiscal second quarters in 2011 and 2010:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="28%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>reclassified</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>from</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated OCI</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>other</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>OCI</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>into income</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>income/expense</b><sup style="font-size: 85%; vertical-align: text-top">(2)</sup></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left"><b>Cash Flow Hedges</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(53</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(9</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(A)</sub></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(20</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(102</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(44</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(76</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(B)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(149</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">44</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">18</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">20</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(C)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(31</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(82</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(16</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">11</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(D)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(7</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">35</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">&#8212;</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(E)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">20</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(158</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(40</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(54</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">4</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(133</td>
    <td nowrap="nowrap">)
    </td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 0pt">
    All amounts shown in the table above are net of tax.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
    the first fiscal six months in 2011 and 2010:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="28%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>reclassified</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>from</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated OCI</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>other</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>OCI</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>into income</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>income/expense</b><sup style="font-size: 85%; vertical-align: text-top">(2)</sup></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left"><b>Cash Flow Hedges</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(84</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(10</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(29</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(A)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(21</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">92</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(206</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(106</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(98</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(B)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(154</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(8</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">73</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">21</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(C)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(40</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(49</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(18</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">11</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(D)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(59</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">81</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(3</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(E)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">20</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(185</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(118</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(96</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(139</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">All amounts shown in the table above are net of tax.
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>Effective portion</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Ineffective portion</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(A)</td>
    <td>&#160;</td>
    <td>Included in Sales to customers</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(B)</td>
    <td>&#160;</td>
    <td>Included in Cost of products sold</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(C)</td>
    <td>&#160;</td>
    <td>Included in Research and development expense</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(D)</td>
    <td>&#160;</td>
    <td>Included in Interest (income)/Interest expense, net</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(E)</td>
    <td>&#160;</td>
    <td>Included in Other (income)/expense, net</td>
    </tr>
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Financial assets and liabilities at fair value</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table2 - us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#8217;s significant financial assets and liabilities measured at fair value as of July&#160;3,
    2011 and January&#160;2, 2011 were as follows:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="40%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 0px solid #000000"><b>July 3, 2011</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3"><b>January 2, 2011</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 1</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 2</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 3</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Total</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Total</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Derivatives designated as hedging instruments:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Assets:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">487</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">487</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">321</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<sup style="font-size: 85%; vertical-align: text-top">(2)</sup>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">17</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Total</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">338</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Liabilities:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">646</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">646</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">586</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<sup style="font-size: 85%; vertical-align: text-top">(3)</sup>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">404</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">404</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">502</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Total</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,050</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,050</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,088</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Derivatives not designated as hedging instruments:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Assets:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Swiss Franc Option*
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">569</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">569</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Liabilities:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">39</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Other Investments</b><sup style="font-size: 85%; vertical-align: text-top"><b>(4)</b></sup>
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,371</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,371</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,165</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Currency option related to the planned acquisition of Synthes, Inc.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>As of January&#160;2, 2011, these assets and liabilities are classified as Level 2 with the exception
    of Other Investments of $1,165 which are classified as Level 1.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Includes $2&#160;million and $14&#160;million of non-current assets for July&#160;3, 2011 and January&#160;2, 2011,
    respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(3)</td>
    <td>&#160;</td>
    <td>Includes $404&#160;million and $502&#160;million of non-current liabilities for July&#160;3, 2011 and January
    2, 2011, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(4)</td>
    <td>&#160;</td>
    <td>Classified as non-current other assets.</td>
    </tr>
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Financial assets and liabilities not measured at fair value</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note4_table3 - us-gaap:FairValueByBalanceSheetGroupingTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Financial Instruments not measured at Fair Value:
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following financial assets and liabilities are held at carrying amount on the consolidated
    balance sheet as of July&#160;3, 2011:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Carrying</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Estimated</td>
    <td>&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Amount</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Fair Value</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Financial Assets</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Current Investments</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cash
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">2,299</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,299</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Government securities and obligations
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23,951</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23,951</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Corporate debt securities
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">515</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">515</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Money market funds
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,820</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,820</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Time deposits
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,097</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,097</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total cash, cash equivalents and current marketable securities
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">29,682</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">29,682</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td colspan="9" align="left">Fair value of government securities and
    obligations and non-current marketable
    securities was estimated using quoted broker prices
    in active
    markets.</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Financial Liabilities</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Current Debt</b>
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">5,046</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,046</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Non-Current Debt</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2012
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">599</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">632</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">0.70% Notes due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">503</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3.80% Debentures due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">527</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3&#160;month LIBOR&#043;0% FRN due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3&#160;month LIBOR&#043;0.09% FRN due 2014
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">750</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">750</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">1.20% Notes due 2014
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">999</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,006</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2.15% Notes due 2016
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">898</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">903</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.55% Debentures due 2017
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,161</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2018
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">898</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,015</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.75% Notes due 2019 (1B Euro 1.4476)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,440</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,569</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3% Zero Coupon Convertible Subordinated Debentures due in 2020
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">197</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">246</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2.95% Debentures due 2020
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">541</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">522</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3.55% Notes due 2021
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">446</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">456</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">6.73% Debentures due 2023
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">250</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">323</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.50% Notes due 2024 (500 GBP1.6025)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">795</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">856</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">6.95% Notes due 2029
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">294</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">375</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.95% Debentures due 2033
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">523</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.95% Notes due 2037
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">995</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,120</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.86% Debentures due 2038
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">700</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">773</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.50% Debentures due 2040
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">539</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.85% Notes due 2041
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">298</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">291</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other (Includes Industrial Revenue Bonds)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">41</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">41</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total Non-Current Debt
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">13,680</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">14,581</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19207-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 14<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15<br> -Subparagraph b-d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13476-108611<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13467-108611<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6447952&amp;loc=d3e13220-108610<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 159<br> -Paragraph 18<br> -Subparagraph c(2), d, e, f<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 157<br> -Paragraph 32<br> -Subparagraph a, c(1), c(2), c(3), d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 159<br> -Paragraph 19<br> -Subparagraph a, b, c(1), d(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueByBalanceSheetGroupingTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the location and amount of gains and losses reported in the statement of financial performance, or when applicable, the statement of financial position. For example,  (a) gains and losses recognized in the income statement on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges and (b) gains and losses initially recognized in other comprehensive income on derivative instruments designated and qualifying as cash flow hedges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 205G<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5618551-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44C<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624163-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 205G<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44C<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EDXAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information (USD $)<br>In Billions, except Share data</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 29, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">JOHNSON & JOHNSON<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000200406<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Jul.
        03,
         2011<span></span></td>
        <td class="text"><span></span></td>
        <td class="text"><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2011<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q2<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--01-01<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Large Accelerated Filer<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 163<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">2,740,354,114<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document as an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, and Other.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Document And Entity Information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EGIBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Legal Proceedings (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Apr. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 28, 2009</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationLoss', window );">Litigation Loss</a></td>
        <td class="nump">$ 593,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Net litigation expense</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">73,000,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AmountGivenToPlaintiffByJury', window );">Amount given to plaintiff by jury</a></td>
        <td class="nump">482,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_VerdictAgainstCompany', window );">Verdict in favor of the State's Attorney General and against Janssen and the Company</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">257,700,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationSettlementPreJudgmentInterest', window );">Litigation settlement pre judgment interest</a></td>
        <td class="nump">111,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AwardedDamagesReversed', window );">Approximate damages initially awarded to Centocor, then subsequently reversed by the Court of Appeals</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">1,700,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs', window );">Assessed damages for alleged consumer fraud as to DURAGESIC and RISPERDAL</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">4,500,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest', window );">Settlement payment related fines disgorgement and interest</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">78,000,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories', window );">Percentage of revenue represented by relinquished territories</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">30.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OneTimePaymentReceivedByCompany', window );">One time payment received by Company</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">500,000,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Merck [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageOfContributionToIncomeProfitSplit', window );">Percentage of contribution to income profit split</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">58.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageOfRevenueRepresentedByRetainedTerritories', window );">Percentage of revenue represented by retained territories</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">70.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AmountOfRevenueRepresentedByRetainedTerritories', window );">Amount of revenue represented by retained territories</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">2,800,000,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">COBI [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageOfContributionToIncomeProfitSplit', window );">Percentage of contribution to income profit split</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">42.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Average Wholesale Price Litigation [Member] | Civil penalties [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationLoss', window );">Litigation Loss</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">6,500,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Risperdal [Member] | Civil penalties [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationLoss', window );">Litigation Loss</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">327,100,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restitution [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationLoss', window );">Litigation Loss</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 45,000,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AmountGivenToPlaintiffByJury">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount given to plaintiff by jury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AmountGivenToPlaintiffByJury</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AmountOfRevenueRepresentedByRetainedTerritories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue represented by retained territories.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AmountOfRevenueRepresentedByRetainedTerritories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Assessed Damages for Alleged Consumer Fraud as to DURAGESIC and RISPERDAL.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AssessedDamagesForAllegedConsumerFraudRelatedToCertainDrugs</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AwardedDamagesReversed">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Awarded damages reversed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AwardedDamagesReversed</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LegalProceedingTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Legal Proceeding Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_LegalProceedingTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LitigationLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Litigation loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_LitigationLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LitigationSettlementPreJudgmentInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Litigation settlement pre judgment interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_LitigationSettlementPreJudgmentInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OneTimePaymentReceivedByCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>One time payment received by Company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_OneTimePaymentReceivedByCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageOfContributionToIncomeProfitSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of contribution to income profit split.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageOfContributionToIncomeProfitSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of revenue represented by relinquished territories.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageOfRevenueRepresentedByRelinquishedTerritories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageOfRevenueRepresentedByRetainedTerritories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of revenue represented by retained territories.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageOfRevenueRepresentedByRetainedTerritories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Settlement payment related fines disgorgement and interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SettlementPaymentRelatedFinesDisgorgementAndInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_VerdictAgainstCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Verdict in favor of the State's Attorney General and against Janssen and the Company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_VerdictAgainstCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the expenses incurred by the entity which are directly related and attributable to receiving an award in settlement of litigation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LitigationSettlementExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LossContingenciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock', window );">Reconciliation of basic net earnings per share to diluted net earnings per share</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note8_table1 - us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal second quarters ended July&#160;3, 2011 and July&#160;4, 2010.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Basic net earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.01</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.25</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; basic
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,740.5</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,756.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">168.9</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">175.5</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(131.7</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(139.7</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Convertible debt shares
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; diluted
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,781.3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,796.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Diluted earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.00</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.23</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>

    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note8_table2 - jnj:ScheduleOfEarningsPerShareReconciliationTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal six months ended July&#160;3, 2011 and July&#160;4, 2010.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Basic net earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.89</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; basic
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,739.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,755.7</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">168.8</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">175.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(133.9</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(138.6</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Convertible debt shares
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; diluted
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,778.1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,796.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Diluted earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.85</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the reconciliation of basic net earnings per share (or unit) to diluted earnings per share (or unit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Topic 260<br> -SubTopic 10<br> -Publisher FASB<br> -Number <br> -Article <br> -Subparagraph <br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EFPAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Business Combinations and Divestitures (Details) (USD $)<br>In Billions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="3">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Apr. 03, 2011
</div>
          <div>Crucell .N. V [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 04, 2010
</div>
          <div>Acclarent Inc [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011
</div>
          <div>Synthes, Inc [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessCombinationsAndDivestituresTextualsAbstract', window );"><strong>Business Combinations and Divestitures (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets', window );">Acquisition price allocated to amortizable intangible assets</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 0.7<span></span></td>
        <td class="nump">$ 0.7<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice', window );">Business acquisition cost of acquired entity purchase price</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">2.0<span></span></td>
        <td class="nump">0.8<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable', window );">Non amortizable intangible assets</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">1.0<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount', window );">Business Acquisition, Purchase Price Allocation, Goodwill Amount</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">0.5<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage', window );">Business Acquisition Cost of Acquired Entity Cash Paid Percentage</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">35.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage', window );">Business acquisition cost of acquired entity stock issued percentage</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">65.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice', window );">Agreement to Acquire Synthesis</a></td>
        <td class="nump">21.3<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid', window );">Acquisition cash paid</a></td>
        <td class="nump">$ 19.3<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business Acquisition Cost Of Acquired Entity Cash Paid Percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_BusinessAcquisitionCostOfAcquiredEntityCashPaidPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business acquisition cost of acquired entity stock issued percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_BusinessAcquisitionCostOfAcquiredEntityStockIssuedPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business acquisition costs of acquired entity purchase price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_BusinessAcquisitionCostsOfAcquiredEntityPurchasePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessCombinationsAndDivestituresTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business Combinations And Divestitures Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_BusinessCombinationsAndDivestituresTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash paid to acquire the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 68<br> -Subparagraph f(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total cost of the acquired entity including the cash paid to shareholders of acquired entities, fair value of debt and equity securities issued to shareholders of acquired entities, the fair value of the liabilities assumed, and direct costs of the acquisition.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will be amortized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51<br> -Subparagraph e<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 52<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of goodwill arising from a business combination, which is the excess of the cost of the acquired entity over the amounts assigned to assets acquired and liabilities assumed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 52<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 53<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will not be amortized. Does not include goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51<br> -Subparagraph e<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 52<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Pensions and Other Benefit Plans [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">PENSIONS AND OTHER POSTRETIREMENT BENEFITS</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 6 - us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">NOTE 6 &#8212; PENSIONS AND OTHER POSTRETIREMENT BENEFITS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Components of Net Periodic Benefit Cost
    Net periodic benefit cost for the Company&#8217;s defined benefit retirement plans and other benefit
    plans for the fiscal second quarters of 2011 and 2010 include the following components:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="52%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Service cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">144</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">121</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">37</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">33</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Interest cost
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">214</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">194</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">46</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">50</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(277</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(248</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Recognized actuarial losses
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">98</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">59</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net periodic benefit cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">181</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">130</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Net periodic benefit cost for the Company&#8217;s defined benefit retirement plans and other benefit
    plans for the first fiscal six months of 2011 and 2010 include the following components:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="52%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Service cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">287</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">247</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">74</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">67</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Interest cost
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">427</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">394</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">100</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(555</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(500</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Recognized actuarial losses
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">194</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">117</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">25</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net periodic benefit cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">358</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">265</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">189</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">189</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Company Contributions<br />
    For the fiscal six months ended July&#160;3, 2011, the Company contributed $119&#160;million and $16&#160;million
    to its U.S. and international retirement plans, respectively. The Company plans to continue to fund
    its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International
    plans are funded in accordance with local regulations.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationAndRetirementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 87<br> -Paragraph 264<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 158<br> -Paragraph 7, 21, 22<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FAS106-2<br> -Paragraph 20, 21, 22<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Implementation Guide (Q and A)<br> -Number FAS88<br> -Paragraph 63<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 30<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 03-2<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5, 6, 7, 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 8<br> -Subparagraph m<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph q<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 106<br> -Paragraph 518<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EBEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segments of Business and Geographic Areas [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesBySegmentOfBusinessTableTextBlock', window );">Sales by segment of business</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table1 - jnj:SalesBySegmentOfBusinessTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">SALES BY SEGMENT OF BUSINESS
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,339</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,463</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(8.5</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,454</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,184</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,793</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,647</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,239</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,110</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,994</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,443</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">22.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,233</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,553</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,869</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,865</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,702</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,265</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,571</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,130</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,447</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,438</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9,150</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,892</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15.9</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">16,597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,330</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">8.3</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2,684</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">3,023</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(11.2</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,791</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,390</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,475</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,413</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,630</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,316</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,662</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,875</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12,292</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">11,191</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,741</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,751</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,262</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,606</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.9</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13,003</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12,357</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,055</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,090</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">17,715</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,871</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">11.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">32,770</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">30,961</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">5.8</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Operating profit by segment of business</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table2 - us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock-->
    <div align="right" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">OPERATING PROFIT BY SEGMENT OF BUSINESS
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">549</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">669</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(17.9</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,714</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,833</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(6.5</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,275</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,876</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(32.0</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Segments operating profit
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,538</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,378</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(19.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(116</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(158</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide income before taxes
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">3,422</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">4,220</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(18.9</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,122</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,454</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(22.8</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,923</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,803</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,219</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,578</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(42.3</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Segments operating profit
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,264</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">10,835</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(23.7</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(332</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(335</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide income before taxes
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,932</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">10,500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(24.5</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>Includes litigation expense of $290&#160;million and $540&#160;million recorded in the fiscal second
    quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011
    includes a gain related to the Company&#8217;s earlier investment in Crucell recorded in the fiscal first
    quarter of 2011. The fiscal second quarter and the first fiscal six
    months of 2010, includes net litigation expense of $115&#160;million and $202&#160;million, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Includes restructuring expense of $676&#160;million recorded in the fiscal second quarter and first
    fiscal six months of 2011. Includes litigation expense and additional DePuy ASR&#8482; Hip recall costs
    of $127&#160;million recorded in the fiscal second quarter of 2011. Includes litigation expense and
    additional DePuy ASR&#8482; Hip recall costs of $223&#160;million recorded in the first fiscal six months of
    2011. Includes net litigation expense of $42&#160;million and income of $1,542&#160;million recorded in the
    fiscal second quarter and the first fiscal six months of 2010, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(3)</td>
    <td>&#160;</td>
    <td>Amounts not allocated to segments include interest income/(expense), non-controlling interests
    and general corporate income/(expense).</td>
    </tr>
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SaleByGeographicAreaTableTextBlock', window );">Sales by geographic area</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note9_table3 - jnj:SaleByGeographicAreaTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">SALES BY GEOGRAPHIC AREA
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,447</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,438</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">0.1</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Europe
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,543</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,832</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">18.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,543</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,375</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,064</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,685</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">14.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">16,597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,330</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">8.3</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,055</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,090</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Europe
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,726</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,934</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">10.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,979</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,655</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,010</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,282</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">32,770</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">30,961</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">5.8</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SaleByGeographicAreaTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of sale by geographic area.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SaleByGeographicAreaTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesBySegmentOfBusinessTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sales by segment of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SalesBySegmentOfBusinessTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8721-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8736-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 131<br> -Paragraph 27, 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8906-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8813-108599<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ESSCI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">$ 16,597<span></span></td>
        <td class="nump">$ 15,330<span></span></td>
        <td class="nump">$ 32,770<span></span></td>
        <td class="nump">$ 30,961<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">8.30%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">5.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consumer [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">3,793<span></span></td>
        <td class="nump">3,647<span></span></td>
        <td class="nump">7,475<span></span></td>
        <td class="nump">7,413<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">4.00%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">0.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consumer [Member] | U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">1,339<span></span></td>
        <td class="nump">1,463<span></span></td>
        <td class="nump">2,684<span></span></td>
        <td class="nump">3,023<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="num">(8.50%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(11.20%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consumer [Member] | International [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">2,454<span></span></td>
        <td class="nump">2,184<span></span></td>
        <td class="nump">4,791<span></span></td>
        <td class="nump">4,390<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">12.40%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">9.10%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">6,233<span></span></td>
        <td class="nump">5,553<span></span></td>
        <td class="nump">12,292<span></span></td>
        <td class="nump">11,191<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">12.20%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">9.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member] | U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">3,239<span></span></td>
        <td class="nump">3,110<span></span></td>
        <td class="nump">6,630<span></span></td>
        <td class="nump">6,316<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">4.10%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">5.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member] | International [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">2,994<span></span></td>
        <td class="nump">2,443<span></span></td>
        <td class="nump">5,662<span></span></td>
        <td class="nump">4,875<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">22.60%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">16.10%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">6,571<span></span></td>
        <td class="nump">6,130<span></span></td>
        <td class="nump">13,003<span></span></td>
        <td class="nump">12,357<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">7.20%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">5.20%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member] | U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">2,869<span></span></td>
        <td class="nump">2,865<span></span></td>
        <td class="nump">5,741<span></span></td>
        <td class="nump">5,751<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">0.10%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(0.20%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member] | International [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">3,702<span></span></td>
        <td class="nump">3,265<span></span></td>
        <td class="nump">7,262<span></span></td>
        <td class="nump">6,606<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">13.40%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">9.90%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">7,447<span></span></td>
        <td class="nump">7,438<span></span></td>
        <td class="nump">15,055<span></span></td>
        <td class="nump">15,090<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">0.10%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(0.20%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">International [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">$ 9,150<span></span></td>
        <td class="nump">$ 7,892<span></span></td>
        <td class="nump">$ 17,715<span></span></td>
        <td class="nump">$ 15,871<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percentage Change</a></td>
        <td class="nump">15.90%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">11.60%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesBySegmentOfBusiness">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage change in sales by segment of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageChangeInSalesBySegmentOfBusiness</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueGoodsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingInformationRevenueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EZIAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Pensions and Other Postretirement Benefit (Details Textuals) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">U.S. retirement plans [Member]</div>
        </td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PensionsAndOtherBenefitPlansTextualsAbstract', window );"><strong>Pensions and Other Benefit Plans (Textuals)</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
        <td class="nump">$ 119<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">International retirement plans [Member]</div>
        </td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PensionsAndOtherBenefitPlansTextualsAbstract', window );"><strong>Pensions and Other Benefit Plans (Textuals)</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
        <td class="nump">$ 16<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PensionsAndOtherBenefitPlansTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Pensions and Other Benefit Plans Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PensionsAndOtherBenefitPlansTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionContributions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash or cash equivalents contributed by the entity to fund its pension plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionContributions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note7_table1 - us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="40%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Total</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Accum</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Other</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Foreign</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Securities</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Employee</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Deriv.</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Comp.</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">Gains/(Losses)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Currency</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Available</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Benefit</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#038;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Income/</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Translation</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">for sale</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Hedges</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">(Loss)</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(969</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">24</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2,686</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">100</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(3,531</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2011 six months change
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:30px; text-indent:-15px">Unrealized gain (loss)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">435</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:30px; text-indent:-15px">Net amount reclassed to net earnings
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(139</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">116</td>
    <td nowrap="nowrap">*</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net six months change
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,787</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">296</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">128</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">128</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,339</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">July&#160;3, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">818</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">320</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2,558</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">228</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1,192</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Substantially offset in net earnings by changes in value of the underlying transactions.</td>
    </tr>
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Legal Proceedings<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Legal Proceedings [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">LEGAL PROCEEDINGS</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 11 - us-gaap:LegalMattersAndContingenciesTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 11 &#8212; LEGAL PROCEEDINGS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Johnson &#038; Johnson (the Company) and certain of its subsidiaries are involved in various lawsuits
    and claims regarding product liability, intellectual property, commercial and other matters;
    governmental investigations; and other legal proceedings that arise from time to time in the
    ordinary course of their business.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company records accruals for such contingencies when it is probable that a liability will be
    incurred and the amount of the loss can be reasonably estimated. Through the period ended July&#160;3,
    2011, the Company has determined that the liabilities associated with certain litigation matters
    are probable and can be reasonably estimated. The Company has accrued for these matters and will
    continue to monitor each related legal issue and adjust accruals for new information and further
    developments in accordance with ASC 450-20-25. For these and other litigation and regulatory
    matters currently disclosed for which a loss is probable or reasonably possible, the Company is
    unable to determine an estimate of the possible loss or range of loss beyond the amounts already
    accrued. These matters can be affected by various factors, including damages sought in the
    proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced
    or is not complete; proceedings are in early stages; matters present legal uncertainties; there are
    significant facts in dispute; there are numerous parties involved.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In the Company&#8217;s opinion, based on its examination of these matters, its experience to date and
    discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in
    the Company&#8217;s balance sheet, is not expected to have a material adverse effect on the Company&#8217;s
    financial position, although the resolution in any reporting period of one or more of these
    matters, either alone or in the aggregate, may have a material adverse effect on the Company&#8217;s
    results of operations, and cash flows for that period.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u><b>PRODUCT LIABILITY</b></u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#8217;s subsidiaries are involved in numerous product liability cases in the United States,
    many of which concern alleged adverse reactions to drugs and medical devices. The damages claimed
    are substantial, and while the Company&#8217;s subsidiaries are confident of the adequacy of the warnings
    and instructions for use that accompany such products, it is not feasible to predict the ultimate
    outcome of litigation. The Company has established product liability reserves based on currently
    available information, which in some cases may be limited, and changes to the reserves may be
    required in the future as additional information becomes available.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Multiple products of the Company&#8217;s subsidiaries are subject to numerous product liability claims
    and lawsuits. There are a significant number of claimants who have pending lawsuits or claims
    regarding injuries allegedly due to ORTHO EVRA&#174;, RISPERDAL&#174;, LEVAQUIN&#174;, DURAGESIC&#174;/fentanyl
    patches, pelvic meshes, the CHARIT&#201;&#8482; Artificial Disc, CYPHER&#174; Stent, and ASR&#8482; Hip. These claimants
    seek substantial compensatory and, where available, punitive damages.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In August&#160;2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR&#8482;
    XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System used in hip replacement surgery. Claims
    for personal injury have been made against DePuy and the Company. The Company has received limited
    information to date with respect to potential claims and other costs associated with this recall.
    The Company&#8217;s product liability reserve has been increased in part due to an increase in
    anticipated product liability litigation expense and costs associated with the DePuy ASR&#8482; Hip
    recall program. Changes to the reserve may be required in the future as additional information
    becomes available. The ultimate resolution of these matters is not
    expected to have a material adverse effect on the Company&#8217;s
    financial position, although  the resolution in any reporting period
    could have a material impact on the Company&#8217;s results of
    operations and cash flows for that period.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u><b>INTELLECTUAL PROPERTY</b></u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Certain of the Company&#8217;s subsidiaries are subject, from time to time, to legal proceedings and
    claims related to patent, trademark and other intellectual property matters arising out of their
    business. The most significant of these matters are described below.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt"><font style="font-variant: small-caps"><u>PATENT INFRINGEMENT</u></font>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Certain of the Company&#8217;s subsidiaries are involved in lawsuits challenging the coverage and/or
    validity of the patents on their products. Although the Company&#8217;s subsidiaries believe that they
    have substantial defenses to these challenges with respect to all material patents, there can be no
    assurance as to the outcome of these matters, and a loss in any of these cases could potentially
    adversely affect the ability of the Company&#8217;s subsidiaries to sell their products, or require the
    payment of past damages and future royalties.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">MEDICAL DEVICES &#038; DIAGNOSTICS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In October&#160;2004, Tyco Healthcare Group, LP, (Tyco) and U.S. Surgical Corporation filed a lawsuit
    against Ethicon Endo-Surgery, Inc. (EES)&#160;in the United States District Court for the District of
    Connecticut alleging that several features of EES&#8217;s HARMONIC&#174; scalpel infringed four
    Tyco patents. In October&#160;2007, on motions for summary judgment prior to the initial trial, a number
    of claims were found invalid and a number were found infringed. However, no claim was found both
    valid and infringed. Trial commenced in December&#160;2007, and the court dismissed the case without
    prejudice on grounds that Tyco did not own the patents in suit. The dismissal without prejudice was
    affirmed on appeal. In January&#160;2010, Tyco filed another complaint in the United States District
    Court for the District of Connecticut asserting infringement of three of the four patents from the
    previous lawsuit and adding new products. Tyco is seeking monetary damages and injunctive relief.
    This case is scheduled to be tried in October&#160;2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in March&#160;2006, Cordis Corporation (Cordis) filed patent infringement lawsuits in the
    United States District Courts for the Districts of New Jersey and Delaware, against Guidant
    Corporation (Guidant), Abbott Laboratories, Inc. (Abbott), Boston Scientific Corporation (Boston
    Scientific) and Medtronic Ave, Inc. (Medtronic) alleging that the Xience V&#8482; (Abbott), Promus&#8482;
    (Boston Scientific) and Endeavor&#174; (Medtronic) drug eluting stents infringe several of Cordis&#8217;s
    Wright/Falotico patents. Cordis is seeking monetary relief. In January&#160;2010, in one of the cases
    against Boston Scientific, the United States District Court for the District of Delaware found the
    Wright/Falotico patents invalid for lack of written description and/or lack of enablement. In June
    2011, the Court of Appeals for the Federal Circuit affirmed the ruling, and Cordis moved for the
    Court to reconsider that decision.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In October&#160;2007, Bruce Saffran (Saffran) filed a patent infringement lawsuit against the Company
    and Cordis in the United States District Court for the Eastern District of Texas alleging
    infringement on U.S. Patent No.&#160;5,653,760. In January&#160;2011, a jury returned a verdict finding that
    Cordis&#8217;s sales of its CYPHER&#174; stent willfully infringed a patent issued to Saffran. The jury
    awarded Saffran $482&#160;million. In March&#160;2011, the Court entered judgment against Cordis in the
    amount of $593&#160;million, representing the jury verdict, plus $111&#160;million in pre-judgment
    interest.
    Cordis has moved for the District Court to overturn the jury verdict and to vacate the judgment.
    If that motion is denied, Cordis will appeal the judgment. Because the Company believes that the
    potential for an unfavorable outcome is not probable, it has not established a reserve with respect
    to the case.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In November&#160;2007, Roche Diagnostics Operations, Inc., et al. (Roche) filed a patent infringement
    lawsuit against LifeScan, Inc. (LifeScan) in the United States District Court for the District of
    Delaware, accusing LifeScan&#8217;s entire OneTouch&#174; line of blood glucose monitoring systems of
    infringement of two patents related to the use of microelectrode sensors. In September&#160;2009,
    LifeScan obtained a favorable ruling on claim construction that precluded a finding of
    infringement. The Court entered judgment against Roche in July&#160;2010 and Roche appealed. Briefing
    on appeal issues has been completed. Oral argument will be held in
    fall 2011. Roche is seeking
    monetary damages and injunctive relief.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in February&#160;2008, Cordis filed patent infringement lawsuits in the United States District
    Court for the District of New Jersey against Guidant, Abbott, Boston Scientific and Medtronic
    alleging that the Xience V&#8482; (Abbott), Promus&#8482; (Boston Scientific) and Endeavor&#174; (Medtronic) drug
    eluting stents infringe several of Wyeth&#8217;s (now Pfizer Inc.) Morris patents, which have been
    licensed to Cordis. Cordis is seeking monetary relief. Trial is scheduled for September&#160;2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In June&#160;2009, Rembrandt Vision Technologies, L.P. (Rembrandt) filed a patent infringement lawsuit
    against Johnson &#038; Johnson Vision Care, Inc. (JJVC)&#160;in the United States District Court for the
    Eastern District of Texas alleging that JJVC&#8217;s manufacture and sale of its ACUVUE ADVANCE&#174; and
    ACUVUE&#174; OASYS&#8482; HYDROGEL contact lenses infringe their U.S. Patent No.&#160;5,712,327 (the Chang patent).
    Rembrandt is seeking monetary relief. The case is scheduled for trial in May&#160;2012.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt">PHARMACEUTICAL
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In
    April&#160;2007, Centocor, Inc. (Centocor) (now Janssen Biotech, Inc. (JBI)) filed a patent infringement lawsuit against Abbott Laboratories,
    Inc. (Abbott) in the United States District Court for the Eastern District of Texas alleging that
    Abbott&#8217;s HUMIRA&#174; anti-TNF alpha product infringes Centocor&#8217;s U.S. Patent 7,070,775. In June&#160;2009,
    a jury returned a verdict finding the patent valid and infringed, and awarded JBI damages of
    approximately $1.7&#160;billion. In February&#160;2011, the Court of Appeals reversed the June&#160;2009 decision
    and the judgment of the District Court. JBI will file a petition for
    review of the decision in the United
    States Supreme Court.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In May&#160;2009, Abbott Biotechnology Ltd. (Abbott) filed a patent infringement lawsuit against
    Centocor (now JBI) in the United States District Court for
    the District of Massachusetts alleging that SIMPONI&#174; infringes Abbott&#8217;s U.S. Patent Nos. 7,223,394
    and 7,451,031 (the Salfeld patents). Abbott is seeking monetary damages and injunctive relief. No
    trial date has been set.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In August&#160;2009, Abbott GmbH &#038; Co. (Abbott GmbH) and Abbott Bioresearch Center filed a patent
    infringement lawsuit against Centocor (now JBI) in the United States District Court for the
    District of Massachusetts alleging that STELARA&#174; infringes two United States patents assigned to
    Abbott GmbH. JBI filed a complaint in the United States District Court for the District of Columbia
    for a declaratory judgment of non-infringement and invalidity of the Abbott GmbH patents, as well
    as a Complaint for Review of a Patent Interference Decision that granted priority of invention on
    one of the two asserted patents to Abbott GmbH. The
    cases have been transferred from the District
    of Columbia to the District of Massachusetts. Discovery in these cases is ongoing. No trial date
    has been set. Also in August&#160;2009, Abbott GmbH and Abbott Laboratories Limited brought a patent
    infringement lawsuit in The Federal Court of Canada alleging that STELARA&#174; infringes Abbott GmbH&#8217;s
    Canadian patent. The Canadian case is scheduled to be tried in October&#160;2012. In each of these
    cases, Abbott is seeking monetary damages and injunctive relief.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In August&#160;2009, Bayer HealthCare LLC (Bayer) filed a patent infringement lawsuit against Centocor
    Ortho Biotech Inc. (now JBI) in United States District Court for the District of Massachusetts
    alleging that the manufacture and sale by JBI of SIMPONI&#174; infringes a Bayer patent relating to
    human anti-TNF antibodies. In January&#160;2011, the court issued judgment dismissing Bayer&#8217;s
    infringement claims. Bayer appealed this ruling. In addition, in November&#160;2009, Bayer filed a
    lawsuit under its European counterpart to these patents in Germany and the Netherlands. The court
    in the Netherlands held the Dutch patent invalid and entered judgment in favor of JBI&#8217;s European
    affiliate, Janssen Biologics B.V. Bayer appealed that judgment in the Netherlands. In addition,
    in March&#160;2010, Janssen-Cilag NV filed a revocation action in the High Court in London seeking to
    invalidate Bayer&#8217;s UK patent relating to human anti-TNF antibodies. In May&#160;2011, JBI settled all
    of these cases and received a paid-up, royalty-free license to the family of patents in suit.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>LITIGATION AGAINST FILERS OF ABBREVIATED NEW DRUG APPLICATIONS (ANDAs)</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following summarizes lawsuits pending against generic companies that filed Abbreviated New Drug
    Applications (ANDAs) seeking to market generic forms of products sold by various subsidiaries of
    the Company prior to expiration of the applicable patents covering those products. These ANDAs
    typically include allegations of non-infringement, invalidity and unenforceability of these
    patents. In the event the Company&#8217;s subsidiaries are not successful in these actions, or the
    statutory 30-month stays expire before the District Court rulings are obtained, the third-party
    companies involved will have the ability, upon approval of the United States Food and Drug
    Administration (FDA), to introduce generic versions of the products at issue resulting in very
    substantial market share and revenue losses for those products.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">CONCERTA&#174;
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In January&#160;2010, ALZA Corporation (ALZA)&#160;and Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI)
    (now Janssen Pharmaceuticals, Inc. (JPI)) filed a patent infringement lawsuit in the United States
    District Court for the District of Delaware against Kremers-Urban, LLC and KUDCO Ireland, Ltd.
    (collectively, KUDCO) in response to KUDCO&#8217;s ANDA seeking approval to market a generic version of
    CONCERTA&#174; before the expiration of two of ALZA and JPI&#8217;s patents relating to CONCERTA&#174;. KUDCO filed
    counterclaims alleging non-infringement and invalidity. ALZA and JPI subsequently removed one of
    the patents from the lawsuit.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In November&#160;2010, ALZA and OMJPI (now JPI) filed a patent infringement lawsuit in the United States
    District Court for the District of Delaware against Impax Laboratories, Inc. (Impax), Teva
    Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. (collectively, Teva) in response
    to Impax and Teva&#8217;s filing of a major amendment to its ANDA seeking approval to market a generic
    version of CONCERTA&#174; before the expiration of ALZA and JPI&#8217;s patent relating to CONCERTA&#174;. Impax
    and Teva filed counterclaims alleging non-infringement and invalidity. In May&#160;2011, Alza and JPI
    filed a second lawsuit against Teva in response to Teva&#8217;s filing of a second major amendment to its
    ANDA seeking approval to market additional dosage strengths of its generic CONCERTA&#174; product before
    the expiration of Alza and JPI&#8217;s patent relating to CONCERTA&#174;. In each of the above cases, ALZA and
    JPI are seeking an Order enjoining the defendants from marketing its generic version of CONCERTA&#174;
    prior to the expiration of ALZA and JPI&#8217;s CONCERTA&#174; patent.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt">ORTHO TRI-CYLEN&#174;LO
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In October&#160;2008, OMJPI (now JPI) and Johnson &#038; Johnson Pharmaceutical Research &#038; Development,
    L.L.C. (JJPRD)&#160;filed a patent infringement lawsuit against Watson Laboratories, Inc. and Watson
    Pharmaceuticals, Inc. (collectively, Watson) in the United States District Court for the District
    of New Jersey in response to Watson&#8217;s ANDA seeking approval to market a generic version of JPI&#8217;s
    product prior to the expiration of JPI&#8217;s patent relating to ORTHO TRI-CYCLEN&#174; LO (the OTCLO
    patent). Watson filed a counterclaim alleging invalidity of the patent. In addition, in January
    2010, JPI filed a patent infringement lawsuit against Lupin Ltd. and Lupin Pharmaceuticals, Inc.
    (collectively, Lupin) in the United States District Court for the District of New Jersey in
    response to Lupin&#8217;s ANDA seeking approval to market a generic version of ORTHO TRI-CYCLEN&#174; LO prior
    to the expiration of the OTCLO patent. Lupin filed a counterclaim alleging invalidity of the
    patent. The Lupin and Watson cases have been consolidated.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In November&#160;2010, OMJPI (now JPI) filed a patent infringement lawsuit against Mylan Inc. and Mylan
    Pharmaceuticals, Inc. (collectively, Mylan), and Famy Care, Ltd. (Famy Care) in the United States
    District Court for the District of New Jersey in response to Famy Care&#8217;s ANDA seeking approval to
    market a generic version of ORTHO TRI-CYCLEN&#174; LO prior to the expiration of the OTCLO patent.
    Mylan and Famy Care filed counterclaims alleging
    invalidity of the patent. In each of the above
    cases, JJPRD and/or JPI are seeking an Order enjoining the defendants from marketing their generic
    versions of ORTHO TRI-CYLCEN&#174; LO before the expiration of the OTCLO patent.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt">PREZISTA&#174;
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In November&#160;2010, Tibotec, Inc. and Tibotec Pharmaceuticals, Inc. (collectively, Tibotec) filed a
    patent infringement lawsuit against Lupin, Ltd., Lupin Pharmaceuticals, Inc. (collectively, Lupin),
    Mylan, Inc. and Mylan Pharmaceuticals, Inc. (collectively, Mylan) in the United States District
    Court for the District of New Jersey in response to Lupin&#8217;s and Mylan&#8217;s respective ANDA&#8217;s seeking
    approval to market generic versions of Tibotec&#8217;s PREZISTA&#174; product before the expiration of
    Tibotec&#8217;s patent relating to PREZISTA&#174;. Lupin and Mylan each filed counterclaims alleging
    non-infringement and invalidity.
    In July&#160;2011,
    Tibotec filed another patent infringement lawsuit against Lupin in the United States
    District Court for the District of New Jersey in response to Lupin&#8217;s supplement to its ANDA to add
    new dosage strengths for its proposed product.
    In August&#160;2011, Tibotec and G.D. Searle &#038; Company (G.D. Searle)
    filed a patent infringement lawsuit against Lupin and Mylan in response to their notice letters
    advising that their ANDAs are seeking approval to market generic versions of Tibotec&#8217;s PREZISTA&#174;
    product before the expiration of two patents relating to PREZISTA&#174; that Tibotec exclusively
    licenses from G.D. Searle.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In March&#160;2011, Tibotec and G.D. Searle  filed a patent infringement lawsuit
    against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Ltd. (collectively, Teva) in the
    United States District Court for the District of New Jersey in response to Teva&#8217;s ANDA seeking
    approval to market a generic version of PREZISTA&#174; before the expiration of certain patents relating
    to PREZISTA&#174; that Tibotec either owns or exclusively licenses from G.D. Searle.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In March&#160;2011, Tibotec filed a patent infringement lawsuit against Hetero Drugs, Ltd. Unit III and
    Hetero USA Inc. (collectively, Hetero) in the United States District Court for the District of New
    Jersey in response to Hetero&#8217;s ANDA seeking approval to market a generic version of PREZISTA&#174;
    before the expiration of certain patents relating to PREZISTA&#174; that Tibotec exclusively licenses
    from G.D. Searle.
    In July 2011, upon agreement by the parties, the Court entered a stay of the lawsuit pending a final decision
    in the lawsuit  against Teva with respect to the validity and/or enforceability
    of the patents that Tibotec licenses from G.D. Searle, with Hetero agreeing to be bound by such final decision.
    In each of the above lawsuits, Tibotec is seeking an Order enjoining the
    defendants from marketing their generic versions of PREZISTA&#174; before the expiration of the relevant
    patents.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>OTHER INTELLECTUAL PROPERTY MATTERS</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In September&#160;2009, Centocor Ortho Biotech Products, L.P. (now Janssen Products, LP (JPLP))
    intervened in an inventorship lawsuit filed by the University of Kansas Center for Research, Inc.
    (KUCR)&#160;against the United States of America (USA)&#160;in the United States District Court for the
    District of Kansas. KUCR alleges that two KUCR scientists should be added as inventors on two
    USA-owned patents relating to VELCADE&#174;. The USA licensed the patents
    (and their foreign
    counterparts) to Millennium Pharmaceuticals, Inc. (MPI), who in turn sublicensed the patents (and
    their foreign counterparts) to JPLP for commercial marketing outside the United States. In July
    2010, the parties reached a settlement agreement to resolve the disputes in this case and will
    submit the inventorship issue to arbitration. The case has been stayed pending the arbitration. As
    a result of the settlement agreement, the outcome of the arbitration regarding inventorship will
    determine whether pre-specified payments will be made to KUCR, but will not affect JPLP&#8217;s right to
    market VELCADE&#174;.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In December&#160;2009, the State of Israel filed a lawsuit in the District Court in Tel Aviv Jaffa
    against various affiliates of Omrix Biopharmaceuticals, Inc. (Omrix). In the lawsuit, the State
    claims that an employee of a government-owned hospital was the inventor on several patents related
    to fibrin glue technology that the employee developed while he was a government employee. The State
    claims that he had no right to transfer any intellectual property to Omrix because it belongs to
    the State. The State is seeking damages plus royalties on QUIXIL&#8482; and EVICEL&#8482; or, alternatively,
    transfer of the patents to the State.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In January&#160;2011, Genentech, Inc. (Genentech) initiated an arbitration against UCB Celltech
    (Celltech) seeking damages for allegedly cooperating with Centocor (now JBI) to improperly
    terminate a prior agreement in which JBI was sublicensed under Genentech&#8217;s Cabilly patents. JBI
    has an indemnity agreement with Celltech, and Celltech has asserted that JBI is liable for any
    damages Celltech may be required to pay Genentech in that arbitration.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u><b>GOVERNMENT PROCEEDINGS</b></u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Like other companies in the pharmaceutical and medical devices and diagnostics industries, the
    Company and certain of its subsidiaries are subject to extensive regulation by national, state and
    local government agencies in the United States and other countries in which they operate. As a
    result, interaction with government agencies is ongoing. The most significant litigation brought
    by, and investigations conducted by, government agencies are listed below. It is possible that
    criminal charges and substantial fines and/or civil penalties or damages could result from
    government investigations or litigation.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>AVERAGE WHOLESALE PRICE (AWP)&#160;LITIGATION</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company and several of its pharmaceutical subsidiaries (the J&#038;J AWP defendants), along with
    numerous other pharmaceutical companies, are defendants in a series of lawsuits in state and
    federal courts involving allegations that the pricing and marketing of certain pharmaceutical
    products amounted to fraudulent and otherwise actionable conduct because, among other things, the
    companies allegedly reported an inflated Average Wholesale Price (AWP)&#160;for the drugs at issue.
    Payors alleged that they used those AWPs in calculating provider reimbursement levels.
    Many of these cases, both federal actions and state actions
    removed to federal court, were
    consolidated for pre-trial purposes in a Multi-District Litigation (MDL)&#160;in the United States
    District Court for the District of Massachusetts.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The plaintiffs in these cases included three classes of private persons or entities that paid for
    any portion of the purchase of the drugs at issue based on AWP, and state government entities that
    made Medicaid payments for the drugs at issue based on AWP. In June&#160;2007, after a trial on the
    merits, the MDL Court dismissed the claims of two of the plaintiff classes against the J&#038;J AWP
    defendants from the case regarding all claims of Classes 2 and 3. In March&#160;2011, the Court
    dismissed the claims of the third class against the J&#038;J AWP defendants without prejudice.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">AWP cases brought by various Attorneys General have proceeded to trial against other manufacturers.
    Three state cases against certain of the Company&#8217;s subsidiaries have been set for trial: Idaho in
    October&#160;2011, Kentucky in January&#160;2012 and Kansas in March&#160;2013. Other state cases are likely to
    be set for trial. In addition, an AWP case against the J&#038;J AWP defendants brought by the
    Commonwealth of Pennsylvania was tried in Commonwealth Court in October and November&#160;2010. The
    Court found in the Commonwealth&#8217;s favor with regard to certain of its claims under the Pennsylvania
    Unfair Trade Practices and Consumer Protection Law, entered an injunction, and awarded $45&#160;million
    in restitution and $6.5&#160;million in civil penalties. The Court found in the J&#038;J AWP defendants&#8217;
    favor on the Commonwealth&#8217;s claims of unjust enrichment, misrepresentation/fraud, civil conspiracy,
    and on certain of the Commonwealth&#8217;s claims under the Pennsylvania Unfair Trade Practices and
    Consumer Protection Law. The parties are currently awaiting a ruling on post trial motions, which,
    if necessary, will be followed by an appeal to the Pennsylvania Supreme Court. The Company
    believes that it has strong arguments supporting an appeal. Because the Company believes that the
    potential for an unfavorable outcome is not probable, it has not established a reserve with respect
    to the verdict.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>RISPERDAL&#174;</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In January&#160;2004, Janssen Pharmaceutica Inc. (Janssen) (now Janssen Pharmaceuticals, Inc. (JPI))
    received a subpoena from the Office of the Inspector General of the United States Office of
    Personnel Management seeking documents concerning sales and marketing of, any and all payments to
    physicians in connection with sales and marketing of, and clinical trials for, RISPERDAL&#174; from 1997
    to 2002. Documents subsequent to 2002 have also been requested by the Department of Justice. An
    additional subpoena seeking information about marketing of, and adverse reactions to, RISPERDAL&#174;
    was received from the United States Attorney&#8217;s Office for the Eastern District of Pennsylvania in
    November&#160;2005. Numerous subpoenas seeking testimony from various witnesses before a grand jury were
    also received. JPI cooperated in responding to these requests for documents and witnesses. The
    United States Department of Justice and the United States Attorney&#8217;s Office for the Eastern
    District of Pennsylvania (the Government) are continuing to actively pursue both criminal and civil
    actions. In February&#160;2010, the Government served Civil Investigative Demands seeking additional
    information
    relating to sales and marketing of RISPERDAL&#174; and sales and marketing of INVEGA&#174;. The
    focus of these matters is the alleged promotion of RISPERDAL&#174; and INVEGA&#174; for off-label uses. The
    Government has notified JPI that there are also pending qui tam actions alleging off-label
    promotion of RISPERDAL&#174;. The Government informed JPI that it will intervene in these qui tam
    actions and file a superseding complaint.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Discussions have been ongoing in an effort to resolve criminal penalties under the Food Drug and
    Cosmetic Act related to the promotion of RISPERDAL&#174;. An
    agreement in principal on key issues relevant
    to a disposition of criminal charges pursuant to a single misdemeanor violation of the Food Drug
    and Cosmetic Act has been reached, but certain issues remain open
    before a settlement can be
    finalized. The Company has adjusted the accrued amount in the second
    quarter of 2011 to cover the financial component of the
    proposed criminal settlement.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In
    addition, discussions with state and federal government representatives to resolve the separate
    civil claims related to the marketing of RISPERDAL&#174; and INVEGA&#174;, including
    those under the False Claims Act (the qui
    tam actions), have been ongoing. The Company believes there are meritorious defenses to these
    claims, and it remains unclear whether a settlement can be reached as discovery is not complete,
    there are significant facts in dispute, the damages sought in the claims are unsubstantiated and
    indeterminate, there are numerous parties involved, and possible outcomes are uncertain. For these
    reasons, the Company is unable to estimate a range of loss. However, future negotiations may lead
    to a narrowing of the areas of disagreement and the liability may then become reasonably estimable
    in accordance with applicable accounting principles. If a negotiated resolution cannot be reached,
    civil litigation relating to the allegations of off-label promotion of RISPERDAL&#174; and/or INVEGA&#174; is
    likely. The ultimate resolution of the above criminal and these civil matters is not expected to
    have a material adverse effect on the Company&#8217;s financial position, although the resolution in any
    reporting period could have a material impact on the Company&#8217;s results of operations and cash flows
    for that period.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The
    Attorneys General of multiple states, including Alaska, Arkansas,
    Louisiana, Massachusetts, Mississippi, Montana, New Mexico,
    Pennsylvania, South Carolina, Texas and Utah, have pending actions against Janssen (now JPI) seeking
    one or more of the following remedies:
    reimbursement of Medicaid or other
    public funds for RISPERDAL&#174; prescriptions written for off-label use, compensation for treating
    their citizens for alleged adverse reactions to RISPERDAL&#174;, civil fines or penalties, damages for
    &#8220;overpayments&#8221; by the state and others, punitive damages,
    or other relief relating to alleged unfair business practices.
    Certain of these actions also seek injunctive relief relating to the
    promotion of RISPERDAL&#174;. In the Texas matter, the Attorney General of
    Texas has joined a qui tam action in that state seeking similar
    relief, and the trial is scheduled to commence in late November&#160;2011.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Attorney General of West Virginia commenced suit in 2004 against Janssen (now JPI) based on
    claims of alleged consumer fraud as to DURAGESIC&#174;, as well as RISPERDAL&#174;. JPI was found liable and
    damages were assessed at $4.5&#160;million. JPI filed an appeal, and in November&#160;2010, the West
    Virginia Supreme Court reversed the trial court&#8217;s decision. In December&#160;2010, the Attorney General
    of West Virginia dismissed the case as it related to RISPERDAL&#174; without any payment. Thereafter,
    JPI settled the case insofar as it related to DURAGESIC&#174;.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In 2004, the Attorney General of Louisiana filed a multi-count Complaint against Janssen (now JPI).
    The Company was later added as a defendant. The case was tried in October&#160;2010. The issue tried
    to the jury was whether the Company or JPI had violated the State&#8217;s Medicaid Fraud Act (the Act)
    through misrepresentations allegedly made in the mailing of a November&#160;2003 Dear Health Care
    Provider letter. The jury returned a verdict that JPI and the Company had violated the Act and
    awarded $257.7&#160;million in damages. The trial judge subsequently awarded the Attorney General
    counsel fees and expenses in the amount of $73&#160;million. The Company and JPI&#8217;s motion for a new
    trial was denied. The Company and JPI have filed an appeal and believe that they have strong
    arguments supporting the appeal. The Company believes that the potential for an unfavorable outcome
    is not probable, and therefore, the Company has not established a reserve with respect to the
    verdict.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In 2007, The Office of General Counsel of the Commonwealth of Pennsylvania filed a lawsuit against
    Janssen (now JPI) on a multi-Count Complaint related to Janssen&#8217;s sale of RISPERDAL&#174; to the
    Commonwealth&#8217;s Medicaid program. The trial occurred in June&#160;2010. The trial judge dismissed the
    case after the close of the plaintiff&#8217;s evidence. The Commonwealth&#8217;s post-trial motions were
    denied. The Commonwealth filed an appeal in April&#160;2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In 2007, the Attorney General of South Carolina filed a lawsuit against the Company and Janssen
    (now JPI) on several counts. In March&#160;2011, the matter was tried on liability only, at which time
    the lawsuit was limited to claims of violation of the South Carolina Unfair Trade Practice Act,
    including, among others, questions of whether the Company or JPI engaged in unfair or deceptive
    acts or practices in the conduct of any trade or commerce by distributing the November&#160;2003 &#8220;Dear
    Doctor&#8221; letter or in their use of the FDA-approved label. The jury found in favor of the Company
    and against JPI. In June&#160;2011, the Court awarded civil penalties of approximately $327.1&#160;million.
    Post-trial briefing is underway, and if relief is not granted, JPI intends to appeal this judgment.
    The Company and JPI believe that JPI has strong arguments supporting an appeal and that the
    potential for an unfavorable outcome is not probable. Therefore, the Company has not established a
    reserve with respect to the verdict.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Attorneys
    General of approximately 40 other states have indicated a potential interest in pursuing similar
    litigation against JPI, and have obtained a tolling agreement staying the running of the statute of
    limitations while they pursue a coordinated civil investigation of JPI regarding potential consumer
    fraud actions in connection with the marketing of
    RISPERDAL&#174;.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt"><u>MCNEIL CONSUMER HEALTHCARE</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in June&#160;2010, McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (McNeil Consumer
    Healthcare), and certain
    affiliates, including the Company (the Companies), received grand jury
    subpoenas from the United States Attorney&#8217;s Office for the Eastern District of Pennsylvania
    requesting documents broadly relating to recent recalls of various products of McNeil Consumer
    Healthcare, and the FDA inspections of the Fort Washington, Pennsylvania and Lancaster,
    Pennsylvania manufacturing facilities. In addition, in February&#160;2011, the government served
    McNEIL-PPC, Inc. (McNEIL-PPC) with a Civil Investigative Demand seeking records relevant to its
    investigation to determine if there was a violation of the False Claims Act. The Companies are
    cooperating with the United States Attorney&#8217;s Office in responding to these subpoenas.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Companies have also received Civil Investigative Demands from multiple State Attorneys General
    Offices broadly relating to the McNeil recall issues. The Companies continue to cooperate with
    these inquiries. In January&#160;2011, the Oregon Attorney General filed a civil complaint against the
    Company, McNEIL-PPC and McNeil Healthcare LLC in state court alleging civil violations of the
    Oregon unlawful trade practices act relating to an earlier recall of a McNeil OTC product. The
    Companies removed this case to federal court and have sought transfer of the case to the United
    States District Court for the Eastern District of Pennsylvania. The Judicial Panel on
    Multidistrict Litigation denied the transfer request, and the Companies moved for reconsideration
    of the Panel&#8217;s decision. Currently, the case has been stayed pending a final decision on transfer.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In March&#160;2011, the United States filed a complaint for injunctive relief in the United States
    District Court for the Eastern District of Pennsylvania against McNEIL-PPC and two of its
    employees, alleging that McNEIL-PPC is in violation of FDA regulations regarding the manufacture of
    drugs at the facilities it operates in Lancaster, Pennsylvania, Fort Washington, Pennsylvania, and
    Las Piedras, Puerto Rico. On the same day, the parties filed a consent decree of permanent
    injunction resolving the claims set forth in the complaint. The Court approved and entered the
    consent decree on March&#160;16, 2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The consent decree, which is subject to ongoing enforcement by the court, requires McNEIL-PPC to
    take enhanced measures to remediate the three facilities. The Fort Washington facility, which the
    company voluntarily shut down in April&#160;2010, will remain shut down until a third-party consultant
    certifies that its operations will be in compliance with applicable law, and the FDA concurs with
    the third party certification. The Lancaster and Las Piedras facilities may continue to
    manufacture and distribute drugs, provided that a third party reviews manufacturing records for
    selected batches of drugs released from the facilities, and certifies that any deviations reviewed
    do not adversely affect the quality of the selected batches.
    McNEIL-PPC must further submit a workplan (with deadlines) to the FDA for remediation of the
    Lancaster and Las Piedras facilities; that plan is subject to FDA approval. After completion of
    the workplan, third-party batch record review may cease if the FDA has stated that the facilities
    appear to be in compliance with applicable law. Each facility is
    subject to a five-year audit
    period by a third party after the facility has been deemed by the FDA to be in apparent compliance
    with applicable law.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>OMNICARE</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In September&#160;2005, the Company received a subpoena from the United States Attorney&#8217;s Office,
    District of Massachusetts, seeking documents related to the sales and marketing of eight drugs to
    Omnicare, Inc. (Omnicare), a manager of pharmaceutical benefits for long-term care facilities. In
    April&#160;2009, the Company and certain of its pharmaceutical subsidiaries were served in two civil qui
    tam cases asserting claims under the Federal False Claims Act and related state law claims alleging
    that the defendants provided Omnicare with rebates and other alleged kickbacks, causing Omnicare to
    file false claims with Medicaid and other government programs. In January&#160;2010, the government
    intervened in both of these cases, naming the Company, Ortho-McNeil-Janssen Pharmaceuticals, Inc.
    (now Janssen Pharmaceuticals, Inc. (JPI)), and Johnson &#038; Johnson Health Care Systems Inc. as
    defendants. Subsequently, the Commonwealth of Massachusetts, Virginia, and Kentucky, and the
    States of California and Indiana intervened in the action. The defendants moved to dismiss the
    Complaints, and in February&#160;2011, the United States District Court for the District of
    Massachusetts dismissed one qui tam case entirely and dismissed the other case in part, rejecting
    allegations that the defendants had violated its obligation to report its &#8220;best price&#8221; to health
    care program officials. The defendants subsequently moved the Court to reconsider its decision not
    to dismiss the second case in its entirety, which the Court denied in May&#160;2011. The claims of the
    United States and individual states remain pending.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In November&#160;2005, a lawsuit was filed under seal by Scott Bartz, a former employee, in the United
    States District Court for the Eastern District of Pennsylvania against the Company and certain of
    its pharmaceutical subsidiaries (the J&#038;J Defendants), along with co-defendants McKesson Corporation
    and Omnicare, Inc. The Bartz complaint raises many issues in common with the Omnicare-related
    litigation discussed above already pending before the United States District Court for the District
    of Massachusetts, such as best price and a number of kickback allegations. After investigation, the
    United States declined to intervene. The case was subsequently unsealed in January&#160;2011. In
    February&#160;2011, the plaintiff filed an amended complaint, which was placed under seal. Thereafter,
    on the J&#038;J Defendants&#8217; motion, the case was transferred to the United States District Court for the
    District of Massachusetts, where it is currently pending. In April&#160;2011, the amended complaint was
    ordered unsealed and alleges a variety of causes of action under the federal False Claims Act and
    corresponding state and local statutes, including that the J&#038;J Defendants engaged in various
    improper transactions that were allegedly designed to report false prescription drug prices to the
    federal government in order to reduce the J&#038;J Defendant&#8217;s Medicaid rebate obligations. The
    complaint further alleges that the J&#038;J Defendants improperly retaliated against the plaintiff for
    having raised these allegations internally. Bartz seeks multiple forms of
    relief, including damages
    and reinstatement to a position with the same seniority status. The J&#038;J Defendants subsequently
    moved to dismiss the complaint in May&#160;2011, which is currently scheduled for argument in August
    2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u>OTHER</u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In July&#160;2003, Centocor, Inc. (now Janssen Biotech, Inc. (JBI)), received a request that it
    voluntarily provide documents and information to the criminal division of the United States
    Attorney&#8217;s Office, District of New Jersey, in connection with its investigation into various JBI
    marketing practices. Subsequent requests for documents have been received from the United States
    Attorney&#8217;s Office. Both the Company and JBI have responded to these requests for documents and
    information.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In July&#160;2005, Scios Inc. (Scios) received a subpoena from the United States Attorney&#8217;s Office
    for the District of Massachusetts, seeking documents related to the sales and marketing of NATRECOR&#174;. In
    August&#160;2005, Scios was advised that the investigation would be handled by the United States
    Attorney&#8217;s Office for the Northern District of California in San Francisco. In February&#160;2009, two
    qui tam complaints were unsealed in the United States District Court for the Northern District of
    California, alleging, among other things, improper activities in the promotion of NATRECOR&#174;. In
    June&#160;2009, the United States government intervened in one of the qui tam actions, and filed a
    complaint against Scios and the Company seeking relief under the False Claims Act and asserting a
    claim of unjust enrichment. The civil case is proceeding and discovery is ongoing. An
    Information charging Scios with a misdemeanor violation of the Food Drug and Cosmetic Act has been filed by the government.
    It is expected that a proposed settlement of that charge will be submitted to the court for approval.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In February&#160;2007, the Company voluntarily disclosed to the United States Department of Justice
    (DOJ)&#160;and the United States Securities &#038; Exchange Commission (SEC)&#160;that subsidiaries outside the
    United States are believed to have made improper payments in connection with the sale of medical
    devices in two small-market countries, which payments may fall within the jurisdiction of the
    Foreign Corrupt Practices Act (FCPA). In the course of continuing dialogues with the agencies,
    other issues potentially rising to the level of FCPA violations in additional markets were brought
    to the attention of the agencies by the Company. Law enforcement agencies of a number of other
    countries are pursuing investigations of matters voluntarily disclosed by the Company to the DOJ
    and SEC. In addition, in February&#160;2006, the Company received a subpoena from the SEC requesting
    documents relating to the participation by several Company subsidiaries in the United Nations Iraq
    Oil for Food Program. On April&#160;8, 2011, the Company resolved the FCPA
    and Oil for Food matters through settlements with the DOJ, SEC and United Kingdom Serious Fraud
    Office. These settlements required payments of approximately $78&#160;million in financial penalties. As
    part of the settlement with the DOJ, the Company entered into a Deferred Prosecution Agreement that
    requires the Company to complete a three-year term of enhanced compliance practices.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In April&#160;2007, the Company received two subpoenas from the Office of the Attorney General of the
    State of Delaware. The subpoenas seek documents and information relating to nominal pricing
    agreements. For purposes of the subpoenas, nominal pricing agreements are defined as agreements
    under which the Company agreed to provide a pharmaceutical product for less than ten percent of the
    Average Manufacturer Price for the product. The Company responded to these requests.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In May&#160;2007, the New York State Attorney General issued a subpoena to the Company seeking
    information relating to the marketing, sale, reimbursement and safety of PROCRIT&#174;. The Company has
    responded to the subpoena.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In June&#160;2008, the Company received a subpoena from the United States Attorney&#8217;s Office for the
    District of Massachusetts relating to the marketing of biliary stents by Cordis Corporation
    (Cordis). Cordis is currently cooperating in responding to the subpoena. In addition, in January
    2010, a complaint was unsealed in the United States District Court for the Northern District of
    Texas seeking damages against Cordis for alleged violations of the federal False Claims Act and
    several similar state laws in connection with the marketing of biliary stents. The United States
    Department of Justice and several states have declined to intervene at this time. In April&#160;2011,
    the District Court for the Northern District of Texas dismissed the complaint without prejudice.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In May&#160;2009, the New Jersey Attorney General issued a subpoena to DePuy Orthopaedics, Inc., seeking
    information regarding the financial interest of clinical investigators who performed clinical
    studies for DePuy Orthopaedics, Inc. and DePuy Spine, Inc. DePuy Orthopaedics, Inc. has responded
    to these requests.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In recent years the Company has received numerous requests from a variety of United States
    Congressional Committees to produce information relevant to ongoing congressional inquiries. It is
    the Company&#8217;s policy to cooperate with these inquiries by producing the requested information.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt"><u><b>GENERAL LITIGATION</b></u>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In September&#160;2004, Plaintiffs, in an employment discrimination litigation initiated against the
    Company in 2001 in the United States District Court for the District of New Jersey, moved to
    certify a class of all African American and Hispanic salaried employees of the Company and its
    affiliates in the United States, who were employed at any time from November&#160;1997 to the present.
    Plaintiffs seek monetary damages for the period 1997 through the present (including punitive
    damages) and equitable relief. The Court denied Plaintiffs&#8217; class certification motion in December
    2006 and their motion for reconsideration in April&#160;2007. Plaintiffs sought to appeal these
    decisions and, in April&#160;2008, the Court of Appeals ruled that Plaintiffs&#8217; appeal of the denial of
    class certification was untimely. In July&#160;2009, Plaintiffs filed a motion for certification of a
    modified class, which the Company opposed. The District Court denied Plaintiffs&#8217; motion in July
    2010, and the Court of Appeals denied Plaintiffs&#8217; request for leave to appeal the denial of
    certification of the modified class. In May&#160;2011, the case was dismissed with prejudice.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in July&#160;2006, five lawsuits were filed in United States District Court for the District of
    New Jersey by various employers and employee benefit plans and funds seeking to recover amounts
    they paid for RISPERDAL&#174; for plan participants. In general, Plaintiffs allege that the Company and
    certain of its pharmaceutical subsidiaries engaged in off-label marketing of RISPERDAL&#174; in
    violation of the federal and New Jersey RICO statutes. In addition, Plaintiffs asserted various
    state law claims. All of the cases were consolidated into one case seeking class action status, but
    shortly thereafter, one action was voluntarily dismissed. In December&#160;2008, the Court dismissed the
    actions of the four remaining plaintiffs. In April&#160;2010, those plaintiffs filed a new consolidated
    class action against the Company and Janssen, L.P. (now Janssen Pharmaceuticals, Inc. (JPI)); and
    in March&#160;2011, that action was dismissed. In April&#160;2011, one of those plaintiffs filed a notice of
    appeal with the United States Court of Appeals for the Third Circuit.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In April&#160;2009, Ortho-Clinical Diagnostics, Inc. (OCD)&#160;received a grand jury subpoena from the
    United States Department of Justice, Antitrust Division, requesting documents and information for
    the period beginning September&#160;1, 2000 through the present, pertaining to an investigation of
    alleged violations of the antitrust laws in the blood reagents industry. OCD complied with the
    subpoena. In February&#160;2011, OCD received a letter from the Antitrust Division indicating that it
    had closed its investigation in November&#160;2010. In June&#160;2009, following the public announcement
    that OCD had received a grand jury subpoena, multiple class action complaints seeking damages for
    alleged price fixing were filed against OCD. The various cases were consolidated for pre-trial
    purposes in the United States District Court for the Eastern District of Pennsylvania. Discovery
    is ongoing.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In
    May&#160;2009, Centocor Ortho Biotech Inc. (now Janssen Biotech, Inc.
    (JBI)) commenced an arbitration
    proceeding before the American Arbitration Association against Schering-Plough Corporation and its
    subsidiary Schering-Plough (Ireland) Company (collectively, Schering-Plough). JBI and
    Schering-Plough are parties to a series of agreements (Distribution
    Agreements) that grant Schering-Plough the exclusive right to distribute the drugs REMICADE&#174; and
    SIMPONI&#174; worldwide, except within the United States, Japan, Taiwan, Indonesia, and the People&#8217;s
    Republic of China (including Hong Kong). JBI distributes REMICADE&#174; and SIMPONI&#174;, the next
    generation treatment, within the United States. In the arbitration, JBI sought a declaration that
    the agreement and merger between Merck &#038; Co., Inc. (Merck) and Schering-Plough constituted a change
    of control under the terms of the Distribution Agreements that permitted JBI to terminate the
    Agreements. On April&#160;15, 2011, the Company, JBI and Merck announced an agreement to amend the
    Distribution Agreements. This agreement concluded the arbitration proceeding.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Under the terms of the amended Distribution Agreements, effective July&#160;1, 2011, Merck&#8217;s subsidiary,
    Schering-Plough (Ireland) will relinquish exclusive marketing rights for REMICADE&#174; and SIMPONI&#174; to
    the Company&#8217;s Janssen pharmaceutical companies in territories including Canada, Central and South
    America, the Middle East, Africa and Asia Pacific (relinquished territories). Note, in Japan,
    Indonesia, and Taiwan, JBI will continue to license distribution rights to REMICADE&#174; and SIMPONI&#174;
    to Mitsubishi Tanabe Pharma Corporation. Merck will retain exclusive marketing rights throughout
    Europe, Russia and Turkey (retained territories). The retained territories represent approximately
    70&#160;percent of Merck&#8217;s 2010 revenue of approximately $2.8&#160;billion from REMICADE&#174; and SIMPONI&#174;, while
    the relinquished territories represent approximately 30&#160;percent. In addition, beginning July&#160;1,
    2011, all profit derived from Merck&#8217;s exclusive distribution of the two products in the retained
    territories will be equally divided between Merck and JBI. Under the prior terms of the
    Distribution Agreements, the contribution income (profit)&#160;split, which was at 58&#160;percent to Merck
    and 42&#160;percent to JBI, would have declined for Merck and increased for JBI each year until 2014,
    when it would have been equally divided. JBI also received a one-time payment of $500&#160;million in
    April&#160;2011, which will be amortized over the period of the agreement.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In April&#160;2010, a putative class action lawsuit was filed in the United States District Court for
    the Northern District of California by representatives of nursing home residents or their estates
    against the Company, Omnicare, Inc. (Omnicare), and other unidentified companies or individuals.
    In February&#160;2011, plaintiffs filed a second amended complaint asserting that certain rebate
    agreements between the Company and Omnicare increased the amount of money spent on pharmaceuticals
    by the nursing home residents and violated the Sherman Act and the California Business &#038;
    Professions Code. The second amended complaint also asserts a claim of unjust enrichment.
    Plaintiffs seek multiple forms of monetary and injunctive relief. The Company moved to dismiss the
    second amended complaint in March&#160;2011. A hearing is set on the motion to dismiss for August&#160;2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in April&#160;2010, a number of shareholder derivative lawsuits were filed in the United States
    District Court for the District of New Jersey against certain current and former directors and
    officers of the Company. The Company is named as a nominal defendant. These actions were
    consolidated on August&#160;17, 2010 into one lawsuit: <i>In re Johnson &#038; Johnson Shareholder Derivative
    Litigation</i>. An amended consolidated complaint was filed on December&#160;17, 2010. Additionally, in
    September&#160;2010, another shareholder derivative lawsuit was filed in New Jersey Superior Court
    against certain current and former directors and officers of the Company. The Company is named as a
    nominal defendant in this action as well. The parties to this action have stipulated that it shall
    be stayed until the <i>In re Johnson &#038; Johnson Shareholder Derivative Litigation </i>is completely
    resolved.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">These shareholder derivative actions are similar in their claims and collectively they assert a
    variety of alleged breaches of
    fiduciary duties, including, among other things, that the defendants
    allegedly engaged in, approved of, or failed to remedy or prevent defective medical devices,
    improper pharmaceutical rebates, improper off-label marketing of pharmaceutical and medical device
    products, violations of current good manufacturing practice regulations that resulted in product
    recalls, and failed to disclose the aforementioned alleged misconduct in the Company&#8217;s filings
    under the Securities Exchange Act of 1934. Each complaint seeks a variety of relief, including
    monetary damages and corporate governance reforms. In February&#160;2011, the Company moved to dismiss
    these actions on the grounds, <i>inter alia</i>, that the plaintiffs failed to make a demand upon the
    Board of Directors.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In May&#160;2011, two additional shareholder derivative lawsuits were filed in the United States
    District Court for the District of New Jersey and another shareholder derivative lawsuit was filed
    in New Jersey Superior Court, all naming the Company&#8217;s current directors as defendants and the
    Company as the nominal defendant. The complaints allege breaches of fiduciary duties related to
    the Company&#8217;s compliance with the Foreign Corrupt Practices Act and participation in the United
    Nations Iraq Oil For Food Program, that the Company has suffered damages as a result of those
    alleged breaches, and that the defendants failed to disclose the alleged misconduct in the
    Company&#8217;s filings under the Securities Exchange Act of 1934. Plaintiffs seek monetary damages, and
    one plaintiff also seeks corporate governance reforms. The Company intends to move to dismiss the
    federal lawsuits on the grounds, <i>inter alia</i>, that the plaintiffs failed to make a demand upon the
    Board of Directors. The Company intends to move to dismiss or stay the state lawsuit pending
    resolution of the federal lawsuits.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In July&#160; 2011, in the <i>In re Johnson &#038; Johnson Shareholder Derivative
    Litigation </i>matter, the Company filed a report prepared by a Special Committee of the Board of Directors, which investigated
    the allegations contained in the derivative actions and in a series of shareholder letters that the
    Board received in 2010 raising similar issues. The Special Committee was assisted in its
    investigation by independent counsel. The Special Committee&#8217;s report recommended: i) that the
    Company reject the shareholder demands and take whatever steps are necessary or appropriate to
    secure dismissal of the derivative litigation and ii) that the Board of Directors create a new
    Regulatory and Compliance Committee charged with responsibility
    for monitoring and oversight of the Company&#8217;s Health Care Compliance and Quality &#038; Compliance
    systems and issues. The Company&#8217;s Board of Directors  unanimously adopted the Special Committee&#8217;s recommendations.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Starting in May&#160;2010, multiple complaints seeking class action certification related to the McNeil
    recalls have been filed against McNeil Consumer Healthcare and certain affiliates, including the
    Company, in the United States District Court for the Eastern District of Pennsylvania, the Northern
    District of
    Illinois, the Central District of California, the Southern District of
    Ohio and the
    Eastern District of Missouri. These consumer complaints allege generally that purchasers of various
    McNeil medicines are owed monetary damages and penalties because they paid premium prices for
    defective medications rather than less expensive alternative medications. All but one complaint
    seeks certification of a nation-wide class of purchasers of these medicines, whereas one complaint,
    the Harvey case, seeks certification of a class of Motrin&#174; IB purchasers in Missouri. In October
    2010, the Judicial Panel on Multidistrict Litigation (JPML)&#160;consolidated all of the consumer
    complaints, except for the Harvey case, which was consolidated in March&#160;2011, for pretrial
    proceedings in the United States District Court for the Eastern District of Pennsylvania. In
    January&#160;2011, the plaintiffs in all of the cases except the Harvey case filed a &#8220;Consolidated
    Amended Civil Consumer Class&#160;Action Complaint&#8221; (CAC)&#160;naming additional parties and claims. In July
    2011, the Court granted the Company&#8217;s motion to dismiss the CAC without prejudice, but permitted
    the plaintiffs to file an amended complaint within thirty days of the dismissal order.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In September&#160;2010, a shareholder, Ronald Monk, filed a lawsuit in the United States District Court
    for the District of New Jersey seeking class certification and alleging that the Company and
    certain individuals, including executive officers and employees of the Company, failed to disclose
    that a number of manufacturing facilities were failing to maintain current good manufacturing
    practices, and that as a result, the price of the Company&#8217;s stock has declined significantly.
    Plaintiff seeks to pursue remedies under the Securities Exchange Act of 1934 to recover his alleged
    economic losses. In May&#160;2011, the Company filed a motion to dismiss, which is pending before the
    Court.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In April&#160;2011, OMJ Pharmaceuticals, Inc. (OMJ PR) filed a lawsuit against the United States in
    United States District Court for the District of Puerto Rico alleging overpayment of federal income
    taxes for the tax years ended November&#160;30, 1999 and November&#160;30, 2000. OMJ PR alleges that the
    Internal Revenue Service erroneously calculated OMJ PR&#8217;s tax credits under Section&#160;936 of the Tax
    Code.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In August
    2011, an arbitration panel ruled that Mitsubishi Tanabe Pharma
    Corporation (Tanabe), JBI&#8217;s distributor of REMICADE<sup style="font-size: 85%; vertical-align: text-top">&#174; </sup> in
    Japan, could seek to modify the proportion of net sales revenue that
    Tanabe must remit to JBI in exchange for distribution rights and
    commercial supply of REMICADE<sup style="font-size: 85%; vertical-align: text-top">&#174; </sup> (the Supply Price). Tanabe
    commenced the arbitration against JBI in 2009 pursuant to the
    parties&#8217; distribution agreement, which grants Tanabe the right
    to distribute REMICADE<sup style="font-size: 85%; vertical-align: text-top">&#174; </sup> in Japan and certain other parts of
    Asia. JBI has counterclaimed for an increase in the Supply Price. The
    arbitration hearing to determine the appropriate split of revenue is
    scheduled for November 2011, and a decision is anticipated in 2012.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company or its subsidiaries are also parties to a number of proceedings brought under the
    Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund,
    and comparable state, local or foreign laws in which the primary relief sought is the cost of past
    and/or future remediation.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LegalMattersAndContingenciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Inventories<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 2 - us-gaap:InventoryDisclosureTextBlock-->
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 2 &#8212; INVENTORIES
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">July 3, 2011</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">January 2, 2011</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Raw materials and supplies
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">1,383</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,073</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goods in process
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,897</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,460</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Finished goods
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,133</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,845</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total inventories
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">6,413</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,378</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Chapter 3<br> -Section A<br> -Paragraph 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a, b, c<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E64AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Details Textuals) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FairValueMeasurementsTextualsAbstract', window );"><strong>Fair Value Measurements (Textuals)</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RealizedGainOnOptionNotDesignatedAsHedge', window );">Realized gain on option not designated as hedge</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 102,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Deferred net gains on derivatives included in accumulated other comprehensive income</a></td>
        <td class="nump">228,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">228,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">100,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss', window );">Reclassification of foreign exchange contracts into earnings, period</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text">Next 12 months<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge', window );">Maximum length of time for hedging transaction exposure</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text">18 Months<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Other income/(expense), net, related to foreign exchange contracts, non hedging</a></td>
        <td class="num">(7,000,000)<span></span></td>
        <td class="num">(21,000,000)<span></span></td>
        <td class="nump">8,000,000<span></span></td>
        <td class="num">(69,000,000)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Other investments</a></td>
        <td class="nump">1,371,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">1,371,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">1,165,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average rate on non-current debt</a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">4.08%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotionalAmountOfForeignCurrencyDerivatives', window );">Notional amounts outstanding for forward foreign exchange contracts</a></td>
        <td class="nump">23,000,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">23,000,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotionalAmountOfInterestRateDerivatives', window );">Notional amounts outstanding for cross currency interest rate swaps</a></td>
        <td class="nump">3,000,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">3,000,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Non-current assets included into cross currency interest rate swaps</a></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">14,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Non-current liabilities included into cross currency interest rate swaps</a></td>
        <td class="nump">$ 404,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 404,000,000<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 502,000,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FairValueMeasurementsTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair Value Measurements Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_FairValueMeasurementsTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RealizedGainOnOptionNotDesignatedAsHedge">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Realized gain on option not designated as hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_RealizedGainOnOptionNotDesignatedAsHedge</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6887037&amp;loc=d3e80784-113994<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average effective interest rate during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 22<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all assets resulting from contracts that meet the criteria of being accounted for as derivative instruments which are expected to exist longer than one year or beyond the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Section A<br> -Paragraph 4<br> -Chapter 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FIN39-1<br> -Paragraph 10A, 10B<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 4, 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13495-108611<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of after one year or beyond the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FIN39-1<br> -Paragraph 10A, 10B<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Chapter 3<br> -Section A<br> -Paragraph 7<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 4, 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13495-108611<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the transactions or other events that will result in the reclassification into earnings of gains or losses reported in accumulated other comprehensive income. May include the time period over which gains or losses will be reclassified to earnings.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 45<br> -Subparagraph b(2)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6887037&amp;loc=d3e80748-113994<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investments accounted for under the equity method of accounting as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 18<br> -Paragraph 6<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6903542&amp;loc=d3e32014-111567<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityMethodInvestmentsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5618551-113959<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 45<br> -Subparagraph b(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6887037&amp;loc=d3e80748-113994<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MaximumLengthOfTimeHedgedInForeignCurrencyCashFlowHedge</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotionalAmountOfForeignCurrencyDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate notional amount of foreign currency exchange rate derivatives. Notional amount refers to the number of currency units specified in the foreign currency derivative contract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Notional Amount<br> -URI http://asc.fasb.org/extlink&amp;oid=6519104<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotionalAmountOfForeignCurrencyDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotionalAmountOfInterestRateDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate notional amount of interest rate derivatives, which relates to the currency amount specified in the interest rate derivative instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Notional Amount<br> -URI http://asc.fasb.org/extlink&amp;oid=6519104<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5579245-113959<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotionalAmountOfInterestRateDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Earnings Per Share<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 8 - us-gaap:EarningsPerShareTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 8 &#8212; EARNINGS PER SHARE
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal second quarters ended July&#160;3, 2011 and July&#160;4, 2010.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Basic net earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.01</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.25</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; basic
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,740.5</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,756.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">168.9</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">175.5</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(131.7</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(139.7</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Convertible debt shares
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; diluted
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,781.3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,796.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Diluted earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.00</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1.23</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for both fiscal second quarters ended July&#160;3, 2011 and
    July&#160;4, 2010 included the dilutive effect of convertible debt that was offset by the related
    reduction in interest expense.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for the fiscal second quarters ended July&#160;3, 2011 and
    July&#160;4, 2010, excluded 51&#160;million and 68&#160;million shares, respectively, related to stock options,
    as the exercise price of these options was greater than their average market value, which would
    result in an anti-dilutive effect on diluted earnings per share.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following is a reconciliation of basic net earnings per share to diluted net earnings per share
    for the fiscal six months ended July&#160;3, 2011 and July&#160;4, 2010.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Shares in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Basic net earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.89</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; basic
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,739.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,755.7</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Potential shares exercisable under stock option plans
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">168.8</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">175.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less: shares which could be repurchased under treasury stock method
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(133.9</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(138.6</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Convertible debt shares
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Average shares outstanding &#8212; diluted
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,778.1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,796.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Diluted earnings per share
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.25</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2.85</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for both the fiscal six months ended July&#160;3, 2011 and
    July&#160;4, 2010 included the dilutive effect of convertible debt that was offset by the related
    reduction in interest expense.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The diluted earnings per share calculation for the fiscal six months ended July&#160;3, 2011 and July&#160;4,
    2010 excluded 52&#160;million and 68&#160;million shares related to stock options, as the exercise price of
    these options was greater than their average market value, which would result in an anti-dilutive
    effect on diluted earnings per share.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=6945512&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1278-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 13 - us-gaap:SubsequentEventsTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 13 &#8212; SUBSEQUENT EVENTS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">On July&#160;7, 2011, the Company completed the divestiture of its Animal Health business to Elanco, a
    Division of Eli Lilly.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">On July&#160;14, 2011, the Company completed the acquisition of several over-the-counter cough and cold
    brands in Russia from J.B. Chemicals and Pharmaceuticals Ltd.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">On July&#160;15, 2011, the Company announced the definitive agreement to divest the assets of its Ortho
    Dermatologics division in the U.S. to subsidiaries of Valeant Pharmaceuticals International, Inc.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segments of Business and Geographic Areas [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 9 - us-gaap:SegmentReportingDisclosureTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 9 &#8212; SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">SALES BY SEGMENT OF BUSINESS
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,339</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,463</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(8.5</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,454</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,184</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,793</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,647</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,239</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,110</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,994</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,443</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">22.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,233</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,553</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,869</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,865</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,702</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,265</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13.4</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,571</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,130</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,447</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,438</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9,150</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,892</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15.9</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">16,597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,330</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">8.3</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2,684</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">3,023</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(11.2</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,791</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,390</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,475</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,413</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">0.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,630</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,316</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,662</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,875</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12,292</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">11,191</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,741</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,751</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,262</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,606</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">9.9</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13,003</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12,357</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,055</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,090</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">International
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">17,715</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,871</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">11.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">32,770</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">30,961</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">5.8</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 12pt">OPERATING PROFIT BY SEGMENT OF BUSINESS
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">549</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">669</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(17.9</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,714</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,833</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(6.5</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,275</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,876</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(32.0</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Segments operating profit
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,538</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,378</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(19.2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(116</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(158</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide income before taxes
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">3,422</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">4,220</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(18.9</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Consumer
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,122</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,454</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(22.8</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Pharmaceutical (1)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,923</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,803</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Medical Devices &#038; Diagnostics (2)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,219</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,578</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(42.3</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Segments operating profit
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,264</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">10,835</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(23.7</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expense not allocated to segments (3)
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(332</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(335</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Worldwide income before taxes
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,932</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">10,500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(24.5</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>Includes litigation expense of $290&#160;million and $540&#160;million recorded in the fiscal second
    quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011
    includes a gain related to the Company&#8217;s earlier investment in Crucell recorded in the fiscal first
    quarter of 2011. The fiscal second quarter and the first fiscal six
    months of 2010, includes net litigation expense of $115&#160;million and $202&#160;million, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Includes restructuring expense of $676&#160;million recorded in the fiscal second quarter and first
    fiscal six months of 2011. Includes litigation expense and additional DePuy ASR&#8482; Hip recall costs
    of $127&#160;million recorded in the fiscal second quarter of 2011. Includes litigation expense and
    additional DePuy ASR&#8482; Hip recall costs of $223&#160;million recorded in the first fiscal six months of
    2011. Includes net litigation expense of $42&#160;million and income of $1,542&#160;million recorded in the
    fiscal second quarter and the first fiscal six months of 2010, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(3)</td>
    <td>&#160;</td>
    <td>Amounts not allocated to segments include interest income/(expense), non-controlling interests
    and general corporate income/(expense).</td>
    </tr>
    </table>
    <div align="left" style="font-size: 10pt; margin-top: 12pt">SALES BY GEOGRAPHIC AREA
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,447</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,438</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">0.1</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Europe
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,543</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,832</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">18.6</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,543</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,375</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,064</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,685</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">14.1</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">16,597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,330</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">8.3</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="64%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="11" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Percent</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Change</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">U.S.
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,055</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">15,090</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(0.2</td>
    <td nowrap="nowrap">)%</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Europe
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,726</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,934</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">10.0</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Western Hemisphere, excluding U.S.
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,979</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,655</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12.2</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Asia-Pacific, Africa
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,010</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,282</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13.8</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">32,770</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">30,961</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">5.8</td>
    <td nowrap="nowrap">%</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8595-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8538-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8981-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8380-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8984-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 131<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8844-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9031-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9054-108599<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8924-108599<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EZCBI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Details) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="nump">$ 2<span></span></td>
        <td class="num">$ (158)<span></span></td>
        <td class="nump">$ 12<span></span></td>
        <td class="num">$ (185)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="num">(40)<span></span></td>
        <td class="num">(54)<span></span></td>
        <td class="num">(118)<span></span></td>
        <td class="num">(96)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Gain/ (Loss) recognized in Other income/expense</a></td>
        <td class="nump">4<span></span></td>
        <td class="num">(133)<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="num">(139)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Sales to customer [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="text"> <span></span></td>
        <td class="num">(53)<span></span></td>
        <td class="nump">27<span></span></td>
        <td class="num">(84)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="text"> <span></span></td>
        <td class="num">(9)<span></span></td>
        <td class="num">(10)<span></span></td>
        <td class="num">(29)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Cost of products sold [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="nump">12<span></span></td>
        <td class="num">(102)<span></span></td>
        <td class="nump">92<span></span></td>
        <td class="num">(206)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="num">(44)<span></span></td>
        <td class="num">(76)<span></span></td>
        <td class="num">(106)<span></span></td>
        <td class="num">(98)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Research and development expense [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="nump">28<span></span></td>
        <td class="nump">44<span></span></td>
        <td class="num">(8)<span></span></td>
        <td class="nump">73<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="nump">18<span></span></td>
        <td class="nump">20<span></span></td>
        <td class="nump">19<span></span></td>
        <td class="nump">21<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Other (income)/expense, net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="num">(7)<span></span></td>
        <td class="nump">35<span></span></td>
        <td class="num">(59)<span></span></td>
        <td class="nump">81<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="nump">2<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(3)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Other (Income)/Expense Type Two, net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Gain/ (Loss) recognized in Other income/expense</a></td>
        <td class="text"> <span></span></td>
        <td class="num">(20)<span></span></td>
        <td class="num">(2)<span></span></td>
        <td class="num">(21)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Other (Income)/Expense Type Three, net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Gain/ (Loss) recognized in Other income/expense</a></td>
        <td class="nump">6<span></span></td>
        <td class="num">(149)<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="num">(154)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Included in Other (Income)/Expense Type Four, net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Gain/ (Loss) recognized in Other income/expense</a></td>
        <td class="num">(2)<span></span></td>
        <td class="nump">16<span></span></td>
        <td class="num">(2)<span></span></td>
        <td class="nump">16<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Other Interest Income Expense Type Six Net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Gain/ (Loss) recognized in Other income/expense</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">20<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member] | Included in Interest (income)/Interest expense, net [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gain/ (Loss) recognized in Accumulated OCI</a></td>
        <td class="num">(31)<span></span></td>
        <td class="num">(82)<span></span></td>
        <td class="num">(40)<span></span></td>
        <td class="num">(49)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
        <td class="num">$ (16)<span></span></td>
        <td class="nump">$ 11<span></span></td>
        <td class="num">$ (18)<span></span></td>
        <td class="nump">$ 11<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative instruments gain loss on statement of financial performance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net gains and losses recognized in income during the period on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges, on derivative instruments designated and qualifying as hedging instruments in cash flow hedges, and on derivative instruments not designated as hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 205G<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44C<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 205G<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44C<br> -Subparagraph b<br> -Clause 2<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of a hedge deemed to be ineffective that is reflected in current period results of operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeNetHedgeIneffectivenessGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 7 - us-gaap:ComprehensiveIncomeNoteTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 7 &#8212; ACCUMULATED OTHER COMPREHENSIVE INCOME
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Total comprehensive income for the fiscal six months ended July&#160;3, 2011 was $8.6&#160;billion, compared
    with $5.3&#160;billion for the same period a year ago. Total comprehensive income for the fiscal second
    quarter ended July&#160;3, 2011 was $3.6&#160;billion, compared with $1.6&#160;billion for the same period a year
    ago. Total comprehensive income included net earnings, net unrealized currency gains and losses on
    translation, net unrealized gains and losses on securities available for sale, adjustments related
    to employee benefit plans, and net gains and losses on derivative instruments qualifying and
    designated as cash flow hedges. The following table sets forth the components of accumulated other
    comprehensive income.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="40%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Total</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Accum</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Other</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Foreign</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Securities</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Employee</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Deriv.</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Comp.</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">Gains/(Losses)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Currency</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Available</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Benefit</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#038;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Income/</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Translation</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">for sale</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Hedges</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">(Loss)</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(969</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">24</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2,686</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">100</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(3,531</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2011 six months change
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:30px; text-indent:-15px">Unrealized gain (loss)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">435</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:30px; text-indent:-15px">Net amount reclassed to net earnings
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(139</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">116</td>
    <td nowrap="nowrap">*</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net six months change
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,787</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">296</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">128</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">128</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,339</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">July&#160;3, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">818</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">320</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2,558</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">228</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1,192</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Substantially offset in net earnings by changes in value of the underlying transactions.</td>
    </tr>
    </table>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Amounts in accumulated other comprehensive income are presented net of the related tax impact.
    Foreign currency translation adjustments are not currently adjusted for income taxes as they relate
    to permanent investments in international subsidiaries.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for comprehensive income.  Includes, but is not limited to,  the following:  1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7)  the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e689-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e716-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14-26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e640-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e709-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNoteTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EIBBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERATING ACTIVITIES</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
        <td class="nump">$ 6,252<span></span></td>
        <td class="nump">$ 7,975<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to cash flows from operating activities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of property and intangibles</a></td>
        <td class="nump">1,532<span></span></td>
        <td class="nump">1,445<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
        <td class="nump">339<span></span></td>
        <td class="nump">305<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
        <td class="num">(504)<span></span></td>
        <td class="nump">604<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts receivable allowances</a></td>
        <td class="num">(33)<span></span></td>
        <td class="nump">46<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of effects from acquisitions:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
        <td class="num">(576)<span></span></td>
        <td class="num">(555)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
        <td class="num">(620)<span></span></td>
        <td class="num">(88)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Decrease in accounts payable and accrued liabilities</a></td>
        <td class="num">(444)<span></span></td>
        <td class="num">(1,719)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase in other current and non-current assets</a></td>
        <td class="num">(920)<span></span></td>
        <td class="num">(704)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Increase in other current and non-current liabilities</a></td>
        <td class="nump">1,199<span></span></td>
        <td class="nump">218<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH FLOWS FROM OPERATING ACTIVITIES</a></td>
        <td class="nump">6,225<span></span></td>
        <td class="nump">7,527<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
        <td class="num">(1,054)<span></span></td>
        <td class="num">(897)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from the disposal of assets</a></td>
        <td class="nump">143<span></span></td>
        <td class="nump">109<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
        <td class="num">(2,049)<span></span></td>
        <td class="num">(871)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
        <td class="num">(16,820)<span></span></td>
        <td class="num">(6,695)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales of investments</a></td>
        <td class="nump">10,582<span></span></td>
        <td class="nump">3,800<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
        <td class="num">(62)<span></span></td>
        <td class="num">(21)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED BY INVESTING ACTIVITIES</a></td>
        <td class="num">(9,260)<span></span></td>
        <td class="num">(4,575)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Dividends to shareholders</a></td>
        <td class="num">(3,043)<span></span></td>
        <td class="num">(2,839)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
        <td class="num">(929)<span></span></td>
        <td class="num">(780)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term debt</a></td>
        <td class="nump">3,586<span></span></td>
        <td class="nump">956<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Retirement of short-term debt</a></td>
        <td class="num">(6,194)<span></span></td>
        <td class="num">(3,598)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
        <td class="nump">4,404<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retirement of long-term debt</a></td>
        <td class="num">(5)<span></span></td>
        <td class="num">(12)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options/ excess tax benefits</a></td>
        <td class="nump">717<span></span></td>
        <td class="nump">386<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED BY FINANCING ACTIVITIES</a></td>
        <td class="num">(1,464)<span></span></td>
        <td class="num">(5,887)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
        <td class="nump">118<span></span></td>
        <td class="num">(162)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Decrease in cash and cash equivalents</a></td>
        <td class="num">(4,381)<span></span></td>
        <td class="num">(3,097)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash equivalents, beginning of period</a></td>
        <td class="nump">19,355<span></span></td>
        <td class="nump">15,810<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, END OF PERIOD</a></td>
        <td class="nump">14,974<span></span></td>
        <td class="nump">12,713<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AcquisitionsAbstract', window );"><strong>Acquisitions</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Fair value of assets acquired</a></td>
        <td class="nump">2,248<span></span></td>
        <td class="nump">909<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Fair value of liabilities assumed and non-controlling interests</a></td>
        <td class="num">(199)<span></span></td>
        <td class="num">(38)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Net cash paid for acquisitions</a></td>
        <td class="nump">$ 2,049<span></span></td>
        <td class="nump">$ 871<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AcquisitionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Acquisitions Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AcquisitionsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7<br> -Footnote 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph h<br> -Article 4<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 45<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 289<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effect of exchange rate changes on cash balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInInventories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 32<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 32<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 32<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3095-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3098-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForProceedsFromOtherInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to reacquire common stock during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 20<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForRepurchaseOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow from distribution of an entity's earnings to common and preferred stockholders, including minority shareholders. This element excludes special dividends, which are included in a separate element for capital distributions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 20<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfOrdinaryDividends</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15, 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15, 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 17<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 19<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 31<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 16<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 16<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfProductiveAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 19<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromShortTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 123R<br> -Paragraph A240<br> -Subparagraph i<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 19<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A1, A4, A5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 5<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProvisionForDoubtfulAccounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 20<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 20<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfShortTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets and Goodwill [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS AND GOODWILL</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 3 - us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock-->
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 3 &#8212; INTANGIBLE ASSETS AND GOODWILL
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Intangible assets that have finite useful lives are amortized over their estimated useful lives.
    The latest impairment assessment of goodwill and indefinite lived intangible assets was completed
    in the fiscal fourth quarter of 2010. Future impairment tests for goodwill and indefinite lived
    intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">January 2,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Intangible assets with definite lives:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Patents and trademarks &#8212; gross
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,520</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,660</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less accumulated amortization
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,819</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,629</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Patents and trademarks &#8212; net
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,701</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,031</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other intangibles &#8212; gross
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,609</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,674</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less accumulated amortization
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,048</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,880</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other intangibles &#8212; net
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,561</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,794</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Intangible assets with indefinite lives:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Trademarks
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,080</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,954</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Purchased in-process research and development
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,036</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,937</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total intangible assets with indefinite lives
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,116</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,891</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total intangible assets &#8212; net
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">18,378</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16,716</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company reclassified $971&#160;million from purchased
    in-process research and development to amortizable other intangibles to reflect the
    commercialization of ZYTIGA&#174;.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Goodwill as of July&#160;3, 2011 was allocated by segment of business as follows:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Med Dev</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Consumer</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Pharm</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#038; Diag</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Total</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goodwill, net at January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">8,144</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,225</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,925</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,294</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Acquisitions
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">538</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">538</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Currency translation/Other
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">320</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">52</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">39</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">411</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goodwill, net as of July&#160;3, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">8,464</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,815</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,964</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16,243</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The weighted average amortization periods for patents and trademarks and other intangible assets
    are 17&#160;years and 27&#160;years, respectively. The amortization expense of amortizable intangible assets
    for the fiscal six months ended July&#160;3, 2011 was $402&#160;million, and the estimated amortization
    expense for the five succeeding years approximates $840&#160;million, per year.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 42, 43, 44, 45, 46, 47<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16373-109275<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13854-109267<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EEEAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details Textuals) (USD $)<br>In Billions</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract', window );"><strong>Accumulated Other Comprehensive Income (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
        <td class="nump">$ 3.6<span></span></td>
        <td class="nump">$ 1.6<span></span></td>
        <td class="nump">$ 8.6<span></span></td>
        <td class="nump">$ 5.3<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated other comprehensive income loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AccumulatedOtherComprehensiveIncomeTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A5<br> -Appendix A<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ELPAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details Textuals) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets', window );">Purchased in process research and development to amortizable intangibles to reflect commercialization</a></td>
        <td class="nump">$ 971<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks', window );">Weighted average amortization periods for patents and trademarks</a></td>
        <td class="text"> <span></span></td>
        <td class="text">17 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets', window );">Weighted average amortization periods for other Intangible assets</a></td>
        <td class="text"> <span></span></td>
        <td class="text">27 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense', window );">Amortization expense of amortizable intangible assets</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">402<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense', window );">Estimated amortization expense per year</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 840<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Intangible Assets and Goodwill Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_IntangibleAssetsAndGoodwillTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassifed in process research and development to amortizable assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_ReclassifedInProcessResearchAndDevelopmentToAmortizableAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average amortization periods for other Intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_WeightedAverageAmortizationPeriodsForOtherIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average amortization periods for patents and trademarks.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_WeightedAverageAmortizationPeriodsForPatentsAndTrademarks</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of intangible asset amortization recognized as expense during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph a(2)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate estimated amortization expense for succeeding fiscal years for intangible assets subject to amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph a(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 4 - us-gaap:FairValueDisclosuresTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 4 &#8212; FAIR VALUE MEASUREMENTS
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company uses forward exchange contracts to manage its exposure to the variability of cash
    flows, primarily related to the foreign exchange rate changes of future intercompany product and
    third- party purchases of raw materials denominated in foreign currency. The Company also uses
    cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both
    types of derivatives are designated as cash flow hedges. The Company also uses forward exchange
    contracts to manage its exposure to the variability of cash flows for repatriation of foreign
    dividends. These contracts are designated as net investment hedges. Additionally, the Company
    uses forward exchange contracts to offset its exposure to certain foreign currency assets and
    liabilities. These forward exchange contracts are not designated as hedges, and therefore, changes
    in the fair values of these derivatives are recognized in earnings, thereby offsetting the current
    earnings effect of the related foreign currency assets and liabilities. The Company does not enter
    into derivative financial instruments for trading or speculative
    purposes, or that contain credit risk
    related contingent features or requirements to post collateral. On an ongoing basis, the Company
    monitors counterparty credit ratings. The Company considers credit non-performance risk to be low,
    because the Company enters into agreements with commercial institutions that have at least an A (or
    equivalent) credit rating. As of July&#160;3, 2011, the Company had notional amounts outstanding for
    forward foreign exchange contracts and cross currency interest rate swaps of $23&#160;billion and $3
    billion, respectively.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair
    value of derivatives are recorded each period in current earnings or other comprehensive income,
    depending on whether the derivative is designated as part of a hedge transaction, and if so, the
    type of hedge transaction.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company entered into an option to hedge the currency
    risk associated with the cash portion of the payment for the planned acquisition of Synthes, Inc.
    The option was not designated as a hedge, and therefore, the change in the fair value of the option
    of $102&#160;million was recognized as Other Income in the fiscal second quarter of 2011.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The
    designation as a cash flow hedge is made at the entrance date of the derivative contract. At
    inception, all derivatives are expected to be highly effective. Changes in the fair value of a
    derivative that is designated as a cash flow hedge and is highly effective are recorded in
    accumulated other comprehensive income
    until the underlying transaction affects earnings, and are
    then reclassified to earnings in the same account as the hedged transaction. Gains/losses on net
    investment hedges are accounted for through the currency translation account and are insignificant.
    On an ongoing basis, the Company assesses whether each derivative continues to be highly effective
    in offsetting changes in the cash flows of hedged items. If and when a derivative is no longer
    expected to be highly effective, hedge accounting is discontinued. Hedge ineffectiveness, if any,
    is included in current period earnings in other (income)/expense, net, and was not material for the
    fiscal quarters ended July&#160;3, 2011 and July
    4, 2010. Refer to Note 7 for disclosures of movements in Accumulated Other Comprehensive Income.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">As of July&#160;3, 2011, the balance of deferred net gains on derivatives included in accumulated other
    comprehensive income was $228&#160;million after-tax. For additional information, see Note 7. The
    Company expects that substantially all of the amounts related to foreign exchange contracts will be
    reclassified into earnings over the next 12&#160;months as a result of transactions that are expected to
    occur over that period. The maximum length of time over which the Company is hedging transaction
    exposure is 18&#160;months excluding interest rate swaps. The amount ultimately realized in earnings
    will differ as foreign exchange rates change. Realized gains and losses are ultimately determined
    by actual exchange rates at maturity of the derivative.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
    the fiscal second quarters in 2011 and 2010:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="28%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>reclassified</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>from</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated OCI</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>other</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>OCI</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>into income</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>income/expense</b><sup style="font-size: 85%; vertical-align: text-top">(2)</sup></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">second</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">quarter</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left"><b>Cash Flow Hedges</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(53</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(9</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(A)</sub></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(20</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(102</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(44</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(76</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(B)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(149</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">44</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">18</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">20</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(C)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(31</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(82</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(16</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">11</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(D)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(7</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">35</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">&#8212;</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(E)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">20</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(158</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(40</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(54</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">4</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(133</td>
    <td nowrap="nowrap">)
    </td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 0pt">
    All amounts shown in the table above are net of tax.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table is a summary of the activity related to derivatives designated as hedges for
    the first fiscal six months in 2011 and 2010:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="28%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>reclassified</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Gain/ (Loss)</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>from</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>recognized in</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>Accumulated OCI</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7"><b>other</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>OCI</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>into income</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff"><b>income/expense</b><sup style="font-size: 85%; vertical-align: text-top">(2)</sup></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Fiscal</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">six</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">months</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left"><b>Cash Flow Hedges</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(84</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(10</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(29</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(A)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(21</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">92</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(206</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(106</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(98</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(B)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(154</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(8</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">73</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">21</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(C)</sub></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(40</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(49</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(18</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">11</td>
    <td nowrap="nowrap">&#160;<sub style="font-size: 85%; vertical-align: text-bottom">(D)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(59</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">81</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(3</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)<sub style="font-size: 85%; vertical-align: text-bottom">(E)</sub></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">20</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(185</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(118</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(96</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">$</td>
    <td align="right">(139</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">All amounts shown in the table above are net of tax.
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>Effective portion</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Ineffective portion</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(A)</td>
    <td>&#160;</td>
    <td>Included in Sales to customers</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(B)</td>
    <td>&#160;</td>
    <td>Included in Cost of products sold</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(C)</td>
    <td>&#160;</td>
    <td>Included in Research and development expense</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(D)</td>
    <td>&#160;</td>
    <td>Included in Interest (income)/Interest expense, net</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(E)</td>
    <td>&#160;</td>
    <td>Included in Other (income)/expense, net</td>
    </tr>
    </table>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">For the fiscal second quarters ended July&#160;3, 2011 and July&#160;4, 2010, a loss of $7&#160;million and $21
    million, respectively, were recognized in Other (income)/expense, net, relating to foreign exchange
    contracts not designated as hedging instruments.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">For the
    first fiscal six months ended July&#160;3, 2011 and July&#160;4, 2010, a gain of $8&#160;million and a
    loss of $69&#160;million, respectively, were recognized in Other (income)/expense, net, relating to
    foreign exchange contracts not designated as hedging instruments.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Fair value is the exit price that would be received to sell an asset or paid to transfer a
    liability. Fair value is a market-based measurement that is determined using assumptions that
    market participants would use in pricing an asset or liability. The authoritative literature
    establishes a three-level hierarchy to
    prioritize the inputs used in measuring fair value. The
    levels within the hierarchy are described below with Level 1 having the highest priority and Level
    3 having the lowest.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The fair value of a derivative financial instrument (i.e. forward exchange contract or currency
    swap) is the aggregation by currency of all future cash flows discounted to its present value at
    the prevailing market interest rates and subsequently converted to the U.S. dollar at the current
    spot foreign exchange rate. The Company does not believe that fair values of these derivative
    instruments materially differ from the amounts that could be realized upon settlement or maturity,
    or that the changes in fair value will have a material effect on the Company&#8217;s results of
    operations, cash flows or financial position. The Company also holds equity investments which are
    classified as Level 1 because they are traded in an active exchange market. The Company did not
    have any other significant financial assets or liabilities which would require revised valuations
    under this standard that are recognized at fair value.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following three levels of inputs are used to measure fair value:
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Level 2 &#8212; Significant other observable inputs.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Level 3 &#8212; Significant unobservable inputs.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The Company&#8217;s significant financial assets and liabilities measured at fair value as of July&#160;3,
    2011 and January&#160;2, 2011 were as follows:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="40%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 0px solid #000000"><b>July 3, 2011</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3"><b>January 2, 2011</b></td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 0px solid #000000">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 1</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 2</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Level 3</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Total</b></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000"><b>Total</b><sup style="font-size: 85%; vertical-align: text-top"><b>(1)</b></sup></td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Derivatives designated as hedging instruments:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Assets:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">487</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">487</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">321</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<sup style="font-size: 85%; vertical-align: text-top">(2)</sup>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">17</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Total</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">338</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Liabilities:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">646</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">646</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">586</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cross currency interest rate swaps<sup style="font-size: 85%; vertical-align: text-top">(3)</sup>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">404</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">404</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">502</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Total</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,050</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,050</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,088</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Derivatives not designated as hedging instruments:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Assets:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">28</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Swiss Franc Option*
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">569</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">569</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">597</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">19</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Liabilities:</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Foreign exchange contracts
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">27</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">39</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Other Investments</b><sup style="font-size: 85%; vertical-align: text-top"><b>(4)</b></sup>
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,371</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,371</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">1,165</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Currency option related to the planned acquisition of Synthes, Inc.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(1)</td>
    <td>&#160;</td>
    <td>As of January&#160;2, 2011, these assets and liabilities are classified as Level 2 with the exception
    of Other Investments of $1,165 which are classified as Level 1.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(2)</td>
    <td>&#160;</td>
    <td>Includes $2&#160;million and $14&#160;million of non-current assets for July&#160;3, 2011 and January&#160;2, 2011,
    respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(3)</td>
    <td>&#160;</td>
    <td>Includes $404&#160;million and $502&#160;million of non-current liabilities for July&#160;3, 2011 and January
    2, 2011, respectively.</td>
    </tr>
    <tr style="font-size: 3pt">
    <td>&#160;</td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">(4)</td>
    <td>&#160;</td>
    <td>Classified as non-current other assets.</td>
    </tr>
    </table>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Financial Instruments not measured at Fair Value:
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following financial assets and liabilities are held at carrying amount on the consolidated
    balance sheet as of July&#160;3, 2011:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Carrying</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Estimated</td>
    <td>&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Amount</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">Fair Value</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Financial Assets</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Current Investments</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cash
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">2,299</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,299</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Government securities and obligations
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23,951</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23,951</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Corporate debt securities
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">515</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">515</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Money market funds
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,820</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,820</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Time deposits
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,097</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,097</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total cash, cash equivalents and current marketable securities
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">29,682</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">29,682</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td colspan="9" align="left">Fair value of government securities and
    obligations and non-current marketable
    securities was estimated using quoted broker prices
    in active
    markets.</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Financial Liabilities</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Current Debt</b>
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">5,046</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,046</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px"><b>Non-Current Debt</b>
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2012
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">599</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">632</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">0.70% Notes due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">503</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3.80% Debentures due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">527</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3&#160;month LIBOR&#043;0% FRN due 2013
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3&#160;month LIBOR&#043;0.09% FRN due 2014
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">750</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">750</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">1.20% Notes due 2014
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">999</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,006</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2.15% Notes due 2016
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">898</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">903</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.55% Debentures due 2017
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,161</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.15% Debentures due 2018
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">898</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,015</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.75% Notes due 2019 (1B Euro 1.4476)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,440</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,569</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3% Zero Coupon Convertible Subordinated Debentures due in 2020
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">197</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">246</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">2.95% Debentures due 2020
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">541</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">522</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">3.55% Notes due 2021
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">446</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">456</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">6.73% Debentures due 2023
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">250</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">323</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.50% Notes due 2024 (500 GBP1.6025)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">795</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">856</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">6.95% Notes due 2029
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">294</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">375</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.95% Debentures due 2033
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">500</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">523</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.95% Notes due 2037
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">995</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,120</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">5.86% Debentures due 2038
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">700</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">773</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.50% Debentures due 2040
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">539</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">489</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">4.85% Notes due 2041
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">298</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">291</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other (Includes Industrial Revenue Bonds)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">41</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">41</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total Non-Current Debt
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">13,680</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">14,581</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The weighted average effective rate on non-current debt is 4.08%.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Fair value of the non-current debt was estimated using market prices, which were corroborated by
    quoted broker prices in active markets.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19296-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 159<br> -Paragraph 17-22, 27, 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15C, 15D<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13504-108611<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15A<br> -Subparagraph a-d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13537-108611<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44A, 44B<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19207-110258<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 3, 10, 14, 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15B<br> -Subparagraph a, b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 157<br> -Paragraph 32, 33, 34<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EEEAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Earnings Per Share (Details Textuals)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EarningsPerShareTextualsAbstract', window );"><strong>Earnings Per Share (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares excluded from computation of earnings per share</a></td>
        <td class="nump">51<span></span></td>
        <td class="nump">68<span></span></td>
        <td class="nump">52<span></span></td>
        <td class="nump">68<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EarningsPerShareTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Earnings Per Share Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_EarningsPerShareTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 171<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 13, 14<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Severance reserve and the associated spending</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note12_table1 - us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table summarizes the severance reserves associated with the restructuring plan
    recorded in the fourth quarter of 2009.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="88%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #000000">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">Severance</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Reserve balance as of:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">345</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cash outlays
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(77</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">July&#160;3, 2011*
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">268</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Remaining cash outlays for severance are expected to be paid out in accordance with the Company&#8217;s
    plans and local laws.</td>
    </tr>
    </table>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 146<br> -Paragraph 20<br> -Subparagraph b(2)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EV1BI">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Fair Value Measurements (Details 1) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">$ 489<span></span></td>
        <td class="nump">$ 338<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">1,050<span></span></td>
        <td class="nump">1,088<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">597<span></span></td>
        <td class="nump">19<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Derivatives not designated as hedging instruments : Other Investments</a></td>
        <td class="nump">1,371<span></span></td>
        <td class="nump">1,165<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">487<span></span></td>
        <td class="nump">321<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">646<span></span></td>
        <td class="nump">586<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">28<span></span></td>
        <td class="nump">19<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
        <td class="nump">27<span></span></td>
        <td class="nump">39<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Quoted prices in active markets for identical assets and liabilities Level 1 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Significant other observable inputs Level 2 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">487<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">646<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">28<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
        <td class="nump">27<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign exchange contracts [Member] | Significant unobservable inputs Level 3 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">2<span></span></td>
        <td class="nump">17<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">404<span></span></td>
        <td class="nump">502<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member] | Quoted prices in active markets for identical assets and liabilities Level 1 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member] | Significant other observable inputs Level 2 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">2<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">404<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cross currency interest rate swaps [Member] | Significant unobservable inputs Level 3 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Swiss Franc Option [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">569<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Swiss Franc Option [Member] | Significant other observable inputs Level 2 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">569<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Quoted prices in active markets for identical assets and liabilities Level 1 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Derivatives not designated as hedging instruments : Other Investments</a></td>
        <td class="nump">1,371<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Significant other observable inputs Level 2 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">489<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">1,050<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
        <td class="nump">597<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Derivatives not designated as hedging instruments : Other Investments</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Significant unobservable inputs Level 3 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
        <td class="nump">0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Derivatives not designated as hedging instruments : Other Investments</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentDetailAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentDetailAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investments accounted for under the equity method of accounting as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 18<br> -Paragraph 6<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6903542&amp;loc=d3e32014-111567<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityMethodInvestmentsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value as of the balance sheet date of all foreign currency derivative assets not designated as hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624163-113959<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624163-113959<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EYVAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Earnings Per Share (Details) (USD $)<br>In Millions, except Per Share data</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Reconciliation of basic net earnings per share to diluted net earnings per share</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
        <td class="nump">$ 1.01<span></span></td>
        <td class="nump">$ 1.25<span></span></td>
        <td class="nump">$ 2.28<span></span></td>
        <td class="nump">$ 2.89<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average shares outstanding - basic</a></td>
        <td class="nump">2,740.5<span></span></td>
        <td class="nump">2,756.6<span></span></td>
        <td class="nump">2,739.6<span></span></td>
        <td class="nump">2,755.7<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential shares exercisable under stock option plans</a></td>
        <td class="nump">168.9<span></span></td>
        <td class="nump">175.5<span></span></td>
        <td class="nump">168.8<span></span></td>
        <td class="nump">175.4<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod', window );">Less: shares which could be repurchased under treasury stock method</a></td>
        <td class="num">(131.7)<span></span></td>
        <td class="num">(139.7)<span></span></td>
        <td class="num">(133.9)<span></span></td>
        <td class="num">(138.6)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt shares</a></td>
        <td class="nump">3.6<span></span></td>
        <td class="nump">3.6<span></span></td>
        <td class="nump">3.6<span></span></td>
        <td class="nump">3.6<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average shares outstanding - diluted</a></td>
        <td class="nump">2,781.3<span></span></td>
        <td class="nump">2,796.0<span></span></td>
        <td class="nump">2,778.1<span></span></td>
        <td class="nump">2,796.1<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="nump">$ 1.23<span></span></td>
        <td class="nump">$ 2.25<span></span></td>
        <td class="nump">$ 2.85<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=6945512&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 20<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 7<br> -Paragraph 18<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 36, 37, 38<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 21<br> -Article 9<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 11, 12, 36<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 20<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 7<br> -Paragraph 18<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 21<br> -Article 9<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareReconciliationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 26, 27, 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1930-109256<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 20<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1500-109256<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6920599&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 171<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 40<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 128<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 07-4<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E25AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets with definite lives:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FiniteLivedPatentsAndTrademarksGross', window );">Patents and trademarks - gross</a></td>
        <td class="nump">$ 7,520<span></span></td>
        <td class="nump">$ 6,660<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization', window );">Less accumulated amortization</a></td>
        <td class="nump">2,819<span></span></td>
        <td class="nump">2,629<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FiniteLivedPatentsAndTrademarksNet', window );">Patents and trademarks - net</a></td>
        <td class="nump">4,701<span></span></td>
        <td class="nump">4,031<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Other intangibles - gross</a></td>
        <td class="nump">8,609<span></span></td>
        <td class="nump">7,674<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
        <td class="nump">3,048<span></span></td>
        <td class="nump">2,880<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherFiniteLivedIntangibleAssetsNet', window );">Other intangibles - net</a></td>
        <td class="nump">5,561<span></span></td>
        <td class="nump">4,794<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Trademarks</a></td>
        <td class="nump">6,080<span></span></td>
        <td class="nump">5,954<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIndefiniteLivedIntangibleAssets', window );">Purchased in-process research and development</a></td>
        <td class="nump">2,036<span></span></td>
        <td class="nump">1,937<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total intangible assets with indefinite lives</a></td>
        <td class="nump">8,116<span></span></td>
        <td class="nump">7,891<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets - net</a></td>
        <td class="nump">18,378<span></span></td>
        <td class="nump">16,716<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
        <td class="nump">15,294<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
        <td class="nump">538<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherChanges', window );">Currency translation/other</a></td>
        <td class="nump">411<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
        <td class="nump">16,243<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consumer [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
        <td class="nump">8,144<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherChanges', window );">Currency translation/other</a></td>
        <td class="nump">320<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
        <td class="nump">8,464<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
        <td class="nump">1,225<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
        <td class="nump">538<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherChanges', window );">Currency translation/other</a></td>
        <td class="nump">52<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
        <td class="nump">1,815<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
        <td class="nump">5,925<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherChanges', window );">Currency translation/other</a></td>
        <td class="nump">39<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
        <td class="nump">$ 5,964<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Finite Lived Patents And Trademarks Accumulated Amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_FiniteLivedPatentsAndTrademarksAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FiniteLivedPatentsAndTrademarksGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Finite Lived Patents And Trademarks Gross</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_FiniteLivedPatentsAndTrademarksGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FiniteLivedPatentsAndTrademarksNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Finite lived patents and trademarks net.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_FiniteLivedPatentsAndTrademarksNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other Finite Lived Intangible Assets Accumulated Amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_OtherFiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherFiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other Finite Lived Intangible Assets Net.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_OtherFiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNetAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -Clause 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 43<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 68<br> -Subparagraph l<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 34<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 72<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 72<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -Clause 2<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAcquiredDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherChanges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other increases or decreases during the reporting period in the carrying value of goodwill that are not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillOtherChanges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts (original costs for current and prior period additions adjusted for impairment, if any) as of the balance sheet date of intangible assets, excluding goodwill, having a projected indefinite period of benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTrademarks">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IndefiniteLivedTrademarks</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 42, 45<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross carrying amount before accumulated amortization as of the balance sheet date of intangible assets not otherwise specified in the taxonomy having a reasonably expected period of economic benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherFiniteLivedIntangibleAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIndefiniteLivedIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date of rights not otherwise specified in the taxonomy having a projected indefinite period of benefit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIndefiniteLivedIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Restructuring<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 12 - us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 12 &#8212; RESTRUCTURING
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">In the fiscal second quarter of 2011, Cordis Corporation, a subsidiary of Johnson &#038; Johnson,
    announced the discontinuation of its clinical development program for the NEVO&#8482; Sirolimus-Eluting
    Coronary Stent and cessation of the manufacture and marketing of CYPHER&#174; and CYPHER
    SELECT<sup style="font-size: 85%; vertical-align: text-top">&#174; </sup>Plus Sirolimus-Eluting Coronary Stents by the end of 2011. This will allow the
    Company to focus on other cardiovascular therapies where significant patient needs exist.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">As a
    result of the above mentioned restructuring plan announced by Cordis
    Corporation, the Company recorded $676&#160;million in related pre-tax charges, of which approximately
    $164&#160;million of the pre-tax restructuring charges require cash payments. The $676&#160;million of
    restructuring charges consists of asset write-offs of $512&#160;million and $164&#160;million related to
    leasehold and contract obligations and other expenses. The $512&#160;million of asset write-offs relate
    to property, plant and equipment of $265&#160;million, intangible assets of $160&#160;million and inventory
    of $87&#160;million (recorded in cost of products sold).
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The following table summarizes the severance reserves associated with the restructuring plan
    recorded in the fourth quarter of 2009.
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="88%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #000000">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3" style="border-bottom: 1px solid #000000">Severance</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Reserve balance as of:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">345</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Cash outlays
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(77</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">July&#160;3, 2011*
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">268</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left">
    <div style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&#160;
    </div>
    </div>
    <table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; text-align: left">
    <tr>
    <td width="3%"></td>
    <td width="1%"></td>
    <td width="96%"></td>
    </tr>
    <tr valign="top">
    <td nowrap="nowrap" align="left">*</td>
    <td>&#160;</td>
    <td>Remaining cash outlays for severance are expected to be paid out in accordance with the Company&#8217;s
    plans and local laws.</td>
    </tr>
    </table>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Of the 7,500 positions the Company planned to eliminate in the 2009 restructuring plan,
    approximately 5,700 positions have been eliminated as of July&#160;3, 2011.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 146<br> -Paragraph 20<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 5 - us-gaap:IncomeTaxDisclosureTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 5 &#8212; INCOME TAXES
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">The worldwide effective income tax rates for the first fiscal six months of 2011 and 2010 were
    21.2% and 24.0%, respectively. The lower effective tax rate was due to higher income in lower tax
    jurisdictions and the U.S. Research and Development tax credit, which was not in effect for the
    first fiscal six months of 2010. Additionally, in 2010 the Company had litigation gains in high tax
    jurisdictions.
    </div>
    <!-- Folio -->
    <!-- /Folio -->
    </div>
    <!-- PAGEBREAK -->
    <div style="font-family: 'Times New Roman',Times,serif">
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 136, 172<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 43, 44, 45, 46, 47, 48, 49<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph h<br> -Article 4<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note2_table1 - us-gaap:ScheduleOfInventoryCurrentTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="1%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">July 3, 2011</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right" colspan="2">January 2, 2011</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Raw materials and supplies
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">1,383</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,073</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goods in process
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,897</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,460</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Finished goods
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,133</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,845</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total inventories
    </div></td>
    <td>&#160;</td>
    <td align="left">$</td>
    <td align="right">6,413</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,378</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Topic <br> -SubTopic <br> -Publisher SEC<br> -Number 210<br> -Article 5<br> -Subparagraph a,b,c<br> -Name Regulation S-X (SX)<br> -Paragraph 6<br> -Section 2<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfInventoryCurrentTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ESSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Foreign Currency Translation</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">January 2, 2011</a></td>
        <td class="num">$ (969)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Net six months change</a></td>
        <td class="nump">1,787<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">July 3, 2011</a></td>
        <td class="nump">818<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Securities Available for sale</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">January 2, 2011</a></td>
        <td class="nump">24<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss)</a></td>
        <td class="nump">435<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax', window );">Net amount reclassed to net earnings</a></td>
        <td class="num">(139)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Net six months change</a></td>
        <td class="nump">296<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">July 3, 2011</a></td>
        <td class="nump">320<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Employee Benefit Plans</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">January 2, 2011</a></td>
        <td class="num">(2,686)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Net six months change</a></td>
        <td class="nump">128<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">July 3, 2011</a></td>
        <td class="num">(2,558)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Derivatives &amp; Hedges</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">January 2, 2011</a></td>
        <td class="nump">100<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss)</a></td>
        <td class="nump">12<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax', window );">Net amount reclassified to net earnings</a></td>
        <td class="nump">116<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease', window );">Net Six months change</a></td>
        <td class="nump">128<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">July 3, 2011</a></td>
        <td class="nump">228<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Total Accumulated Other Comprehensive Income/(Loss)</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">January 2, 2011</a></td>
        <td class="num">(3,531)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease', window );">Net Six months change</a></td>
        <td class="nump">2,339<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">July 3, 2011</a></td>
        <td class="num">$ (1,192)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated appreciation or loss, net of tax, in value of the total of available-for-sale securities at the end of an accounting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6887037&amp;loc=d3e80784-113994<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of net gain (loss), prior service cost (credit), and transition assets (obligations), as well as minimum pension liability if still remaining, included in accumulated other comprehensive income associated with a defined benefit pension or other postretirement plan(s) because they have yet to be recognized as components of net periodic benefit cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph i<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 158<br> -Paragraph 7<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 17, 18, 19, 22, 23, 24, 25, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 45<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 52<br> -Paragraph 31<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 52<br> -Paragraph 12, 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FAS115-1/124-1<br> -Paragraph 15D<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross appreciation or the gross loss in value of the total unsold securities. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -Subparagraph (e)-(g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 19, 22, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) in accumulated comprehensive income during the period related to pension and other postretirement benefit plans, after tax. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 158<br> -Paragraph 7<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 22, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges after taxes. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase or decrease in deferred hedging gains or losses. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 31, 46<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 20, 24, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 46<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 20, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Pre tax change in the balance sheet adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity for the period being reported.  If an entity's functional currency is a foreign currency, translation adjustments result from the process of translating that entity's financial statements into the reporting currency. Includes gain (loss) on foreign currency forward exchange contracts. Includes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements. Includes the gain (loss) on a derivative instrument or nonderivative financial instrument that may give rise to a foreign currency transaction gain (loss) that has been designated and qualified as a hedging instrument for hedging of the foreign currency exposure of a net investment in a foreign operation. Does not include the effect of taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 45<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6939497&amp;loc=d3e30304-110892<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 23, 24, 25, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -Subparagraph (a)-(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 52<br> -Paragraph 31<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 52<br> -Paragraph 13, 20, 30, 31<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents Other Comprehensive Income or Loss, Net of Tax, for the period.  Includes deferred gains or losses on qualifying hedges, unrealized holding gains or losses on available-for-sale securities, minimum pension liability, and cumulative translation adjustment. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 22, 23, 24, 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e599-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification adjustment for unrealized gains or losses realized upon the sale of securities, after tax.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e689-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 18, 19<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net of tax effect of the reclassification adjustment for accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges included in accumulated comprehensive income that was realized in net income during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 31, 46<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 18, 19<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Change in accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges, net of tax effect. The after tax effect change includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 17, 20<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 46<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6935481&amp;loc=SL5624171-113959<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 121<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Appreciation or loss in value (before reclassification adjustment) of the total of unsold securities during the period being reported on, net of tax. Reclassification adjustments include: (1) the unrealized holding gain (loss), net of tax, at the date of the transfer for a debt security from the held-to-maturity category transferred into the available-for-sale category. Also includes the unrealized gain (loss) at the date of transfer for a debt security from the available-for-sale category transferred into the held-to-maturity category; (2) the unrealized gains (losses) realized upon the sale of securities, after tax; and (3) the unrealized gains (losses) realized upon the write-down of securities, after tax.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6920433&amp;loc=d3e998-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 24<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 17, 22<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(3)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6KAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Inventories (Details) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Summary of Inventories</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Raw materials and supplies</a></td>
        <td class="nump">$ 1,383<span></span></td>
        <td class="nump">$ 1,073<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Goods in process</a></td>
        <td class="nump">1,897<span></span></td>
        <td class="nump">1,460<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
        <td class="nump">3,133<span></span></td>
        <td class="nump">2,845<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
        <td class="nump">$ 6,413<span></span></td>
        <td class="nump">$ 5,378<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryFinishedGoods</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6386567&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNetAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryRawMaterialsAndSupplies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of merchandise or goods which are partially completed, are generally comprised of raw materials, labor and factory overhead costs, and which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryWorkInProcess</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EPEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statements of Earnings [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease', window );">Sales to customers (Note 9)</a></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CostOfGoodsSoldPercentageIncreaseDecrease', window );">Cost of products sold</a></td>
        <td class="nump">31.20%<span></span></td>
        <td class="nump">30.20%<span></span></td>
        <td class="nump">30.40%<span></span></td>
        <td class="nump">29.60%<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_GrossProfitPercentageIncreaseDecrease', window );">Gross profit</a></td>
        <td class="nump">68.80%<span></span></td>
        <td class="nump">69.80%<span></span></td>
        <td class="nump">69.60%<span></span></td>
        <td class="nump">70.40%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease', window );">Selling, marketing and administrative expenses</a></td>
        <td class="nump">31.40%<span></span></td>
        <td class="nump">31.00%<span></span></td>
        <td class="nump">31.30%<span></span></td>
        <td class="nump">30.80%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease', window );">Research and development expense</a></td>
        <td class="nump">11.30%<span></span></td>
        <td class="nump">10.80%<span></span></td>
        <td class="nump">11.00%<span></span></td>
        <td class="nump">10.40%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InvestmentIncomeInterestPercentageIncreaseDecrease', window );">Interest income</a></td>
        <td class="num">(0.10%)<span></span></td>
        <td class="num">(0.30%)<span></span></td>
        <td class="num">(0.10%)<span></span></td>
        <td class="num">(0.20%)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InterestExpensePercentageIncreaseDecrease', window );">Interest expense, net of portion capitalized</a></td>
        <td class="nump">0.80%<span></span></td>
        <td class="nump">0.70%<span></span></td>
        <td class="nump">0.80%<span></span></td>
        <td class="nump">0.60%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease', window );">Other (income) expense, net</a></td>
        <td class="nump">1.30%<span></span></td>
        <td class="nump">0.10%<span></span></td>
        <td class="nump">0.60%<span></span></td>
        <td class="num">(5.10%)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringExpensesIncreaseDecrease', window );">Restructuring expense</a></td>
        <td class="nump">3.50%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">1.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease', window );">Earnings before provision for taxes on income</a></td>
        <td class="nump">20.60%<span></span></td>
        <td class="nump">27.50%<span></span></td>
        <td class="nump">24.20%<span></span></td>
        <td class="nump">33.90%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease', window );">Provision for taxes on income (Note 5)</a></td>
        <td class="nump">3.90%<span></span></td>
        <td class="nump">5.00%<span></span></td>
        <td class="nump">5.10%<span></span></td>
        <td class="nump">8.10%<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProfitLossPercentageIncreaseDecrease', window );">NET EARNINGS</a></td>
        <td class="nump">16.70%<span></span></td>
        <td class="nump">22.50%<span></span></td>
        <td class="nump">19.10%<span></span></td>
        <td class="nump">25.80%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CostOfGoodsSoldPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cost of goods sold percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_CostOfGoodsSoldPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_GrossProfitPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross profit percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_GrossProfitPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income tax expense benefit percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_IncomeTaxExpenseBenefitPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InterestExpensePercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest expense percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_InterestExpensePercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InvestmentIncomeInterestPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investment income interest percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_InvestmentIncomeInterestPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other non operating income expense percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_OtherNonOperatingIncomeExpensePercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ProfitLossPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Profit loss percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_ProfitLossPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research and development expense excluding acquired in process cost percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringExpensesIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Restructuring expenses increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_RestructuringExpensesIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sales revenue goods net percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SalesRevenueGoodsNetPercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Selling general and administrative expense percentage increase decrease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SellingGeneralAndAdministrativeExpensePercentageIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EQCAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets and Goodwill [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Intangible assets and Goodwill</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table1 - us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">January 2,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Intangible assets with definite lives:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Patents and trademarks &#8212; gross
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">7,520</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,660</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less accumulated amortization
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,819</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,629</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Patents and trademarks &#8212; net
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,701</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,031</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other intangibles &#8212; gross
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,609</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,674</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Less accumulated amortization
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3,048</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,880</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Other intangibles &#8212; net
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,561</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4,794</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Intangible assets with indefinite lives:
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Trademarks
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6,080</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,954</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Purchased in-process research and development
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">2,036</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,937</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total intangible assets with indefinite lives
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">8,116</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">7,891</td>
    <td>&#160;</td>
    </tr>
    <tr valign="top"><!-- Blank Space -->
    <td>
    <div style="margin-left:15px; text-indent:-15px">&#160;
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Total intangible assets &#8212; net
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">18,378</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16,716</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note3_table2 - us-gaap:ScheduleOfGoodwillTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="76%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Med Dev</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Consumer</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Pharm</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#038; Diag</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">Total</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goodwill, net at January&#160;2, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">8,144</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,225</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,925</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">15,294</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Acquisitions
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">538</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">538</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Currency translation/Other
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">320</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">52</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">39</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">411</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Goodwill, net as of July&#160;3, 2011
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">8,464</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1,815</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">5,964</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">16,243</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of goodwill by reportable segment and in total. Disclosure details may include, but are not limited to, the carrying amount of goodwill, goodwill acquired during the year, goodwill impairment losses recognized, goodwill written-off due to the sale of a business unit, goodwill not yet allocated, and any other changes to goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 47<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfGoodwillTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the aggregate amount of goodwill and intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Topic 350<br> -SubTopic 20<br> -Publisher FASB<br> -Number <br> -Article <br> -Subparagraph <br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E24AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Details 1) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Operating profit by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segments operating profit</a></td>
        <td class="nump">$ 3,538<span></span></td>
        <td class="nump">$ 4,378<span></span></td>
        <td class="nump">$ 8,264<span></span></td>
        <td class="nump">$ 10,835<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percent Change</a></td>
        <td class="num">(19.20%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(23.70%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ExpenseNotAllocatedToSegments', window );">Expense not allocated to segments</a></td>
        <td class="num">(116)<span></span></td>
        <td class="num">(158)<span></span></td>
        <td class="num">(332)<span></span></td>
        <td class="num">(335)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Worldwide income before taxes</a></td>
        <td class="nump">3,422<span></span></td>
        <td class="nump">4,220<span></span></td>
        <td class="nump">7,932<span></span></td>
        <td class="nump">10,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments', window );">Worldwide total, percent total</a></td>
        <td class="num">(18.90%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(24.50%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consumer [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Operating profit by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segments operating profit</a></td>
        <td class="nump">549<span></span></td>
        <td class="nump">669<span></span></td>
        <td class="nump">1,122<span></span></td>
        <td class="nump">1,454<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percent Change</a></td>
        <td class="num">(17.90%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(22.80%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Operating profit by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segments operating profit</a></td>
        <td class="nump">1,714<span></span></td>
        <td class="nump">1,833<span></span></td>
        <td class="nump">3,923<span></span></td>
        <td class="nump">3,803<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percent Change</a></td>
        <td class="num">(6.50%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">3.20%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Operating profit by segment of business</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segments operating profit</a></td>
        <td class="nump">$ 1,275<span></span></td>
        <td class="nump">$ 1,876<span></span></td>
        <td class="nump">$ 3,219<span></span></td>
        <td class="nump">$ 5,578<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percent Change</a></td>
        <td class="num">(32.00%)<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(42.30%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ExpenseNotAllocatedToSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expense not allocated to segments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_ExpenseNotAllocatedToSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInOperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage change in operating income loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageChangeInOperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage change in operating income loss excluding expenses not allocated to segments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 4<br> -Section 08<br> -Paragraph h<br> -Subparagraph 1(i)<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Pensions and Other Benefit Plans [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of net periodic benefit cost</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note Table: JNJ-20110703_note6_table1 - us-gaap:ScheduleOfNetBenefitCostsTableTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Components of Net Periodic Benefit Cost
    Net periodic benefit cost for the Company&#8217;s defined benefit retirement plans and other benefit
    plans for the fiscal second quarters of 2011 and 2010 include the following components:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="52%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Quarters Ended</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Service cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">144</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">121</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">37</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">33</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Interest cost
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">214</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">194</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">46</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">50</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(277</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(248</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">3</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Recognized actuarial losses
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">98</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">59</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">12</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">13</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net periodic benefit cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">181</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">130</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">Net periodic benefit cost for the Company&#8217;s defined benefit retirement plans and other benefit
    plans for the first fiscal six months of 2011 and 2010 include the following components:
    </div>
    <div align="center">
    <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">
    <!-- Begin Table Head -->
    <tr valign="bottom">
    <td width="52%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="5%">&#160;</td>
    <td width="3%">&#160;</td>
    <td width="1%">&#160;</td>
    <td width="3%">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Retirement Plans</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Other Benefit Plans</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="7" style="border-bottom: 1px solid #ffffff">Fiscal Six Months Ended</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">&#160;</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 3,</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">July 4,</td>
    </tr>
    <tr style="font-size: 8pt" valign="bottom">
    <td nowrap="nowrap" align="left" style="border-bottom: 1px solid #ffffff">(Dollars in Millions)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2011</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="center" colspan="3">2010</td>
    </tr>
    <!-- End Table Head -->
    <!-- Begin Table Body -->
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Service cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">287</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">247</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">74</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">67</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Interest cost
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">427</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">394</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">94</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">100</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Expected return on plan assets
    </div></td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(555</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(500</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of prior service cost/(credit)
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">4</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">6</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(1</td>
    <td nowrap="nowrap">)</td>
    <td>&#160;</td>
    <td nowrap="nowrap" align="right">&#160;</td>
    <td align="right">(2</td>
    <td nowrap="nowrap">)</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Amortization of net transition obligation
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">1</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">&#8212;</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Recognized actuarial losses
    </div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">194</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">117</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">23</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">25</td>
    <td>&#160;</td>
    </tr>
    <tr valign="bottom" style="background: #cceeff">
    <td>
    <div style="margin-left:15px; text-indent:-15px">Net periodic benefit cost
    </div></td>
    <td>&#160;</td>
    <td align="right">$</td>
    <td align="right">358</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">265</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">189</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td align="right">189</td>
    <td>&#160;</td>
    </tr>
    <!-- End Table Body -->
    </table>
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationAndRetirementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Topic 715<br> -SubTopic 20<br> -Publisher FASB<br> -Number <br> -Article <br> -Subparagraph (h)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 1 - us-gaap:SignificantAccountingPoliciesTextBlock-->
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <!-- xbrl,ns -->
    <!-- xbrl,nx -->
    <div align="left">
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 0pt">
    </div>
    <div style="display: none">NOTE 1 &#8212; SUMMARY OF SIGNIFICANT
    ACCOUNTING POLICIES
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">NOTE 1 &#8212;
    The accompanying unaudited interim consolidated financial statements and related notes
    should be read in conjunction with the audited Consolidated Financial Statements of Johnson &#038;
    Johnson and its subsidiaries (the &#8220;Company&#8221;) and related notes as contained in the Company&#8217;s Annual
    Report on Form 10-K for the fiscal year ended January&#160;2, 2011. The unaudited interim financial
    statements include all adjustments (consisting only of normal recurring adjustments) and accruals
    necessary in the judgment of management for a fair statement of the results for the periods
    presented.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
    amendments to the disclosure requirements for presentation of comprehensive income. The amendment
    requires that all non-owner changes in stockholders&#8217; equity be presented either in a single
    continuous statement of comprehensive income or in two separate but consecutive statements. This
    guidance is effective retrospectively for the interim periods and annual periods beginning after
    December&#160;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
    material impact on the Company&#8217;s results of operations, cash flows or financial position.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
    common fair value measurement. These amendments result in convergence of fair value measurement and
    disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
    the interim periods and annual periods beginning after December&#160;15, 2011. Early adoption is
    prohibited. The adoption of this standard is not expected to have a material impact on the
    Company&#8217;s results of operations, cash flows or financial position.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance and amendments
    issued related to revenue recognition under the milestone method. The objective of the accounting
    standard update is to provide guidance on defining a milestone and determining when it may be
    appropriate to apply the milestone method of revenue recognition for research or development
    transactions. This update is effective on a prospective basis for milestones achieved in fiscal
    years, and interim periods within those years, beginning on or after June&#160;15, 2010. The adoption of
    this standard did not have a material impact on the Company&#8217;s results of operations, cash flows or
    financial position.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
    pharmaceutical companies should recognize and classify in the Company&#8217;s financial statements, the
    non-deductible annual fee paid to the Government in accordance with the Patient Protection and
    Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
    based on an allocation of a company&#8217;s market share of total branded prescription drug sales from
    the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
    in the Company&#8217;s financial statement and will be amortized on a straight-line basis for the year as
    per the FASB guidance. The adoption of
    this standard did not have a material impact on the
    Company&#8217;s results of operations, cash flows or financial position.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 22<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Business Combinations and Divestitures<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations and Divestitures [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATIONS AND DIVESTITURES</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Note 10 - us-gaap:BusinessCombinationDisclosureTextBlock-->
    <div style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 12pt">NOTE 10&#8212; BUSINESS COMBINATIONS AND DIVESTITURES
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Company entered into a definitive agreement to
    acquire Synthes, Inc. for approximately
    $21.3&#160;billion, approximately $19.3&#160;billion net of cash
    acquired, subject to the terms of the merger agreement and currency values at the time of closing.
    Under the terms of the agreement, each share of Synthes common stock, subject to certain
    conditions, will be exchanged for approximately 35% in cash and 65%
    in Johnson &#38; Johnson common
    stock. Synthes, Inc. is a premier global developer and manufacturer of orthopaedics devices.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company acquired substantially all of the outstanding
    equity of Crucell N.V. that it did not already own. Crucell is a global biopharmaceutical company
    focused on the research and development, production and marketing of vaccines and antibodies
    against infectious disease worldwide. The net purchase price of $2.0&#160;billion was allocated
    primarily to non-amortizable intangible assets for $1.0&#160;billion, amortizable intangible assets for
    $0.7&#160;billion and goodwill for $0.5&#160;billion.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2010, the Company acquired RespiVert Ltd., a privately held
    drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of
    pulmonary diseases.
    </div>
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2010, the Company acquired Acclarent, Inc., a medical technology
    company dedicated to designing, developing and commercializing devices that address conditions
    affecting the ear, nose and throat, for a net purchase price of $0.8&#160;billion. The purchase price
    for the acquisition was allocated primarily to amortizable intangible assets for $0.7&#160;billion.
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51, 52<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1500-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911361&amp;loc=d3e7000-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6911361&amp;loc=d3e6927-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911361&amp;loc=d3e7008-128479<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1490-128463<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911361&amp;loc=d3e6996-128479<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4922-128472<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4934-128472<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Appendix F<br> -Paragraph F4<br> -Subparagraph e<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4926-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1383-128463<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1392-128463<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1497-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 67-73<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1524-128463<br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 88-16<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6909870&amp;loc=d3e1486-128463<br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4845-128472<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EQYGK">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Fair Value Measurements (Details 2) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
        <td class="nump">$ 5,046<span></span></td>
        <td class="nump">$ 7,617<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">13,680<span></span></td>
        <td class="nump">9,156<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract', window );"><strong>Current Investments</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">2,299<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_USGovernmentSecuritiesAtCarryingValue', window );">Government securities and obligations</a></td>
        <td class="nump">23,951<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCashEquivalentsAtCarryingValue', window );">Corporate debt securities</a></td>
        <td class="nump">515<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
        <td class="nump">1,820<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimeDepositsAtCarryingValue', window );">Time deposits</a></td>
        <td class="nump">1,097<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total cash, cash equivalents and current marketable securities</a></td>
        <td class="nump">29,682<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
        <td class="nump">5,046<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">13,680<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.15% Debentures due 2012 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">599<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 0.70% Notes due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">500<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 3.80% Debentures due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">500<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 3 month LIBOR+0% FRN due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">500<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 3 month LIBOR+0.09% FRN due 2014 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">750<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 1.20% notes due 2014 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">999<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 2.15% Notes due 2016 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">898<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.55% Debentures due 2017 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,000<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.15% Debentures due 2018 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">898<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 4.75% Notes due 2019 (1B Euro 1.4476) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,440<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 3% Zero Coupon Convertible Subordinated Debentures due in 2020 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">197<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 2.95% Debentures due 2020 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">541<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 3.55% Notes due 2021 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">446<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 6.73% Debentures due 2023 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">250<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.50% Notes due 2024 (500 GBP 1.6025) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">795<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 6.95% Notes due 2029 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">294<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 4.95% Debentures due 2033 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">500<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.95% Notes due 2037 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">995<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 5.86% Debentures due 2038 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">700<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 4.50% Debentures due 2040 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">539<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | 4.85% Notes due 2041 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">298<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Carrying Amount [Member] | Other (Includes Industrial Revenue Bonds) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">41<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract', window );"><strong>Current Investments</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">2,299<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_USGovernmentSecuritiesAtCarryingValue', window );">Government securities and obligations</a></td>
        <td class="nump">23,951<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCashEquivalentsAtCarryingValue', window );">Corporate debt securities</a></td>
        <td class="nump">515<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
        <td class="nump">1,820<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimeDepositsAtCarryingValue', window );">Time deposits</a></td>
        <td class="nump">1,097<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total cash, cash equivalents and current marketable securities</a></td>
        <td class="nump">29,682<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
        <td class="nump">5,046<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">14,581<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.15% Debentures due 2012 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">632<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 0.70% Notes due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">503<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 3.80% Debentures due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">527<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 3 month LIBOR+0% FRN due 2013 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">500<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 3 month LIBOR+0.09% FRN due 2014 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">750<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 1.20% notes due 2014 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,006<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 2.15% Notes due 2016 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">903<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.55% Debentures due 2017 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,161<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.15% Debentures due 2018 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,015<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 4.75% Notes due 2019 (1B Euro 1.4476) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,569<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 3% Zero Coupon Convertible Subordinated Debentures due in 2020 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">246<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 2.95% Debentures due 2020 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">522<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 3.55% Notes due 2021 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">456<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 6.73% Debentures due 2023 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">323<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.50% Notes due 2024 (500 GBP 1.6025) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">856<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 6.95% Notes due 2029 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">375<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 4.95% Debentures due 2033 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">523<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.95% Notes due 2037 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">1,120<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 5.86% Debentures due 2038 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">773<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 4.50% Debentures due 2040 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">489<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | 4.85% Notes due 2041 [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">291<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Estimated Fair Value [Member] | Other (Includes Industrial Revenue Bonds) [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
        <td class="nump">$ 41<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrestricted cash available for day-to-day operating needs, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7<br> -Footnote 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7, 8, 9, 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 22<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MoneyMarketFundsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other (not elsewhere specified in the taxonomy) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),16(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 13<br> -Article 9<br> -Subparagraph 2, 3<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 16<br> -Subparagraph a(1)<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShortTermBorrowings</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimeDepositsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TimeDepositsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_USGovernmentSecuritiesAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt (bills, notes or bonds) that are issued by the government of the United States which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_USGovernmentSecuritiesAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ESFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock', window );">Presentation of comprehensive income</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table1 - jnj:RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the Financial Accounting Standards Board (FASB) issued
    amendments to the disclosure requirements for presentation of comprehensive income. The amendment
    requires that all non-owner changes in stockholders&#8217; equity be presented either in a single
    continuous statement of comprehensive income or in two separate but consecutive statements. This
    guidance is effective retrospectively for the interim periods and annual periods beginning after
    December&#160;15, 2011. Early adoption is permitted. The adoption of this standard will not have a
    material impact on the Company&#8217;s results of operations, cash flows or financial position.
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Requirements for common fair value measurement</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table2 - us-gaap:FairValueOfFinancialInstrumentsPolicy-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal second quarter of 2011, the FASB issued amendments to disclosure requirements for
    common fair value measurement. These amendments result in convergence of fair value measurement and
    disclosure requirements between U.S. GAAP and IFRS. This guidance is effective prospectively for
    the interim periods and annual periods beginning after December&#160;15, 2011. Early adoption is
    prohibited. The adoption of this standard is not expected to have a material impact on the
    Company&#8217;s results of operations, cash flows or financial position.
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Adoption of standard update related to revenue recognition under the milestone method and its impact</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table3 - us-gaap:RevenueRecognitionPolicyTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance and amendments
    issued related to revenue recognition under the milestone method. The objective of the accounting
    standard update is to provide guidance on defining a milestone and determining when it may be
    appropriate to apply the milestone method of revenue recognition for research or development
    transactions. This update is effective on a prospective basis for milestones achieved in fiscal
    years, and interim periods within those years, beginning on or after June&#160;15, 2010. The adoption of
    this standard did not have a material impact on the Company&#8217;s results of operations, cash flows or
    financial position.
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock', window );">Pharmaceutical fees paid to the government</a></td>
        <td class="text">
    <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
    <!-- Begin Block Tagged Accounting Policy: JNJ-20110703_note1_accounting_policy_table4 - jnj:PharmaceuticalFeesPaidToGovernmentPolicyTextBlock-->
    <div align="left" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-family: 'Times New Roman',Times,serif">
    <div align="left" style="font-size: 10pt; margin-top: 6pt">During the fiscal first quarter of 2011, the Company adopted the FASB guidance on how
    pharmaceutical companies should recognize and classify in the Company&#8217;s financial statements, the
    non-deductible annual fee paid to the Government in accordance with the Patient Protection and
    Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. This fee is
    based on an allocation of a company&#8217;s market share of total branded prescription drug sales from
    the prior year. The estimated fee was recorded as a selling, marketing and administrative expense
    in the Company&#8217;s financial statement and will be amortized on a straight-line basis for the year as
    per the FASB guidance. The adoption of
    this standard did not have a material impact on the
    Company&#8217;s results of operations, cash flows or financial position.
    </div>
    </div>
    </div>
  <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Pharmaceutical fees paid to government.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PharmaceuticalFeesPaidToGovernmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Requirements for presentation of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_RequirementsForPresentationOfComprehensiveIncomePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 8, 10, 12, 13, 14<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2155942<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 22<br> -Paragraph 8, 12, 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 13<br> -Section B<br> -Paragraph Question 1<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E6YAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 02, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 14,974<span></span></td>
        <td class="nump">$ 19,355<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">14,708<span></span></td>
        <td class="nump">8,303<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, trade, less allowances for doubtful accounts $327 (2010, $340)</a></td>
        <td class="nump">10,982<span></span></td>
        <td class="nump">9,774<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note 2)</a></td>
        <td class="nump">6,413<span></span></td>
        <td class="nump">5,378<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetCurrent', window );">Deferred taxes on income</a></td>
        <td class="nump">2,306<span></span></td>
        <td class="nump">2,224<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other receivables</a></td>
        <td class="nump">3,290<span></span></td>
        <td class="nump">2,273<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">52,673<span></span></td>
        <td class="nump">47,307<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment at cost</a></td>
        <td class="nump">32,435<span></span></td>
        <td class="nump">30,426<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
        <td class="num">(17,461)<span></span></td>
        <td class="num">(15,873)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
        <td class="nump">14,974<span></span></td>
        <td class="nump">14,553<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net (Note 3)</a></td>
        <td class="nump">18,378<span></span></td>
        <td class="nump">16,716<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net (Note 3)</a></td>
        <td class="nump">16,243<span></span></td>
        <td class="nump">15,294<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetNoncurrent', window );">Deferred taxes on income</a></td>
        <td class="nump">5,653<span></span></td>
        <td class="nump">5,096<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
        <td class="nump">4,193<span></span></td>
        <td class="nump">3,942<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">112,114<span></span></td>
        <td class="nump">102,908<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loans and notes payable</a></td>
        <td class="nump">5,046<span></span></td>
        <td class="nump">7,617<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">5,689<span></span></td>
        <td class="nump">5,623<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
        <td class="nump">4,405<span></span></td>
        <td class="nump">4,100<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AccruedRebatesReturnsAndPromotions', window );">Accrued rebates, returns and promotions</a></td>
        <td class="nump">2,933<span></span></td>
        <td class="nump">2,512<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee related obligations</a></td>
        <td class="nump">2,104<span></span></td>
        <td class="nump">2,642<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes on income</a></td>
        <td class="nump">808<span></span></td>
        <td class="nump">578<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">20,985<span></span></td>
        <td class="nump">23,072<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt (Note 4)</a></td>
        <td class="nump">13,680<span></span></td>
        <td class="nump">9,156<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred taxes on income</a></td>
        <td class="nump">1,888<span></span></td>
        <td class="nump">1,447<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Employee related obligations</a></td>
        <td class="nump">6,202<span></span></td>
        <td class="nump">6,087<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
        <td class="nump">7,227<span></span></td>
        <td class="nump">6,567<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">49,982<span></span></td>
        <td class="nump">46,329<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</a></td>
        <td class="nump">3,120<span></span></td>
        <td class="nump">3,120<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (Note 7)</a></td>
        <td class="num">(1,192)<span></span></td>
        <td class="num">(3,531)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
        <td class="nump">80,836<span></span></td>
        <td class="nump">77,773<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: common stock held in treasury, at cost (379,263,000 and 381,746,000 shares)</a></td>
        <td class="nump">20,632<span></span></td>
        <td class="nump">20,783<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
        <td class="nump">62,132<span></span></td>
        <td class="nump">56,579<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
        <td class="nump">$ 112,114<span></span></td>
        <td class="nump">$ 102,908<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AccruedRebatesReturnsAndPromotions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_AccruedRebatesReturnsAndPromotions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Subparagraph a<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 15<br> -Subparagraph b(1)<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 9<br> -Section 03<br> -Paragraph 15<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Section Appendix E<br> -Paragraph 289<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Interpretation (FIN)<br> -Number 48<br> -Paragraph 15, 21<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedIncomeTaxesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 14<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e653-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 130<br> -Paragraph 14, 17, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FAS115-1/124-1<br> -Paragraph 15D<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e637-108580<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6920043&amp;loc=d3e681-108580<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 12<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Topic 210<br> -SubTopic 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br> -Section S99<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Concepts (CON)<br> -Number 6<br> -Paragraph 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 18<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Section 45<br> -SubTopic 10<br> -Topic 210<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 9<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities and which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 22<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 16<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FAS115-1/124-1<br> -Paragraph 15D<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 12<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Staff Position (FSP)<br> -Number FAS115-1/124-1<br> -Paragraph 15C<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 115<br> -Paragraph 13, 17<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Chapter 3<br> -Section A<br> -Paragraph 4, 5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6379932&amp;loc=d3e22054-111558<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7<br> -Footnote 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating loss carryforward is presented as a reduction of the related deferred tax asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31928-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 41, 42, 43<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31958-109318<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31917-109318<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31931-109318<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, is classified according to the expected reversal date of the temporary difference.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31928-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 41, 42, 43<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31958-109318<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31917-109318<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31931-109318<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNetNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31958-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 41, 42<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31917-109318<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907571&amp;loc=d3e31931-109318<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -Clause 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 43<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 68<br> -Subparagraph l<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph e<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 34<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905597&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141R<br> -Paragraph 72<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 42, 45<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6386567&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 32<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 25<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 21<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 22<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 17<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 24<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e2410-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 6<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e2417-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6410544&amp;loc=d3e1703-114919<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 8<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Section A<br> -Paragraph 4<br> -Chapter 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Section 45<br> -SubTopic 10<br> -Topic 210<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Paragraph 1<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount, at the balance sheet date, of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 8<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 12<br> -Paragraph 5<br> -Subparagraph b, c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),16(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 13<br> -Article 9<br> -Subparagraph 2, 3<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 16<br> -Subparagraph a(1)<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShortTermBorrowings</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4568740-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4590271-111686<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Name Accounting Research Bulletin (ARB)<br> -Publisher AICPA<br> -Number 51<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A3<br> -Appendix A<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4568447-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Technical Bulletin (FTB)<br> -Number 85-6<br> -Paragraph 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TreasuryStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ELHAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Details Textuals)<br></strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rates</a></td>
        <td class="nump">21.20%<span></span></td>
        <td class="nump">24.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income Tax Textuals Abstract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_IncomeTaxTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 47<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph h<br> -Subparagraph 2<br> -Article 4<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>59
<FILENAME>0000950123-11-075098-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950123-11-075098-xbrl.zip
M4$L#!!0````(`"B""3\:DY/@_>\``.A_#``0`!P`:FYJ+3(P,3$P-S`S+GAM
M;%54"0`#RY5!3LN504YU>`L``00E#@``!#D!``#L76M3XSJV_7ZK[G_P,'=F
MSJDBY`']@*;/5'@V9[J!(F$>GU+"5A)U.U:.)`.97W^W)-MQ0@*DR4.R-4.=
M!D>6M/=:^Z%M63G\^^,@].XQXX1&G[?J.[4M#T<^#4C4^[P5\PKB/B%;?__M
M?__G\$^5RK^/;KYZ`?7C`8Z$YS.,!`Z\NY%W<^.=T"C"88A'7AOU>IBEO7KU
MVH[\?WUO_Y-W3(<C1GI]X?UR_.O$795*,L81XM`GW*<&:^S4LT^.D_%H=.!]
MK.Y7&[5ZW:LW#FI[!^]VO>MONN'C'0L]D"KBG[?Z0@P/JM6'AX<=>7F'LA[<
M5=NMDH@+%/EX2[<\"$GTXYGF\N,[F%?:_/%)^X==U;J^O[]?59]F3:&C@&1M
M\_V^K^H/TZ8!GFK'L;_3H_=5^$`)6ZG5*[OU?,]D`1D)IWN-^H?G[M`MTAN^
M1]^SQO#[CD\'R30^5&J[:2L@20^A8=:RB_B=ZC+Y(#]SP,?S#J5Z#KC?QP-T
M@[N>4M>!&`WQYRU.!L-0SEA=ZS/<_;P%0U=D'[4/M=V=1QYL>57=CZ0$C01^
M%%X+^P*XIA@`G_C)91)\WFI#+_@;7.CSTRC`0:>V]WL<0H>U#MS-@<JL\PT/
M[N"?"[B+14CVA,+DHIXS]`F,)V*4_`5_DT!>Z1)@NI(%3R@VA>[XXA];O]7@
M?Z#@O=K[P^KXMG%7'/>D0647X))FQ@%^'(;$)T+/Q0L(M-.FFFCWH"7`)N3=
M1S$G$>:\I3OCS4?"MWX#Y1VD8NI.#JLS^W[;X.>8]A@:]HF/PO'`$_I\W>B'
MU4EE'%8G]'XXQ(S0(*<Z@9@X@5G\)A&MU/8JM7?01W8U:XBC(-<,"+PGNPYR
MC0ZKN<X/JPF'%B+4-QQ(#71.\#WQ,>\THZ!S0E`OHEP0GQ><9XGTB?`@>TYT
MQ[U5<^^ZC]@`^3@6BH+%IMJDL(Y<ACBVVTZK.!PSRIW=MLI`L^F$K%!\VE@:
M5@[NS(Y_A6+0AJ->.7B4J+V3UT'GG-%XR#M777!1<208@1BHKG7:#]0V@CU%
M-VNBN\\WT))?=3.YU060N@Q<L-![.--]M>E>1=A^=!<V79"Z#%PXC1D=%@!?
M:;U:EC*@9G6YHDRU@A9Y=$NXXJ7>=46)S3#'U9A*4F.R@&16QR%+Z+:!P+A)
MYKGZE/-?RT^O"NJHRK1EP3RG5%!2E>^A\2:IY>KH)M71-\D$"W.<\B88KH9N
M4@U]DTRP.@MP(=@]`[$)LUV-6;US.AB&=(0Q..)[S.3^?4OPN\%<L-@7,2-1
M[YART8P"N(;9/9[TLJF$F8!K`%6]@%#;?0G4Y-6&GP7U"(52GB;$"X?H\A'5
M+[2(":#2:V\`JO$[BAQ0JP,*?AI+`2JSJ`EY.]?0!%)34.Y^4?"2`6^BD911
MBVBZ:;4?8*213)!GAC<'W2KC7&V_`C^-CRN.<W.3E]N("+B@4CG>N=;*4RBK
MQ:,L!)PJ83HGN$LB:'J$(_A-6()^,NMDTDJN$\+]D/*883[CTTGWJ]6CM9,H
M1[6ZZMZVM%XFNRA,8C27,&>48=*+IJA22G(DJLCSHJ!L>/T+(*9#OO0G607:
M^>6P,Z_J,#N=3IWPZ:/?1U$/2R0%0[X]CI>1>R3(/;Z(9.*E4#Q')/I*.3\:
M?<%!#_*P&QRJPA_OD^%,SYN*GTIO>J8]&\QCQ-A(YM8W>$B9S,::`UF[[IPA
MPCK_1&&,.^.PE#[QO:0R83N!SZ[5V)U+8DUA7PJFY#H:)2II]3$6JE`/BA@+
M>P'VKI4Q%7I3G:4JTXVR?L<]+/^9\5<:]01F@Q-\)]JC86X1H2`!1#0@$@\[
M"?F$6A!`!,912KV?(JSIG'PMK(DNEL\KXXS">%KJPD5N'T*YF:G5\>K]"8Z;
MJ^3FJ3PRR_E,K8U4&8Z8-B>7.3J;3DSC:+&J!//U5F4:,4^Y(`-8#\LJ<XZ+
MB]%2U:5*P\E495?=K"^C"*FKA%:R\16YY4\0UG1*%B*S7*95F$;+I3C)TL5N
MT_VDW8%[21DE^)3PWA9'68I\4B-B)RE?7'^7.'J;O/HN<O!>FJ.TY36KDGC)
M%;W_90D=E3=QA#2'D`H0.RDY;]7M:N;IFMO$F%WPBOER"I-NN6V,@VS;NM)>
M6O7'4=$0*MJ[)VA)V:-\C:D\GM&"[%$!8B<E9Y/+%7W&N+JJCZ5!NUR+;-.C
MML4K[*6P\8S&S#U`-(B0*2!EYB0IT<-#X_E(;'UNN*1EC33(TK#1@E6-Q*/4
MA"S7QD@+&&GQWLBEQ&M[3ATL?KA>V5F(FWI>."97F4L^XW-\7,G'QIA=NF6V
M!6';[I7VLI))QTF3.&GM\^QE^4G2=6[2+$HFD)2:EJ>A>[9M%BLU(J4F9;M/
M7$YI&"U33.PDYDN'`Y5X`6[PT4!N^>TJE'9Y26N+E,O9/UZBE[Y,+Y=;^\;7
M*\KE[A4;4POF[BV;5^PF)X^64++X7E(>,FTE$U]X";'$ZQES7T$L\G)F.1O(
MRU6,--TYVER)7$ZD=G0TB(X6O_2UI-5UJ<Z>,IV.-A\\M;1GVB7BHP75Q]*_
MT5"FI;4%?+1V=;VD8YY+]A3;^(A=L$?8TP<'E+HL;O31`:XL[C9(VN8MK=X=
MN;03!!P=3:&CM2_'?L,!\5'8.<'WQ`>&-:,`V(=Z$065^]P2AKWB:TP301,Y
M0<R<E'9"=]U';(!\'`N%8&&0FI3+3FS<UP`;@4?C=Q0Y6UDJ-O#36"XV+@2M
M*00M'SKGYHS`(PL[K0?">>>,P4>=JZ'\HN]T_9!;7%Q$PUCPSE=\C\.&)<C-
M^G;S&\)_C(%3HBO)M>`KK;1DOWX!"1'S^R.ES:EO5$\;:85K?5L5/E_F55EY
MLSF`]*DW<*'/3Z,`!SF4SBC#I!=U3A_]/HIZ6+IGP9"?'GO9N1)]^.\%=,8P
M%_"+3P<8F@]!;;@C%[BZK'");3DI\WE\,TO4BDGUDJIE^2YBUG3X.2+15\KY
MT4@K/(M"7ZF/).7&9%0`I?CHU@DZ$AR)#4"S&H8"%YDX@9DE'-V#'^@CNYHU
MQ)"WC)MI*J?7C**R/K#+<=E(+BMPBD1F^3AY=51^H([(AA+Y@:Z-QG7%3WMI
M+'?`.!H;26.`QM'8)1;V$WF]B87M5';+/7.9O-;EWAJ(_'2YMZ>I7'/)1;&9
MO+;DHJ:6>N]>(G)-$7G/4"*[],)@*J\QO2@&F5WEPE@JKZMR40@BNTS97":O
M+U->#Y6GEWR.R([(RR=R_14/14PFLDLMC.7Q.E,+ZVGLEGL&$WFMRSW;J>Q*
M<,82>9TEN#70>/8VQ3F;7.N6$'(9&TSKIN]?7`BYW>SM<09&T#F.&<.1/QI[
MH1OY&N64IRH#S+OK\3]/W:$"(L4AA4&BL)ACM(1_J>=X,3J6@7.O="V&A6!+
MF+;KF&:`=RL#TQJ.:0N_C^.8]B:FN>S-$-:5-'MS_#,DDRLH_Q;A5Z=A.L-*
M#>4+Z;GIV*TQ^S8.N9<*V`4QO#)ECJ8C5KXC`<9'?Q0HI[(HXBW_#!?;RP#&
M>\VW0+:Z38WN.:UQSVF+M(5Q=6<[..*6E+@;/Y1DH65^6>B[I*QHG40N,X=?
M=+['%#@+"6(+A=B6LQ<+Y&@SLP(8KKH*!$=+H.4-YEBNJC,_ZIBY`<^9HI"`
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MY(1P/Z0\!OAF?#J)N=++I%HFNIJXOS`;69\ARK56<)DYD:B@R`28NZ?$^0EK
M_,0FMQXY+[%Q+['9+3S.3]CA)S;^'-AYBLUZB@T_;G7P;QS^3=8]79BP)DRL
MO\ZHBE"UE2.]0/VEEJ952SWV$3$V(E&O<X.'E`F@>G-`8["#W*EF8^Y8PO_<
MD6:)U*T^QN*<T7@(LH[EN1!XH.6=,H%4+:E6=*.LWW$/5I56,]1/N2`#64:%
MJSF@RXUYJI2K;M:7]8`WARRII<<^#L/.Y;TE<![%'((,YTW_CYAP,OG@*Y'F
M\GX=8.PM"XP]#4:MT_3]$#&9;%Q$?A'PR`0">58.22VM0?X<)/-?N:0L(%QN
M;1-`+Q$S&17M`&=BSG+S33,*Y.8P=H]S1J/DFVA:F%K0?%!AJM2GK'/%1)]V
MC@@5V.];8'<2L:]@9CWU.+"%A0AU(CXZIH,AB@CF.6@3*960B8PK,T4C2GT9
MP-]P0'P4PD+MGOB8=X#YD+N@7@160/QT#V#GMM,R'/!LBW&ZWR/UN"W=60[N
M1.9$9)`X)_#R=ZED$SK'M,?0L"_''D_FME68YT[//7CL(S9`/HZ%8EL1634I
MHN/1&GFDMG-$RM-G%QVCWLJH":V6@5S'-.+Q`/A41/>4"N<<TR;SJ()Z*J,R
MJM+[K8*2;&,>K'2$LII`9<)P_A8NER<7V3ULM"3HHHVCT_+HY!+G,B?.)CDR
MM]RW:;EO@<\J%*&,\E1E()E[9.)8]'8669TWE2E->:8<DQA.)Z^.CMJ8Q^4&
MQ&.Y%X\1B$/J6J?]0.T'.FNBN\\WT))?=3.YU060NC!EG6>X<!HS.K1E3^D+
MAJQE*0-J%D;M,C_,6]#A7D4%,,B%'2Y(71@NS$V?G.&:ERG-!<O%1OLP<[FM
M2;FM14QP0==V)KQ^1XLU""^K'F]SRN2P,][RYF-'[DDHCW5`H2#9"="=&\*A
MX\":`J(\$E`>ZT>B'HY\$.1H=(E$S+!TI^GE40Y@*78F]?+JT`N]A)0IN;0T
M:]YCAGJX\Z\^#3%'(>Y<,^+CSEB%CG^KXU^B_4SY2O?CNXO/2OEJ)Q%Q@7F6
MD[`P<"[ZLI#IF*[HL:G-&:7#T7*+S$Z,>MW&F0)`^_;=,A:<"_?<P8#.9&U"
M<NX1;\Y@UV:PFSS)SYFK53B^^3W4`D"[88/=<$KL8%X;S!M=PV[\_$PC-N:D
M<<HL;6PV-3-.%YN->^[T.7NCW`Q8W;F;ZXM<>\OUU>Z4SG4O)?96XU);([@*
MN65!X$O$6=NYCFMPG/GC<1L??X\C4.S^QA.#\5FSM?U*[7VE\7'I9\U^P\S_
M83@I%WKXJ@0R*BJL)J!OG)P;B)$SCY#?N")6_.VCALGWEB_>G#R$W)3EU^2)
MWA_><*+W1!39-Y6?C?UE1Y&-B[@FS_RG2N4V(L)K85]&HDI%7X[E-:F?:ZI3
M)9XI9("1_*H&74)//SVLII?U&/+^J9YN6R>GUZVLFX#<@T[&8LAVEW(C)1)T
M8B-3VC'A=*]1_W``_4R.ID6<?;_J]@1'=$"B>1W+B$H.>!_2=SZOYZ=='%9S
M$LP4^!JZ>:(U/=@0?GV=RIYT,%<-,WMH*:GFS&*6R/E>@!OM>!CB:7+`=>\(
M]TCD'874_^&U4:^'`^^2"NQE!$JKN*07`>U]L$Q8(LGMZB3J75.9NV#>!AKJ
M+A).WN#NRR;YUU!\@BF<7!VW_W-]ZO7%(/2N;X^^7AQ[6Y5J]5^[Q]7J2?O$
M^_>7]K>O7GVGYK49BC1145BMGEYN>7F;?=C=H:Q7;=]4'V5?=7ES\FM%Y.[<
M"42P!0+^M2<^3<QDKC+J7L5;3!'3O0/'/!3"K9^W0MP56QX7HQ!<3A<45.FB
M`0E'!][?VI!8<N\2/W@W=("BOVVK"]L<K+Z[]72Z$OWMB,\417_V^.2SZ8E,
M?BIM88&)<_)??.#5:T/QR1L@!LJK"#H\\.#"JSI.^@H('X8(%!#1"*L;+Z_:
MIZ#UOZ+!\-.?/S;JC4]>Z_;;M^;-?[RK,Z]U<7YY<79QW+QLZ_Z:Q\=7MY?M
MB\MS[_H*^'-QVEJZ3.\3F9Y.37?<[F,/`2%DUB^_%,F+(Q0'1`"'B#S+@`RD
M<7`@2H#DQ2YXH<@G*(31DP<DW$-1X#'Y[>;0(`+F<=TW[],X#+P[#!\BV9_L
MZGL<*6OV'HCH>T(.GXQWG!_G+!NG-1Z'=KW?:1]:18D@M=V/B1SI=3D5`DUY
M?,=)0)!\.\7[10Z3BMZH?=*+G%%VI?[IUZ<R>(@KOX#D%Z+)R<M.INZL?_C$
MO684Q2C4T]#?*>7!1,XH&P`>E7]X7<K4O5W"?9!GA!'SL/0M'N2C,6));_7W
MM4^-;4^ZFAT%RU,D,N4G^AUKAD1^&`>@RS#T4/`]YD)?_T6"1[@T=IA4.)(J
MC&!F,`^&_9C)6FW^!JT'(`0#D1(8(^QCSF&>J1*^QX%:Y,G.P-Y13TU"R8F\
M+B)L/#/91-X"CCX.83ZI+G1&D`PPA$^A+0YV5D;_$U65SL,`J1(%4?\``$"Y
M<IY2\]NJR9A\8U\I>1@%B`7<.Z+PC_?+6;-U]*M'.(]QH*>)0.1`*UY0U5.0
M?;<4J."/./G&/:V'1&RU!)?C2R-DN"_7Z/=8(DH'6#,AZU</D_0$@_214)"#
M!ZK0APCD\/LHZF%)"-`/>/0^#0/,>(ZPGKQ;C*199HKW,)'?"RCO0AX':4.L
MA_+55MV8QGP2TUES]:CJ0#Q04.X002:$O;M8*/\!7!.RY9BR4C*2$*`7@]5#
MF@_*]'"W*\/]O5288)0/]5]`W90[J34D'-*,53:87;J3$3%2W.Y"8SW*"?!8
M5BO&YE9_E]K;*6(P`@KH4*$!\X"N!D1(4FH(TH\4H8E2AZ(#^#$%@/#Z"":-
M]%CRN\:8)!`!?^$KAS#/?:2F`1W3H<P?94*[[?F(][UN2!^XU.O8[0Z3G-<8
M6P$K2(Q@BO_/<#\EUV``BE$>XUY^$YN7I(*RG5([Q_D^M::2.'*/F=Q!CN5L
M9O<@B:$'FC>3.RP>,(Z\VYW6CG?>;%XK+EV<W;0T.^<0<SA-2SW*SW%S,5JF
M#I/VR1UY!3GA=TE-_"CG"P@!+)JF<QBJ^[>4IEW"N)C-TD0BK2FIAY2Y&<(*
MJ8QK>HX)K=.T`)3'\#V.8DDCGT)"K90>0RS7G@GR80Q>-Y(T%'V:H$/OOB?$
M28(ARH)*%L<U6O%0)C\2-!@*0)8+O/$,8:A`?CVKHDYN+#GS``OIK]1G#^"6
M(0<"I4DGGT2F(70W!+RA>^@;_@1>S9JRG.,L(:7SE=$",;\OD0Z@34B'XZ"D
MEBI(I7:);\^),[8=F:+E#<B[0Y"?J.ZSJ8#9^'T"`ZBT2X.K!Y&Y$Y!.)7E3
MEB;3296?4'`:2;NQJ4G;8(G!_1Y'^(FQU9Y84FK4>7,*2)!S]<OV\GI$BVT(
MY._3A\1'36QO]/STN4*Z*DC(]5_-7S]$G)/NZ+D\>];28WOLM&0.!$EU#+2Z
M"W'J=;L8_#4B09J0G5,(')$*#S+9`4MD>N[9<N0:L)$?7S/Y76N*#%D@:7:[
MLKWL_QA!-&GZ8ENN$Y3C`)7<::/Z@E$(O:DF4KI3F)5.\VYD)/5)2/2?<']B
M*W*>J7L'DX"^U+@RNZ-^EB*B1(^3B@%D?V#AJ7J*\C%4@.1W8)!R3C+)\QG1
MM`Y8W//D&W0P(J.#<>`"WP`&(NU&&P).OC`U4#-[0%P!QF2'4EY("<(0J+.=
M#*Y\DO2@@71"7$B"@XG(N`/)7^)-%X)6=:=RJSN9!,"J"KBBM>+)_DFO+RHP
MA;P'D=VKY15*`V7BF"=HNCQ+7V^TS%\YK"Y6V!E7SDY!K?/K9HO4UBX@!XL$
M9:/Q%^@6O:+6R%74GA-_Y76TG_+Z]4:^&-28J%-=7/[S]+)]=?/Z&I0O5XYL
M:EY"^<9YDY&,J*C;#SP];;GEB(-%`6<_;]6VO#OI8ICZ57XT1$&0?O1``M'_
MO%6OU?XRHZBH$6NKX;_(:M,T!$*M$-3,[Z@0=#`]\R`=X<-[/<`X1U"Z$,&\
M&]XMV+[N^E]"_U7!GB#\E'@?@?(O`A_1!X:&G[?TOUM/*LV_G-`PA(Q2AK!O
M$)*D,_]UCA"ODW3.B$Q&-:`^E48!?S?4\.`N1]ZN7A.^9=153$U7,+W&6V?W
M!,TT5CUCTM-V?T2#T2OL/F7)'?)_]!A$S.#`^[/O8UBD/*'&W.)_XE<E10[J
M[X:/B7,CD7S0>E"1EU1G-^@A2QYT.8#'L/@B:8T\[V;?!-LT9__OA88:3_EI
M?7OWX^[*>;60%/G)U3Z\87*SG,0+WN#-D)]3N1X%5L(R5U;.EPOT3^OQX_X'
M<T'>>U];*<AKM?DSN03J0\[8H]DSC@W#O[M=WS76QAO;'_?>V67C;;7$)LD2
MP"1O_GY[KVXLTN^V=S]\7%F2,#/^5]629.K:*]?6SRWQ5K&BEI%#ECR:47`1
M"13U9"6KR3D6O#QK[-W<&GLQA=BPZMZ=6G6WFY?G%T=?3[UFJW7:;OU_>W_>
MW+B1)(S#7P6O'T_\NC<@-<&;]NY$L"5U6QZUI)'4]L[^TP&111'3)$#CD%KS
MZ=_,.H`"`5`@<;`HP3$QMD@0E965E?>AC2]/M<]75Z=_GE]<5.;VC7"IF129
M+)),?5T88(!3"#PR"Q;:PGI$=[P;<\$],J^:Y4I>0OEY[L5"+QL&3CR?>LTL
ME[GU8$'/$W'D!W[`W*7/XANP/+Z'^OC7X'RB21G+U8+X(NC.W8K"?^T$KC]?
M<V"WCK5/`?:>D@%!P)C;<",08I$$)-PUN2(NO&-)1)QO\;P1(AT=?Y[C8*S>
MFL%^7+@L6Z0^-%Z77;T*G8J]'-N^_S#A+\_K4J*>D>&RX'<E\EET9'=*G2N&
M7I**<;K1DQ7:0/2V'[%7`)-8_=!HWIWV_V;TGWI=7ADH*^KK*FNYU^J72JH`
M-``:DWW>+WNP75_S0_NP5*]!`Q,YNJ"83PD&;+V8%@K$5K:7*FGZY;=@!WJO
M7<`;5*T%V]?[K\E5=0&Z.&9!!,N`Y3AQ-9\&K)7P7+7UH3%2E1K:>K]=`#A%
M^8%-?"6.OJL/6M4'O'8&KM4I,]XE'3W8ZC\)E%-=8F':W[5;,-A(4HTH3A$1
MI(VXKUO<U\KLKWB.O]#\*M<"=KQ:0[W?4I;E#_3^H'M8+%]](=_16]T"<8'*
M-9#A*U+Y-G,!561_3^_U%9;]@U%%/*"1_:_CH7WP^0R?SEI$H_'JO'(U[RZT
MZI3@Y'V]541\5BUF1KT#T^:N`W<RIQ4B\#1/,8M*LU@QV%IMUIXIH`VF<E]5
M"C#T4:=`8IQREY\G)N62!$I0QU`W#&6I8Z`/1XV71QE1J^)#^TP_7+_EE5IR
M16(ZQK!8YE_%,J"O#XKPH.KR$FMLY"#*>UW"BW$M4#%^'@V,:/-+E@A`2T>U
ME=!#&+0YE!%:><Y=3X@7)^&)H!7VLP69^%%Y)7:)("Z627*/%8+]?_^Z._\\
MYI`-NK]65R+].4P.8_V'@H74KX<7Y="T-%ZIRZJ`>1M4_,4];_R++Y@Y"RS^
M3+'`4J%MDKT..UFJ@;^!O\C[54RV:Q[*J65LEX#V!>3&*7FL<<7::$^=\MH,
M3&#C06S=6N.2=/A;[8>-[1(U'%)5X\K45-E%:S[8U$JA,>IH@FFFG]GF41WS
M;*@;W0)NT*H]=.UV@?+`:H'KZ2-U@3-Z>KNJ0&55K@UI/HH:_DG)IZ+J.?<Z
MRKI67COV5//_GP2N2^S),^O'MZ`.DP\TY4.)R]11-[.[UU85LHZRR7#=4EN^
MU-2;0]+-LEUZ*NEFW;["NMG04%;]`=U,8<SU]7:WS,XVI<4<\$6?'+#"4ZVO
M#^E?I;_F>OSY[./-V?@?J0,=]E*.+_SZ6)W^1/`X,"'VD;CF`XDEQH:=96FO
M]O2J"?QS/8K!8W$,3*R<-P;14=+&M/1G[?5/=8R;A&VE1>-W"1[>3)/V`96B
M*!DKKTT=\*P?VI(VB!"S!S(#&3]W6^U$S(<UW?5CG4&3:<0"Q&AQ[/D>H+*#
M00:-;Q^;$?^@+X'5AMU6RFK8N9-V(]U$8NE=.[9K&E%%'X]/IN7^@>W(H_5>
M_;"9KM2V8^/^E>$$\<8<W5CP_-/X_$;[8WSQ]4S[<C:^_7IS]N7L\JZZ\2QW
M4@`V\`AE.D_8AY;\8!,=*-6XYH2UUF=3-^B@$[ARK+,];W#\:+J6>6\M<,0#
M#FHPO3EG"!AYU+'1+P``&);;FM.[ZKC`#NUH13K`0<R3P"[[O(4&NOEX&V)L
M<88=EZ,.R?[<<J='P"]=6%^$B.G/W5@GO*F8:,6;?//%)]Q\8>PO[#B]\!R*
M%K;&!"M5PD<90-AEA`+L/9DK&4?A8Z[E?4_?_;WCNLX3\"?O&.2FS_'E/Z\8
MX%,`^9'V,V:=4*;$`U`9!_2BEK[:G$P!4QF0)PZ4;V7W4^5]A%EC=I!/KA5&
MQSDVV1)L3I@]]<1$A6C-Y&Y0*\:N5FP<3+BE\73*&</B.98MP);(0;'.;.;A
MN]?V-B$N#MA)G+](:`GI:L&W;Y%P'QL6Q(UA]^;XYMAN0DGF$EQ5%R3.UA&]
M6\*)$A[OVN^1!"&$+<PI"8.PPE;SK"6Y2^Z?^9Y]D8/!]L:3<L33O#5^-">'
M4>4&?"10$1+;U"%\W(,=#CV!R^%(@$L]IW%@H1M$XVA0K:&M\ET-U1`L%8(?
ML+?`188S0]Q1P6[Z8C(2W$60[#Z]7.Q1L0,V.>:!#@8B)G(.VO,Z-G\#IQPX
M'KYL@3]R0>YH5[3MN6,_.`@,[>V=0G&@REB^XV(SH``WR_B-`,;TV666D4,'
M(>$H'/$4]HOGS7MH`WC*'Y`;$`TNEL[6N2<3$Z@[EB!#L>LQS)H/+N&;H1F6
M4;(*Q:_E!]21*?57@G\OB.DAR]3&VCO1]1_1`O0&;WH?WP9<OFPK-9ZY,S=I
MSW)Z3U$Y"^C,K,"G3<T1F^&H$G%U$CQ?ND+8E?]E1@N0_=SN1(#=\Q0A_/G/
M'8Y$H=3%%-S*9.EXL9`I7J9S<6MI'WL^K>&>C1C5O#EAX9KH[A]K)]$X)<$6
M&)1LVDR*=`A?3\S)G-L0=&0-N_W1Q8?+P$R'M%E*G/RF!/3I*1]@\30G]'DZ
M5TK:G[?&YO`NL&$!E.')DSGXZ(R9YCG2Y`24=/B#Q..JS!B*W3S6%\RA7()U
M\,>A-@ST>23O.3?"2PV\TYE8%#WAE`<J07%66S@V!^=$/(>#S.C?0!@X^\V,
M0A+X*!_6KFOG]D1J=<:!00LJ*7KX621D#P6%7;V$Y!%@L1>SA?"Z&2GF63BA
M@<LC^(O5^9VST5SQEF3IN*[NM.\$I0FD4`Z!6%G3GI"8E^:4<DEJ:R(WPLM)
M!\EP?$BT+]@5,$E?R+L)67%2C_$!=COE04C`Z.=@_X,N&(ZG2;WPT6F88A<A
M`)2O)VY@<E_TVGF)]>(<P^*'+)?J9K,(KGJ!E%U04.D8H@6=X2A=8<VD:WF2
M>D+G=+CB[N.PH%C*)V`FY%$<"YZY#*<6X?[P,[JO:8Q;:)]!(_`^@,%'57X[
M2D%.J)2LI2![(U-WX*6N$SS,8Y=8CF)$`##XD;%;X>P+3KPO:0^\_2``(+@I
M9=-K)&79`4M&32&14$V4M+M)G&CD*1\S@2C+)TM02<YG;+`)HMU<8^.V`YH'
MO$BH!)MI51>D%8TH1$*$&\YW,#W6?F.7R@Y_A(FH.@H`P`67,58X/3(FI[CD
MDDF!T>([1G[O/W!G#W6E,ZH2O"^<EL(Y*5<Z&//A7&>S'PK?AM^P7W;%B*8;
M,D,!Z#"7PX"^/QKN1M&]=![#F9@XOC&\28P?GL1N$N..%:HB+ZEN0OF@B@3L
M#:4;VF`/>)/8Q*^(@<G'E.`1PIY,F<M(G7KM]C`I->A`K"/?_'&,\THU,S3S
MX*=4,6:<U".$8YSJU&RI4"A3,N4J+HY=Q3'H%FV$B1Q8S#SCZJAD=F]0/GES
M36%12-R)BOY(A^*M2`%G/WS-D.4B\W529LSG!B(DTI`R/CTS+A2XE`7DNN+E
MIK@+S)Y8FC^L9;`$)=Y^`%T"7VKA[$M\^&EN3>8Q=F,QJW.-*8?WF]G!\)`Q
M3(`.:('3IM<ZJ7>'[F%DB+`YZDRE7@U,DX\;I&PUBM*I-<,+1#/14[P]'N=D
M>-'X>Q@A4K.3L75$F+2@&#PGR@#`[(4]XN2MM3>;E"V`VL<\&'%!7JGJP;/N
MZ1DPCSD=8!4LE]B3,9S)!W`@;!*!RG<OS9,0'_V8JEM1+A1R-&1B;S[WOSU\
M$[G;#?P-_`W\APM_4WMQN`_E3E$?A!78]_@?:+]^T-Y=@*;#Z@_NQ==U07)X
M-'FXN!:0R/;%?B'9`B>OB11B<;3]G@!6-N^=&G,CXS41@>2JV>\!Q'Q&)^?[
M!8:Z=EXW%6PUEB!$3.)DO&"5MNO>WW[5'HE+AY`+VYC:R7+[%?J2=\8ZSX57
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MC3#I9$6+#\3!,CQP!U>FL#P,^#.3#:I5T4[W[>BJ,ZZX3Q`;?:QYJ'FH>:AQ
M:NU11\B:+:^*P=]1=GS#@<9M7Q;=U:I79XUZ]3)I%<CJ;;2JYJ'FH>:A`_!R
MT=FK)2M)!?)B51#H6V3Q&KVLT-L>W#M;P-TMGGV\#[![]66+%0"S^CAQN33<
MV:HJ0V97+_&O9MY8KD:D+=Z(E+T&9Q.(5KC>W'FR1<]HUMG3O'=X4W!L`HRM
M2<T?KZ,WJNOY*:/(FN:HXC8VS5$;^!OX&_@/`WX56[LT#Q73+]5OV'EX-'FX
MN%XTS5'5((6F.>J.R'A-1-`T1VV:HS;-49OFJ$USU/HOH7J--9L%#W_!5W`E
M/.M'LUJSVHZK-:U0D[AB49%FP6;!<A9LFJ#6MMQ;;!/ZNG?7-$'=8Z985M9\
M]<KN3FDV0X4Z76V3'728F6+M0^V%6BH2#O/HBE<L-_GWS4/-0\U#6S[4=$9-
M<..1"@GY.\#]KMTZ[,8+H'@=^`9&6Y=&''1KU*PD>M4OBE%"446C;S4/-0\U
M#Y6O;[U.MU<EC+RV2L0=`1Q4+R%WA,S(<A8I+KNW\I3$W]_T3VWZIS::5O-0
M\]";>*CIG[JK,%&I4\).\!<??+)7^#-[VQ\&_$W_5"7X7V4@-OI8\U#S4/-0
MX_G:HX[0JTW'V1'"8:%LQ3UBMKYYW=4HC]N"?]!-5:L/U>\*6--*527ATSS4
M//3:'VI:J:HQU'J;3/-A5IMYM?.5#95<5%O`/:HOOZP(%1\8$7<J&#1=6AO5
M0JU`J^Y+FLE_)>@ZZ\`9??R$-J:#/X:@I_,J7O9M5,+;HO^\J,1M^H3M4^[S
MN:D?Z'KKT-Q-1]?E5H*0UMKP99#;6G._S4^-^AL>VR1+18N//!<JW)WHC%+@
M5I_-9@1;SA)MY8!=YMBY(4\EJE1EH("*L1M:VH71<FZ3UXB8<0F(F2R"*>T)
MIMV:"^)A@^))X($B2-PBE='*X.ACJ3@Z<3S*Q%>N,PTFR/&=Q?0UH.FD5#3=
M$(^8[F1.NU-/R2-9.*LE6`6:W#_IP#%V6BK&SD4:P#O6:>K]A_`3CC,=%8C7
M@+BS4A%WA9WL(JQMCZPT%;&00OC)<7GG=M:SG4P<N`5_!:8+!^IIQ$;(?P\6
MS]%>.WK4S#W^39=^T](U4UM@W@CPGI\'T==+UFJ%_O#GML%VP#_4-2"?%9-Z
MBV==>P)RTF)M(#<A3V<MZVE[>P=;TL<"(6RA,!H"A^ZG]++''UNVY[L!7GZO
MNG;\'.7L;5D=\W=&_(,)J$+$#],1;[)UP_/ICQ+/E7@6?).9D:F]GX5I40X1
MT(D(>!'(#\L'B6E-P"::F[[VY`2+J79/$4``(70J@D?0C@*$>A[:2:ZV,BWZ
M!>S*]F:`&H%FR[RW%I;_?*S%ES(1G._$/[HW/7CGDIA>X!(J=NBR%HY;@"NX
MM&SX.O`0([!:L%RA/NC1A_@%HN\!"#"T8:U,-.T8T(%'\*QP,_3G$KP27#@=
MP@S\N>-:/AWT`%_"PJ8/\+`5@*\#U[&\.4&X_;E+R-$"Y:0VM^!!$)W/X5'#
M8O@B0#O%IF6O`H`G\!C9L&TB,+,0&Q0"CBU\*4!O^7-NED8+H%$*A#)QK7N"
MYX&=9_!![8)"8FAS\Y'2'/W5PQR%$0?FF1(^?8ZMTY$?AA?!LQ5/WXC.'NZ<
M*4W5@*MOF_;$@ML?$3Q<K&/`"UR;)].=)J\-GJ#(R6-08BK>>T'"YL.#2QY,
M)!3M_CG*WL.E@6YG`1ZM-L$&/C/8/5`:L!_T"3#BMN#`5L`!$!`&LR`U?#E\
M\V@"Z0#V..7%D@(]BFLON/?(7P&\8?&,4&/<C;T<7_'U^/98F](67/!J^A&#
MD2_CK8`I)'@&OIU1ZXFS!#)_AE<0QD"`&BPX779S(EQ[?+")1R2$LR4DY@+;
M`/CA``#4J37#RXL-D!DFN:N$OG@2<0(@!F2$P0HP##?*7[";"\>RQ'L#)*>S
M=2BK%WND^Z!-QR1Z>`*>B^1(*$M@D&C,`-0<=@GX?L-<I\&O'G+H8.'C#OE"
M*[RRR!IT^61A_8C`5HYGX2-Q+)H+S]'F8!F`T/DKP-MBP7EY/D/.T]Q"S5BP
M@JA).+)J<?7NR<1$9@/`LHL*5,HU'F0ZS)0-#Y*1S=I16JB+\?-GV(!/:>-?
M#84#+#D!SB9MAK(R3^9E%A'@,O;GXG:HY'JTD/\@OAF*V#(!B%@\'K@UP.#L
M*5XU>EAF7-S%:*JV*3W(905#!#+FC!1!H\P4KA*7&1)P><?J;`^<.&DIWT[[
M9^#@I::RDE(U/VAVOG0RD&9A>`4C[N*\D#M(!U8=.AG$[1C$MQ(E,=IR@$^Y
MCVPB$L5PU0!U,@$*[.V`>=WCM.1;D<;_-C*%-2(3-V7M*B,'@YNUKF,SP"-%
MV[3!&)*>:',MG&K%IL?OK/?F1UIU6V]B)$X#?P/_6X9?Q8;6*CY4O,E_*SWP
MN>`-6%%N:=PE1&&H)V51531VUK##Q+;6SH6@_3:I3C_H?3:I?KF;=AI%<B.A
M'&*L"=KV04';.1!H:1;=X<):\]B8U]J!.$3'Z<8APFO._E\BS"5-*C6$4O-0
M\U#-#^TC%SJ\OV/J5FDN9O-0\]`.%_-55H'F4][VVE.@2!)X=UC]:((&A7N%
MKY/9>DU1>?QR,QY\<4D#'M\<M]@11&4+=AO<[0Z848!SJ:80X,_2'!W-!<\K
MQJKO+-I@;P^@=3I9-9_ER7_\IFEIT#S4/%3_0WMUF5U$Z4>-WZQYJ'E(=36Y
M\9L5!;'?+=`3O<&>NMCK#:MO=G](CK).XRC;Q1)L9<VHVCMH#?8*L8=6`3^>
M:FH`_JSQEA7PG.JM7J$I\@W^U,4?`#=L?&8J65'-0\U#K\9G)J>)YNH+T7C6
MFH>:APY&I6[22)N'FH?4$;R-R[LHB.T"UE"#/&615V26L&K2]_;)\CSMDVO:
M$^V*-@_[K^9VYW1L]I7-76JPMW?LO9+I%*^8`$=-"<>KQ%[%XEG<J,8'W3S4
M/%3_0ZIIT/BS)J>S>:AY2$65N'%B%06QK:RBUR"O`&290\S*N\CX3:,E-P\U
M#RDI:_>C);/1(.=1#WD*;8F]U;H9O=7*90Z%YEWJG4'U,R]?KU"M$T3US[D8
MA$8_:R+O+DRFLBFFF?RG&1P:/^*#'QSZ7T4OS$DXSX:&,]FXJ6BZS`J449R9
M9$[^"BPV\`3;_-\^VS@*1@?)-#G.O5.%)],5G[\Z9O,/,@8<Z'QT3L9,!9Q$
MDC8-ILVF,K%16A-"CX@M#&LE=`,Z@HPRJ6C23/J0F5=Q9F4,AZ73!#WMYW;T
M?&RPGM%-?@%8MAW[B$]9$D>*`UHV3)C+H@L&DCPB[E6<3:?$L\%JK?33P6*I
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M.Z_;>GND;`YY0>#V<<,_.X_$M>FD:H],<$RUQ>=U._>PLCP;N=8+GH+<CC[J
M*1M!*PJ=<I?><5<.[8TU)?<R;2A!"SVC0`!+8=#VP0&^.#9YY@.ZM1E0E1I'
M;.C#ML)-;PH!I]IE1\\@W/.5XUF*I$@:>DOA6I-BP#6)=&_BH;W5`FH34-AU
M^O\:^2NP8%'JDD>E3D0X&+MG7N:*1'L1)7^D]X?*#@(I"EUS_]_$0R4+^<@Y
M.4IZ;ZFG\A$]E1B/>LBRZ=C[),..\@0Y\AGQ!?:L]/LGT].(\&EK@8?1LK\"
M!_^X=YWOQ-56KC417,2R-9.&F]F?[+UY@ZG-A7B-#^W5@1FYJ:6*/0I5X\)4
MGO>51P;"CWU*[OVJ3K^`XM/36PJW?"\&W%ZO_R7(N#K._LT_I-K-[QT;O;_A
MD</'@8NSYD%':K>,MA)NCIZZL8Q^IWH3I]23;AT/6G_3+D$A#0^YH\8AMY3U
M8_9:G==SU3O'PU;:56^HX"70BA0L[^.J=R*8EH[MS[6+\X]7-^S#5K?S*Y#!
MIYO+YOSK`$TY+O`2;1RW1C'RZ"I!'@-U)SP4`FT?[,$X;J]K`FH<\DA==<_0
M6ZUJC;M:N4";JOTQ$N@K00+#D;(=;D<5*X.E'W+ON)=JVPV4.&F\4<KR="RO
M?$792EE6_E`)2E#XS@.1'EJ^4O=XL,[:1]H[XZ-V%KB.9AQWNX/^>R7.W="[
M784Y0*%FS*IQ@,[?M/\C</XG3K!R;/B733O'8(+#;8#E<!8;&K3&(RP;Z*?=
M4H-<U,UX:A^:X[]]/$H3"(J<=*^K;!YSK_V*!G=VJ((HBXJVH00!=-6-\G5[
M!W;5^\>#3MI55\/MUU;7K]-IOR+G/]B":SZ?=E=[UVNUM,\?KXWC?JO=4T,I
M'(R4+5T8'M[5'ZWS]Y$2A]P>*3N9NS.HUMZK]=9WT]6\CAJ\7^603\6\OP+^
MOG[5.VJX^4;J\G-#-UY3E5+O>-A/N^QJ./D&ZE[VP>#`+GN7*G.)D^XJ8KT7
MZ:)>L?$V?$4NO>[Q<(WE=]6PWMOJ^O/;HVJC.J4?,NO^^2YLDWAN3P//=S%1
M_X8\$CO`]C?VU%/#>%/7;U<$LJ;^YDT\I!I_9\6JZYGYY1YZ@5H,HZ/WA\KJ
M=$97[PW+O/.5=7'?NH7G$\%=8MO01^*:#T0#ZF.M:S7:D,2Q8R6+M#^)Y6G=
MX];P;\>5018OL<3FH`D@TBHD>5\-5AJI\X;63P0[6CNNZ]S3'BM3[9[WZTTK
MJ(QJ*<,RRDV[E#_Y[P^!=_1@FJM?$'S:RN[4\B8+!_NR>G=P+3\NG,GWO]-G
M!070CX`.'AX`$E2_@!"B)UACNNQGQ((@T9TEN3-_1`N&Z]%Y7/#'#9G]ST^W
MUH\OF*CIP=ID^JW5^3U88`/5G_X>(\[3JY.[?UV?:7-_N="NOWZ\.#_1?CKZ
M\.'/SLF'#Z=WI]K__G;WY4(SCEO:G6O:K,F[N?CPX>SR)^VGN>^O?OGPX>GI
MZ?BI<^RX#Q_N;C[\P'<9^&/^GT>^],OCJ3_]:4-OOB0*>MJ1EF?[RK3P-=J<
MN"^O[LX`?,8SZ(P-[?SRY.K+F78W_M^SVVJON^,NID_65+[G%L6>YIL_Z)5G
M+:_QSLTLU_/A_[T)B`[/^J'1'%_:A3=L@`W_T:)7C`'9-H[;?V-?`(OXVUHK
M;`U!6#CPN+2\6)?>:#0]?$>;`U."ASAD</[L1_`H6^;?@6MY4VL2U54CO%^/
M;X]!D?6(Z6(C>QL3$&!=9T6KLW&=B4NFEA]R!I.U3H;W,W#$SMDBF[??.M;&
MTRDGW\6SSK(;`!D(R8FS7)GVLS8WL0NRSRO`M0?3LBF'P?UE[&8CNSF8)M?I
M?''3/:V"+5X38#"./;:GU/*Y=L#8(;[E$B2(C\0F,\OWW@[+[$LL<U?4*,-.
M^S(W[<>XZ?79Y>WYU>6M-KX\U:[N?CN[T:ZO;N]NSN[.;\Z^G%W>:1_/+L\^
MG=]5QVN1`3BV&+!Q"4K)-6S<@4NN<>0"C_"X_HU?K\37]_SKB>.%_$CPDW"3
M@U^!5<)C.&9%_"`Z/CJ!A?<5I!8_?X2MQKZ,>#QC;P1(?@H:D>GZQ$UA\1;S
M&;#?A&W?)^$VWWP']EZ[X@[CG8H[GF_[_@;^!O[MWW]('?`YKXJ:`0TBGPT;
M<\9`BTTZF]%_*+0W$4>^1J:K(HS,)2QD4C:8*IZ;B@]5=4Z?F)S^IQ#05!FM
M!=#.J[_6;(<X6$;KZ'6OV*U]167V6-/$C:WN66VC.3+PA5IWO<L5\KH?Z.Y>
MZZ"06^(^6A-"C<=J8CL[S<#M*IN@:;25#3)WE"U0ZAQ8AM,Y,@?B^15<BQTQ
MV#;4O1'J9E.K6\=3<=..6F7(V0\,V)`I.A0#U\8(,+H,^6#'DJ7*QA%A.Q[&
MN_8@BW6NKX??5SAX;><-=+-RW@YD`UE"]<V`OP\Q-UXZKF_]QQ0#UU>NY8!!
M):F$']ZQ`*@:^7WJ:EZJ`B8%N:I?_7!O5JWB<OW6V<37HC"MU/^]N7,'"5B=
M=VZ?(.Y#8MV0B?-@6__!],.)'Y@T$WWA@**IQF`D=4L/>LI6Q1C*CI(Q7E$%
M?F;*B$)>OR(9TU53@K*IYNIZ7XI`IF@"_'X3KW(FUS:95TWF50-_`W_1]Q]T
MBD:3>:74N:GX4,695[<@HED=0)-[]<KSDM["'IO<*W6SDU[W[IK<JSJ],.VA
MLFE$[:ZRH`V4]<+T#VQZE'JY5]TB`[BJ!:WS.KU_U4)FO*:!6H>??-7K9;5H
M/)#DG^Q&H@>R@2;YJDF^>ED*JLK.J\_Q595L]PI^5M2^2<RJ28M1]3XJ"UB3
MF/5V$[,4+E(Q#&7-RR)MZ"N&[!6-23B`U*Q.3]G$QG9?W0[_1?I]*PR:HLE9
MHH?>"3SL6O<![8Z';[UWM0_1.I_6&EE%F50$P[0:!L$B!'1TFEVEQ[KT3<0*
M\/C/AC&*'E^R*!1-QOK9Z">^8"#XCF;Y'FL_B$]:Z/.T3=:F+9$>EM8344#"
M4L3@?0B29;-FB#/@5VRA<)7U%#3I=\O5XEE[LOPYW2)O\Z9=NXY/:(-!;3SQ
M69)9JW^LG<N@LD5X#IM+Z,)DRCJB3AQW:MI@RM)7+YP)W=E#L#!?[EJ8W@QP
MUPYT530*1/R[9(X0/1+6I1"?>^T-`0=20\"74*!,X[]X']5!K//?^.3DZY>O
M%^.[,]'X[^3JR_7-V6_8$?"/,]YGM3*6Q9IL3V1,BAZFZ_WV<K$IVJ'TY^&Q
MQ'CN&>/1Z2IP23EGH+?RY]YQ)_%DN+)G`AA,,=%,[9F8KF8^.,!_\@--FP2R
M!7FGP)>A[VR$G@-NI#RT`7`&PDO0\\39*;7\X5>V93\`]\6_`MLE<,IHW["F
MTI-GWIP5^3<S=+20O>,=8WPN\>N4'R&:`A?N)/QE/IK6@DI1W(QG+HBNF=-_
M!YZ_I+TA7;+`CM2A&"'`O9UG0N*,7:<+X,IIRTT!,X\F[^0+/#1@KX8#6EBS
M9\P5-L6A38D'E$U[8,/13$QOKLT6SI,V)],'XC%1%*48\]Q@XM.D92Y0)K'&
MEB`7@F5`]\`RGMDZ:<?Q.OK:OH5\ZF[K3>3#-O`W\+]E^%5,&VT>:AXJU5.R
M7<XB52:;R](\]"8?VO*RC%'W;RY+\]";?&C+RT)=G`=S6;;<W"?')?!]C2O>
MABZ6&A<]X\Z9&I<\1=_.<8T+HA<X?;V:"H;PX<_HY?KP[H*ZN.HL`#KAOL`Z
MI:CP$-:X)@^NU+@B>U^K,ZR3+;$@QH=]4_.^J]KN(O=UC:L*?W>-2]97Z<W6
M^XUZS6M<D'+$G,F7KZ2H[G?3#DQ7BBVU66Q)VGDME1#Y<VO>C?I9N1BEIP+G
MVUQ*X=W>U.."2<IZ?YB5'ZX*<@N5(^T5NQV]USG,X@L:;99"ZI.Y:3^0<GE$
M\U#ST,$^M(\<V4XK^\)^C6=0:.\PG6$?A5$J/I12K-51)"E6Q8?4;4%:X^TM
M_89B%KNY!#:`_0TG"ZP_GF*&DIQ+M8?[^BI[HG=4-Q@.'L>&L8W9\%\J7'IE
MY?I+M2\JZ.$I%*`/%.Z$,U)VLI'15K942&'0VGHGDZGO4>!O]+2EI7"7[&8K
MX%8;&LH>=J=]J!Z?MM[+K`141?=HUW#+*]+K=&-405N%RJKS,EF(%!'K)*IQ
M^O@)33R%/X9_^Y6GL/-OHSZ/+?K/&C(W@9?\A"77RWGPF_+EUU/K<R?EK[/>
MQ-FMI=EFG/!:\N[FIT;]#8]M$@>`YNU#DH45W-O@WO--V[?,Q>)9<V8S#Q0_
MRXY9A]K],U<`:>@3``X(UHQ@%0D6%KH+6IQ"JVO,":LBS+?]-/(N5+<UIH:N
MQRL=XQ4MZ;5%6!X)GWH8J&.E.7QGO*)'\\T?FK4$\O-YX0M/DHGJC:2RHEA-
M$+[:=GS^H`_X9=_"2S&HR@&`]V-]D8>+/O-5V4)@I*^(NS2Q2`>>?B3BQ;"[
M>&6J!Z=H32W3M<@N!9PO50Q64:AYQHGKFKBW<]-]]16:0ZE",W/OBI9F#F.E
MF6?CF\OSR\^WVO79C7;[V_BFPC+,6!F;!=<$?5B./;$65M@.Z-[TK$F<8<&U
MT3S$+-ZAJ;4(_+7BP>@)!FEJ?:0HC=Q<V8DU?/%ONO2;UL:+^!;*SP;]-U%^
M<^CP'W3>ZFXC`/XI+G;V`("#QDK3ISYGGWHJ?M]\F_K7FG/V<8-FH(Y##+32
MZEOS%0.PXJY>I1_\^)&XY@-A)^UI3N"CD8L:4$R3I9ICN82PXV&T]4&W=:Q(
M;D`J>+W^<8'0AFKAK6LPR:C30Y`(^4'<B>515D9]&O!&-.&<%34S:/<.)2C%
MZ`^/U>U>-N@5(>)]L(H+XGF_""IXFEN3.8C-8($=N<#67`7N9&YBQ@0C"M\E
MIA>XSYPZEL2?.].214E%J0G&<5;4]$`:&QN=40E;4(T3G3@V""O?0L8S)?<^
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M04=@7QTEJ,3>@/57UUCP@`)>^;J8-K&NA`!J8EV'!/]!1W4J''=]T'AIHEU-
MM*N)=AU(M*M]7$<:<"$`2QW!H8YK2:EH5V>DKF\1HUV]3%=S.4301+MR1[N4
M+1?!:%>!!BQ-M*O"4%$G,TAZ,-&N82:';*)=RH64%`9-895$L6C78'BL[)!4
M%NTJ`)YJK.`0HEWM0IEO]1@K9>;;'&ZT:R=?-H.W"79M"';M'A=@L%-<1F&N
M]K9AKNRX5F9(BRU<3EQK0TB++?-VXEKII8.9I6Q5U`S>D@<L@+PA*QP(;S^D
MS)1\I=6#(ZEZ,`<6E(EKQNL(1S'E[_;L\Y>SR[M;[>J3]O'K[?GEV>VM-KX\
MU3Z?77V^&5__!L<P!G*^K8POWHXOSFZUC_\2H,B0Y%STU08T^]TW$1!LX&\"
MLB^Y5S(#32!)FNK#PXC'5K,B:#WX3<5'J/Q@`E4BN]4L=T);G^QB0!]L*/D$
M""A8BB'`97EBFH<4?&@?WN&OQ[<I-G&A*UTD8[Q8B[]:(.SVJR_#J":.-<PL
M"$R-8OUM5R*ME3^>R]V7]L`DT\(#W5[UPT!V!LX8*@N<T3ZT(#X=;JL$U77T
MP4C9^K".WN\JVRBX6W'AFB`(JFTN3/N[=KLR)R2I:!8GQPC81EU\]0^I)HFO
MYZ:[!,(.?&NR%Z;8/*0<`99.9.7;*SN+M'8-ILK.P!G%_#+5RMM7E#JCHODQ
M&BFKX8-MU%562VVW#RVW3QWSHP_L4-F#[>F]GK+`@=%;8+168W\T#^WI(=5$
M\1<R1<-#.R6/UH1X/,$%YZ-KIY;Y8#L>&";[R&]O'E*.,$LG/F7LDK8^S)R5
MO7=9A\`IVUFSU=@E5:*WHP]:BLP03;7FU25,H].$17:W2WH#90N)^KK14=9-
M,ZC8+*F5'?[IN(OIDS5MYM>__H?>M/HWT+OJ1EH!N(ZR+00:]:]2](YTHZ>N
MK-.'F5,E]PZ<T2O29?Z5J'^%<O9`"1Q5SQ0+@=C3.S6H@I7D%0XS^U*GI17F
MS"JLHORY*1`[[`*E!O[]PG_0E5`[%H@U+3LK7;$I$6M*Q,I=KBD1*TGC;AY2
M\*'7X=LJU&9)[]=0P%($PH[>*C+W9)^FW#O#R/3Z-S5B)5)35Q^,E`U+=?7.
M2%E7W:AB-VWIQ*=.+'2@=P?*!KD!.$/9',U6D<['38IF\]">'E)-$#<E8F_L
MH==AK^PH-?IZ7]WTGK[>,91MLMU[3;-$U;,^>GJ_KVRXNZL/U=52C:K[?I=.
M?>J8'T9;;RN<96'HAKHF^:@Q0)32:YJ'#E,6-S5BS4.-8=+3!UUE11T`UZL>
MN&K")ZWMHB<'P3+5,U\&>EM=\P6,_I:R=O6HR23>V3[HZ*V6L@$*L*TZ/67K
M/GI-APNEE)_FH<.T7IHJQK?ST)LV4(R>WNJIZP0&Z&I(D&E,E,,U48R!/C!4
M)N"ANET1#*-IPU<L`17GY];`GXJ`V-)'_0/U\O0R8S&*U3ON,!OPZOKL9GQW
M?OE9N[ZY^G1^UTSDBQ]P4W#9P%\?_`==5]A,Y&O*+9MRRZ;<,DO':<HM2].F
M>UVUAZ;U:^A(6E$]W"`S8E9N/5SI5!I/M=?>&>_5<(SH`T/9Z02&/JRAB7TU
ME-K?;KC?KG2J8+:6]JZM"FVW%<Y<UH>#ZO,2JJ'M3CNS'J!4XBZ=@&_)PQ(^
M\31G15S3M^P';>4Z,\M7@EX[>D_==HQ=O3.H'KB*M(;1*PRRG/U8$=LCL`$?
MMKQP)J9/IIKO:)X@\G>=DOEP53T.LOA@_L/9[P9ZVSB@"VV@UH?VP:'#E`K-
MLB?.DFCW9.:X1//-'Z3D//!B/46Z[>I3'HM`V-7;[4.-B1O#2JR\IH=E$U)I
MX%<+_H..'30]+)N@2A-4P9\V095T):,)JI2FT!JZH;C*;>C=7@VM$"M1N=OM
MK;*HFL#*RQ;BJ(:NDSL#-U2W=JKSF@9='5C(I*.W#66G5?;TWL&ZH+OMK:9R
M-"&3?'@=ZNV^NN'KEC[L5!^`K$@AZ!QGU:\V,9.]GTZG4SR@M><-%$^/J/V*
MEZ-_E$[5!Q(S&>BC3*JMD@UO8<"U]%[K4(,F[>YV&4=U!TWP19^<A>6D^D,^
MI'^5_IKK\>>SCS=GXW\DGI=N#W6QS<REM7C^1?O_[JPE:-^7Y$F[<9:F_?_I
M]`/=(ZZU+F?6*W8VK\"<>)U$!4\?/Z&N</AC^+=?>5"'?QNYAUOTG[53WX2`
MY"<LW"1'AC9%D-:#3;G#5.M\+4%E:X[_#%I<"R=L?FK4W_#8)EX+:-[!BVH4
M%C3G]F013('4%I9O/=`26(UPK<.9:3^W1ZWH/4OFJ=5,N%\_][HIW[AD@B<Y
M1;^N/R?:C$40//C8GK*U_V(%&O0E[!'7\\,'K1_:DH4:8'7TTNKP3F]%)K[U
M2!;/Q]K=RS]AZUAB9Z;V8%H(VD)H3[CLB;-<F?8SV\*P;0Q^]31BN@L+0+/L
M1^+YJ&#A/D[<`&DP:V\4F/C6.!P"6`D%+^Z>O2BVGY8>[<4F?M9)&48OXZ3:
MK7;BFS6TYJ;75%:R2PBG_,O0+N\R`&Y\.'4_<-%^E+'<'_2WI/K8D4O$DDF^
MQ]JF2XEO0>[(BM6U4W(=/&OCVQM.R-UA^U?M-VN%,('%H$T<S^<Z%262]F!7
M\/-"QQ;;%D3&;-J=/-!E77ZV\AJ0&VY,-WDM*'JY5DKQI??2GEJ#*7Z@^2YZ
MXHZ_NOO8*7P?QTNPKX$VLLU?SACAWX!KN+3\[#Z\X^?\7H<?VT=P(K[KP-G!
M;1:/\EN!Y_-`;.*:2(GNRG%AD<1K<AY(FF99K*#Z=GQQ=HM5U)_/KC[?C*]_
M.S_1QJ!*;M*OFG2?E!\<9KI)`W^3[I.7\S85U$VR3Y/LTR3[Y':.'6RRCUH3
M10=ZMUM]Z]2"$-90J%6)F[B5.2^E0+.D&F(<9X'KK/;19S.MLJ+753=Y1A_6
M$&39$3AC6'$GN7J[OX+12UP;V/[2\E9S,()UC?Q`^QG-8G5Z=ZI,KH;>4;A$
MNUU#G^Q227+L6>;1M3FQ9M9$U\8SUYJ82A!A1V^IFZ>#(\S5)<)N#1/.0D6U
M:=;>/%320ZJ):\6:PAI]O3=2V\PQ>GJGAH&IE=@YPZW2;9L"XD4342CZ_@;^
M?<!_T*[SIH"XB2DT,07\:1-32%<RFIA"6:IL'0-LBH+X5J;8-'&%U%JV05O9
M2958O*&L`\]H9?:CW%&#;.(*+R*]K8\&RI8*M_6^PO/*FKA"6:CLZP45N2J!
MZ^GMH;JQV$YFPX_RB#!45INX0O-020^I)JX5BRLTP^8JM734'C8G?_+?'P+O
MZ,$T5[_P%AXW9.6XV,#CU/(F"\<+7'('%/UQX4R^_YW^0L!!/P)H'A[(5+MT
M?&3:T1/,\Y#]C%CV8^!9-O&\$V=Y;[%IH"DK:UA+`G_<D-G__'1K_6!^3>K6
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M'0)6L?+M6)LYKF:N5J[SPUJ:/ED\LX=_;AO'4HG=O:@%C3VJ_6R,4IZBE70`
M[L3TYK&EI[KF!??_)A-?U-8"]$M:V89_+(G[@'5P(>18<34)7)?8DV>4A`'6
MZ/KLAQ:KNT-2`[QQP_$K7"XW^>+PC6!NFI.YYLU-E_Z:HP)NZG()<'L^$&L,
MQ@EQ?=.RV=OQ..BU`=P]P5:U>X+F*_6`3I.(U#J]OZ'3&=%`M]+O_8V]"#[\
MW9G;'BS)D(=-L\0G#!;V(`7H>.W$+"Q47KE@0\->'Q;./=#*E#R2!?8QH@O!
MU0EF)A:E,KH!YCAW5B8V[/+P4>S7E6)J5T;)K*)Q(R$+"D'D>[YI^Y:Y`!1B
MU2<_1"?P\0MT%3!`"?S"?\:O1=WUY?$?Q_`LD(CE:U-KRLL!76*"W'&>[./P
M28I#CKM[RUG%.^U-&%!LF9DS"3P`S&%%I2[QB.E.V(ERM#/2@J.?!A-?U(8"
M:KX3VE4*('PT)Q-DE*PH%W9W[TPMT<+$Q*IS6I$XP[).)X!#LF`5CVA/H@$*
MJQ#'B[4*8'7\;@6V*B^]/VXE+^&3Z46ED&PA^`5`!:P621NK'<TERLW_4.$,
M+`0(V<+_-#V/^!ZEZ)^-E'<#&WCIAYR+M(X'2<AH(:7C3.D=HHNTCGN)Q^HD
MT%16V\J@T!OBK:P_@#%H%_[T6*>7T7ID5WY.%AS74S=XP&.<.(_$?18D)5,3
M)QX$Q5O"21TMG069!`N"5?QS<T%H.3`H7$`H%$V4KP$QLWX#HHIY%2R`7YBP
M!B>:O5_M+,2-)Y,%,%Z\*\C($'-+WD30)Y.Y[2R<AV?!:MEOI_1[7LL[)1[`
M#0#H,NZHD`">2=P)\`SK/_@9YW&,%YC3*5Q:3V+?_-K-Z'7C^X%+C17`O&[>
MG[N."7!2IIYU[5J@,2>HEM[3^,."C[`3I.A@ZE?\CL:O9XZKF7:Y-IY]NA*=
M3X>K0H^^(`_FXHOI8PWAV)Z>``G"<8"T!XI_]6JT(:G1N1"AJA9M:+(:?7'V
M>7R!,[U/SLY.SR\_5Z<QQU6HEJQ#O9/XSWO&(9@BA_?6@ON#6H8UM>"VH4QV
M\8H].HM'UJ?A$3Y&(;PPGSQ0,:3R?^!?UA*;?CR8[I0WC$29KRTL$RX@J",Z
M[1JP`$;N!\#75AB#<_'CB$71-SG(VF%;],@Y1AY05-C(W.$AUEF&-Z/P?I5^
MM$!BP3=/"$$@!)MS@?UK,]=9,N48-6S\M]QXPD&H32J.`I?UMH#O+%>[YSR@
M.M%Q)TD$UA0#$#^9N(`EQLZ\`)2JB4SYVM.<V*C*@;8&V[VGO)#M-4*XT,2%
M9DWMA6G83,.DC2&$#@D\#>2`::/F#H(42`7>"584(!IU]BER;]<)'N;T:3@Y
MRYF"C87].S!_)N*V'9VMEU1D@>V#^$'S`Q`Z9>#2I3G`E.`\SP%*0)[_9/GS
MD#BE[B.<,CCIN21"`*7#S5N(0T.QS`T4-".(>#E]%:(O-&\`]P&E'-`H+!^>
MI^:2Z(?$",_RO$`TE_EW`,(_=HHV<!W08QU0IT-->!:X2+A<+XI49IJ2`[\&
M6C#M"6&X&-^>:-U>ZZ@-_^L=:Y]"H*4+$*$)/X3;&`"`CLMU![$[9CGZ"ZH8
MH3CC.'B:6ZB^,V*020N^DS"Z@J]1Y,:/U^)'$MB,&IWHL`&8\!@$P8F7L,5P
M`306\5OZP3UY=F*$Z@ES1=C-].CHF4KGQH^?*3"PJ_OGD&>AV>>XGF@$194A
M<VD^`-5Y2-A^C!_(3`2)++`C\PM?[&"'*[%!^.17S8.+"=_.K`G%/2.)2,U%
M>D.CBW([.-.IX#N(:/[%:D'P3>MK`US85>L9N`J"^VNXVQ6:7'"'V5J!S6\+
MWJ1?J89,\/?<8$8%$8"#'5!44!(#\%8!+AD^K-DX`0#QM0+%%:^DX/\;&>#!
M-OK;BE.?VYEMSU#CIO;?O<F-&!2FY(>YY(HCI_N(5G7^!/)2)`AZ8_""A/V?
MD'@"N"4@Y3@WA(O@D06[=\%"7*C`%[V6$@)0%QZG&)/E;$]X;[+V=&\N*/?Q
MYH2`QL_I%"&><+MC;J(_#7<$FT#Y/05:ART2>O^$8R#EW5SQ!]S85/`#-Z#Z
M(E@^"W\>RAF@;V<14/0A0Z0"DCNTA0Q")XY-.=32<4F(Y1C#TS5B4?YH+OBS
MO`\6:)VHL?C`RI;F<]'M`+1P*-2WQAMG4X<8$TO>7)LMG"=AKX+L8QLH7Z\(
ME5!\0R#^XQ[_`Y3/TZ\G=]K%^?CC^<7YW;_HLO=A["IXZ8*6I>C$Z&RCRAGQ
MHW6%$I%*^1,]E:\@EN$7MSX<GJ>+X[>I%XS)-9#B$\RQ`;.2H+$A3A>D"O5-
M>?0&NL$#$__"`!=>0:H]"(E!U5W!PQ%DR3G'3AS6I#I9SBT#<#-K2B*%S)R2
MOP)S\BS^?C)=-/`EE1L]8V[`04>J"CRA!$Z$EX"JCAQSE..(6SP#<6YQ.0UB
M!+;JQ[@*ETX2:PE5BZ0>!;(=9+X%?&*:<DPHI%Q0V2/6&.H??#./IK7@YGRH
M'^G\U.!X/02!'3;>TGM4&9=XVOQN43>S)QSGX7+L67$UN:=%-,`+T`6LH0X8
M-=F3M;-[@AOW(MBJT_^_(,Y!](?G)(X\%^%(+OE-5X6:9Q'M"`..GB67_&9,
M1X"7W3._%?VMB1K8TYRS_!6AWN;P-<A2Y24B,]"R_QTP6-FM0YV3*=)7-W>_
M76EG?]R,N?$PZ/ZJ:S?GM]=G-Z?C"_G#B[,_QO_\>GXI?W;Z]084A=OSD^C#
M#S,T$.UGKK6O3']"8P,KLH`K#!?:HW]2U/XVOCF_8S\%2X5'A5E;Q;%+M3@4
M`.CMT;63?UW_=G83K0-,AKKJ$)')EHQ")0W1QO4O0K[+7(+J>\3VJ'J.KT*"
MIT<A*`X`#WC(BK.=ZF@0-)MQ\``V2V3(,7<E:SQY)85)>*SE'?T&70BV@YHG
M\-/()Z\!_P:='>UIWJ"2>Q?BZ&+`_^^%-IX0X"!@J[C:[;/GDR7%;6;3RQL0
MM.Z,EKZ)YZGK&"[WG/;$7"W,"0N4P8,/H'X?:R<2>2*S!.GK\5L/%,IE_STA
M:&!.21AY8#`(FYG?R"0'A%T2"R46YTS"YHX8BM#NJ"+'^U12YNL@,5&"8"Z4
MR)IC33W736)_;GD<JYP>LN1J)BNF(-.]@BV$AAW#'6K\XG::T7>AGHB$.[%6
MW".[_NZ,/JM9FR"9QRM8"*4;6.?!-9=P?JE<7@B$;?D[6R/)Y"DN0\U:4C_7
MM7<N1WF\K2:5.*=.+)P6P6*:`,>"=3>"(6FQ7`<(55F5--GSR[NSBXNSD[NO
MS*<*0J-F;?8D\IMN*ZSUI#-2Q_](^B]#6S#TKX8-N/$>HA3R7>!7&%*5.$>J
MIS5R;KF61Z.O@1_Z.?F%$,Y.>@^6<'5C.D'B$N">IL2;N-8].EL(D$7C)J#$
MAP_&?H1N*,#A+SRB.3%77IRTK\=W9Y=WVOGEIYOSR\]G7^"/B(KI?^%[E"-I
MV58+U4%0R8'\[`<10J0^,-!@D$0_B!`X)G!.>9X"]0A2@O8X;[+<4!\^UL:R
M4^!%L(`.+?)(0@\S-S,H*Y0UL"F9H9@2,@5U-@XW\1)R&H51R$4YJ#KWFW&O
MHRW2B3S0.JCGQ`SEE61)K7F!J+^8NUP9/P^?838/8^2AGA!:34RP8"H($RW4
M:N3"..\)TC[0L+,XPG7F\&5)49%+U'SFX77X3^`,PA9FCFPJ;UWG&8255:6F
M^N7L]/P$>/[IV1_G)V>WL>%ZY^//EU>W=^<GU8760%&^FO@.F$:RIMSJZMK=
M\\3!TDT@U0E>C,]@BJW`=KG6M7?X'8NV82F/=@M**?4MG/!FV2C,9]:"*M'\
M$L438,Y`ZYO`0V?VU#FZ93JM4,3/SF[?1\"DN4/0CO%=-/%/G`!T/!%P#S\6
MLO[$L6V,_$\"GQEL[`+#-?+((VWO/2,FGC2U46'A&&6!3?7EZE*VR#3,A`#S
M"U4OS(^@<8:`WW^*,'Z3L-E\*F('.O*#I1-Y.;Q@N43#XM_!E*:X8G(`[H?=
M,YKDAVD3+O/$<#N6JS(S(4>?\-K.,$L<&1@R(GX/N=D;^YZ#?JS]YCPA&C`;
M@KV(IBFPQ^Y!\DI\C7MHPI_>N=SF8\Y_O.JG8#,L4_8KC(T)/:NIY2TMSR/\
M,YKZ9"$W]$6@@@`F:.*%K;'$=Q[VI/@5N5[.DQUCLNA6`2KC7BVV!@#(7RV]
M%788)H58[I(Y<,S5"@B='MKOIAW`<:S;C71Q3M*V,&>68)=9MI_JL@N)45!B
M!J'&:100PS1?@>IEZ$)S21AK0IH+=\Y4KRC.0Q[ED'8X&P+>B1&[2`;1'8'6
MCX8\?KMT;$(M7)D/HC%ITP$$J*I99!:::);'#@_?,)F3:;!@:MP]9BY9C")2
M+H!A5,=*`?$">=H7S-R+46)?1_8$I!'C4N_89^_YV3*DQK$?:@%R/&T3/_(2
MYTS9"RIJOZ.(>^;>`'BQB861@BE^#JPIB')!,!*0_)OWNC:^Q_H0[<*\QR\=
M%'J";[*OX)F/H.?"KVZC`%[L9>QKMDKT#&/G7\C4=QT;?C)^).+%X8?OUY@H
M;O%_6;#G#]GHC4"Y!N(,O(2+Y%T"1+8\YOJ8CXXK<5QY=9II1]!8Q$PZ<?'9
M484<G5XI/-.D,?HGK8'X\,E<`/^5F34GC+3;P,E^`VM`!=,.[R;5<>+"+K%9
M?2>1%E(,Y]`A+69L*Y0$^*Z%.?E.0P>N!7J:S:V<E0BM?Y`>(33@C:3/=AW8
M))D"@3#"LV/*."."_T2F]!!.+'="N8]@LM32#Q8TI0]/FF-\Z3Q&^0HRIP1.
M@KDC-JAVA%OE4S*QO$K31;-E]D?,)M9N83N@"&OO^'^\#Y6<#7PC)`-)@8T<
MUX+RMM!RSDQ66RV3QAWY87KA[0R]=9((L9FJ=LT`O72.HRWV]'ZOHP_ZK4PJ
M-U#SH&Y%EX"Z9-,]PW6C89:9Q9SG>$@A[UJ[?QH(8Z9D(2--.*#I7:8)*K,`
MD\$C]2I"+2:C4`G#D<]$/0+%L0E7`]-WQ"']#.PFVL12)&V>I\B&.%F+2HM0
M(1,'&#LKOFB8=/1S;Y0<5(03?'A2@S`=*18YZG1MM0!1_;-A&(F?4@>F2XX$
M%.),V:":8QG1U/T9NTGKI`-80XL5CRX!!-//'$Q<1Q\A^YJMR5<YG[$+R+16
MY))38EL8KN+KT\0LID/%?Z]])!.3A?$B_S(W9[U0AG#-)70<TU1<6POL&<H"
MEK##S4T>[1.)/#0"*#)1Y*B=&3I49;N7IP<X(:.NE)5<`LK3].$;9T)/*)J<
M?B5%UUF^-$%[!40O?78CFV'PKO.:"VM&;L&,%R)<_/U^*TZ3L*<DG64R":C3
M3;PY=MOQ($%.7=GDS@G"NX8W?6$Q47F_<)RI]K`()IB(S9/0J%BG\8_(79M0
MA)\B`;<VOB]@>8Y+:^(Z!+V%H.NB7F![CLLLLENR\I-G,N+A=;$5S;E'MQ'%
M>$2"3'K1<"\UE5`XB7@U=QN#Q,+)4_1WG"FF;4.$6S8R&T8E6#\42T=$E8/>
M6/8]NW1HD'T$57`6\O[0IF%\TXLB)"(M"WYRA9(::#=8"NZ+VCL6-H0ADAFZ
MB=CT-`Y0J"+QE(1MK(:*=?Y/Y-Y=%UVM8<BE<FOX.QIRLGX?U^B%VIZFFL>T
M;BY4BBK91?1K'@%Z6<G^\YGX\]BM?V<[3]KU#$[,I6SGO?;%<5W,NQ3N198"
M$88F.>\"L]SVV#5F1Y5+(6<>B)CYB:>2>L6KM#JYBKS&4;0;``+4D*FO_4&U
M5E#1>.$+-=DNCJ^1O8N'<FF2<:MB0U(\7_&$<FHF`'[__8^3W;QJ;-67E4Y&
MK;A.C"BD"D5*@J@(AM'SDZ]_?#W3QJ=_C"]/SB2B#,-$[`GIFZOQ[;]N95+_
M[5^G-U>?SRYH4C.&`A?,!QZ2+',%;U!^!T9;[[0'O)0`P[+\$-YSHHF.<B,]
M"G=6@B1]1JFH>,8Y>;O"$.,U>B_')V=?[]"]7"'U\X-:N=9B7=,Y`20Z$\<5
M1"C^?L]8!5@:'DAG[:/E8%582*H?S]]O9UFE.46XZBI[1DJVLB2#ART0=QY_
M_7(NIP+1;(.CN\M/\/O5W`P3#L3&O!!;L=?(=#O06X.6/ACT0KL\58W)8ZD)
MQVF:<Y>'<+@Y!:<1RG:AS*R7AJ=5IR&(:0(YTX7@$AK_8:Z"Y.9"\S^RG653
M0[A?XJ=Y3,%GU:>8O@AH)SXKR`LK5]%A"I*;_UZL$J<5[BQC!',;8$DVWT&E
M<F6-7Z!8X:3.KPPKI*35J1&5;W%SN$K#"8_?2KA^>6]*E&\M7Y,OIN>9DSFH
MX[Z_+A]NS[]<7UV>2_<BN@`IMRC.MD$Q&.CM=D?OC+H1&0ST;L_06QV#<?!;
M<S%#%98K'>^/!<ZV]W7#DGR'E(/3?*=0D8;=U9R_)IW_Y^7];[+D/W%"`J#?
M,74O(I:PEOV$&AQK-))B::VSV-UI)-(A<M/(W=G%.,8[(QI!\R^^HC`&X86`
M;*I&RDR9HH/Q`;'IG(&;C3&;1;"\M\PH_0X[<F#-,TM_E+D25M_'4&M&03HI
MM"T?;*@OFQC9$U5;*'JH$X7!CJO>A+S+%+?D',]W1EQJ,)P*;D;Q^@!*#*\^
M!AG)EL;B0YMEA-G"=`Q]V8AL%I(*#2<:8H]A]DX<+XON1WF'M&H6($'S5@2I
MUHPI"97"B,\DDF.:O<J*C]BYA1D%%B99/#C8'02NK'1;1:*$=&6U\<)S\`4O
MWR_I"LFJA7;!<B*U>Y?56>6X1MCF6':/"^%W8MKFU-R"_B7XDO$-^C;+M#D\
MW,\@/MPI7->F@IP6!\9+42CF]=UY:_VL\Z/Y#)R/932@::1=7)R`I8R?;J=N
M"E[(`*:YQ$(@<X53YI%;,Y<8U6=Y!%+-JOMGRN>PW<T&,6MR3/"M4B<:?3?G
MF_,`7BZIJV$/DTWA@2C`SQWU(0ODP7A<@:Z;)-L8LEE"PS&'4?BW>)8P=<%1
M,$0:+`V_I7I:PQ/G1QMWE`:T?Q`:H:Q[,MX/=.43EV8-AQE44G[!9^+2`ARA
M>EX23`-8P)\\OY#N7VQI_1'F5Z-G'?A8Q"((+=+`$[Y`>`OU/^*)PL'&-",!
M=I3,L+!HX9=D5:&S8>)I'[%93@*?0$CR0HD=R4@.-Y4,G;3"%8].K(7YH%W^
M$5XF4*VQX06-,4Y\2:O^S7J8\QL`GUPX]A1[,G$&(NB0HP:5K@3A:%__D4*_
M+Y#NNOD-9(O7!>\9A5<(VK5\-59YS//AD4-8TR/,A&+)8<]',\S,X$XL(<58
MCB9++8LGJ-205'QQ?G?^F78UT\:?Q^>7MW?:I_.+LYM;[>J3-O[X\>;LC_/Q
MW=FI=GGVIW9Z\_6S-KZ^OC@_X8W0WHTO3\=\<$+U!70S9[%PGJBOD29"P4^B
M?@QA88Y@O0_$)L`G>=<82P21&,&!+$)CCH8$T!E[&KHSP<9<6!.>]<WW)]$;
M[^`4OAW3ZFFP,JQ@\IQ%K/@ZEG0HS&(YR!4F<9$?*\N5*V;Q#B(P&%,0Q$'5
M&L;?'8_(23J4#BG`?(WG%6;:T1@I#38PV<"WEJ)NZK*NB:0,EC76#4Q(/+?2
M"[,BHP0VA)8\TLYR>=-G,1#G!9,)\;Q9L(@4-5Z22#,Q0X/``YD84(6YTSI:
M8K<7_.C98TA#-7+FL(S-=;G))`%;4D1KF!`"0>%.CY")QQH,R97?S"%`%54I
MQU37@A4+F[C.HQDV(XN+[T\8M:+9.Q%M39>6C=#Q])I/I^/W-/L=E'1ZCB2D
M*W1PB'.B/AA!7B87F[Q8@<<S4-7EB)*R?#FMLLYVC#?!$06L\4#8/RI&1B_E
MGK_>%/:0.9Y<79Z<W=Q)2G6E`8'T3*'QQ?^-X[E8^(GDEL?CI/KDT9?));$6
M1T*87\?:UH4I7U=??K\^?\]SJF27:L;S^'0^73?-,EZSXG,D*@FV_0]TF+G>
MT5?W'F/2J'CC5O_Q]?3D2CM'"8[U@NC&XGN9.+3<`T3N`BXF?8XJTQC(=[B<
MI9_&N!'RR9"MAQ<YXN_F^DV,$H43Y"$SGS4>#E8Q^BWQ,'$7@-1XF9H<G>8"
M)OG^8[Y[>AB"4U$%5-3-"9W_!0?"<0P2RBK(7P%KAP)HIVDAS*:/I-1Z[J@X
M]MKS(<);02D?J9G3,1#J'NCT'$3%C]3D2OH-\/4[\L@MB;4KIGV]'8?=[K`/
M,CRX]@Q\.PUP=?0A4)=MG,SQ)S$J#_-5&%SBM3%J0[V?=9[$JKA_HRL*$#3E
M_6!9F"WOM>#YWN'=V.I:O'`?7KP.=(^15Y?BCU'`KO<B7>4?+_YC"CBY_X[3
M&>\-N6[N4TC6>,_&8^#O23\-KC2\="11E>?4\;#2".B&V`\X+H\'3P4K2SDC
M$5MB9Q5=^[4#DQ"QTX'%_$*@1L']#MU"G!C8VGBM:;F@V+`-4@[M;V+_V[%L
M$9*B]4M3,V1,45]5>;\;R9/KL'(%14XJ34,C\Z)59[&QE@%W-^=')_^Z.)/:
M`5Q<U9WC.M03[)=B*3O)8(VWW8@(@US`)#7-Y2E6QQ?')S0=X?KF5%)\MG&_
M_6GZN'X*ET:(V;>I+%KP\CC793_8+3$N]!=(N3]KG(*]OK":LDZO@M#91=]`
M\#DNMTR&)S$ZU"ZN6%#MZNY$T*3(C1#G$$55(BX=,>EDH$/XIM>=>%QG#E/-
MT;%T?;Z58_8B6*$["44KD@+[,Y4(4M5,^OS.&9)Q&A"QY8@0Z-N+T\'FPZ*$
M$$MS3?H?Z%F&Q\"0M.4ARI3`?)_L-=$%3$2#,%W28>Z\"BKK<ZB9NVB7@K"^
M/(.%$O$8^N<6+(8^_Y[IA9_,Y3//S&(Z8/A!.N7E5F:S65"X0B[JXWF=Q4@P
M)_6QM1AV8\C9J/G%W,/IG"6AF,2"5E3ZB+*7PLH)2S!+4Z&]=6Q=G*QC*]O*
M3,=5):EB-V?_=WY;EV\DZW[>6?<80I-$.?\DWQWC#[^/AWMR2PV=MWC?(#/2
MQ84NT;"^QB*VX0ZEY1ZO7?ZDV`G!6V^3LF(P4<X0]_+*&=\I@BK-O\G/(_:>
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M/P0DE2K*V=>%3$CN,4LE&O;ZXC9D%O?9FFRVY#PAB7!6GDXG7*CR<G,6E`T'
MA=T_<U6?-O-.*]LU:0PYG`/`3SE,)*`=Z19KV>3\O,3#<7ZRWCD)GY0CZFA$
MQ$/J<AI)E#<I(R7SKNAL.4YG=-\<S_=@2+/.++P-;GPC$?*23EF13A%=#"E?
M+]W>86_+:?3$Q-TV[`@_`5H"+(OL29%^4$.:S-7=;V<W6FKC/>W+^.[N[.:V
MAAR8#56I4=)U/,?P.FQKQ:K(8H'?Z+MKC/=>7+]_+VC<QX)HF^5Z4FT(4SL<
MU\,>HX+T&<?DMPSX%SU99F+_`Y8PO3"#G*8?,Y]OS*?VCZ\G-W)(6^I^$.>'
MZ(U?(OF8VCM@J$6JTV0>RL#$\.K)#>_2*TK-GQSV*1]M@(T\O3GM1H8S%J:T
M<M>+\$([MSUQAPA`>`123TJ$EIG@'V<7)^/3,]GP0*\8RHFHO#%B!AQ5/)/0
MHM@D0$"Q.##R..\]OOV+A5W<;"M89EF47Z[/W^NTGS'B#LO\O>`^;66Z:!@1
MBE9.+HJT0[$LS;.1)MT%/K;F2)[3L>#?LB-78MFT/?F<Q]LP\8Y7/4<S+%E'
M4)Z<PR<Z\-)<T70H/LX$MKJT&(7%:)JEU*`=X]Y;/#]'JM.+TL)!7N"YDJ@Z
M*O8+D7ME\O0<P;G2X&=[C7?'D]\6:R4MP1KM)IHR\C0GS&9TR1%*'VMF4?)[
M9B-51,$V[>_K,]+6M?N`EW+3B8BLDQX>9=S8QX8QZ[Z^)`U7R?12NX6-&/HH
M)2'RSCW7)(OU5G)"7*]Q!,RQAX?'CP#9[[!S,VX;B-2],%66>>>6KO4#.>LJ
M(\,&OW\?9L-Q""0P^95E/@36K1Y$\'*U<)Y9PRY3FO;$.<C<\586CG["=FLR
MV6HT#9:56*\U.0@U])EU#THLMDX@TC"]*#,\7%M,"A6]^^>$3:&3X`D?9M<B
M8T-SO"O8=BVDF["V@_9W3._.BH$EBMQ[W@/$\FE'53K&R@E9$%M46E_6340)
M`6V3$C9C1"S]\^OY_YY?R(7`M+X=>RC&/L7B4_@5[-?D2CI?66Q@74MS)*#J
M3A$#=?<S"&A;KH8-/T"KPN+3>M!=+O$40>)?3SZ">%XL\'$N8L2?[Q,XI55+
M81/[B</[(L,35`--*?A"[]"2G:]@[^&\(#8;TY%G^@*1LGI_6H-I>C&1Q/+O
MP\W%0_&H1N-<)I&*"B]@R]$A5ZBY3,G2INIWN!H'FNV6]YCB?[&?B3HF5J8.
M(`&=8;?O!>$-9_B6!'["7Z^WY*:]BI\CV!D[HG/9(J%1@_X:]H[^?/7'V<TE
M-MB5I_'5VCSZPOI.M*@MHLBW95<KGBB0,HN$?C:5&N)88:*4'BEYX931'$/^
MI"D2Y`=0D<<JC^CX,#H.XUEC8XRPJ:9'V4ZH%^&0SH7,)$TQI2Y5+Y7[VX,*
MY?('&>G#Y\^\XSA!14+$)9@BP48(NKPV@E)PZK)2>1NRR40?:ZE5/:])X_;\
MLR[\UM*$03H>->#CQ/34%1&%"Y"N81-L[9S-YA-#SJ+2]XEK+:DA.H%C%N5>
M<K[R3$Q#1CMY8CU:"]2T!"=WHQ$T5!'G&A9:F^S]$GAKVW#D^7!U7+@Q7+/Q
MYS/MS]^N+LYNQQ=G<-U`WFCOQG]>2]9+5'Y1[PPBAOFH00OUS<?O7NR>T,2.
MWR.O^^\:[$,R^3%@C>*:$B:/`XB)+#R8D39,FUY:UD@]=!Z@P:EA4C=3NN1^
M.VN7;\8K)">LD29+V:=N"JG,(=1U<.BNQ2<#QZ9PAPZK&(0Q'[O'F[<QCCYS
MS0"+(GFDA^[OR0H+%ZB8X/=&*#1T-C8N1W$!Q@F=3Q:RJX@/1E*6339@`MRR
M9ZQ[U9CW$O]S[BP(K>.[IH.'U\A*^`OY1"=>,<#I_MI\1H-5C((*.X6S.2*L
M'`!>1S$.B)@$W'1%?R'ML`A&X/(>)X4RWRBJCL()\R79PUNG[8'#PQ+SIB@!
MLO.<2..7118RHED^7IVV)1;8BM)#V#P3,'I8(>\J<#&^Q*F(3A<Z"E7_BXCU
MO?MR>O&"$R%W_"Q>>5SI[67EW-9L)N1+5-9L\W9BK/DOJ.2TP(/6)=$QY'SH
M"_/$VSZ;AL=:D9FL[Z?(I\4AEZ[L=0OG5HN^%S&JBD9;`='HTKG*IH.\H#`D
MP1+]0F6[)1FJZ90;6R.]HPDVCYZAL\GD-=V.%(Q!UQ%O6:_!R?/#7&LOS:R8
M*&G?EQ$>8E3V4:TSQ'1'J"^<")$YCYW2HO5.^*O;%'F=''TG^4)9\(O2)@;T
M1I!E:!,-L*LC9ER9$:XHC)<*YL8^F+<V>?:HWHPL@`W>8K-!>`\_-F"&[TS,
M30[KG%UQ$>_H=6`$R4LT^6\F6PY\B-+3X*)'O9I^T<ZG)O6EL053^UCKVC^`
MNH/)]V<I>S%>.\^*7)C;-+5X%NCBBFXSMAFJ?'TG=#J\",S$`5S+GC3I'>*N
ML9R$(9V1K&&#1'NB%?+4E4]LVWM>/((8,YFO0K0*B#T9NE\XGNBVT]-\I'81
M@OFRGO3BO,*WQK/K:14T#\3@A4-R6;,!^%UAAB6^389>Q&]GIN7B(/@I"ED4
M4L+Z.`$VBLH-.M!]PA3R"_-)C\)*=MC$@*$\:I'T<[<7[9*W;PWC2MBMU?*#
M<(;QS_WCY--4+,=58[E)9`Q)&PY5PAG7IECU^`O8C;A,8-,YS\0&.3AG[DS@
M1F$/6RIG/U!52>?PHMS&B,Y$.%:H]F2GW,2-:Z>?VH8#$S24>FH,=\+A3,=1
MAA.BX=`LGT4"HXZ>*[2H&/OAHQEXKT)1^3[3;((UK2:.J1".5U:ZS,(E9MAP
MDWN08ON(MXR2!YR)^RVWQ.4];3ULR_@0-NADB3I\,)89S2Q0N,4N[SM6AVV6
M,F>QGN!="N/'Z2FIA9BB"I-]]SY_R:;0H\,F!"#%5@ZPBD@;N9K-Z-`,=M_.
M;7H:CAN*V]1RYO!'W(J@ZJ1-%JCSFSQ/(O0;.A-.AWSP+*W9IVV]U\TO71/F
M*!UY)_1`(<U6\V</YU':S!SA\R^$!R3[E:C[6#8U->E=I9IEZHA-AA9C-!J$
M]`C'TC[63L--1'62XEL^6P[;`U&5`!U^Q/.C<.@I098B^CK]'J"O"KTZH@='
M5+,5'H]`GCPYT;Q'A2RYN;3YO:F[8\L]R6,:0S*(GZ_0NF(LEQ_ZID:',>8E
MM*#4+BN]8^U2.`7$KB/_O8_"#QC_,P-0*(-PSCB5C8ZVHID!)NU--66-"R.C
MD)Z%V.,QS=06?FJFAK#DF"D/PC+;B1\;,SLBHF4A0[ZNI(:L!9G3CCCL^+(S
M<I-1ZAB&J2?F<VA:O1<3E($\`KXWD^<8H>%&C2>TOT/?&[T;*(\YWAC]9/=@
MY"'9:$F-<G)0@ZA0/X\<;8](]DO:P"9,&`GI7"@Y:V,HY<!X^FU.O;.BC5'*
MX^>7?YQ]CJ7UAN<W@Q/V(O>$-,Z21EZY0P2D&>]>OV'Q]57H*3JSV='"!(&*
MKA29<"3D<?'(XK-(I4+LBDG$2,<BO/Q78&F^N8R<)J+*)EPI=%-M!)FI$9]E
M]RB>@PR!Q4/!8>I'Y&'@4,3HA2*!]\D$78-VXT3`PGYYU=F.V-HM\%@.4624
M<:\WSU<A,]A?+$$@I/_(H1PIDK15!V;SR>JBMP2:FFCCB;_>//YE=(=\7HYP
MK5S+QAFRU#?Q'5/V6+_U>%837F":RL!GH%(7Y;KCG-YLD\DCG%UM/\!)@/H]
MA<5,&TCQT7(6L=2I<(N1ZAW;8ICAP',N6':`4,U#2)=445^)?MPA3Y;R&]A$
M0)&!#5##>4Z38X/-*=H/W'EA3B8N=@+C,S*X^<**H]F;_@+&Y+,8+%K4U*A#
M>J8/1I-CD?X<FX1-7L/[P=+.0T1&\%89N8T+>QV/-21=IL`(CW;H[92\9K(M
M]<@&%LKI+A[*GR@(STRLQ*A4?#(7.UWG:#KW*489O]0S+%T:8%6$SY:F)$1%
M$S`+_GC$M][KR8L:)PC)"!&,D/KL'*8$)*95RHD'/&[E<^K$>SU9$-,-<V)2
MJ#/*+/+HH?!6D<QR$6,/1/@_!$F.HZ&CB>JD/.N(24D1H/*8PX33L:@:<1%]
M4;R+.??#>=DBF<?D+^.+1I/MN8TJ6A.Q?8=A-FZ3B67XS3V&B^_*.,.QUM1F
ME6U`"Y%&+3L,@GI\!#18;3AWFD9A'!R,&\X`Y",O;?+@X#XH/6/H&]`^E;B8
M;;HNZ]<5)C?!ZO@'("UBC4)EBN9IX[O@$YM/J>9``X#/'#H`-?2:`.]PW"F=
M.4KOE-0S"[\*;!Z]H,QW0;/.,--&`$^F\ECI"<YT]R4*T>7K)05/9<4EU!ZB
MUEJ1*I!'G<!P9T*CL'@(@OGW7AK/+7HJR&H>#Q!0T..SN^6QW2)=8L?9W9O'
M=OOSE*G=@A+CH[M+F-J=/;!;*(`53^V6@C7L34E?-D"YQ&,$4F3LWY,XK39>
MF-YW4]?&[G?J"Q:]$)S`\L`*AF]BX2;X$_MEPO]6*PO^P+D&^!`6DWPA/ZR)
MHPMS/;(A=.T6F,4<BV<=,))-+%^AS>IQ1JMOSCFW#M/@A<8GADEP)T14'ATK
M1:']@UQMB7J!(V90BKY]Z-G"'HN_"!*0(XD82Q,!(=2FD0=R^4VS@8#MH&U!
MLXE3[A$*2S&GS@N'UR7T<IWR=Q`GINCMKOEPUZ7*%IKK.@%*_@^Q8[E/J69W
M&BS"X\GR&3!"*91.7<ZIXL3&:;G=^A7%D'"!A!\;OPJG0J0M4-S`RU8!YGD]
MAH*'G[;`'F^@&V-68B\!\Y>*L>>`/NXR%?/"8E[9J"T?LU#PR).=>M>Y8E[K
MA&=,,C)DG(H)*'%]I-O#XSKT4=0CL1"!^KGBQE*8:<60)@Q2#]CCP@S;^2/0
MT=19/SDFAJJ9;'`MOA'5JO1PQ>:I,:^[<YX<HDXY,>U/$-K:'Q;^P#*E0<`B
M01?=H!O8BPC^QK)-,5N64_)$>/9IM($/'C_]BODWM_)$YK!'.OX[E0[1&H[&
M&O.,OU!%$S>7#DBF(5N$"TCLYVY*G.98;DDB7/`BQRJSLAW)$-'%5@QQ%@L*
MQ,=?^'RZ,GP1DXIAL8^6D4$MEEL_,<Y"UH\M91@SABICQG$:6Q9199I8P'@;
MU66`AV*\GG,LVHZ.-]<-WP_TX,Q`D4^LDW*XE2;@,C]]!D.*A'.8?$X%_!'5
M/:4N_)D4'L:J(XT<J1"WZT:U)F84O9,J$V*AUK3@,XNCB@('?#(6=V%N5+P8
MW%J2[0+>\@(SNIE#@9\.]6K&J"T4W)_H'0S-0?B/]T*LTBAR,D@H)SW1K!!N
M-8$Q%_5)2W4H=X"N3=&FG?8"X<J.R%1BA=K1],^T03<LQ_?Z/)0"D9-B;==C
M-@"3&_4BH-ON#>29-E*4EO,+MCR[IMA%F\3[+HH795]%I",/2QL(]W>B\LX'
M5S'5/YHL.D@.%HU;VFG]S+AT9K,I;%%7RB!&TF`C/%/?PU3%-2Y'O^0FO91?
M1A]ED4J.P[1P)=T0CU=FN`A$1E^.$"6W$M?CE/RL7>J^TM>./6_\,J;D5!:_
MC+.A@4Z1$D7P!!\ZX422$D1/Q!#6:V1B$WZ2\A?C4)REG:RQ-(DG\]_%$VCX
M`+<TN2`C+S/D'R6(N<Z#:R[EN^1,:*2>,K[U=##!]>1;%Q-@_&91*4;3QIB?
MQHFRW,+4KQA`!!F+/2$A;:;#C4D"1[$D`2E4M7:=HG-:OT:PL<2LM(K'$S(2
MRY)T<;LQBXYBUXGR"48:#,H878D49"HJO<V9;\PND`0>_#YR&3DV%M4#9^#)
M]):X^WY4BL6D*I_(@II]J$HFW.5K.TU-+D&!$(X[X`9\+-$7##0:7Q1.H0TB
MEM@/Y@.C96Z88402M+85FE=AZ(49DV%RB_`O\F1CE)3P2I]"&55CTF$?4QI0
MO`]"'ILA425K%(4KCT8ZF!\@6Z1,LN(B#`8`.(CNSJ?3\1%K,$"P1RJP;DD&
MAQE*X;P*"1]1="+4EJ[/4S,^X\/AA!1-%`W,UB?0==J#X^0(;9$;'=W;>SXD
MESE'09MX,D6)Q$R8NURN\&%)K`DA!M#038&FMAAS#<^MS<E.$Z4QB<ED:\[,
M'B[/BN;O<+T\ITP4-G2F8*Q>)LH&)W?Q2=PJ?O#=%O>),*<;TT9PR.&$.>(E
MC(G)Z31HAY&VA.=`<@1+=,K(@[Y8&@OM.XL%FTLA'-Y81"RNH1O8MN0A9V,.
MHC0;RJVXFLQ*,ZDJQ2/[:$SC]%N;;H'1?JSRA7?UE%*/HUT*LYF[1IGMS'T\
M*;DVZX$D]K,T,[JRXPXSN+Z<7)Z=7V`?WMNO7\YNM-_.QA=WOYV,;\YJ2.22
MQT@G]0Y=8^WXHWQ#9IY,,"QS:CU:HK$*/`9[.+J^/@D+\^,_9.!&O^9-(7E@
MAS/*L$!9=B++5_==]`?P0WA'F`<4I=&P=T4I.15F"`FFP>1B+%7LWG5,5O@2
M^1`16*IFXAP3)JEY7E!8F<-0N0EQD8,/Y!(Z%59D$LID%AMWL56PAV4Y/H8O
M8MHR;0]KVA.ZLQ1WNI1WCE##?Z%&(@8)Q?K6;AIR^K">8,-62B43_LE['O#:
MD(H3.CX!A<`IHF2#6(OQ.,^`;Z+&`M:,QR)9/7@RKV`M"BP;;3RC5EBQ:U7#
MVQ%81@972+35"IEH/U'B7WB1-B5"L58X(M[#BM83,2$&*-MH^CU`7'$J9W>!
M9V2L8YLG@A'FM^;I;U)1'D.:96-Y<HXI;5<@-[#H9MT4"%L`\[SN=0^7OU:'
MJTMDS'KLL;U(K!'G?(0E?FPZ7)CMQ)8)24_<6XXV!F-@@Y*/8X28]AOIR.8D
MWOB1]G5T0=-R!2JI@XE#='5W$O8FE.L/!(+#^K2PO\AZI5JD`_`D@/7V`>)7
M$?VS1;:?,2US(48)OV/=#@KW:Q-3<X7/G!;"35/JX)@IROW('$S.G/4UAQCN
MGNT=04)V8F-7%U=*YN,;I&MG^*)/1'*]'N$BJ[G*>O\M&@/F4-;?)R[)KI(S
M8FF;RT10;.OJPA?3;,->T_%;Q0O70K8N.G9@BDQL*J3T.XLJ>S&VCE(RJG_W
M).61Z8#1-$FA!8;5>C3:&PI`]-IS'D17B:3H6CQZHP#6(Z?K!5#*-1"L:\*6
MK@/0A!SMQIHXQ]H5SQ@SEQ@+?8ZW$8H.RD:O,Q*4RQJNK.B<1A+-8Q55.SS3
M2FR:>PIX894_CRQOD>XHE>"$EJ\\J#'R.:T!D2`WHZ]KU?IY[IC/0`*#E[#0
MV&?4#D'D5/*.=7)3/5Z4RQM=>#)%A0U;S.\$?CHW::QO24PO<$46&V8!(*.G
MC(>6Z,EJTUU2)Q/?/^M1MP2!3Z;H/CJ+P`;5'&<I>O,`=N8\V>DNM!:OR^'I
MC-'3F"NT0),M&@S'S*2%'^9GHOZ-V;MA`8XG9YV(>A]J0`%M6*EY20NL%I.5
M4BR3`),N+JD9&!H'@RT[D3I3A=>)JZCAW9"O(*9225H!>_GZ1-C0.<0+;W51
M[,V]"F8,%)=.DO;6]%ZA8(9Y#1Y9L!2C>].?S)DOAC$*U$%I3#<T-"*`(R-'
M0C*>[Y2.:^0,"0$0<G/JL/Y5+#<#(RHL9<FGV8BF-+<P`=+QNHX-JAJPU1G0
M-O44L&9AIO;DN-]7V!7X'3W)*0$%#;,FW@LYCF?(Q"*C[$A!%HSKY:/BO3#I
M.O%[B&\7_3J/M3'U5_,D1;GS-0(B(-5C-$RWRT^(8X\1!J%AUM!IQSU.9MC[
M)GXVW.9$EY/+VTR^2.?'(,VP`26_OF%6F[0]E/./Y.@9WVJ"`B/:.[*L,"R8
MBY%?Y*\/7QIJ$%/TL(1%.)]8:VH&)H!ENC0#-(27K9,&=.FL-Z6EY)?+\YH\
M%IE](WMQ-]_&HK'<IIJ^IMNLMTC04\K$UA*6,TH["&TIQGB(8&572ZSR0B-?
M-&%C?Z.W!#F4^<`T[[7^(_=@R<PL7OF#G4N.T.#5J"D2M^!Y'M^Z$!']YS9T
M&MK44(7FD/!"&HNVCN163BQ_FA=YTW94U!!:KX`50^(3N=ALV"=#*K.I@*RU
MU/;UX467*KY#]B_0*?R[]VM]C$0.SG=K\OW>G'R'T\424P0V_*DX*EHN,J.0
M<D#H2\,87_16R1?"`W_9IFIKW7TB5#FYA2DM@5KO2V*;RS5OF;[%1$TYFI6C
M+)/)M0TSLJ0L!NWV&60%X(=U(O=$V%`<S[%V*V40A'08"_BN73F1QL/`$-T(
M0B4D9H%B2PK@-7`SA/OK'`PRS&^)(Y5&ZB>1/B+13]C$A0==XQX!JC%[82[4
M)J_8MFVQN4"7-R\%?C$W5:0)4M,37>$NU1F8%B1E./$^72P/B8H>5'=19D5=
MU]/Z#$E8B&604$7Q?B$YV5@"-/U"BKK=8^`!FQ41.=Z&`\OIV8K`M4O$U<#T
M5FKT>XECB"6:",>%,%.8>Y5;\12*T-`&?2I,$I).4$PK%$C!WS`,QO1RT5Z%
M^1:LE,F*/'])[EC"UDNV2\,(#;`B;!?)`S=<:^=>@MKG0Z'0-&,1969>,J;L
M830.U(_;B>/[VD>@FO_@X[3:S@T-<CWN$RC#_Y,9?(^$$F>,6[?Z.DUO\P6*
MU)%$:U\F_R`>,C)I:'$4S5T3TWC\%#F2\\0U+8\:+'98&<>TRZ4<@A(O.HKU
M.I7B<;S&"K486A%A+EQ0UY]#KY+48'RW^7WKR@SV5Z?ZI[BW+'R-A3OW3/<0
MPE%F&$*/C[G>]:R;`#=S0<.);%8X8\)K68"QRX[)0.:")\>D.7@CU683^XWZ
M'T6Y*3BDE&;=\H,3-Q]A@$\FL;N0DNKII/0F.4WK2\)39R1/(<O]8!Y`-U(7
M=VO^O7:.3S3*8='>A5$+$,%EZ(B:9"X.@RV!$@24;Q;;Y5.,\//@G0YHIW&3
M1K,(LT]I9PZ6L,`\4)&6-]N@Y0DGB"M%1Z(Z`=:?D@>5UV*$9DKCG^@<Y(P4
M'G/C_(.W=64'$=9!X.M88G28S#DE6##'CHG+.J;]R94:5)UG]T:4]W%M,5D0
MB5R,CA^@+YP&$[)A!^EY9$R#E02Q7*8M.7*Y!R#>$WX#MJ)FMYAC:BYX=9_$
MDZ6K)#PD<Y,Z&"GC$]5:LDY!;[H-GSP?<VZ)EI,7Q9-0K'@A9Q?E#-$A\PS4
MB`V[!.$!V$3_=#,LVHI8+'6B@CYK.2X:UY1ZN&Z1M7V9]W`74XH&*"$X32N0
MG)#1!8Q*,6@>"T^#H7X].C&*K5:-OS1C#D1-S6+6AH6U.M&0!V%9R,8'G_@0
M&AT?J=$AF?0\KB/<ECQM5?*:<J-OK1&&W(Z$\]NPR'`JY3-DA#@V.0HRYA_I
M:>DGK`6H'*8&,G+"=("P[7/D,(@*FB1S*:OE1U2?_$*?E!=W!5?5\><)-0R[
M2--%.)\.I=?&-B3"E@V/H-H^X^LD!ZKN[<1RN"'ZCO[W^Y+<1)S+O]10<W=O
MT>7X[N;LY.HF7FC&SR\Q;2[:*TUTP*%NLA,T3GI/8A#('%:-#T'9@E+"S5\Z
M5-K$E7O)!(?K<`N:UR<7ZVP]#'=E-&NA3BDQA20T=$.+FPEH637,K06G@<@-
M^A#.*,J8WNXVU!QH@QH>(>1]O^42P4T'E^C[.4KS$\1T!MEE08M39SPT$.NM
MHH<=3<+4QF1>`R.0]4*1*,6&AGLW=$B@RE_HS1/+T`'*:1WUN(+/DBRHS>V)
M+IBBDW&L>4'86D&T'SF7>#=M'8(_XU3.,H?R]0S9T"XD-@0HPKL8,475Z:C8
MG`63PG8<4E\&NB1\RSJ<A'$T%H*1+OLD),LP(E(E2TR]98.XZU>6H7@>"[JW
M=-LDK6<4]R2>7OTNST)*[2-U2T`S8C='<B&>_0"L8:<&=`):M+\(,.NS$^EU
MK!16MO.EJ3RIOA>7B(1DNA<JNUAYEKC&8;.VC&Q14?W!._@++^9CF+K^Y&C>
M$GC&$9\J$S;%%YI@N`(&JV:8JX,OYSSCWX`)#_.+UX-MG_B8HA,PBH*5+S6#
MI&5IGTZNQ]&4%J0GEK@N-=$"'"V<!_1`A)L1_>Z%$4LY&W=3A#FUJ/WS8:#L
M]&ES;)I3`8O*&4R6+?>`8_OG_#G6EE]TE_#I"E*W!]%^G]\\3HO'V-(R%J\/
M'Z193I%/0JJNCV814*^B2'A>;Z$_"WM(I!-\'!(!.5!U9'X`3>9+BFSUMXA,
MP5NEC%(1%(XI"]*1T*00;,,DACN(&I20G<NW)"XC+SDNSEWS+QY^LEB"/665
MUZ)(Z2KA+!CJFERR('9%N_GP-`"@$,E?)K]7X%V44$9L4R)00+1.44';.#!X
M_P'[G@*6;@G3DFEQIIQM2"6,1V)O#(>7A+<O640Q&*96/$JM0*+>M&(D%B(^
M"L2'C#^^`1D](G6&*OHF-3>IUP?0[`$?I.<WCH:!A:W%PZ24-7(4?7UH/!E^
MQB+.-.Z'P461J2+%L]=[(KSEXOXT!]BZ)`RO*67MR7SR>./1M`JS>"P*/SF%
M^_L$C(DI0_&^D1M,5?G:VPYO_<9&0/!;)BC'8SV2PM$!@D3%2OKZ[Z6?BN$5
MK-3#D[YABS!=4(Z,<(L0GV/C@;C1;:X[Y<5X9QJ@)M2!`C8`MC1984W76H<S
M,1CBB]0#G<^&$"J\G-8JLZ`L:[3B%,M4E0K)^%^.^WTM4SJD$"IP8U*`<_4U
M73QA-R?$0&@JZE1/T==ZT;`&DS/NF\5123?G=^L-%:7R*,%YXM@,P:S8;%^S
MB895I'7D=*1G(QH?Q6)-$/6P0U;R\8Q*&J@0R:#1._8%*&K\B9A74"XF2*L,
MB!"?4#=X-"3T&[;T6`HO6O\E6\BL5\WZ3#5A4_+MR6V&$IGN.2(`0HOA96I1
MTD>N8JZU@^$325,2EC-[WH;K2]5UJ5$KEB:,/5=!3F7&5:*,MBW0S3&]UJDD
M.MKZYEND<+A1Q.'XQ.Y\W.V47`?/+"]E9:(EQ?-*]$V\3D[8CI2RL*X1K1W1
M'CM2\W$J$(Z%A9O%N\.*ASB)^<'4XM,`LZ"BM,"^O%W!V?-/,Q^?T\[4G&O*
M)D]=@HA7F*$J&%<8YW+/[+`)8^2J108:"^"E7)<3QP9!3PUR9F!07P8+=#%Q
M3-:%5%B<)9*O)[%WR*4[?IA,*<&]UH9@84V>D\5`','ARY`1,WC"LM2PH7E>
MY_/KUH(WC50\NSR[&5]H:[/<ZAJGF)G<V=6UZW!>E"X:(],,%,K`T7)G@1Q*
M>U(*A30\-*.@BW?M,K:2D%G1'A$JY-X(FOJ-2;]L>A%K]*6-9SC]VQ9CP-F`
ME-\L#RN3)JC"F;0G1%CRLM97@/>(%:'0:*YOV@;8=&SJC.'OHVV^J!D)9,7N
M?C(W"&<(1"VB:8,CT58@FMM%S9:E8Q,?Q:T\8)7^C.4\LS=Q:U]ZG?8NBNV*
MUG_<W\%>])[5G,"U]FDN,W-)R\4I/"LK@DA.N&`8CY4:B.9`5M1$3*A.K;YP
MA5NNW$-HK38LM0:C-3B.8867RDD]$\*.M2(KC=IX>OK;AG(O"#CY,7V+AV-;
MA-LY?<=\.4XLB!RIR6`:.IA^B&2`4?FTH-E(OG=12[`(/_$7(GV+D/F4M86G
MZ^HI9J.SHGYS=IYKMVSCP4:'N#YN/0IFK*%NX_M$+)D9IZCKQ8XN@<CU'5/]
M,[9=WOLE-0LIS/V)-#LJQ6I0Y.+%_HN$DQ(K%Z(9E91EL!.'YW?+79441&DF
M&N=#+F\`)N9V\S1V6C3">_('\OP%GN.)?=)9D[!(87@.!_^E3T5!EPB6HH3^
M4M&@YX%IJS$J9Y9+%"Z5N&Y$`3E3XZ7$HZAQZXLMS$5'A$00*QP\B8/&(MS>
MG)]<A8E1:U:BO#$Q"CJ6`[6>47^LC1<A$V%)^Y048I,JJ1L3`Y"4G,4)\1%]
MS#9CJ3:T]3Y?:`YFSH(ZUD42'7V%&`-L)ISQ['YD-GV,<\J4EEAFO#7"#)[C
M&;=4Z(28R;#<:#8^=M%:)5F@#=B7,2(S6;ZA%SI(Z=K%\?5Q_J3[7^4<BJRR
M7I3L$3KC*$Q-^0N#R%G[='QY4A)GBQD]#Q)\5S"&.UKR=&*Y$V`ME9I`J;4M
MK!#B1%B)I]'$[;#2YN14"C!*3B9I/D_"WY06:DQU*NC:&(>&NA@1%VU3]/3&
M(>NNWS"_3M*H[C$O@9)PBK)L8'"FU4K3N'1\@<^IGW4/6&^PPT\YTW=CAOL0
MWAC\]'Z!D1VXU`\\A$JGF(-*`6CE(0@AYD*TQ9Q:66F[^'OI,'BCKM#?E\2J
M:((49H6*W#`L7^"QO;3LJ\RQC6DN2:"HJ`LXQ2]KZ8WM]G%8052X0T'`3>#R
MFZE*CS(A8UQ$RGA9][I%<V[#:3_4MVG]H'U)(ODM.!%`PM0M(8FSV'ML$#&/
M>$G3B'-;22\W>C@5.1^<LT6)'Q5R"?:B%*>6R$ED'$.D(;Z4H,B=O#1+4>H(
MC7:=>P\$*GF"I8P7*7<_M`/'T?/:V/.<B17ORW4[`=D)/SZZ7M#++7F:XT9A
MJ(0\)W[S[AR]VO;T?=16:0+43/B@+7W]!^^/:;Y?*'S6WT?C[+PY`9O@$\X[
MEV)+[T[#GGT"%V&X$TN/\:+0UG.)]R."R`^P%#W:AL+BMI54YDV5=%I(>7/V
MY?QD?'H6GTC!X3[_<GUU>2YW<W;<Q?0);#L=%P!6*F=DK!G1OYLK+$2^,ZTG
M_/>Y/07)Z8D:-/S!-7'@\LHN*[;N#>'L`?/@YMB`43)\?\/,LG_`_W$L1[O*
MVDQR'TP)LLD/SG283LMR7'$8`)MGFK6U,'E$HE6=PL+M6).ZODWQQC`RS3(W
MY+DG0,58H'I/_"?,IOI"W,EW.;7GQ#D.^S[A=\S`7S]O9$1T<BSEE"P9B.>I
ML+P6UUE(>6D8\@[%DTQD$GUI8DX&3[_"W:%O0XRHD4*/4B`UF?A@]%(R'W1Q
M/?B&A11@#"`*Z3NLM&(][)0`%CFT)45?:3\%,0\]=DP2-WG#WDS!UK^FDX2H
M9\G`MLZ'PB!OB=O$ACAK>JSQ5L`A=]73>6+$8WEOC@5U3WMSB9-%5B#E:7P6
M2,X['S4FR?"6"T&U9IQ.PO9'R`N(R\92T3\%2SHQ;7-J,EDH;$W:09;?$":K
M^/QY:SI=,#&O<Z\F?7X,G%&[-B?H)]'>1=M'&HX6!9YWZ?B$1S*1OXI,SQAS
M%3P7KQE%I]P8#!@KM@^76L)BZ($A%!OJY,1G&*WY`B(TN`=0+5C7!G.=VV2R
MJ#WF-YV?+?4%;#A7KHD[P@X^"S#E4-=N<'H:P]==X.(,O7?L90DLW=$@1O*K
M:*I:/*>)K3-H1<0LI5DDR1DU73J'`7&:S(]J'TL)4O<\08KJX/DE%&WW&5%L
M%D5D;4CK)/>RYN>(C*+U:QQZ"`V=S>5U'70S`;>(2B.22(D.-$9:G*M@3E#8
MM9&+57%"?)O2KD0",,$6+M2UP1H2Q"4EKZPXUB).!N+'<6/\;*/HX!Y&E)'B
M2[C7V!SW'=NT9.-Z8)3%RAU!0O:&28K!.X'@1>E\W7;J4P"ZSHL)X@%SY&O1
M#@$@ES?,P7;1<*=Q-AF-6?*617!277YH3S@W#2N3H]?21.TU1'(--=;(T$37
MQA$-<?#</SI3H->2*"G*]N.\+<U#PC'$C]!<8K_B_\`"X<!&;I6'R:S\-.IU
M<[#4CU7`YBO&3<AD?7=.&RZZL"]5==P_)R8\P@-VX-($XCF;>X=A%)NU_69Q
M%N))\>44=YF^L2-*V&$CL.F+N0,^E'"T?YTHN!>!]PW.AA3O%^\1D*R)C0H?
M6*(_]PBSBLSUG+SPGJ][`L.N(M&E8"J+&(&!L;5GS5M1ZET7YAQO/%4Y`]>X
M3'S<R9RVB0M+."A,T4%^%".T(KV=A_V`@1`^[O/$F8H4QDP$X65D6/)8^#.K
M+B0CJKA>%AK%&1D766M,&$]BRV[9D0EPND_U6!MCKPJ7]T['GGF\Y)M'H:0U
MD)\E:[&J['TG!W0R.$*4).\!\9"YLT#90F4?XQ09\9X$>UA+E<L3#0^OM+@>
M/.>-Q798%XFI!1R;9NN$ACIM`8+1H7C4.W["V.W=7/)$U3"I-3Y42)KS%@VL
MB/FY'#MQ8L9`9PI1&.+@&/J%GI<5IMILZG]S*^'Z-,0U`R#J6$HI@KX0JYPD
MFI0@C"?SL>-QTL(A`FYX55B+L:#EI]Q$2<NK8$%3WDI^(WW$A8=TQK<!E7\N
MHX@X*\][[CL<.5LH<>Z,=*TH!L.&I+$725XJ^1D^RL=:!8)+LA'B@)`%=W[>
M$]'/E:DH"&-1:I!;UT:4@)FA/+5_$<X69945E?;0Q"A>.@&$HQ+IT&"6D!G.
MR1!-N+`WB^1$9#%9QO[%64G99<)??<_FTD95_S,+T[9H,DG`&BBF#R/11!EF
M2J>BF$L<A^R&(5@]ZF;JS'34#V:FQ0<CTF:'SVPB"5I"/GTCDS"\YDN4>XDQ
M*6'I6-S$YGW%I!+1C,COVN^8!TU>*7094S-#7PO'B$OUP*IJY/:5HM0CUOF6
MHHJ-EV67F+]8$!GM2L\K1T.TB(HHII>@PWK):K?(-#S%);KPV=`6:]-D71P<
M$2LEH.I(5`085OZ-F2`Q1ITN[[@8<4'6-"*6JYAH%2$R4-;RDAB1,BM>E'?2
MRA@Z)81W9=O40"9+NPC59$G@<"WAP<4!,8#6D%O0O%6\JF9TZ24ZEI70\!26
MV'T6_;"T"WZP8B]GRWYT3)<:'Z>"H]:9"4Q1`[:P5/^W#ST#-;HMQ5@82<^4
M9<Q;D&RL%R-K<0LE>>;)7<MB/>E"W9]EYZ9K+7+$CZ>B2'PRP2*E!@*;/8+K
MK4WQN<W5I0A[O,(PI=.77$9(*_T^K5402L0MIR-[P6Q&*^+"Z^FQT73`G\*,
MA'AX4Z!!Q%R23>JR&%<6IXH=2QJ[VH93O908*?7^1K4RZJ$3#B'V7N!/,6TH
M&LV$_"C5V!'I0N'=VR=7R@N]0^L]Y"'1XN[R_E625A3SR:WOML;V(MR[R*]'
MV7:"I![*\Z0%+H6S@K>E`OT%FP/S9L.W*T++)<)\?8&MY`F%+8O"W(C0ESF/
M]W)"#R-S1O,=IZF+K!^F'`Z663-+Y8B:4<ED$_KP:&(V^J9-5H@>JI_2O)#D
M!JDS$P?)<STG8S+,/5+AE"!1L2@;G3F9\=(8;^"(QF3$);/9?M&L]VM;B0K6
M_BT:>,=%$YNI0CD97J0G^#66'6'5THIIVS;@P?.0@X@.$6#CTW"E$SHSL.LY
MOSERZF\D]Z3A7G@B$IPI)*"A&XH6%8>34V^8"NEPQ\M))$4BC+,^%]-H;AJF
M3+-9AIP1.9A4;5-_.&_V@>S-H\'\N,T7P[3<1U9:&7__3]X-/19?CC?#]GCG
M6;KQQ(B9^$HIN`#>;]K6T@D\[*DZ=5:A"^T%ZN!DP5NRU>+]65?+6G(Z43*#
M*)YA%$MH7NM'Q+H'QVP$R0\?3R_:,"Q,;MZ9.><K=G'T5.UPUT0C/>;%7M,Q
MA?5YCK/M'(N'443\,]WCS9ZA<='4.LFKN>7$E;\T$+\`6<(^+.&N"J>_)W5`
MGJE,;6M,9@A<N'4>]YG$$GKY,5!;$GVYE)<X3ZC_I)E$T7S)>T+[-C+C?<4F
MU9*E%2Q%2\,P)+!N&_-1!B:WS4V;57FSV<Y4*BQH][_UG[!<X_O`9[G$8M."
MNU&-*%%@H+$BGR/,W(GJ:N((8<98B`+>$=/TXNM(E9F_F>XC[!H3XO3LE</5
MOCAPAK84]SS_*$.`-S(\VO-PEGD8B>1]OA,3CK*'&[W[_?K+A12^BSD)32EA
M.S8W+B*C,,5)W)C8AJ,HX%J6=WJ>,4\/E+,#PTR4LA,$PV99V9.]).T4V<MZ
M]CK?^-JF0[5):E=]DDCH'G.?+!N+%G*V$Z2#")0Q8Z1A.W"YV?6[D['<NXB;
MDY*]++R2E$7R#/SSM=J6V'A8/J$U4V@F(Q/TR?%)LFB89N='B5%2IG&$4IP)
MALWNT]KE1EEE%DZSF)K/H0M74DJPS6FERGBV;UO6N73M!A$^A<MK?]<3`Y]S
MD&VDS&QP1L1E;)R)A`US8UUK,PM,I/"E+"K)#]HQ!B>S"K^Y7$BS[D774\QB
M*3U9CA%E37_D3AN3&L7,]K/LF&L_Z844C(%[%"2C7;+T=9'F$'5222-ISW<F
MWZG;(,PJP':\%+'80V$]B,@Y.%8FL^&R;)8-V<*>E\N-:+"`^1#80AA$=);6
M1`-<>F1CO=>ZE9:XG5*GV&1;;Z$2`?'5G$^`V?=??L^J2*%?W;S?.#4]?I-$
M'&KKZEII-%IT=_!8I+0.8?JS;!=.W.8/J1@5_N)U\8R%)?/].\`OC-%HQ(JK
M4K_&PHICAI:;1#MED5_`VAR#W<3RJ6Z)B[Y\C;@NZ![,F`!,3GBPB;TL1NP(
M*MAA4W38,'*]9>TN(F!&G;ZX+G?F#T$DTVJ;0*SW*-;7,MQ!DJ$6(Y6I9B73
M"8"CY/5W[/OW-,LOAHTP^XJ-5P]3SF!#7K!*V<.P][=?<5HW)=@CNN%?-)_\
M\'%#K.P]4MLHIN`]^'%(HCS7>T*3CJ@KC[JIIEC)S=B50Z>6,ZT05&K>M56D
MT$4YTGS7=!`7JM(B44IC&8.,Z=!&N2GIBU)#=+`G7:HHXL#TQ7/5B*!C$V[9
M4K3O$N8@TJU(`-$49W\M(SD<(,[VB%45C`7S1A#A/>%:CUR'&\-!F#TCV"/5
M>CR!49IO9\F=!:5Z@&IIA)%'?!P%M7MP2U$H$U-@CWFG9(^U)80S1/V.I[[1
MZBN6]B-T#QGE4BMW&<$B&24VUYB>@N0?HKE]+#3&*#(<5!9K0"Z87'B;IRS9
MGU=2>;3:B_K^0U]<NX[1Q-3?9?E>O)26NA'04QXK-HET%]D$X6TG(VD?N19`
M&^0VZ9G]:`%/1B*C_)JZK4`EQJ?@$5X)06?<62;S9J&"H/,Q'G!0WVT<M`C'
M2P-'6*VL1VF2-!'-I9T+J!M;YP,,,.S,PRZBABXJCH<#7**!SMOO\A(,2W2<
M9^UN5J9@P[#.!WQ?0*<?2@/[-AZ3_,E_?PB\HP?37/UR01[,Q1?6G7%L3T]H
MDC5ON'D'5^,C@/_][_0W6`EP!END'\&5?'B@$A4H[^@H>N(CBNH-SXB%`?.^
M&W"M$5:^81ZH<=A8^90IK;#%$`[J@H8_;LCL?WZZM7Z`2N_/O3,4[=]:';"=
MD*1_^GNT9P#H].KD[E_79]K<7X+%_?7CQ?F)]M/1AP]_=DX^?#B].]7^][>[
M+Q>:<=S2[G`<!#?0/GPXN_Q)^VGN^ZM?/GQX>GHZ?NH<.^[#A[N;#S_P70;^
MF/_GD2_]\GCJ3W]*K;G(0HW1UHZT(GA1IBHC[#%S>75WAOL*.7W[5V#0MW<W
M7T_NOMZ<7WZN4F6A82'`$DI.EOCW5P#<@S$,QO62/=MTUK1*U,]A&6]F!">\
M[Z+FAYN^O$0A=!TA-PN[5$VQD:ZSDD?"1:W`SOZXXJCJ#@%5M\"B%A8H$$=G
M&.T29A6`"Q2&U7V^2*RBL8)83XJUP:BQY).3?UWC](=XXC[[D.>+G5V<G=Q5
M($*O%X&7W-;:CL)>P(1FAVEBT);%D^E-++]-!EO05^%,`AKH%#//X'B=1]-#
MA9NBV#57U**E(W(D*U+#&#<BTP8I@EXC4"B:LJI?QV&RG1R;)WP@590-Y,K<
MBG7;B&Y%V!LQH?DGNCNBMVBJ_=P?]%.[\HKP!*U.1D.)AI[`+@6PF!A-J83Y
MV>AWDV_C&Q%OBF^`OU?TWT678=3"FX61TF&,!MBDO8XV$_)X&V(/TXF?7+"'
MCQSTM-'Z!*.=?"?>S?0]K"=_T%G$Z.[B*@B&,-",CD8$27GSS#TOHF+I2Z?!
MR18--6^6Y893\_#4_;!KTRHLNFCW>XDWHT/+!_O'0@6)+L$0`(^D(P"CMS;&
M(466L/;S<)!\]%U(0[15)->81*F.!ZAY7ZT.*[4&8,I?L(1'X8=B["#VEF1I
M'71F*@U6TTIOJ4="RG4*8W#A[JAT0[_)/"[66J.\.YS0MM1K[(*#G;%MRN(Y
MNV<(FI#%PEN9V&[O?WYJ_:3=4X<O_4_\:H6^;O[5DS7UY__SD]%J_>VG+*WH
MCB[_&S&G"6;HN]HCA_S>\7UGN0[Y5*PP'/Y-ED%`'Q07_C3K![TMG^]L^;Q1
MR?L_^&X"0RFB&JCS1<2!*0.2\7]^8O_^*?4.L),]8J\`@EC]T&B\1/M_+?H/
M?>N[4[@`I@B"T4OIO<_8;3Z49(#&B1<3C[%S'N!L.T!OQ4W,AUIA]&R@SW4B
M_NA,GW,0<0BU.?G.4K-^T?[?!(S9V;HD7P=2T@XX.\+S^L7HK7[PFVK1[)9?
MCO`C^K(;QG6T>W/!<BF0[?Z2Y!=%3JS6A]+NP`O$7AB)R6`D*Q8O%XV"T*FC
MBZ[[<^XG.]U>I2BME69/4/ER`G]A/GLEHSB#MT2(W.&4W@T&.9?#[]-YXUZH
M.I;3V&$D_5_JT'2[/RR1IN/\/)55?Z"JT$L&W+K&N-F`8R*YD_"7]/$3*OSA
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MN[`6819/'=LSNB_OSYQ@AQI+N-3%4!!,/3F"[X]X3!=CN]@&CY7`\I#]O4NS
M^X%">9<?VF7F]^./Q]K)G"QI+@W]R5I^C7;A5UCGFT1#6D.S]6@&3H2R6&V'
MW,V,'3_#5.B^0R*@O1/Y,6.O"=]9.`_6Q(LF+(M4N^/;8WQ3?)3C3/O#7!!T
M)*[CAN?6,,X@MU[<AB]GLH2"S'<\H?2`8NB:3JKX1?O]\O<CQ&YKT.I\L^$=
MQC<S?.H;FV?QC4I50[S\W_:_07)0ES/U-']RW.NPJXIC7\UB(>QSFN[$EGO%
M?+T8:D$<E(#5-(&1ZQY6(TYJ#P.=,@TK1T"5UI6&8WJDL[OU@>&9[E04V[S[
M-+[]^)X/"N):&R88\Y:-3AA+95J2",6PKWD*>GB&K#FDG-[!<@%9;"-\KW"B
MAT,5,1T5JWP=^\AYLI&;TZ0LRKIIUBG+'8XE*M&1%,]4#V<0`(T2BX946,4;
M['81M1O!0#`VVZ59("(FD@8KZUC$Y@UB#1\JNYB?C4$CD?$;OH3WB62K/`06
MLP!P0''8SQ`S]!UO%39E$#%F6NQI+7GC*H^73]L!'77)/HJZJ=%&[8*;)YJ.
M</F!9?JNJ)+BR4-A5CD_`O$5#;M9%!V4'%A`%^XPT\K%_`@38<243I!)D[#K
M3EIR,(M+4LG!!ZG1$=C4HIHMG"=:4BI-\^160&[9D29-2N`H&^1-.;*D"F[:
M7C<O/IF6"_(Z(%>S\-*?VVCZ4+RP%1J1%$>B9*'DPE\C?+82/B!6PO%S,8&R
M09@(;HV9?5CH0#U#`28XF/A\.,'>(_([>4H$&TKXB.V/;5;(D/Z&**4W"Q+1
M*8ZJQI_'XVO*G,\_W=SR[)=T3K]:Y_-LE=V8_79\GON57&=NW5LYN#UV<0)>
M+SNT&-_/8/GL_:KP_:VN;54<OETEA^\DTS-I#O$-W+@'FV*P,3@V(C"6POD"
M[AK.OL[99Y;K^>F,/?1/2+7XE-F'3-&T99;/8.220*IK%UGQ;G0L4ET88("`
MYF\CY_;G#F=HSOV_.:\5^6_AZ;-E0@87K*;42RT&8]*)V"&$L!1SJ""WE=9"
MR$5"/YW>P3O?+DTT-"2?=M@"`O]DG=82(,NI__(FV4`[CV!-+S)'*1&5"PR\
M,;R#!Q<XT78B<8,96;+,T>Y-CX_]#4'!]@)SB_`V'NQPV2*T#$OG.5UQX126
MDV+G'OY<))U0G+A<1L6'LG#YU$H('R$'90DTM::2N5&VI<%6K$CLO,A/JA(Y
MG2I%3E?V?L6=?I\(\:Y-:WKG?*;]D)!4&_&S$9G<W[4U'AM15*HHPEHMA_?0
MR1S"X,UIC2'GT?\AH@F`YV&MX<9NBH*_1`XA/5*7T9T%]!\`=Z;IM4S?GQ$>
M.>:^M8@4LN+(USPE_MK%<4>BA)VM,9[-\'E\/^W/0TNCL+2;-PG@"?QR"Q_<
MW1E`Q3QVR,7L"6T%0]O83WPN<A!.85C<TZ[8=%V:]!_KQI'6_(`6.;"R?RJJ
M'2SNHN$8EC6.<X*9=,"10;QR$Z,SD<G$NNZC^&'R!*-<2S87B[>7"K-P:2F[
M1[!QS(,N55A0162*LMRCE7N/1&1;<Z5DJZ.EKTOI0$^=C?!^S)`YPK)X21#C
MZVE3?5.8:%R_B9%I>0)3+3MM)PY8E?#LYHG;TS2DE+>VU[QZ81R+EW)>S<Y%
M8OP)Z\5`W_2*Q6,N=,E)`#DQ];H$X*M-[1_T*T[MWS95OWE_WF2["DH3:+YM
M714'+!4U*CAHAVFS&D\4*YH06#9H+$]=:Q>%[M560YA/H3[#?..TPX9%RLXS
M7Z?9_%G/AMX9=BJGJZUV(0/7&A0`;A]9[I\=AV5FT8817LD'O3,>AZ.LH@$%
M#KG;;U5ZR+7>^4]HE>'@.>Q9IL;Q=W2CH^P=;^O#BHN)2C_B.VKUBXIAE;AY
M7^\:RIYT3^\,E"RQR9W<F=/4>RG7,Z\QOHN%VLEAT(O"^#%-K!W;4Q1:Z`!Z
MT[9]9[-MGQ-IC9G?F/GJ5/`?.OSEF?DE"K;\#0/PI]Q^KW/%T"RO&*<%NSK,
MZ#][[^I`E=""SI6REGNMCI#S1#,>&@3DQ3\X1^21>(?<)D+%A_9A&EV;?C@8
M&-0TG$/C?O=B98=`;&6[18J4_0_T7KN`^Z%:DZFO]U^3;^2"T+DPDV#)^U/S
M:#,-VBKA*FGK0V.D*C6T]7Z[`'"*\@.;^$H<?5<?M*J/L.P,7*M39H`EI3=%
MJ$LL3/N[=@L&&TFJ$<4I8E-;$36P?Z`/J<;LKWC)HM#\*M<"=KQ:0[W?4I;E
M#_3^H'M8+%]](=_16]T"CNC*-9#A*U+Y-G,!561_3^_U%9;]@U%%/*"1_:_C
MH7WP^0R?#C[7>'7>CIIW%UIU2G#ROMXJ(CZK%C.CWH%I<]=\["A6TQWQG*:H
MRH_5%:Z5^>V9`MI@*O=5I0!#'W4*9&(I=_EY)DPN2:`$=0QUPU"6.@;Z<-1X
M>901M2H^M,]\M_5;7JDE5R2F8PR+I9I5+`/Z^J`(#U(K$2YG7M2N.7'K^6P%
M,KL2W:6B;80PO^W<MW9J[EL".4V.6Y/CIDZ.6`-_`W^1]ZN88]@\E%.YVB[O
M[@O(P5/R6..*M=&>.F6L&9@X@?6")7%K7)*V:*C]L.D`UU/+?*AQ96JA[6(L
M'&Q&J5!*=;0\-=/7U!^:-=2-;@'O;]6.R7:[0!E>M<#U])&ZP!D]O5U5?+8J
MC\XX&CZAAEM6<B6I>LZ]CK(>I=>./=7"'JSJ<_+,.EHN:&;3!YKIHL1EZJB;
MT-YKJPI91]D<P&ZIK55JZH$AZ6;9@\]4TLVZ?85ULZ&AK/H#NIG"F.OK[6Z9
M'63V&&I)N.$+AE1>ZO.^\1W=%]L,G!+7>J2]*:7.]9]-R[YP/._<OA7=)Z46
M]]?$G3GN$CM'OM5`3'=3$X*24+J?\,U>N^]B&]*9LU@X3[0)+[V\%FVN&BR7
M6"L=MEVG\S.?Y7[NTQ#K'ORW!Q"(>9YP+CC+*380(W6""'6ZX3G3A"EL)9Z2
M%9FZU5<;G&H/WT1PH8&_@;^!_W#A;X*#A_M0[AC*(,R,O*?F*VA4'[1WJ%2Q
M`-E]8<MT2T@.CR8/%]<"$I?PR0@6F>X7DBUP\II((1Q3@:4&^ST!'-BP=VK,
MC8S71`3CJ&YXOP<@`:)=G9SO%Q@'0PNOFPJV:A<6(B9Q,EZP2MMU[V^_:H_$
MI:,ZA&U,[62Y+(*^Y)VQSG/AE36>^VYXL&S?X6.>&WQ0?"`J/O"A..6@Y%W[
M_8O[/^A+R%*)/E$'5K-@LV`Y"[Z"*\&<N<V"S8+E+-AT8$VBBT=*FA6;%4M<
ML<;\^E#W/,')@Y\6SI/V&XT/UFPZ[JNA<:&4LV9W"N[NM98.?')<`HMKY,=D
M;MH/A*:8N.;$5Z@K<9T9O9N'OFT'][M>5K;5^BKX?3$%XRVB-RM)-1.[7G"_
ME;=#$G_OQL+A45QZO<6SRLS"SG\5<F;OAIRW:>K2/-0\].8?VD?2?UU:U8[R
MQJB^\.1EX;$#W.^,5A;DY6M4E6P@L^;U0.`?9+5JJD3G^EB:SK7C?JMOCE?1
M/>ENK1LWZE;S4/-0\U`-ZM:K='#MR*K;RM;1*]R>HWJ<52*6M_*!Q-]?1(LZ
M*<]S58FR4IM*ORNYE=F>M%&BFH>:AYJ'U/-9G>`0,FTBNKE8&!\EGJ^YID\T
M[\E<E1T1K$289`X&/!`'R_#`'5R9PO(PX,],-JA613O=MZ.KSKCB/D%L]+'F
MH>:AYJ'&J;5''2%KYI,J!G]'V?YB!QJW?5ET5ZM>G37JU<ND5>V<W4:K:AYJ
M'FH>VK>7BPX'*%E)*I`7JX)`WR*+U^AEA=[VX-[9`NYN\>SC?8"=.1]7J?J!
MZN/$Y=)P9ZNJ#)E=O<2_2FN(BR_ZY"PL)[6FZ$/Z5^FON1Y_/OMX<S;^1^+Y
MO34B;?%&I.PUX\5",Y=@,/N>YLV=)QNK;K%[*.OL:=X[C_#_+J']L[$UJ?GC
M>-.F#Z8WJNOY88=4ZX>VI,U\F^:HX6ULFJ,V\#?P-_`?!OPJMG9I'BJF7ZK?
ML//P:/)P<;UHFJ.J00I-<]0=D?&:B*!ICMHT1VV:HS;-49OFJ/5?0O4::S8+
M'OZ"K^!*>-:/9K5FM1U7:UJA)G'%HB+-@LV"Y2S8-$&M;;FWV";T=>^N:8*Z
MQTRQK*SYZI7=G=)LA@IUNMHF.^@P,\7:A]H+M50D'.;1%:]8;O+OFX>:AYJ'
MMGRHZ8R:X,8C%1+R=X#[7;MUV(T70/$Z\`V,MBZ-..C6J%E)]*I?%*.$HHI&
MWVH>:AYJ'BI?WWJ=;J]*&'EME8@[`CBH7D+N")F1Y2Q27'9OY2F)O[_IG]KT
M3VTTK>:AYJ$W\5#3/W578:)2IX2=X"\^^&2O\&?VMC\,^)O^J4KPO\I`;/2Q
MYJ'FH>:AQO.U1QVA5YN.LR.$PT+9BGO$;'WSNJM1'K<%_Z";JE8?JM\5L*:5
MJDK"IWFH>>BU/]2T4E5CJ/4VF>;#K#;S:N<K&RJYJ+:`>U1??ED1*CXP(NY4
M,&BZM#:JA5J!5MV7-)/_2M!UUH$S^O@);4P'?PQ!3^=5O.S;J(2W1?]Y48G;
M]`G;I]SG<U,_T/76H;F;CJ[+K00AK;7ARR"WM>9^FY\:]3<\MDF6BA8?>2Y4
MN#O1&:7`K3Z;S0BVG"7:R@&[S+%S0YY*5*G*0`$58S>TM`NCY=PFKQ$QXQ(0
M,UD$4]H33+LU%\3#!L63P`-%D+A%*J.5P=''4G%TXGB4B:]<9QI,D.,[B^EK
M0--)J6BZ(1XQW<F<=J>>DD>R<%9+L`HTN7_2@6/LM%2,G8LT@'>LT]3[#^$G
M'&<Z*A"O`7%GI2+N"CO915C;'EGY5$3YD__^$'A'#Z:Y^N5V,B?38$&N9J=A
M4_=SV_/=`*G=P[Z;V'3SW+[U39_@9U>S3Y9MVA/+7%P3=^:X2_B#W(&R\W'A
M3+[_G;Y?*+;T(U!O'QY@KY>.3YBJ^XOV^^7O1UCLWQJT.M]L^*+[C>[".#J*
MWL"JZ;=^1UN\(^<F,S;G>!:*V4^FY?YA+H)HBS2&`G_<D-G__'1K_?A"FW#`
M=LGT6ZOS>[!`H'[Z>TS-/[TZN?O7]9DV]Y<+[?KKQXOS$^VGHP\?_NR<?/AP
M>G>J_>]O=U\N-..XI=VYILV6-A<?/IQ=_J3]-/?]U2\?/CP]/1T_=8X=]^'#
MW<V''_@N`W_,__/(EWYY//6G/VWH4;`]5K4CK2*$ILUKR&7-%)KFL)>)$/+X
MA1-GN3+MYS!=8?`K2&-XGS6S)J:-(Q,XYC33\PB(:I1%"\N\MQ:`2`!S24PO
M<''R`CP,6$6V%A"<PP`"'NCP.>)%'9T!'DY<^-VT`].5GFCK[,LGX-GX"C8<
MPGOS4QFZK3?1U;V!OX'_+<.O8D]&%1\JWJ>VE>Z[6_`>8BBWM`X31A2&>J+N
MJJ*QLX8=)K:U=BX$[;?/8OI![[//XLL-(=,H\@+-?ZTD8JP)VO9!0=LY$&AI
M(/AP8:VY\_EK;:(7HN-TXQP\G*MG14;Q+Q'FDB:5&D*I>:AYJ.:']I'.$][?
M,76K-!>S>:AY:(>+^2H+&?(I;WLMBRN2Q]0=5M]=MT'A7N'K9'8/450>OUQ/
MCB\N:4;1F^,6.X*H;,U)@[O=`3,*<"[5%`+\69JCH[G@><58]<VQ&NSM`;1.
M)ZMLH3SYC]\T57G-0\U#]3^T5Y?9191^U/C-FH>:AU17DQN_65$0^]T";3T;
M[*F+O=ZP^GZMA^0HZS2.LETLP5;6F(6]@]9@KQ![:!7PXZFF!N#/&F]9`<^I
MWNH5&H3:X$]=_`%PP\9GII(5U3S4//1J?&9RFJCM^$VJ:/-0\U`E=W@_*G63
M1MH\U#RDCN!M7-Y%06P7L(8:Y"F+O"+C\%23OK=/EN=IGUS3GFA7*^PK\E_-
M[<[IV.PKF[O48&_OV'LE#99?,0&.FA*.5XF]BL6SN%&-#[IYJ'FH_H=4TZ#Q
M9TU.9_-0\Y"**G'CQ"H*8EM91:]!7@'(,N=PE'>1\9M&2VX>:AY24M;N1TMF
M;=K/[4?B^31+@T);8F^U;D9OM7*90Z&137IG4/W8IM<K5.L$4?US+@:AT<\:
M*K<+DZEL$%<F_VEF7\6/^.!G7_U7T0MS(NIZ'!K.U%RRH#F"OD.'L:U`&;4Q
M97#R5V"Q20K8YO_VV89O/1TDT^0X]TX5'JY2?(38F,T_R!APH",V/9(U4P'G
MW$T6\*4ULUB")F^H"U3ES^E)@$E.Z!&QA6&MA&Z`'_Y,F93V-+=PC%#&:XU7
M<69ES#>C`W$\[>=V]/R2M8>F9_2ST4U^`5BV'?N(5<3YXDAGCIN8?O'RX`L^
M(,,EWHK-65L\OXJSZ91X-EBME7XZ6"SUTO'(URS7&3%`PGO[ZHZF6_AH3F(L
M14:V0UD2NQ$YD57A'*EM)P(5G"+5+F&*5&=]BE0(Y<?GC^8"AU[=S@GQ/X,%
MN@)]Z(V/A^I(XZ'R8NH-SGT*:5^3;@>M"I&'.2$"-8K!O..7=IM`Q68\8?7)
MB[.F4(&9DP4%;V*Z[C/^BDT-UAPV+ACHGMHEJ+4R(._9Z6L>'G_&7"K*W-_\
ME*E!O^(I.]M.S6G>O[N"4>^4H,UCSJ-!$FW60X+?W>K=.UN!=>;YUA(91XE.
MG6J&W5#-K:X9-NG(&E.VJ]@)1C*KQ"-\;1-#(O'/BL;HIIMTF_(?VFO![PFW
MP5*#1<U!UWW0M5[U$].;EWO$">F3/TS2UMLC9:L5"@*WCQO^V7DDKDWGP'MD
M$KC<-`(!Y=S#RB;:UFKD9[4[^JBG;*RV*'3*77K'73FT"]N4W,NTH00M](P"
MH5*%0=L'!_CBV.09_2G?B:_-@*K4.&)#'[85;J]4"#C5+CMZ!N&>K]!YK<KI
MMQ2N:BH&7).R^28>VEO5J38!A5VG_Z^1OP(+%J4N>53J1"R-L7OF9:Y(M!=1
M\D=Z?ZCLR)FBT#7W_TT\5+*0CYR3HZ3WEGHJ']%3B?&HARR;CKU/,NPH3Y!C
M[!%?8,]*OW\R/8T(G[86>!@M^RMP\(][U_E.7&WE6A/!12Q;,VEB`_N3O3=O
MV+ZY$*_QH;TZ,",WM50;2J%J7)C*\[[RR$#XL4_)O5_5Z1=0?'IZ2^'A`L6`
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M*,($A]L`R^$L-IYJC4=8-M!/NZ4&N:B;\=0^-,=_^WB4)A`4.>E>5]D\YE[[
M%8V([5`%4185;4,)`NBJ&^7K]@[LJO>/!YVTJZZ&VZ^MKE^GTWY%SG^P!==\
M/NVN]J[7:FF?/UX;Q_U6NZ>&4C@8*5NZ,#R\JS]:Y^\C)0ZY/5)V!GQG4*V]
M5^NM[Z:K>1TU>+_*(9^*>7\%_'W]JG?4</.-U.7GAFZ\IBJEWO&PGW;9U7#R
M#=2][(/!@5WV+E7F$B?=5<1Z+]*OOV+C;?B*7'K=X^$:R^^J8;VWU?7GMT?5
M1G5*/V369_9=V)#SW)X&GN]BHOX->21V@.UO[*FGAO&FKM^N"&1-_<V;>$@U
M_LZ*5=<S\\L]]`*U&$9'[P^5U>F,KMX;EGGG2YL7D+>_;MZ6J@4;YW:*-,[M
MLW<8ZXUSH][`E\3_2&PRL_P3Q_,]^J*WVC=78$OJFYL346^P;>Z)LUPYMNBL
M#]C1KF$)9VI--(XG#1'%5L.O5^+K>_[U!+ZF7<>Q4RV^SK1Y&]IAVQC\"DHS
M/(;S%<0/7.);+NU834<O\#9/5`'CC[#5V)?BS3/+FP"?]@@0\U3[*S!=G[@4
MZ+"Y.?Q'2[.8"L=^$W;AG83;?/,-<7OMBAN^=BIN0+OM^QOX&_BW?_\A-23F
MO"KJS3"(5&@VWXB!%AMQ-*/_4&AO(HY\C4Q711B9A2YD4C:8*IZ;B@]5=4Z?
MF)S^IQ#05,VL!=#.J[_6;(?8YU_KZ'6OV*U]167V6%,#]*WN66V=TC/PA5IW
MO<L5<H(<Z.Y>:]_V6^(^6A-"C<=J7&T[#;_L*ILO8[25]?EWE,T7[QQ8P/D<
MF0/Q_`JNQ8X8;!OJW@AUD]O43:NNN(:Z5AER]@.'%I(I.A0#U\9A6>@RY'.V
M2I8J&R>V['@8[]J#+-:YOAY^7^$<G)TWT,U*03B0#60)U3<#_C[$W'CIN+[U
M'U-,6EZYE@,&E:02?G@W<<G4\M5(MU!7\U(5L##^T]Z?(^L`;E:MXG+]UMG$
MUZ(`K-2.M[ES!PE8G7=NGR#N0V+=D(GS8%O_P2&R$S\P:6+@P@%%4XTY%>IF
M@O:435(VE.WL;[RB@LC,E!&%O'Y%$MBJI@1E,__4];X4@:RZ?,1"65K[3;QR
M<1V>?F7]T&@_PR;S*K_ZT61>-?`W\#>95TWF59-Y5>$Y\<RK6Q#1+,._R;UZ
MY7E);V&/3>Z5NME)KWMW3>Y5G5Z8]E#9-*)V5UG0!LIZ8?H'-LQ#O=RK;I%Y
M*-6"UGF=WK]J(3->TWR3PT^^ZO6R.F8=2/)/=E^W`]E`DWS5)%^]+`559>?5
MY_BJ2K9[!3\K:M\D9M6DQ:AZ'Y4%K$G,>KN)60H7J1B&LN9ED:[`%4/VBKI6
M'T!J5J>G;&)CNZ]NP^4B[5<5!FW_S>)R]A';M5?<>I^W7;J?#5[L%3>>3()E
ML,`Y5#2TCZEC+ID34#@?R;D]<9;D`B3HF^XA-]C40VXG!!Y\;[E7FY;7;;V)
MM*H&_@;^MPR_BME'S4/-0Z4JW-NEOM#6U\UE:1YZDP]M>5FHUM]<EN:A-_G0
MEI>%VL4'<UFVW-PGQR7P?8TKWI))X%J^1>HI$&&+GBU7"^>9D!J7/"6N]7A<
MXX+HNDE?KZ:\<WSXLVG9WH=W%S1L56<>.1MX,GFN4XH^FM:"NF3K6Y,[:FM<
MD;VOU1G6R9:8Y_'#OJEYW\41U)6\H`D3-:Z*U=*>62M9UU<PR-;[C4P?:A5`
ME"/FS.%Y);49OYMV8+K/$2;;.JVREW9>2T)M_A#MNU$_*Z17>D99OLVEU&_L
M33TNF.NF]X=9:8:J(+=05OM>L=O1>YW#S.&E?3>D5AR3N6D_D')Y1/-0\]#!
M/K2/5*M.*_O"?K5=`LMCFN(#&'O:.TQ1W$=^O8H/I>3\=Q3)K5+Q(74[V=5X
M>TN_H9@,:2Z!#6";K,D"R]BFFN_09'QBNK9E/ZB14<Q^<M"M=3,'UZNBTQX\
MC@UC&[/AOU2X],K*]9=2J%70PU,H0!\HW%!AI.R`#*.M;,:YPJ"U]4XF4]^C
MP-_H:0L6DINM4XF;K8!;;6@H>]B=]J%Z?-IZ+[.@1!7=HUW#+:](K].-4075
MN95UX,UD(5)$K+/>D=?HXR<T\13^&/[M5Y["SK^-VH6UZ#]KR-P$7O(3EEPO
MY\%ORI=?3ZW/G92_SGH39[>69IMQPFO)NYN?&O4W/+9)'`":MP])%E9P;X-[
MSS=MWS(7BV?-F<T\4/PL.V8=:O?/7`&DH4\`."!8SHWMD$$+)>[B&?LATWH5
M<X+A22]GYL'V-4QI%4L[5:WL6LFT7H6T2PW.\,5*IC..^FOBWLY-EV`UL#VQ
M%A:-_K[I`J;AI@*F;?!V\'5+VW=;OXLU,+<\S42?D(0AO-;WIF=-X@Q@15S-
M0WRBXVAJ+0+LCY3^!(,T:K'.FJOC(E/M+S$ZFR!Q:JF**NVZ'O^F2[]I'><4
M@:^VG&O0?Q/E+(<._T'G@>[6F?F?XF)G]V4^:*PT[8-SM@^F0O?-=P]^K3E<
M'S=H!NHXF$!IK;YC4C$`*VZV4OK!CQ^):SX0=M*>Y@0^&HVH`6E21(EICN42
MPHZ'T=8'W=:Q(K'V5/!Z_>,"H0+5PD778)A1)X(@$?*#N!/+HZR,^@C@C6CA
M.2MJ9M!!3$I0BM$?'JO;5&;0*T+$^V`5%\3S?A%4\#2W)G,0F\$"9W6!K;D*
MW,G<Q`P$1A2^2TPO<)\Y=2R)/W>F)8N2BD+]QO&!CS@W.J,2MJ`:)SIQ;!!6
MOH6,9TKN?4Z*2O":3A&6KS!H"JLDW%FEQ/&#U!\:Q^IV`-0'H_[Q*^KD?LH=
ME8H;*S7$G(L9*V4.[:VIL1T/S-A`%]K*='W:?=BQCS!48CT$3N!I]S3B<*3-
M7&>IS:P%L<TER0PWM(_G_E+C`9MP*X<?1FD#!OYM_[L)H2@?0HF2\9KHR3::
M1A,].2CX#SI.4.%<RX/&2Q,_:>(G3?SD0.(G[>,Z$C4+`5AJKVUUG!5*Q4\Z
M(W6]51@_Z64Z+\LA@B9^DCM^HFQ"/\9/"K3(:.(G%08?.IEAMX.)GPPS.603
M/U$N2*$P:`JK)(K%3P;#8V6GH;'X20'P5&,%AQ`_:1?*I:K'6"DS@V./@X&V
M"0SL6EVS7AFS2V1CM/8.&MXP%\3[^'Q+'I9`XU>SCX%GV>2-CP(:194T^7'T
M!D,^M^.+LUOMX[^TV[//7\XN[[2K3]K'K[?GEV>WMYLNU%N(JO2[;R(JT<#?
M1(7R6I4);S?(C*:HYC""0M6L"!H3?E/Q$2K?OUJ5\%(URYW0"OE=M/B#C6>=
M``$%2^+NP3O0/%3O0_MP47T]ODW)6MJ7(6\4ZP15"X3=?O79Q=4XTX>9=2ZI
MKO2_[4JDM?+'<Q04MLGL=D5<J-U>]3WC=P;.&"H+G-$^M$@BG8&H!-5U],%(
MV;*'CM[O*MM/LEMQ/88@"*IM+DS[NW:[,B<DJ6@6)\<(V$9=?/4/J2:)K^>F
MNP3"#GQKLA>FV#RD'`&63F3EVRL[B[1V#:;*SL`9Q?PRU<K;5Q2_5]'\&(V4
MU?#!-NHJJZ6VVX>68*2.^=$'=JCLP?;T7D]9X,#H+3"!I;$_FH?V])!JHO@+
MF:+AH9V21VM"/)YBB6-TM5/+?+`=#PR3?239-@\I1YBE$Y\R=DE;'V:.5-V[
MK$/@E&T8UVKLDBK1V]$'+45&S:5:\^H2IM%IPB*[VR6]@;+5#'W=Z"CKIAE4
M;);4R@[_=-S%],F:-F..7_]#;UK]&^A==2.M`%Q'V3KF1OVK%+TCW>BI*^OT
M8>;PL;T#9_2*-$]^)>I?H9P]4`)'U3/%0B#V]$X-JF`E>87#S':K:6F%.;,*
MJYC;UQ2('7:!4@/_?N$_Z$JH'0O$FKZ!E:[8E(@U)6+E+M>4B)6D<3</*?C0
MZ_!M%>KUHO=K*&`I`F%';Q5IY[]/4^Z=861Z_9L:L1*IJ:L/1LJ&I;IZ9Z2L
MJVY4L9NV=.)3)Q8ZT+L#98/<`)RA;(YFJTC[U29%LWEH3P^I)HB;$K$W]M#K
ML%=VE!I]O:]N>D]?[QC*=OKMO:81>>I9'SV]WU<VW-W5A^IJJ4;5S8=+ISYU
MS`^CK;<5SK(P=$-=DWS4&"!*Z37-0X<IBYL:L>:AQC#IZ8.NLJ(.@.M5#UPU
MX9/6=M&3@V"9ZIDO`[VMKOD"1G]+6;MZU&02[VP?=/162]D`!=A6G9ZR=1^]
MIL.%4LI/\]!A6B]-%>/;>>A-&RA&3V_UU'4"`W0U),@T)LKAFBC&0!\8*A/P
M4-VN"(;1M.$KEH"*0SQKX$]%0&SIH_Z!>GEZF;$8%>H=7YHYF7\*X:[S)==G
M0Q88F]@6[TA.RN3`WY"5X_J6_7!NSQQW265`N+,W/G2RK1UI!1&W81(ENQ"O
M:!2ET>:S**^NSV[&=^>7G[7KFZM/YW?-6,HXEVNJCAOXZX/_H(MKF[&43<UQ
M4W/<U!QG*?I-S7%I)F6OJ_;DP'X-;7DK*@H=9(:-RRT*+9U*X_4FVCOCO1K>
M07U@*#NBP]"'-4QRJ(92^]M-N-R53A5,6=3>M56A[;;"Z?OZ<%!]<DXUM-UI
M9Q;%E$K<I1,P]REYFK,BKHDN)VWE.C/+5X)>.WI/W9ZD7;TSJ!ZXBK2&T2N,
M-)[]6!';([`!'[:\<":F3Z::[VB>(/)WG9+Y<%6-/K+X8/[#V>\&>MM$80IM
MH-:']L&AP[PBS;(GSI)H]V3FN$3SS1^DY&*(8HUUNNWJ\WZ+0-C5V^U#30PQ
MAI58>4TCUR:DTL"O%OP''3MH&KDV094FJ((_;8(JZ4I&$U0I3:$U=$-QE=O0
MN[T:^H%6HG*WVUNE$C:!E9<MQ%$-K5=W!FZH;@%AYS5->SNPD$E';QO*CFSM
MZ;V#=4%WVUN-IFE")OGP.M3;?77#URU]V*D^`%F10M`YSBKB;F(F>S^=3J=X
M0&O/&RB>'E'[%2]'_RB=J@\D9C+01YE46R4;WL*`:^F]UJ$&3=K=[3*.Z@Z:
MX(L^.0O+2?6'?$C_*OTUU^//9Q]OSL;_2#Q?1<7.YA68$Z^3J.#IXR?4%0Y_
M#/_V*P_J\&\C]W"+_K-VZIL0D/R$A9ODR-"F"-)ZL"EWF&J=KR6H;,WQGT&+
M:^&$S4^-^AL>V\1K`<T[>%&-PH+FW)XL@BF0VL+RK0=:RJ81KG4X,^WG]J@5
MO6?)/+6:"??KYUXWY1N73/`DI^C7]>=$F[$(@@<?VU.V]E^L0(.^A#WB>G[X
MH/5#6[)0`ZR.7EH=WNFMR,2W'LGB^5B[>_DG;!U+[,S4'DP+05L([0F7/7&6
M*]-^9EL8MHW!KYY&3'=A`6B6_4@\'Q4LW,>)&R`-9NV-`A/?&H=#`"NAX,7=
MLQ?%]M/2H[W8Q,\Z*</H99Q4N]5.?+.&UMSTFLI*=@GAE'\9VN5=!L"-#Z?N
M!R[:CS*6^X/^EE0?.W*)6#+)]UC;="GQ+<@=6>&K=DJN@V=M?'O#";D[;/^J
M_6:M$":P&+2)X_E<IZ)$TA[L"GY>Z-ABVX+(F$V[DP>ZK,O/5EX#<L.-Z2:O
M!44OUTHIOO1>VE-K,,4/--]%3]SQ5W<?.X7OXW@)]C701K;YRQDC_!MP#9>6
MG]V'=_R<W^OP8_L(:]A=!\X.;K-XE-\*/)\'8A/71$IT5XX+BR1>D_-`MN\S
M\-\?"I:9%VPUT"ZAU4!'O$,T2/CX_)DX#T`5<VLR=HD9;X[P-CL*=+0C+1]^
M-C0.V%R1?\!]`V['%V>WV"S@\]G5YYOQ]6]POF.PF#9=HR:K+>4'AYE5U<#?
M9+7E53":1@%-3EN3T];DM.7V`1]L3IM:TZ,'>K=;?9OL@A#64(]8232DE3D;
MJT!CO!I">6>!ZZSVT5,YK8"HUU4W1TP?UA!+W!$X8UAQU]!Z.WT3#UO:`MM?
M6MYJ3ERB:^0'NHG0^Z-.GV:5R=70.PIW(FC7,!.A5)(<>Y9Y=&U.K)DUT;7Q
MS+4FIA)$V-%;ZJ:CM?7^4%TB[-8PS3)45)O!',U#)3VDFKA6K`&XT==[([7-
M'*.G=VH8CEV)G3/<*JN\J9-?-!&%HN]OX-\'_`?M.F_JY)N80A-3P)\V,85T
M):.)*92ERM8QK*PHB&]E8ED35T@MV1RTE9U*C#5*RCKPC%9FV]4=-<@FKO`B
MTMOZ:*!L17Q;[RL\F[*)*Y2%RKY>4)&K$KB>WAZJ&XOM9/:U*8\(0V6UB2LT
M#Y7TD&KB6K&X0C-8M%)+YW4,%MU<%U*PTJ=3I-+':*]-)DU6+=W(-9/P!W$?
M84-WSROX[L3QWNQ$T1!UJ2-%<V/M#54%]7E1$*V>=A8+YPDM+!Y\"Y;P*/S0
MHU65'GDD<&J@O[@,=YYF>IXSL6BEX)/ES^EC\7K>%:@]#,1$;:D3N/"36,EK
M:Y1BV*7N\-7&#(?#)F95GE__Y="2U&-CGP&`K0"]%3=Q%]EZL.YTSK&U>W-!
MN9")!=V_'+"YLP\WQN^F#0SW.8*LK4M]/)30WKL%O%:J648GIC?7G,!?F,]E
M=]NJ)(@QJ*6O7_E4'2PDDNXPDOXO=6BZW2_3T51%#E;3S>I-=;/ZKZ*B[88L
M3<M&#7\BL3A0ZEW)3C!=0IO`3'@KD7NBK4P@!7@:=2QS@A8!?3*T'E):1;&E
MT9#P:`<1[$VRT!;FDU=KIY#<UN.NOH.$W0^O.%L0VAKK%KO5.+;X9DJL7\;P
MQ12__+0P'W+:^3-SX9'__I#X>?36D\!U\4.:9?4O8KKPCE/LTI)O@:.CE@'_
M8TMDO2M:[=29!,OPD6LP:IWI)_C,R[G</]MLI<SW9"V%T&RS$/Y_VE+A>Y(+
M,2BV0Q_^_U%K<-3JQ!>+O2NY%!)ASA6,UM$_X^_&'T>O/+-]RW\^@<]=<W$.
MO_[Q#_*<\]W(WL&&[[;Z;(74=R66<I9+Q[[UX9;<SH%A>%>![_EPSREOD=;]
MR-3^L7<U^]8>B46UP+8X7/37/VE3,K&60.?_\]/YY2=`Z:#;ZO2ZAM&-`;5A
MU02$C(S#%D&WONGG)IQ_$2^V;NJ[UE?\9"V(>P)'_>"X>9%_`2*9:&-09!?8
MBQN8#7V+O'CLM>MK7@?W"VOR:>&8?B;:6UVV7$M"^]?;4QGG1R.@L7ZG)?Z1
MUY>66%_]!FQ/#WV"_J6YS$O+OU_]=GE[=<GZYFO\+WG!^%O7U_S#602V#\80
MQ4O>`[UTY!76WK&^Q)^@@?P#9+!]2TS/L<GTW/,"XNY&.QDOB]I!P>&[`9G>
MD'LX8^^&@*BRO;$]O7:=I8/BP\L^V388AFL7:OUD^W"9>D9;G&N^%<N!KI.\
M[FG0C3J=G:&C[<\^6X_$OG.N%Z#;^-9L]O'Y]V#M!M[-74+B!S9>N2\#UQW&
M,;=AO76H4/>`YP(";`-=KP#,]",0MP^_(M,[XKJ6[[@6R4?"W[X0=_(=_G]Y
MCSZH3)B'@-!A=(UW`$?:A^<1^!^(KZ7Y0+Q/CCM>+`AH1&*4T"?7#."@:-?0
M.^>$N/BR4S=XR'DML[?1`]3WY#WL#HJTGR<37=G\'8@.%UZ9+:Z&OP<V>K<W
MH]L8K*$[=94(BH^!!QCWO/'DK\!BP1141*]F]`.73+G,`07]&M1NGF8-[WJ)
MH`6EW#[#I\3[=FY/DO1R';A$WD$;%(#C3H^!OC-H6^^.RG#*"6O98'^[#:9"
M]^(>O?77`"B3N>F1:]>:O+2Y+F-'K6_`_A8F:AOIVTLAP+7KOA-TU6Y.\-IO
MO%'PM\O'?)RL5>K6&-T^T[Z8P$%BIF%>VCL!V]?ROL5^^_)>^JA>=>6M;()%
M@I@2YV?'F7JWSD(B1J`-%_0)<DK8OS?RVQ3];_V6=/"6M$=]#ES>98M"FG(/
M<L+::;5KAC6'%,N`M+MWK.:&U=@=JWP2RZ7CCT4CVCLGG#6T)7VF7*!.IR=?
MH(W+[0)5+EI,N]B]8:5P[:`]46RU:\96/K@,H[\#7)\L>"6Y`+U[>@W/P'=@
M$-RYYI0L3?<[R(-)L`RH[@?*+ICH_V&MK(O:3?WV2`9V-RBJVT5.^VIHU+F+
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MTNX(.[L__)=5TWATXW,N6Q32`C3=&M0,Z\XTW!KN':OUP"K8."-X\8I*B?8(
M80YU@6T!*`WX7>F8@M_9._B[D38%WM@[\+M2>UG@7X0C]4#+N:&#_,2P\IP!
M_ZD%/_IV2AZM"?&^P5N^G5KF@^UXOC7Q<@6=VNU8:D4V2%N#O2%$5@;@1GNP
M.^!YT"SNX;?KN>DNS0D)?`IT+JRVVNG`E053*1CL=<N!,IN'[8([P^A5#549
MV"L)=YF7>P?,];JMBC!7!"H1(=D&JHMU__NNV5F]409[NXAYVS>LG'E`&)"W
M_`!_E(]@,LBZ."0GUJ.U^'9-;'/A6T20[[<QINL_D&]_SIT%\<P%^4:S';Y%
M2[P,=^^GO_=[]8)]8WDKXD[S4!=`UVD/C*W@NR6^SY+OKUWR>S!]8+*;CSXM
M@^8,PT@_Z8U+1[!>V02+P7GN!\@R@E&/C\^\A**$T&\OGC3SPH(29/Z<N%(D
M!F`W[0?K?D$P^\ZO+,HZ',;AW0V,"O>1,^+>Z@YKW4<94<+!J+L-S+%`7"'X
M<I)RKV\4@^_2L;D_$J<$HPY?A\_D2')1[0I&R1LIXE)1:R>[.USZ2NVC@#O&
MZ)2UD^@9UNKW?/U=N27^BS>BW>&NN5QK5@'BBPINAL.VO6^X199[+H@1U>WA
MOD'>V@I+WTFWW:EI)P7\1<:H+@HI8+QEB"F1&K]/T$NBE4Z[M?^];'M5C<&H
M.J#/1/==+A&\<O)-,YA.=QM2R@E:#1LN<O&'VQQ>"5O&'GC>>A.\DD*JF2(C
M==%JH/S&D?`M^BWPA<^N$ZR\;V`WG&`I&U:IL<^^@7&;4XH;[4P>K?#^[IZ<
MO/OK*'%^K"U]7IA;F0R[3IB_?KO-+2Y;=5)1`0MAF*DVU0KG:[G/&W:8EWHD
M0WK?(&]W28=]-:"NCG5V2S\7#NO53)0LUB2C$^M6!NMVBJZ40J("[-0M;YNL
MD6U>*C%>N@<U;J`,BPGIZ24>6N.62I7"-<*]FT]II-!M2-W!-G*M]Y(:I]S-
M.%AJ6^.ZV^S#,!3:1\YCVH51MT:91OG^SVNW#;VDG^R=6>PD4/OU;ZM*BZI.
M:$NU.FH%?"=*Z=5_HTMQ\=+F,Z**5`W@2](<!_7+DG)C'WD\"/NDJMTN2OL`
M:6VWG7:4VFD!M:PUS`R;*'.5=CJB=KM^@WGKC6TA1U_T$JEXMVK7$["M,OKA
M[FGN[)W#PE^LI/YVM;#\O/9!:KO#5`&;](J]"$2%D)_`VYR)XWZ[<OVY\^VC
MY?AD,M^B65TW(99VW$YZP\>%96/WM/GV/2A?;".8<`-L!<,VFRBWB6;J;@:Y
M=[.AA28[(PS^[IC<EKNW0'@)<JQ8`+X"W0_:O5H@W-6Y;H16=MT8S`UA?[`+
MA#?$7%C_(=//0*97]M4*><BEXY\2SWJP:?JQ]QN9/FR-Q;3D^'AE5-Z595@G
M"]/SK!GF]L(V0;)YV+7?="=SD'`@[,C"6=$&Z([(F@ZS?TMI4#8:&/$M%`!(
MWE?:3W@>2)@7(KI8ABMA&[Z*&8<AS--*0*P3`[NS)D/$I@X>!SLS/Z/U2C!0
M@+V*K.KJ<1#U>J7UK+0(!'^^7L^0U\>\<T_:5IS7Y08LYVX>41?..0QA]VT,
M![EWP0'*`%_DY553?F`,4P#,6K((A$5ZD_1V@I$:B%PYIDUC+TF%<HM.".'*
MVG8KEP+Q3G)FSS#O0+3*8;DNF,D"S-.'S\0FKKD`!C*>+BV;3B3QK<=:RL?0
ME.;,HB@T%>VK0.-NH6DHNK.=VWP+[4'1?15I"MXM?V=AK;0H2Z9"^A.Z%4\M
M[\%Q'^C7M$%<2O7V;N;I(%:@NPL0TA;H`*H_Y]9D?N($B^E']`KQN0/3KP"5
M>X>;#EPV38*UM-N6-R2G8V%5O-$9]N5][`))F1O)Q0RRMC(:J+25''25M9'.
M2*6-Y+KN65LQ2CR3/PAH]1-__&!:MN>7U.6@AT.M!C*4J<M$4/Q)<*HKF?*N
M&7+!_36=TH=#.&@U[4XFV$]_OVX/_L4@V7VI+<%-ZY2=%UIC*VC35F+`BH&;
MX\D$TZ\]X*3H_N(#\XJV)^CUH_Y5FU<J!DW.9@3]X:@(-*SU!CX&FFA)&!H-
M!MTLF-+6*P.RO*[@430[;2?0<`J<U#NV+)J*E(`7URH,4CY4#5L%0;JPS'MK
M86&?G9*PU#6B)C(O+E88IIQ#`[JMWNXPB5XKIQB[FUB4P\%_+PCO*A?C?%@>
MX_K/UP`C:G_8E9CZ`(NBU>@-!VD<K13@ZMYR3CXPZ$8]7&K;,I6OJ`6X9`Y&
M"5@G41GN^-&T%LA[0+*AD^"63`*7TLYX^N^`M7L$MG0U@WM7N+E1&G<N&\@]
M8B%G:Z1V&C-1`@TG["'XC"6[>.<VO`\#EF%C<].;?UHX3S12Z9W-9F12&GFD
M<]GJX58*53G'&+73A*2BJ#HE,TP)"3MZP]>4J='?7#N>[P*;<YGO`3#AE<9N
M^L/^CEC:%61%\).3B'J]7:FH5OP`MP.[S&:ZS.09K"[;6[#^MZ6+J*-1/\VL
M*1O,/>(AIQ9N[$H:E:.AM*/N]#J;=+$\,%2T@7QG=&08HS2CLL`&%L#W$0PX
MQ%,GN/=GP2)II99D576B%KX[K5\)Z'E5N$&9H-N^-;46`0KE2*5CJ15DRL;)
M+%>!3R_1U>S,=&W+?L!L-^J-9!/-2W"FXZC!Y*TO`[BJ][NKS_UP=[R;:QX]
M/DF.<0C[W=6#CSM.,OD*=IQTC^]D`;5'*>XOR1^>=[V\\V?;AI$TRC/7*\N?
M-NBTD@Q47F&GQ7,ZKMO]%*_3AL4SC>Z2L#'LM)+PO+1H:3#F))3N((4NMP,R
M8U[]^KAZ-@O>FA8">0@@BW;X,LA;PK#3!JYY.)!VH"^ZB[:Q^RYB@+RXE=C3
MO!$?*NU1&O?&8&!L;UW6/+[U#32@A8FDD%[QD[+A0:[M;@]LK?L7S?._G;C!
MA"P6WRX?#W+SF"GV9"T6*0*YE/WVBNPW#MRN6TPT37=\"9'E;SET<NZTY\W0
MIN/@[(?E(WO8HGQWYPSJA"Z1`"(.(S+:EUGDMS//AV5\@IW-/IF6^^T/<Q$0
M^3]/+6^R<+S`36GDENH_'27</`C+3M"=F*[[C#BZ(2LX"\`E(\E:X!O;4_P7
M!H$>009C8H(O`*)+;]H`54]:+QQJ;V@D*#;7RJ4"FV+0I4_*,A+*5/W`YM3V
M1YU>(H9;/[!Y-<!1,KFB-&!9=DW1Y.%4)U]KE#`UMH&A(NAS>OBZG6'">BT&
M_?I9V=/;.3"M.^(NI1'#>^)ZHWXR2R8_T!5NMGP!5.I6G>72L6G"X:GU:$V)
M/0V=%:GF5+Z[='9]FRPG.,9)G-LL7!#47*Z]#&!;Q[UNK<#FN^7I>#6,/>,U
M/["`UT%)P%Z;[I5[ZV.X@MXC\<-M96L&K;92P<Q:M$0HMSGYLJ!D[L]QX`/#
MP$+SK7"8])U2Z+HIV2H;EBP!MEQ^W0I@._>\H!R<=0QC-.QV-L/%EBL(4WY<
ME0%3*4IOQ]AX:&D:8VX(<@;O=H%@/88JXJ?P%RN`OD8KW+''/NM,@^;XG7/I
MV`BLZ]!2H5RU.SG46G2<I'@%2X:R/A3D%?$)5TK_%2%A!P,!4#!\32C8J4D)
M(*%3/Q+0V4[+:&^=Q2ZJ=:)RP4BF8JVMDA^$G>X3AN7ZG10\[@C$;@;O:-0K
M#X1=F][TC$'2--L$Q"FY]\]M]);*4VYO0',[I<Y39IL7+:SMLKY[6`N]W<+K
MP,Z(ZTK5%+Q2E>?RE4#,_5;"4?3"HN5!F-.OTBL)1'@LG+5:4CBXW4ZFR6]8
MK@2X<F:+=EJ);-I"<"&G+:F*J37*!5JT8CG0Y:V4ZR5<TCM")U7VE(<]H]M-
M>$A?6K,L"'/ZGH?#A'3<&D(Y7QD@D"MJ@+%CH2SF1;[0.U$PP&\TM_);/-/Y
M&W_]-YKR_(VO&7Z:QRUXU$X$!+8`O>(]\S3O(MLSC#12JW=_V>I1&3OL)>)V
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MHP)`IM@>+R]=,K`Y\]][G92TM>V!=:U'VOE=]([*7T'P[<1U/.^;:.K\35C4
MW[#6Z-L)%LR9$T$>W]HOX3ZYF2S0BF\A:EBRQ19>X#_%X8^JMCS1>_^&3)P'
M&RO5S^VP8K&,%CAIQ3';PE'+/K[QWN'?SGY,Z'""!&4QMAL>'7O]-UZI]0W6
MV3D13$V$;'7MBJ+%.!BTO$@G*%>P5P\=>[M[-OB![EZ,;`\I()\G]=7L?XM3
M;Z=X<O:ZZUV+MX]Z&Z2J8CNIBH)3?)`'BX$=.-A`-3F_8?]O6[`5(8QM1)IB
MV]ZQ6-](SJ)1=".U*;`IGBDU$5+K/3]Z182RDP0T#N7&5R+_C+0&%0>Z_:VV
MK=BN=^V[<Y0<"*7L3JJZP*HQL"(8V.$*I[F.5=U_S:)--=Y6A#+*T8(VN&$K
MQDC69#TV+!7^Y*WE2G+@&L.46$7YH"J"C+K()RTAY`TC=0=NW2Z@<+U&%.XD
M\I/#R-XT#K<@O^'NRL(!8JY>=:.[NR6I+FYW]JVG=&=]U>BHF=B2DS!>-W:K
M$20%;*?7B<6=7$@-*>XLC]/:G+YIW)5CIW3>@O&7,Q'N-=[.O0>3TEJ6OF&L
M;B\V1@U9%M9>CEZCAJU(6+1`7.4`<5NB2I-6UW[PB-LU//<:F=S^@QA';XO$
MJDK]>XW20YG88^<U1DKJC6PK8[F<V[^1Z0/AK0['/HZP+6>P7R??'<P$H%K@
M7SS4%W:7,SU^7[LKK[@I;4+'_C>:3T7IIC5F4`=X>5[TN;T*?._;!7DDBW8^
M_Z[JFWN):[Y0%MA-J^I5:7_IA]?)=7BJ;JK,NLY\(DZQXS-"F5X:!STP#+3+
MQ\!!4D*(AV*:PH&SL8*[/[!=&V]RUYW#Y'G2G+\2[1:CE39<<&LP:MA'B<?5
MRQGGWO^>BUW,WC!?AN+>]IDS[ME*ZW:KXC[JT9*5VY[Q2K97ICG039NQK.2N
M"YGEAW0W"UKH_;2>P6KNM%(5__7@H3R-XN!O^QX=`<KAHF9C4+G]UVP6*K?_
M/1J(V^%BRW'SE;2SVVA+Y9I-O^-N*NALMY&+;[672^+3`SVWB8A3VL0+`YRE
ME$5V-@1$7EB_2K"+IH[</:_(-WCYMH6PKQ(/-$R_19GTIC98!X^+)R<_)C8%
MK`\=$9^<P,W?_6F#LEX#(G8O.DOK/ZT$X,T9[O->[Y?95XV*+=G]ICK5P\?&
M`2L!>1W;*L)</W\[VF!"'#HBMKO2^Y5YE2)BA]O\&M&PB[13AKWGS$-4%.H]
MW&?5%+=7P>.]B6NMV!S[&S)9F)YGS:R)R3XY,;WYIX7S1%^XG:S^^R4\HAEM
M;4F_EB'=?LDXT&>F:UOV@W=-W-NYZ9*/IF=-=O`"G5W?RHAM`ZL\'HXB2%/7
MV1:4O#9;$ACCN-TK&9A\FE4:7MK#RO&2%QCCN&44`N;46@0^F99%,1L.B:^T
M/3B%J*93`4`%**<>_&Q!/:UM`1)\E/'M._,'>L.1QUMV`+^^6A&7<J^M7='7
M@4MD^#H__;UUW.[*`.9>NQ*84[":#K/1+@OFJYD0H_BK*QL%PMB>XK_._@I`
MR"TPQE.*T[^?$*/;@%`1\#FMW61[UP*P+U<+YYF0&[*`WTREX,Q)WC#82]-Y
MNTE4O[1H:3#FK$DVD@&K;6$$!/O/7X@_=Z;G]B.H>C0>&88>3RUOLG`\N$"%
M,TV-Y+SC_*N7#W5.HNT,$EX:%:`N+=-0Y<WDRRL\M"/*EUA7PF8^6?!^<@%2
M#7[F`W^U[A=\1)L\)X_;="5P^&XR%V`[&'+#_RGP8;O5[&*8;!BR"R1K>V'V
MMLA22$T"N71\L#3A*63<8P_-25`]I`?HBF4F_R?"!Y6`J00F"B8SO054Y;L>
MO5&BPNOUHN+;[9/E>=\^N?#5MROJ`<I7>=%_0_126EG`:T91P>3S9(N7UXRL
M(HK3V^)/M:7POF(<9O+X@H38R(`J<NG?'@Y+JMLY7!$BG%C/M?8\JN;VINUE
M[R@K3TVI1O8JCK2#DL$'B<NR6&!#GJI+YI=Q*3(LKNQ2%BPC+)?4]$H&LCX,
M[)RPGZRX.%@<[.@W?C7[WWF$:8*]5HL"QYD^68M%83=XKSU*Q%'%RW==$KFH
M!U"[.:?Q)>?7%(;@"YE:$W/Q[90\6A/B?1O;TV^GEOE@.YYO3?)U;NV-VHFH
M;6'`KN>FNS0G)/`I?/DZR)8'1\[(;[_=3:1C%UUR2ZKH]DNCBA""79`_-$I'
M?DG4N2V"QI._`LLET]/`!=9R#5S(V25K+`%(LOWOIA5+AFV7,RT%8M:<F6J-
M94C0KI'4(5)6*@F64B@PZ26H$N*MN$<G61-5)6R[T&`B72`'@%CM?^TZ,ZN,
MX<)M8]A*,OEHB7QK[ZHS&RVN,!5:?;>[UFX/4^BC^,[SY@)V4^1YUNHL*1/U
MR$^NLTS+ROQ(9J!?ALF;Q/MBV8X+5J0H8("['7]+1E)-"305M<22]E;C%M3`
MW:YWHMM.DN6;0]YN5WHPZB08ZIM#W:X<J1,2GC+(@Q?R7+*/Q"8E";Q>DN]F
MK+8]2+O>^4$R@;,TF';,5>\/,[A0)6C*!U1*X[V\,+G$],@I8?\^M\>3B1,`
MU5V;SR9F,MI3^,0-8NGBI90K#))Y<[M!4_F.<GJXNDD_3;4;NB$38CWB:THX
MD%XO[?*_N'+)L.8TJ0=IU%X85N2YM@\\NA0*3S;/WKAB6<#EY!>IFM3NT%&C
MC,L^^X&E/Y>`PT&RB"7?VJ7#FP^MHSQH+0YON:RXG2R^V@*`:B#/:RJ.<LB0
M;4!'A<M<G#C+I6/3$DIO[/NN=1_XR$#N'%#T'HGKT=KN4W+OWY))X.YT$.SM
ML1WU0-7LIVUG=ZBJVV(NA>[0-YF#+`]]B[DT3F4W*8KDR104*GQX[+KH&=S)
M89.^2V/`.R=NN<^-H%6ZU0)7$S;;.ZS-[GQ%P8X;'M96"UQ5V.RH\LU.P;[,
M+(8[^S%9!%,0P&6%Y@?#48IK8#L8JMI!SJP0(]F]L=0=W+GFE"Q-][M7%-F]
M4;)];.9BA6'*:<.TTAPQ.6&*H_62^*73I]$?I!WORPN7"6I./7K8&:38`#N`
M2AV;>>IM<YHFK13]/K9(?@AVC\2EL)D=8=@Q'I=V]TK#0DX2:6][$LQW\(SU
MT=Z<3)%D"K.A]K";XJ5*6ZD8-#GC`BF-B+>"9GWR]BZ,.?7F1N_?9>6\+F<C
M>_?9*]^83U],(!P+7C2VI[?!:K58MTEV&E8WR(8F8\VR(,S;+F18%H1_.N[W
M<_O:=2;$*XXY$3I(@RNV4C%H\HJB9(UF7FA8O(S%/01S*L4)F090VF([@+1S
M+#R5EDH":C<QE<QWJA1/>>EI-Z"R')4[7+!NOY,4GIENR%P+Y\R9&XV&B<!U
MGH61`_G.Y/O<64R)Z[&X='$.#5A(G,9+JY8%8UZ'<MLP$LK6SC"6U6^LTQIL
M.L?4[ET5M!1KC88)[>ME,'SK@29$W!+?7U#'07F:<5+F;UAO#3#'?K@C[A)=
MD-M,2'HA`&3T$C9?^DK%H,FK<J3D*E0)SK<3TW6?P4#\=D-6CNO#28Z7&(65
M*\VBGE0Y>WC5O8DSSX?U??(-/I7@+K"%;F^8,")5V\*W2\<GWK=3^([E=;,F
MSKGVE]+/X`"V9\U\0O(U[>G6>WP)6&\)JL`1M%5<M)345/4/\6YNN?E/<5@O
MF>YT2"F';_W(=X`U4VE)V_MD/>9DHTG3\``(](DL<NYOD*+.*+\_RIER%IT<
MX/;.%KGW!\9#O0PTC=9L_UGLI70U9I2LAU'_`',SSV2.]UX.[\HF%<KX;C)/
M6/TCQ+DX^8ZP7OE0DOR+3ORE&&R]VDO:59)5T-+Y2Z]F_E+2^6VE@O:27M)#
MV.,68G`T2CJ)#F"'"EN#9=%I7A*MV0XLZP"=(/\U'(Z2GN@]2_O2V6FW7E=D
M.;(^KS#L)^L9#X%(V8BX7-9$ZW"O84ZG:+*9OOKTF=M9T3Y$37LK'FJTDJU?
MU-_BF?4PS]>^;E@S_WS9Z5N!QGV0/":_STE4-!\4B5Y:.85@9W"`%S"W&EJS
MN_`%;UH%SIBZE="R;,'<''1PF*9@;G]3S=PS_22JE`^#FMEG:0>8/^92\QF6
M)B"V4--:>]9C.".-KE7YA-I.U@*I?XQ;&(-&_R!=3EL1ZFC?_NUU=EJ!R*^;
MH>:XBQ7LLKUO[]I:I.(5),N4>"%S'F$R#3;'_KZ8/ZQEL+P@]H,_OYK=64N"
MK9JQD'&MRS..\/VT<)[HU_E20?]N##7V3034C@NN0>W8Y/F+Z7XG_J?`GGIC
M7Z`[;R/]*O(>4YHPO@!HV;LJ/Q&RZ)XNB8_G>.TZCQ80Q\?GKQX]:LL&\+&;
M"D[J+JU'56\X3$24\T-0">0Y>U$9*>VA2X:<U5&4CO-N+^G4R`]!)9#GQ/FH
MG2RD*AGRJ&M0F3@?I"1.Y`>@$L#S=K%*=BS<&7"0:/"[*_?:='W^!^UV[5E8
M30"OA0^7P*M\TWWF4XIY,VRY/L3#)LQ3HXS^8<G.A^7"N+?]YRTWZ2;L@3TB
M@`JCJUG\I66<\RA9X[X3*%7O)F_OZ&Y"]Z]M.]5<Q&0W_)VAJ6-3.4N#DL9V
M:;O"I\T%4X"O9IG377+4-Q890#6BA7-),RT_?)OW)>I&;T!!WFY3)]C,_)M8
M\)MXT3=\TW8;S+._##CCFPO%8]21N)1VY\-.0D"G+%4.+.6,#>DE^RE4!_')
M-D,;C&ZR#TAUH.TPLZ&3,C"A,("[%\A7<)#9P)1"?,8PV=BV2IAWFO>3['E2
M)8A;W9!^L@RQ]`N2L[57.VE_5P9*.=-JVLE^W-5!O!WC,Y*U&=6!M@OC&R5S
M%2JX%#G;<*2,;ZH0F.V.LI>TZ:J$K12FW$XZI*J$>1>F/$@VK7@91&R+S%N[
ME=;_H#/J)J]JVD*%8,D[,FR4O)4Y84$7$C;W>#07!`>9[]]UWDLF6^:`M(JM
M51%-*VUSSG+EDCFQ/3H^%"E__&A:"^QF"H;>+;PGZC<\GOX[8)V`+@D82G?F
M#Q8E6V\A7H9;9)14["J#-Q]>3K%1)IGRL2#7<-)U(L1H)X54^8#FQ41H%?\S
M,!?6[)GVY:>!0D\M3.P,:#Y,K/E"[ES`M3E!?P)(3OK7@O;6$;-[V8RC&S)9
MF)YGS4!@B6?-'V6@9I",O]4!>CYDX5NJ9QR=9,'@[@#EVU@"*>%MXRSI:A8Q
M)?C)(IABB`669K\7,)1!`?EW7Q;417%T94O7M%KL'*4TD*X.X'R(^6H#I2VL
M_Y!I-.!;>O_8M3Q@6O+\V#+))5WY+!7,;='PF[.@+9/#922!7BDRNBF^UXJ@
M3<')I^PFYG289^'V[_U!TN;)LW"IL.;T!O63,;Y=87VA07SA+HVC3KK(?6'=
M,B'-&Q_NI#._[2&58EKEF<+]7C\=DZFK%8<J9\?$=C+78RNHX$LG[EHHK]V[
MD3+8;?.B.P.X:UCA*-E0MB((=U4),IP>=:`P)XCM9$'"UB#>$,]W@XE/A=&)
MX^4>E?+MQ'&GEO<M]H*<3HIT[2()2AQ>/CG%`S64MJXF4SKME?.J*I+HVHG,
MH2UAJ&X#VXTG+'\#-V05N),YV$)7,S[V!OOYEI%%E^Q2^O*ZI<*9=T9A0A?9
M%<ZKV17<)=MTGT\MS+:SIZ50[S!I]&U8L1S0<L966LF^ZUN#=N?P)*>/`>C3
M!)029K6?B'P;ETRKR1_<!H**8-\]]Z]$X//.5L^'Z'X_6>:Z:<F2@,L]K3J9
M<E\`.F"^(*+]9W3#X@1S],ZOENN*Z8X4F^SOF7_]2N#.B>-6,C%G9\#1+*=^
M2"K:KD&=<(EOL4EM*9[P:DR75M+O6@I@M>XUMZJ15#8JVRO-[L/Q>O#?.?,1
M1`HD?\,WNN(W#L4W#D:^,'%"[4Z#JBRXOZ(%/OUVZYM8@Q:''H[GZ[?;;V>V
M;_G/N^TEF:V28S,N69G6E%L5XGB96Z"L60WM9!/?',N6"&=.349H@<7@C#3Q
M<\\+$(BKF5PG6(8;LYL<`O[RPMF`8BC@BXG6FO\,>SQQ%@M"XT0>YLJ6J1B(
M/)PLR'-"4NU6<HNXY"B9TO=R-8-/I@%:<6E.PEV3D).<XL5U2X4S)XI33(LB
M<,X=U\]U#7.6J22[864N5P94>9/=AJ6`A3;NU8K2Z]D/XDXLKQ0;K/,"=&G+
ME@EE3I^PD=3VMH82!'=)50.#43+A+EH@U\*[>G<[W12[<[NE=W5X]=+8:[$]
MY[2U!TFG^X:ETXV84\M;.1Z\,V_Z[XX^V'8_C31>@"GG'DH)2W9:W78:.C<L
M60YX>=6^E*AP*>"5,,O4Z/9Z:3(P<\$R0,LKG$?)</-6H#U::)R`,7?J!/?^
M+%B,)Q/,FBR#8R9;C6Y:L"30<@9[DN4B^6&[`7M$.%=S6Q4YM<($N\U:K`20
M\J$J<2^WAZALI:_32W;RR5RO#+!R2DLCV9TF-U@>,=W)'*[K*7DD"V<E30@,
MYYL+/W(X;!;#>F7@L]U*.>6=(:IF:SL/2N\G2[^5V]R.9D8_Z417;FN[C\A-
MFO9E;BY2\>!M-V1A^F2*#^+;)O#?EP'J?6#;.JS0W#M;6$O+QL?B^Z.MRZ[L
MC+A^7)E$F?SM:@8;&R45RW`E&17GEY]8?[88%@H`GQL1&]YQ#GH*M;SNG%/X
M.T=U1BEHZ`URHB$_Z!NP<3(WW8=2\@9ZR0%_:2N5!$LIY67]I/55`LB[\H)J
M$%A%-D[=>%/DL)$QNX\;&($PM;Z=+5<+YYD0VBW=Q0?RU;)VTS24!`!%0(R*
MY'8#L=U/TS-V`)&-B)[^:?ESS![(=^EW!'J0\+'E@&A]"[Z)@;(ST[7A)QX8
M3<$RH+P80V@3J[`%/ABDS*!\>=GRP,R93]T:)G-_MP43'>K>#4X2",AGQYEZ
MZVZ"'57\UBC9JS=MK9*@^786H!LB9S_V3L)NJA(TVGK&-ED_FIR3I%/2EJH$
M\98\H&;[[3-Q'EQS-:<L_K/K!"L:I3Y!KX1K`;NGG^4>3]3N]Q)LM,IM8#0]
M'WY;R;AOE8!MU1U@T#42W*=*X'8IM3>,9*MQA0@T_ZS,I-%7Y3;*Z<30Z26D
M:.WTL0-7ZPZ3$:T:+]TN$'?J91/IF,[+U?J=9&K3_HEY![3W^\G2"`4VDO<<
M>H->K;QQG<[SPMEI)?OUE`#GSH[3G@B2U`5/.<:L43?4VU^HP7!4A9C;`.,6
MZGAGF!QB62UP%6F[1LH@LFHWDO>F#[K)9EC50K:#3ME+"7M7"^166GFGWZU"
MZRJ/3//JO.W^L&8R+:;6=`PQ!'9/=)'?K.SV:Z;@DC67]C"96+0/TMA>PK6[
MR;Q1)5"__58Z*=E=]=+[#N@WAG6XU/)F=PDO<SW0E&/5`_G6X?79K6'EH%N+
MZ1Y5S>1WY-7B88S"'OGUVN$@F0)9)6B[N/':[4H,@TP8=W"%#P;)KHA5@EB1
MUM5O5:+%E+6-W![]T2`1&M\_:]W%)&XGNRLHL)'\/J9N'3ZFS<QE![3W^O6B
MO00?\*"62$<FQ+EU]WZM*EA17W6_)J]9WOX`O635?:7P["*N^^UD&GFU0.9W
M,-7D'*E:OAF]FNS(733*;NW`;><A&R2;;BE%!'EUM4XK.;:BVHUL+Y9&1G*&
M<K4PEA(LZ562UY*?@G=R+27[FNQ!-.P"^2A9(%(OMG/;\2G]G56@YEW<=X-D
M)Y5]D$MN]WI;4=1OX;3>90-DL<`.O\0FKKD`$,;3I65;GN_2UL?E=?,<]9*E
MIOD6+PSPSD/#!LDN!S6!O&M?CG:*7-D7DG/6&+13_%J[@`RWGWPT/:Q$6>+W
ME%F5DL*;A"]UK<+PY'3KI_"I7/#P*LB/CNLZ3Y@373@_O)]L%9&R3`$X\I;*
M)DN>JX&C@D$^]<%>Q:2>G:#'#B)S9S$EKH=%\OXS&S.`?>3AI]AJS6<]NW#N
MS9V#3=1@<ZY#F8(88%J4>'N@@R<O4BF@U;O=O"U%C)3TH@JV>V?A9)H55@"J
M,"C+:"4=6AM`+',O%=RW8KO!H2^!^TQ/G8J,[20`^TFB.K0S-`:4"T@@)5<J
M`$H*@6>!,ABUJ4-U5U!>.-J<3?]:@V'"`91<9G<P\G;-[2=O_$M@?+W][#R"
MI8?N)&G6APJT#_99,I\X%[S5;+%T5E76!O\DUL,<4#[&@L0'(HJR3ZU%`)^R
M.W`5^)YOVLCIMU61DW?OJ(=]HT2A6P3[EH"4MXM<!E_V/M;/8&_[R&$@9.UB
M,%3X-+;8QY"GE5>[C\2OP)BR)F7=C!ZO4WIQ#^E@E+6#0K>BU^^KL(<"-Z(S
M4F('A6Y#E_LB"NWA_W=T],EQ?-OQB7;+VK(>'<%7__WAQ[V[@/_X_P-02P,$
M%`````@`*(()/]3D@%)?%@``S#0!`!0`'`!J;FHM,C`Q,3`W,#-?8V%L+GAM
M;%54"0`#RY5!3LN504YU>`L``00E#@``!#D!``#M75ESW#B2?M^(_0]<S8OG
M099*\B6'O1,Z/8Z0NK22O#UO'12)JD*;15:#I*2:7S\)\"@>``GP*((EAQ]L
M2\CDEP<2B<3UY1\O2\=X0L3'GOMU;_+V<,]`KN79V)U_W0O]?=.W,-[[Q__^
M]W]]^9_]_7^=W5T;MF>%2^0&AD60&2#;>,;!PCCSGEUD/)CS.2(&:W?IFH\.
M_.=Q'?_RWIL%SR9!R?>,R>%;^N?]A_W]^`-GI@\,X5>,P]';2?J;&\`TP^R7
MGXU/!R<'1X>3B3$Y^GSX_O/Q!^/V)FKI8/?G(S`Q0"[7__SBXZ][BR!8?3XX
M>'Y^?OM\_-8C<Z`]G!S\Z^;ZWEJ@I;F/73\P70OM&=#^L\]^>.U99L"4DB%_
M>21.PN#X(/V6L`7]WW[2;)_^:']RM'\\>?OBVWL11`G^>XDP]`<\<28G)R<'
M[+=[H`/#^$(\!]VAF4'__G'W/:7YT_WSK>4M#^C/#RYB.YZZ]J4;X&#]W9UY
M9,FDAD]2=I^#]0I]W?/Q<N6@Y&<+@F9?]X#5/C7!X<?#8RK.WZK9'2@`^^X^
M`1^/8.0_4!?R&Z#A\&@(X0(%)G9:8DB9J($`KYQC0'_J^RCP0;/?/,]^QH[3
M0B^U/#N"V$9O]4Q50-Z'RZ5)UM/9/9Z[$$0L$[S4LKP0W-2=WWH.ML!$R=\-
M`*M^0`7\'?(#$EI!2(!58[-SN32&T=RT?#9*QD1S&F7\Z>PL]+&+?.8>R)L3
M<[7`UBF,2<VCA@KSKD$W5ZH2=Q78ER9QP4[^+2+W"QBX&^M5Q*@-F.;Z$G)2
M@0/].UR&#DV`IL$"D7-ON2)H@5P?/Z'OD$(MFZM+@7?'D)LK586Y"NC$I8'?
M(W99-D'=^P*X^I!EA*3-"*W"7`7T-9J;SBWQ+(3L5O%2Q$A)@Z9#D]O[!8*Q
MM(F2\O2-/WT+7<T%UPA@?'3:XB@P4PK&`3AI'#"34-`DZG+9-`5R;OJ+*\=[
M;HLDPZ?[%*FWU*AQ<MXN*^\LU^TVR56#=65B\O^F$Z(;&.8A8C%':`!(P$=-
M0]'0]-+0,!GJCL>U?@:T=@E,!YE+]UEH3^EGYV-^/X-]JU&^@_&]S:2L[6RL
M@ZC3..&MY-8:5O/TJYI=`5B#L?'11W^%P//R*0JV-6-TL7E;`+<TF$6]@(6X
M,^2B&0YN(<^J`U--VB>PQ"T:PQ/X5:<@4Q]IC+([+Y.O#DSJ/%")U1:!/Z"7
M(#1K]=V(XQ;<1!*^$J>VL*M"GR1>.19M@6;21C5X583=@$HG9I"O6?"7.4</
MWKU9'[[JR?LT[U$+NQYMM=_7(55CU=[H=>L6TIXISZA/1Z@;#VIHVT(3U&DE
ME5A+W18>;RU#$ELU:5M@\J582;A-&,9"6*9C44H8MZX!<DX8:(M<&]F)./1;
M+9:J<4#)#P^-?2-IG_VGZ=I&1&SP5J:[`2I>NH[1O3\\HJ"P;SD>[3+PGPR-
M\2:B^GM_L(J3H1C7AQI<,=G?HPT&`,SQK!P8A^Z7\$C>-6,L;%O#S/0?V6Z%
MT-^?F^:*;>`X0$[@)S]A7KQ_.(DW2/PM_O$?"9#U;RA(^#OF(W+85PN_/A@2
MX!5VL;]`+%K[55`+#5/0&7.?DCQ^DU@)1_AGSM;EK2-QBP.?EE\IMWT,J41"
M/R/>DJ>[^'->-=C0AR][*\J5EMX]8B/R=>_#X9[QC/!\$7S=FPQLAM\]\O.[
MR\HJ?J49"@WU-D,!+-\,[S0RPYWY?`-C!L$P($#DO@]7*R=3L^<91$BBMVF$
ML/E&.N(9Z<M!(=9W.P#(;B5*QZGC\GB0\#`B)FQ(3=CT-W1)[S!*AS)EZ,..
M;GD!P<\N7RPGI/7@XOI2KLO(D`W3_VTT@R$C0->0'MI%H'+"J;(8,#[(FV\3
M-U3%RP2.0DC)Q)$5P9"M!>L!(W].K@=BVFAIDI_\D"]L.Z`MFWFNP*Y9F:0,
M.(3-V(2N1G".^>3(1FM).?$R.5=71BU-YN$'?UQM0-Q"FN&R47#C7>5ID2S1
M:**FK$"Q1=[W%":;6"=3/#E=>B3`_\Z5+>0M)F0TB!75_%+2AD(1Z\/G_O8M
M^XUXI>FE/-GN6"T62"H:=FTB%JBOQ$&:'QNEJ$85'*4DBBWT\6U?\;'#E*1"
M%EZ_2P?M>KK!.IZ"K^;RD'J1^IX>-.IZ\@-?8TYC,64K(>OCJF#LZ[6BU/!0
M55RC>7<X*=9H8H:&-S,R+(T-3R-A9KQ)_M5UL:GJL%52&)N4%DIR5'W5P2H/
M8"65KUIL::&K6W`-#F6E=<:3DB/$S*@G).RB>EW*T&`<^U)UD]-::>VQC3CY
M,F2OW;?F:%=JG4]%<1)"`R@-1MJ7&>H.?*4JE\(X9(GW=Q:G(:X_(6+.T6_A
M\A&1Z>P".R'\E`'TIV%`#Z';F9V\F=1&F<,PY3\KV@-B.N?><NFY$:[3("#X
M,0RHDSQXYYX;'_\'^.@QN$<6Q*9`M"[4DN-@.7Q#DV\JB2T%+V0*N>P@3B@^
MZ;!4*"$F^QF[&.+67+-=((1`YI0_Z*+J-#5,=]IO:F27<!T-5ID%BBII".3$
MEGQ$%=&/U2$4Q92P/7?QNM5$,@+S.R1"BW,O=.PS=(=6(;$6U$5_0+)`'@C;
M8+B^#SSKYPT*%IY=,&D+/F,T;0MQ,_MU-)I.JA^G3U/4C\7T+\/+8,R,'#<C
M8M=7VMK@E'V:R3869<CL5D+@:\^G)9'I[,%\X<1B90Y###B2(,^C1O"S\P4=
M5/WO+N#^9F*7_O8*.G]R1/N?R(9?7\YFR`K:*Z?M=P>+@@W=)QG@MJ0>B8%Q
M,GQ2)*F,"[JLC>SD_%!TK"@Y573K^0%!`8[R2':XJ+UW-O_BCOME<\4HIFK[
M>KODZ1.,7W0\OO((/>*TF<N>VG^&?D`5T-X-U;ZRXZZGI@P)=SL>30`$B0&G
M>QX2@EQK_0#37S^V;X?>IO:5'?<V-66,HP8AHZY;!-AM5I>!>=D%BOX6K5XW
M9*:3\#Q#FU80#6L9LR>YUQF:`<4=LAS3]]FJ7]*6V_>V\]G!.F-[E\IM'>A=
M49G<5_<=)1Q=J`R!K3MR%Q_;8;_L0CWCV"8O+@OEY@(TW>_!#5M]98?]KY5>
M,AGP*!V/X"=6'/'_+S0=/%MC=W[J1Y60#AVOQ5=VVO%:Z*7O3;?].MX/%\1P
M\+^1G60;4S>CCE."?;K;B6U>BC10,2OKXR/:N5T'7;7.']OH:]SI8"G)3>-_
M3@/0V`EMNH,3!(\H&[AE%Q][C>[9A=YZ/TZRK;#Y3\]AIP+2CIK)FCL.GDT_
MI9V/=C?IDX^D3967Q-/*`QLZN::X=\;:GLXVHO<=2%4_^8I=M3LERAU7V,*6
MD@8O!Z3[Z`^+&S'2G=M9;FP;=Y9?;QOL:QX42'&73E4P0B-SPW!O$/G/#,3(
M)DRCZ86&\.]ST)_G8)MM;8EIC8C8>//#-4,;NHH]S(86T:'WTK'VK8.*JK:\
M6[`*OQ]N-2FGO'21*(].V]L0Z"80B!'TK\N_0L@E'7;:-3@W":&I++OMD*-]
M2;J!K5+PGL0XDN"U-9IXE*SH+O4T>AI+`G@/UU)TMCI/S_+YD&P@<#,0`M*&
M"AM5-M?4/)68Z_?>#GUGF](5BUII/H\Q<\9%+TU?H!D"_'3U-#TJ+.X"E:WU
MM$,EY+0^J)U=($5>(1*LZ<(/NV<61L)5/+_B&*:ZN6;95S58;8>+[=R,IX>)
MY$!K.WX(S%'\]1]'6BF>!V]4`\=OGFLIC1U9`HT,(0-7WZ&#U=1BS%4&$;33
MS`X"E(GZ]9O^76/S$3M15=2UV5FWA><`6I^.<\&:8XEZDH$%J<8\H,_(*COQ
MIAQJ;2L(&93B7)S72`<[5*A<_X+;_<(CP0,BRS./$.\Y^XQ>1O7<5CKH7C`'
MXN(=Q^;$I(!Q:ZYI]:*^.E-LJ+%91)"UG0$!8!(B6RH\5;35VR0BU#U,=KC7
M#\00[M"C&2#_#@4A80N%,&M>>FR=KZ!M62)-U2X+7VHF-'B\NERN'&^-T!UB
M1Y"DNHH$C::VDT2O[UPI=KS,VWNU$8W75F/S5*#6>`[EN7.:K]!KI"KGL**&
M.ABDE`@+L(YCSW2F'I*14;;B(R#1T4SUJ+4M>U:>U^<<*)$U9$=\=;1V1Z)I
M6Z9E4LG:N:JQCL:KPJMOSE&N4D4;&-D]Q83I-7<_'I7*<P-0%D"9?W<#1)#/
M,U]7C'4PM50UKRN!QS$"YZY/$^W\XC4:S)[=>GIB=9Z(C2\EUV157_2&0!W!
M8*:5V9]0N]ZO\ES`P->W7*`5019F*H%_.RB^=2![-[Y03OYDLB/6HW"![L2M
M/](WU-52Y]$-MU71N=QDQV)S6<#1+#,,=FGD;EA>6?YQG,V]HZ=38`Z8W.&?
M"V0S;&%><)<AVC'SRX@L=7IP<(O?$K0RL7WYL@+?14EAH.Z\BQ25GCMDI:`G
MMJONKMLX1I<]UW5K4G0+2"$L<_,&67K(:]+LD)?Q)L>W\_=<$D3^=)9TEQ+V
MH\H#:AL6]!F7]'V1@0^J0=8VP\&U<":3_G*@MQVB!9#8S^.B'G?#KJ#ED)EV
M0;&9!Q;X6/DOO6<O*1PJ3<[<P4BO.?;H8UHAN.\4,O[H'&MTQ5MFQ>H&NVQ,
M2`8?B%%Y+M$X%ETI3P]>1$>%!:]Q;._KVCK,EN3G.V&K%QLZK(I#8N-%4M.T
MA@H4=R)19;R"8,#'.;?>FW+5]PJ=\*T_^3"\^1/)Q?8NM7B-!BXI06!1'>[U
MWH@1B5JQ3")N^CJ-+-*&P-J'P_??.^0C4"T])7Z!GI#CL=I@[*;I.:53"S1`
MZ-87=M\$O7F#ZP^MN+U&EVFE,+Y7?=(@A-PC5N'X!BDT,1U:D;:7V,5^0-@5
M7N+!0I;P-?J*K&[TG:^P1:HHH>;8/O?;UVC@G`*T3?AI[)G.Z,%*_]YSBJ^U
M12L7A1:#&9/C<)OEE0)(?;L-O0S$OX/AP0T1`\P_N,YOIJ/N^4BU]?C<2]OG
M"Y/,N<?X^,U>8R#C:T)NN7GKK]UG2LC)0V'E&O*Q0@V9<C$8FZ&KR/SKGZ2O
M^U8C'^2("'O+;3J#3)F]_78'=IBZ?-P<`=7(!^O)3<R8'BE1$K%^1C%0"*8W
MS0!8&$Z>,'3KL_4/GTZ'KK!KNA:;(4$*+#I?K4(\2B.K",@WL0:5Q/@F2S;.
ML(7U*0/I7[X@8F$?\3)-"9K!#*KNLIE-?G52"0I*&KR<=8=6T=/C,)YFC^EP
M$R91TQ$:32R,QJ7>+.CT9+N$M0IM1VZN@C02Q=JA[)6+##7VJF@[0GM52"/Q
MHJ`&&<QM[&Y7'MD\Y@Y3CLTN3YX-)8C&:$P)L>KSE,$Z81HXIL0&8<GZ`E,-
MN#9WLTY5ZQ';CBN/OC6T;/SX[OLAW:]6FZ#($(W1A!)B:5N,$X@=5:,:S@2Y
MQ+LT$^0*6-]9AQ\JLZ[*-LG(V5F9@VZ]N$),SB`J)Z/&\Y!<=@?^?F/2VG&P
MIMW`<QS$'K&%(:=Z0V(C+F.T?!,Y]=V"DCCR@Q?O<ZBQ<F7S,9JS4B!]-WF4
M<"<OZ<3OP;%Q+-ZY(F/'2O)=L&NE@!K/=PKA9CJ#G]@AE1L)']21(1JC327$
MTCZO2AU2Y92U"O$8#:L@7OW<:*BN*I!_FFPK;S(YXA+OTN2(*Z"V\]^BD("?
M9ORI$-5732M1Z]:-*]PX<R9'7CZ!C36(U'5B"(==6<(=-&WU\'ND0W@NBU"X
MMYANZBU=FRME9CE&.V%V.5%%`5S'SIT\<"5K[%S[G;!I3B)!J4*'.:_8&S?/
MPBGUURS93EB2)YC$\<4!)[=/F%Y;>>61"R]\#&:ADXC`G]96-!^A`:L%TG>;
M47*UK/Q=!+44([1>K4P2-?_!G@<Q"3J#D&'3ZXT`--,0QVZBAB,TET@4;?=D
MREPPQ^UJ,F0C-*"<8/H6`)5OE1F/:;+P)7:$:1`!Z6U@(.N4W)HDB/_#BH\^
MILBC1_*6GHL"DZRCV6VR7)"]W=<'G2)[PBOH=?P!#97$;D:<SCK11Q6OX3I$
M+TZ25D2;:Z3^,DHMK@F6DS"ON.:^4^+SJOVFI(VF]U3V>P"0:I*LI[-[/'?Q
M#%MTO2>:`;%['!UL98>;^$0@N)NQ;UQ@WW(\/R2('@^,&-$C@!E6QH:7L6'6
MZ2UXG/+1!N91$2:G>-09COQ+QY`8%5\/WN`Z+N-*J(V(W#!=VR@^Z]P1U"L3
M$^:E-^P"=)0_QIJ"?%<$2>D,1FCD*3M69'HDMXSI?5EQM+41-^\4B,1-M&6`
M'XL`,UP,QL;(\3$21IU"3VYRO$6$3;O*.#\5<::7/P*-$1-U>UTEFL=[IY.M
M(+2+(&].S-4"6Z>TA%;&>5(*-#$;&FD21E%G25D9,:].X2??`NL]8C<Z0TXO
MKL%L=3T`<&7TD\,B^A1QE@V#GV?4*?1K-#>=>/,&[Y+0HTDIG#,2(T?3*:3<
M(?DRGE+<+K3O/QP^T.)M25/OI8.B\2;BT/6EKURP%_329*>$]H,"VIA%YW?4
MAH\^^BNDUSH]<4>926DHW)`8"4VGD.*7FOSD@N+LJTSE^/.A""\A9YTV"NCY
MQYZ,F.$V<8N\M07ZOARX2@RA'[>2(W7M82KUA9>_8/(1;=C!5OQ3P75R\J0#
M+4$4T-TC\H0M)"U-KOU@4T55`V46'ZKD&<=K%64ADLMOI*V8)]@!,^8%&L>+
M7F4IZ%*8%="7D.D3R%.7_DRX;TJ-?`=L7"5>_:.<6I3VRD)EEV'HSFP`F`E)
MYP3R>+DN+<=H!]Q`3M!QO!=>)]TW$[L^72#B[K)2HMXYR^>DDWC,>JCM.G5R
M/!#(H5D->OKHX'E<HY"/^@K<=LX'*J6-?>*]7J5[B7I://79+&&D,ZJ3<@5?
MMK"6SJB,2>?E`GF9'H!K:/(FBR?EDH*Z:`G[`::_8LD^E(PF/0_N7[*JRI18
MI'<E8]65J'H3(+/P4`N[<AUB6U#3FS<A_EGPESE'#QZ[7K8(>')4^815_3-0
MQIO--XS`,]A7%"LJ(`$;V0X_'AZS<0U^D-FYLOE`S>V<\F1J@S07GV!SH1+8
M!CP&&5]5[4''UH;R-;X.MP-C;N56X`8.,CBN$3K=X#KKN]#']6.YQQ"47+`]
MR\&\1Q-/R+MG>WT.%2+YS_@HQC-U)K_<)Q_=U#78^Z9$@</D'O=2]!-IVE_N
MD7</:<7%7G&\7:](WO1+]Z[GWO13<I+FK'[Y3-9GFNNQ?A&L#Q?*;?F)4?H2
M_B))]\LYLLXAJ;3Z0FA/GM#TG3BE2-/3=WYY6L'3^E!RXIE;=<S,*T]*CB9)
M]\MQLHXCJ;1DVK35^3CG22^UV;<B@\$\0\GCT[FPHG1-3\JTLF'A23PE\RG0
MCLMR"H(UGGWVNDA:M2AUQ%F-*FT\KUV-.AKL<;/"-7`0<=.W(:HOD54A'N21
M3<`F@#WPY7MJ*D]?VV3`^XYJW>C^Q_TW[PD1EPIRCRQZM3(]"AF<FX2L(05@
M78%C'$FZ$5I/4K)Q[/B-#K(5]%!K7"FJ$9I62J[Z`IH.AKWQ7+2^,<E/%%R%
MKBUAU%J*$1JT5J9Q[.=^P$O(K%:>CV5Z9V7K$1JQ4IZQ;\7C))TGI:2SP7ZU
MH^ZW&`G/L]?NCCHN[5.K/M\^[.8TSN[(=R4!:N<!G>^%+)[AKM7ZIQ+H\IGN
M_C6=JR3788[VI8E/^O8/5^*0?ZWB/Y:$D#OT+Y3NRP']PB/,J^$__P%02P,$
M%`````@`*(()/YDTJ`(M&P``'SP"`!0`'`!J;FHM,C`Q,3`W,#-?9&5F+GAM
M;%54"0`#RY5!3LN504YU>`L``00E#@``!#D!``#M75ESXSB2?M^(_0]<STOW
M@\N6JX^IVJF=\%75CI"/L-T[\S9!DY"$*8I4\["M_O4#\)!("@0!BB22%&)B
M.LHV`.8'9"82F8G$W_[^OG2,5^0'V'._'$T^G!X9R+4\&[OS+T=1<&P&%L9'
M?_^___ZOO_W/\?$_+QZGANU9T1*YH6'YR`R1;;RLC<='X\IS7>0X:&T\F_,Y
M\K-1C<GI!_J_R4^?_M>X]%9K'\\7H?'#Y8^%7L?'Z3<NS(",2?K%'SO[,$G^
MXF#W^V?ZGQ?R=X-0[0:?WU]\QPZ_'"W"</7YY(3^^,'SYR=GIZ<_GR1_/,J:
M!GC3[NWM[</;QZSEY.2?M],G:X&6YC%V@]!T+93V*O3(C_[Q)*,D&Y_^+-'\
M?:=]2M#DTZ=/)_%?2=,`?PYBPJ:>98;Q"M5^P:AL07\ZSIH=TU\=3\Z./TX^
MO`?V$9EBPT@FV?<<](AF1DS%YW"]0E^.`KQ<.93Z^'<+'\V^'/W;_3<993(Y
M_?7T(QWC+S<NF;PY?G'0>1"@,#AW[6^>9[]AQ[E"H8F=X,B@@__^>+,!0@;Y
M8'G+$_K[$Y$!3MJ@]*N)_?\WG0C=(C.(?$39.1"CD=^U<^HF>Y`WZ8&^LSWH
M.^N!OF?T'D;F7JN\':(5:A^02]4D9?;[<('\"^2B&0X?'-,59$FA$?JB57""
MI49JA?8G-(]7\7YV$07814&L7I`W]\W5`EOG9#,3G&^ID?JFO4Y!R`W5-_5U
MZD-NJ+ZI%^3]1B.V@B7[WJ6W?,%N;%+0;U_A5Q2$."2*3E`$9`9JA?(IFIO.
M@^]9"%';5(S*JDZM4/1(D/J11;`*T\/NTADU@NS([YJGSO0M40(KK-#,+*?F
MY\\QX0LRA&]%+^C8QLMD4S@RT@_E2=Z,@MWPA#0]2=N<,`?HFNK-IXYM;VEB
M29)W>_=(+YJ9D1,V)CCKWCG%\<P<+]'R!?F2U!:[=DVIZ3AR],4=4JK(@=?X
M+>-@XXK80"ZFVM3X84H4K'$3HF5@A-ZVS8_Q<3C#8V\ZD.;?"YB(!"/71G:&
MBGZZ^;$K'1F'=)#37TX_&L?&%0XLQZ/F,?EA.XB1C&*8KFUDXQ@_I"/]F)PT
M,_H=SRH0[="#KN<S5R*>SYD9O,23&@7'<]-<G5`M>(*<,,A^$^O%X]-)>K+]
M2_KK?]$COATYZ'Z6$?5LOFP7W3%?D!.[//BM3Y31'YIA?`[)]M[,C#A_QT$5
M"GZ?(I8M+YW[152$<;,/I#S<4"TG8\Q\;RDPTRD%GC`<S[>1_^5H:[:>,&1D
M*W97L9HP;F,U$1A:KH#R99]8$C*NTEV937NQ30-:=XPW\HM_71(+.EHB_S;=
MM0K?9C5HZ\,/"]-?FA:*0FR93N7GV<W:(N*6&.ADV"OTBBV4G"3,N>N1LX05
M5)(DTJE+%;=KQC'UFXA\%+1<D<'*6JTC+$6;B0F$)1R4<!9W#H-J-E.GM)_!
MIEV$^U,D'P5W1+8A>NXXVN@\4*,SHX,>1N*S2`7EC'9=RDY\@F))3"6]!05;
M-<U;P4_.>)\IIR'[RU'H1VC[2\\-"9]?.[%6)X?'1$H%9>S&72`?QU%&8^;Y
MQO:8]]DP4@H_[\#0\J>8?Q70_.@YSE?/?S-]NX;J0DOE=-<0"X#"<^N/"/O(
MOHI=G@]$'KVZ*69W48XDCIU=+H@0HCK6+C95;-D(Z>DMQX"QR*3H9O-,V28;
M!I8B]Z08?A+UM&0')6I74O>Q]K9H;TL+WI;.CO-9D*./\WRC,]FTM^``/]^I
M+%`_E06*=C?B_D9^``"2=$7T\:L9XE=TX](`:$S7-[)$4R\(+M:_(7M.M/8C
M<I+H]@*O+M8W+ID7M.&`+"WO8LT:[!$'WWFGO3X)4";C571QU!6_"XB81?^\
MDU<H_`F"%@4Y*`72(FLK07+IN:%O6N$S^21W7^9W48:$G((1GKO7[U9LJF:T
M,4,(@GV48;GTB3*YC'P?N1;1'B'R41`^$O4AA$JXM_H(B8@@L?4?B_?`1!Y$
MI"H/JX8/!XM+F!/+IWQM&:O>#K1EK&R6*_!(&A>B`VJK>J_ID]1<VN8>H=#T
M.`LEJK([-)?><N6C!14Q"H>VR0CFVO+-AU/G.C0=Q$X,8K909\-[07@_JZ>6
MT:ZMU*I'%""BBA?7[RNRE*@RFZJB75MD9(9?PDCI1^X0^Q`CTJ$MPF)>EZ9.
MJ%?W)%++^_G-:T;I;N>>""8]&TXNJWL_1'_U(K\YS:7>_9#\A-^;4USL#--)
M(+?SYXV]YEL>F&/XOD9`(425WWA&B9"QP8))*F@#)V<'!Y-PT!;.NFVWG)TP
M>,!"QD:*^N<#0+UKN*3@?SD4\"43*(7_ZX'`+UE3*?J_'@CZHF66@O\$,,7_
M4+U0VD'>_2Q/:Q*Z13LKN:4@ATS"2=WJPF_M1L6W(<2F2^LOR)+5W,?!_=Z]
MN^'K^]E7[!)&PJ;S@'S"3$O*5><O01QC9O@_VAH8IH)\1)8W=_&?R+YQJZR0
MZ]D,6;3_@^=362%F19-%;_PI^#.7$-_"O.0&`H":T$&W"D(TRM:%9C)GA->"
MK>T/)D6EU0VV,:.#<37U,#$Y3@?C>6H#=BW/0[P4<U`FC$Z^A7)'IMN,3BU8
M.L/F,#-LP`BSPLCK&-*#)PP5,9'5$<9$G9;8@`NVW!%<F`X]&3\M$&)ZF?*Z
M?>.KND(!GB<59'D>SRX_"&#K']/EN.YY8YR7X0:O%+1-KB_$C>Y"7'/']=,;
M#H*O/E%[]RNJ-BH3\:H:PDRZTS?S],T\\`AY8M5*441]CM#G"##GB`VHB_7F
MG[]AY--DT/44O2*'8X*)=C[`LX7HU`SI^M]X5$9_S*X"77[>=TGE'D4DQU"/
M]<9=16$03_^$?S+A]0"%XTP:QQE('!^E<7R$<WR14Q5,S2\F0F!.`(W4!Q,X
M2\+&#?,,W&FG$Y@?6ST']9\Y/AX#1I]Y6G'1;B5B*IRZRNRC.!><@X,ITQVL
M)L"4;\:L:'T#2U(4AYB2*:Y(]);I"`I5<./&Z89!6LTZW*R#3)X-9Q"8:*?8
M?,$.D6>T+^2JD52'XC)_.Y/X.R_,M#*RSX-44><:Q`M9/S,=?6O8<Y=QQ+JG
M^6-_3]D<7O\1$5IN4;CP[!N7/M1</$]L-[2*29$9`$R<2-"JDM6>8,Z([2*M
M4IH`,_E%S>5N-"&8&A-J)H2MVL"4H)">%!G55JXU`3T=?40'&)U7IN]Z:.'2
MX=3AA%.5B&3?<:\Q7,DX8PCRF;0@GX$0Y+PW^)OO12MBO`D%"+A=U0LQF[SM
M"E$F.E]Z$?\YM.;#P4J!$ECGBF0F2=A#ND0Q=C%6Q>PJ9H!)G-A6S>VJ[@*#
MZ?OKN#[3RO/IR3JFBT$T_R*#["CJ/(Y!B)=FB.YG&^IDP<H-`2KEJ)'X,C4V
MEYOA)>4(R&WA%H(L/P\>L1Q3:R-[,+OS@(WLJ>?.0^0OK]!+[)#AV!3LIH,V
MCMF0AI37/WC1:ID!%5+.-5&K&K=UZ_3."U%P%:'DN?E[M_K!E\J6W9#RA`F?
MH^I;L-S6W9#T_.8)DI-KV='LH%<BB1+S4V[?#5G7>+Z0H*K<O!NB[H@M(T%4
MN7E7O$368RW,3OG&'1%$:\2+TI-OVPTYM&:[Q**5FW='E`1!'1.#7T77*]^T
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M#'.S+_MRLK/D,#?\'1]0!F>8NW[)>Y2!V2\MJ?_R08//DQAO"M*6/`9QFS<8
M-T^'7)IQ6=_:!ROW'U9)8:"V9D/B#@"T*D#[3H'6+&.4O^;!D\W'TH(.KIVK
M=T!VNW1%[-RE=L[[L7N-ID[)9E3G;O.7D+#6*:BIK[3_L`IO900+^G]:`^#5
M=.)Z#Z[]M/#\\)G82+ER`#5ST&0@I:@Y.!12]OO3-^\5^2Z=J2=D17Y:CB2[
M)\"KVR/85QFVY*VS$H\((1/JJ0S7K>>B]:WI?T?AU\BU!3'5]E*&YQDOT15:
M>0$671]NCP'HMKUU&M0]+;<IM[ZQB8^M;&XV2W7A^;[W1JFJ0,ILJ32I_CEU
M4=QYKA67*PIK%JNN$S`T4BB4.XVZ.)`FI@:8[(0N(`J:)&"2&KJ8`R'C!4PF
M1!<S4&OJ@$F>Z`(]US@"DVS1E8(3M9_`)&IT,1%,ZP).'D07D*OV\9TL`^A%
MSD;DV=1%57HIJJ*Z[)FBVAM:D/4E\?XNB2L1LI;N;.R7-C`%4<WDF0P3F4[`
M$*J/TD*5#0:AS"XOAV"G%8!BNCG7W#?"9%,O"#:/W#PB)W[A)EC@E63!8)'!
M0%0]J5BYVJKO`OB&5/MOM/((AK][1,^@B+ME<MJK?K6DZMUXMK7-[Z,NDB3Z
M5CP[C"3:6_VEU/W$+J]S.2P)YL9GK9@QGHZHXLUA@A)FS58LU_X37D>[*P[-
M2MWQ%5;2/%6<>LJAF6U3%A-'SY0GCC(`:*&#PL0]TGWGT34VG<1M=S^K?/NH
M"H[,`&!0YC<Q>8B5O0&HT"21M#:!@M<!`(I"FK`PE(I>8%[:XFX5,G($QHQL
MB*U2@,"41I'>WW?%"$QY%&DL%7)4SD&"'LH9K86AG5TM.KO`O`C7N0<%>!SI
M(9DXFOP3)\-=()<,&SXXIIM)]*XD_U(6Y&P4PW1M(Q['>/#(%*,0)S)MI.-N
M95N=2#]9"V1'#KJ?Q5..[`+F#:R`=XZ7'$.A<<>CCO%7KO9J-!:(2%2C-2_N
MTXW`0PM3':"X@Q,!Q=CYC[I6ME>&(66VE$7S]'$C._7=U%ZV*PI,40Z%038:
M"4(H:P^1K-/*T")9M3*8!U3/M</$U8A1`0>V#G`?/6RS>4O<CCNG=@]E]E44
M0)/`5;@E(;=P@`)N`H"U>ABBR*C#EMNCR0*7_EA8H))XU-P2;O\S4&:,T/>$
M_%=LH4M"N#`7%/H`PI)%4J3`%#L!0G/]OD)6B.Q'%$:^>Q]S7!)8$<;&&P(0
MTO.EYX?XS]AG>S][\+'GYUCLTD<V%E]/L<'`HG_VB<Z(][G[%P?/$S^VY+)+
MC`AV'JC_/Z`!@,I$!*D1`.&\0V%2(1-;Z6^E]%55=W#'3D$3MF9[`10$;PU@
M<<L!%!IO#2%OXP%3O:-%O&*;#IB:'9TAY^XU8`IV=`:_L.6`J=#1(MRJS:=<
MDP-"-HP^[.N86ALQ-44Y,?V'8H:?$E.=Y/;+I+%@0TI[.VQGO\Z1T3DRARW_
MX&1B#!M\G[6JB10@.RX+%N0#"?>SWY^N7<*N:XDLDZ:#J;[?WC!S2+BW3J2!
MFW#2E&>'B5:898>=4C/Z;?>PS6Z=8Z-S;+2^`"U#S=\XXBU7-I&<1XWDNJM.
M5H]+M."7*`Y+\!/42TW!61V"RHN-1M+<@.*N/T"]H8_WVG\_$O_]4V+BD*/>
M1120KP94U+\A;^Z;JP6VSGUD5L?E/I7E.QO-\&9&-EXLZ]L1C7A(`&&YK069
M4OV(5C1L[,YO7&*^+>/H\<4Z_:/8(4)B)'5O"67E[[,%RA:-H[9J^@#SR$NO
M9^%@P8<*S?]^P/+;-1_WB24A@[NUEMJT==0@1F@0+9'/]/*R&K1VQEF81"@M
M1,Q?RW0J/\]NUA81M\BFPUXAFA46WQS`YMPE)BFV@DJ21#JI=W<+R4=!\Q49
M#(QSERD<V?/V9>X<!M5LI@:35<NE783[R]FSV@B&NHD>NA&\71/3$3$<=MN/
MTOC=A2GKG=*&[^!XMW^#-T^1B/'+:M^6*?C[4Z7!M_U36Q^++YNX9E)SLO*[
MS%:`+,LJ!F18E:R5@V:K57-C9OML&6%XM#.9"7"*PP$K^$,URJIIG-;$9\6Z
M*DEQD$'%SG"06+OMP4MQGH,(:JTS!BL[,)`]HE?D1G650F0&4(?2=%"0DO/-
M\^S@#E7B839M+_7$M\ALF7-T&;\/=./&W]LHFJUH,1-/Q#O#L)ODU3)S]J&Y
M[H1AR:Z:I&>OER25`];Z.@:F.*6D[2B+EB<0\J1=:]#DJQU?TWZ.CBG$B-2$
M(8,[B9?R0FA,M`-D=-OY2*)3HTO-&J,,:]-4IV?I]"R=GJ73LWJEO;?T+.51
MOS%NFH=J^.K(7TN1/_4WG,%'_L:H-PXQ^G=/=B4S^1UA`T0K?#:/!'('4_?X
MU2Y5%="8+;N+"=83)M&O+3)I?6,W0'=>2&P3V@O9SUXFR`SR:MHK6_7MW'PE
M^PF])8[=B,Q9.GG$I+Y`A'%1TN[9?$?!+78]HIG761%KHOR*HUS_$9$_WZ)P
MX9&_O)(FK%E10D&O7'K];CF137Z5+GX@S"WM#@_C""%MFC#E%]K!:,_@-P^C
M^GKP33#6*#HPM=^;<F6OZ@I,O?C.N%U8B95KQP\L>#W&@X#VND,)6/>3$#*@
M0/490]S.6A"W,PC^NC0C,-DZWN.;%LYE%(1$I?IT2J:>.Y_B5V0G[VZ(N>Z:
M#:H^?#VZ2Y7[K*[<_<HA1J_'*-@Z$6SP=RRO(]];H<H/%O\,:96^^5ZT(H)W
MZ46T0"`*XE_<NVPL^PP$'_7SF]<.ZMQ`@(+_^@;M@&@O:@QH7B\^_?MH"6B^
MKY:1YC1#V1,VS,2(,=IC^J"5FPU)<G>\@:5Y:#Z<DK2*?=&S4RV:L0"8K(NF
MDZ(5U4&(9O^F?5`P;>GZB"5G\/KIV]F55W6+`B84OJ[HJ=C&:U6[P[ZKW094
MJ:4=^.7M$6X7VL\X\@NG(XSC53_X\>EC"]*H_L&/@\W"U]=/#_/ZZ?@E6J?%
MZ#NA^DXHC!N*W-N5P&F7N%TY\)JJX]\3#M7*TW<M]5U+K46&*4W-S:;T:[PU
M$WA9MM$H;4&8$L:=Q_.37DQ@$,AHHS!,2V8@LL+()ZM[2:R>.:J.\[":MC]Q
M9+D>$3%@')$9W&T,PS23NO'"8`@P`8"FFQ:;6Z"EZ31<IEVND\S*@1:V&/\>
MJ+TK4((6AW'I*$-YZ2U?</*D27(6I]<T<9@\YLRN3SLY+8O<1LSRH\4REQ\/
M0G':S5%EHW*L/R(<X.2&ZSKWD]AI57089<+(()"C4BI;`PM"R*U>7FHK$4*+
M/1RF@';"KHKII__T$>+NAP+]6BN'2<Q>Y#AWK]7U,,LMVOKTN64YID\VS1O7
MJOPZJU%K)_BU&RY0P/O\;A/U08T:J:C3;R5&`A,F$!:632G,,F,.%PJ+R\$<
MJJ71[`H-X/J8A[FS:M-7P)_,[Z(D*B."@AV-$5T@,*$8'E2M!@8A%,U-,X'E
M$`BN-!H%DH9ZB'QK80;HP<<62BM&416SI'[@/ZG`WKA$C.:8_"O):1=?M29C
MM[V\.7(NO8`Z?U/+PKYVR0*M"S1R%EARG`$L<7GN:<6P[<KLO<IUPP]@ANC]
MDS?L.(3NR*VZ/-1\N(Y9O<RAEV:P>#"QO;UZ(L[N(F/U#"<I]I?5`KP)@@C9
MM"(@^0=EL#902GRB9_!/H6=]3PAJ`VC%</!.A5Q+M*4="/*IF(E_CVT*3/RY
MN[6NVX?`5%+M;@K*&P^8<J@M<+C(SE2N>3HFO!)[5#H-OXYQ&BIVL!3R7R&E
MH6@_@`ZT<0)M2I)1N@WX`$]-F:*YZ3SXGH40K:!=*7P[=:;CCL:V)P0YH\7`
MDVKJ<^1:&'&K*54U;C^)]0F%8>+)O5@35;4R7?(UA@(0[@4B080_V;MYDAP\
MT-)!@`B%6K;JC$3FEB'1K[V+F;[UG7,#,_?7UM)!""+/\OQ[/UQX%]@+D;7@
MY4?4M&\M5>05^<1D_,>",']@.LD1:KL:U=DC8OW:(O,1!T0WV9R;O#LMU*63
M2,JJH+X$DU8B+>?;&ZDYN1HNC!K)5.Y':PQ,4*:5.\\:`]S1$:T44=46^Z`L
M]HZHOUC?F=3I0$OV9K]><X[Z,@,,Q.AO`DVR`L&AV/^#9U)E*%,"N<XI;H_6
M3-;$#<FUHAEM6CMOX%?L/"#7=$*R;M7'#&8S]:G8\JQ;K8%*"ZS<\I1@W(WE
MLLLH0X3!YK96JM!H*^P`K;"QE@$4M[7$*OT)E]'5YA4D[AO297(0I?IT)3RU
ME?``W3X:E:89]BZ]0]"TYB8$KX.2RT'U"+C^C^=RRIWB"T#5<+0<JN+D-F*N
M]&O<X&K2H/T7/I)#N8]?XA/JLY<\T$[6;H;#IY6#65>(I'IW07+ZIL4C6ODH
M(+]$]L7ZD7*8B^QGY!,I\NC#:S6D"X_26L0VSF;=AWSI$=3M'(PH#[L<G%`/
M4(Z2JEV$);%@;$1Q"%+BK3QFNA\^84%2'CJ5QRFM+,!<+)`TVGB*HWQS`$(^
M-1##2F>J"62J]9K<W&_ZD1:%KL\8.F@K&[15<I>@^XBE<)*$ECGMR3_,LK#[
MU<&:]A9#+I3%KI2=G1<C"]T@R$WN3>H<97%=;(<LJ!U?QA9]V+QV!"#E\0E%
M,7T!\E\11T/4]@(1:VZPAM4%WAD@H=WP&8GH]<*2/>)Y)A\HL2!W"^.T5X;A
M>KERO#5"3XAFTKL68@:S:UNKCVD+,E=>#W#6`XSWLI;'\H`JEP=PT'LDNDV;
M%6C'5RFNR*>*@^4RJ-@5-076#$PQ31&T6M!A"(`J9"E=CY[C?/7\-].W14"Q
M>H'"(P$"&.6)A]O^!PX7M'"2!)"=GHI-FJ;*EKU(8.*P;<+:63+9I.@^W*GC
M5^CZ5*K<R=KML6Z`+M?*]^XF9SMQ"[:H07C33I^6M!-V!$[840BCW@#;=,NR
M;S839L9!X1/5UYNKV[9YSWLS^(-CNO>SL]/33]P[WYSVVOFKTOE;PS/#`U/#
M;:U<O>[/ESV*+4+;:]J[K;W;!RGZ!^+OOER8_GSGZA&_:6O685P(?QWGCGWU
M_,+'6`8BM[FRZ;P/B7#N+'G5C%:V5EXV_/H=ASS*&>V4T?S@>\2Z"=?42J+2
M19\86,4YACA8>4%.]Y1`B'3LY+11W#QJ'BR3[MT+R:^TF*:_EJ5UTPV&PBN2
M1Z\-6>3?=Q$ULN]G#U[Z*N2U@Y?TL0(D%/]K,"C$V>`0?$-LCU5R*?"*_"P_
M*3)CCR&BM=DMP1Q$96'5[[F#CT%6[L9@;G\V1<;8K<'<]FR*263S!O-P5!-I
MD]KSP3P9U3K2C<4`YCFH5G:$!D9"^7&H,4V`C$&0SL,GZ&D@8_=\Z+C8@2:&
MI+^G_WDQ`T1^\Q]02P,$%`````@`*(()/T$%POT6=```MM,%`!0`'`!J;FHM
M,C`Q,3`W,#-?;&%B+GAM;%54"0`#RY5!3LN504YU>`L``00E#@``!#D!``#M
MO?]SXSB2)_K[BWC_`Z[O]K8JGNI[=\]T[^Y<R+9<K3F7Y;54W;NOX\4$+4$R
MIRE20U(NJ__ZAP0(?A$!`B!!@M5[<3?;+IO(S`^0F?B6R/S7__6\#]`3CA,_
M"O_MFW>OWWZ#<+B.-GZX^[=OCLDK+UG[_C?_ZR__]__UK__MU:O_N+B_09MH
M?=SC,$7K&'LIWJ`O?OJ(+J(O(48K;[?#,:+?S4+O(2#_>#AE?UQ&V_2+%V/.
M#[U[^QK^WW??OWJ5,;CP$D*0_(E2>/_Z7?Z73T2FK4__^"/Z\YL?WKQ_^^X=
M>O?^Q[??_?CA>W3WB7T9^.%O#X0((KC"Y,?GQ/^W;Q[3]/#CFS=?OGQY_>7#
MZRC>D;9OW[WYCT\WR_4CWGNO_#!)O7"-OT'D^Q\3^LN;:.VEM%-*S9\?XH`3
M^/`FYR7]`O[UBG_V"G[UZMW[5Q_>O7Y.-M\P$37H?\/!P"]$<-[]\,,/;^A?
MOR%]@-"_QE&`[_$6P7\_W\^E/'YX`U^\"?$.!O+&>\`!80:$?DQ/!_QOWR3^
M_A!@_KO'&&_%M((XKI`"K#\`UG??`];_7N7PIHN4=SCVH\TR]>*T?X'KS#K)
MOHI2+^A?ZC*;,WE[[ZM9R$>YS;`6K3.Y`_C7#9&O(CE^3G&XP1LN.Q!J,"3*
MIS`/(!NM*P0#L/8H%O8%I;7UD@=*D/C$G><=J/MY@X,TX;]Y!;]Y]?9=9M[_
M/?OUW^;A$W&647RZQ2FG3U%1_RKXY$TN)'PUC:N2>O&:4R$_*H!G7[Q91\2[
M'=)705GUMG&TE\F0<8S$?_];\!"<RUD1,L9)=(S76`,OHV4PC!F$?4"HPB2%
MPU>?E]_\):<Y083JO[+OG$B8EHW\7$QJFLC/R/LX<2DIF8<?H@3+9)T74J(7
MMU&*T?N7Y^(.:4=DCM[Y9$DQ31*<)@3O['D='&&I\C&*-E_\()#VD4Y35W:G
M#ZMJC^IVW>U4EX<-^^6\$&-&[1B]R!DBSK&F@V.`I67T.4*/\D6O4&C#5=E'
MHW0,9T@F`"3S$1\<^@B%'W!MZTWV;,MF;=LEIS>QH:MMA3N<+0X;I"0?@;.X
M\`+8T;D5N+))D8M\@7=^&(Y`ZI3LRZ5&7U$$:[:>X/7K7?3T9H-]9N;DAW/K
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M:AWT<&.9'^I>>6G3@)Q]UVUT*\2L#S.C#ML,!/1=C[BPA\^'7M`C_>O`E'#>
M`/?KP!,MSL_^WF[,*T1LC75.%`%55R,L[#\^L@+<_8_HY3&.@:6?K+W@/[$7
MRPU;_FF[<9;1LS7D&7W$&"#@X-S$5=W-=:&Y;X9:O/V"@^!_A]&7<(F])`KQ
M9IXD1QP+QE+Q?9?%G(2HY44=<'GU&[!!G`]BC-RN[A1#4%WE-7;54$KS<Q0<
MP]2+3]=^0':<TG&M?==%2<Z(65:.G#IBY-VJA*2#JZH@[)"A5(#RO"3N:A?%
M\BW?V5==AK]"RO+@4]J($W<[],*.K0Z\H"L&V^NS2>L>'Z(X]</=,O72H]P!
MR#[OM/,7TK1]`)`M+'(NB+%Q?`[0V/MGQP$-W>3BC+8<\#!]@+.JM4Y<3?&I
M^_B:<[%E<3;\.YOQ-E6:W?4\ITVOZW_EY/\_FW$M;6567&,OC_L]3-31%LWE
M`3D.-/N7*/YM'M[%T1HGYSY1];&YEI#_*%A;Z&NX/4R0'Z(#(^W"_^GU,QAC
M4Y>XZF"E`4X0T(8^OA/WL0--OO9#/WG$&SK\*DT^^]BQGQ:*7E,.J<Q#=O8&
M;XD8*;[QG\@^[BP>J!8,I)PTVY)K:QG=Q.\CGHD]:?!SR5!`1$M^=.NTNG53
MH;E_O.&5NT;.^Q5ECFI!AL+XPH95C#.K7L7>!I/5RF]R+RK]WLK`U06P8'@%
MT1&95AVIQ'9&TL?:VB_O[>'4>I$^XECA$R0:KM?4S:K!!!;7)E,\XUU16%I)
M##7%F!A7J[ANX>IA1!Y.NX?:+AK&.)*6%PF.7>BUO)<^QI'TU$"S;;O1,Q+,
MPNJ!\BN9'SRHV`$/EZ9FU`F5J>"K&1:9);'QN&ZTI0GZ*!HA'>OY>_AW:A)O
M__3V`S4(\HN_749A<MSC^!/>/]1NFT4?#+L^D(L(0U__J_%)K\EX-7=-=KA:
MBXS(/D*_LL_,#W9;6+HC254<M>'P%`DT@T"#J*^MV<'=HQ?OO34^IO[:"Z36
M(/YL>)MH$I=;ANB;0>U#+D!M0*N?.K45!U+K<;=F/54>]FSH$]X`P2O\Y*_I
M:X@KW]N%44+8)%*+TFDTO'WI0^'6IFXQJ.WIBE-3CJPAREHB#Z+XBK9.37-\
MH-H(9\V.%:A:&;:=+5;#:OGZF!YC/-U#,,3O%-GL^8##1':/W8Z4FU.L+K#Y
M5L8&7MV=31=YNVQT5%L<QAR5N:.,?5L+'0*N8KL](U:YIPF_O#(PS!BA`UEY
MG[!7BX$=5X80Y>6G"8GQ9@R1W_ZUQZ=_B&<N7[<#/.W,(:.XV8,`.@SSXL4Q
M\4.<)$N\@W\FTV=?=FZG:--NH+0$Z3(R.8,)XBP0YT&&@G`1KEB&,B0M_-QR
MM$=@.$6:;;=XG9+I8!ZNHSU>><_W1,;+*$S]\$CT?D%<,O71,JTR(>#&UYE#
MY./5'INN^9C+UBF>F'-#C!TB_!`PG*"")2IX=EEH](-,M;S(`:8$&:$_BE#,
M>^_+)R)*['L!S8]P/!P"'RM#V:3-'`>U*>#4PMLT<>@O#?3DL!0/2;B@G`W=
M7G)&7:S#)@B%30"`?05`(@$PBKVQ.B)?M['U_:!`M/X"!T<4-FC6)1J;^%$.
M4]N->O.3A>'SUDW7_SCZ,=Y<'6,RS;)G^Q)+:F[2;F!TQ+!@-91\XDN7*4.G
MXVN"RRUBS-TMT_XB8QOG@!B++(F%M8N37["_>TSQ9DH&WMM5CJ$8I^0ZBN_(
M/`;;I5`>R]J1UO#7+)V!\]N7UH0&O93I*&5-03D]Y#&"U8-%ED,Q0=LH1@=&
ME"Z!TL:@8=WKCJY8;#G#_Q)]H+H)ZMH)]NZ`M;HDB]QMC%KN2FRDSJP1NI$W
M$U(:GSMK$+.#&D<T5*ZV?>C=F)O0#._1ONI>L.?3)-TPSOMO*S??7\>==[?;
M[F'NN1W=<`]XM=WOI?94=)4=;7-C!="U!QY#);WF^?N*U%[7Y#>B+"G2+]LI
MG()Q%\W*$RF64ZU1ZJY3*4K`<E/7Z.)A](#-8WJ:4/G6ABX(F-O4ABR[YHCT
M00!8K!&2KFZ]$RFY1-$63/3*1[^9N2KHTK:\F+P3[O=</O0Q'1N^*=+OO(&V
M/P:C*5X>(+8\X$-$6I>>&(O?^;C6-M6BO36POLQ\NB8"'P,(NRLO5<R[2TIH
M^(.&;I`U[4E"94P6UBAB*]4L4:PLT5T$NUL%?P.A8UX)G=<%G2TI!W4[LK&U
M=_:I>BBJ[XM:4QK>&74$S;U12S*#NJ-.,C:^]D6RE_-C<DAVX??FD;J):<TE
M=1K>X7Q2O:BN=JMV>R`-TE9K1XJ2'$@J\8W!79Y5#S;JL9&XP6($6]E$A^K#
M/>F7%5,G?!U>2"S7CWAS#/!B>X5C_\ECP<E)&E-@R3S,P_,76P+$"]>^%]Q%
M+,CHVO/CG[W@B%?X.;T@4OXFN;&PSJ7ENXQ^P%HXC<FY\7!'.)8)B@IRR$O1
ME@B`GD`"IV\[^NG#_#7(?WE-D9WH<I'@$J40"I6D@@RUN5SP6:%57+0)`N$0
ME0[]"O(A*J##$,WK*,;^+IP]KQ\)7/H8`H)&A7D!--LXNO#4`9+?;YH@T+[L
MTY&@T^TE8X!PQ@&M,Q;NGO_KX+8`8SA[N(134%8;8'TBRP5,.BSESX24EJ'=
MVHV-&(+CUM(2E:[=&$K5Q8(H*[3.>,'V@S*CS[)0\L4[N+4D_9ZP"&S`,L11
MN%OA>'^%']);HJVL`H?$E&0?N[&<9M&YH:AE'LW6XJ/GAS=$9R1K*1QOHW@/
M1=L[;B[:\'$SQ+UUF.;BNGM/65I>MT=J82M6*EZRP0E9)M!#N$TN9Z<GCDZ!
MM]]93!!(AEZ`;"^;MAF%A&/97?"]V#P\'-/D!C_AX%WSWJ*IA:.=A1I$OJ_0
MD][M`+PW'H#WXQN`]_H#()#>[0!\,!Z`#^,;@`_Z`R"0?K@!:/3T]W@=[4+_
M=SB/IL?%E]'^$.-''"9YFH@\@<,=7`1%8?UJIE]6;H:\SV[+`PT'Z"_=I4&?
M>#M%DFJL"`KQ8''`KCTJ$F:Y52:H2$:223GI<J\SAGY3U6<CDKSA_117^JE\
MR;NXG+M;)%WA9!W[!P"_V)(N"[PD\;?^VF._N?22Q^L@^O(3WNPP[UFI!VI#
MJJW%M!?;1@Z1,XZP%-[*3Q;],(T0]N+0#W?$?`["E^+#.MCVW5<XT#_.<,L=
M8,X7AE@T[,`;`7-$N9=]HSNK_N0]^_OC_@:'N_1QL5WY>TRE(ZXP.P#G!WV5
MKI,8=FMJ[0:[H_`6S#N3``54!!CEE`A!WQ62[?(.LCT0RPX38MS9$Z<H.<9.
M[V8[=AHWZC_>4,M,FX_Q33[&P)T9,9VB^4T1E^#<TAUFMLD\W.*\DX3KH=LH
MO<H/LZ;)3TR!2Q](K-XZ%S=[B9XZ*\]ATV\OZ1I23R@[9<HI;1(B@3E)`AF(
M;*@0#GD)RL0K?^7B?LQ^%\O"$F%G\N9%]G#VY01"$R=D_\!V"V0E*5]IDF])
M5V=SE,M-A3!PAKK-)(NX3?/#&I,#C08B(SJJ4$)M/(30QMAIFZR4T?[!`<RJ
MC.DD?_3NI:6P).MG`59`*A:+!>.D?&M$'!=?*_JE+O@Q0SY2X[PIX@X[6JB,
MT@C-M!FTEJWJH;6BR\W2]FNU)=Y#F6YWN);MMR20\\C);DL0ZHG49MX3KTYQ
MCOT`MQ$?:65]F\V/:A,;.,"UGVX_"XS]/XIFZK9"HE-?P]+#2I]R_WL:R'.)
M^3E4JJ8.&)$'R\7\@WFQINZWZLG^<(K7@T<;Q6)L^1C%*83>7D1Q''V!2SY9
MO*KH2T<1IW*A\YA1M;2Z^M?`K5/X(I!]E1*ZJ"#<*4BSFYQ$$KE^WT1>R%[W
M$>TF.G[P3I`*SZ&X"H-DW@*<_4,M3&,XZR)NR8]"+YCNHR.-B96Y,IG1F1!P
M8XOF$+F)ML>FJV+FLEG0/,X4$D`<P=-'QS1)B>G`#`#7L.1_7[QXTW`4WL6L
M^L$L<V(Y6,:.AE7+EV(.Y[GS;BD_$C(W0VGK<=B@`IS,`#51M=5$A51#F-Y:
M^=K+INE9`&Q@=YP;+0+7U>B$N5=X?LMIN)F%*5E+ST/Z;`)$D=1YTF\V?*8G
M$S@\=XE.&^/D)89]99KN0WIDSG.MPK*.<4,E=@V%D%PC4B4PR9%-A<CL92/B
M-I=%Y+);[ULL?NNLTV!X*]"#P/6_^>M!T_;HB"(JT,:<9%8T,VM&"W^QABXR
MD;6$`N6,6;Q7#NL%B\!X^2;_31:*02,QVK_1-A76FBFK!\R>-=_C!!.K><QX
M2(U8\MWPMMLH,#=9X4>#6FJ#!(+H=/9M/M#NK-)$[+(QYA!@7MW`.Z[H0&<C
M7D[`AA4V"6?-^"2#X3+OEQ?@I/$58.4+1\>3=2'S8TFY=-KG9G7JG8XA@9S3
MY!U50$V6Q61-([*#2U(R&\0CR,UQ&25DJZ?62\%WCG+9R`3.L]:H)-755"FG
M3IEH"%&TV"+W>BN"UZ2]5'*R43_$T>8(3ZN2*-B,0(,;7R)>G+*[M'N(X84*
MK8_^8?KLRQ_2M2/6P^-3I>A]/R]]..6WRV41R,::""%4V5$\4E;VF]8S9*VQ
M'D[)!<)<17LBJT2/&[YOIZI*`;IHHUC-&'VGBJ9$S75)J[]'XQ/99C3/)G,3
ML3>5[?UB(\%>?*,&A`'\8[:K+_+R<#G&[R0U.E#346H._G#:?R;0--S(DA!P
M61M]:7MR[32_J_A=]+ZFT'`((,\L4=+W$7CKKAW']=W&@'>K$"`\I%P12BO2
MLO&$WJRYH_HDAO`JF?<UVPZ?@M](,,D#1-EQ,9!!E([CHWX+2,M[2H;ZQ3P[
M]:_#M7?NWT)R:P>1+0;7<LD1.?`O40=W4FD\.F<B@*;I2DHMQ^1(:F*UTK0O
MT;B=B!JEM@OY$@WF0.I2#^H^*H,ZE/-8^L_MG4>U\=B<APB:GO,HMQR1\ZB+
MU4;/")51.P^[*/MW&P)YAW0;U>%T>#%ZA;=^B#<7."0_I'<$QQ+'3_X:PZV#
M]$RJL8VKU^X:0(J#%0,$^@=G&A)T.QNC#%#&`0&+"<J8T&NB;B_2+8FO2CB>
MR;L6R.M2[[F]&BE^M9$MO1&)8E]Q<@<ETQQWIBOJ`+GMCFL0%.J?]_K8]!_F
MIW6*-_<X/<;A(H3?L<?3VM;01&(LLX(:IES1]/&U5SNU?/8]`>>)&%-(709_
MD+R==XKO!X8OQ#MX)"LSLAQ0G`,Z`"#/>1ZB\^XH5[M=;.]B/XI+T^YEC#>^
M_FRD1VPLEF@"76Z3IIA=#C99\=_1/,C^.ONMT6)#UGPL`]H,3SZ$:ES##=H=
MW#)%U"LE54D;H_34S=P,DBX</CBF.'3G`5TYNLQM&0\Z=27H?*9S&?&G@;X>
M0IWZ,;L)9GC<Q_O18XT[8IEQ+EO)B$VLI14E-P;4`32W*0MH=<VL@[1=+(\=
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M+<D0A:X%:4K1Q7(J+%#&`_T*7%#&IG7,@V4(REM<\@$M?,Q1/'@!_;>7H&C[
MX[@LP\`<QF0#.HIO4]M[4W';.FTB**L\.`OEET4LS]<%TU_WHI)U89S*A+W`
M.S\,&^1U:VA+G*8!WOSBIX]0.LS`[FHMQV.&$E!-5JE`TT6A)-)8MUF(+**<
MT!?"BE:"L[N&$U_EMNL"61K7$_9B!"4+G\BF:DSWOLF5GZP#6D(Q$?RU\45H
M*UJVXA,,!+<=J$#V&`7O26W#D1W!CN#]9X<^D]^2&HZR6^5N>M;9\+T]);7V
M,%.B92-X=:F$W:1+#M_(5SSZY:,7[Z3Y<\6?CF!E<":V<"D@D;?5W'_&S]YD
MGQ'NY72FDAE>$UZSM&OVW00=8HQ2[]G:8KU%_RK+I9<%SU*XN5N!7!P3X@.2
M9/;,HFMD%B?XSHVY207FMJ:45%<1I)RZ6!DGBH`JC;#N=`W824:%IMY@+\&/
MD%,*<@[P9/(H>@C\'4NJ`O59\W=_L<@B1[.T+AWU3L/-V1\K5_YG:RI)(NK^
MV%A9ZUB#:W6)5+D7`*6J?5$-%3E?W"M22#M:8%GK:\FZ[+^D3BGC$_:'**2%
MCZ(M?5%\R")%T4.F2V[?452F>=)=]ZQD]90=.?BXU#TK_)Q>$%%^TUGL:I,:
MP6+8$+9PL=P2;ZO%GJ&\]A;;X`HSSJA@77%\P!U1]O8N@GK`JUK\SI:K^\^7
MJ\_W\]N/#K/^KA_QYAC@Q7:)=^"P[O$!7@M`A;<\J__%*?NCRCY;4VN9K[>;
M\%VTEK,&GYO11SGW<D6$">1BXU^H='>P-,K=.BY/N?R'&VZ%T2[(U.K1$3[$
M$<RL9&R3;&R)(CQD6Q!K*2X^+Z4)+(H_M2N'PMO;?ME/XZTD;_:'4'%1M_'D
M&%7,`Z6^..OH6G^AI;,`(!WQ8#B[Q/+(B[OPV*'FBB[G7[73=@&I7LIIY/%0
MCBV@H8,K]69$73)DD1GAD#3WK$MCL2US:P.:'>/H("^C4OUS.Y,IT[!M*XRV
M:R,1=2*WCCKZ@<Q"T.V2WG-I"-VE''"+PQ9H'W&TB[W#H[_V@H]Q=#PDB^TE
M5/B+R5Z/_F+U)6JN?]*"D*,R*:TAYTO[SEBU5_6M9>VT?\M6[66VB/&%5Q$Y
M9_8[FL/.:2&7-IUTCGF:^-ZK.V_M;_WU!$VW,2'S-=GG(A3/>%T(C=P^:Y`S
M^\1!1[3##>_,BR$8,[G#\?+1B_$]A@[R`[^IN*EIXW:NQTRT+NZ&<T*$%:*\
M4)792.YSS'J$3Q9?VR@IXQ(J(P,'.U[BK^G="N8#>2`#F="!3".T\8,CG%B+
MOW#G6L^[[HK)J6EL^==NG*1">)GR2:1NJVUG7.TZ@0G*R`\?7"3'6;N[-E+N
M@?M:8<J2[G5G@1?@233M+_MV'-97$5QF>T*)VVI#A:-MNZ/$W5L=QUB+C6J8
M<&Q:G'$?*^Q-V*W#6=LOV-\]PB4NO+S;X=LC+'L76PHU61S3)/7H2Z8F*S2D
MX<8Z6P'E5ML)H:ZFM9*PBY5SABCCB!A+>D%+F:(2U[8.8`B`%0>B96!#G$"8
MPJT=/F2CDK"QB(H6Z!5;7X_.;62+AQI$,\<AIS(JUZ$"JW`>.B@'K;+&PN^\
MX#+:[Z.0R35-628?[R'`J^@R"@F&A";%O,(/Z1*OCS&-_)$,<&>JK6NNV0#3
MQ;>61$!,!NY3RU+`3KB0`QPO2((*41P78+/1BZ4Z;']P75"GQ2)?I#Z,^P:&
MF3EV=TY<JVOXHA=O[KP3+:`7QP05;=?)[!6$W;AZ>UUBI/9&?6%5\[6P#.,(
MZ:]?/8`L*!,&E:7ILO0<MB\4CN`N2@E%GW1(MK3#SSA>^PGMB&.X@6UK&JU_
M0]$A[90W3QP(<;:AA:B_HQ<DDGL%O28M`R84=*T'4=3O%#A+Q'FZBZW0')<\
MWD*K\X:*P=`;28T!><&;OE1<\+A2,H5QMX4TW+0_);Z'7K_XD/2"+W1FS^PU
MWC512'@@<TRS[/?G_3?=PUVI9.:W1+O=A&<56)<YKRQ(:3&/N"@(K!Z5A(&5
MO^C,E8GD<A-@M4_YFNB_EI8H'$9%6?(%05E1UE5%&=-U*2^<G22LXPB6\$B$
MR\+^HS"YP-LHS@ILK[QGG'SRPXCT^8G7+)J&FRJ5V3^.Y,^?</H8D;\\D4\4
M>XWA)'"V*1FZDZO%TP?O7:>A5(UY9AJ^MQ;,9R_/3$9\4@W:&T.>&27LAK!*
MEWEF8&Z(\2,\9W[*M/Z6;.=4S_S4S=RX%ETX?#1,<>A:@:X<78RAPH,74`4N
MC8\,!UR7K\GN]4B?U-[B]"-1<>XQKW#B[T+XPR+^=[*1\+<G2"_C)8_70?3E
M)[S9$;?;%.=IA[0;%;79+?D"U')_#%PO1V`M]W@=>$D"@<HLR&_S]R.;6!?A
M%8[])P_6EPFOM3Z'^EB9G>%TL24SMT1U^F3HL/I.KUU8*=(S2-_I^MG^L7?Q
MT*SZC<A/3]"YA*@0$2HQEH1$\U)B(:B'S4G`SV3_M&J1XJL1E5[.T5Z[_KPG
M`:I'=ZHHSNF3'DFC2HB4X[I?@M[X',:8>-W?\89[Y4HO3&,_(8)?T104K+Y?
M2__5A9%=V^L.N2^;*R1#(!IZ`<*]/#>W3$#$)$1,1)6UN7;VW3M=Y>3_JRF8
MXIBKI$L[JDL!Z)*U6ZT;XGR#NSA:8PQ!-!J76LH6[>ZT%&1M7VE1=JC@-Z(+
M+<TAX?=96ATWT'66WB`JQ\+Z799EY5+F<*SB2<9VDR5S>-,GSP_@-OTZBI=>
M4#KF+Q97W,4QAT?C`[P$7V'V7\/%A`V&X]H,V>M"U3QIO^^ZSI?VL/>U,,LE
M?+6-XE<)D;%\S5A(V=^>AT=>1ZD7F.YXK/2O:,>3^,]H'X7I8P(I9,.=PXLQ
M&791DOU^?%(G3N-R1A8Z3>6%+/965_=C`6U??D=<M\"2OQE/URC612-S-:7#
M[%5,>B0X.T82W@SH-AK6$9A!*3([&+;S4Q"4-OT1Z;6%DS,S7JV<@C&6#I:.
M_(TAS[^4OD.E#\MGL0YSOIATGJS\**OQM#Y5X+G/^'+GQ6E(7*)W\%D(<Y;`
M6E#2J?G3MEJI(X`=76SD]!=:WYA--=F'*/L2E=)ZNZO7I--/A=_2^KKBK9I:
M%#Y*5P?<*[`PV$;UL6TEMA9PHZ'&&:^_-&FOP_@<O2Y2:_#9]UHZS-JHM=AE
M_$_N?U@46Z,G5GS;5HNU1+"CQ,VLRLZ8?3`.'ZS50:6T8+K#-&`.E*HD0B<I
M^::M5C6RM*--8A9_.5<=I_ZOL1L*G5%V_H`>Z?B0X'\<07^?R/]9$7Y"?6GX
MKK4G4K&VY(6D;/Y2_`G1OR'XHU,%4O9)R?'HC,B0H=!0`)<&GFQO_#2KTR4\
M/6C^M+4Z:0A@2:.:./VE^"L<915_;]S;]JY7&IU33G6I-T"FVI7@]>M=]/1F
M@WVF6.2'<WTBOV(7E;.0K/M.@H51[:]M-4;"QHZ2G!//[D/9;QPN;R2@B\%O
MZ-[AO`F$F;#W(CL<KGV<7)QNO?088TBVRG\M5`Z#AJWUQE@X2RJES_<O\"VJ
M?`RU4]CGX)=*#5PJHW%/EO2TU4@[75F)=GFRKRRNJGK8V4F8R%94[C9SS;W1
MN)IRISKR"ZP\[*YX73!-V+L"H^O?7C@,>]O38R<5:C%`/^F;=H^([;B%/@1L
MN%&NQ!$7A-$T08PTO4]>T/OD++`8<?J(,Q@\L*6W@11=-"]5%\W#7*P-`QCB
MDY,W-,P<LT#S34E!_J>W/_P+>J2DQQ?9D]T@\@M$>G_HK>GU8UB^C.0QV.SA
M=.WU!_G6^"V#7=;CBOWIHUM5P4!]]J?F9#%H?_05+B2^5&?2TKJUY4OVT@N3
M"7J@4M<??=%&_<06N>K8KRO8*+\L66RO_=`CVS8ON(L27Z,RB5[3EED4#,3J
M]H8\3*+`W]`(F`N/_&V-T?(18WKA-89Z)"8]D>=8,!R9`6/;R$(@E;WBD7W4
M,B^0D%6G-%"4XDCT0@PO?Q#ON`M5.9(H88<AEI0_FQI2+6VL?>LH>4*3X-7!
M5TALI@,2CMVM:9(M)E(++ZJLB*M*^IM)ZU$^/[I3X1O?>_`#^LI"3X^;&KA1
M9C4$KM'ZLNOJB9IW%]TN4;>MX'8$U]3RH&#F4-67D#SW,0HV.$Y8H(9R92IO
MX*C<H1)"L7;3E5U_+:WBW2DE68GZ/_.PL?-4T'>>10NP@T=A`30W9`X+4S:M
M3$#XNGVZ7L='O+G'#V2AGMSC]!B'"=EJWA&EB6@:OC/<NHV&U6XS*/QAN+J%
M\=MPHUXR?54M7<`P3BACA3)>B#!#!;<NS\/M8U&MRS-(,>,X(3\P3'!.<Q@I
M)E5*A7N\#?":;-S21XQPDOI[NMN/'H(LC"9!FR-&7_STT0]1%&)TPEZ,ME&L
MZH?79,P3',-9ML_2^:#DN'Y$/ME])Z0->UA#_-\GO/'7GE_J6$)D<URG.6&0
M@'R(GP\^2\19_F3M!0%IL\YFY4,4\]RQZ^AXB#*YGJ*`]$.6<!_>$%.I2`-Z
MV$ZH[6)OG]321PR8:]%+'LE(PW_`;S\1$2$J-[WTXABN&7[V@J/L5:QF6T=9
M%TV`Y:D7VR#2G2.-).IT@$8X4.VC/Y1X39"7(LX.47Y=)GWK@`[T#FL6;F2^
M\'*Z_`E-;Z\0_6'V[Y_G/T]O9K>KY03-R&\7U^AN=C]?7(T0U3+UXE2*JS)B
MN#QB#WCGAY!(#%P+(S4J=*I="T>V/D/F\*!)FAHAVV+)#IW4[1P=0.D"R@^C
M3)%HG_3H2M)IC=>4F"/?VG<ZL+()0V$@G[SX-\PV98FT)-F@#]TAHR%9!*XQ
M,54BUBU.%7;1V,190ELEC%*B6BWYAQN$*[S%A#W<<K*S4^48-+9P,P0:(/@(
M&$BO:\(:W+OX($Z>!DWQ4W/"PHK[L22[J@@YAY!"10&(`_+I'?U(;H!T;GY&
M<>/3>-/CZ"%X')&58GJ"Y"U0&P)6>@>:X3^.$EF1#U4C-UVM!X7WO1D&77O4
MDZ&+.^$<)C3;3TH7S#F7":)\NG@4>PA49?=R((<<".;,8/>YCI*:;W22QN<*
M'V*\]NFY#ODYP%EDT70/)SF_T]]+NTV^$K)$WGD9`"O=(R@%8+5?M-?SEG%U
M/*'.T_N4A8'$7YDXU&K*`DW0F8.85#V$BU3K%ONTGA,U27Y$7JFC-B4.#A,$
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M%%X;$%=\8R2ZNJ0M21=#X$Q>\5@QVQ9A%86F99!]R@&'2?'`$V="Y!%QI=`[
MYY-#J=*UUN0@^M[IY"`'<#8YJ"4W]+-RSC8FARRC!"7?WA8L['2:T,J$'\VV
M77M*&,\<H';ZS;(Z.1\LB61R0BAIYOR,L!&.X)10"T>+4[9&.:R=%%9F7>LG
MA9TQ?'5GA7>0AX%>R]#3G[LH26.<^C%]DRZH^6)B/)9H.[H.L=DQ^;U)'SVB
MJ^=6$74*:V""T`4G.W.LRB*N=33IP_8'[Q.%@YB-<OU-^\;$\IL:.+Q:T+)1
M?=F-+AEZLR9F0;9LP]9U@PRN6/I1G-"41%8OO$>PXFY8:KM98U]&^WT4TC>_
MC>_#:I\Y>@HF$3=_]:604]?\97PZO>6B-!$E.F%/MB9HGB1D0]OI&5`'454O
M?IC$"=!&K]#!B]$3L$#_X]WKMV_A"1-*X"$W>N$=T\<HIN7*OYU\>/]V\O8M
M_1_[>_(OR*<XT8?)NW<_3/[\[8?2'UM5-;<>1"C+<P:YR\[KN]>/KLRH.`\)
M-`$KB/QK@]+@\*N-E+;B^!J2K_)D>W9J=O:(4_GV\J_'X$1,$8%5C!I#XTO+
MOWKAT8M/Z'U+(#IBI#AN/+DTA"\]6PB)3NT@F^MY$M?LX?N&_%`)HXRHGJXK
M>BH^EQC)@*IO-S2PH1>W48K1GQQ.&?<X]6"'.?-B>,J;5()GM_[:E^VO=!JZ
MF1CT(?&YP!R+K@;JR]+%XW,NB+,IE[5%&2,7^S`M^%(T.&OESCI6D*KZ&)^4
M&PK1AVZT7RXRU_9F65TFZIK3V8$,^1W+65).#+6*8!,?A2GI""+*;AZ2R0PG
M^DF]VA$?2P*P+ETC3Q;6M4^<;.SOO'@1TZ2U&ZJ]=SBF^;?4>WUYR\[;:I50
M]G;:A!.*8L1XL7TW%$=`E)W+'+,&O2$XWQCYV!@<+4R*DP6'V9,*^!1K,LV/
M--1V4F_1>0QD0MBS"\8!%2Q&8@LRY`(;&%F_&^D\._Q"GK3['>H^.Y74U7O^
MM?,C89'P4JT12]U:8ZI<;5NIY8/BMB*W47!?*+BC+0D#KK,GX5^.8%-2%5JX
M*Q%+JZL9#=RZ*#(G6U7E+BK<45"%^N;R5A38X>U$$$1?H&3&=11?1<>'='L,
MZAF.%&&U9C0<W4RT`9K?2W1!J'TPVD;"3G<2G"%-E,I9HOSQ3\'4SM..OO"I
MCGTYWX3BW'"<7L;;G?&QT^Z\U(LB);KTZW;JIF#>;751*LF3<TC@1BL_#!U'
M"19%)W#[U^CZ`5\,95W(=\P*M9%_WO)5C8)]I\<T7#ORLY.1Z(D*=/Z6:82=
MK:IF-ENAV?3^=G[[<0GY<-'RI^G]++L%^[/#6S!(I4DFAB<<'O''*-HD\KPI
MXD\='1,WB)T?^BKD'7);GJ2++95A&07R[?C95ZZVX4)AB^UWHY3Z>U@AEVX3
M8D+C.2A1!%2[;;);"ZC<7#,YL[SU"4H$H@ZGG#3=W%T<;:47WI4OW"BE0$BN
MD!+I!G2AF-X2?<0ACKT`<FQM]G[HPQP"H1^S9WCE*;NCT6WLR,T:0<L=;RM,
MNH9I)E,7AY)QFJ",%\L!5^&&,G:=ZO18!Z2JV<-Q[6F>:\AC#\B\*C+,^#K<
MN4'1$**LD!O_BDSC042SG&7],7O.+G"GZW\<_1C>G1(G0/:?"?A7:>A.!XIM
MXV`Z@^@6(,/8TQ$N"<`5%[W(94!<"`A1R\1`($=M>3IL3%/G_BN"G?ZHHZ\P
M^(H2;$I*@,7>:\C#F2><I"`+V_TK8EODG[N9'U7B%T<;>G+K'RLU\^WB,0K:
M>3US3MY%3M,&J'7)V9^<O^OE@C0O_6I?N=)AH;"%ZC9*J:^Q0B[=%#4;;@MK
ML`[B*7QO+F7F:R<T1!RV?UEULK5W\%,O<!LX0(/$;Z,0,LMZ*8UY`Q-J5F!5
M(X>/3950*@].M3'HJI.>#-T?GI99Y*];,B["55O?WEH)7(SC!?/8+RM&XOK*
M:.4]9W)GC]`;KXP$7[ORYXW"5V];E%*;771)N7;S\U2O4^^9JP=Z\<#(6]9Q
MO=!^.51!Y84GGV9;@#O1L[0CV>'_=PX/_]FIV4UC_9'\`V>)T<]$+*5!%\@V
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MR2JZQZ#G/BWP63Q,7T5V3+D?5BU#3WN$W2E"M9`+I1'*):/Y,2HI,^#/=HUI
ML,#D'OL^CU_^/[JFO6"HJER<JQR<C?+'[_`76J%\2[<8,*"H..WR<OE^=.?)
M=*JL23R37E-7"6[U815);LWQZ&JSB3Q=/*%N[;]N"6_M8E$FO2W8L2B/$I\L
M"HU6DZ-_],F^+]SY#X'+L`\:@WOA$7=T6<J0+SM2D7SL*%ZJ4?3\Z$%+9NT#
MH$:>G>*?@/*K!R"-RK0[!3MUEE85W$1SW#&AUPU"#Y_]W.Q60=G*;>YSS5L&
M0Q3Z3E1+BFYS09;1JZBO4,1,7;2]?N@'@T'B<_#W[$["Z;4#$T'P1DU^$='0
MI'4)<:48732H>OM3>_GG<CND`[UTSS+:KM>ML!;G+Q^1ES]4='J_#"^4\15F
M_RUMNRY9-(CZE:(V@=;WN88B=KSBI5S0"\[O)02A%@<*&<^1G":8=T[IUOVK
M'#C5<>,C^1=-<IE5,*6[B:"<%CV+>L+;+88W+W0W[Y7N#1SNXNM=5G\QK6V(
MHJ;.`D&T8<GU4XVGO6;*Y>G!F0A>W+N)9]7J!2DHEC[V?%H;D_%`Q&Y(N,E3
M^2O:C,5<!$#D=M*`H+V!""3HP3)*7,9A$5783:;@RT4?P_R1U0Z&X[U:R57C
M&:69V%B,Q@2Z>M8QP=Q]'M*1N<^9*>//SIOKM7^[!;CW#5IY""&8P`XEP-Z8
M"@8+5M$0J%S<CE6*T:MW9\+&8S'9)F@-&Q<-3!TV+0TR];'3I&'HI0MLRG`<
MLZ&D*YJFQ2SQ/LOR1*TKC,)7^;^%X,9C7&TFR08*XS0SH^E0&YTM@QMFXCNW
MNBYSG9W`?H-.:6]_HYCA],/3)#9H0F#LT9'G%M@.F_/!8V]E+82Z-A(:U6!J
M0%8,J@%67>_:7M8>0UUS[H.%NEK"JQOJNF2QKO/;GV?+T<2ZDMU5%H67)7FX
MR^)MH*)M2C9=4(Z")F.0W7P:$'#T1,L88GZUV!J;]D6CL6R=;GPS;A"YF/%#
MG.&$%E).)W0UD'-UL<,PZI-ZY.8F>YU",!YR;`=H2J%A&;1!XPO6&&^2:Z*F
MD`1PL;UCJ=;\)]RX<==IZ.P9I":DTK6](1:#RWM-63I&3U`N[*80^,#U8<&I
M[1:]-R"*::J*A^P/T,9/#E'B!8#+]9:\YA,NCHD?8B(5JQ$(TSO/4J0[4362
M&,E4I0%3.ED9X&L]76G(9WO"*ECF%5+IJI+S'<64U=PO3>\3\T@$^K3`DX!R
M:'E%PB/I--789"26)8`AM:0&^5M;CH"_;4LIL1B%450AUQ`0]H]>@NG3?5\N
MNKMUVB<O/<9^>B)+T,LH"/":&NQBJV$1;2B-8R5G`%JVM&N!MNT2R4!:NXN_
M">*LZ2ZCQ!S4N8LE#H=6]7(!\I6/QS@S[W(=Q>5NH2?B@H,=Q52E3<7M[&4(
M]GQ":XG2=(XSE-+*M`<A["\J9ODRN[X1G2NZG`[U>T>8BVQT-S+ZQF9"8.R'
M^.T/[T=U(W/MAUZXMG`CTTAH5(.I`5DQJ`98.]Y0:,C:XXU,SGVP&QE+>`UO
M9*[GM]/;R['=R"RVBWA#^B,^7?G02>%&M8@1MG"[8&D`<;XXT9#>="'2P-W*
MHH.LA3D#E'-PN;80`ZZ%.O*_P6$!K3V9E9YWK_1D<72/#]E)P&);JB2K7L!+
M&SI?LRL@"9;IFEA:K,P5LEA;C!=\Z`EMJ=2PX\6WO`/J90G*$-:EFL,C.9-Z
MC.)TA>/]%7Z07L_+OQ_!^9((@/`4J4GR5J<G(LX63X2`_*N4T$?`P-J93UNI
MC>[^DD+XC4#X(>OK'/)Y34?7&[YWH^M*`$7E%TW)=;5&R;F+KA?$P2]VU74+
MWKT);5WXU(]I8ET0?C2Z7C;S>9(<(0/`8GL3A3L#!R]KZ-[3-T,2N7P]+&V\
M:+,L]B8!S@?T##C9GP^Z(S&:&((<Q'CF!0T+D7_N?E9HL@9=N=O,";8UOSHE
M=-1VRS/"&=;F"6$L.EY9]L&68W&@EWNS9QRO_40>Y:1NYWXV:`0D7/_K(&FU
MHFZ2Q.)^@"9]R_B@G)&+1T0ZZ-6Q@3C[FJZA*+B(D7E#_D0+,T(NKZP*ROA>
M$0G.F3M?=XS_FJ/]]8:;.ZL9S<6SV,Z>US1_SSWQ^(N0QM*%&_@/!((_>4%#
MX(T9"3<#V`8F'\(N^'3]91OYNKA.Q@\\"^>(@"54)J*7532^!GXH\77A20W[
M10X3<Y@QP%QGN:IHZ;T,+OT!R^$.9Y-B>'<X]J/-^?M4B4V:D7!CDVU@<IML
MBV_`02R.O?.[("(?S7U+9P3/EZTO]9HZ&C0#6/E@M<"CZSA-Y.GB,,N7*Y/B
M(G*""#-$N4VR:W["L,O9@VU`.O?T5_.?YU>SVZLENIO=H^5/T_N9P]3?_B[T
MM_X:WJ&Q'#%DF707!?Z:+))6^#F]".17E;J-6Z;9-A*MB[J5.*&"%>*\T*_`
M#5%V;JNM&?5(GOS\*QLE5=#NYT^?IO?_B1;7:#G_>#N_GE].;U=H>GFY^'Q+
M7R'?+6[FETXC7G@ZM=.5GZR#*#G&6&5+S4W<%5M7P2@77->57U>W=/AW2Y*2
MT4<%`Z6Q#RV\JMKU[<^SV]7BWJF^?XRBS1<_",@B<9X7M&`/.O4MP)2(&YMH
M!Y5;23>,NJK73L8NEL0YTKU=P3-[,MR'>?6'46EPJ^GMQ_G%S0Q-E\O9:HFF
MMU?HXV)Q]<O\YL:=#5Y[?ORS%QQQ`5^Y@%.T<6-A6D"X01DAT-4M+0FZF`LP
M0)1#R334Z\S!Y5>8PO5T?H]^GMY\GJ%/L^GR\_WL$YF+G*Z[LLH>)NNNIB8=
M2[/WMF[)"Z08>-8!\_`IT9<2[VGU_H#7E#A,6'TP^CCI+DK2.+]/S2K%&"QJ
MVI-S=*G9$7Y^UVD)M_85:$>Y.]V,,MYT[<->Z%79(\Y?UUH'O)#**C_R,R^5
M.C=\W_(J1B5`IWL77M<R/S8<C9-4XL[OPW1Z?,#S0KP#E;['!RAJ&.[T/:%6
M2T=%!/5!Y8=JYFBT3]3TI>ETZ,G8H)S/^+P3SSES&>T?_)`5\-36-]W&;E3.
M#!K7NG:8=!7/3*8NNL<YH1*K/@X)["-2[(@N/B_GM[/E$ETN/EW,;Z>K^>*6
M'1!<S6F2S!79)+7:(/T]_#LUD[=_>ON!&@GY1;%\!BQ'+Y`]=59\:ZXNC03_
M%CP$)GVZB=9'<$6\,&G#=H>S0IS7:Q>3N%;7@\UJ=)-!WYM8G.E@-?3Y"][D
MI86GTE851W529XBAM1GFYRV?L`>>A26)4IND9KMVYJE%W+:IE@ZVRFQ'9+=&
M8\5MV*`O![)GD]$U'B0[9MZ+`JI.)"70"ONW./=6;QVFX8;?26C-Q@:MV\[/
MVBSLS]CG-T!P-I)?$HW'&[08Q&)>-^S>P69ZTV$W'+T>U@.]*:IRA:")U-T>
MN%0"A?0+C53+<EM`*&9ZDNQ^U<W,G8J*IN7!6450?[A4NH4.3CF[QS_3".+T
MY&YTKO"6;#`WV0$OI'.?[N$TY7?J&1?;CYX?)C<1I,V5#)01!3=G%2U`\@.+
M#NAZ<9#&,@FJZM'6_$R?UAB8H#(%"("G--`+1J7F/;K!TWLOV`WE/5Y'N]#_
M'4.50.("8Q],D7YM;0%%C[.37Q[]]>-E=`R(J$5ZDLWGD!CX*J9KN!-U-9]P
M^AB=!W%WH#.L+74&S)<=K8@,N@#I(&']D)K20I08HM2(X94R\6P0)8@XQ>Q=
M(J,YM-G9!G^#D^1'-N$EZ`OM@C7M@@>,XE(7'&D7I+P+V.O%?0]=(%G]]]D'
MEZ4<15"S@3#>0)(OT@6E#DC@^@)><1[XN\[TT4N+WHH>4H]Z[>.!$"L_]3Q$
M*4$"WBWKY^R/M$@JZ]CR:U!:=B69($(<V'ED">/M,-I[\6\X)=S]-4:;8YR+
M0Y_(U'8W`U[7K1_QY@B%-NXQ64$?URD5COP#QT_XXK0B`D#2J"157M^UH>3H
M.J\]Z/QZKSO:WM8O[>#5/&M&!8R@0@=EA"!S)I!BR<Z2M-NEC(77B99P8[!9
M2&(29SAA5T&-.4FBM0_.'24''&X(;9<;B]A_\J`NSCP$L/08"]9LL&0K5F>0
MCQ<.N6^Q+%=(&T*NMAEM(1>[C:Y8>]QTM`!7WWMP(JA$94)W&VRS\1*55N[D
MEXP:+2OCPF2MH(;OWW!X,5X'Q%#]K4\`TN0-TS59C1P#:K>+RSE!398'/J4W
M!O,EF'["FQWI`$R?1Y-?P8TT[P2EU2K;NS9638!U&S5$-H!IJJ'(+9*5;J+-
MT5G[LGVZM4)S@.?&5_(M+-216=H;_$RFS*25Q0D/!]CCVU**T]*,+]AR-'\^
M_%9?1WR^HV_Z=M"-NUJ0^O8,'F$?JEER2ZV&UO:6**KK7[*IC"%=18Q9I3*^
MW?1\JO:0N6)"MGH8$@(YV5^W0#C=[6)Z<(&\/;S1S<NQ@=VNTRK(TD+XBY\^
MTL5Q7&;2:D,K-/.L5DB*@3Y;!,R8)R&NZA/>/^!8T`%:K88W>@,PW/8UF@SJ
M`K3E$9=R0;QIMO!$66,Z-_[*V@^^=^R&BWP<'#?E&>\%F_)>\CF/U3?L%9W*
M(_0X;/9L/0LX7FQY5";<\^)H%WN'1W\]A2-!C<")5E0<G/6W!YN?])N3&/:<
MOZU\TE#TQ3:OA8JF<!&?4T.4G*70`PO^Q#[VJ(3=<XM=>;X_^,`[/$&_\5-_
M1WMBB=,TH/%DF7N4AEXTM'"S6]<`P??G!M+WMB-O%K=V399_C8K/)WP.Z\5"
MR&PIWVZ;20\KHZ!`(-E'#W%,T+K7)3W=/IS:#_T4W_A/>'/GP?4<.)A5[&TP
MW+,E];-NW4;#+P/TH>2AQLH6P\89:XI3C\2E#1%MB;*FU+<7C7L[E4XA<DPV
M=;=&Q$'0^Z("Q"M8_CN9A[N.34#'YB"&%;9<^MN^M\XC0>%&7GDW??:UZ_MG
MH?!@Z8I/!S-Q+3D:[X[S8-E?:0N'KT6Y)#=D'3E/\5YVMR+XSFTJJ9K`90VI
M?32X;D@DD.>`^A6^1/33$:C#?10$UU'\Q8ME&6"%7[I5"8'0(J4H?>9,+6HR
M-"@&?(NRCP??M[<7?`SWR((+=)6CTVWL^@99!UI9^_5:#FX0)F*U"NT8AU]M
MA'EQ@OME&I45T&5K\N@?+D[L6'E)5K)T5WD#TI$_7IQ$Q.[]Y+>FU=Z0`HS0
M-'KI8FWSLLI]7";:`[169OYP0ID@J"S)!/Z0W<_DTB`N#OVKD#H"F=ROS@O9
MDOQAL/X$)FSCVC@;@(CM2=#`H0E(I6G06J*JI2?6XYB0<AA)2<X++X`@W^4C
MQD*3O8Q">C$!0<.YX5_AQ-^Q-#%-$U"?#!VG7.VM"\L&T1^WP:VI;R@-"0X2
M5#'+C"FB7*73`F?-(OM'-"F4^^0JVI/I4.F_1$U<3PER&.(9H?Z]PPE!)DS3
M*N9,H5@SAQI5'&36'\`FY73(6L?)6C1<'S(;`!4?/6L0<'@@K2U=XS&UZ-EV
M<I9\V[DS/`=:B*=>*6NU'4O^@`9@53^IT="!P]262BM[0"7QX2A6U.<92.?A
M-HKW=$&A4D2]IN-(\]H$J^(I-=H-[R"UA=+(_%IJ/!85S/U_`]"+4_9'O=G<
M@)+K.=T8M'AFUR;C<'XWE+%QEF_4;+H7XE]TF.V%,4M9#OB$)Z`O+U<THIK-
MF@\?Q]0&'H]H,FD[:&R3N6"RU/])*?=_=84YFHCE8<$ZB8<:`J(Z=>%X4L-)
M_(UY<U=!RV;PB@CF=KAZ\3-F`@FB;(OL=Q`\66Z,6&N'?L4B.+"W926UW\Q*
M:K\$KU_OHJ<W&^PSPR(_G-L3^=7?9F%*N-T='P)_?1U$WKG12+X9UC(:!<T+
MAJBD[$W/1:+52K+0;Q#["-&OK*W!!-G^02>OX("<<.55T!1+L594AE^1=0#+
M%V8M2`RZ/FLMGU:]">90R\3&LUCK&[GG#KEJ$3?XH(]I1=>P%UX<<.RQWT$(
M"(2**-9W;8F-[G!.`[KF<5T#I3$=X"G%-#S2R^GQ^"&@V$<A#/[H/$JG`6V%
M-ZLHD^W\Q%CC^^%G52T`?/YL_'C0F5)#DOI*C+_QCU*4MT*KB!^1U1+]#C'Q
M=0$2$B!>#B2-4-(+$+T\L%\!$,T)N1<D#N?8*_R0%M&1///%/9'PBB:WN:,Y
M6Z5W?WJ-75VTFD`K,K*UP=3;+E(;1/UN]2$MQ;U.BJPFT!BQUH@U'_Y5>&M8
MOV!_]PCFPY,-QX"&S.IA%+Y:'^,8YOT-H>[.I.A!*5EE'V+\"`>H$!'-%RZW
M.%UL5]XSPT=^#_D<\!5F_Y6861>";DRO>Q>4E[#MJ0V^C.TJJB0C485B9=D*
M"1,66UK5C=%%G##BE(=]5-Y;3P#2I?^,]E&8/B:0ER[<V<NR4,J;*I-<X[2L
M%97AU_4=P/+5?@L2@^X!6LM73Q98SJ@KM\;1G);]@9&K%N?]0(\H]'4%.DMZ
M1VO`.%R\$RGC(R2,SBJ(XN3..S4$_S1\[Z)ZNC/QA3/`SSC>^.MTNH-20"FH
MCA>>UQ-K^&YX+]XH,/?3PH\&]<0-$M3,+OL691^C[&L7;K2-V'Z(MMY3%$/P
M%:2)I0\3_SE!TY2H8(A/Z",.R:XEH#<.7H;QKUZ8)#C,"R_TB5GE0%V#=NA+
M\[=+%Z?RBZ6/<70\P(.D/"H98D&G-&UP,GWV99&_[<DY?O/6$CX_/K&%N[<#
ME0Y`Y:_/:#!E]<T9)S@I![0#3901)8LE0G8,+T6%F!N?G>DU=:S)&K!J6FN`
MIW\-;0;0I(U2E7/^(@VRM</_()[IR0NR-&W+QRA.5SC>ST.XBZ:'XHK[W#:$
MW"AD>\A</;MC[4U96X$3U4V8(%H]H41GDH7!$5*O4D(+E8@Y#O.S@SH[K2Y]
M[=8N&RS-I>V(K&%0_99HK"O%TQ1G.-WYO/P8$;E#4.$E7A]C%O^:7GIQ?")+
M(#HI291+LZT;[3,"QM6S%:+>]%<7PKE&?5ZBHB$J6M)BG[PQ6VZXL(.VL$J8
MDKP9G6>BAR#+X.S0"[-3R[.)1<N.M%JZO`S4`L5MJ`6:WBQ(3WS)O5U]23,&
MZVD'Z3**#Q&];H?[]9+]N+.73U&(3Y]HN>'K8[C1M!5E*S=VH@F&VX@ABM[L
M0RWVN2+1%H@U0;3-2.RB+92LX/46VK@SAI6_QU?X$"6^[J31V,*-$6B`X`9@
M('UORM\L[KFVP->(?SX2G6^!8)-]_C6<(G4^/1K_J5'[TZ(1GA)9.1T:-N*I
M,\`54,XJ:;(RE`45BI+'-;)Y!FZ\.ZZ^A!?@]^P5$&R!I+4F!=\,?_$M%91?
M>M<^&/3"6\)=6&<U^\YI-<C1R:NZI6XAL+VZC9?^DQ_<X=`+P/BDAB+^S$'I
MY09Q\Y++@F^&+;4L%:`^&<"GZ,"_=6HX8Q5;63&YM=SVS(C=2'Z$DNNKZ"[P
M_##UM]N+TU^/L2CHJOES!Q&T&N+GH;(-WPX;$ZL4I!X'R>ICTS;P&BYOA2Y.
M"-JYB?-L#61'@:01.N1`'D[H[Z1=3;6'\"!]`'&8@2>"A^HA/*W%X=IO3BLK
M^]A1=IU&T?-<.EHR][:+D@I92R43T7?^I2_=YW.M"G^Z]2#?0&.046.+,:B)
M$(185QJE'TAASL55:,UI@EB#$40-U33_1I%XM:G!&%1'!$'J9:2R#^=IRL+J
M>)N;,61-U7@.0H&RCR#E.WU3ELS#6YSR.CC79!3A9.<ZB+Y`<0*<S+9;O$[Y
M&S:)`@[$VXTN#]JQW"R<]&AO%C94%[9]TT6++TU0P1]E`D"\/SS%+-=H`NU@
M![0@"6*B3!`3AGX=T2>JO2RQ#_01Z2P4)I]PV=5_/08G]&&"P#OUB'R9>G$Z
M.NQ>>/3B$WK?(WS%Q98KZ%=XB^.8F%=(])X^=X'T!)NB.@T\'@R.&_(%L2!/
MZZ&AM6.7I1?@Y!Z3O>,10SU/>(I]ATG'D\WV#BOR$;0A,/S13#N(_+#&K/6@
MQS=M1*NGQ@(B**-"RU6S'`(%H8$2""A.1BR"32.T/B8I,:,X02]NHQ2C']RD
M9+8(*LY&<$='$%S-H1A!GX_@)B-E\?HC2E)6%CU91L'&R'<8M'5P46(*++\]
MT6TX[)6*F52"8+^$)A9A'@)(C,Y%6(%(%J:'.-H<UVF"$D+%S86,)23,&0",
M@;S!QYBLD>[B"/+*FW@"S7;#>P$C0-P#:#4:U/H-)*J'R$-;Q!H/;_/2*!L[
ML`ZTL1,CMR7\0*:]Q`'Y9)<]WI^&F^EF[X<^O&:#74R6T]!L[]"9I(/=A*5N
MR/<7'>D-N^.P(JP@/2\EFR>&@"345<J(I\P<VYJCWQZ99!%^T#DT6T:U4S"C
M[B;Q:<^ZL"LG"1'"'LCOW>,$$]_P"%G6R1XKB`[0*QF\V3.<W!!YI^M_'/T8
M<A$1C[ZF"=H3LR503WR<1&/VUV&EB$[[3(:."NT+@2CPD?)BZ?T+;KE;S?DA
MSI"X5Y2Q1'0[,3;/ZZ3_P!MM2OV7N2)74:^CZ0#R7ZY`'E<@/X0%*E6@-2C0
M,.ZZB*QG1_H\E;"1+VY#9'A'VQXJ]Z+F%`9UD6W%JZEO08C?9^;)K\?FUBQB
MSA"*;XP&<5%]#&"6:=/G\(9R*XQ=FVVN05L73L006.$[-!L.[#*,I));S5@W
MG-8`9C/WA-X5P:DW5,:)0K3V#G[J!?[OV,W9MVV``SD(&E)P6RM.U,9?M"<U
MO/OH"IM[D[9T!G4NW824I`2Y%56@&JOWZ:4'7K`I_67%)3GQ/;W`"\D`1_D`
M9\N789U3$=U$XY=H:.Z12)/AC,+D`F^CF*=$ATS:G_PPBOWTQ-TIV656J;`"
MM)]P^@@5&_+GS(8KHU'(Y6+5-0K@YRNZ$0@U\&IQ-(@%ZYBBJ,LUC:?-Q4.%
M?(@)R.<-*B+B,A:[7#CWJQ',"F0S42O)-,=URSOF49IY<4A$2=`#&X=#'#WY
M":RCR3]12H>#_,/I'GR\O3<OJF:PF/%UH>-1H>-9WV93)^O4/=?Q_"``CB;]
M<X*8Z?B>Z;A?TO$A9U[2J]D:X@*'V#0XI@4-5S-:"Z#5V<>`@(.9PE@ZF<9#
M>2Z^QL](C6ZM;POR79-+S.)OOW,3?VMY5`FV?&'_D(WJ,&Z&A1&!>S;R+'K-
MAG<F)G"X_]!I,ZC+T!=(9#*@.W2I-JZU6`=0M[,5FDWO;^>W'Y=.K+W[@-!U
MA76+MO.XE1="G;(ZJ+='R.*RV"X?/=*7BV.:I&2!!!?"S644S,FX>7+:%BY_
M/=H59R]NHYU@\IJX&0W$B,`I/R.#2G2@.$APA*_=EE"P@'OZ\\?7:/G3]'ZV
M1(O/J^5J>GM%O,T(*NJ(:PM![<$+POXWB2WJ-Q]EC:@:O'(-7]VV@U?L-1.L
M7G7'#TD;'R(7DP1G^1H#WWOP`Y9;'HJ^[\E<<808&2]%6RC3\^0BV^OX$+=>
M_^8R3*D(TW!S4PA`=AB?,O;3-`?;4+6W$[7A5\L6P/-%=`=2@ZZM.\O9H,6,
M)#TR+1%%A"KB9-$T145Y+<?U??OLBW'X,-7"?E0]X+)D)9=Z'A)TM,N2L[X1
M.7A59;7N9!TM3RQU1V79TI'F\,L9*P(KW:6SM8L;>".QZ9*;LV[8^K1':-VF
M':-MXKJ$QV7G9E(W6$.)T"@M?@B@0V8YA-U7O+_"#^DML0B6]5]AU*I&KK(=
MZD`I,AZ:8.CM*$XI=#WS8;ACQ2>@R:3TK(K7]OP$&339$M+M<9LQ-O+1*XX"
M&EG;N\,%8')UA/`Z/]HL0BS-H2_]<O@]MT)HOI^6?#;H7KE1!L$PDZ\1^1RQ
M[Q%I@%@+%YM;,^&_>_WNNW\"[21*>H1S[@W!013NO=O\^FU&`"1G^?Q0%%J\
M*:[*LOH2:5I;Z4O7UE836FQM^6<.K>U,!K6UD0:CL3:5\!]>__FMR-H^C,G:
M]$:@9&WIEZ@W:R-?ZLYNE6^=6UQ=<(G-%1^ZM+IS*33L#IJ,Q_*4`+Y[_9UP
MIOO3J&Q/<QS*U@=-^K*_:X(WQ5A>S:SY<]=6*!9?;(C5;QW:HD@0M3GR5J.Q
M2"T8LN7GG\=DE`8#4K++;=:J3],T,,LQF:2N.8["%,W-<%0FV"C^MZ__1,RO
M4%VB<C^@%^\NT.P81^C=ZV^__=/W+\=FBN9FV)L)^D^ZB]/RI\Y-L":VQ`3S
M[UR:X)D0&B8(&<]&8X(J\3_\$_I_,3&VR^AXB$)XLD;HISX4J%T>'Z)XXX<T
ML_W9'.F'Q%C?OQV5;>J-5-DV28N^;'/I/VN:9NE+UY99$UILF/EG#NWR3`:U
M69(&H[%*E?#O7_\@6I:.R][T1J!D;HG_W)NU02Y]77LK?^O<XNJ"2VRN^-"E
MU9U+H6%WT&0\EJ<$\/WK/WT0V=ZHSDAUQZ%L?="D+_N;P4L`3?NK?.O:_@2"
MB^VO]*%#^ZM)H;8_VF0T]J<&\-WK[]Y6]X3OOT4OOGO[%GV\N"-[PN_?OO]N
M5'M"W3$IV2)].-.7+=[ZVA?RY4]=6V)=;+$A%M\YM,-S(=1F""U&8X5*\;^G
M"]"*$?XP)IO3[/^2R85^CW?RVFO/U7A6GC6A)?>#(UAUKDS7G*L1K3A5PG\K
MWNM]&-5Z4V\$RK>"/:XU`X/-7O5CUS8G$EVRW`Q&L=^KBZ&QX`Q&M>/3@/!=
M;;;[,*I;>>U1*"\Q@S[W>ZLO.-"^>ZA^[-H&1:++PM&*+YU&I)V+H1.4!FU&
M8X,:$+Y[_>?O1=/@J&[BM8>B$IT&;?H+4/--`F3./W=NC$+Q99%J_C@"9$2"
MZ,2K^>,*D-&"\2T]C:F9Y;>CNHDP&)!*X)K?;X",OS4)7:M^[=HPA<++KNFW
MHS!+@1PZE_7;41FE#H@L!_><U:!/T#S<'),TAD=PO"KX111NDE&=DNJ/3N6"
M?MO:0NT\Z+OTXOCDA[M[#-46\&:ZCXYAD93@RD_6000Y!81FWIJ*FR=_+<'R
M-X`=4`XWH+,D]?=>BA?;7##3T30CX68HV\#DX]@6WWBR='D/P7GR3+.FX\S.
M58;%!ZL-GEXF9'UAZH^X\\0\$_1P0EE31-LBWAC]2IO7YK)A'W>GV0/<%6$V
M??83B9:)/W7WD%LF=OGYMDK>WK1&(J#JJ39\BGZ%CT>D$U?1WO//5T.JC\>A
M%U7199HAEGDPW<B%U-,.]KE#_2@\HL`?YLDKEF01C6$M?>D=:`+]&S_$<_(K
MF7_I3M;U#->M.^JSGYU^&&!F;`V\:=843YD35*1'R4DC3AO]"M01)=_*0H1G
M('=YKN7+1R(MGH=++\#)Q6F)=\!^L;TX)H1O<J[:IHT=Y#@WAI9G.M=N.6R^
M<T.QZDFVB\3:C`+4H*8TT,4)95308HLX'1<'+/91NLF%;A'&F@V6'Z*$#A99
M="?98$5;])#1L7<PRB6CI:T3'Q!"4>MDL>7%KF=AZJ>G.])ICUZ"[V)_?;Z!
MZT!G>%?1"3#W&JV(#.I`.DA84T]."Y6(T3KV"3B0O,@](X@X141)NG`KO6#W
M2MAI"79BCGEY=LR@'SCT0V_05;YH$.R)&KP]#[7$:1K0]=&==X+_W.,`WKU=
M@VQ7?K(C'43_3"MKL?I5@HYI1V9X_]0%+G=/;6@,ZIW:"UA3TH(4RFBAC!BB
MU%"97%:[CQ%T8I_](#]DR.,,^98BWY21LXINC&#-.(?PRJ-`WL-F:K'-KO;N
M\8&P(+_$FXO3/4X](LIFA>/8)R1]W+RK,J#B<GME#+:^S](FX6C#92A?TV*>
MK([XM6^)&&S`.#E4HN=X[V(1-UD=Q!GNN(2;[&5BCCLMZ#GQ1B/`;<T7L=O<
M+G[(F,+P/J@E2.Y_#)L/ZGM:R58OV$2I?`T^QRK>K\#7.,0[X'J'4(!=XF/W
M-8^$TAC7/8V@]=<^0C(C6_\TR-AV#520=.Z3>L/?9*\E_*Y]U(CP]^*SH%9[
M[#\<8?A7$:LQS`J1+@^!+SHP,FKMUC=I@A/Y(T539SY(2RZ%WRG30*L(996E
ML_JSE(YS7],9)[&O=1EG&O%JX`>&,P$ZSGW*0#BM^8X;/_5W=`"+PZ:+TV6T
M/W@A\5&"`#/M5L/["@,PW$=H-!G4-VC+4P\_RENBTKDA67_DC26A:H/X`BNX
MD@(7F5?7O+&].QB%E,+0.H-VH[.(>L"==J,Q6459HE9V(0G2&X-EZ&+KW38^
MD3GJ-^E3LLI?A]=S@7!<FTM_&E1G:WQKHT>_</M"2E-()\NJKAW86M,O28=%
MZRA>Q.EC=.%'*5X_DI6<5/<5WP]O#5H`N'TT?CRHQ6A(4E,!W@;11BAK!5N@
M?@U+H;NMH"PNYFZ]@=T!L#?U+$*\\LD^BM^GK['_!(<U;)(\"9`H6PQOE)H@
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M@M4]=M!M%"*O^`(B;SE^CU)P-V<LUX]X<PQP\1ZKA#^Y.)7^U92GPIR,&W?0
M%FYY'69*8_`%6CL!ZQ'E&1FX9A29.'TU67[^Y#SEA0!N0]8+Z=>CF:G.+R$5
MGPZN:(URZ#V9<YT10P2!/>)J3HZAT6X\:B0$I%*H2J-1J)9`(CTEXRU1AP0;
MXM-_LOO#07#[)#_O/__"P0F_6,C\3+_ZYV%/\46\Z\?&["MT^^0P\:&9J*]O
M7Z.?[=\V3=?KP(MQF#9=,8D^<O`V02IJ_OR@]L6P+PPD[.M'0/Q#>E/D3@-;
M"MQ%"7N;8V\4&8.:FXQF9JW!4$RJ^?=CF$_/A-%<K]WTD87GT8OWWAH?4W_M
M!=<8)W>>OUE%'R-B$B%]'AL%_OJTPL_I!2'[F\`Z6M!P$*#<%F@>IFQ*8-A@
MY7;2U4-<*W00$$)`"0*6"UKH5T8-`3E$Z3FYO^\)]190'P!U&J'T$:-=3L]-
MA/8`,`N(_<9IWL7XK\<-32'4D!Y#N^4X8C4;0#5%:PJ:.8_7E,JD&;%)VB-.
MP&UN"VOH2C&;!X+N[QR=T_P5@Z&SMX-*$K*DP9LK;^_M<'(=Q=,@P#N\N8S"
MA(QD?!U[QTV6AF,57>(8'I!>Q<>=\(UX%VH.]F3=P>>;M_:DAMWE=953&!$`
M%%%&$A&:*".*.%5$R>99=\BZ):.,*&DGV\?^>F*3]<26](27]<2:]\26]H27
MP/Q^]?E^^G&VG%_2!#3W\^7=[/YJ>N/FQ7W_FK&5:T9C?SBL('%+/(B7/"[B
M.R].LW^4]G\T@>MBR^X]>?:T=Y(]9TM:;G;WG8#SJ``KB'L+`6@+47"=#4T1
MT6Z@A/B_*]?_E!I<'68W_)R@BZM]6\!I#N,G#HQ=W><Y_\9NLS>^]^`'Y#<X
M(4B)*^IHMT)Z8[;=A@XPLU\-Y(YM6`RUFQV7:**,J%U;_H$A#_$.9MQNMJS7
M`55[#DH`/=:(3LMA%+ZBSZRC((`X3[XG<1BUH^B$6PR_W$<A3KWX5/5KUMR`
M,9-1^H:67:7I,#KVD2LO8MXIK5P+88-*?,Y7"NB%P.6\[&7]D$:I%[3T.!8Z
MB_0#[1UZ#$HW4:4H*W=>9D:$2$^?</H8;>;A$W%YL)]*!-6U)![$A("CPF/&
M$/.R8ZVQ]6;51F#.E9`U1JPU*C6?H*)T!RI(]&.'.):OXCO!N\*Q_^2E/FE&
M)O04;7#B[T)Z.$.VXH]XLV-3.SSHH&31CX@]72FQ<K%WZ82:(?#E"-H_LP3*
M_'R7I:Z9/1]PF&`H971->H%X-6F(BE%K!\\OS<'E3S'UFP[[+--4+HDN<1(\
M<51&A!6P`C)T5G?YG+H[TGGIB5=1O9;0>?FF!G>"PK[Q*I^H6AI:OJ_A.:1P
MAA4D)ZL2,K0$JL.CR<*%SW,W?>\GOS6$>#<W<;/DT('!%QDF\O>VK%`(+)]I
M4?$]@@;.@[U+!3_S'W_R<4Q&[_%T@Y^($LAU2;>QZU)U.M`$Y5@-,/6F:=H@
MFHK+Y0W&HVZ?L`<+M.K"+9>S\9V!(0W'RF<"M*:#;1#VKXJ:D)HTLDRBLILJ
MJ:KSTI]7&,J$;"YP2'Y([P@8_J81EAV+[2KV0G8BL7@(LK"-A)UV2"??#A1=
MS<V=.Z&8NJVA[W%F[P*W/O%3:B@CAX#>!)4IPBE[01.5B*(7C&P_QWN*+;;=
M;C@'#/N#M``=Y20</OIEU1,;)YZS;QP]UQ4)RBVL4<+>;.9<I'H=)A:YYMZC
M+PYD=DG]<,?VA#=1K8AMXY>.\N'(A>;CKI!V0#/B18H_XF@7>X='"&ANV$$T
M?._(O%0`<E/3E;P_LVL0M6:"_-L)*G_M?#]0O,O/J@DDUV0X9L\ICD,ON#PF
M*5'G.)F&&R@/?P,)MM@LHY=YH1U1UWD8NG1%KIY6^Z`_'>X*NBE#`R>)H*,1
M)XIRJC24`>B^HH3Y9:OSG`V&77&C>#C8GIP;0^@*GYN`+=R]*7\'H.=JWU;5
M;^1/%Y702T@8N<MC#$]LVW2-,,=<,D$9R>$C',X1G0NX@L9HS?XN25EDTH-W
M<436<.D)MEI0VA3N.`\P8=]B*QW*Z4_H'I15.\UYT+B3X?M8@5D.X9!#P`6$
ML`6$VH#;TUU7*BO5U>XZ6@K=L6CJ):H.[5V(K=GH2\&1EGK5<G<Z[45I]UGH
M-KY2*,>2A9ME&JU_>XR"#9GO6(A(=K=KLT]I:?`R)\18#=O7AAV@'`CJ2Y-'
M+\99\W^FGK4%K)(R$"]^Z26/Q&T_^1O(J/PYP9MY>.V'7KCVP]UTG?I/UO0>
M8BR`'>+\(!'S"V")_/`ERKFB@JV#N$F3+JDAG*W0Y73Y$_J\G%VAB_]$U_/;
MZ>WE_/8CFEZNYC_/5_/9LLN`02Q52/8T)R(/+;<'R5RM#$Y.>8(X;42)NSC;
MEL*L75AQ47>M1"VQS.)1-G"J[J>8KL'/4V;:Z&<>D,09O0KH:K^67-1%MVOV
M06W5ER4<!3-^=8BC-:1?@?J0<$M(_=8&;L&C0ZLL$"7YZE<>Q%KO<.Q'&W^=
M_1;28ML8)_&]$+@PSC#_$[`<WE$9=(;($1\XBH<,Q5J`8O#+G:1R4!IC+YD^
M)&GLK67IOC7:.;T$4@,ZNQC21]+W95&CZ)(+I.3L\)HV0[_RAH.'5K:&XP5D
MR466)[N\$2)++\]:)+(H/"WYZ/DA7`PMPOPR8+'-5AY>0&Q[&\5[\@\L,0J;
MA(>/7[;;)3RTV0[50:.>;8JL%^B8(""/@#Y:A"CG`+5W<QZHQ`1Q+BYBI7OM
MG^5QOX=G7=&V_-IB4SS$<!(M/91*E)^2[$`E`E`)2'63JP3IF&VN$H>"R<AB
MK*]PZOF!8O6@TW`\\=9B2$U1U\U8>EM`:`FO%X'-FCE>0;3"4_A-GG*!;(0J
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M#NAZ4SDS.+4K--*4OBB"&9!=$98OGL:AEBQ@0:%YYQ^YS)`CTY]F&7M3D9I0
M@A(HQ_V1)=]E2@!:%>-'T`YZ+D(=U1AT(;M4N<<'>#<6[O2NZ02?.[V=DXI_
M=BFGE+OONSB1H+(KN$KE0[JB+NZP5/=QPRG0#=YYP2<O35D@]65$CS-P"&<9
MLHHIAFW=J)81,*YGK1#UIG2Z$&I!>-`.90VIZE6:HE\=UCSIA&OV<7J#[NX7
ME[/9U?SV8RV$:T"_>WQ(\#^.Q,YG<)"C#(^0?N[([RK$S_VNAMSN.EWEGQJ^
M'T>W2_V0EN1#/K."ZY9U>HQAZ@MY7OLB!E.A_@;M73VD,@18O)QJB:RW2<,$
M2OUM5*DMJRJ0U:`HFH]BU9(]XKK'ZV@7LFKKC37>#-HY?<FG!G3V9$\?28\*
MIQ9=\@@/E1I-4%:0;02%V=K"FFZB`\_<D:3$?KQX@XZ'#3$A%&>6E$;D1X8^
M+FBC8[@A^TRHU+;W`V*&44A^8NE4P0Y]LI_P]P=!I(^+%^CY75?V`(@^`U;.
MQMK-7;\JUX-7?S^NC\O%H)5.->BA1N5,H\B&83B6+:FZ'N).G5$?>2N]T-_A
M16?83;D#-$_+7@#AEUG*`-?.W7Z/0#OBL[-S'[T^<5]4F4CUX(=93JKF-7QS
M$[=%E9M@<&,UD;\W2U0(+"VB7/Z>K@>N(`0V]5.XD!W%BKRPJ)D7AV3[D-SA
M>`GO)&$%%:[]P*?B&TXO9L1<SRIMH-<GDRZ8!YA##$$V31V<%(2T(TH,5:F-
M;KKH"/X,'>F"!R_QUS3-'^:=<2"=05\8PUYAXP='F$7$7UA[!P,/;2Y.Q0T%
M7%`TFJINH^'?K^A#X6]3U"T&?7>B*X[PM12Z.)U?-"%F0RY/_3O#TGD$9@6$
MZ@5(:Q3D([(@C(E!\S@$>DH`0U:'YO`1Q_E-YSRD+TN@.[(C$<,[YB8"X[AU
M5D.4W4/K8QOL9KH1C"S?:-X:E9I/>%HX6E6*?4(]29ZEM-.Z4S@/D7EU#=:W
MPY>/1%"R`Z/6?VYQ`L/4;CG\C&0(BD]+FLT&G9N,9!*$5_'6B#4GZH:8>Z]/
M6T[<NS5\:X;/#ZF+%TU?-1\_Q"1L!5\V>%U22-03\+"Z.?0Y3DR#]](T]A^.
MU..L(JB<5U31Y/5JVFAT/=]K+4,1RF5!F3"H+`T49*_*DQ<V&C[]A+6.%&<^
MLIWI*`\HGX>'8YK0LASOJL6PN@SFOQ\CV"P=8G]-;(X8G[>F+QGW7OP;/&R`
MB<S?$!6F61$D#P*I4.B=LSI4ZGX:)VR%^._M#7/Y#5Y$CU>CAP3'3]0Z?<HR
M@_-^=*/X7CJ*@Z!22/>AGT$ZAC(H'T8W0!^T!L@9(MD^X-*+XQ-QZ6R=CC?3
M/3Q-%3S@D<+C%!!KZG1@OC(TLD&9):E/-E-XL<U%-\'`FV_*=7]<#LM7AT=U
M$5,JQ<S3I]W!+#H-Z)Z5_#I_74G5J.F2IE*>FE-#E!PJZ$V*EY6,I(MQ'#'\
MX4ZZ[F(,-;.S<I?3D%T`"Q-TGQUQ:;5T<[9E`(H?:K5`TYM=ZHE?SW=-6^7U
M9(O76T-D1U?86C=(61U5MEQGJ\(8K[%/%QX.R[L7N5@8$MA7-MI,4P/7N7UD
M$.HY?52R]V88C<(VY/#A!E!\[S9SCX;TY(^OJN4"H*@P+ZJ<1HB,,)EOV"?K
M4U%Z.(8XR^2+=QB%790R3AL8AZ25:PMI!%,W$RT4`]B*3.P&@ZDDV1^+U>CB
M*)M.^6SGZ[$?R?,%R*`+,^B:_'Q[A/W"8GL7L=5F,@O\O4\3!$K,JRO143U*
M,>P*Q4N5EGW0F^UV!JW_I@5H3A"GBAA9N)3/":."LILG");[(L<:YE@/.5;B
M&!XPPE+$H_`!#7CGU*`@"BNZ(O\V=P4FM$?G$<P[1L,QM.\1%_[!J`M,W42S
M=YB@G`/8$?`8F</HU#FW`G=1.`H:IM@&<4GR7["_>X1S7H+0VV$N[16+?J2A
MELGBF-)'502;C?L)SA)E/$M#S/BA$L,)RD09*4AX2I^K16UUVU+TSI?3YH!K
M+^JRL4G8B$3%Q^@5CXWM6$QNZZ?E0L%=5`H*.E2>NTQ4H02IO5""SJ@:=>BV
M%'_LI/Y=`4A4[6<VO;\59808YH"O+^%*3#["GHUQLJ&IE!QB](8?SBH8L6R'
M=K)U[[*ST>Y+.AIWE058TK)*ELI7LG"ZC#"[;4EZK%I9]AF:$(611@XBIUQ+
MIWITHB<?&V\XU<DKV+ZXC5*,?GCI/ITP>U))HP5E-9?%G[I-#BP2^SP'<).\
MO>U^)`+6?%3VV80_/F5?NM!B38DO^6%D&GMA$M"KXC?TNFL,3QK/TRJ3K17'
M99SZ0)N2Z\>,QJ!%"1%:HNW-@-K!:WK#J,J>/;('C%U@EZ!Z=:AC,%0R199*
M[IGFLE"T=FV06N#J1FB$:@##4\%H,C;8A9;+/2:CLR]3=-6\$:'-BI#2A[[)
MQ2E[PK78\O`MK<>^.@W=//C5AU1^]*MN-?C#7UV1)/N`BU/^.F]12C_KWDHL
MX7LXH23#!X_G,P+.7@+W@L;AXU_BC?9^2M,7GR=F-<EY;T+#6=9[<Z"EO/?M
M$?8VPYI"$F<-OH.ZT7A#TTP,\KYW0>8[CSU<YLF6!,:FV6X,;WL;`,E?]@H:
M.7[7*Y5(XU6O'Z*\.;\0`0+C>/%JC*SM>U<;LXRE@2F>(T?YP/AL8*"T:*LI
MI[V!SYZS2[$L*#JYC=+LB0#>K"*>0;]M=VB3'ZF[,.P>(Z^B27M\SL=(\`X^
M"N6,^'."!!%6*.<%9^V<VV@=6K?>^B6*@\T7?P/WTZD73&!/2AUAVMMEB!4_
M:$U'%.X2X5Q'\O<9(=$1KZPCV<K>Y7*^"""FFQ+)@KWVE>M@\XJP]>!RH92]
M+:OK8C4$C[-]ML,TC.60\1#/4[R7W;L)OW0]\C6A14\+)-(.H`%E\9JT`+Y#
M],-.#_2S\L+)??[@ZQ:G9X_XNH0*</JH8$`C!=H_E^M!>$4X1HXA+F$@F]8-
M^4]`*R\1G_S%"R$Q!J3!V$3'AW1[#)#'&_Z/#^__A%X0>WH[(3]_^[9V;6Z"
M>A73NI<GFI:%OF^V,5"<*J)D)^SAM(MS;B&\^D%"DOR(R&2YCT*4P)?H$0?P
M]H0,#&L_@:KK<*Z-7GSXTP^3]]]_F+Q]^Y9>)WWX\[O)G[[]GOZ;1?VUBF,0
M;D[N(8%-5I3T.HKO"'&^Y%AL!9F?FXM*6*$X_!;$4B?P74='<H-N-*S(*@@=
M+Z@B0A:5Z<(QO+AZH/LR%_UU2:4'HBTX@U(/^,+LYX-L(P;0`)AE#AKX^\G_
MIA/XH*ANT1SMD#7.UP@CN%OJBN^XWWMD<BW!\UT^K2^@Y)$9VB$,@A:NPQ:D
M(.JA"DKI!S`/D;A-%C':2!\=(%UB=\3A!5_\)+F.R7I[09\45=.)E6]/)1\Z
M"!]H%#D/%Q!^-6QX0(,(=16%CQ']&K'/^TVTI+PM;RL\JZCE)%EJ7QW>VKH@
MKCNY.N([&B*T])]3C.4FUOCU\':F(3PWMH9/![4XI1R"!`RD!2)-$&N#LD;.
MLK:U@_'V]9_>_A-B8#8$#-'$GM,:JOQ'VZ$`Z5E$'5F8'V-H9>^R\TPH>*MA
M8I'GWSNW23$`B556/W9IER))-"R3-QN3;6I!^8#V49@^HIOYQ>+^_R&&>GU_
M.TXS[3@R?5GJC#Y+UC;4\\]=VZE8?+&95K]U:*4B0=2JP%N-R$:U@)R9Z.NW
M/U2L]-LQ6:G!R)1F4YRUZLM&5U\(@).FA58_=FV?(M'%UEG^TJ%MUL506R9K
M,R*[U`#Q_O6[[\Z6M=^/R1*UQZ%DAREMTZ\5+D)L9(BE[\=ABS4`3>:8?^S<
M(L\DT39*TFYTAJG"\N'U=V>V^;[G$AQM;%-O1&KFB:*P?M]CU4177R(C$RU]
M/PX3K0%H,M'\8^<F>B:)MHF2=J,S4166;U__^<Q$OQVAB>J,B,!"TR^1^2%S
MZ>+E"F_]$&^RQY]WA.5T#QF??L\NE^\(LWB)XR=_C>%IZ&6,-W9R^62<$7\8
M"[PGJ,R=IJT#_B@3@#Z>12^8#)T"GOJ'K0H`.\-YH#B3#"?$&+U!+]9BH,,7
M7"\528#>@/KS-'1@,PM3/SU=>LGCG>?+\M@:4W%;EMT0['FE]I8H>W'_K>32
MK)5!;9%H+B>#&!WR!T()`:F1E`@Q1%MJB=8`Y2"`,F2Y#XCE3T_@H])IN(%J
M>0>87*[\Y!`E7B"+E-9IZ*K8ARZDHM:'*9;>S$E+^'I@&6LTH;-<2B-&\X:0
MI#-KZB@/H#D@FH4%?8G]%+^*MEN(8P[X"Y)##O:0@\6<:)=)&R*QP6[CZ,G?
MD,G[]#F!-+#YBYHIE`^DF>-MK$\@:0=S91D_>/?^`E@B/WQ9>H55L!T^&YQ1
MEXB2/%Y.ES^AZYO%+TMT?;_XA!9WL_OI:G[[$4TO5_.?YZOYK%,"2(F`$+&6
M##YF.=<QCIFX2Z1C]GDYNT(7_XGFMS_/EA8'#$2#A_CD/^`)GKP`PD/93F4>
MKB$2'E]A]E\;0T:'"UP$_:'$<L*WGIPK>L'YFB_].P^:8;?4-SL9!C];5`!B
M^@,NJ%E\,%!*J,T?%<H&K[0OU6SG(OC?`%`1XJ_1:.!`?FV)%)G>\S>^N7'P
MYFZB\6WARMZE.@JRMXR"%K!AH[/)FCM\59M7O%QLK_W0"]>^%\Q#$)L^`&!/
M!B1["<VV;K831L#XCJ(5HMXV%;H0SM6N5(^4[,3SIJC4EDRC[,7."%[N=(%:
M>ZR2O=3;0A<\T2[8TU=Z6+3-&-V16:5N:;=SLS-2HSX\$\(V/$%KQ.OZ&.T<
M8,>SM&I!VA$?J*EP3W<QII8))P194[0\A>DC3GSS35A)0/;B;>4]%^G":F]V
M+!S8SV\O%Y]F:#7]CV[[JSMX31>%O*#J'>G+&*>99\ON(Y)^H=S-;I?SQ>T2
M36^OT&+UT^P>W2V6J_O9:GX_^S2[7:&+V>WL>K[JMI&L/TN$.ZP^`$TO+S]_
M^GPS7<TX'C)6=_>SGP#HSS/$QJX+F%E60X1L^&C]ESY0\'H;Z(X`6/XTO>\D
M<98UAE6B)Z+WJU++V4=0G"5:7*.+S\OY[6S)U.OC;/'Q?GKWT_P2$4#33AIU
MG@3Z%J=YZIR\X/=9\D,;EF^4/]H$T'1-=B1'>G!*L'ST_!#2`5V3B?6*>,4=
M+5.UB/_]Z`7^]D1`PNG#=1!]^0EO=CBIQAUT.8,IR4%S%8,D+*L4R((*8=`B
M1H4X[,@&!$),(F>A`18[4YX@)4'_T]L?_F4,6,^->QZ2%?&>;FRSTAL-&3,'
M3TG;`"9_=RL')$B8Q<%)-N/%T3RK=V,+:S$`..`2?\31+O8.C_[:"S[&T?&0
MP(/\8YC"8VSZBUH07P=+1?ZF`_^_\!S+Y4:(M6()'[)V['<N-;QM!]>KY24I
MCD-BLWL_.9#U%IZ4LJ!]?KU\;?^Y8U;\[9='`C,AMD:7Q#=DY;SS&M\6:[8;
M_O35"!`_?=5J-.CIJX%$TH)^>6.V(4-%<Z=A<5\S--6Q;!_87DR_'%Z6$-H+
M<KTG;@;'&R^0FGGM"P?7*6(A\XN3ZI^'O2(1\:X?!O*OG%K=J&15WFZ8"=M7
MV/<M67H9O&$\_]QUT+=8?'',=_5;AR'?(D'4$=^\U8CBO;6`O'O]_NT_05[;
MXK74J-XM:H'8CB&/T[V\+G?2E)G7B(+K/$_:(,'(6S0?S.Y;R]:8)^J^L<!\
MXCYU<$5`D(D"A4!Z/'WV9<&QRE9NU%(33%D5%4T&5S\M>13Q$_0ZC.D:;8A^
MA:8.E6Q%&)S9TU6T]_QS;Z_QO1O%4@(HJY3TX\&522%)/>,P^;[NM7YE;1SJ
MSVQ_"*(3QI`B!%)MB=\E*[]VHSL*X<N:(_ET<+UIE*-^\99]C?+/G:UYVP%0
MRSV*^?A&D=M?K^GH9N8:+,WI.6\WICGZ3"CCB?JF0PV!+N$YR^-#@O]Q)+NP
M&61A2IKNO_)/$?NVH6+<H#(W9_NM">TZ9:N)])\OEK-__PRA);.?(4Z@RZWY
M313N5CC>7^&'])98KKW*$D#Y54I((Z`]*=54XEFC/WF@^?V]&\&QO,.EN.4P
M-N13]((^'?^VGT<3"B5I*7/W>#!^]\\*2A[)&&:WPE&87.!M%.,\;@PGG_PP
M(J-ZFH=$`DS=894*//F`##?I([SV@'<ZE5)F772N7,.+1EL4$J-"9,1DYEGX
MJ=2(BXVXW(@(CFH$F?"(28]*X@__BF;8L:FM\[(@+O3`.O,`+[`@&(_&$Z>T
M3\D_6N;Y'[\**N*<BO)I6<VPK)MHQPPZ,8IKD<K#/#*5?P$?.G%S>@+S0FZE
MZFPL0,7:74MQHTE7=&LO"+*'+()CZ::/A[]G48O.;UGD7PYZQZ(2HS[%%1?J
M4[IDAB;\)9>+RY4N"&#1[VTV-![<"\AZZ>YX0M/E/?K)/T!1*X`&64S<%#FW
M.S;V[D*S@'?B)>05!FJ?.*@M(!$SKRIP]O=AZPD(F=>=+?ML`I.#XQH"Y@+;
MTSC#?"A%,5$!D`ZTAM?ASL"YLK<F-*A5=)12ZYT2.^Y9U)XI%1E_4$'7Q80V
M7"?4WVH-UPDJ?S,Z51C<F[&]$M]*S9/DB#>PH2(_P&VU#2=GP&*TOL^XFPQ=
MHC;],7I*0^&[64UV1).?XS!V[#@G8_AUN-;^>DW@<26]Y@W8:Y9\\8B5S6)H
MM#P<Z?QEGZ`GC5H[SE"C!TZ8IZ:YJ;ML-3IR*2X+P2YYFC@X&I@@__QEI?/D
M-:U@-B7#&P:B46H;-T/9C]O(:J::0LZ;C<Q1G,'1\A!9F_&XAHI`+10I:S\Z
M7]",J]D)](FID_'W-%A][_"6:;3^C2U<;.SF).1&NW-KA&^X2Q/2&N..K$%0
M^8+8*V=SSO81'E\08[8@3H`P\MDR^/!5;!B&[@N'>>MHFAQ!,IGK*,;^+F21
M.>O3*O;"Q%MG=S[T7P&[`=K\_<@NRV\QZ<>5]RS.VGF>.20;%'=BN`ET=-7=
MY:#)H64X]W;NE7OZY/D![,2W40SOEI=XG<6=";!!R@P".DUC_^&80JM5=.=!
MH%5+G;;.?5RJW%/GZFBP9=;N%+>4;4>&E48N"2Q69J,2)>V%DQN%[+'3RLK7
M`YO!0]1[P]"8_(JR0A5>U>"R"<HX(LX2E7BB@NF$)M(B"RS"N)>%)"L#-0LW
MHKWL\+WXUV-P0A\F\-KZ78]XEZD7IR-![(5'+SZA]V+0HW/%^=1#L"\54T^W
MSC7C-&I7W*;36KAB$S9C=<7F&-JZ8AK:GK,#CXR`(2HXEAPQ]<.+K\,/6^C"
MK\P/VT`\%C\LPUFO-3C()LX>VW'MWFQWI\ZVS1;/T>_7SH`VY:JFO6!GP=">
MZZ@7#UT[L\5"HBW+L2XJNN'IM,"HU:=ES&F<#&M;Y4]+^R6]+3=^8'T:XAU(
M?V=QU6&YC_M;@8BZP-9"Q'8GC']1DJ>U+E)B3Q.6V[K/18DMMF-;E-CM3KU%
MB1V>X[O]`(/L3P>-J8]+U5IVCHY&&9)NHSB2$"^BOK_C#23M7X2+`S"^C=(B
M;W^FU<+@%MVF+D*]S&`5X5YZ[08.^3(12A!)Q)JSVA(+\O\I!41(E.M+3!-6
M7L%-\)<=A#M`2*!%#&%($&X*A%Z"'GM#J`X%&Q)B+6BD]UV%F\"!>F:"MM=(
M3"8::*>^5NH[;9%&FK*1]'?3G=QH=+"7J_\VJI<+\HI(\BJ1GIR7=0VJ2,9,
M%TLR06PKDVK$NCA,OY=[,+^9@+0RP'(T.FCW'--$^6JG*?2P1'A-(U:UU5>@
M:CUW;YZGLM*)(U(NF_M1,^4J:G25RI/QQ63R!U&N7KM75N=L-.K5:G-JHD7T
MU/>/H"EV>FH%B=R0WHGY&W'J+?<G29_#.-NS_!0%M$YD5A=P$9;6`;&?0&9I
M^LHE*]+0?*_5'[MQG379ZCZ=PZ>NO`:_PNH72)N5?<$99:S9<0O[.VS8R\M4
M)@%B(F157WH/6^S@UGKJUU*GT6.-%\$X7=D]7@=>DOA;?WVV=\YB9Q;;HAM(
MD^"XP60C3=!GQ9?;N31[;,?EVFQWIXZ+L\5S-*[.+J`V+N]<@O*6<LL#`XD_
M*SD^+@<BQ@[>CE'LS_-5KZW;>+Z>NQF`>WNHJ0J9&X$3>[8<DM_C+&>N.W\H
MZ`^.AT$%1R]:Y4*^Z2A,2><'-#,K2W<BZ7KK7-QXNYXZJ^S<++/HQ9=IK#)Z
M@2'91*TK'JQE?NFN/GP8P$)G7=I4YZRDV^LJNSQ-D3L')'B2?4<&YM%+6"W:
M:4"90[_M`=/O@$21T<@R;3?.QFK'E%V,%<*#+Y(L2JV5X&N"./FLJG'!8()*
M+%#!`TV=I%D:HH?*F<\.M#L\1HVM9;Q2?_27JZA((ZV3=GT4V=:52=;=YE;7
M3MO=9QYU_73CVN)BVZG%"]I9]0&YD.P#ETI7%K&N<?!71^I6L&X://C*L:+I
M"0I'6?94[#**-WY2R0DE36/?\.WPBJ<4G.N@],-!U5$AA6#-#=^?%[UTF?*^
M)8*XW,!FXM'L^`0.1>[B:$V6(%"PCFC/XS3<7.$G'$0'P+.*2@N/AE2DG>BY
M"$2UT`%%=&H'8@.'K':65!`"F=,DZVJ4446<+'T=5"(,2\_R4MS-^KNOSN"+
M=WJ4>LBZ(N9=`5&,FVI7B%?A"?R)F&^`URF<E>QQO/;A2J:_`#YUH&R_JM.B
MO]A6Q9Y7G'[QX@W>7'E[;X<)N">H/;@1](7LP^']6+/(W$&)OQK4\S2)4-^Y
MLH]1]C7BG[OP$F:"'X@./_M[LL=&FTQX/R2K3[+S/B$O@T74^!*2A*ZC>(+2
M1QRB)*\<2CZ+,Q[HX01_19<$$LOV?CA@+W"SSFXU?KP+.**>,J=#T-]B"_=*
MTL6WXGO'28]E`(39CL\_=I?F6"R)(F4N-`)EAF;.BHJWA4*%%N!QNK488$RR
MGV\(9_)O\B_RPP-9YI!__/]02P,$%`````@`*(()/Y6<+7*+/0``APH$`!0`
M'`!J;FHM,C`Q,3`W,#-?<')E+GAM;%54"0`#RY5!3LN504YU>`L``00E#@``
M!#D!``#M?5MSX[B2YOM&['_0UKST/)3+LJM<Y8[3.^%K'<^X+*WE/CW[U$&3
MD(1NBG3S8EO]ZP<`+^(%``%>!(!VS)GHJA(`9N:7`!*)1.8__N-UXTZ>01!"
MW_OEP_3@\,,$>+;O0&_URX<X_&B%-H0?_N/__N__]8__\_'C?Y_?WTX<WXXW
MP(LF=@"L"#B3%QBM)^?^BP<F#]9J!8():7?E68\N^LOC-OUQX2^C%RL`V?<F
MT\,#_']?3CY^3#]P;H5H0/03&>'H8)K_\@/1M(3DQY\GWSZ=?CHZG$XGTZ.?
M#[_\?'PRF?](6KK0^_,1#3)!?'GASZ\A_.7#.HJ>?O[TZ>7EY>#E^,`/5JCO
MX?33?_^X7=AKL+$^0B^,+,\&'R:H_<\A^<=;W[8B(I1"]]?'P,T&./Z4?XO9
M`O_M8];L(_ZGC].CC\?3@]?0^9"0*##^AXP9_`\T=J:GIZ>?R*\?D`PFDW\$
MO@ONP7*"__OK_4W>YP_OCP/;WWS"__[I,L7QS'.NO`A&VQMOZ0<;PC7Z)![N
MYVC[!'[Y$,+-DPNR?UL'8/G+!S341PS!X=?#8\S.O_&'^R1!V(WWC,;Q`PC"
M!ZQ"80MJ*&.T).$21!9T.]*0#R)'!-+*%434GX4AB$(DV>^^[[Q`U^T@E\8Q
M>R*QB]R:!Y4A<A%O-E:PG2T7<.6A1<2VD);:MA\C-?56<]^%-H(H^V\+@F4_
M($/\/0BC(+:C.$!#M8:=.DIK,MI#2Q]&"DRPPJM,.%N>QR'T0$C4`_BKP'I:
M0_L,[4GM5PV9P?LFNKU0I4:7(?O*"CR$4S@'P6*--N[6<F4-U(68]O)BCB1#
M#IK?\29VL0$TB]8@N/`W3P%8`R^$S^`&F5";]N*2&+MGDML+569P&:(SE4;C
M/4*/6!-8O2_1J"&R,N*@RPXM,[@,T;=@9;GSP+<!<#JMEZR!I"1HN=BX7:P!
MVDO;"*G<O_6GYVBJ>4@U(K0_NEWIJ`PFM1A'2$G3!3-;"MJLNM1AVA)R887K
M:]=_Z4I)89S^3:3!3*/6QGDWJ[PW6[=?(U>.K&L+!O^RW!C\0-L\6K&((K0@
MB#&.G(22K>FU)3"%WCWO:\-L:-T,F!XLE_ZMT(',S][W_&$V^TZ[?`_[>Y=#
M6=?36`^K3FN#ESM:9[+:FU_\X2J$M=@;'T/P5XS&O'I.%MN&/;K:O"L!<[R8
M);.`+''GP`-+&,V1G=5$#+_KD(1E:M&:/(9>]4IDKB.MJ>Q/R\2]`],F#90:
M:H^$/X#7*+8:Y=UJQ#VHB2#Y4B-U)9NW]`G2*S9$5T(+9J,<>;R._1"5'\R0
MO6:C_U@K\.`OK.;EJ[G[D/`>=<#U:*_SOHE2N:&Z@]YT;R&LF>(##:D(3?M!
M0]^NI#'\M()";.S=E3S:788@;?RN70D3=\4*DMMFP)0)U"[$2Q<^;=TBFDO<
MH,;`<X"3\8,_UN&N&D:X^^'AY.,D:U_\H^4YDZ3SI-B;T(DH=7V[1)R+`P#\
MH$'6Z!]^YQ%W]HB0MNPH&\:U'H%+QA'L]DF*OE1V)(X@!/;!RG_^Y`!(@B7P
M'PCQ'P^G:0S"OZ%_^CWY.,)TXWN+R+?_)-,EG,41CHIP"D?+E'BQ3K^?'!^?
M?#D^.3HZ_79T>#P]^G)8X*:H%V=!F3,KL+,OHC^6E*(>))&V^/1$',(?[35T
M<WU:!OY&1M8I$7XG%N,0D>L_X9&Q9_HI@'Z`QOGE`UH1_<`!P2\?CKX=[A'8
M.,"2N0=/?H!]KMBJB$,VI-3F.:>?OWX[^7*"&#433''FF#`>[6#\O$<8KZ&+
M%EZT!*_\8,M$K]1JQ]?GTV^?C[\:"EHS3R)8'>T1JW_Y;HPD&R2DL^=:I=V.
MM]-OA#,S\1+A2@2QPSTB]AMPW?_R_!=O@2Q9WP/.31C&(&`BQVB?\_KE:/KE
MU-@9)\.=`)+3_6QWZ>)^#4/;<O\_L((KS[E$RP8%1%;3'8>?I]^.OIEGLT@Q
M)F"I3$_V`EW&:D(W.K%!W[E&_U9=.M$'>6U-0:J!C0HN&13[L3;*=&$5$@.B
MT-)<&`I,,$#8CQEQADAR"%FN13M]E7[?S>V3KXE%9-BBU<R-R$JU'W,AXR^9
ML.P=AMINQ]O7;U^FY*1A%E+B7`D@MA^K("/Y`0W+P0G_O&/DVY<OGT^^?345
M'B8S`JCL9\-/C^.(UL!R;SP'O/X78)]J*^UVK)V>&FFEB7,E`-@^G1#W8`4Q
M2UYT9VUHTXG6+&?LY/#KZ:&QOB,!ID1<?WM$:QX_NM"^=GVKZG[&E@^EC2F@
M,,C/1'Q2AR*]C?A4O8[H]9*"_6XMO9GX<GB$+R20J>GZ^+X,_:709_)3TNO?
MY:XDBOJQM,)'(OPX_+BRK*=$28`;A=F_5+4E_>??,SJV.^H85Q=8^-S6[=6[
M/?GX(:<3NV"VS$E+C\)$IOA:ZAQ]_D\*+^)=54R/1FF79X4X,[G93%FVP!*@
M/LYM(B0F]83T9Q`\^B$@;2M+WKXG737.+YUU)PVS+NWV/NTZD'\'(A&Z2\T,
MF$YTP@M;>8]31RE^]];+#W24"Z#EXFB31?STY!:>5]"P9'91CBM%&6N`,JD?
M!ES*NJ@(Z=_\X,\;CX2<AUQ\*PV-0+5"<^&$-$HLKZ$'0[3AX^`P+I:5AD9@
M6:&YX)X8RZ*+I-"P61H"%:&TX-7K!%#D1Y9;@F=P"U(TS49^C#NN&Y39&)-D
M$!)ME@VC]&27$8'8JG(J9'1*]E=]^N-C*7H0%!Y%U?QLA2KME"C,:3J_OQB_
M_NZXSUD5T@I*:\/1IW"4F;_]PJS"+2"<F"AW$TBOZBH]!V]J62^M26*3-&DY
ME@F:<)--SH/Z[%2"3_8^*7M<DSVW.7N%M.-(0WM56#6H68X*GWJVWT`)-`EM
ME_[&@AX-BO+ORD0OHD$Y`&6:V0YL%0+/5`=M6>`&\433?TH;S76>0C';IZ)2
M[/>^ZU[[P8L5.!S!EUJIWAIJFE(5>HG:D;HEJPET4M"J/_]^I!XOBHIAQ&BD
M]@76$PFS0HMD$"D\+^6VC/U7#!'IE^358A("QC,LJ<TU1;&9\)'ZDC.FDW>=
M:V2I4F]]Z,T,`+-,<.;#,-^)S%@XBZP;@4]_?N.G+":U^]2BOO*]\+TPWH#@
M!]@\UEX&T1HHL^UHMC^6.XU([>P*JNSG:RO86#:(2;I')@+T9EKB0"=5NTV&
MBL8/X&"B+\$SM$&20LU:>7Z(6`F9V(ATTA(I$<*'N9Q4;AQ475=W(+IZM=T8
MOWW/K25>V(],=]6;52M7G1R+F<OBH&?WN@K=P-?S$;B%SZ`F-GXPF&A'=3??
M\DJ?J8,H;SI$D%&7]@(#<RLBGCC/>0@L!VRLX,_P>^#7@H;$NZE"5$Y5LW5?
MC*>]W9<-"6LAO\_9!F?&^+N46$<<:.9`HX*>R66J#,>F3>MZ())HIU'A6@QC
MZNPBJ(<Q[7=_)HX/CIAH2SF6K&`_<X"78*HO5\2PBWD3,^*K>>N1S$&_$YO%
MI^5Z+>A-+-%7=*%>X\*VN*9/.]O;Q45=@].Y`Y9LSN5.ZFV',O&4UIY;[?QS
M@VC2SB)J5I5B6W6ZT&TB,/2BR)IV;O(>C<0&\;%LQ,9NIJN#&)=O8TEH%&(/
MFXKY&B//<5\7!YH9)LU[<\OK@C'HB`B70SRFVG\0?LO"NVE`_N?#:34@/QUP
MXB\GA2$GNS$GV6"3G[(_*8G.KW/)L;YYC7N_/+\&2.(6=![\[S[:<SR2S@M_
M=LMZ!=-R#%43M5GT]#MX(:9&NMO?@V?@Q>`>V#Z:59@EODI@.0OTT5L%!)G8
M6Z*43I/\'I"@11(\?^T'\X+`9TM*O8;F*=]Y1+W1[X7%0=Y$*E\-\K(NL^4U
M]"S/ACA+':Y80B252(%VLR_63V^]D&`D1?\KY3F668\E2^5H&&_>I[4D2J5>
M2I^XER@Y\YQ[D#CS[0@^HT6=:WQ)]%7[!K)$*/H+")[!^1:G^L1K51B)/6*6
M&$75/)5&L_YN4H++O7GV]CF'64^<&R>QRA?-;V\6[PC%2ADVOVX6Z#V664OG
M3J]'GR6",9F$:++:,)Y`-_90_R!46$-W9Z@&GO1Z&IWL`N7EDO5,FM-6BWG&
MUKD,'`X'>L%RM7ER_2T`"W0B#Y#)#:@O"3!+S):J(&G4J#QG,8MR'>*!!U\2
M;SE/X\6ZC6MQO-7U43W->N8_L&_LH>%J65-'*F0T9D8:#$#C6Q#KWZ>:0,S6
M5AZZOT_[<_/6W^QK">P"1.A,Z/P&H_6%%:X%<:[U,ACT&B^9!K3VYITF&N"!
M%=X3=$9?$&ZC\=T!VMU!*_"V?.BK=(%*]JQLI:>U:_1T,'R/G@V7I+;+!YR0
M$95Z=5,J\V*]'/</NZE:;T^5KD)=D_-M^J.8WU9R),4OJ9F8U9T^DHQI=P%/
MO8U=6"XXWY:G)S?_K&@GG7$5Y6&8)"Q#0!CF&KA;=H5@%.EH`I0B?(RED(S(
M#LM,'=MEBU5YY_)6]MC&FQ6)472>N*V9TLL9/+K,LM)*VCGKK/)SY]M)0=NO
M]-^3CVEF";XG'],)C??D8V\D^5B^,.\L9LMMVO_K;<>P]]>YXLU5U;@E'!5I
M;K(!:&V5VP,LM:O8`C3:^S*FJ0O@KPOF,K?[2?%BQ@8_6]AVI.H0^T`5](T7
M@<"S$FJ8,J>VTE[\5*K'4V*/L^3><J)0Q+J9O*,(,<C3`STV%QH#Z5,N"0\6
MK[,N3AZ>Y@J@6N.+4T+(;&L1>ZM3;DG%4'IQ37HS#<%F:',..96/ODYP:&\8
M[C0-`AN+>`62K/PW'NNB@7;&ENAL%JBRW.WMT#?PK<N5%7A(2"'B?;%&<F7%
M,'RK7K!D'2>HYX1T51JL4.6#LPVQFZJ]2*G2A1]%>S9T(<%8HGRJW$"JYFD3
M8O7K%#F^QO*PK,HU\PY4:(JJO.PT=H[R%4^"#59'W>>@*!_:72@,@_^Y%4);
M`.ZTG2[H\M66A77*1%_0]F3;]@/L;P"NUOB5)'X/M`)W,7;$H/,]YCN<Q5$8
M61Y.#,4"7+*_68H@R9QVUU=])5.SDPPEEGOA;S:^E_!_%D4!?(PC8G3XV43!
M><VWN/%9$.`3!+G(INA-'X.:I4Q]<*S=11L]<)$P]ML:VNL+/W:=<R2AISBP
MUYBO7Y'-%SS@N+,XV"XB9*C^`-&Z5L>QPSCFJ$4')CNGY]/SJ8C0)+GP/:3`
M(<F1=`D>HP6PXX"\\&^[T/!&-$>=>F%WH(SSRC6+L9=?0C=&_UK;TL5-'?8(
M9FF.-'OCS&E?<S8D_`N<=?*69N'.9"/#=VAG_L#>HT)MC:04;SVK'LOE^[7J
M3RJ,-2&#34JC39+AU+J!_XJ1>'D>F4H#M2Y?`71N_88W+V4?:<L1E4U:*EYU
MUV]+ML;R-D:`?:9;N/4T5NHJ-F$>LZ"X]@-D37@7,=(OS]X^H#-LB(C$,XJ4
M._-"-YE?SA]Q&&%S]0Y$L^6#]9H4NR=6+#H`78+DOQPQ[)\$/5>*_<M!AUJ#
MO>5*%UE;+Y)&Z-^2V_'PQD.R^FY!#_]ZC8#":1RN7?_EG\!!/U\ME\#.Q4G1
MW3U]U\25(>/N'"Q]8LFZ5AB2;/M96ZI$]_-952N`JN6VKS5&3+HC=:.SA'?V
MC&P,;+4AF826"W;.&`I<.*`'2:KDS9D3G6FQ1?;^9;-VQM[9SS9$\TNK-XH,
MS?A%D\BH2TL;]>SP,=U6ZH$FN["J=Q#E$`6!=-+M2UQ<"3CGP$-_B.8NVK6&
M7H#[^Z19*V]_?&=+;M\5$#0^A52$AW\FMA/I,_>19$"4EA0ADNU^_FC_1=V6
MW[[G>*;H@PNR<^Q1^;IW7DL1:=Y*W-6\Z/25MZ+8@PCOC1WP+I$8GHG[)OQ_
ML>7"Y1:GS@D37\U0AD5?GS3-L.B+[\RP^';P=2#+0IN5HU_ME-P2N_HV.Z?,
M929-UFD)^=5#2Z<+_P9.)IF95P#N+(`A3OE/DL\FJR['ZAOB(V]%JX>0W3#W
M*-INAS6W;VXWE$2&&KNQ@\L<(TDE/5OH=!\?>^NZW8<,.[M&J>&J.JFU&"K=
M#RT=OO+6%;F3\/KS-.GJ`,6[UC#'$>F1S3IU2+.7Z=+IP?%0IPO]_);=_9#Z
M;LDMIX[D6:E'=Z!6IYYN"M1RE-^/1J5&':30ESNN6J)$V[VMJQ$F,MB(5*NK
M*/HZWZJVFP2G%BT8BA5^U6TID_F2CLO=/L+6!A;IF]R(9:))NFFXS)=TU/`!
MPWT&EN2;5.P.2[>$&2_W%=U4>E^QQH,(LZ_\"3J8NL,OUA(PR'U%-YT>."IS
M$!GV]D[?(%WN]0'.7K^MHW$RA/M][T+-2OGMI<*JEI.BIWC0/7U5SXG0?_#<
M'L79V:BAQ8;JZ<;;A5G\TW=Q%I)=M$5AM^PY&J;MIW13<T5O3[H+,G-0FW]5
M)A]BD=J"N.)")JNA(V-D/_FNYST+-%O0APB6&3A-1Y8>'LGG$2;579*:8<C(
MC&`4HZ^PTG1,#ZMI.O*JM<712`G;XGAJTW10&69'2/";JTW%DQ<=MO^*T6I,
M:#O?%O[67,-6=`A52X8(6O74.Z)<Z57!ED(UHW8=LZ7Z.D-R.IE!QV1(XV*U
M-)KQ'P,`F,7K!/JHGFD,[>,A5>%@T%)V%T%L`]>]>V:7M:VVT$FB5`7):]U6
M*=<N-ST5$G1B=HD@D%G$1(76R!A@:,2/]$T<13:WG/)W_.8CVHX*7`U22)4Z
MLP2,<YPY,+9<E@G;>A2-YF9-_[)IV8HQ,]94BA@N_#`*<5I)LE(Y5QYB<3M/
M$X_/`VA7+?T.XZA`OZ/"5Y5"DN.WLYR7&#]SR<?1/]\@E+T51*OA61B"*+SS
MH[,-=K;\S3A$]C>TH=K6KQ!2!?SZ9A40UZ1\@:Z+I!)[/%>,_%!O0L&J3/>5
M_FG@TB-;+UH3]RKSZ%!OHI%QPC\XU$G7N%`R8^>4,3D80A(81C6D(@[&=IR]
M'<N")@P<#C*W(*T<@_0((]*1'5-F5(B29&M7EEC\3"(REJ$;>4>NL\A!:DV`
M`L[[NUSOHB/)DUUD#@,DM>@F#&/@(%GB/V!+N`_5D?C$^#5*0AC<`C+&*1HI
MOY;PVX=2,88;OP(Q&,^4Q1!3EG%J*IS!JR?T3D=0[KB&ZDR/$MA;"J6!PV=N
MP<IRYX%O`X`CY9BA,M-JJ`SI.-GU5!P50V*[?33=O17P;`A"5N@(JV$/R_HM
MTJ85`60!(B0X'(EUOL6!6Y:'8\'JL1#"O52='/ABS=9A(18&B81H@P,UN$&B
MGZK%3T*]!(%I#GB06\S<8<YN/]"F_2?3NU;Z55-LZ,ZU$N5F7.M=(+Y\VP]F
M0;3VSZ$?`7O-<WTVM#<*K@9>1NHFJ^T`Y]L["UM:L^7NG[>,.#^9SOIN<;*<
M#!)?,02:*0O,:#]N:VWP:E1(.H85=@8-^KM/CB=X1.9226FCAXBI6I(MBA2J
MA]G)^MB\X#-TYP"1@A]$L/<L:C,#L*`3/LR^I'[Q0BS><@+[>(WUP%)XJRE0
M/LCM*W6R[#QER;I*7BOA>$,_>3R$3OY+&"V>7$@+V9/JK0T<-7W*9I84.]H9
M@HWXWH-GX,7@'J0``.=\>X^=.1YP'A#!$`T)`<UYT6H4L_`69LN,B]`DNJ8+
MYM(CZ(^W-$O:!;O1'6%EYZY`J'5CC]XT\#M$HG[PYRX2;@27R_/M?\;!EJEN
MK.;*/`ABHBTK&(N)/+..WMI$<9K,`_"?L;/:D*<ER06MH&.5VM,0-(7YR6Z)
MI@=?3H[Z32;0^[X0A@#]S[FT-FC;PUG.SEP7K("#5M`PWH#@.K!BYQZ0Q"(/
M_@4(\+)X&<0KZA[1931#M*`3CWEYBH/#K]^FQUJK1D')K2W^3\K3-;Y(O83A
M"A%#?L91&>Q5H-TPABA#.^9V6G#Z!4E<:RUHMHG1"/A.?=W]T,`8R1!=:,U?
M'B=WC%:%DR.MU6'F@0>(3KZ9MML`&3=.=HE",^0:>Q@";R,?&8RGVMAS_?C?
M$(,;2/++X*";TLEJ%QK"244BV5_5L;$5FTSGG7BF#E/8%)HR^WMC?`_#)Q`X
MELN^6:FV,.K:N49]EH!2[QC7,S0BV@%_6Z/1<4XL$ERW$P`[SX)8/Z,@%.1I
MF*QSRK>-!0(GD5,:>KD`JV39H0<--+37QIM(O;QI(%YP[BJ!*2&4&0Q0^5U9
M:@P1;<K1*-.\OQ#$^=H*-I8-X@C:G)V)WDR9:&D:D!]JJ*2:$;7V+[1_0CLZ
M6R&^PHA]0F&T,^1<PJ`^A^C@Z[>I/D[(GD("*-OQU>L3\*CEM;BMM=E7J+=4
MC>2G,'<^<T8@V,,-`F::>U&0--`;$QK%O'<A/3OL7RSTK<S[C/U,"+CJ,V5>
M0T.6-1;YF:0_'TP/IU^HJ6M[/0T-G<?6<BW/!HLU*+S<RM[?3$FJVMST07_&
M=PR^"QWL8YZD?2=)Y\E/OWI6[$#TBY*G.#F9L^4U]!!A$,'MI]DFV-XAL6Y*
MRB*0-U\<TJL-E-O&`I+/2\54:-?.HNL3PZ1H$Z^@-*.=*D3IJE?&KD;L2"'$
MF06PIQ+]!S\)?[9<<NR++JP@P(5D_F6Y,<WJ$^RG%F*&9F9("_(P4N39=:I2
ML=$F<G,?K1$7H%^[0-/>JA#A8*DPN5G#(K@#$0=H;G.],>:2KET\:3_PWGC/
MB#T_V")>*7"6?]8:OC*IVJ6KZP>NRY3V!^LUS?O(FXS<UEJ#R:6\M]*'FH%;
MDDR3-:PY@!5:N:F`VA:!5P[8//"?0!!M<4DV'$J&C<&GM+P0!3]^<ST/-7R:
M^[)YM$*UEEH71%>ON%P3KEV69D6E;I4BW?1$68SVD9I`#$RK/ZNL7,E&CT9E
M7[9/3Y</PUD^=[YG2QD_Q0[Z82E"]5AM'U)5+TMESD&5T4Y/,!G$9AB.SC'$
MRG.G,E&=J-]VK#;J+;0>H9N4O_0<DGQQ[;N(TS#)Y,GQOHMW->F*19RKD7KT
MF@300A,4Q@9(JK>H%C0D)#5V.9!:`'2<\FT!%YCHW5=^?6<Z?U*;!V>)^-X,
M*JVF*K$>"WPVV\6,QJ9AR^-EK.>?.2XECE#Q',(],F*B`$0P(-8-.A3BG!?G
MP$-_B+`K+A35BY[&-4V%>F)[_+=(HGK4W,4T%6GF:*3^SEL?AWD&FTOPR/>@
ML1J:AC2+C]YN+W3RDQ:$U!Q?QVML',H<7D8:B;58^T&$-?O<#P+_!>?]IYWB
M:*TT0+?A!IE*=E]`:C5EL\"CN;7%44?-P575AOJ#R:)\I"XVQ&X0(])K\J&#
MRFIK!*XLXK6SGNCO=A(&[L&C%>'W+%$<D"(V<R0,'Q-,S:<ET$EO[$2Y&.D!
MZ&KSY/I;`-*T4$+S5*"/WI@+,C%6#TNJ[DF*8'3H$UB3:6WUQYA#_%AOGH4F
ML)DSEC=%QW5373_J(15.8M#FN/8;`B9*<GUC$_+!QT=YG/W;=Q$I*T:J0_K5
M3[N!U=URM[_D:L?I.!7L(0!6&`=)!4K6^S1:(_V!IU$]UL6>&9+\/:CG,>#&
M,*<=]`Q+:J)Z;S4O]VZFQ9N86*>7.$VG#0D<Z,\NB)(KG:P4*/XK4TITJZZG
MH?74F/[XRS/A]I+&X311-`^LR)FC35*[_E)F^AYW^:\WT7_QK],\4G]W0<')
MM2[.JA2`-;[K?0;)>0?G?;D#T6R)#C[\)4!L!/W1EV9II!M'5AGDR@H\?%E0
M6@V7T*Y51L+"$^FDOPJ(<,%;T@U&?1Z`)PLZ:>*M+-ZCZ26E4"^MWU<*<9!G
M,#>]+GHI'=.<2&\-2.K#7"YY;J9IN]Q,DY]*XRK)U=176IQ]DNRZ_@L6Z;4?
M7/KQ8[2,W7HB!8ZG5:Z_UG-2DA>>95TPX/:7.?H]X=@X0^;;O)+A\2&@N)\-
M5-S",0IM!;.`B,TA)ZHY"!9K)&/^@9'=2W\34H@-`>!/S`:>,!J>Q=$:<?9W
M+8%G15+UUD8!72=?`.!O8P#X)@QC,7"SE@8"FY$N`"JY[#<-U=*=1\)RTWU.
MUDI_-*EDBR#9F\EH@)'"L,KW9E@/?.K-11+.EIEKIW;>/>+F(MX-,?&7DVP0
MU3F)$Z]D3AO'G&:V5+R-7,)GZ"`8P\PXPKE`YQ9LV%,XW53-NP8L*+L+AXG*
MS,L]S0;N+DD1>4IF_/1N-O]1<^"*I(HLC/(&?#'&0TV^KC30+76&IN_ZF*L)
MI:7F&#+I%@'4Q*/X[MKJ&LDJJ?T0HYUK]@0"@DUX#I9^``HQCC^@1WC/@IA(
M9=?B*(F]]0.@TXZ#<X6&2;4]IIKLZ>M&J-Z>9"&BSO*6F^KUB=S,W/F>GX@,
MQ]EA:;`+XS1UT%QEFL@7.<5(>!FTB2[)])T-;*V%YDC6Z!6!SD0/X&X52B3#
M"29F-]4>3!;A(JA*6!':3,A[!`,2(2[5<`F>@>L_%6ITY?E-SVRT'07XO02I
M@H1+35&![S2:YKK1B;>Q^A<7@$3%?T?&=F"Y.'C2V4`/8@E&\)FS?XMVU%PI
M1-D8Z:4!";-.3L\4C$N_:@YDB=9![O!4F]AX(9HM<0[D<.&[="=<I87FF-7H
M'>FE.RZF$^(R@EX,"+?TU/GT9IIC2"=ZI&$_V=U"YA3F./79334'E$UX[CT]
M.AA9@&V5YW,KA+8`J&D[58@VJ2,+TI3LD3Z@J')["=TXH@9",%N:!FA.^$A3
MS?P&X&J-&#Q#=%DK<!?C4O"S91(R,(NC,+(\<GACK\?R0VB^3LLSE-]4CFSU
M%I4$:U67[*]*+]I.`EF%Z7EWT"H+&4,&Z?I9$X6XLK!'&)FZL!D=9:;)>X"D
M$]M1'"`>+Q#3*VH`'KV9YCL(G>ALWAO_GJH868:C=ZY=_Z4>6G8L$5J&1YF0
M850'EQ4""7/6Q-Z=4)JKF%>XU"6.J`I\'&?EG&]_#;'/?99=IY[9$7Q.\J.R
MV6HSB`:AGTS$LHG9AB]Z5)J)3I8SYX\XC99X\.^![7LV)&6*=P$6#WYWY1GF
M,ZK4J_U\RN.,!Y$'72U-=.(2MG&^?<K#1WKT)*>YLB>>`\ZM0C`FAW.Z0O07
MT;]'C<B2ZXO'9C;V&+->-#+/4`TCK]53-RMP<*82Q"4!DF:9,1J.61%8/(]G
MKQ#)3$5='D2ZC5DUQ"0P'EL7B0Z_@0.7(/EO05@7UA.,+)?_;DBXL[EVJ0R7
M=,4P,UBSQC6..,Y9YU>]D^JMT$LEJ?L<E6"S-R*KHHEO9FUBT8[C4X6,,[H6
MF!F!7^6X4G<$;Y>UBA5"2B$VT!B41(S3D:8"J8L#A\U[Z&NBBE)J/P9]*#'4
M^1QBP%JQ2]4EM3(4NXT!=QI?G4\7VL`O;GQWNEPQ^70APV5G&T*30'+M7_UW
MAY63$*"UMZ`8EZ#1;$Z>O'6\,N4.8O"5*9>O\?@;Q;GOI!+:K0@"NB^O($R7
M@;QF*%_IK2WQUU[[`7G-"!R2FX`<D<640WH$<S5$FM7N5YG:6(I%AO&+GA\6
MC@J+MNA@?.&[+K!)%HS9DI]3I-4H!BM,&W9'Y([,)LR#GSZ:;M`.;G.#U8#+
MUW@<CS4^S^,0>B`,05)W`XLQ>STO`C^W^XC4@<MGYQLK?=2CLAK.ENA?G!C+
M"S`O)D0Z&:P*`MR-YQ!24WR9LF4RG0U6"`DN1^^&3#/@=G-<<`<QV''!Y6L\
M80[BW'=2">W6#`'=EU<0YN'"O%PGI9T3Y^.=$:;"JU<0V#"D&YC-?<S5`@'F
M>O-:J5\6[L%3NE/.EK>^MWH`P>82/-(SEK&:F@LVFZ<1N9R*3"[6?A`)@EQI
M.PZ4*TR-R&E07+<:4.:T-1=E#E/C,>,*KG.DU7%@KZT0G78+^?3Y5PO,3@;C
M+L#=>`*-YOE*-@L<)*1@FQ=0X"!/;6T^Y%2VQG.<+ZYHN/P2+@;9:*:)=#(8
M>0'NM+CX^</[@\!Z^/7PF("*_N%WXHM*BA"Q/##L9KK[6-B4"^4H-'`S)A<,
MGH/_@]V)SY:+%Z4SI.-!L$7J3.H=4J:H8#_=`9=@I>><X*D&/`$TCG/EJ5RC
MZ0*8$\JJ4;#"JL#J;JY&L#CJ;:U6[4>[6BZ!C>1S]8KL3V\%[I'$9AY=&!0]
MD.MN@A[(<=17Q*^9FX)4W]^/]%<`:8:RB7_<-1=6LB<@.H-(E\QF=[YG(P',
M@CDB*OU+P5!"1C'Z1W16!8CH;7);G84M%!Y)H1_B#7"FM.N9GC^@0KN:S./\
MDJ9G7O.;FX.CKLDZBUN0[DI')AXZ./6A7[RQ#%8E'EOY=4#[_-Q4+X,A:E.>
M5^U5IC:.^>I28RE3E6GW!49YGL=XLT&KZFRY@"L/+J&-0VF2=WUH+Y_[+K0+
M\0-9XD>D:9./DTL8VJX?Q@'`62"3@7"FQ\)0D]U8DWPP%6GQ:BSQDMMQ&BO)
MA\2#Y@%A?>[2+PE$.RI+BM.(2I[U2)"3O67E'WA:4MZ4[^;>477N%5LKJHV'
M/[_=$<5-O,-IK:JT7X4@WJ3B-U?WKKL1@V*9/S8#XYE!D>6M(,Y/D6S?GH,K
M[+Q`UZW/J./ZC,IZ3Y+N$\MS)OD`*HJ-I=\FM7++K`E-.\G^2NJIB9#(FYJR
M`ZB:K*VPS&NU23(YE@E];<&`&.0_@(59++V4VDWES]6IC/M-2,=)J:<"!<]9
MV!'(LT/YS57,4!I%O`G9T%[5_!/!(9MN#2R,9785JK/7Y]27^O:(6T^2YFI2
M\R34"EJ<G-:*,@M5">);G+SF:NMD<#$HI`[B,#"6*80.IO$F=K'KCSQ[Q_EY
M`[`&7@B?02*"^M3Z6IU:A5$F9)A):9QTZJF8=/BV)]KRJC96&JBI\UH3^IT?
M<:=7<Q=E%>VH$M\5@&VB>RPSJUJQKSZ-OE6G4=9E@OI,DDX:5%/L5O)4(>&\
M^<-I:UHIR`+I>RO".[2#'ZS2N-KL*3WVA`!_%5A/:VB?X:"=^GPZK;GWTV&P
M?S\;*/&)Y$--DK%4.,@3XN[!$TYTSJUDR6ZJQ+-?H4;,'A3JI2R<I`&+W*,O
MPL18-K!LQJ`M^Q%Z5G(GZ3F7D#Q^C_"9LC8'IX?5.9C/N^(P9!*6!E*@QU3^
MV).0WUS%1*10)#8713NJFHXBR&134I27L<S*6["RW/3U`;8"ZE.P=LM-NDR*
M?=2<<38P29%$LF61RU#@X:M0(7^(9'\5\Y'(^8<5X;2A51IYTU&PGZK9V`JY
M;'H*\C:6V5DJL%J?FK5+\')[)6^R"P0@@.X!\>(()6B1Z*N\D"^-/+'-LMTP
MJB:K-)[4TL#";(YEWE+OZ1YP=OC:!OM%^+9N\E,R@I)ZP<9?VRWL-7!BG$+M
M$@3PV8J(PQ`K*1'N=PMZ.-OWC5=X"Y`^X$0&$@B6?K#!KS*YA]+^OV'"]>``
M;.]M(=!*"1D2\I-(W!R2#BHH_X41**`\TX5$"F-2OYS5\^VYY>(IMU@#$'T/
M_/@)XJ?F`E$,C5U-4!AQ;@HY5<9GD5R"R()NS20YD3!)TB&4V"3<W>9\^T_@
MK!"8Q/+$+I\U?#K?)G>$^7IPBZE#/YYO:8/=P_#/!T:)HWU^7$T%6@Y_2!'!
M#6*"]N17M*.J=6+_6K.K32LF&79:)^T4@2F:LU<HK1P-@[TKC(RTV*FAU$5[
MY:2>><SPH(R+2W^#&&5&@K492E,%$IA!Y2"R-KRSLT<I.0=9+@A_@,TC"&AG
MF.*O:D/[VFML?C8I,C.>NN,7?H@.4WP<*6U,1Y/"D@[Y]ZE9N>Z1A)%TUE>O
M3XA!0(6)T\YDJ#ALZ9`SDPK7C1<!).DHX2VE^@Y$3-R:.I@.8!-_.N36H2*9
M%ORB4/^`1GIX\7FHRG0V'6$97KLGKE8$-^K)G<9RW4<.>85;+3+2MP!]`5_;
M0U[N/&[`R[PRX-9Z26^'\YL`N,!D,0%BCW[TP2?RM1\'[6=RI?=XD:8P6RP=
MHPSQX3R@V&<GX>/<-=?4";5G+^9.'OG*4%,3M5#CT$)\=8A5F^F+Y#57F<]2
M1&/K\-!Y8(=B*+G"]@,`5UZ6?34CF>F#:FBO'B"ZT"O7U7PFA@F64>)5#-!B
M=!$CBCU[F^TT.,-N(\["/<U`7)B=82)5>K"KN/O-K"D4C%-%H*^!U2N"R,5Z
M9GOUQ35[NS4ZLHDKGGM@^RL/_HUK<K`LWR2M-_KK'#_%(PEW9:^O6W]&57;0
M?J>HT*5U:QF--"!46%AI;H-N6ED8Y(WJ7$$".NR<?2L18@P?Y)`40#:)\&/&
M3!)<W6GL.U:5:61\F!A077*7=7_%H7&@[SZ]'DT'Y<&S6#^&X*\8C72%<YM2
M7O+6,GSNNDS2/BIB@2IT\Q)7,)LJ"6*J4,-]EL%NJRQ)18/<\P`F-NE[.TP,
M/'7FV/Q,TE$0H_0<;0!+&,U=RZ/DA3FI3J.L.TE#D>0KF_M(F"""29S\)!U0
MU4MY[*-/U`H_Q,RH$GTG+]Y;23')1/@9=&7!9W(7>YK;?BB%;^EEL<TK3K9F
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M$SL"V%,2!]Z,B#4I_2>D(+SN;T==>%+H'.ZB9PGXNA#.-CC`\&^"\FPYQP06
M%M8+Q"<46W3$!GH[VB4FC\*#_7&%=/+%\1`@J9+,D[-'%ZZ2P".)!4QBM+>J
M<5RAI&IW.L:]L2P&'.<6XD`WT$:S2KW?JB:5A%#,.='CSJB'ZMP!)%ZT=CK0
M+EP5"^D-J^O;41J6!'I[!!WYD>7J5C(MO?R>UN_43VM%8X1KI^5WZI.IDEMU
M<^NHY9[,*ETW'@F&3X*8TQ^;;\TE1M&^SEH;IO2Z>\O#T;/)DTTHQK5X0WOU
M[G9I)<W!Y'.F\65W2BCS@KORNS*,1%2M4L*P^<*Z@_2I[XLOD$D?;T#`3,U2
M;:!XD:*G5*D2J=TS1ZKLYVL+354;Q!&T+9>)`+V9ECC02=6N#`05C1_`P41?
M`NQ@24IJ6BL/V9_0IN=F%>VD)5(BA.^M:(-:T[2P9?)NX,6ZF6P1"#'(4PI]
M@9T]@<!*_BU)T!5R'\BU'$@7`YZGT0)H<WG4;FOM*62KSC,M)(O62D/4!=0]
MC\>BL:1=>A.Z_00"&\M[!2Y(0J<;&M\T@TJLG[FX2C"93><O6B.=9<+THS.7
M]`+.@Y^=IR@(-[0W&]D&YC)KNS6B>MX[[^1RC>295"R.D;Q2P:$#X#E`TDR3
MWSQ8KR#\`3U"<Q;4@:S<\BA7?\7HYQ\@6OOH%USWGJ90;I[[<T]?-U<]]RZJ
MS!KM=_G:U]YT]6J[,:[]GD[I4'B!ZW=X<Q6N?UEDX12#;XCZW#SA)ZRQ17O4
M>5K/=2)_`94-_WX/]7X/]7X/]7X/]7X/]7X/]=;O0O1QG[W?A<C<A>ASA_5^
M%Z+-74B_+Q*I$S*EAV?,9V8V)^=WJU%TL0:;+C5:,SB>AU_W`.?3M*,X0/)"
MA^%@10U9IC=3E9>V@VIGLY7.4(KK5^UR^M_"*(VF)YEJT-;CIEX)RISE-384
MLB:V='A:T`"<"%[C@JF*SA>:@TS#3&5LY]9)+;I:.&69)LZM]]1E[ZG+WE.7
MO:<N>T]=ILLCJ9&G+OO5@Q%PB$<Q+#X(FRU_75QY:&O="N:V:CN03C!3TUNU
M96P\A]"TREZ++'?"/;77`F%.QIQAY#VQF<K$9HRH%$ZN]F;_H5QW?69I0WXQ
M>=:TN\7I-3,I*8X)'V,2K$69LO1FJKP<;72ZDI2TPDGW!`6<57E@CTA>U>D'
ML+#"DYO>1E?(YUJ<#QYG0@::%$?2Q/$A7X]*HLBXR$`J9B>%&.9)B=-6RX*M
MC9AE,Y;#F%Y'I9%4V&Y4NL[%M=\+9*L!K(?:V#U8I-3]2L`4%>RG0KG.;#O>
MQ"X.+&;5YKTEHB>-<"5S,F/"&YS_)EL02>R\%:ZO7?^%E-4,DWJ^J,EL^6"]
M4E1S3]]59>=):4JFY'N227;5?*#-,ZJ^[*S0#B#A9;:\![9KA2%<0CM-ZU42
M"K<Z;IMAC%*T=BQF)XWI@3X/\/K1G!_6*]S$FUO@K:(UFB5P`PCOSHV76@K9
MUE,2#45Y6H]DE/ZTYC)3H>.#Z=AT:%><NB("ZE'BSH_0)$2M\&)_%J9V4*$!
M1;=Z_X)1.M<[]YDN?CXX/!F;,EZ"QVC';-%>OB1A9TGB0NKF)];1*-4196JG
M$5]/OIP<=TW?"`)]%(+Q)I525IVB%#*=C5(,&<9VRG%T>O+MV[C6"PK'O)0S
M_.:JG`DB3&0W*(+J,M*'%+LMDQ6-5FNA.ZA4HMF98=1*G7_%3&FEW@W.N#*F
MT"K@/-65"SE?OU[:A2Q>\O6SC1_C,&JFE4Q3.IG.ZE&DWHO+LC'26_&J"$K6
MKI0.,'L:I`!,'D:_L2>5+^Y\SR;*3T_JSVZL,<8\LD>:!+0H%>L1NC""0!1;
M1@\C`&;0KET1(>IEX3VP7/@W<+`E,?-FA$:*6XKV+$N\JS'';3FV4H2/#[XV
M/-S2/L2ID#BL,;#I2S6N*>D\(;TU"6;*^1%ZM<5MW<,<R\<7N(3GM%6U&`H(
M,YL['.I':LDFU];YS3=B/8OWJ*;HH[DL)3JK6D,;E3=W4THP,\QSY/T_EDU8
MS=,![=+F/?@+RP6UU7-ZA!_(YNW1GW&9!=^%#MY8=C^07'!75N`AN:$U]5?/
MBAW\".;?)S_MOC&)_`GYBL(E-J>X<7FEM.PCB0?F_QX\`R\&WWW?"9-Z5ZF$
MT)?QBVQTJ$K^2UEO90=0NP@SQ9UGZY!D1_`5H^(D`;ADV6Q)^%GXKB,%L$1?
MS;&5X$3P^8MB6+_C<,EYX)-2>!*0"O;3'$Y!+@2+0W0MVM<QE9*+FJR^`P]M
M\>Z9YYPY&^A!S#<V"-(\%W+K<N<A-8>_.X,\!X,^D_P>"1\);DT*7#X#UW_"
M4DG9RU,(G]E_Q3#`H5EH1M@@#/%B)Z4P`WU'<RT:B.O\TDAOW=I%0R3BRASI
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MRD6LFZ:`-FIS#60NEWH!>F$%P9;$L>,2!<!)B*5PPLXF(CN"<I@%=#=/,"++
MW'AR8%Z%$=P@`V6VS-F540NY[B;IA!QGX\F.N5LF*8OD-?30OT'+S8W:"XMP
M&MYR7C5U'U*YXK0R`MIR.VP:HXR")(#^S'-*@=91:E$[9[OUCY?<J,MHZE'M
MIN+Y>](N0AAI`&<ND\*SNHJ<:-+G/CSN/*2R@/GN<RY?73H+8:0*AY/-X/_'
MKNUGR\5R07)>K)%!]P""3<'+S2LTTF(09:M83S-L9P3+\SYB76)HA\+B*ZT5
MO(CPF,XNORZ^^X@*#S.]`'8<D/7T+,J.<V0AI>`HV,]<H`49',^A)<F86)%9
MHQX(]3)7"X38&^;1K)(\?KX'MC^LX$\07<>>(X!_8P]SL6]D;9AGM"IPQPD(
M+\&3'T*1.<]M;2[>7+:X8:=F@2TNJ4[6O<FJ(,-E;_4CB@$!RLUW[LFH</+N
MU0$A/N[8O1#BDAAI(I9\KIW[0>"_8)XIVD1MI:4S07;*Y#4_:1R.U&5PZWNK
M"+&*TXT^H(\QXB#HS=0[PL6O-^@<9#D[]+CNKM+(C%A@-50%"$^+6`#T'7%`
MO35"VP,(+V.09,N=>?0;86Y+761:O^[EDJV#NTP`DH<77Q"20DN3("F0K8/?
M2@02U%)TGI3:&@5+D7`=G$D"P%S[<1`!X`EB4VUN$CQ5VG5P^P@B)(&.J<A4
M4%'KH!&!!3Z++FC%ID;!4J![T.J:/<*R@*^"J!1:F@1*@6SNNUN=,,')@D11
M*;8U"I<BX=S'L!HA<P57:WK5Q(:V)B%3(IS[=%,C9.Z@\+FRV-0D7(IT<]]8
M:@3+@_!"]F#F,O906\3HSR4UPN3*E=A?RHU-0J9,>0:.[GO_PPMPA0WE<F.3
MP"E3GH&C^_;_L(8RA_]J<Z,`JM">0:2['7`-ES+NF7)KDP"JD)Y?HI@?IX&E
M\9!*8Y>]GW.WWM1A5!>C3<QF$W5DA2GI;`LK@]JYW:S-?'1'>_/]ILH'BM^:
M[_$Z=@%?)?;+2FN3]LL*Z>R@`ZW,&>(EDP&HVMXHB*K$IR!]T1PDXC`3QZC:
MW"2(JK1G"$T/]#$XQ$[9'LYA)WK*+C0V":TRY1E6C.)(&DVHA&[Q2*%:>_-`
MJD<-375?]A+"98*'*NW-0ZD>2'34<\&<02Y&)#:G:G.3,*K2OEOPICWO3GO)
M=;<`*^(RF"W/XQ"Q%N*P^^_`7P76TQK:9SBW'SOUW6DM]5TV'BYDE(TXL3QG
MLAMS0@95G0PO)33)J(1SY;-/A.RF2H+W[35P8A?,EFF]GR1A+D(\0"IW$8>1
MOP$!>3V!U/L6/N/*A?@]!2N_7]<!5<W>)@3S*/^._.F5*2W/^K*;4);+".;G
MM%4&6B_:FT/+9E"PPI42"!/%+=+,?`#`::L,PB8-S-%ATSZH\^G7!=,.V?VD
M>-5B@Y^9'3M2\^A+W8S`JSCPG]CGI_+/V@N\3*X.SRH&6VZ(*QC9?!<XOV``
M04C^@7469DBQ<1"M$6_+E`Y/"/:L%ZS3MY0(-3B2]Z\7]:/Z"/)52!IFMYS$
MFNV'&H=]VIY_P4J>"M>-L&3^X2-]\Q&:UT<5XEW5O;)H\%@TH^KNKEK'Q=KR
M<,T.4EWX?%MV"U$,/N&>BG>`9M7-:YB(<C32V`E:76G:]*8V,P)E-OE]';O0
MDJ*T5'V$%!>BS2G/JH)9?(&NFSI@']!@L>76BM:?'!Y/J^[=W6B39+C$MYL.
MN//I9F,J<>UFY)"J8F7N=\QP-BO)_OU4MV2!E$F2D^-:JK>J2=D*E$+=2W$.
MM5N*J9#_!DB4@W.&/H.VE[,-=F+_3=!(+IK":S^86Q%(TF,]!)8#-E;P9]7,
M[C36[T?JLCVUT/E,'3KQ.R+U(`DTJW)LJQ_4P<:L($R&1YKUZQIZ,`+D*%,3
M;4%`:8$W6F2LY`"&*4X;%H?Q!NJL*M=QA#?JK@K#&69<:L-A=!B78=\[T3VP
M72L,X1+S-@]\&X3HK!0")-0U$M$E.C:Y_A,^<#WX&9N\S:CC>(9I1P\<9P;+
M`2V\J%>WD<*ZFM/ZZ?-S[?396%=SJK:N)F(F@,](3,_E]U:W^-M(=N?;70-<
M)QLK"XX[.]_^$S@K7.,/A'#ED;:-U3@'^)B*K:;`1<X:[TJAH;WR]SF#Z4"V
MUS0(@&V1J$5W]SSQ'H9_,@*6^,W?$K8T_MD.2;70%EEE!C+QFJLZ93:+G`4/
MG0>](@71$1<=@Y&Y:9.KBXQDYE5^0WOU`-&%7K'$^4R,)ZKG(O##\((\W;6W
MR#@%")7HWHJ:<1;N:0;BPNSHD)6U9X/S?)O_\9\0!/A`L;W%QXGF*N?<CN/?
M:44EP<YTH!3XXO&G3G]S`72Q_LK50$B_:Y"*,:?99IW1>>,]Q5%(F)RRMVI>
M:^6HR2AG#3P:1^/9M6EL'DG!?#0ZF(]&O$$7V#R6@OEX=#`?CR^"FG9V3%R1
MG.@2D4[J+6^.,X[GK*@RHL/3E>&P#F\\;&Z",+T2V-6E$L2=-X!Z'6A2:IXB
M\#@;SW;.Y;R0?*V#9K!&&8EZL-@;D2V0>*0R#P55&G=^E!U8<9QY>H8M-""S
MB*]%`WW''#T;2`#C,5=Z$5`V8;=[T$;ZM]Z81M*%,)[G9K@,+,X?%:U]IU#[
ME9+PD*)F,IW-T1L9KGHKS5-\IO">IG.?:3H'<'8/FE]A\0+#\#I`=,[(L,P$
M`*R&ZF=BT\42C_J]Q7P.'(YU904>3@(]!\%BC>36^!SH6RT@*QMB@L:8D$$T
M>0)4Y8VSD+";]I$AHS*XP&N>YBZJID^34/-$&HT<:/<&HQ^M._,BZ$`WQBO,
M`MAQ0,ZU5Z^V&Z,9B1\87_B;IS@!;+:LR7.#DPM05+2G<56%SHI.@FQC[(G=
MO3WC&'B=O@?8:K0C)`>\U?,7Z>E1;9$N]==D?2[1=.8Y]\`EYQ\;89XX@]@+
MMD1?U?GYJ(1>^*%8,K[&WNI2)DBB1TO%U\A=EEE3B_OY$KV82D)S"()GP(BU
M:>RA0XH3007=Y3-IX$FOH`ILW5>X9(;&<-IJ,<W8.I>!P^%`+U@X?-4N&\4F
MU*WZ!P##S*I;D8Q`ZC%$9M<*-&.6-=-P0C%ON>D<]'6`:<@-TNGL>6&%Z[FU
M35R'?E!BA'+NY#<W!;)F3D;ZNIN\9J])BS8GF2U-P9C+Q$A?9&>YU*]>8<0"
MEM+&)$@IY&OW0KH?,.<XT6P0;>>NY6')X/L>\OX7G=N?_+!PKB^@*]+))+A%
M^,DNM_19K!E/Y)D6GT!V%JG>IB`LS5@&M7[E>;ELX&)B?K"5A37O-AH\<XXR
M($<0FL!A&"?QL-&?[V)\*3A;SOT08C;#*Q=N(`GF$'=="@]HBK;TP6M^Q-)F
M[1]<J3CRN/%L0/A_\"_1W^5T2V;<D:B8#,N9INES'4D_SR,Z85CBF1EYP6FK
M"N!&9VQ^?&?3/DA6[.9-'YNHLR7B]90I\(;VV@N]@?XA@V`'OCX]L^UX$Y.%
M@3@-\-UQ`-;`"TE$'FK7'/GRM7:I6AAU0H:=E,:=)`-K<MN:Q!/R8F`J#7J8
M0`)B%PB&:36*LO@8JIBS&=:*E9$&RE!XOP/1;/E@O:*_N;&#%R&<"`WA%D4!
M?(PC?''RX.-R]3ATSW==$B6=9'N@:'3O7U`5/--A'N49,OJ6Q3!US44C:_[Q
M"7/W:(4`_>5_`%!+`P04````"``H@@D_<TU(<WX0``"7O@``$``<`&IN:BTR
M,#$Q,#<P,RYX<V155`D``\N504[+E4%.=7@+``$$)0X```0Y`0``[5WKC]LV
M$O]^P/T/.G]J@?/:WFV2[B+;POO*I=B-#=MI^ZV@)=IF(Y,N*:W7_>MO2#VL
M-R4Y&^EP0H+$%F>&,_SQ,1R.Z/<_OVQMXQES01B][HW.ACT#4Y-9A*ZO>Z[H
M(V$2TOOYIW_^X_V_^OW?;V:/AL5,=XNI8Y@<(P=;QIXX&^.&[2DV%FB]QMQ0
M=/<4+6WXLCSXA7.V<O:(XZ`^8S0\DW_>O.WW_0IND`"!4*0DG)^-PI(GT&E%
M5.&5\>/@<G`^'(V,T?G5\,W5Q5MC^N11"G.#M\AP$%]CYQ/:8K%#)K[N;1QG
M=S48_$G_/#/95C'WA^_ZPXN>@1R'DZ7KX`?&MW=XA5S;`=OI7RZR594]`QJ)
MBBOJ;D-!^_W^[&7)[3/&UP/+X0/GL,,#H,"<F"$#HR5X&.V'?-C&LFECFB3U
MB,G;7RAIY\/A:/#[T^-<F1_4#]866NY1V81^R=81I%X,9/$28`G(9:GEA`Q1
MXC<#KS`D38GVU1U=7EX.5&E4*BG0@E#A(&KB'H!L&.\1I<Q!#G0B]5T^V>T(
M73'_*SR0TJ\XL_$"6MF0'S[//J::0SX?C$WHT:XM._/$V6!^R[8[CC>8"O*,
M/\)PV.([["!BBP5^<0`.T3.(==VKP1?J%VAHX16A1%DR?#M\-S+ZQAT1ILV$
M"R.E;T3J,%0E1JP6PZO&^,ZOR`AJ^O[]("D_6;4+8VU"?U*?0:*`CJ>:]!$>
M^-P^21&GB6Q3ZE>9\:A9/I__-("Q%KHS+!SNFH[+85++Q+&0HABQT7D*L9BT
M#IA\8.X1I]!$8HKY?`/K0B8V.B+-@/HQ!4\@T`")AA+9892/T0,B_%=DN_@)
M(]F`<G42?G.-/(2*233X_)#"1XHSE#PC*O`(TJA#)T#G(YA%UP3<K+$0V!%C
M:GU@S-H3V\X<3!7H-;A=I'`[RC8\X0:BEA&([\98/HISO%9=?+*Z<06A6"A<
M,%MSM-L0<PQN=C">SCT<*W%HD+P\3R(92#?8R@CD>V"&-1BJBB.HYQV:96;,
M<_V,J<7KAQ1>VAFS0R<R8TIW>0ZVJ48"'\"4EJ[Q@LV1C<-Y4D-5B)'G$X;<
M\/F64<%L8BDO/BQ0`RQT1[[[3)%K$:#XWOCN6*/A,$/5V6$8QW"!7K#(6>5R
MRS5CZTUZ45.[*R6K6\+J37IQ<$I1ZJ;`B\I38`=9$K*I#"#`O`2>@XHKW&`*
M-3M3&]%LY*HP:`!\F_(>`^'*S_#B'%,&^VCL$`]+PZ^N@_2K.))Q:.LPZMS*
MU!BMX59V$)\`\:@RMMK=^F5JW-8`M=N_5YF#2\^]VCFW]I1[Q*Y#K@QR"WGN
M50(XGZX0MS>GX>95T<%6!C8]8,50G9\"58=0L,"Y2X'_<L&Z^V>YL/B+6/)I
M,1*CM/,1"C`\"5V#E]BZZ;=LVJU:U9U:-U<5`A-=6XH(-(M*>5BZ%:3@-#GC
M^%@W,Z6BMS'NKIG]9G[$:V1/.3,QEKE(?H]//=4T=FJ[H@08$0E=@_L-'FS>
M;MEV2:A25/I`=^09^B>!WAG,.F4(-;`,D["$.\>H4.4T1<5V6%4(`I3?_.N\
MVLO:>_X.L)Q,E^S4%AT0/^I36;H6+Y_25SJ'3X?+NWHY>QU6Z?.\U`&>KNT+
M3^RZ%B[:2A1L(G2M7G;[T`&@3]329F;IP$C%.HHSL3I,0DQD((AQ<IQVC@\T
M;9[:Q45XNP8.0WG;+>*'R6I.UI2LB(FH`TLC<ZD#7LN4V<0,V[XDK0:6]/&4
M)U9ZJA'!QE&R$8CN4`M0"].3)JM;)#8/-ML'(&46%6(RNAB6SX62,@TE-)H-
MU2&3@4S@^J>!"4N*<3FO@$M6CEJ'2A`X0;9\,6F^P;#23F$/1L'C=V">\5?V
M@O)BA$:%682^6,.3F\@>C-;2(96)5`8X.CP*1TP^'EW[9\=T8V=,.67%ITLE
MXKO=N5*=2&\,F@KT&KAJQGT[#$]X8[7JFZK:-U1/?$&UP[`"AM'3WO+DFK/?
MV@AV1\&EWE\M?&]5^[YJA==5.R3RD(B.FYPRS2`IA4,W(&HG)U?.3=:F)I^>
MF=P!607(Z!BK0*\9=Z?`V`U'_<47^1=>:"^Z*'?/1=?\F<T?'2U9!<7#0MOX
M7=>O<_10YPBBW%'$#Z<<11C?!9\Z0,O?=%'VA@OMS18U+[;HL"J!570:U)-I
M?(7*2'6S9.X)>&(0I9YK!DW1>7@W0HH:/CXBDH\U(Z"XV;ON'F_U.__B2IAH
M[F'%=0X?Z8KQK=+8`Z"0HA`+%=H.+L:,?)03D"?*B,CZ/X!$_B.OC9SAE:%N
M>KR2MUU>]P39[FQYF:1ZMN%X==T#E/KR7LKAN^'%'V#MV<O6#BBD^()[(16P
MR0;RZPU$(&ZFI*0NH@0A;(>Y`R-G$.@>"`#X)/LT4HTAZQ'_-I!,X!I\+=MM
MM*QJ.[!@^Q6-?I3R7\=:Z)U5K4UTZ%>R^?98R^M8#L.KJN7Q$?E*AM^%E63:
M_7X0O645OL5O87T/9C/N&#1U[6Z)FV^]BWL?F:GDZ3D_>8S0IL/+_NB\/WI[
M]B*L0-?*JM13XVOH$+_>MI0"BD5^ZP=\4H4+J<+%J*X*QRY1386`K[(*2I;`
MYMF:/4/W)O[5Q",0D*M#)H_\T#\REZM]A<126>**_AJA7>G:,QD'V'9$\*2R
M+C&K3)=S3,U#Y>:(,8;?3E,&OYB;RHJ$3.I3/052-TJ7[)0!@^R-;V+U^5=K
MJPIABF=4R-'[A+=+S#WO#Z;H/Y+/O0G=N\C[RF);1.A'!V^EPP,ZN4N5HR`U
M^L"9N[ONJ7NLKPB0]`P*FT[I@E_W'.[*J5:5P11,F+50<BV7^]YG0LE`G>D&
M@<MH8E>E<@5*>29DES6DL*?2$[:D+G?XF9C82Q)!:\J@3E,D6[H,;<.M_QLF
MZXV#K?$SYFB-QUOHL.1OQ3-5<L0#XU/DR/,),&#!D05]E'\1`40G"/!,]Y0.
M%&V=[2I;(!G'J61\CH2FK/<T?Y!.$'XDS]C*`@>J%.+8D<M11RW:,HH=Q`\G
M6K3T4@[!'+PD3I:=GGO@U#,SDA82Q:ZTX;G\K]D4)H=II49;J'X8,2@5G-0U
M1FT!_XNM\0D[Y2U7Q"WL_D7!GC'HPY$9L;(<==1,>$;HNK21R!<2&'GR+`8X
M8(Z%XZ5OW;_L,!48P$@NQ#JZ1CV*&188=K<;7ZVD[CG%C:H<+&GI1I7LBPW'
M62A4XVJS@7M6W;P83XN-FY.7RL;%>1IV:3_/XYN(X_=&6UTUGI?_?=S*Q":H
M9&&CZMZ[,I26U#/^M%D%DTF/_D6JZ75-3]FF-2WQFDB^65K"-ED%OB$P6C.\
M!/=0S+#C<O6*!>B_99(OLMLH0]M&EW)L_N42H6++&7!EE[8)H_!.BOP^5T#2
M)DNRKXW+M:HD>9LL+,HL*4"O`E,[K`U45Q.W^&U#S,TM<VWK!L_PS@6W6/Z:
MXF=J8;[@"KS#W&'FER?L;)@5>``UF6,MH$1\2S=&OBD^10?5%Q\83US*YX=X
M"VE>88[,MB!G_LPQ+-^5C/B0.D^U/>ZFG[U=F!>>&EQ^OZS#FAQ<)XS3KV"]
M)D"F`B.E0G&O%4+)7+ZSHRMY!Q1%]UOG(%N-IUV0EG@9-L_L6JSMLCZ87Y@S
MMFUY%(>M!0O>T`CLU!`U-?$6]^,R;U?FX%J+M5VX_HJY14QGO$9R%I`&('H(
M[,LI;">.,QQ6&U\M,PH:7AMOR3.Q82Y$MDS)B6N;7=:PPN.M?%/A`_1JNF`P
M6Q/JD-7JYO`+^(;A8"BD::G3I7Y?;89!9Q=+GU^NM\=?8(,A+)T-?(>]_T,'
MI2*7CQY`M_.HOFEG8P)<*:7FG-F6WKH*#(T:IHY7IYQ)!T)K5$GB1@V:8]N&
MZ?\#.$4<V>`@C*TM>(=RN7!@6/FK:XGN>;*<1ILA.-F1'A*,,9OM9+&O]?V+
M:;LRKJ?B1ER>.:I8GW2N1(E^\$K"&VTPF?HO'/G(\SF"G:&^->IP-FRJIV#I
ML5"!H5'#E/_XB=$)<"'Y3F!L6Z^WLSY_PWA*+1]A;G[@;'O+Y.N0+FCOFP'[
MI!N\8CR\Y>0%7")"&5>G\!ZR,)+C4NYA[#H'+UIU[."B3%]IA3(M``1L\WM.
ML$,OV7B5&!LUU/,%)$QZV\K1-FK.`Z'@\!)8[H,0]B-!2V(3N8N`#;D?PK?&
M3AC53^YF3Q+1KETM:(O%G8N];,,)Q?$]5FYQP]NLN%Z+/2M2.U+<+K5EPDJA
MXE&"5JG^P%SN8$R+M$_2M,X`G?+M5!SV)86*1\I;I?B<O!3I'2ENE]HR>%&H
M>)2@5:K?R]SR(M5C!*U2_1,I7HFBY:U2?%'<619M[2JVKIO'*5JE_&*/[>))
M,4[1+N4W1+N2)FE:9<`#66D]@3A)P^H?=R:W&T3E_D1%J6\.J=/TXV%L>8Y&
M]S9A&L`Q54S&X\1D%<3IO+S\J9^[,N7$#/=N-9G;><8UQX[C/?+36V98G3X^
M2!/OB%@SOL;^NPI!2.(8%:[#V\YV.';=R<H_AYEA_RX(;-T<9O+:&8IA8>*<
M!#_TDNSU%5@;[?[>P5IE0RNSM?2(3@^83:@<VYN:>.>P-QN=BF@M`Y&<+%5M
M"^;%V;R(U'QG$R?+4"U+H\8]PBR\5B3'.>GFX*470-./7TB(7BG2KQ![LIPK
MBVR][*2/W\C..^4CE+0T(&[8RWB"WO(E[A3%'C6=6`%?F,GXA#L;=D/`73,W
MT/L3&1;%1`V;,*%X`3TQ7*--+%,#@YX09EMHR5HZF]]RU\2V_>DY@4GR<=,)
M+Z9IJY_22?6>K)*F7?_8=1`/&(LI(M:"?6#/F%/E\<E;10\R%^W&9N:7<,FH
MSA@SU0F>-[UZ3#G^Q;76WD%VW.TM3=[2`2,/8^"O=8>VL+3+=/:Q;>,UMH+[
M2AXX<BW?EU^P6\RE:W?'W?71$SQ%1#LW`,7O7<HP=X6D^0R6AD?T'1`_JV2=
MCU2^NZ#.C#^`$O(,<D+#GZ*:K,)#.W#_U%OIT'C)@[VO):U=9WPR6'%SB+\7
MH.Z]3$US92B;G]=RPS%QQ;71FR1YHZY^7D0I'Z@RU&T$*Y%X\\B*`FV9Q"W9
M<!;H&.;'^1.G*'X=X.O*;+1Y9EC%"H,WRJ+W@<K==BKM/\?A.EE,\SU_OB<R
MLPE6ALDNG6N?5]JJV/Z<O.AB^PF2=JDOHUA:`Y)$K3)!'=%J+$C2M,J`Q1[*
M#IK#N0A%"Y779$6EB%IH@C9#*D'4L`FQ]Y"#Y:X@4;T,<;,G$][]?K]M&/AM
MX+NIL[/CACL1."E'W#1&1`"]E;QQ,_6X5:-!YHWHIM,D3<,&'($?4VN&363;
M?B=/!V[2%.T,2LP/\J>W12IDF'[><./GG(DGC\2]:Q1(Y`TPS:%Z&0%MS"1(
MZNTE[8>Q(B%<;,E3<?@@%:C='A7D-KS;B:P]:O2IT*`T*>_*UTHL[1R^A29X
M/ZYR*&5N2/O-[#RMNZO;7;S>6+MKY\AHN!LCF_R-+1GJG%!O0PJ+XAT69$W5
M=:SB/]A:1URNLO0M/2LX+IFY:VG+E]"CHM$`6O)I.W6_9=PB(C8S)`XY\PF:
M]GJQ:2,AR"KRRFOVF[(+%MQAG+$$G"2DG:".]XA;X=&93"#B`H<W:.65OK(M
M>??M9:YD\G*=R4K^4$GZ6HP"HF_9(]\/O-]X@(__!5!+`0(>`Q0````(`"B"
M"3\:DY/@_>\``.A_#``0`!@```````$```"D@0````!J;FHM,C`Q,3`W,#,N
M>&UL550%``/+E4%.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*(()/]3D
M@%)?%@``S#0!`!0`&````````0```*2!1_```&IN:BTR,#$Q,#<P,U]C86PN
M>&UL550%``/+E4%.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*(()/YDT
MJ`(M&P``'SP"`!0`&````````0```*2!]`8!`&IN:BTR,#$Q,#<P,U]D968N
M>&UL550%``/+E4%.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*(()/T$%
MPOT6=```MM,%`!0`&````````0```*2!;R(!`&IN:BTR,#$Q,#<P,U]L86(N
M>&UL550%``/+E4%.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*(()/Y6<
M+7*+/0``APH$`!0`&````````0```*2!TY8!`&IN:BTR,#$Q,#<P,U]P<F4N
M>&UL550%``/+E4%.=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*(()/W--
M2'-^$```E[X``!``&````````0```*2!K-0!`&IN:BTR,#$Q,#<P,RYX<V15
M5`4``\N504YU>`L``00E#@``!#D!``!02P4&``````8`!@`4`@``=.4!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.3.0.11</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ReportType />
  <ContextCount>197</ContextCount>
  <ElementCount>249</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>65</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>true</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0110 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0111 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0120 - Statement - Consolidated Statements of Earnings (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/StatementsOfEarnings</Role>
      <ShortName>Consolidated Statements of Earnings (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0121 - Statement - Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IncomeStatementPercentageToSales</Role>
      <ShortName>Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0201 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0202 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0203 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0204 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0205 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0206 - Disclosure - Pensions and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/PensionsAndOtherBenefitPlans</Role>
      <ShortName>Pensions and Other Postretirement Benefits</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0207 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0208 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0209 - Disclosure - Segments of Business and Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreas</Role>
      <ShortName>Segments of Business and Geographic Areas</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0210 - Disclosure - Business Combinations and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/BusinessCombinationsAndDivestitures</Role>
      <ShortName>Business Combinations and Divestitures</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0211 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/LegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0212 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0213 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0401 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0502 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0503 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0504 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0506 - Disclosure - Pensions and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/PensionsAndOtherBenefitPlansTables</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0507 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0508 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0509 - Disclosure - Segments of Business and Geographic Areas (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasTables</Role>
      <ShortName>Segments of Business and Geographic Areas (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0512 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0602 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0603 - Disclosure - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IntangibleAssetsAndGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>06031 - Disclosure - Intangible Assets and Goodwill (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IntangibleAssetsAndGoodwillDetailsTextuals</Role>
      <ShortName>Intangible Assets and Goodwill (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0604 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>06041 - Disclosure - Fair Value Measurements (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurementsDetails1</Role>
      <ShortName>Fair Value Measurements (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>06042 - Disclosure - Fair Value Measurements (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurementsDetails2</Role>
      <ShortName>Fair Value Measurements (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>06043 - Disclosure - Fair Value Measurements (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/FairValueMeasurementsDetailsTextuals</Role>
      <ShortName>Fair Value Measurements (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0605 - Disclosure - Income Taxes (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/IncomeTaxesDetailsTextuals</Role>
      <ShortName>Income Taxes (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0606 - Disclosure - Pensions and Other Postretirement Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/PensionsAndOtherBenefitPlansDetails</Role>
      <ShortName>Pensions and Other Postretirement Benefits (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>06061 - Disclosure - Pensions and Other Postretirement Benefit (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/PensionsAndOtherBenefitPlansDetailsTextuals</Role>
      <ShortName>Pensions and Other Postretirement Benefit (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0607 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>06071 - Disclosure - Accumulated Other Comprehensive Income (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/AccumulatedOtherComprehensiveIncomeDetailsTextuals</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0608 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>06081 - Disclosure - Earnings Per Share (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/EarningsPerShareDetailsTextuals</Role>
      <ShortName>Earnings Per Share (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0609 - Disclosure - Segments of Business and Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails</Role>
      <ShortName>Segments of Business and Geographic Areas (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>06091 - Disclosure - Segments of Business and Geographic Areas (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails1</Role>
      <ShortName>Segments of Business and Geographic Areas (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>06092 - Disclosure - Segments of Business and Geographic Areas (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetails2</Role>
      <ShortName>Segments of Business and Geographic Areas (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>06093 - Disclosure - Segments of Business and Geographic Areas (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/SegmentsOfBusinessAndGeographicAreasDetailsTextuals</Role>
      <ShortName>Segments of Business and Geographic Areas (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0610 - Disclosure - Business Combinations and Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/BusinessCombinationsAndDivestituresDetails</Role>
      <ShortName>Business Combinations and Divestitures (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0611 - Disclosure - Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/LegalProceedingDetails</Role>
      <ShortName>Legal Proceedings (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0612 - Disclosure - Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/RestructuringDetails</Role>
      <ShortName>Restructuring (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>06121 - Disclosure - Restructuring (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jnj.com/role/RestructuringDetailsTextuals</Role>
      <ShortName>Restructuring (Details Textuals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element jnj_PercentageChangeInSalesBySegmentOfBusiness had a mix of decimals attribute values: 3 2.</Log>
    <Log type="Info">Element jnj_LitigationLoss had a mix of decimals attribute values: -5 -6.</Log>
    <Log type="Info">'Monetary' elements on report '06043 - Disclosure - Fair Value Measurements (Details Textuals)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '0611 - Disclosure - Legal Proceedings (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 0110 - Statement - Consolidated Balance Sheets (Unaudited)</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Jul. 04, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Jan. 03, 2010'</Log>
    <Log type="Info">Process Flow-Through: 0111 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 0120 - Statement - Consolidated Statements of Earnings (Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 0121 - Statement - Consolidated Statements of Earnings (Unaudited) (Percentage to Sales)</Log>
    <Log type="Info">Process Flow-Through: 0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)</Log>
  </Logs>
  <InputFiles>
    <File>jnj-20110703.xml</File>
    <File>jnj-20110703.xsd</File>
    <File>jnj-20110703_cal.xml</File>
    <File>jnj-20110703_def.xml</File>
    <File>jnj-20110703_lab.xml</File>
    <File>jnj-20110703_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T
M-6(Q93`X-S,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U
M,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S7U5N/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U5N,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;G-O;&ED
M871E9%]3=&%T96UE;G1S7V]F7T5A<CPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T5A
M<C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VYS
M;VQI9&%T961?4W1A=&5M96YT<U]O9E]#87,\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,#8N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y7V]F7U-I9VYI9FEC86YT7T%C
M8V]U;G0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,#<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y)
M;G9E;G1O<FEE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DEN=&%N9VEB;&5?07-S971S7V%N9%]';V]D=VEL;#PO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9A:7)?5F%L=65?365A<W5R
M96UE;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M26YC;VUE7U1A>&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Q+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^4&5N<VEO;G-?86YD7T]T:&5R7U!O<W1R971I<F5M/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^06-C=6UU;&%T961?3W1H
M97)?0V]M<')E:&5N<VEV/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^16%R;FEN9W-?4&5R7U-H87)E/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$T+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4V5G;65N='-?;V9?0G5S:6YE<W-?86YD
M7T=E;V=R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M0G5S:6YE<W-?0V]M8FEN871I;VYS7V%N9%]$:79E/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$V
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^3&5G86Q?4')O8V5E9&EN9W,\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,3<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y297-T<G5C='5R
M:6YG/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W5B
M<V5Q=65N=%]%=F5N=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3DN:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y3=6UM87)Y7V]F7U-I9VYI9FEC86YT7T%C8V]U;G0Q/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^26YV96YT;W)I97-?
M5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#(Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M26YT86YG:6)L95]!<W-E='-?86YD7T=O;V1W:6QL,3PO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9A:7)?5F%L=65?365A<W5R96UE
M;G1S7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,RYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/E!E;G-I;VYS7V%N9%]/=&AE<E]0;W-T<F5T:7)E;3$\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y!8V-U;75L871E9%]/=&AE
M<E]#;VUP<F5H96YS:78Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(U+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^16%R;FEN9W-?4&5R7U-H87)E7U1A8FQE<SPO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970R-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-E9VUE;G1S7V]F7T)U<VEN
M97-S7V%N9%]'96]G<C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C<N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y297-T<G5C='5R:6YG7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R."YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/DEN=F5N=&]R:65S7T1E=&%I;',\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,CDN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y);G1A;F=I8FQE
M7T%S<V5T<U]A;F1?1V]O9'=I;&PR/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,P+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^26YT86YG:6)L95]!<W-E='-?86YD7T=O;V1W:6QL
M,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970S,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9A:7)?
M5F%L=65?365A<W5R96UE;G1S7T1E=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,BYH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/D9A:7)?5F%L=65?365A<W5R96UE;G1S7T1E
M=&%I;#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,S,N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&
M86ER7U9A;'5E7TUE87-U<F5M96YT<U]$971A:6PR/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,T
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^1F%I<E]686QU95]-96%S=7)E;65N
M='-?1&5T86EL,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-2YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DEN8V]M95]487AE<U]$971A:6QS7U1E>'1U86QS/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4&5N<VEO;G-?86YD7T]T:&5R
M7U!O<W1R971I<F5M,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-RYH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/E!E;G-I;VYS7V%N9%]/=&AE<E]0;W-T<F5T:7)E;3,\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y!8V-U;75L871E9%]/
M=&AE<E]#;VUP<F5H96YS:78R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,Y+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^06-C=6UU;&%T961?3W1H97)?0V]M<')E:&5N<VEV,SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970T,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D5A<FYI;F=S
M7U!E<E]3:&%R95]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0Q+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^16%R;FEN9W-?4&5R7U-H87)E7T1E=&%I;'-?5&5X/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#0R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4V5G;65N='-?
M;V9?0G5S:6YE<W-?86YD7T=E;V=R,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,RYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E-E9VUE;G1S7V]F7T)U<VEN97-S7V%N9%]'96]G
M<C,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T-#0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y396=M
M96YT<U]O9E]"=7-I;F5S<U]A;F1?1V5O9W(T/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0U+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4V5G;65N='-?;V9?0G5S:6YE<W-?86YD
M7T=E;V=R-3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970T-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D)U<VEN97-S7T-O;6)I;F%T:6]N<U]A;F1?1&EV93$\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M-#<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y,96=A;%]0<F]C965D:6YG<U]$
M971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#0X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M4F5S=')U8W1U<FEN9U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0Y+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^4F5S=')U8W1U<FEN9U]$971A:6QS7U1E>'1U86QS
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#4P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@/"]X.D5X8V5L5V]R:W-H965T<SX-"B`@/'@Z4W1Y;&5S:&5E="!(
M4F5F/3-$(E=O<FMS:&5E=',O<F5P;W)T+F-S<R(O/@T*("`\>#I!8W1I=F53
M:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0<F]T96-T4W1R=6-T=7)E
M/D9A;'-E/"]X.E!R;W1E8W13=')U8W1U<F4^#0H@(#QX.E!R;W1E8W17:6YD
M;W=S/D9A;'-E/"]X.E!R;W1E8W17:6YD;W=S/@T*(#PO>#I%>&-E;%=O<FMB
M;V]K/@T*/"]X;6P^/"%;96YD:69=+2T^#0H\+VAE860^#0H@(#QB;V1Y/@T*
M("`@/'`^5&AI<R!P86=E('-H;W5L9"!B92!O<&5N960@=VET:"!-:6-R;W-O
M9G0@17AC96P@6%`@;W(@;F5W97(N/"]P/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?
M-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A
M-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S
M+U-H965T,#$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5$6$%%/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/D1O8W5M96YT(&%N9"!%;G1I='D@26YF;W)M871I;VX@*%531"`F
M;F)S<#LD*3QB<CY);B!":6QL:6]N<RP@97AC97!T(%-H87)E(&1A=&$\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,CDL(#(P,3$\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N
M="!A;F0@16YT:71Y($EN9F]R;6%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%)E9VES
M=')A;G0@3F%M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2D](
M3E-/3B`F($I/2$Y33TX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X($ME>3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,#`P,#(P,#0P-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE
M;G0@5'EP93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,3`M43QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#Y*=6P@,RP-"@D),C`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT($9L86<\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/F9A;'-E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&
M:7-C86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^,C`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&]C=6UE;G0@1FES8V%L(%!E<FEO9"!&;V-U<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^43(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE
M87(@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/BTM
M,#$M,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5N=&ET>2!796QL+6MN;W=N(%-E87-O;F5D($ES<W5E<CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^665S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@5F]L=6YT
M87)Y($9I;&5R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3F\\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5N=&ET>2!&:6QE<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^3&%R9V4@06-C96QE<F%T960@1FEL97(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#=7)R
M96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/EEE<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YT:71Y(%!U8FQI8R!&;&]A=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q-C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM;VX@
M4W1O8VLL(%-H87)E<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPW-#`L,S4T+#$Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?
M-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A
M-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S
M+U-H965T,#(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4V64%'/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\
M<W1R;VYG/D-O;G-O;&ED871E9"!"86QA;F-E(%-H965T<R`H56YA=61I=&5D
M*2`H55-$("9N8G-P.R0I/&)R/DEN($UI;&QI;VYS/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#`R+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E
M;G0@87-S971S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$T+#DW-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,3DL
M,S4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y-87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$T+#<P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C@L,S`S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!R96-E:79A8FQE
M+"!T<F%D92P@;&5S<R!A;&QO=V%N8V5S(&9O<B!D;W5B=&9U;"!A8V-O=6YT
M<R`F;F)S<#LD,S(W("@R,#$P+"`F;F)S<#LD,S0P*3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`L.3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PW-S0\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=F5N=&]R:65S("A.
M;W1E(#(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#0Q,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M,S<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$969E<G)E9"!T87AE<R!O;B!I;F-O;64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L,S`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPR,C0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97!A:60@97AP96YS97,@
M86YD(&]T:&5R(')E8V5I=F%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS+#(Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,C<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!A<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R+#8W,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W+#,P-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M<&5R='DL('!L86YT(&%N9"!E<75I<&UE;G0@870@8V]S=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S(L-#,U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`L-#(V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S.B!A8V-U
M;75L871E9"!D97!R96-I871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$W+#0V,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q-2PX-S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='DL('!L86YT(&%N9"!E
M<75I<&UE;G0L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30L.3<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,30L-34S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y);G1A;F=I8FQE(&%S<V5T<RP@;F5T("A.;W1E(#,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."PS-S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPW,38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D=O;V1W:6QL+"!N970@*$YO=&4@,RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$V+#(T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$U+#(Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@=&%X97,@;VX@:6YC
M;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#8U,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,#DV
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/=&AE<B!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0L,3DS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPY-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Q,BPQ,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#(L.3`X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@
M;&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DQO86YS(&%N9"!N;W1E<R!P87EA8FQE/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#`T-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L-C$W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA
M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#8X.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C(S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!8V-R=65D(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+#0P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L,3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D(')E8F%T97,L(')E='5R;G,@
M86YD('!R;VUO=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L.3,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPU,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8W)U960@8V]M<&5N<V%T:6]N(&%N9"!E;7!L;WEE
M92!R96QA=&5D(&]B;&EG871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#$P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D('1A>&5S(&]N(&EN8V]M93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3<X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@
M8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C`L.3@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C,L,#<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B="`H3F]T92`T*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L-C@P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PQ-38\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E
M9F5R<F5D('1A>&5S(&]N(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PX.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#0T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16UP;&]Y964@<F5L871E9"!O8FQI9V%T
M:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPR,#(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#`X
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<L,C(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-BPU-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B:6QI=&EE<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#DL.3@R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8L,S(Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-H87)E:&]L9&5R<R<@97%U:71Y.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@+2!P87(@=F%L=64@
M)FYB<W`[)#$N,#`@<&5R('-H87)E("AA=71H;W)I>F5D(#0L,S(P+#`P,"PP
M,#`@<VAA<F5S.R!I<W-U960@,RPQ,3DL.#0S+#`P,"!S:&%R97,I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#$R,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,3(P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L
M871E9"!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H3F]T92`W*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ.3(I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPU,S$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2971A
M:6YE9"!E87)N:6YG<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#`L.#,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S<L-S<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,97-S.B!C;VUM;VX@<W1O8VL@:&5L9"!I;B!T<F5A
M<W5R>2P@870@8V]S="`H,S<Y+#(V,RPP,#`@86YD(#,X,2PW-#8L,#`P('-H
M87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#8S,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P
M+#<X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L('-H87)E:&]L9&5R<R<@97%U:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV,BPQ,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-BPU-SD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B
M:6QI=&EE<R!A;F0@<VAA<F5H;VQD97)S)R!E<75I='D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,3$R+#$Q-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,3`R
M+#DP.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q
M7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,#,N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$4U3T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-O;G-O;&ED871E9"!"
M86QA;F-E(%-H965T<R`H56YA=61I=&5D*2`H4&%R96YT:&5T:6-A;"D@*%53
M1"`F;F)S<#LD*3QB<CY);B!-:6QL:6]N<RP@97AC97!T(%-H87)E(&1A=&$\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@
M,#(L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^0W5R<F5N="!A<W-E=',Z/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%L;&]W86YC97,@9F]R(&1O=6)T9G5L
M(&%C8V]U;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S
M<#LD(#,R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B9N8G-P.R0@,S0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E:&]L9&5R<R<@97%U
M:71Y.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VUM;VX@<W1O8VLL('!A<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)FYB<W`[)"`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL
M('-H87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT+#,R,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-"PS,C`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K
M+"!S:&%R97,@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#$Q.2PX-#,L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPQ,3DL.#0S+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5')E87-U<GD@<W1O8VLL
M('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<Y+#(V
M,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS.#$L-S0V+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P
M.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V
M,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,#0N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$4V64%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O
M;G-O;&ED871E9"!3=&%T96UE;G1S(&]F($5A<FYI;F=S("A5;F%U9&ET960I
M("A54T0@)FYB<W`[)"D\8G(^26X@36EL;&EO;G,L(&5X8V5P="!097(@4VAA
M<F4@9&%T83PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VYS;VQI9&%T960@4W1A=&5M96YT
M<R!O9B!%87)N:6YG<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&5S('1O(&-U<W1O;65R<R`H3F]T
M92`Y*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q
M-BPU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XF;F)S<#LD(#$U+#,S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,S(L-S<P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`S,"PY
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O<W0@;V8@<')O9'5C=',@<V]L9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-2PQ-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT+#8S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDL.34P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PQ-3@\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!P<F]F
M:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#0R-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#<P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(R+#@R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(Q+#@P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4V5L;&EN9RP@;6%R:V5T:6YG(&%N9"!A9&UI;FES
M=')A=&EV92!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-2PR,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+#<U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P+#(W,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/CDL-3,U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E87)C:"!A;F0@9&5V96QO
M<&UE;G0@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PX.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#8T.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,L-C(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPR,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&EN8V]M93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3@I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#,I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,SDI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S
M="!E>'!E;G-E+"!N970@;V8@<&]R=&EO;B!C87!I=&%L:7IE9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B`H
M:6YC;VUE*2!E>'!E;G-E+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3DS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PU-S8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<G5C='5R:6YG(&5X<&5N<V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4X.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4X.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5A<FYI
M;F=S(&)E9F]R92!P<F]V:7-I;VX@9F]R('1A>&5S(&]N(&EN8V]M93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPT,C(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#(R,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.3,R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L
M-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F]V:7-I;VX@9F]R('1A>&5S(&]N(&EN8V]M92`H3F]T92`U*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C0V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S<Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PV.#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#4R
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DY%5"!%05).24Y'4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)FYB<W`[)"`R+#<W-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,RPT-#D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#8L,C4R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB
M<W`[)"`W+#DW-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY.150@14%23DE.1U,@4$52(%-(05)%("A.
M;W1E(#@I/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D)A<VEC/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S
M<#LD(#$N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XF;F)S<#LD(#$N,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(N,C@\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(N.#D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1I;'5T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P
M.R0@,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B9N8G-P.R0@,2XR,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,BXR-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,BXX-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0T%3
M2"!$259)1$5.1%,@4$52(%-(05)%/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XF;F)S<#LD(#`N-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#`N-30\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$N,3$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF
M;F)S<#LD(#$N,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^059'+B!32$%215,@3U544U1!3D1)3D<\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S
M:6,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S0P+C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<U
M-BXV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPW,SDN-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(L-S4U+C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1I;'5T960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-S@Q+C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#<Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S<X+C$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<Y-BXQ/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q
M-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P
M.#<S+U=O<FMS:&5E=',O4VAE970P-2YH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15!%04<^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@
M;V8@16%R;FEN9W,@*%5N875D:71E9"D@*%!E<F-E;G1A9V4@=&\@4V%L97,I
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY#;VYS;VQI9&%T960@4W1A=&5M96YT<R!O
M9B!%87)N:6YG<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&5S('1O(&-U<W1O;65R<R`H3F]T92`Y
M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"XP
M,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]S="!O9B!P<F]D=6-T<R!S;VQD/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2XR,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"XR,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"XT,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M.2XV,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y'<F]S<R!P<F]F:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8X+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8Y+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8Y+C8P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<P+C0P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5L;&EN9RP@;6%R
M:V5T:6YG(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S$N-#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$N,S`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`N.#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y297-E87)C:"!A;F0@9&5V96QO<&UE;G0@97AP96YS93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3$N,S`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`N.#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`N-#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y);G1E<F5S="!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#`N,3`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#`N,S`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#`N,3`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#`N,C`E*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@97AP96YS
M92P@;F5T(&]F('!O<G1I;VX@8V%P:71A;&EZ960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`N.#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XW,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C@P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N-C`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B`H
M:6YC;VUE*2!E>'!E;G-E+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$N,S`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,"XQ,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP+C8P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#4N,3`E*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')U8W1U<FEN9R!E
M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C4P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N
M.#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16%R;FEN9W,@8F5F;W)E('!R;W9I<VEO;B!F;W(@=&%X97,@;VX@
M:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"XV,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-RXU,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-"XR,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,RXY,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W9I<VEO;B!F;W(@=&%X97,@;VX@:6YC
M;VUE("A.;W1E(#4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+CDP)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-2XQ,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XX+C$P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DY%5"!%05).24Y'4SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,38N-S`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(N-3`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DN,3`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N.#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V
M.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q
M-#5B,64P.#<S+U=O<FMS:&5E=',O4VAE970P-BYH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14E"
M0D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]N<V]L:61A=&5D(%-T871E
M;65N=',@;V8@0V%S:"!&;&]W<R`H56YA=61I=&5D*2`H55-$("9N8G-P.R0I
M/&)R/DEN($UI;&QI;VYS/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-!4T@@1DQ/5R!&4D]-($]015)!5$E.1R!!0U1)
M5DE42453/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!E87)N:6YG<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)FYB<W`[)"`V+#(U,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-RPY-S4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^061J=7-T
M;65N=',@=&\@<F5C;VYC:6QE(&YE="!E87)N:6YG<R!T;R!C87-H(&9L;W=S
M(&9R;VT@;W!E<F%T:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;B!A;F0@86UO
M<G1I>F%T:6]N(&]F('!R;W!E<G1Y(&%N9"!I;G1A;F=I8FQE<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,S(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0T-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@8F%S
M960@8V]M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D1E9F5R<F5D('1A>"!P<F]V:7-I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#4P-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S(')E8V5I=F%B
M;&4@86QL;W=A;F-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^0VAA;F=E<R!I;B!A<W-E=',@86YD(&QI86)I;&ET
M:65S+"!N970@;V8@969F96-T<R!F<F]M(&%C<75I<VET:6]N<SH\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@
M:6X@86-C;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-3<V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#4U-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DEN8W)E87-E(&EN(&EN=F5N=&]R:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,C`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#@I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$96-R96%S
M92!I;B!A8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D(&QI86)I;&ET:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-#0I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PW,3DI/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M;F-R96%S92!I;B!O=&AE<B!C=7)R96YT(&%N9"!N;VXM8W5R<F5N="!A<W-E
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DR,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W,#0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M;F-R96%S92!I;B!O=&AE<B!C=7)R96YT(&%N9"!N;VXM8W5R<F5N="!L:6%B
M:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ.3D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.150@0T%32"!&3$]74R!&4D]-($]015)!5$E.1R!!0U1)5DE42453
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#(R-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L-3(W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-!4T@@1DQ/5U,@1E)/32!)3E9%4U1)3D<@04-4259)5$E%4SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9&1I
M=&EO;G,@=&\@<')O<&5R='DL('!L86YT(&%N9"!E<75I<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,#4T*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Y-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S
M(&9R;VT@=&AE(&1I<W!O<V%L(&]F(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,30S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8W%U:7-I=&EO;G,L(&YE="!O9B!C
M87-H(&%C<75I<F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M+#`T.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@X-S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0=7)C:&%S97,@;V8@:6YV97-T;65N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$V+#@R,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+#8Y-2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&5S(&]F
M(&EN=F5S=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,"PU.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W1H97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#8R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DY%5"!#05-((%53140@0ED@24Y615-424Y'($%#5$E6
M251)15,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DL,C8P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L
M-3<U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY#05-(($9,3U=3($923TT@1DE.04Y#24Y'($%#5$E6
M251)15,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&EV:61E;F1S('1O('-H87)E:&]L9&5R<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,RPP-#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,BPX,SDI/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297!U<F-H87-E(&]F(&-O
M;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.3(Y
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#<X,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R;V-E961S(&9R;VT@<VAO<G0M=&5R;2!D96)T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4X-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDU-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5T:7)E;65N="!O
M9B!S:&]R="UT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#8L,3DT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#,L-3DX*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!L;VYG+71E<FT@9&5B
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PT,#0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E=&ER
M96UE;G0@;V8@;&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!E>&5R8VES92!O
M9B!S=&]C:R!O<'1I;VYS+R!E>&-E<W,@=&%X(&)E;F5F:71S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.150@0T%32"!54T5$
M($)9($9)3D%.0TE.1R!!0U1)5DE42453/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q+#0V-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@U+#@X-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5F9F5C="!O9B!E>&-H86YG92!R
M871E(&-H86YG97,@;VX@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E8W)E87-E
M(&EN(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0L,S@Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,L,#DW*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@0V%S:"!E
M<75I=F%L96YT<RP@8F5G:6YN:6YG(&]F('!E<FEO9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3DL,S4U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L.#$P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#05-(($%.1"!#05-(
M($5154E604Q%3E13+"!%3D0@3T8@4$5224]$/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-"PY-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPW,3,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06-Q=6ES:71I
M;VYS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9A:7(@=F%L=64@;V8@87-S971S(&%C<75I<F5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#(T.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDP.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!V86QU92!O9B!L:6%B
M:6QI=&EE<R!A<W-U;65D(&%N9"!N;VXM8V]N=')O;&QI;F<@:6YT97)E<W1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.3DI/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S@I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&-A<V@@<&%I9"!F;W(@86-Q=6ES:71I;VYS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(L,#0Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`X-S$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V
M,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X
M-S,O5V]R:W-H965T<R]3:&5E=#`W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C
M8V]U;G1I;F<@4&]L:6-I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C
M8V]U;G1I;F<@4&]L:6-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y354U-05)9($]&(%-)1TY)1DE#
M04Y4($%#0T]53E1)3D<@4$],24-)15,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7
M,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W
M=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD
M=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@,2`M
M('5S+6=A87`Z4VEG;FEF:6-A;G1!8V-O=6YT:6YG4&]L:6-I97-497AT0FQO
M8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#PA
M+2T@>&)R;"QN<R`M+3X-"B`@("`\(2TM('AB<FPL;G@@+2T^#0H@("`@/&1I
M=B!A;&EG;CTS1&QE9G0^#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`P
M<'0G/@T*("`@(#PO9&EV/@T*("`@(#QD:78@<W1Y;&4],T0G9&ES<&QA>3H@
M;F]N92<^3D]412`Q("8C.#(Q,CL@4U5-34%262!/1B!324=.249)0T%.5`T*
M("`@($%#0T]53E1)3D<@4$],24-)15,-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#9P="<^3D]412`Q("8C.#(Q,CL-"B`@("!4:&4@86-C;VUP86YY
M:6YG('5N875D:71E9"!I;G1E<FEM(&-O;G-O;&ED871E9"!F:6YA;F-I86P@
M<W1A=&5M96YT<R!A;F0@<F5L871E9"!N;W1E<PT*("`@('-H;W5L9"!B92!R
M96%D(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE(&%U9&ET960@0V]N<V]L:61A
M=&5D($9I;F%N8VEA;"!3=&%T96UE;G1S(&]F($IO:&YS;VX@)B,P,S@[#0H@
M("`@2F]H;G-O;B!A;F0@:71S('-U8G-I9&EA<FEE<R`H=&AE("8C.#(R,#M#
M;VUP86YY)B,X,C(Q.RD@86YD(')E;&%T960@;F]T97,@87,@8V]N=&%I;F5D
M(&EN('1H92!#;VUP86YY)B,X,C$W.W,@06YN=6%L#0H@("`@4F5P;W)T(&]N
M($9O<FT@,3`M2R!F;W(@=&AE(&9I<V-A;"!Y96%R(&5N9&5D($IA;G5A<GDF
M(S$V,#LR+"`R,#$Q+B!4:&4@=6YA=61I=&5D(&EN=&5R:6T@9FEN86YC:6%L
M#0H@("`@<W1A=&5M96YT<R!I;F-L=61E(&%L;"!A9&IU<W1M96YT<R`H8V]N
M<VES=&EN9R!O;FQY(&]F(&YO<FUA;"!R96-U<G)I;F<@861J=7-T;65N=',I
M(&%N9"!A8V-R=6%L<PT*("`@(&YE8V5S<V%R>2!I;B!T:&4@:G5D9VUE;G0@
M;V8@;6%N86=E;65N="!F;W(@82!F86ER('-T871E;65N="!O9B!T:&4@<F5S
M=6QT<R!F;W(@=&AE('!E<FEO9',-"B`@("!P<F5S96YT960N#0H@("`@/"]D
M:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/D1U<FEN9R!T:&4@9FES8V%L('-E
M8V]N9"!Q=6%R=&5R(&]F(#(P,3$L('1H92!&:6YA;F-I86P@06-C;W5N=&EN
M9R!3=&%N9&%R9',@0F]A<F0@*$9!4T(I(&ES<W5E9`T*("`@(&%M96YD;65N
M=',@=&\@=&AE(&1I<V-L;W-U<F4@<F5Q=6ER96UE;G1S(&9O<B!P<F5S96YT
M871I;VX@;V8@8V]M<')E:&5N<VEV92!I;F-O;64N(%1H92!A;65N9&UE;G0-
M"B`@("!R97%U:7)E<R!T:&%T(&%L;"!N;VXM;W=N97(@8VAA;F=E<R!I;B!S
M=&]C:VAO;&1E<G,F(S@R,3<[(&5Q=6ET>2!B92!P<F5S96YT960@96ET:&5R
M(&EN(&$@<VEN9VQE#0H@("`@8V]N=&EN=6]U<R!S=&%T96UE;G0@;V8@8V]M
M<')E:&5N<VEV92!I;F-O;64@;W(@:6X@='=O('-E<&%R871E(&)U="!C;VYS
M96-U=&EV92!S=&%T96UE;G1S+B!4:&ES#0H@("`@9W5I9&%N8V4@:7,@969F
M96-T:79E(')E=')O<W!E8W1I=F5L>2!F;W(@=&AE(&EN=&5R:6T@<&5R:6]D
M<R!A;F0@86YN=6%L('!E<FEO9',@8F5G:6YN:6YG(&%F=&5R#0H@("`@1&5C
M96UB97(F(S$V,#LQ-2P@,C`Q,2X@16%R;'D@861O<'1I;VX@:7,@<&5R;6ET
M=&5D+B!4:&4@861O<'1I;VX@;V8@=&AI<R!S=&%N9&%R9"!W:6QL(&YO="!H
M879E(&$-"B`@("!M871E<FEA;"!I;7!A8W0@;VX@=&AE($-O;7!A;GDF(S@R
M,3<[<R!R97-U;'1S(&]F(&]P97)A=&EO;G,L(&-A<V@@9FQO=W,@;W(@9FEN
M86YC:6%L('!O<VET:6]N+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@
M-G!T)SY$=7)I;F<@=&AE(&9I<V-A;"!S96-O;F0@<75A<G1E<B!O9B`R,#$Q
M+"!T:&4@1D%30B!I<W-U960@86UE;F1M96YT<R!T;R!D:7-C;&]S=7)E(')E
M<75I<F5M96YT<R!F;W(-"B`@("!C;VUM;VX@9F%I<B!V86QU92!M96%S=7)E
M;65N="X@5&AE<V4@86UE;F1M96YT<R!R97-U;'0@:6X@8V]N=F5R9V5N8V4@
M;V8@9F%I<B!V86QU92!M96%S=7)E;65N="!A;F0-"B`@("!D:7-C;&]S=7)E
M(')E<75I<F5M96YT<R!B971W965N(%4N4RX@1T%!4"!A;F0@24924RX@5&AI
M<R!G=6ED86YC92!I<R!E9F9E8W1I=F4@<')O<W!E8W1I=F5L>2!F;W(-"B`@
M("!T:&4@:6YT97)I;2!P97)I;V1S(&%N9"!A;FYU86P@<&5R:6]D<R!B96=I
M;FYI;F<@869T97(@1&5C96UB97(F(S$V,#LQ-2P@,C`Q,2X@16%R;'D@861O
M<'1I;VX@:7,-"B`@("!P<F]H:6)I=&5D+B!4:&4@861O<'1I;VX@;V8@=&AI
M<R!S=&%N9&%R9"!I<R!N;W0@97AP96-T960@=&\@:&%V92!A(&UA=&5R:6%L
M(&EM<&%C="!O;B!T:&4-"B`@("!#;VUP86YY)B,X,C$W.W,@<F5S=6QT<R!O
M9B!O<&5R871I;VYS+"!C87-H(&9L;W=S(&]R(&9I;F%N8VEA;"!P;W-I=&EO
M;BX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^1'5R:6YG('1H
M92!F:7-C86P@9FER<W0@<75A<G1E<B!O9B`R,#$Q+"!T:&4@0V]M<&%N>2!A
M9&]P=&5D('1H92!&05-"(&=U:61A;F-E(&%N9"!A;65N9&UE;G1S#0H@("`@
M:7-S=65D(')E;&%T960@=&\@<F5V96YU92!R96-O9VYI=&EO;B!U;F1E<B!T
M:&4@;6EL97-T;VYE(&UE=&AO9"X@5&AE(&]B:F5C=&EV92!O9B!T:&4@86-C
M;W5N=&EN9PT*("`@('-T86YD87)D('5P9&%T92!I<R!T;R!P<F]V:61E(&=U
M:61A;F-E(&]N(&1E9FEN:6YG(&$@;6EL97-T;VYE(&%N9"!D971E<FUI;FEN
M9R!W:&5N(&ET(&UA>2!B90T*("`@(&%P<')O<')I871E('1O(&%P<&QY('1H
M92!M:6QE<W1O;F4@;65T:&]D(&]F(')E=F5N=64@<F5C;V=N:71I;VX@9F]R
M(')E<V5A<F-H(&]R(&1E=F5L;W!M96YT#0H@("`@=')A;G-A8W1I;VYS+B!4
M:&ES('5P9&%T92!I<R!E9F9E8W1I=F4@;VX@82!P<F]S<&5C=&EV92!B87-I
M<R!F;W(@;6EL97-T;VYE<R!A8VAI979E9"!I;B!F:7-C86P-"B`@("!Y96%R
M<RP@86YD(&EN=&5R:6T@<&5R:6]D<R!W:71H:6X@=&AO<V4@>65A<G,L(&)E
M9VEN;FEN9R!O;B!O<B!A9G1E<B!*=6YE)B,Q-C`[,34L(#(P,3`N(%1H92!A
M9&]P=&EO;B!O9@T*("`@('1H:7,@<W1A;F1A<F0@9&ED(&YO="!H879E(&$@
M;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY)B,X,C$W.W,@<F5S=6QT
M<R!O9B!O<&5R871I;VYS+"!C87-H(&9L;W=S(&]R#0H@("`@9FEN86YC:6%L
M('!O<VET:6]N+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY$
M=7)I;F<@=&AE(&9I<V-A;"!F:7)S="!Q=6%R=&5R(&]F(#(P,3$L('1H92!#
M;VUP86YY(&%D;W!T960@=&AE($9!4T(@9W5I9&%N8V4@;VX@:&]W#0H@("`@
M<&AA<FUA8V5U=&EC86P@8V]M<&%N:65S('-H;W5L9"!R96-O9VYI>F4@86YD
M(&-L87-S:69Y(&EN('1H92!#;VUP86YY)B,X,C$W.W,@9FEN86YC:6%L('-T
M871E;65N=',L('1H90T*("`@(&YO;BUD961U8W1I8FQE(&%N;G5A;"!F964@
M<&%I9"!T;R!T:&4@1V]V97)N;65N="!I;B!A8V-O<F1A;F-E('=I=&@@=&AE
M(%!A=&EE;G0@4')O=&5C=&EO;B!A;F0-"B`@("!!9F9O<F1A8FQE($-A<F4@
M06-T+"!A<R!A;65N9&5D(&)Y('1H92!(96%L=&@@0V%R92!A;F0@161U8V%T
M:6]N(%)E8V]N8VEL:6%T:6]N($%C="X@5&AI<R!F964@:7,-"B`@("!B87-E
M9"!O;B!A;B!A;&QO8V%T:6]N(&]F(&$@8V]M<&%N>28C.#(Q-SMS(&UA<FME
M="!S:&%R92!O9B!T;W1A;"!B<F%N9&5D('!R97-C<FEP=&EO;B!D<G5G('-A
M;&5S(&9R;VT-"B`@("!T:&4@<')I;W(@>65A<BX@5&AE(&5S=&EM871E9"!F
M964@=V%S(')E8V]R9&5D(&%S(&$@<V5L;&EN9RP@;6%R:V5T:6YG(&%N9"!A
M9&UI;FES=')A=&EV92!E>'!E;G-E#0H@("`@:6X@=&AE($-O;7!A;GDF(S@R
M,3<[<R!F:6YA;F-I86P@<W1A=&5M96YT(&%N9"!W:6QL(&)E(&%M;W)T:7IE
M9"!O;B!A('-T<F%I9VAT+6QI;F4@8F%S:7,@9F]R('1H92!Y96%R(&%S#0H@
M("`@<&5R('1H92!&05-"(&=U:61A;F-E+B!4:&4@861O<'1I;VX@;V8-"B`@
M("!T:&ES('-T86YD87)D(&1I9"!N;W0@:&%V92!A(&UA=&5R:6%L(&EM<&%C
M="!O;B!T:&4-"B`@("!#;VUP86YY)B,X,C$W.W,@<F5S=6QT<R!O9B!O<&5R
M871I;VYS+"!C87-H(&9L;W=S(&]R(&9I;F%N8VEA;"!P;W-I=&EO;BX-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U
M,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V
M-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S+U=O<FMS:&5E=',O
M4VAE970P."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P139!04,^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^26YV96YT;W)I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY);G9E;G1O<FEE<R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DE.5D5.
M5$]22453/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X-"B`@("`\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"B`@("`\(2TM
M($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(#(@+2!U<RUG86%P.DEN=F5N=&]R
M>41I<V-L;W-U<F5497AT0FQO8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM
M97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@,3)P="<^3D]412`R("8C.#(Q
M,CL@24Y614Y43U))15,-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$
M8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P
M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I
M;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D('=I9'1H/3-$-S8E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0Q)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$
M)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$1O;&QA<G,@:6X@36EL;&EO
M;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0@8V]L<W!A;CTS1#(^2G5L>2`S+"`R
M,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0@
M8V]L<W!A;CTS1#(^2F%N=6%R>2`R+"`R,#$Q/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@
M+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E)A=R!M871E<FEA;',@86YD('-U<'!L
M:65S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1L969T/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C$L,S@S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ+#`W,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY';V]D<R!I;B!P<F]C97-S#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#@Y-SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PT-C`\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^1FEN:7-H960@9V]O9',-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L,3,S/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#@T-3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;"!I;G9E;G1O
M<FEE<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$;&5F=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XV+#0Q,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-2PS-S@\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@0F]D>2`M+3X-
M"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T
M7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q
M93`X-S,O5V]R:W-H965T<R]3:&5E=#`Y+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);G1A;F=I8FQE($%S<V5T<R!A;F0@
M1V]O9'=I;&P\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L
M+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY);G1A;F=I8FQE($%S<V5T<R!A;F0@1V]O9'=I;&P@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y)3E1!3D=)0DQ%($%34T544R!!3D0@1T]/1%=)3$P\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@
M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%
M3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R
M86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G
M9V5D($YO=&4@,R`M('5S+6=A87`Z1V]O9'=I;&Q!;F1);G1A;F=I8FQE07-S
M971S1&ES8VQO<W5R951E>'1";&]C:RTM/@T*("`@(#QD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4
M:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%(#,@)B,X
M,C$R.R!)3E1!3D=)0DQ%($%34T544R!!3D0@1T]/1%=)3$P-"B`@("`\+V1I
M=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26YT86YG:6)L92!A<W-E=',@=&AA
M="!H879E(&9I;FET92!U<V5F=6P@;&EV97,@87)E(&%M;W)T:7IE9"!O=F5R
M('1H96ER(&5S=&EM871E9"!U<V5F=6P@;&EV97,N#0H@("`@5&AE(&QA=&5S
M="!I;7!A:7)M96YT(&%S<V5S<VUE;G0@;V8@9V]O9'=I;&P@86YD(&EN9&5F
M:6YI=&4@;&EV960@:6YT86YG:6)L92!A<W-E=',@=V%S(&-O;7!L971E9`T*
M("`@(&EN('1H92!F:7-C86P@9F]U<G1H('%U87)T97(@;V8@,C`Q,"X@1G5T
M=7)E(&EM<&%I<FUE;G0@=&5S=',@9F]R(&=O;V1W:6QL(&%N9"!I;F1E9FEN
M:71E(&QI=F5D#0H@("`@:6YT86YG:6)L92!A<W-E=',@=VEL;"!B92!P97)F
M;W)M960@86YN=6%L;'D@:6X@=&AE(&9I<V-A;"!F;W5R=&@@<75A<G1E<BP@
M;W(@<V]O;F5R(&EF('=A<G)A;G1E9"X-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B
M;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@
M/"$M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^#0H@("`@/'1D('=I9'1H/3-$-S8E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SY*=6QY(#,L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIA
M;G5A<GD@,BP\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O
M;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@,7!X('-O;&ED("-F9F9F9F8G/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#PO='(^
M#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN
M(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^26YT86YG:6)L92!A<W-E=',@=VET:"!D969I;FET92!L:79E<SH-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^4&%T96YT<R!A;F0@=')A9&5M87)K<R`F(S@R,3([
M(&=R;W-S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XW+#4R,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^-BPV-C`\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^3&5S<R!A8V-U;75L871E9"!A;6]R=&EZ871I;VX-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L.#$Y/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#8R.3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY0871E;G1S(&%N
M9"!T<F%D96UA<FMS("8C.#(Q,CL@;F5T#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XT+#<P,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-"PP,S$\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X\
M(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V
M,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^3W1H97(@:6YT86YG:6)L97,@)B,X,C$R.R!G<F]S<PT*("`@(#PO
M9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^."PV,#D\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L-C<T/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DQE<W,@86-C
M=6UU;&%T960@86UO<G1I>F%T:6]N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XS+#`T.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPX.#`\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^3W1H97(@:6YT86YG:6)L97,@)B,X,C$R.R!N970-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L-38Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT+#<Y-#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L
M:6=N/3-$=&]P/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY);G1A;F=I8FQE(&%S
M<V5T<R!W:71H(&EN9&5F:6YI=&4@;&EV97,Z#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1R861E;6%R:W,-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8L,#@P/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#DU
M-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY0=7)C
M:&%S960@:6XM<')O8V5S<R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L,#,V/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#DS
M-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E
M9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T
M.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;"!I;G1A;F=I8FQE(&%S
M<V5T<R!W:71H(&EN9&5F:6YI=&4@;&EV97,-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C@L,3$V/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XW+#@Y,3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P
M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C
M,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;"!I;G1A;F=I8FQE(&%S<V5T
M<R`F(S@R,3([(&YE=`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,3@L,S<X/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-BPW,38\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B
M;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#QD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R
M9VEN+71O<#H@-G!T)SY$=7)I;F<@=&AE(&9I<V-A;"!S96-O;F0@<75A<G1E
M<B!O9B`R,#$Q+"!T:&4@0V]M<&%N>2!R96-L87-S:69I960@)FYB<W`[)#DW
M,28C,38P.VUI;&QI;VX@9G)O;2!P=7)C:&%S960-"B`@("!I;BUP<F]C97-S
M(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!T;R!A;6]R=&EZ86)L92!O=&AE
M<B!I;G1A;F=I8FQE<R!T;R!R969L96-T('1H90T*("`@(&-O;6UE<F-I86QI
M>F%T:6]N(&]F(%I95$E'028C,3<T.RX-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#9P="<^1V]O9'=I;&P@87,@;V8@2G5L>28C,38P.S,L(#(P,3$@
M=V%S(&%L;&]C871E9"!B>2!S96=M96YT(&]F(&)U<VEN97-S(&%S(&9O;&QO
M=W,Z#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@
M("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N
M.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN
M9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A
M9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T
M:#TS1#<V)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/DUE9"!$978\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1L969T/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY#;VYS=6UE<CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY0:&%R;3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SXF(S`S.#L@1&EA9SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SY4;W1A;#PO=&0^#0H@("`@/"]T<CX-"B`@
M("`\(2TM($5N9"!486)L92!(96%D("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B
M;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY'
M;V]D=VEL;"P@;F5T(&%T($IA;G5A<GDF(S$V,#LR+"`R,#$Q#0H@("`@/"]D
M:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XX
M+#$T-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,2PR,C4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C4L.3(U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ-2PR.30\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^06-Q=6ES:71I;VYS#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,S@\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q
M,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C4S.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z
M("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY#=7)R96YC>2!T<F%N
M<VQA=&EO;B]/=&AE<@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,S(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XU,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,SD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C0Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY';V]D=VEL;"P@;F5T(&%S(&]F($IU;'DF(S$V
M,#LS+"`R,#$Q#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XX+#0V-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PX,34\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L.38T/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-BPR-#,\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M
M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV
M/@T*("`@(#PA+2T@1F]L:6\@+2T^#0H@("`@/"$M+2`O1F]L:6\@+2T^#0H@
M("`@/"]D:78^#0H@("`@/"$M+2!004=%0E)%04L@+2T^#0H@("`@/&1I=B!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L
M<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@=V5I9VAT960@879E
M<F%G92!A;6]R=&EZ871I;VX@<&5R:6]D<R!F;W(@<&%T96YT<R!A;F0@=')A
M9&5M87)K<R!A;F0@;W1H97(@:6YT86YG:6)L92!A<W-E=',-"B`@("!A<F4@
M,3<F(S$V,#MY96%R<R!A;F0@,C<F(S$V,#MY96%R<RP@<F5S<&5C=&EV96QY
M+B!4:&4@86UO<G1I>F%T:6]N(&5X<&5N<V4@;V8@86UO<G1I>F%B;&4@:6YT
M86YG:6)L92!A<W-E=',-"B`@("!F;W(@=&AE(&9I<V-A;"!S:7@@;6]N=&AS
M(&5N9&5D($IU;'DF(S$V,#LS+"`R,#$Q('=A<R`F;F)S<#LD-#`R)B,Q-C`[
M;6EL;&EO;BP@86YD('1H92!E<W1I;6%T960@86UO<G1I>F%T:6]N#0H@("`@
M97AP96YS92!F;W(@=&AE(&9I=F4@<W5C8V5E9&EN9R!Y96%R<R!A<'!R;WAI
M;6%T97,@)FYB<W`[)#@T,"8C,38P.VUI;&QI;VXL('!E<B!Y96%R+@T*("`@
M(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S
M,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V
M.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3
M:&5E=#$P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT<SQB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64@365A
M<W5R96UE;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1D%)4B!604Q512!-14%355)%345.5%,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%
M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO
M;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT
M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO
M8VL@5&%G9V5D($YO=&4@-"`M('5S+6=A87`Z1F%I<E9A;'5E1&ES8VQO<W5R
M97-497AT0FQO8VLM+3X-"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM
M=&]P.B`Q,G!T)SY.3U1%(#0@)B,X,C$R.R!&04E2(%9!3%5%($U%05-54D5-
M14Y44PT*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@0V]M
M<&%N>2!U<V5S(&9O<G=A<F0@97AC:&%N9V4@8V]N=')A8W1S('1O(&UA;F%G
M92!I=',@97AP;W-U<F4@=&\@=&AE('9A<FEA8FEL:71Y(&]F(&-A<V@-"B`@
M("!F;&]W<RP@<')I;6%R:6QY(')E;&%T960@=&\@=&AE(&9O<F5I9VX@97AC
M:&%N9V4@<F%T92!C:&%N9V5S(&]F(&9U='5R92!I;G1E<F-O;7!A;GD@<')O
M9'5C="!A;F0-"B`@("!T:&ER9"T@<&%R='D@<'5R8VAA<V5S(&]F(')A=R!M
M871E<FEA;',@9&5N;VUI;F%T960@:6X@9F]R96EG;B!C=7)R96YC>2X@5&AE
M($-O;7!A;GD@86QS;R!U<V5S#0H@("`@8W)O<W,@8W5R<F5N8WD@:6YT97)E
M<W0@<F%T92!S=V%P<R!T;R!M86YA9V4@8W5R<F5N8WD@<FES:R!P<FEM87)I
M;'D@<F5L871E9"!T;R!B;W)R;W=I;F=S+B!";W1H#0H@("`@='EP97,@;V8@
M9&5R:79A=&EV97,@87)E(&1E<VEG;F%T960@87,@8V%S:"!F;&]W(&AE9&=E
M<RX@5&AE($-O;7!A;GD@86QS;R!U<V5S(&9O<G=A<F0@97AC:&%N9V4-"B`@
M("!C;VYT<F%C=',@=&\@;6%N86=E(&ET<R!E>'!O<W5R92!T;R!T:&4@=F%R
M:6%B:6QI='D@;V8@8V%S:"!F;&]W<R!F;W(@<F5P871R:6%T:6]N(&]F(&9O
M<F5I9VX-"B`@("!D:79I9&5N9',N(%1H97-E(&-O;G1R86-T<R!A<F4@9&5S
M:6=N871E9"!A<R!N970@:6YV97-T;65N="!H961G97,N($%D9&ET:6]N86QL
M>2P@=&AE($-O;7!A;GD-"B`@("!U<V5S(&9O<G=A<F0@97AC:&%N9V4@8V]N
M=')A8W1S('1O(&]F9G-E="!I=',@97AP;W-U<F4@=&\@8V5R=&%I;B!F;W)E
M:6=N(&-U<G)E;F-Y(&%S<V5T<R!A;F0-"B`@("!L:6%B:6QI=&EE<RX@5&AE
M<V4@9F]R=V%R9"!E>&-H86YG92!C;VYT<F%C=',@87)E(&YO="!D97-I9VYA
M=&5D(&%S(&AE9&=E<RP@86YD('1H97)E9F]R92P@8VAA;F=E<PT*("`@(&EN
M('1H92!F86ER('9A;'5E<R!O9B!T:&5S92!D97)I=F%T:79E<R!A<F4@<F5C
M;V=N:7IE9"!I;B!E87)N:6YG<RP@=&AE<F5B>2!O9F9S971T:6YG('1H92!C
M=7)R96YT#0H@("`@96%R;FEN9W,@969F96-T(&]F('1H92!R96QA=&5D(&9O
M<F5I9VX@8W5R<F5N8WD@87-S971S(&%N9"!L:6%B:6QI=&EE<RX@5&AE($-O
M;7!A;GD@9&]E<R!N;W0@96YT97(-"B`@("!I;G1O(&1E<FEV871I=F4@9FEN
M86YC:6%L(&EN<W1R=6UE;G1S(&9O<B!T<F%D:6YG(&]R('-P96-U;&%T:79E
M#0H@("`@<'5R<&]S97,L(&]R('1H870@8V]N=&%I;B!C<F5D:70@<FES:PT*
M("`@(')E;&%T960@8V]N=&EN9V5N="!F96%T=7)E<R!O<B!R97%U:7)E;65N
M=',@=&\@<&]S="!C;VQL871E<F%L+B!/;B!A;B!O;F=O:6YG(&)A<VES+"!T
M:&4@0V]M<&%N>0T*("`@(&UO;FET;W)S(&-O=6YT97)P87)T>2!C<F5D:70@
M<F%T:6YG<RX@5&AE($-O;7!A;GD@8V]N<VED97)S(&-R961I="!N;VXM<&5R
M9F]R;6%N8V4@<FES:R!T;R!B92!L;W<L#0H@("`@8F5C875S92!T:&4@0V]M
M<&%N>2!E;G1E<G,@:6YT;R!A9W)E96UE;G1S('=I=&@@8V]M;65R8VEA;"!I
M;G-T:71U=&EO;G,@=&AA="!H879E(&%T(&QE87-T(&%N($$@*&]R#0H@("`@
M97%U:79A;&5N="D@8W)E9&ET(')A=&EN9RX@07,@;V8@2G5L>28C,38P.S,L
M(#(P,3$L('1H92!#;VUP86YY(&AA9"!N;W1I;VYA;"!A;6]U;G1S(&]U='-T
M86YD:6YG(&9O<@T*("`@(&9O<G=A<F0@9F]R96EG;B!E>&-H86YG92!C;VYT
M<F%C=',@86YD(&-R;W-S(&-U<G)E;F-Y(&EN=&5R97-T(')A=&4@<W=A<',@
M;V8@)FYB<W`[)#(S)B,Q-C`[8FEL;&EO;B!A;F0@)FYB<W`[)#,-"B`@("!B
M:6QL:6]N+"!R97-P96-T:79E;'DN#0H@("`@/"]D:78^#0H@("`@/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM
M=&]P.B`V<'0G/D%L;"!D97)I=F%T:79E(&EN<W1R=6UE;G1S(&%R92!R96-O
M<F1E9"!O;B!T:&4@8F%L86YC92!S:&5E="!A="!F86ER('9A;'5E+B!#:&%N
M9V5S(&EN('1H92!F86ER#0H@("`@=F%L=64@;V8@9&5R:79A=&EV97,@87)E
M(')E8V]R9&5D(&5A8V@@<&5R:6]D(&EN(&-U<G)E;G0@96%R;FEN9W,@;W(@
M;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64L#0H@("`@9&5P96YD:6YG(&]N
M('=H971H97(@=&AE(&1E<FEV871I=F4@:7,@9&5S:6=N871E9"!A<R!P87)T
M(&]F(&$@:&5D9V4@=')A;G-A8W1I;VXL(&%N9"!I9B!S;RP@=&AE#0H@("`@
M='EP92!O9B!H961G92!T<F%N<V%C=&EO;BX-"B`@("`\+V1I=CX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA
M<F=I;BUT;W`Z(#9P="<^1'5R:6YG('1H92!F:7-C86P@<V5C;VYD('%U87)T
M97(@;V8@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N(&]P=&EO
M;B!T;R!H961G92!T:&4@8W5R<F5N8WD-"B`@("!R:7-K(&%S<V]C:6%T960@
M=VET:"!T:&4@8V%S:"!P;W)T:6]N(&]F('1H92!P87EM96YT(&9O<B!T:&4@
M<&QA;FYE9"!A8W%U:7-I=&EO;B!O9B!3>6YT:&5S+"!);F,N#0H@("`@5&AE
M(&]P=&EO;B!W87,@;F]T(&1E<VEG;F%T960@87,@82!H961G92P@86YD('1H
M97)E9F]R92P@=&AE(&-H86YG92!I;B!T:&4@9F%I<B!V86QU92!O9B!T:&4@
M;W!T:6]N#0H@("`@;V8@)FYB<W`[)#$P,B8C,38P.VUI;&QI;VX@=V%S(')E
M8V]G;FEZ960@87,@3W1H97(@26YC;VUE(&EN('1H92!F:7-C86P@<V5C;VYD
M('%U87)T97(@;V8@,C`Q,2X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#9P="<^5&AE#0H@("`@9&5S:6=N871I;VX@87,@82!C87-H(&9L;W<@:&5D
M9V4@:7,@;6%D92!A="!T:&4@96YT<F%N8V4@9&%T92!O9B!T:&4@9&5R:79A
M=&EV92!C;VYT<F%C="X@070-"B`@("!I;F-E<'1I;VXL(&%L;"!D97)I=F%T
M:79E<R!A<F4@97AP96-T960@=&\@8F4@:&EG:&QY(&5F9F5C=&EV92X@0VAA
M;F=E<R!I;B!T:&4@9F%I<B!V86QU92!O9B!A#0H@("`@9&5R:79A=&EV92!T
M:&%T(&ES(&1E<VEG;F%T960@87,@82!C87-H(&9L;W<@:&5D9V4@86YD(&ES
M(&AI9VAL>2!E9F9E8W1I=F4@87)E(')E8V]R9&5D(&EN#0H@("`@86-C=6UU
M;&%T960@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64-"B`@("!U;G1I;"!T
M:&4@=6YD97)L>6EN9R!T<F%N<V%C=&EO;B!A9F9E8W1S(&5A<FYI;F=S+"!A
M;F0@87)E#0H@("`@=&AE;B!R96-L87-S:69I960@=&\@96%R;FEN9W,@:6X@
M=&AE('-A;64@86-C;W5N="!A<R!T:&4@:&5D9V5D('1R86YS86-T:6]N+B!'
M86EN<R]L;W-S97,@;VX@;F5T#0H@("`@:6YV97-T;65N="!H961G97,@87)E
M(&%C8V]U;G1E9"!F;W(@=&AR;W5G:"!T:&4@8W5R<F5N8WD@=')A;G-L871I
M;VX@86-C;W5N="!A;F0@87)E(&EN<VEG;FEF:6-A;G0N#0H@("`@3VX@86X@
M;VYG;VEN9R!B87-I<RP@=&AE($-O;7!A;GD@87-S97-S97,@=VAE=&AE<B!E
M86-H(&1E<FEV871I=F4@8V]N=&EN=65S('1O(&)E(&AI9VAL>2!E9F9E8W1I
M=F4-"B`@("!I;B!O9F9S971T:6YG(&-H86YG97,@:6X@=&AE(&-A<V@@9FQO
M=W,@;V8@:&5D9V5D(&ET96US+B!)9B!A;F0@=VAE;B!A(&1E<FEV871I=F4@
M:7,@;F\@;&]N9V5R#0H@("`@97AP96-T960@=&\@8F4@:&EG:&QY(&5F9F5C
M=&EV92P@:&5D9V4@86-C;W5N=&EN9R!I<R!D:7-C;VYT:6YU960N($AE9&=E
M(&EN969F96-T:79E;F5S<RP@:68@86YY+`T*("`@(&ES(&EN8VQU9&5D(&EN
M(&-U<G)E;G0@<&5R:6]D(&5A<FYI;F=S(&EN(&]T:&5R("AI;F-O;64I+V5X
M<&5N<V4L(&YE="P@86YD('=A<R!N;W0@;6%T97)I86P@9F]R('1H90T*("`@
M(&9I<V-A;"!Q=6%R=&5R<R!E;F1E9"!*=6QY)B,Q-C`[,RP@,C`Q,2!A;F0@
M2G5L>0T*("`@(#0L(#(P,3`N(%)E9F5R('1O($YO=&4@-R!F;W(@9&ES8VQO
M<W5R97,@;V8@;6]V96UE;G1S(&EN($%C8W5M=6QA=&5D($]T:&5R($-O;7!R
M96AE;G-I=F4@26YC;VUE+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@
M-G!T)SY!<R!O9B!*=6QY)B,Q-C`[,RP@,C`Q,2P@=&AE(&)A;&%N8V4@;V8@
M9&5F97)R960@;F5T(&=A:6YS(&]N(&1E<FEV871I=F5S(&EN8VQU9&5D(&EN
M(&%C8W5M=6QA=&5D(&]T:&5R#0H@("`@8V]M<')E:&5N<VEV92!I;F-O;64@
M=V%S("9N8G-P.R0R,C@F(S$V,#MM:6QL:6]N(&%F=&5R+71A>"X@1F]R(&%D
M9&ET:6]N86P@:6YF;W)M871I;VXL('-E92!.;W1E(#<N(%1H90T*("`@($-O
M;7!A;GD@97AP96-T<R!T:&%T('-U8G-T86YT:6%L;'D@86QL(&]F('1H92!A
M;6]U;G1S(')E;&%T960@=&\@9F]R96EG;B!E>&-H86YG92!C;VYT<F%C=',@
M=VEL;"!B90T*("`@(')E8VQA<W-I9FEE9"!I;G1O(&5A<FYI;F=S(&]V97(@
M=&AE(&YE>'0@,3(F(S$V,#MM;VYT:',@87,@82!R97-U;'0@;V8@=')A;G-A
M8W1I;VYS('1H870@87)E(&5X<&5C=&5D('1O#0H@("`@;V-C=7(@;W9E<B!T
M:&%T('!E<FEO9"X@5&AE(&UA>&EM=6T@;&5N9W1H(&]F('1I;64@;W9E<B!W
M:&EC:"!T:&4@0V]M<&%N>2!I<R!H961G:6YG('1R86YS86-T:6]N#0H@("`@
M97AP;W-U<F4@:7,@,3@F(S$V,#MM;VYT:',@97AC;'5D:6YG(&EN=&5R97-T
M(')A=&4@<W=A<',N(%1H92!A;6]U;G0@=6QT:6UA=&5L>2!R96%L:7IE9"!I
M;B!E87)N:6YG<PT*("`@('=I;&P@9&EF9F5R(&%S(&9O<F5I9VX@97AC:&%N
M9V4@<F%T97,@8VAA;F=E+B!296%L:7IE9"!G86EN<R!A;F0@;&]S<V5S(&%R
M92!U;'1I;6%T96QY(&1E=&5R;6EN960-"B`@("!B>2!A8W1U86P@97AC:&%N
M9V4@<F%T97,@870@;6%T=7)I='D@;V8@=&AE(&1E<FEV871I=F4N#0H@("`@
M/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!F;VQL;W=I;F<@=&%B
M;&4@:7,@82!S=6UM87)Y(&]F('1H92!A8W1I=FET>2!R96QA=&5D('1O(&1E
M<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D9V5S(&9O<@T*("`@('1H92!F
M:7-C86P@<V5C;VYD('%U87)T97)S(&EN(#(P,3$@86YD(#(P,3`Z#0H@("`@
M/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C
M96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#(X)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O
M;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY'86EN+R`H3&]S<RD\+V(^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0W/CQB/D=A:6XO("A,;W-S*3PO8CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^<F5C;&%S<VEF:65D/"]B
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY'86EN+R`H
M3&]S<RD\+V(^/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F
M;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^<F5C;V=N
M:7IE9"!I;CPO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^
M/&(^9G)O;3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^
M/&(^<F5C;V=N:7IE9"!I;CPO8CX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M-SX\8CY!8V-U;75L871E9#PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#<^/&(^06-C=6UU;&%T960@3T-)/"]B/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CYO=&AE<CPO8CX\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L
M:60@(V9F9F9F9B<^/&(^3T-)/"]B/CQS=7`@<W1Y;&4],T0G9F]N="US:7IE
M.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+71O<"<^/&(^*#$I/"]B/CPO
M<W5P/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^/&(^:6YT;R!I
M;F-O;64\+V(^/'-U<"!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC
M86PM86QI9VXZ('1E>'0M=&]P)SX\8CXH,2D\+V(^/"]S=7`^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SX\8CYI;F-O;64O97AP96YS93PO8CX\
M<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T:6-A;"UA;&EG;CH@
M=&5X="UT;W`G/B@R*3PO<W5P/CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/D9I<V-A;#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C
M86P\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^1FES8V%L/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D9I<V-A;#PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C86P\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^1FES8V%L/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^<V5C;VYD/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/G-E8V]N9#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYS
M96-O;F0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^<V5C;VYD
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/G-E8V]N9#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYS96-O;F0\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F
M9F8G/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,SYQ=6%R=&5R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0S/G%U87)T97(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^<75A<G1E<CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SYQ=6%R=&5R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/G%U
M87)T97(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^<75A<G1E
M<CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE
M.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$;&5F=#X\8CY#87-H($9L;W<@2&5D9V5S/"]B/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS
M<&%N/3-$,SXR,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D("TM/@T*
M("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@U,SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S
M<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#D\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`^*3QS=6(@<W1Y;&4],T0G9F]N="US:7IE.B`X-24[
M('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O;2<^*$$I/"]S=6(^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF
M;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#(P/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C=',-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$R/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3`R/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@T-#PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH-S8\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`^*3QS=6(@<W1Y;&4],T0G9F]N="US:7IE.B`X-24[
M('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O;2<^*$(I/"]S=6(^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XV/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XH,30Y/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM
M($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F
M)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E>&-H86YG92!C;VYT
M<F%C=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(X
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XT-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,3@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(P/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/B8C,38P.SQS=6(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O
M;2<^*$,I/"]S=6(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,CPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY#<F]S<R!C=7)R96YC>2!I;G1E<F5S="!R871E('-W87!S
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,S$\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#@R/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q-CPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,3PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XF(S$V,#L\<W5B('-T>6QE/3-$)V9O;G0M<VEZ93H@
M.#4E.R!V97)T:6-A;"UA;&EG;CH@=&5X="UB;W1T;VTG/BA$*3PO<W5B/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A
M8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY&;W)E
M:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M*#<\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,S4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M)B,Q-C`[/'-U8B!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM
M86QI9VXZ('1E>'0M8F]T=&]M)SXH12D\+W-U8CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!"
M;&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$U.#PO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#0P
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH
M-30\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@Q,S,\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`^*0T*("`@(#PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N
M9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@
M("`@/"$M+2!&;VQI;R`M+3X-"B`@("`\(2TM("]&;VQI;R`M+3X-"B`@("`\
M+V1I=CX-"B`@("`\(2TM(%!!1T5"4D5!2R`M+3X-"B`@("`\9&EV('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I
M9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!M87)G:6XM=&]P.B`P<'0G/@T*("`@($%L;"!A;6]U;G1S('-H
M;W=N(&EN('1H92!T86)L92!A8F]V92!A<F4@;F5T(&]F('1A>"X-"B`@("`\
M+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^5&AE(&9O;&QO=VEN9R!T86)L
M92!I<R!A('-U;6UA<GD@;V8@=&AE(&%C=&EV:71Y(')E;&%T960@=&\@9&5R
M:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G97,@9F]R#0H@("`@=&AE(&9I
M<G-T(&9I<V-A;"!S:7@@;6]N=&AS(&EN(#(P,3$@86YD(#(P,3`Z#0H@("`@
M/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C
M96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#(X)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O
M;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY'86EN+R`H3&]S<RD\+V(^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0W/CQB/D=A:6XO("A,;W-S*3PO8CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^<F5C;&%S<VEF:65D/"]B
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY'86EN+R`H
M3&]S<RD\+V(^/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F
M;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^<F5C;V=N
M:7IE9"!I;CPO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^
M/&(^9G)O;3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^
M/&(^<F5C;V=N:7IE9"!I;CPO8CX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M-SX\8CY!8V-U;75L871E9#PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#<^/&(^06-C=6UU;&%T960@3T-)/"]B/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CYO=&AE<CPO8CX\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L
M:60@(V9F9F9F9B<^/&(^3T-)/"]B/CQS=7`@<W1Y;&4],T0G9F]N="US:7IE
M.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+71O<"<^/&(^*#$I/"]B/CPO
M<W5P/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^/&(^:6YT;R!I
M;F-O;64\+V(^/'-U<"!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC
M86PM86QI9VXZ('1E>'0M=&]P)SX\8CXH,2D\+V(^/"]S=7`^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SX\8CYI;F-O;64O97AP96YS93PO8CX\
M<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T:6-A;"UA;&EG;CH@
M=&5X="UT;W`G/B@R*3PO<W5P/CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/D9I<V-A;#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C
M86P\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^1FES8V%L/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D9I<V-A;#PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C86P\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^1FES8V%L/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^<VEX/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/G-I>#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYS:7@\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^<VEX/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/G-I>#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,SYS:7@\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T
M>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/BA$;VQL87)S(&EN($UI
M;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYM;VYT
M:',\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^;6]N=&AS/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/FUO;G1H<SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYM;VYT:',\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^;6]N=&AS/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S/FUO;G1H<SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#X\8CY#87-H
M($9L;W<@2&5D9V5S/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P
M,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$P/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM
M($5N9"!486)L92!(96%D("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D
M>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG
M<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N
M(&5X8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C<\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XH.#0\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@Q,#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^*#(Y/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P/BD\<W5B('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T
M:6-A;"UA;&EG;CH@=&5X="UB;W1T;VTG/BA!*3PO<W5B/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@R/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XH,C$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@
M4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO
M9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X8VAA
M;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^.3(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R,#8\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$P
M-CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH
M.3@\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3QS=6(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O
M;2<^*$(I/"]S=6(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,34T/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R
M96EG;B!E>&-H86YG92!C;VYT<F%C=',-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@X/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C<S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,C$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q
M-C`[/'-U8B!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI
M9VXZ('1E>'0M8F]T=&]M)SXH0RD\+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M
M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D-R;W-S(&-U<G)E;F-Y(&EN=&5R
M97-T(')A=&4@<W=A<',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@T,#PO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH-#D\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$X/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Q/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/B8C,38P.SQS=6(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O
M;2<^*$0I/"]S=6(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M
M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S#0H@("`@/"]D
M:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XH-3D\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^.#$\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@S/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@Q/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/BD\<W5B('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T:6-A
M;"UA;&EG;CH@=&5X="UB;W1T;VTG/BA%*3PO<W5B/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,C`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM($)L86YK
M(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G
M:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C$R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$X-3PO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$Q.#PO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#DV
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XH,3,Y/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@
M0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@-G!T)SY!;&P@86UO=6YT<R!S:&]W;B!I;B!T:&4@=&%B;&4@86)O
M=F4@87)E(&YE="!O9B!T87@N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG
M;CTS1&QE9G0^#0H@("`@/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#-P=#L@
M;6%R9VEN+71O<#H@,39P=#L@=VED=&@Z(#$X)3L@8F]R9&5R+71O<#H@,7!X
M('-O;&ED(",P,#`P,#`G/B8C,38P.PT*("`@(#PO9&EV/@T*("`@(#PO9&EV
M/@T*("`@(#QT86)L92!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,"!C96QL<&%D
M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@=&5X="UA;&EG;CH@;&5F="<^#0H@("`@/'1R/@T*("`@(#QT9"!W
M:61T:#TS1#,E/CPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Y-B4^/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1T;W`^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&QE9G0^*#$I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M169F96-T:79E('!O<G1I;VX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,W!T)SX-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T;W`^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*#(I/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^26YE9F9E8W1I=F4@<&]R=&EO;CPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M;&5F=#XH02D\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y)
M;F-L=61E9"!I;B!386QE<R!T;R!C=7-T;VUE<G,\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@,W!T)SX-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T;W`^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$(I/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^26YC;'5D960@:6X@
M0V]S="!O9B!P<F]D=6-T<R!S;VQD/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!S='EL93TS1"=F;VYT+7-I>F4Z(#-P="<^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA#*3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/DEN8VQU9&5D(&EN(%)E<V5A<F-H
M(&%N9"!D979E;&]P;65N="!E>'!E;G-E/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#-P="<^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA$*3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/DEN8VQU9&5D(&EN($EN=&5R
M97-T("AI;F-O;64I+TEN=&5R97-T(&5X<&5N<V4L(&YE=#PO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH
M12D\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y);F-L=61E
M9"!I;B!/=&AE<B`H:6YC;VUE*2]E>'!E;G-E+"!N970\+W1D/@T*("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^1F]R('1H
M92!F:7-C86P@<V5C;VYD('%U87)T97)S(&5N9&5D($IU;'DF(S$V,#LS+"`R
M,#$Q(&%N9"!*=6QY)B,Q-C`[-"P@,C`Q,"P@82!L;W-S(&]F("9N8G-P.R0W
M)B,Q-C`[;6EL;&EO;B!A;F0@)FYB<W`[)#(Q#0H@("`@;6EL;&EO;BP@<F5S
M<&5C=&EV96QY+"!W97)E(')E8V]G;FEZ960@:6X@3W1H97(@*&EN8V]M92DO
M97AP96YS92P@;F5T+"!R96QA=&EN9R!T;R!F;W)E:6=N(&5X8VAA;F=E#0H@
M("`@8V]N=')A8W1S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U
M;65N=',N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/D9O<B!T
M:&4-"B`@("!F:7)S="!F:7-C86P@<VEX(&UO;G1H<R!E;F1E9"!*=6QY)B,Q
M-C`[,RP@,C`Q,2!A;F0@2G5L>28C,38P.S0L(#(P,3`L(&$@9V%I;B!O9B`F
M;F)S<#LD."8C,38P.VUI;&QI;VX@86YD(&$-"B`@("!L;W-S(&]F("9N8G-P
M.R0V.28C,38P.VUI;&QI;VXL(')E<W!E8W1I=F5L>2P@=V5R92!R96-O9VYI
M>F5D(&EN($]T:&5R("AI;F-O;64I+V5X<&5N<V4L(&YE="P@<F5L871I;F<@
M=&\-"B`@("!F;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<R!N;W0@9&5S:6=N
M871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S+@T*("`@(#PO9&EV/@T*("`@
M(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M;6%R9VEN+71O<#H@-G!T)SY&86ER('9A;'5E(&ES('1H92!E>&ET('!R:6-E
M('1H870@=V]U;&0@8F4@<F5C96EV960@=&\@<V5L;"!A;B!A<W-E="!O<B!P
M86ED('1O('1R86YS9F5R(&$-"B`@("!L:6%B:6QI='DN($9A:7(@=F%L=64@
M:7,@82!M87)K970M8F%S960@;65A<W5R96UE;G0@=&AA="!I<R!D971E<FUI
M;F5D('5S:6YG(&%S<W5M<'1I;VYS('1H870-"B`@("!M87)K970@<&%R=&EC
M:7!A;G1S('=O=6QD('5S92!I;B!P<FEC:6YG(&%N(&%S<V5T(&]R(&QI86)I
M;&ET>2X@5&AE(&%U=&AO<FET871I=F4@;&ET97)A='5R90T*("`@(&5S=&%B
M;&ES:&5S(&$@=&AR964M;&5V96P@:&EE<F%R8VAY('1O#0H@("`@<')I;W)I
M=&EZ92!T:&4@:6YP=71S('5S960@:6X@;65A<W5R:6YG(&9A:7(@=F%L=64N
M(%1H90T*("`@(&QE=F5L<R!W:71H:6X@=&AE(&AI97)A<F-H>2!A<F4@9&5S
M8W)I8F5D(&)E;&]W('=I=&@@3&5V96P@,2!H879I;F<@=&AE(&AI9VAE<W0@
M<')I;W)I='D@86YD($QE=F5L#0H@("`@,R!H879I;F<@=&AE(&QO=V5S="X-
M"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^5&AE(&9A:7(@=F%L
M=64@;V8@82!D97)I=F%T:79E(&9I;F%N8VEA;"!I;G-T<G5M96YT("AI+F4N
M(&9O<G=A<F0@97AC:&%N9V4@8V]N=')A8W0@;W(@8W5R<F5N8WD-"B`@("!S
M=V%P*2!I<R!T:&4@86=G<F5G871I;VX@8GD@8W5R<F5N8WD@;V8@86QL(&9U
M='5R92!C87-H(&9L;W=S(&1I<V-O=6YT960@=&\@:71S('!R97-E;G0@=F%L
M=64@870-"B`@("!T:&4@<')E=F%I;&EN9R!M87)K970@:6YT97)E<W0@<F%T
M97,@86YD('-U8G-E<75E;G1L>2!C;VYV97)T960@=&\@=&AE(%4N4RX@9&]L
M;&%R(&%T('1H92!C=7)R96YT#0H@("`@<W!O="!F;W)E:6=N(&5X8VAA;F=E
M(')A=&4N(%1H92!#;VUP86YY(&1O97,@;F]T(&)E;&EE=F4@=&AA="!F86ER
M('9A;'5E<R!O9B!T:&5S92!D97)I=F%T:79E#0H@("`@:6YS=')U;65N=',@
M;6%T97)I86QL>2!D:69F97(@9G)O;2!T:&4@86UO=6YT<R!T:&%T(&-O=6QD
M(&)E(')E86QI>F5D('5P;VX@<V5T=&QE;65N="!O<B!M871U<FET>2P-"B`@
M("!O<B!T:&%T('1H92!C:&%N9V5S(&EN(&9A:7(@=F%L=64@=VEL;"!H879E
M(&$@;6%T97)I86P@969F96-T(&]N('1H92!#;VUP86YY)B,X,C$W.W,@<F5S
M=6QT<R!O9@T*("`@(&]P97)A=&EO;G,L(&-A<V@@9FQO=W,@;W(@9FEN86YC
M:6%L('!O<VET:6]N+B!4:&4@0V]M<&%N>2!A;'-O(&AO;&1S(&5Q=6ET>2!I
M;G9E<W1M96YT<R!W:&EC:"!A<F4-"B`@("!C;&%S<VEF:65D(&%S($QE=F5L
M(#$@8F5C875S92!T:&5Y(&%R92!T<F%D960@:6X@86X@86-T:79E(&5X8VAA
M;F=E(&UA<FME="X@5&AE($-O;7!A;GD@9&ED(&YO=`T*("`@(&AA=F4@86YY
M(&]T:&5R('-I9VYI9FEC86YT(&9I;F%N8VEA;"!A<W-E=',@;W(@;&EA8FEL
M:71I97,@=VAI8V@@=V]U;&0@<F5Q=6ER92!R979I<V5D('9A;'5A=&EO;G,-
M"B`@("!U;F1E<B!T:&ES('-T86YD87)D('1H870@87)E(')E8V]G;FEZ960@
M870@9F%I<B!V86QU92X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P
M="<^5&AE(&9O;&QO=VEN9R!T:')E92!L979E;',@;V8@:6YP=71S(&%R92!U
M<V5D('1O(&UE87-U<F4@9F%I<B!V86QU93H-"B`@("`\+V1I=CX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA
M<F=I;BUT;W`Z(#9P="<^3&5V96P@,2`F(S@R,3([(%%U;W1E9"!P<FEC97,@
M:6X@86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@86YD(&QI
M86)I;&ET:65S+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY,
M979E;"`R("8C.#(Q,CL@4VEG;FEF:6-A;G0@;W1H97(@;V)S97)V86)L92!I
M;G!U=',N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DQE=F5L
M(#,@)B,X,C$R.R!3:6=N:69I8V%N="!U;F]B<V5R=F%B;&4@:6YP=71S+@T*
M("`@(#PO9&EV/@T*("`@(#PA+2T@1F]L:6\@+2T^#0H@("`@/"$M+2`O1F]L
M:6\@+2T^#0H@("`@/"]D:78^#0H@("`@/"$M+2!004=%0E)%04L@+2T^#0H@
M("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@0V]M
M<&%N>28C.#(Q-SMS('-I9VYI9FEC86YT(&9I;F%N8VEA;"!A<W-E=',@86YD
M(&QI86)I;&ET:65S(&UE87-U<F5D(&%T(&9A:7(@=F%L=64@87,@;V8@2G5L
M>28C,38P.S,L#0H@("`@,C`Q,2!A;F0@2F%N=6%R>28C,38P.S(L(#(P,3$@
M=V5R92!A<R!F;VQL;W=S.@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX]
M,T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E
M9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0@=VED=&@],T0T,"4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#!P>"!S;VQI
M9"`C,#`P,#`P)SX\8CY*=6QY(#,L(#(P,3$\+V(^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/CQB/DIA;G5A<GD@,BP@,C`Q,3PO8CX\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,'!X('-O;&ED(",P,#`P
M,#`G/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L
M:60@(S`P,#`P,"<^/&(^3&5V96P@,3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O
M;&ED(",P,#`P,#`G/CQB/DQE=F5L(#(\+V(^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S
M;VQI9"`C,#`P,#`P)SX\8CY,979E;"`S/"]B/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@
M<V]L:60@(S`P,#`P,"<^/&(^5&]T86P\+V(^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S
M;VQI9"`C,#`P,#`P)SX\8CY4;W1A;#PO8CX\<W5P('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.#4E.R!V97)T:6-A;"UA;&EG;CH@=&5X="UT;W`G/CQB/B@Q*3PO
M8CX\+W-U<#X\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@
M2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@
M/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E
M969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F
M=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^/&(^1&5R:79A=&EV97,@9&5S
M:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S.CPO8CX-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^/&(^07-S971S
M.CPO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O
M=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E
M>&-H86YG92!C;VYT<F%C=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N
M8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0X-SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-#@W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS,C$\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0W)O<W,@8W5R
M<F5N8WD@:6YT97)E<W0@<F%T92!S=V%P<SQS=7`@<W1Y;&4],T0G9F]N="US
M:7IE.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+71O<"<^*#(I/"]S=7`^
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SX\
M8CY4;W1A;#PO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C0X.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#@Y/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS,S@\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^/&(^3&EA8FEL:71I97,Z/"]B/@T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M-C0V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XV-#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4X-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY#<F]S<R!C=7)R96YC>2!I;G1E<F5S="!R871E
M('-W87!S/'-U<"!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM
M86QI9VXZ('1E>'0M=&]P)SXH,RD\+W-U<#X-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0P-#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#`T
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XU,#(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^/&(^5&]T86P\+V(^#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ
M+#`U,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,2PP-3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L,#@X/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q
M-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/CQB/D1E<FEV871I=F5S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=I;F<@
M:6YS=')U;65N=',Z/"]B/@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SX\8CY!<W-E=',Z/"]B/@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,C@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C(X/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY3
M=VES<R!&<F%N8R!/<'1I;VXJ#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XU-CD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4V.3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A
M;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-3DW/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XU.3<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M
M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/DQI86)I;&ET:65S
M.CPO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C=',-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(W/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XR-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,SD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^/&(^3W1H97(@26YV97-T;65N=',\+V(^/'-U<"!S
M='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M
M=&]P)SX\8CXH-"D\+V(^/"]S=7`^#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#,W,3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PS-S$\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C$L,38U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@
M("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F=#X-"B`@("`\9&EV('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,W!T.R!M87)G:6XM=&]P.B`Q-G!T.R!W:61T
M:#H@,3@E.R!B;W)D97(M=&]P.B`Q<'@@<V]L:60@(S`P,#`P,"<^)B,Q-C`[
M#0H@("`@/"]D:78^#0H@("`@/"]D:78^#0H@("`@/'1A8FQE('=I9'1H/3-$
M,3`P)2!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS
M1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T
M)SX-"B`@("`\='(^#0H@("`@/'1D('=I9'1H/3-$,R4^/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0Q)3X\+W1D/@T*("`@(#QT9"!W:61T:#TS1#DV)3X\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XJ/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^0W5R<F5N8WD@;W!T:6]N(')E;&%T960@
M=&\@=&AE('!L86YN960@86-Q=6ES:71I;VX@;V8@4WEN=&AE<RP@26YC+CPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S
M<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$;&5F=#XH,2D\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#Y!<R!O9B!*86YU87)Y)B,Q-C`[,BP@,C`Q,2P@=&AE<V4@87-S971S(&%N
M9"!L:6%B:6QI=&EE<R!A<F4@8VQA<W-I9FEE9"!A<R!,979E;"`R('=I=&@@
M=&AE(&5X8V5P=&EO;@T*("`@(&]F($]T:&5R($EN=F5S=&UE;G1S(&]F("9N
M8G-P.R0Q+#$V-2!W:&EC:"!A<F4@8VQA<W-I9FEE9"!A<R!,979E;"`Q+CPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S
M<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$;&5F=#XH,BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#Y);F-L=61E<R`F;F)S<#LD,B8C,38P.VUI;&QI;VX@86YD("9N8G-P.R0Q
M-"8C,38P.VUI;&QI;VX@;V8@;F]N+6-U<G)E;G0@87-S971S(&9O<B!*=6QY
M)B,Q-C`[,RP@,C`Q,2!A;F0@2F%N=6%R>28C,38P.S(L(#(P,3$L#0H@("`@
M<F5S<&5C=&EV96QY+CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH,RD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#Y);F-L=61E<R`F;F)S<#LD-#`T)B,Q-C`[;6EL
M;&EO;B!A;F0@)FYB<W`[)#4P,B8C,38P.VUI;&QI;VX@;V8@;F]N+6-U<G)E
M;G0@;&EA8FEL:71I97,@9F]R($IU;'DF(S$V,#LS+"`R,#$Q(&%N9"!*86YU
M87)Y#0H@("`@,BP@,C`Q,2P@<F5S<&5C=&EV96QY+CPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O
M<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH-"D\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y#;&%S<VEF:65D
M(&%S(&YO;BUC=7)R96YT(&]T:&5R(&%S<V5T<RX\+W1D/@T*("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@
M+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM
M/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^1FEN
M86YC:6%L($EN<W1R=6UE;G1S(&YO="!M96%S=7)E9"!A="!&86ER(%9A;'5E
M.@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9F]L;&]W
M:6YG(&9I;F%N8VEA;"!A<W-E=',@86YD(&QI86)I;&ET:65S(&%R92!H96QD
M(&%T(&-A<G)Y:6YG(&%M;W5N="!O;B!T:&4@8V]N<V]L:61A=&5D#0H@("`@
M8F%L86YC92!S:&5E="!A<R!O9B!*=6QY)B,Q-C`[,RP@,C`Q,3H-"B`@("`\
M+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E
M;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T
M:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D('=I9'1H/3-$-S8E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I
M9VAT(&-O;'-P86X],T0R/D-A<G)Y:6YG/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0@8V]L<W!A;CTS1#(^17-T:6UA=&5D/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S
M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA$;VQL87)S(&EN
M($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R/D%M
M;W5N=#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M(&-O;'-P86X],T0R/D9A:7(@5F%L=64\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-
M"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^/&(^1FEN86YC:6%L($%S<V5T<SPO8CX-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^/&(^0W5R<F5N="!);G9E<W1M96YT<SPO8CX-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M0V%S:`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$;&5F=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XR+#(Y.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^,BPR.3D\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^1V]V97)N;65N="!S96-U<FET:65S(&%N9"!O
M8FQI9V%T:6]N<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,C,L.34Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XR,RPY-3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0V]R
M<&]R871E(&1E8G0@<V5C=7)I=&EE<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^-3$U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XU,34\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^36]N97D@;6%R:V5T(&9U;F1S#0H@("`@/"]D
M:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#@R,#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PX,C`\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^5&EM92!D97!O<VET<PT*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PP.3<\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L,#DW/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L(&-A<V@L
M(&-A<V@@97%U:79A;&5N=',@86YD(&-U<G)E;G0@;6%R:V5T86)L92!S96-U
M<FET:65S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1L969T/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C(Y+#8X,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,CDL-C@R/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q
M-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D(&-O;'-P
M86X],T0Y(&%L:6=N/3-$;&5F=#Y&86ER('9A;'5E(&]F(&=O=F5R;FUE;G0@
M<V5C=7)I=&EE<R!A;F0-"B`@("!O8FQI9V%T:6]N<R!A;F0@;F]N+6-U<G)E
M;G0@;6%R:V5T86)L90T*("`@('-E8W5R:71I97,@=V%S(&5S=&EM871E9"!U
M<VEN9R!Q=6]T960@8G)O:V5R('!R:6-E<PT*("`@(&EN(&%C=&EV90T*("`@
M(&UA<FME=',N/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/D9I;F%N8VEA;"!,:6%B
M:6QI=&EE<SPO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^/&(^0W5R<F5N="!$96)T/"]B/@T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M;&5F=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#`T
M-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-2PP-#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^/&(^3F]N+4-U<G)E;G0@1&5B=#PO8CX-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^-2XQ-24@1&5B96YT=7)E
M<R!D=64@,C`Q,@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-3DY/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XV,S(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^,"XW,"4@3F]T97,@9'5E(#(P,3,-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4P,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3`S/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/C,N.#`E($1E8F5N='5R97,@9'5E(#(P,3,-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4P,#PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3(W/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C,F(S$V,#MM;VYT:"!,24)/
M4B8C,#0S.S`E($923B!D=64@,C`Q,PT*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^-3`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XU,#`\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^,R8C,38P.VUO;G1H($Q)0D]2)B,P-#,[,"XP.24@1E).(&1U92`R,#$T
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XW-3`\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<U
M,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXQ+C(P
M)2!.;W1E<R!D=64@,C`Q-`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^.3DY/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ+#`P-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXR
M+C$U)2!.;W1E<R!D=64@,C`Q-@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^.#DX/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XY,#,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^-2XU-24@1&5B96YT=7)E<R!D=64@,C`Q-PT*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PP,#`\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L,38Q
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F
M9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C4N,34E($1E8F5N='5R97,@9'5E
M(#(P,3@-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C@Y
M.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,2PP,34\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^-"XW-24@3F]T97,@9'5E(#(P,3D@*#%"($5U<F\@,2XT-#<V*0T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PT-#`\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L-38Y
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F
M9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C,E(%IE<F\@0V]U<&]N($-O;G9E
M<G1I8FQE(%-U8F]R9&EN871E9"!$96)E;G1U<F5S(&1U92!I;B`R,#(P#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ.3<\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(T-CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXR+CDU)2!$
M96)E;G1U<F5S(&1U92`R,#(P#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XU-#$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C4R,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXS
M+C4U)2!.;W1E<R!D=64@,C`R,0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^-#0V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XT-38\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^-BXW,R4@1&5B96YT=7)E<R!D=64@,C`R,PT*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C4P/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS,C,\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^-2XU,"4@3F]T97,@9'5E(#(P,C0@*#4P
M,"!'0E`Q+C8P,C4I#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XW.34\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C@U-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SXV+CDU)2!.;W1E<R!D=64@,C`R.0T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,CDT/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS-S4\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^-"XY-24@1&5B96YT=7)E<R!D=64@,C`S,PT*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3`P/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,C,\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^-2XY-24@3F]T97,@9'5E
M(#(P,S<-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/CDY
M-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,2PQ,C`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD
M.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G
M:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^-2XX-B4@1&5B96YT
M=7)E<R!D=64@,C`S.`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^-S`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XW-S,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^-"XU,"4@1&5B96YT=7)E<R!D=64@,C`T,`T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3,Y/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT.#D\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^-"XX-24@3F]T97,@9'5E(#(P-#$-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Y.#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,CDQ/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D]T:&5R("A);F-L=61E
M<R!);F1U<W1R:6%L(%)E=F5N=64@0F]N9',I#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XT,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#$\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\
M(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V
M,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^5&]T86P@3F]N+4-U<G)E;G0@1&5B=`T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$;&5F=#XF
M;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,RPV.#`\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$T
M+#4X,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@
M/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!W96EG:'1E9"!A=F5R
M86=E(&5F9F5C=&EV92!R871E(&]N(&YO;BUC=7)R96YT(&1E8G0@:7,@-"XP
M."4N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/D9A:7(@=F%L
M=64@;V8@=&AE(&YO;BUC=7)R96YT(&1E8G0@=V%S(&5S=&EM871E9"!U<VEN
M9R!M87)K970@<')I8V5S+"!W:&EC:"!W97)E(&-O<G)O8F]R871E9"!B>0T*
M("`@('%U;W1E9"!B<F]K97(@<')I8V5S(&EN(&%C=&EV92!M87)K971S+@T*
M("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q
M7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W
M838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T
M<R]3:&5E=#$Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY);F-O;64@5&%X97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);F-O;64@5&%X97,@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M3D-/344@5$%815,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*
M("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-
M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12
M+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@
M(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@-2`M('5S+6=A87`Z26YC
M;VUE5&%X1&ES8VQO<W5R951E>'1";&]C:RTM/@T*("`@(#QD:78@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF
M)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&UA<F=I;BUT;W`Z(#$R<'0G/DY/5$4@-2`F(S@R,3([($E.0T]-
M12!405A%4PT*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@
M=V]R;&1W:61E(&5F9F5C=&EV92!I;F-O;64@=&%X(')A=&5S(&9O<B!T:&4@
M9FER<W0@9FES8V%L('-I>"!M;VYT:',@;V8@,C`Q,2!A;F0@,C`Q,"!W97)E
M#0H@("`@,C$N,B4@86YD(#(T+C`E+"!R97-P96-T:79E;'DN(%1H92!L;W=E
M<B!E9F9E8W1I=F4@=&%X(')A=&4@=V%S(&1U92!T;R!H:6=H97(@:6YC;VUE
M(&EN(&QO=V5R('1A>`T*("`@(&IU<FES9&EC=&EO;G,@86YD('1H92!5+E,N
M(%)E<V5A<F-H(&%N9"!$979E;&]P;65N="!T87@@8W)E9&ET+"!W:&EC:"!W
M87,@;F]T(&EN(&5F9F5C="!F;W(@=&AE#0H@("`@9FER<W0@9FES8V%L('-I
M>"!M;VYT:',@;V8@,C`Q,"X@061D:71I;VYA;&QY+"!I;B`R,#$P('1H92!#
M;VUP86YY(&AA9"!L:71I9V%T:6]N(&=A:6YS(&EN(&AI9V@@=&%X#0H@("`@
M:G5R:7-D:6-T:6]N<RX-"B`@("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM
M/@T*("`@(#PA+2T@+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@
M4$%'14)214%+("TM/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\+V1I=CX-
M"B`@/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W
M838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?
M-3,Q-#5B,64P.#<S+U=O<FMS:&5E=',O4VAE970Q,BYH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M139!04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4&5N<VEO;G,@86YD($]T
M:&5R(%!O<W1R971I<F5M96YT($)E;F5F:71S/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4&5N<VEO;G,@86YD($]T
M:&5R($)E;F5F:70@4&QA;G,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y014Y324].4R!!3D0@3U1(15(@
M4$]35%)%5$E214U%3E0@0D5.149)5%,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7
M,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W
M=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD
M=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@-B`M
M('5S+6=A87`Z4&5N<VEO;D%N9$]T:&5R4&]S=')E=&ER96UE;G1"96YE9FET
M<T1I<V-L;W-U<F5497AT0FQO8VLM+3X-"B`@("`\9&EV('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@
M("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!M87)G:6XM=&]P.B`V<'0G/DY/5$4@-B`F(S@R,3([(%!%3E-)3TY3($%.
M1"!/5$A%4B!03U-44D5425)%345.5"!"14Y%1DE44PT*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@;6%R9VEN+71O<#H@-G!T)SY#;VUP;VYE;G1S(&]F($YE="!097)I;V1I
M8R!"96YE9FET($-O<W0-"B`@("!.970@<&5R:6]D:6,@8F5N969I="!C;W-T
M(&9O<B!T:&4@0V]M<&%N>28C.#(Q-SMS(&1E9FEN960@8F5N969I="!R971I
M<F5M96YT('!L86YS(&%N9"!O=&AE<B!B96YE9FET#0H@("`@<&QA;G,@9F]R
M('1H92!F:7-C86P@<V5C;VYD('%U87)T97)S(&]F(#(P,3$@86YD(#(P,3`@
M:6YC;'5D92!T:&4@9F]L;&]W:6YG(&-O;7!O;F5N=',Z#0H@("`@/"]D:78^
M#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C96QL<W!A
M8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#4R)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y
M;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SY2971I
M<F5M96YT(%!L86YS/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SY/
M=&AE<B!"96YE9FET(%!L86YS/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S
M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!1
M=6%R=&5R<R!%;F1E9#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SXF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O
M;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`S+#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#0L/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$
M8F]T=&]M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SXH
M1&]L;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SXR,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@
M("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D("TM/@T*("`@(#PA
M+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY397)V:6-E(&-O<W0-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P
M.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$T-#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3(Q/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS-SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,S,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@
M/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^26YT
M97)E<W0@8V]S=`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,C$T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XQ.30\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C0V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XU,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY%
M>'!E8W1E9"!R971U<FX@;VX@<&QA;B!A<W-E=',-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B@R-S<\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^*#(T.#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH,3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH,3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/D%M;W)T:7IA=&EO;B!O9B!P<FEO<B!S97)V
M:6-E(&-O<W0O*&-R961I="D-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B@Q/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^06UO<G1I>F%T:6]N(&]F(&YE="!T<F%N<VET:6]N(&]B;&EG871I;VX-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C
M.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^4F5C;V=N:7IE9"!A8W1U87)I86P@;&]S<V5S#0H@("`@/"]D
M:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XY.#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3D\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$R/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY.970@<&5R:6]D:6,@8F5N969I="!C
M;W-T#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ.#$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C$S,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^.30\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/CDT/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($)O9'D@
M+2T^#0H@("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#9P="<^3F5T('!E<FEO9&EC(&)E;F5F:70@8V]S="!F;W(@=&AE($-O;7!A
M;GDF(S@R,3<[<R!D969I;F5D(&)E;F5F:70@<F5T:7)E;65N="!P;&%N<R!A
M;F0@;W1H97(@8F5N969I=`T*("`@('!L86YS(&9O<B!T:&4@9FER<W0@9FES
M8V%L('-I>"!M;VYT:',@;V8@,C`Q,2!A;F0@,C`Q,"!I;F-L=61E('1H92!F
M;VQL;W=I;F<@8V]M<&]N96YT<SH-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D
M97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M
M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D('=I9'1H/3-$-3(E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/E)E=&ER96UE;G0@4&QA;G,\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/D]T:&5R($)E;F5F:70@
M4&QA;G,\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^1FES8V%L(%-I>"!-;VYT:',@16YD
M960\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^)B,Q-C`[/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP
M="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`S+#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#0L/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^2G5L>2`T+#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F="!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^*$1O;&QA<G,@:6X@
M36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P
M,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#PO='(^#0H@
M("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A
M8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M4V5R=FEC92!C;W-T#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR.#<\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(T-SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-S0\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8W/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R97-T(&-O<W0-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0R-SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,SDT
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XY-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,3`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N
M9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D5X<&5C=&5D(')E
M='5R;B!O;B!P;&%N(&%S<V5T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#4U
M-3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH
M-3`P/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@Q/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@Q/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^06UO<G1I>F%T:6]N(&]F('!R:6]R('-E<G9I8V4@8V]S="\H
M8W)E9&ET*0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#(\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY!;6]R=&EZ871I;VX@;V8@
M;F5T('1R86YS:71I;VX@;V)L:6=A=&EO;@T*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY296-O9VYI>F5D
M(&%C='5A<FEA;"!L;W-S97,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C$Y-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,3$W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C4\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^3F5T('!E<FEO9&EC(&)E;F5F:70@8V]S=`T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,S4X/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR
M-C4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C$X.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,3@Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L
M93X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^0V]M<&%N>2!#
M;VYT<FEB=71I;VYS/&)R("\^#0H@("`@1F]R('1H92!F:7-C86P@<VEX(&UO
M;G1H<R!E;F1E9"!*=6QY)B,Q-C`[,RP@,C`Q,2P@=&AE($-O;7!A;GD@8V]N
M=')I8G5T960@)FYB<W`[)#$Q.28C,38P.VUI;&QI;VX@86YD("9N8G-P.R0Q
M-B8C,38P.VUI;&QI;VX-"B`@("!T;R!I=',@52Y3+B!A;F0@:6YT97)N871I
M;VYA;"!R971I<F5M96YT('!L86YS+"!R97-P96-T:79E;'DN(%1H92!#;VUP
M86YY('!L86YS('1O(&-O;G1I;G5E('1O(&9U;F0-"B`@("!I=',@52Y3+B!D
M969I;F5D(&)E;F5F:70@<&QA;G,@=&\@8V]M<&QY('=I=&@@=&AE(%!E;G-I
M;VX@4')O=&5C=&EO;B!!8W0@;V8@,C`P-BX@26YT97)N871I;VYA;`T*("`@
M('!L86YS(&%R92!F=6YD960@:6X@86-C;W)D86YC92!W:71H(&QO8V%L(')E
M9W5L871I;VYS+@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V
M,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X
M-S,O5V]R:W-H965T<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY!8V-U;75L871E9"!/=&AE<B!#;VUP<F5H
M96YS:79E($EN8V]M93QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D%C8W5M=6QA=&5D($]T:&5R($-O;7!R96AE;G-I
M=F4@26YC;VUE(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^04-#54U53$%4140@3U1(15(@0T]-4%)%2$5.
M4TE612!)3D-/344\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*
M("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-
M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12
M+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@
M(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@-R`M('5S+6=A87`Z0V]M
M<')E:&5N<VEV94EN8V]M94YO=&5497AT0FQO8VLM+3X-"B`@("`\9&EV('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS
M97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%(#<@)B,X,C$R.R!!
M0T-5355,051%1"!/5$A%4B!#3TU04D5(14Y3259%($E.0T]-10T*("`@(#PO
M9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4;W1A;"!C;VUP<F5H96YS:79E
M(&EN8V]M92!F;W(@=&AE(&9I<V-A;"!S:7@@;6]N=&AS(&5N9&5D($IU;'DF
M(S$V,#LS+"`R,#$Q('=A<R`F;F)S<#LD."XV)B,Q-C`[8FEL;&EO;BP@8V]M
M<&%R960-"B`@("!W:71H("9N8G-P.R0U+C,F(S$V,#MB:6QL:6]N(&9O<B!T
M:&4@<V%M92!P97)I;V0@82!Y96%R(&%G;RX@5&]T86P@8V]M<')E:&5N<VEV
M92!I;F-O;64@9F]R('1H92!F:7-C86P@<V5C;VYD#0H@("`@<75A<G1E<B!E
M;F1E9"!*=6QY)B,Q-C`[,RP@,C`Q,2!W87,@)FYB<W`[)#,N-B8C,38P.V)I
M;&QI;VXL(&-O;7!A<F5D('=I=&@@)FYB<W`[)#$N-B8C,38P.V)I;&QI;VX@
M9F]R('1H92!S86UE('!E<FEO9"!A('EE87(-"B`@("!A9V\N(%1O=&%L(&-O
M;7!R96AE;G-I=F4@:6YC;VUE(&EN8VQU9&5D(&YE="!E87)N:6YG<RP@;F5T
M('5N<F5A;&EZ960@8W5R<F5N8WD@9V%I;G,@86YD(&QO<W-E<R!O;@T*("`@
M('1R86YS;&%T:6]N+"!N970@=6YR96%L:7IE9"!G86EN<R!A;F0@;&]S<V5S
M(&]N('-E8W5R:71I97,@879A:6QA8FQE(&9O<B!S86QE+"!A9&IU<W1M96YT
M<R!R96QA=&5D#0H@("`@=&\@96UP;&]Y964@8F5N969I="!P;&%N<RP@86YD
M(&YE="!G86EN<R!A;F0@;&]S<V5S(&]N(&1E<FEV871I=F4@:6YS=')U;65N
M=',@<75A;&EF>6EN9R!A;F0-"B`@("!D97-I9VYA=&5D(&%S(&-A<V@@9FQO
M=R!H961G97,N(%1H92!F;VQL;W=I;F<@=&%B;&4@<V5T<R!F;W)T:"!T:&4@
M8V]M<&]N96YT<R!O9B!A8V-U;75L871E9"!O=&AE<@T*("`@(&-O;7!R96AE
M;G-I=F4@:6YC;VUE+@T*("`@(#PO9&EV/@T*("`@(#PA+2T@1F]L:6\@+2T^
M#0H@("`@/"$M+2`O1F]L:6\@+2T^#0H@("`@/"]D:78^#0H@("`@/"$M+2!0
M04=%0E)%04L@+2T^#0H@("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI
M9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E
M<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM
M($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0@=VED=&@],T0T,"4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E1O
M=&%L/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^06-C=6T\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$
M)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,SY/=&AE<CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/D9O<F5I9VX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^4V5C
M=7)I=&EE<SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY%;7!L
M;WEE93PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY$97)I=BX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0V]M<"X\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&QE9G0^1V%I;G,O*$QO<W-E<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^0W5R<F5N8WD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^079A:6QA8FQE/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/D)E;F5F:70\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS
M1#,^)B,P,S@[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DEN
M8V]M92\\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E1R86YS;&%T:6]N/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/F9O<B!S86QE/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E!L86YS/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/DAE9&=E<SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,SXH3&]S<RD\+W1D/@T*("`@(#PO='(^#0H@("`@
M/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE
M($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^2F%N
M=6%R>28C,38P.S(L(#(P,3$-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH.38Y
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C(T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XH,BPV.#8\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,3`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH,RPU,S$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXR,#$Q('-I>"!M;VYT:',@8VAA;F=E
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,S!P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E5N<F5A;&EZ960@9V%I
M;B`H;&]S<RD-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0S-3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3(\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HS,'!X.R!T97AT+6EN9&5N=#HM,35P>"<^3F5T(&%M;W5N="!R96-L
M87-S960@=&\@;F5T(&5A<FYI;F=S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XH,3,Y/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C$Q-CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#XJ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/DYE="!S:7@@;6]N=&AS(&-H86YG90T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PW.#<\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Y-CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3(X/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,C@\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L
M,S,Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DIU
M;'DF(S$V,#LS+"`R,#$Q#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XX,3@\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,R,#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^*#(L-34X/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(R.#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$L,3DR/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M
M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV
M/@T*("`@(#QD:78@86QI9VX],T1L969T/@T*("`@(#QD:78@<W1Y;&4],T0G
M9F]N="US:7IE.B`S<'0[(&UA<F=I;BUT;W`Z(#$V<'0[('=I9'1H.B`Q."4[
M(&)O<F1E<BUT;W`Z(#%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L-"B`@("`\
M+V1I=CX-"B`@("`\+V1I=CX-"B`@("`\=&%B;&4@=VED=&@],T0Q,#`E(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@
M(#QT<CX-"B`@("`\=&0@=VED=&@],T0S)3X\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#$E/CPO=&0^#0H@("`@/'1D('=I9'1H/3-$.38E/CPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1L969T/BH\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#Y3=6)S=&%N=&EA;&QY(&]F9G-E="!I;B!N970@96%R
M;FEN9W,@8GD@8VAA;F=E<R!I;B!V86QU92!O9B!T:&4@=6YD97)L>6EN9R!T
M<F%N<V%C=&EO;G,N/"]T9#X-"B`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!M87)G:6XM=&]P.B`V<'0G/D%M;W5N=',@:6X@86-C=6UU;&%T960@;W1H
M97(@8V]M<')E:&5N<VEV92!I;F-O;64@87)E('!R97-E;G1E9"!N970@;V8@
M=&AE(')E;&%T960@=&%X(&EM<&%C="X-"B`@("!&;W)E:6=N(&-U<G)E;F-Y
M('1R86YS;&%T:6]N(&%D:G5S=&UE;G1S(&%R92!N;W0@8W5R<F5N=&QY(&%D
M:G5S=&5D(&9O<B!I;F-O;64@=&%X97,@87,@=&AE>2!R96QA=&4-"B`@("!T
M;R!P97)M86YE;G0@:6YV97-T;65N=',@:6X@:6YT97)N871I;VYA;"!S=6)S
M:61I87)I97,N#0H@("`@/"]D:78^#0H@("`@/"]D:78^#0H@(#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q
M9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W
M,R]7;W)K<VAE971S+U-H965T,30N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V04%#/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/D5A<FYI;F=S(%!E<B!3:&%R93QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5A<FYI
M;F=S(%!E<B!3:&%R92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5!4DY)3D=3(%!%4B!32$%213PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U194$4@
M:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N
M86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M
M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!";&]C
M:R!486=G960@3F]T92`X("T@=7,M9V%A<#I%87)N:6YG<U!E<E-H87)E5&5X
M=$)L;V-K+2T^#0H@("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@
M,3)P="<^3D]412`X("8C.#(Q,CL@14%23DE.1U,@4$52(%-(05)%#0H@("`@
M/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!F;VQL;W=I;F<@:7,@
M82!R96-O;F-I;&EA=&EO;B!O9B!B87-I8R!N970@96%R;FEN9W,@<&5R('-H
M87)E('1O(&1I;'5T960@;F5T(&5A<FYI;F=S('!E<B!S:&%R90T*("`@(&9O
M<B!T:&4@9FES8V%L('-E8V]N9"!Q=6%R=&5R<R!E;F1E9"!*=6QY)B,Q-C`[
M,RP@,C`Q,2!A;F0@2G5L>28C,38P.S0L(#(P,3`N#0H@("`@/"]D:78^#0H@
M("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C96QL<W!A8VEN
M9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#<V)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#<@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F
M9F9F9F8G/D9I<V-A;"!1=6%R=&5R<R!%;F1E9#PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^2G5L>2`T+#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F="!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^*%-H87)E<R!I;B!-:6QL:6]N
M<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$P/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@+2T^#0H@("`@/"$M+2!"
M96=I;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/D)A<VEC(&YE="!E87)N:6YG<R!P97(@<VAA<F4-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$N
M,#$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C$N,C4\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^079E<F%G92!S:&%R97,@;W5T<W1A;F1I;F<@
M)B,X,C$R.R!B87-I8PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,BPW-#`N-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,BPW-38N-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY0;W1E;G1I86P@<VAA<F5S(&5X97)C:7-A8FQE('5N9&5R('-T;V-K(&]P
M=&EO;B!P;&%N<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,38X+CD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C$W-2XU/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/DQE<W,Z('-H87)E<R!W:&EC:"!C;W5L9"!B92!R97!U<F-H
M87-E9"!U;F1E<B!T<F5A<W5R>2!S=&]C:R!M971H;V0-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B@Q,S$N-SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XH,3,Y+C<\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY#;VYV97)T:6)L92!D96)T('-H87)E<PT*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RXV/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+C8\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^079E<F%G92!S:&%R97,@
M;W5T<W1A;F1I;F<@)B,X,C$R.R!D:6QU=&5D#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR+#<X,2XS/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#<Y-BXP/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@
M/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X
M="UI;F1E;G0Z+3$U<'@G/D1I;'5T960@96%R;FEN9W,@<&5R('-H87)E#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ+C`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+C(S/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($)O
M9'D@+2T^#0H@("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT
M;W`Z(#9P="<^5&AE(&1I;'5T960@96%R;FEN9W,@<&5R('-H87)E(&-A;&-U
M;&%T:6]N(&9O<B!B;W1H(&9I<V-A;"!S96-O;F0@<75A<G1E<G,@96YD960@
M2G5L>28C,38P.S,L(#(P,3$@86YD#0H@("`@2G5L>28C,38P.S0L(#(P,3`@
M:6YC;'5D960@=&AE(&1I;'5T:79E(&5F9F5C="!O9B!C;VYV97)T:6)L92!D
M96)T('1H870@=V%S(&]F9G-E="!B>2!T:&4@<F5L871E9`T*("`@(')E9'5C
M=&EO;B!I;B!I;G1E<F5S="!E>'!E;G-E+@T*("`@(#PO9&EV/@T*("`@(#QD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R
M9VEN+71O<#H@-G!T)SY4:&4@9&EL=71E9"!E87)N:6YG<R!P97(@<VAA<F4@
M8V%L8W5L871I;VX@9F]R('1H92!F:7-C86P@<V5C;VYD('%U87)T97)S(&5N
M9&5D($IU;'DF(S$V,#LS+"`R,#$Q(&%N9`T*("`@($IU;'DF(S$V,#LT+"`R
M,#$P+"!E>&-L=61E9"`U,28C,38P.VUI;&QI;VX@86YD(#8X)B,Q-C`[;6EL
M;&EO;B!S:&%R97,L(')E<W!E8W1I=F5L>2P@<F5L871E9"!T;R!S=&]C:R!O
M<'1I;VYS+`T*("`@(&%S('1H92!E>&5R8VES92!P<FEC92!O9B!T:&5S92!O
M<'1I;VYS('=A<R!G<F5A=&5R('1H86X@=&AE:7(@879E<F%G92!M87)K970@
M=F%L=64L('=H:6-H('=O=6QD#0H@("`@<F5S=6QT(&EN(&%N(&%N=&DM9&EL
M=71I=F4@969F96-T(&]N(&1I;'5T960@96%R;FEN9W,@<&5R('-H87)E+@T*
M("`@(#PO9&EV/@T*("`@(#PA+2T@1F]L:6\@+2T^#0H@("`@/"$M+2`O1F]L
M:6\@+2T^#0H@("`@/"]D:78^#0H@("`@/"$M+2!004=%0E)%04L@+2T^#0H@
M("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9F]L
M;&]W:6YG(&ES(&$@<F5C;VYC:6QI871I;VX@;V8@8F%S:6,@;F5T(&5A<FYI
M;F=S('!E<B!S:&%R92!T;R!D:6QU=&5D(&YE="!E87)N:6YG<R!P97(@<VAA
M<F4-"B`@("!F;W(@=&AE(&9I<V-A;"!S:7@@;6]N=&AS(&5N9&5D($IU;'DF
M(S$V,#LS+"`R,#$Q(&%N9"!*=6QY)B,Q-C`[-"P@,C`Q,"X-"B`@("`\+V1I
M=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS
M<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4^#0H@("`@/"$M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D('=I9'1H/3-$-S8E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L
M:60@(V9F9F9F9B<^1FES8V%L(%-I>"!-;VYT:',@16YD960\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/BA3:&%R97,@:6X@
M36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P
M,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^
M#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D("TM/@T*("`@
M(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY"87-I8R!N970@96%R;FEN9W,@<&5R('-H87)E#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XR+C(X/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+C@Y/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%V97)A9V4@<VAA<F5S(&]U='-T
M86YD:6YG("8C.#(Q,CL@8F%S:6,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C(L-S,Y+C8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L-S4U+C<\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^4&]T96YT:6%L('-H87)E<R!E>&5R8VES86)L92!U;F1E<B!S
M=&]C:R!O<'1I;VX@<&QA;G,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C$V."XX/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ-S4N-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY,97-S.B!S:&%R97,@=VAI8V@@8V]U;&0@8F4@
M<F5P=7)C:&%S960@=6YD97(@=')E87-U<GD@<W1O8VL@;65T:&]D#0H@("`@
M/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XH,3,S+CD\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$S."XV/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^0V]N=F5R=&EB;&4@9&5B="!S:&%R97,-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,N-CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RXV/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%V97)A9V4@
M<VAA<F5S(&]U='-T86YD:6YG("8C.#(Q,CL@9&EL=71E9`T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPW-S@N,3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPW.38N,3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY$:6QU=&5D(&5A<FYI;F=S('!E<B!S
M:&%R90T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,BXR-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB
M<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BXX-3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!4
M86)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M
M87)G:6XM=&]P.B`V<'0G/E1H92!D:6QU=&5D(&5A<FYI;F=S('!E<B!S:&%R
M92!C86QC=6QA=&EO;B!F;W(@8F]T:"!T:&4@9FES8V%L('-I>"!M;VYT:',@
M96YD960@2G5L>28C,38P.S,L(#(P,3$@86YD#0H@("`@2G5L>28C,38P.S0L
M(#(P,3`@:6YC;'5D960@=&AE(&1I;'5T:79E(&5F9F5C="!O9B!C;VYV97)T
M:6)L92!D96)T('1H870@=V%S(&]F9G-E="!B>2!T:&4@<F5L871E9`T*("`@
M(')E9'5C=&EO;B!I;B!I;G1E<F5S="!E>'!E;G-E+@T*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9&EL=71E9"!E87)N:6YG<R!P97(@
M<VAA<F4@8V%L8W5L871I;VX@9F]R('1H92!F:7-C86P@<VEX(&UO;G1H<R!E
M;F1E9"!*=6QY)B,Q-C`[,RP@,C`Q,2!A;F0@2G5L>28C,38P.S0L#0H@("`@
M,C`Q,"!E>&-L=61E9"`U,B8C,38P.VUI;&QI;VX@86YD(#8X)B,Q-C`[;6EL
M;&EO;B!S:&%R97,@<F5L871E9"!T;R!S=&]C:R!O<'1I;VYS+"!A<R!T:&4@
M97AE<F-I<V4@<')I8V4@;V8-"B`@("!T:&5S92!O<'1I;VYS('=A<R!G<F5A
M=&5R('1H86X@=&AE:7(@879E<F%G92!M87)K970@=F%L=64L('=H:6-H('=O
M=6QD(')E<W5L="!I;B!A;B!A;G1I+61I;'5T:79E#0H@("`@969F96-T(&]N
M(&1I;'5T960@96%R;FEN9W,@<&5R('-H87)E+@T*("`@(#PO9&EV/@T*("`@
M(#PA+2T@1F]L:6\@+2T^#0H@("`@/"$M+2`O1F]L:6\@+2T^#0H@("`@/"]D
M:78^#0H@("`@/"$M+2!004=%0E)%04L@+2T^#0H@("`@/&1I=B!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G
M/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E
M,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q
M-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#$U
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M96=M96YT<R!O9B!"=7-I;F5S<R!A;F0@1V5O9W)A<&AI8R!!<F5A<SQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-E
M9VUE;G1S(&]F($)U<VEN97-S(&%N9"!'96]G<F%P:&EC($%R96%S(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4T5'345.5%,@3T8@0E5324Y%4U,@04Y$($=%3T=205!(24,@05)%05,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-4
M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I
M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O
M>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@
M0FQO8VL@5&%G9V5D($YO=&4@.2`M('5S+6=A87`Z4V5G;65N=%)E<&]R=&EN
M9T1I<V-L;W-U<F5497AT0FQO8VLM+3X-"B`@("`\9&EV('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@
M("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%(#D@)B,X,C$R.R!314=-14Y44R!/
M1B!"55-)3D534R!!3D0@1T5/1U)!4$A)0R!!4D5!4PT*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@;6%R9VEN+71O<#H@-G!T)SY304Q%4R!"62!314=-14Y4($]&($)54TE.
M15-3#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@
M("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N
M.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN
M9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A
M9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T
M:#TS1#8T)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!1=6%R=&5R<R!%;F1E9#PO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C
M96YT97(@8V]L<W!A;CTS1#,^2G5L>2`T+#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,SY097)C96YT/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA$;VQL87)S
M(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0VAA;F=E/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@+2T^#0H@("`@
M/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/D-O;G-U;65R#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N4RX-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C$L,S,Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#0V,SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^*#@N-3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<#XI)3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY);G1E<FYA=&EO;F%L#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XR+#0U-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPQ.#0\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$R+C0\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L-SDS/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#8T-SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-"XP
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/E!H87)M86-E=71I8V%L#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G
M/E4N4RX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L
M,C,Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XS+#$Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^-"XQ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C
M:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R
M;F%T:6]N86P-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C(L.3DT/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XR+#0T,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,C(N-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^-BPR,S,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4L-34S/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,BXR/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/DUE9&EC86P@1&5V:6-E<R`F(S`S.#L@1&EA9VYO<W1I8W,-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^52Y3+@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,BPX-CD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C(L.#8U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XP+C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M26YT97)N871I;VYA;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,RPW,#(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C,L,C8U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ,RXT/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XV+#4W,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-BPQ,S`\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<N,CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY7;W)L9'=I9&4-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^52Y3+@T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-RPT-#<\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L-#,X
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XP+C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^26YT97)N871I;VYA;`T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^.2PQ-3`\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L
M.#DR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ-2XY/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/E1O=&%L#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ-BPU.3<\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$U+#,S
M,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^."XS/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/B4\+W1D/@T*("`@(#PO='(^#0H@("`@
M/"$M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO
M9&EV/@T*("`@(#QD:78@86QI9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L
M;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@
M/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@=VED=&@],T0V-"4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#$Q('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C
M9F9F9F9F)SY&:7-C86P@4VEX($UO;G1H<R!%;F1E9#PO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^2G5L>2`T+#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SY097)C96YT/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS
M1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA$;VQL87)S(&EN($UI;&QI
M;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0VAA;F=E/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@+2T^#0H@("`@/"$M+2!"96=I
M;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/D-O;G-U;65R#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N4RX-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L-C@T/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XS+#`R,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^*#$Q+C(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*24\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^26YT97)N871I;VYA;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^-"PW.3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C0L,SDP/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XY+C$\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C<L-#<U/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XW+#0Q,SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,"XX/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/E!H87)M86-E=71I8V%L#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N4RX-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8L-C,P/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XV+#,Q
M-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-2XP/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R;F%T:6]N86P-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L-C8R/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT
M+#@W-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,38N,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^,3(L,CDR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ,2PQ.3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/CDN.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@
M0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A
M8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY-961I
M8V%L($1E=FEC97,@)B,P,S@[($1I86=N;W-T:6-S#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N
M4RX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L-S0Q
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XU+#<U,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#`N,CPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N
M9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R;F%T:6]N
M86P-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L,C8R
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XV+#8P-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^.2XY/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/E1O=&%L#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ,RPP,#,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C$R+#,U-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^-2XR/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M
M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E=O
M<FQD=VED90T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*
M("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[
M('1E>'0M:6YD96YT.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ-2PP-34\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$U+#`Y,#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^*#`N,CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#XI/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/DEN=&5R;F%T:6]N86P-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C$W+#<Q-3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,34L.#<Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,2XV/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L#0H@("`@
M/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XS,BPW-S`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,P+#DV,3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-2XX/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/B4\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@
M0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@,3)P="<^3U!%4D%424Y'(%!23T9)5"!"62!314=-14Y4($]&($)5
M4TE.15-3#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-
M"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L
M:6=N.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@
M2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W
M:61T:#TS1#8T)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T
M)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!1=6%R=&5R<R!%;F1E9#PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`T+#PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,SY097)C96YT/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/BA$;VQL
M87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P
M,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0VAA;F=E/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@+2T^#0H@
M("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@
M/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X
M="UI;F1E;G0Z+3$U<'@G/D-O;G-U;65R#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S
M<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU-#D\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C8V.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$W
M+CD\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*24\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^4&AA<FUA8V5U=&EC86P@*#$I#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ+#<Q-#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PX,S,\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@V+C4\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY-961I8V%L($1E=FEC97,@)B,P,S@[($1I86=N;W-T
M:6-S("@R*0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,2PR-S4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$L.#<V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH
M,S(N,#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/E-E9VUE;G1S(&]P97)A=&EN9R!P<F]F:70-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L-3,X/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT+#,W.#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$Y+C(\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY%>'!E;G-E(&YO="!A;&QO8V%T960@
M=&\@<V5G;65N=',@*#,I#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3$V/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q-3@\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY7
M;W)L9'=I9&4@:6YC;VUE(&)E9F]R92!T87AE<PT*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPT,C(\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C0L,C(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,3@N.3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI)3PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*
M("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E
M;G1E<CX-"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T
M97AT+6%L:6=N.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@
M5&%B;&4@2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9"!W:61T:#TS1#8T)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ
M93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,3$@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!3:7@@36]N=&AS
M($5N9&5D/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`S+#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#0L/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E!E<F-E;G0\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE
M9G0^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^,C`Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY#
M:&%N9V4\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A
M9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F
M)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0V]N<W5M97(-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L,3(R
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ+#0U-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^*#(R+C@\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M*24\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^4&AA<FUA8V5U=&EC86P@*#$I#0H@("`@
M/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#DR,SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPX,#,\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C,N,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY-961I8V%L($1E=FEC97,@
M)B,P,S@[($1I86=N;W-T:6-S("@R*0T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^,RPR,3D\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L-3<X/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XH-#(N,SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<#XI/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E-E9VUE;G1S(&]P97)A=&EN9R!P
M<F]F:70-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C@L
M,C8T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ,"PX,S4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R
M,RXW/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K
M9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^17AP96YS
M92!N;W0@86QL;V-A=&5D('1O('-E9VUE;G1S("@S*0T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^*#,S,CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH,S,U/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^5V]R;&1W:61E(&EN8V]M92!B969O<F4@=&%X97,-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C<L.3,R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,"PU,#`\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R-"XU/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/BDE/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD
M(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@
M("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@+T9O;&EO("TM/@T*("`@(#PO
M9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM/@T*("`@(#QD:78@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF
M)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F=#X-"B`@("`\9&EV('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,W!T.R!M87)G:6XM=&]P.B`Q-G!T.R!W:61T:#H@,3@E
M.R!B;W)D97(M=&]P.B`Q<'@@<V]L:60@(S`P,#`P,"<^)B,Q-C`[#0H@("`@
M/"]D:78^#0H@("`@/"]D:78^#0H@("`@/'1A8FQE('=I9'1H/3-$,3`P)2!B
M;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@
M("`\='(^#0H@("`@/'1D('=I9'1H/3-$,R4^/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0Q)3X\+W1D/@T*("`@(#QT9"!W:61T:#TS1#DV)3X\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH,2D\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#Y);F-L=61E<R!L:71I9V%T:6]N(&5X<&5N<V4@
M;V8@)FYB<W`[)#(Y,"8C,38P.VUI;&QI;VX@86YD("9N8G-P.R0U-#`F(S$V
M,#MM:6QL:6]N(')E8V]R9&5D(&EN('1H92!F:7-C86P@<V5C;VYD#0H@("`@
M<75A<G1E<B!A;F0@=&AE(&9I<G-T(&9I<V-A;"!S:7@@;6]N=&AS(&]F(#(P
M,3$L(')E<W!E8W1I=F5L>2X@5&AE(&9I<G-T(&9I<V-A;"!S:7@@;6]N=&AS
M(&]F(#(P,3$-"B`@("!I;F-L=61E<R!A(&=A:6X@<F5L871E9"!T;R!T:&4@
M0V]M<&%N>28C.#(Q-SMS(&5A<FQI97(@:6YV97-T;65N="!I;B!#<G5C96QL
M(')E8V]R9&5D(&EN('1H92!F:7-C86P@9FER<W0-"B`@("!Q=6%R=&5R(&]F
M(#(P,3$N(%1H92!F:7-C86P@<V5C;VYD('%U87)T97(@86YD('1H92!F:7)S
M="!F:7-C86P@<VEX#0H@("`@;6]N=&AS(&]F(#(P,3`L(&EN8VQU9&5S(&YE
M="!L:71I9V%T:6]N(&5X<&5N<V4@;V8@)FYB<W`[)#$Q-28C,38P.VUI;&QI
M;VX@86YD("9N8G-P.R0R,#(F(S$V,#MM:6QL:6]N+"!R97-P96-T:79E;'DN
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z
M(#-P="<^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1L969T/B@R*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/DEN8VQU9&5S(')E<W1R=6-T=7)I;F<@97AP96YS92!O9B`F;F)S<#LD
M-C<V)B,Q-C`[;6EL;&EO;B!R96-O<F1E9"!I;B!T:&4@9FES8V%L('-E8V]N
M9"!Q=6%R=&5R(&%N9"!F:7)S=`T*("`@(&9I<V-A;"!S:7@@;6]N=&AS(&]F
M(#(P,3$N($EN8VQU9&5S(&QI=&EG871I;VX@97AP96YS92!A;F0@861D:71I
M;VYA;"!$95!U>2!!4U(F(S@T.#([($AI<"!R96-A;&P@8V]S=',-"B`@("!O
M9B`F;F)S<#LD,3(W)B,Q-C`[;6EL;&EO;B!R96-O<F1E9"!I;B!T:&4@9FES
M8V%L('-E8V]N9"!Q=6%R=&5R(&]F(#(P,3$N($EN8VQU9&5S(&QI=&EG871I
M;VX@97AP96YS92!A;F0-"B`@("!A9&1I=&EO;F%L($1E4'5Y($%34B8C.#0X
M,CL@2&EP(')E8V%L;"!C;W-T<R!O9B`F;F)S<#LD,C(S)B,Q-C`[;6EL;&EO
M;B!R96-O<F1E9"!I;B!T:&4@9FER<W0@9FES8V%L('-I>"!M;VYT:',@;V8-
M"B`@("`R,#$Q+B!);F-L=61E<R!N970@;&ET:6=A=&EO;B!E>'!E;G-E(&]F
M("9N8G-P.R0T,B8C,38P.VUI;&QI;VX@86YD(&EN8V]M92!O9B`F;F)S<#LD
M,2PU-#(F(S$V,#MM:6QL:6]N(')E8V]R9&5D(&EN('1H90T*("`@(&9I<V-A
M;"!S96-O;F0@<75A<G1E<B!A;F0@=&AE(&9I<G-T(&9I<V-A;"!S:7@@;6]N
M=&AS(&]F(#(P,3`L(')E<W!E8W1I=F5L>2X\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@,W!T)SX-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T;W`^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*#,I/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^06UO=6YT<R!N;W0@86QL
M;V-A=&5D('1O('-E9VUE;G1S(&EN8VQU9&4@:6YT97)E<W0@:6YC;VUE+RAE
M>'!E;G-E*2P@;F]N+6-O;G1R;VQL:6YG(&EN=&5R97-T<PT*("`@(&%N9"!G
M96YE<F%L(&-O<G!O<F%T92!I;F-O;64O*&5X<&5N<V4I+CPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`@(#QD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@,3)P="<^4T%,
M15,@0ED@1T5/1U)!4$A)0R!!4D5!#0H@("`@/"]D:78^#0H@("`@/&1I=B!A
M;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R
M9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA
M+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9"!W:61T:#TS1#8T)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0S)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$
M)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,3$@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!1
M=6%R=&5R<R!%;F1E9#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@
M,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`T+#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY097)C96YT/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1L969T/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^0VAA;F=E/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A
M8FQE($AE860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N4RX-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L
M-#0W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XW+#0S.#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,"XQ/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/B4\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^175R;W!E#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XT+#4T,SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPX,S(\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$X+C8\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^5V5S=&5R;B!(96UI<W!H97)E+"!E>&-L=61I
M;F<@52Y3+@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,2PU-#,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$L,S<U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ,BXR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/D%S:6$M4&%C:69I8RP@069R:6-A#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#`V-#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPV.#4\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$T+C$\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P
M.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$V+#4Y-SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,34L,S,P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XX+C,\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)3PO=&0^#0H@
M("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO
M=&%B;&4^#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-
M"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L
M:6=N.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@
M2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W
M:61T:#TS1#8T)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T
M)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,3$@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@,7!X('-O;&ED("-F9F9F9F8G/D9I<V-A;"!3:7@@36]N=&AS($5N9&5D
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z
M(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`S+#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#0L/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0S/E!E<F-E;G0\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$1O
M;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^
M,C`Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY#:&%N9V4\
M+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-
M"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@
M("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T
M97AT+6EN9&5N=#HM,35P>"<^52Y3+@T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,34L,#4U/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XQ-2PP.3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B@P+C(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*24\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^175R;W!E#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XX+#<R-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-RPY,S0\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$P+C`\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^5V5S=&5R;B!(96UI<W!H97)E+"!E>&-L=61I;F<@52Y3+@T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPY-SD\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L
M-C4U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ,BXR/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/D%S:6$M4&%C:69I8RP@069R:6-A#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XV+#`Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-2PR.#(\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$S+C@\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^5&]T86P-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C,R+#<W,#PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,S`L.38Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+C@\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)3PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@
M("`@/"]D:78^#0H@("`@/"]D:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?
M-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A
M-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S
M+U-H965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4V04%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/D)U<VEN97-S($-O;6)I;F%T:6]N<R!A;F0@1&EV97-T:71U<F5S
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P
M,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^0G5S:6YE<W,@0V]M8FEN871I;VYS(&%N9"!$:79E<W1I='5R97,@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y"55-)3D534R!#3TU"24Y!5$E/3E,@04Y$($1)5D535$E455)%4SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!"
M;&]C:R!486=G960@3F]T92`Q,"`M('5S+6=A87`Z0G5S:6YE<W-#;VUB:6YA
M=&EO;D1I<V-L;W-U<F5497AT0FQO8VLM+3X-"B`@("`\9&EV('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^
M#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%(#$P)B,X,C$R.R!"55-)3D53
M4R!#3TU"24Y!5$E/3E,@04Y$($1)5D535$E455)%4PT*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@;6%R9VEN+71O<#H@-G!T)SY$=7)I;F<@=&AE(&9I<V-A;"!S96-O;F0@
M<75A<G1E<B!O9B`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!D
M969I;FET:79E(&%G<F5E;65N="!T;PT*("`@(&%C<75I<F4@4WEN=&AE<RP@
M26YC+B!F;W(@87!P<F]X:6UA=&5L>0T*("`@("9N8G-P.R0R,2XS)B,Q-C`[
M8FEL;&EO;BP@87!P<F]X:6UA=&5L>2`F;F)S<#LD,3DN,R8C,38P.V)I;&QI
M;VX@;F5T(&]F(&-A<V@-"B`@("!A8W%U:7)E9"P@<W5B:F5C="!T;R!T:&4@
M=&5R;7,@;V8@=&AE(&UE<F=E<B!A9W)E96UE;G0@86YD(&-U<G)E;F-Y('9A
M;'5E<R!A="!T:&4@=&EM92!O9B!C;&]S:6YG+@T*("`@(%5N9&5R('1H92!T
M97)M<R!O9B!T:&4@86=R965M96YT+"!E86-H('-H87)E(&]F(%-Y;G1H97,@
M8V]M;6]N('-T;V-K+"!S=6)J96-T('1O(&-E<G1A:6X-"B`@("!C;VYD:71I
M;VYS+"!W:6QL(&)E(&5X8VAA;F=E9"!F;W(@87!P<F]X:6UA=&5L>2`S-24@
M:6X@8V%S:"!A;F0@-C4E#0H@("`@:6X@2F]H;G-O;B`F(S,X.R!*;VAN<V]N
M(&-O;6UO;@T*("`@('-T;V-K+B!3>6YT:&5S+"!);F,N(&ES(&$@<')E;6EE
M<B!G;&]B86P@9&5V96QO<&5R(&%N9"!M86YU9F%C='5R97(@;V8@;W)T:&]P
M865D:6-S(&1E=FEC97,N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V
M<'0G/D1U<FEN9R!T:&4@9FES8V%L(&9I<G-T('%U87)T97(@;V8@,C`Q,2P@
M=&AE($-O;7!A;GD@86-Q=6ER960@<W5B<W1A;G1I86QL>2!A;&P@;V8@=&AE
M(&]U='-T86YD:6YG#0H@("`@97%U:71Y(&]F($-R=6-E;&P@3BY6+B!T:&%T
M(&ET(&1I9"!N;W0@86QR96%D>2!O=VXN($-R=6-E;&P@:7,@82!G;&]B86P@
M8FEO<&AA<FUA8V5U=&EC86P@8V]M<&%N>0T*("`@(&9O8W5S960@;VX@=&AE
M(')E<V5A<F-H(&%N9"!D979E;&]P;65N="P@<')O9'5C=&EO;B!A;F0@;6%R
M:V5T:6YG(&]F('9A8V-I;F5S(&%N9"!A;G1I8F]D:65S#0H@("`@86=A:6YS
M="!I;F9E8W1I;W5S(&1I<V5A<V4@=V]R;&1W:61E+B!4:&4@;F5T('!U<F-H
M87-E('!R:6-E(&]F("9N8G-P.R0R+C`F(S$V,#MB:6QL:6]N('=A<R!A;&QO
M8V%T960-"B`@("!P<FEM87)I;'D@=&\@;F]N+6%M;W)T:7IA8FQE(&EN=&%N
M9VEB;&4@87-S971S(&9O<B`F;F)S<#LD,2XP)B,Q-C`[8FEL;&EO;BP@86UO
M<G1I>F%B;&4@:6YT86YG:6)L92!A<W-E=',@9F]R#0H@("`@)FYB<W`[)#`N
M-R8C,38P.V)I;&QI;VX@86YD(&=O;V1W:6QL(&9O<B`F;F)S<#LD,"XU)B,Q
M-C`[8FEL;&EO;BX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^
M1'5R:6YG('1H92!F:7-C86P@<V5C;VYD('%U87)T97(@;V8@,C`Q,"P@=&AE
M($-O;7!A;GD@86-Q=6ER960@4F5S<&E697)T($QT9"XL(&$@<')I=F%T96QY
M(&AE;&0-"B`@("!D<G5G(&1I<V-O=F5R>2!C;VUP86YY(&9O8W5S960@;VX@
M9&5V96QO<&EN9R!S;6%L;"UM;VQE8W5L92P@:6YH86QE9"!T:&5R87!I97,@
M9F]R('1H92!T<F5A=&UE;G0@;V8-"B`@("!P=6QM;VYA<GD@9&ES96%S97,N
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/D1U<FEN9R!T:&4@
M9FES8V%L(&9I<G-T('%U87)T97(@;V8@,C`Q,"P@=&AE($-O;7!A;GD@86-Q
M=6ER960@06-C;&%R96YT+"!);F,N+"!A(&UE9&EC86P@=&5C:&YO;&]G>0T*
M("`@(&-O;7!A;GD@9&5D:6-A=&5D('1O(&1E<VEG;FEN9RP@9&5V96QO<&EN
M9R!A;F0@8V]M;65R8VEA;&EZ:6YG(&1E=FEC97,@=&AA="!A9&1R97-S(&-O
M;F1I=&EO;G,-"B`@("!A9F9E8W1I;F<@=&AE(&5A<BP@;F]S92!A;F0@=&AR
M;V%T+"!F;W(@82!N970@<'5R8VAA<V4@<')I8V4@;V8@)FYB<W`[)#`N."8C
M,38P.V)I;&QI;VXN(%1H92!P=7)C:&%S92!P<FEC90T*("`@(&9O<B!T:&4@
M86-Q=6ES:71I;VX@=V%S(&%L;&]C871E9"!P<FEM87)I;'D@=&\@86UO<G1I
M>F%B;&4@:6YT86YG:6)L92!A<W-E=',@9F]R("9N8G-P.R0P+C<F(S$V,#MB
M:6QL:6]N+@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?
M-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O
M5V]R:W-H965T<R]3:&5E=#$W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY,96=A;"!0<F]C965D:6YG<SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQE9V%L(%!R
M;V-E961I;F=S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3$5'04P@4%)/0T5%1$E.1U,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@
M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%
M3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R
M86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G
M9V5D($YO=&4@,3$@+2!U<RUG86%P.DQE9V%L36%T=&5R<T%N9$-O;G1I;F=E
M;F-I97-497AT0FQO8VLM+3X-"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G
M:6XM=&]P.B`Q,G!T)SY.3U1%(#$Q("8C.#(Q,CL@3$5'04P@4%)/0T5%1$E.
M1U,-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^2F]H;G-O;B`F
M(S`S.#L@2F]H;G-O;B`H=&AE($-O;7!A;GDI(&%N9"!C97)T86EN(&]F(&ET
M<R!S=6)S:61I87)I97,@87)E(&EN=F]L=F5D(&EN('9A<FEO=7,@;&%W<W5I
M=',-"B`@("!A;F0@8VQA:6US(')E9V%R9&EN9R!P<F]D=6-T(&QI86)I;&ET
M>2P@:6YT96QL96-T=6%L('!R;W!E<G1Y+"!C;VUM97)C:6%L(&%N9"!O=&AE
M<B!M871T97)S.PT*("`@(&=O=F5R;FUE;G1A;"!I;G9E<W1I9V%T:6]N<SL@
M86YD(&]T:&5R(&QE9V%L('!R;V-E961I;F=S('1H870@87)I<V4@9G)O;2!T
M:6UE('1O('1I;64@:6X@=&AE#0H@("`@;W)D:6YA<GD@8V]U<G-E(&]F('1H
M96ER(&)U<VEN97-S+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T
M)SY4:&4@0V]M<&%N>2!R96-O<F1S(&%C8W)U86QS(&9O<B!S=6-H(&-O;G1I
M;F=E;F-I97,@=VAE;B!I="!I<R!P<F]B86)L92!T:&%T(&$@;&EA8FEL:71Y
M('=I;&P@8F4-"B`@("!I;F-U<G)E9"!A;F0@=&AE(&%M;W5N="!O9B!T:&4@
M;&]S<R!C86X@8F4@<F5A<V]N86)L>2!E<W1I;6%T960N(%1H<F]U9V@@=&AE
M('!E<FEO9"!E;F1E9"!*=6QY)B,Q-C`[,RP-"B`@("`R,#$Q+"!T:&4@0V]M
M<&%N>2!H87,@9&5T97)M:6YE9"!T:&%T('1H92!L:6%B:6QI=&EE<R!A<W-O
M8VEA=&5D('=I=&@@8V5R=&%I;B!L:71I9V%T:6]N(&UA='1E<G,-"B`@("!A
M<F4@<')O8F%B;&4@86YD(&-A;B!B92!R96%S;VYA8FQY(&5S=&EM871E9"X@
M5&AE($-O;7!A;GD@:&%S(&%C8W)U960@9F]R('1H97-E(&UA='1E<G,@86YD
M('=I;&P-"B`@("!C;VYT:6YU92!T;R!M;VYI=&]R(&5A8V@@<F5L871E9"!L
M96=A;"!I<W-U92!A;F0@861J=7-T(&%C8W)U86QS(&9O<B!N97<@:6YF;W)M
M871I;VX@86YD(&9U<G1H97(-"B`@("!D979E;&]P;65N=',@:6X@86-C;W)D
M86YC92!W:71H($%30R`T-3`M,C`M,C4N($9O<B!T:&5S92!A;F0@;W1H97(@
M;&ET:6=A=&EO;B!A;F0@<F5G=6QA=&]R>0T*("`@(&UA='1E<G,@8W5R<F5N
M=&QY(&1I<V-L;W-E9"!F;W(@=VAI8V@@82!L;W-S(&ES('!R;V)A8FQE(&]R
M(')E87-O;F%B;'D@<&]S<VEB;&4L('1H92!#;VUP86YY(&ES#0H@("`@=6YA
M8FQE('1O(&1E=&5R;6EN92!A;B!E<W1I;6%T92!O9B!T:&4@<&]S<VEB;&4@
M;&]S<R!O<B!R86YG92!O9B!L;W-S(&)E>6]N9"!T:&4@86UO=6YT<R!A;')E
M861Y#0H@("`@86-C<G5E9"X@5&AE<V4@;6%T=&5R<R!C86X@8F4@869F96-T
M960@8GD@=F%R:6]U<R!F86-T;W)S+"!I;F-L=61I;F<@9&%M86=E<R!S;W5G
M:'0@:6X@=&AE#0H@("`@<')O8V5E9&EN9W,@87)E('5N<W5B<W1A;G1I871E
M9"!O<B!I;F1E=&5R;6EN871E.R!S8VEE;G1I9FEC(&%N9"!L96=A;"!D:7-C
M;W9E<GD@:&%S(&YO="!C;VUM96YC960-"B`@("!O<B!I<R!N;W0@8V]M<&QE
M=&4[('!R;V-E961I;F=S(&%R92!I;B!E87)L>2!S=&%G97,[(&UA='1E<G,@
M<')E<V5N="!L96=A;"!U;F-E<G1A:6YT:65S.R!T:&5R92!A<F4-"B`@("!S
M:6=N:69I8V%N="!F86-T<R!I;B!D:7-P=71E.R!T:&5R92!A<F4@;G5M97)O
M=7,@<&%R=&EE<R!I;G9O;'9E9"X-"B`@("`\+V1I=CX-"B`@("`\(2TM($9O
M;&EO("TM/@T*("`@(#PA+2T@+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*("`@
M(#PA+2T@4$%'14)214%+("TM/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA
M<F=I;BUT;W`Z(#9P="<^26X@=&AE($-O;7!A;GDF(S@R,3<[<R!O<&EN:6]N
M+"!B87-E9"!O;B!I=',@97AA;6EN871I;VX@;V8@=&AE<V4@;6%T=&5R<RP@
M:71S(&5X<&5R:65N8V4@=&\@9&%T92!A;F0-"B`@("!D:7-C=7-S:6]N<R!W
M:71H(&-O=6YS96PL('1H92!U;'1I;6%T92!O=71C;VUE(&]F(&QE9V%L('!R
M;V-E961I;F=S+"!N970@;V8@;&EA8FEL:71I97,@86-C<G5E9"!I;@T*("`@
M('1H92!#;VUP86YY)B,X,C$W.W,@8F%L86YC92!S:&5E="P@:7,@;F]T(&5X
M<&5C=&5D('1O(&AA=F4@82!M871E<FEA;"!A9'9E<G-E(&5F9F5C="!O;B!T
M:&4@0V]M<&%N>28C.#(Q-SMS#0H@("`@9FEN86YC:6%L('!O<VET:6]N+"!A
M;'1H;W5G:"!T:&4@<F5S;VQU=&EO;B!I;B!A;GD@<F5P;W)T:6YG('!E<FEO
M9"!O9B!O;F4@;W(@;6]R92!O9B!T:&5S90T*("`@(&UA='1E<G,L(&5I=&AE
M<B!A;&]N92!O<B!I;B!T:&4@86=G<F5G871E+"!M87D@:&%V92!A(&UA=&5R
M:6%L(&%D=F5R<V4@969F96-T(&]N('1H92!#;VUP86YY)B,X,C$W.W,-"B`@
M("!R97-U;'1S(&]F(&]P97)A=&EO;G,L(&%N9"!C87-H(&9L;W=S(&9O<B!T
M:&%T('!E<FEO9"X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#$R<'0G
M/CQU/CQB/E!23T150U0@3$E!0DE,2519/"]B/CPO=3X-"B`@("`\+V1I=CX-
M"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&UA<F=I;BUT;W`Z(#9P="<^5&AE($-O;7!A;GDF(S@R,3<[<R!S=6)S
M:61I87)I97,@87)E(&EN=F]L=F5D(&EN(&YU;65R;W5S('!R;V1U8W0@;&EA
M8FEL:71Y(&-A<V5S(&EN('1H92!5;FET960@4W1A=&5S+`T*("`@(&UA;GD@
M;V8@=VAI8V@@8V]N8V5R;B!A;&QE9V5D(&%D=F5R<V4@<F5A8W1I;VYS('1O
M(&1R=6=S(&%N9"!M961I8V%L(&1E=FEC97,N(%1H92!D86UA9V5S(&-L86EM
M960-"B`@("!A<F4@<W5B<W1A;G1I86PL(&%N9"!W:&EL92!T:&4@0V]M<&%N
M>28C.#(Q-SMS('-U8G-I9&EA<FEE<R!A<F4@8V]N9FED96YT(&]F('1H92!A
M9&5Q=6%C>2!O9B!T:&4@=V%R;FEN9W,-"B`@("!A;F0@:6YS=')U8W1I;VYS
M(&9O<B!U<V4@=&AA="!A8V-O;7!A;GD@<W5C:"!P<F]D=6-T<RP@:70@:7,@
M;F]T(&9E87-I8FQE('1O('!R961I8W0@=&AE('5L=&EM871E#0H@("`@;W5T
M8V]M92!O9B!L:71I9V%T:6]N+B!4:&4@0V]M<&%N>2!H87,@97-T86)L:7-H
M960@<')O9'5C="!L:6%B:6QI='D@<F5S97)V97,@8F%S960@;VX@8W5R<F5N
M=&QY#0H@("`@879A:6QA8FQE(&EN9F]R;6%T:6]N+"!W:&EC:"!I;B!S;VUE
M(&-A<V5S(&UA>2!B92!L:6UI=&5D+"!A;F0@8VAA;F=E<R!T;R!T:&4@<F5S
M97)V97,@;6%Y(&)E#0H@("`@<F5Q=6ER960@:6X@=&AE(&9U='5R92!A<R!A
M9&1I=&EO;F%L(&EN9F]R;6%T:6]N(&)E8V]M97,@879A:6QA8FQE+@T*("`@
M(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY-=6QT:7!L92!P<F]D=6-T
M<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS('-U8G-I9&EA<FEE<R!A<F4@<W5B
M:F5C="!T;R!N=6UE<F]U<R!P<F]D=6-T(&QI86)I;&ET>2!C;&%I;7,-"B`@
M("!A;F0@;&%W<W5I=',N(%1H97)E(&%R92!A('-I9VYI9FEC86YT(&YU;6)E
M<B!O9B!C;&%I;6%N=',@=VAO(&AA=F4@<&5N9&EN9R!L87=S=6ET<R!O<B!C
M;&%I;7,-"B`@("!R96=A<F1I;F<@:6YJ=7)I97,@86QL96=E9&QY(&1U92!T
M;R!/4E1(3R!%5E)!)B,Q-S0[+"!225-015)$04PF(S$W-#LL($Q%5D%154E.
M)B,Q-S0[+"!$55)!1T5324,F(S$W-#LO9F5N=&%N>6P-"B`@("!P871C:&5S
M+"!P96QV:6,@;65S:&5S+"!T:&4@0TA!4DE4)B,R,#$[)B,X-#@R.R!!<G1I
M9FEC:6%L($1I<V,L($-94$A%4B8C,3<T.R!3=&5N="P@86YD($%34B8C.#0X
M,CL@2&EP+B!4:&5S92!C;&%I;6%N=',-"B`@("!S965K('-U8G-T86YT:6%L
M(&-O;7!E;G-A=&]R>2!A;F0L('=H97)E(&%V86EL86)L92P@<'5N:71I=F4@
M9&%M86=E<RX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@
M075G=7-T)B,Q-C`[,C`Q,"P@1&50=7D@3W)T:&]P865D:6-S+"!);F,N("A$
M95!U>2D@86YN;W5N8V5D(&$@=V]R;&1W:61E('9O;'5N=&%R>2!R96-A;&P@
M;V8@:71S($%34B8C.#0X,CL-"B`@("!83"!!8V5T86)U;&%R(%-Y<W1E;2!A
M;F0@1&50=7D@05-2)B,X-#@R.R!(:7`@4F5S=7)F86-I;F<@4WES=&5M('5S
M960@:6X@:&EP(')E<&QA8V5M96YT('-U<F=E<GDN($-L86EM<PT*("`@(&9O
M<B!P97)S;VYA;"!I;FIU<GD@:&%V92!B965N(&UA9&4@86=A:6YS="!$95!U
M>2!A;F0@=&AE($-O;7!A;GDN(%1H92!#;VUP86YY(&AA<R!R96-E:79E9"!L
M:6UI=&5D#0H@("`@:6YF;W)M871I;VX@=&\@9&%T92!W:71H(')E<W!E8W0@
M=&\@<&]T96YT:6%L(&-L86EM<R!A;F0@;W1H97(@8V]S=',@87-S;V-I871E
M9"!W:71H('1H:7,@<F5C86QL+@T*("`@(%1H92!#;VUP86YY)B,X,C$W.W,@
M<')O9'5C="!L:6%B:6QI='D@<F5S97)V92!H87,@8F5E;B!I;F-R96%S960@
M:6X@<&%R="!D=64@=&\@86X@:6YC<F5A<V4@:6X-"B`@("!A;G1I8VEP871E
M9"!P<F]D=6-T(&QI86)I;&ET>2!L:71I9V%T:6]N(&5X<&5N<V4@86YD(&-O
M<W1S(&%S<V]C:6%T960@=VET:"!T:&4@1&50=7D@05-2)B,X-#@R.R!(:7`-
M"B`@("!R96-A;&P@<')O9W)A;2X@0VAA;F=E<R!T;R!T:&4@<F5S97)V92!M
M87D@8F4@<F5Q=6ER960@:6X@=&AE(&9U='5R92!A<R!A9&1I=&EO;F%L(&EN
M9F]R;6%T:6]N#0H@("`@8F5C;VUE<R!A=F%I;&%B;&4N(%1H92!U;'1I;6%T
M92!R97-O;'5T:6]N(&]F('1H97-E(&UA='1E<G,@:7,@;F]T#0H@("`@97AP
M96-T960@=&\@:&%V92!A(&UA=&5R:6%L(&%D=F5R<V4@969F96-T(&]N('1H
M92!#;VUP86YY)B,X,C$W.W,-"B`@("!F:6YA;F-I86P@<&]S:71I;VXL(&%L
M=&AO=6=H("!T:&4@<F5S;VQU=&EO;B!I;B!A;GD@<F5P;W)T:6YG('!E<FEO
M9`T*("`@(&-O=6QD(&AA=F4@82!M871E<FEA;"!I;7!A8W0@;VX@=&AE($-O
M;7!A;GDF(S@R,3<[<R!R97-U;'1S(&]F#0H@("`@;W!E<F%T:6]N<R!A;F0@
M8V%S:"!F;&]W<R!F;W(@=&AA="!P97)I;V0N#0H@("`@/"]D:78^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M
M87)G:6XM=&]P.B`Q,G!T)SX\=3X\8CY)3E1%3$Q%0U1504P@4%)/4$525%D\
M+V(^/"]U/@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY#97)T
M86EN(&]F('1H92!#;VUP86YY)B,X,C$W.W,@<W5B<VED:6%R:65S(&%R92!S
M=6)J96-T+"!F<F]M('1I;64@=&\@=&EM92P@=&\@;&5G86P@<')O8V5E9&EN
M9W,@86YD#0H@("`@8VQA:6US(')E;&%T960@=&\@<&%T96YT+"!T<F%D96UA
M<FL@86YD(&]T:&5R(&EN=&5L;&5C='5A;"!P<F]P97)T>2!M871T97)S(&%R
M:7-I;F<@;W5T(&]F('1H96ER#0H@("`@8G5S:6YE<W,N(%1H92!M;W-T('-I
M9VYI9FEC86YT(&]F('1H97-E(&UA='1E<G,@87)E(&1E<V-R:6)E9"!B96QO
M=RX-"B`@("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@
M+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM
M/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UV87)I86YT.B!S;6%L;"UC87!S)SX\=3Y0051%
M3E0@24Y&4DE.1T5-14Y4/"]U/CPO9F]N=#X-"B`@("`\+V1I=CX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA
M<F=I;BUT;W`Z(#9P="<^0V5R=&%I;B!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS
M('-U8G-I9&EA<FEE<R!A<F4@:6YV;VQV960@:6X@;&%W<W5I=',@8VAA;&QE
M;F=I;F<@=&AE(&-O=F5R86=E(&%N9"]O<@T*("`@('9A;&ED:71Y(&]F('1H
M92!P871E;G1S(&]N('1H96ER('!R;V1U8W1S+B!!;'1H;W5G:"!T:&4@0V]M
M<&%N>28C.#(Q-SMS('-U8G-I9&EA<FEE<R!B96QI979E('1H870@=&AE>0T*
M("`@(&AA=F4@<W5B<W1A;G1I86P@9&5F96YS97,@=&\@=&AE<V4@8VAA;&QE
M;F=E<R!W:71H(')E<W!E8W0@=&\@86QL(&UA=&5R:6%L('!A=&5N=',L('1H
M97)E(&-A;B!B92!N;PT*("`@(&%S<W5R86YC92!A<R!T;R!T:&4@;W5T8V]M
M92!O9B!T:&5S92!M871T97)S+"!A;F0@82!L;W-S(&EN(&%N>2!O9B!T:&5S
M92!C87-E<R!C;W5L9"!P;W1E;G1I86QL>0T*("`@(&%D=F5R<V5L>2!A9F9E
M8W0@=&AE(&%B:6QI='D@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!S=6)S:61I
M87)I97,@=&\@<V5L;"!T:&5I<B!P<F]D=6-T<RP@;W(@<F5Q=6ER92!T:&4-
M"B`@("!P87EM96YT(&]F('!A<W0@9&%M86=E<R!A;F0@9G5T=7)E(')O>6%L
M=&EE<RX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^345$24-!
M3"!$159)0T53("8C,#,X.R!$24%'3D]35$E#4PT*("`@(#PO9&EV/@T*("`@
M(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M;6%R9VEN+71O<#H@-G!T)SY);B!/8W1O8F5R)B,Q-C`[,C`P-"P@5'EC;R!(
M96%L=&AC87)E($=R;W5P+"!,4"P@*%1Y8V\I(&%N9"!5+E,N(%-U<F=I8V%L
M($-O<G!O<F%T:6]N(&9I;&5D(&$@;&%W<W5I=`T*("`@(&%G86EN<W0@171H
M:6-O;B!%;F1O+5-U<F=E<GDL($EN8RX@*$5%4RDF(S$V,#MI;B!T:&4@56YI
M=&5D(%-T871E<R!$:7-T<FEC="!#;W5R="!F;W(@=&AE($1I<W1R:6-T(&]F
M#0H@("`@0V]N;F5C=&EC=70@86QL96=I;F<@=&AA="!S979E<F%L(&9E871U
M<F5S(&]F($5%4R8C.#(Q-SMS($A!4DU/3DE#)B,Q-S0[('-C86QP96P@:6YF
M<FEN9V5D(&9O=7(-"B`@("!4>6-O('!A=&5N=',N($EN($]C=&]B97(F(S$V
M,#LR,#`W+"!O;B!M;W1I;VYS(&9O<B!S=6UM87)Y(&IU9&=M96YT('!R:6]R
M('1O('1H92!I;FET:6%L('1R:6%L+"!A(&YU;6)E<@T*("`@(&]F(&-L86EM
M<R!W97)E(&9O=6YD(&EN=F%L:60@86YD(&$@;G5M8F5R('=E<F4@9F]U;F0@
M:6YF<FEN9V5D+B!(;W=E=F5R+"!N;R!C;&%I;2!W87,@9F]U;F0@8F]T:`T*
M("`@('9A;&ED(&%N9"!I;F9R:6YG960N(%1R:6%L(&-O;6UE;F-E9"!I;B!$
M96-E;6)E<B8C,38P.S(P,#<L(&%N9"!T:&4@8V]U<G0@9&ES;6ES<V5D('1H
M92!C87-E('=I=&AO=70-"B`@("!P<F5J=61I8V4@;VX@9W)O=6YD<R!T:&%T
M(%1Y8V\@9&ED(&YO="!O=VX@=&AE('!A=&5N=',@:6X@<W5I="X@5&AE(&1I
M<VUI<W-A;"!W:71H;W5T('!R96IU9&EC92!W87,-"B`@("!A9F9I<FUE9"!O
M;B!A<'!E86PN($EN($IA;G5A<GDF(S$V,#LR,#$P+"!4>6-O(&9I;&5D(&%N
M;W1H97(@8V]M<&QA:6YT(&EN('1H92!5;FET960@4W1A=&5S($1I<W1R:6-T
M#0H@("`@0V]U<G0@9F]R('1H92!$:7-T<FEC="!O9B!#;VYN96-T:6-U="!A
M<W-E<G1I;F<@:6YF<FEN9V5M96YT(&]F('1H<F5E(&]F('1H92!F;W5R('!A
M=&5N=',@9G)O;2!T:&4-"B`@("!P<F5V:6]U<R!L87=S=6ET(&%N9"!A9&1I
M;F<@;F5W('!R;V1U8W1S+B!4>6-O(&ES('-E96MI;F<@;6]N971A<GD@9&%M
M86=E<R!A;F0@:6YJ=6YC=&EV92!R96QI968N#0H@("`@5&AI<R!C87-E(&ES
M('-C:&5D=6QE9"!T;R!B92!T<FEE9"!I;B!/8W1O8F5R)B,Q-C`[,C`Q,2X-
M"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^4W1A<G1I;F<@:6X@
M36%R8V@F(S$V,#LR,#`V+"!#;W)D:7,@0V]R<&]R871I;VX@*$-O<F1I<RD@
M9FEL960@<&%T96YT(&EN9G)I;F=E;65N="!L87=S=6ET<R!I;B!T:&4-"B`@
M("!5;FET960@4W1A=&5S($1I<W1R:6-T($-O=7)T<R!F;W(@=&AE($1I<W1R
M:6-T<R!O9B!.97<@2F5R<V5Y(&%N9"!$96QA=V%R92P@86=A:6YS="!'=6ED
M86YT#0H@("`@0V]R<&]R871I;VX@*$=U:61A;G0I+"!!8F)O='0@3&%B;W)A
M=&]R:65S+"!);F,N("A!8F)O='0I+"!";W-T;VX@4V-I96YT:69I8R!#;W)P
M;W)A=&EO;B`H0F]S=&]N#0H@("`@4V-I96YT:69I8RD@86YD($UE9'1R;VYI
M8R!!=F4L($EN8RX@*$UE9'1R;VYI8RD@86QL96=I;F<@=&AA="!T:&4@6&EE
M;F-E(%8F(S@T.#([("A!8F)O='0I+"!0<F]M=7,F(S@T.#([#0H@("`@*$)O
M<W1O;B!38VEE;G1I9FEC*2!A;F0@16YD96%V;W(F(S$W-#L@*$UE9'1R;VYI
M8RD@9')U9R!E;'5T:6YG('-T96YT<R!I;F9R:6YG92!S979E<F%L(&]F($-O
M<F1I<R8C.#(Q-SMS#0H@("`@5W)I9VAT+T9A;&]T:6-O('!A=&5N=',N($-O
M<F1I<R!I<R!S965K:6YG(&UO;F5T87)Y(')E;&EE9BX@26X@2F%N=6%R>28C
M,38P.S(P,3`L(&EN(&]N92!O9B!T:&4@8V%S97,-"B`@("!A9V%I;G-T($)O
M<W1O;B!38VEE;G1I9FEC+"!T:&4@56YI=&5D(%-T871E<R!$:7-T<FEC="!#
M;W5R="!F;W(@=&AE($1I<W1R:6-T(&]F($1E;&%W87)E(&9O=6YD('1H90T*
M("`@(%=R:6=H="]&86QO=&EC;R!P871E;G1S(&EN=F%L:60@9F]R(&QA8VL@
M;V8@=W)I='1E;B!D97-C<FEP=&EO;B!A;F0O;W(@;&%C:R!O9B!E;F%B;&5M
M96YT+B!);B!*=6YE#0H@("`@,C`Q,2P@=&AE($-O=7)T(&]F($%P<&5A;',@
M9F]R('1H92!&961E<F%L($-I<F-U:70@869F:7)M960@=&AE(')U;&EN9RP@
M86YD($-O<F1I<R!M;W9E9"!F;W(@=&AE#0H@("`@0V]U<G0@=&\@<F5C;VYS
M:61E<B!T:&%T(&1E8VES:6]N+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O
M<#H@-G!T)SY);B!/8W1O8F5R)B,Q-C`[,C`P-RP@0G)U8V4@4V%F9G)A;B`H
M4V%F9G)A;BD@9FEL960@82!P871E;G0@:6YF<FEN9V5M96YT(&QA=W-U:70@
M86=A:6YS="!T:&4@0V]M<&%N>0T*("`@(&%N9"!#;W)D:7,@:6X@=&AE(%5N
M:71E9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H92!%87-T97)N($1I
M<W1R:6-T(&]F(%1E>&%S(&%L;&5G:6YG#0H@("`@:6YF<FEN9V5M96YT(&]N
M(%4N4RX@4&%T96YT($YO+B8C,38P.S4L-C4S+#<V,"X@26X@2F%N=6%R>28C
M,38P.S(P,3$L(&$@:G5R>2!R971U<FYE9"!A('9E<F1I8W0@9FEN9&EN9R!T
M:&%T#0H@("`@0V]R9&ES)B,X,C$W.W,@<V%L97,@;V8@:71S($-94$A%4B8C
M,3<T.R!S=&5N="!W:6QL9G5L;'D@:6YF<FEN9V5D(&$@<&%T96YT(&ES<W5E
M9"!T;R!3869F<F%N+B!4:&4@:G5R>0T*("`@(&%W87)D960@4V%F9G)A;B`F
M;F)S<#LD-#@R)B,Q-C`[;6EL;&EO;BX@26X@36%R8V@F(S$V,#LR,#$Q+"!T
M:&4@0V]U<G0@96YT97)E9"!J=61G;65N="!A9V%I;G-T($-O<F1I<R!I;B!T
M:&4-"B`@("!A;6]U;G0@;V8@)FYB<W`[)#4Y,R8C,38P.VUI;&QI;VXL(')E
M<')E<V5N=&EN9R!T:&4@:G5R>2!V97)D:6-T+"!P;'5S("9N8G-P.R0Q,3$F
M(S$V,#MM:6QL:6]N(&EN('!R92UJ=61G;65N=`T*("`@(&EN=&5R97-T+@T*
M("`@($-O<F1I<R!H87,@;6]V960@9F]R('1H92!$:7-T<FEC="!#;W5R="!T
M;R!O=F5R='5R;B!T:&4@:G5R>2!V97)D:6-T(&%N9"!T;R!V86-A=&4@=&AE
M(&IU9&=M96YT+@T*("`@($EF('1H870@;6]T:6]N(&ES(&1E;FEE9"P@0V]R
M9&ES('=I;&P@87!P96%L('1H92!J=61G;65N="X@0F5C875S92!T:&4@0V]M
M<&%N>2!B96QI979E<R!T:&%T('1H90T*("`@('!O=&5N=&EA;"!F;W(@86X@
M=6YF879O<F%B;&4@;W5T8V]M92!I<R!N;W0@<')O8F%B;&4L(&ET(&AA<R!N
M;W0@97-T86)L:7-H960@82!R97-E<G9E('=I=&@@<F5S<&5C=`T*("`@('1O
M('1H92!C87-E+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY)
M;B!.;W9E;6)E<B8C,38P.S(P,#<L(%)O8VAE($1I86=N;W-T:6-S($]P97)A
M=&EO;G,L($EN8RXL(&5T(&%L+B`H4F]C:&4I(&9I;&5D(&$@<&%T96YT(&EN
M9G)I;F=E;65N=`T*("`@(&QA=W-U:70@86=A:6YS="!,:69E4V-A;BP@26YC
M+B`H3&EF95-C86XI(&EN('1H92!5;FET960@4W1A=&5S($1I<W1R:6-T($-O
M=7)T(&9O<B!T:&4@1&ES=')I8W0@;V8-"B`@("!$96QA=V%R92P@86-C=7-I
M;F<@3&EF95-C86XF(S@R,3<[<R!E;G1I<F4@3VYE5&]U8V@F(S$W-#L@;&EN
M92!O9B!B;&]O9"!G;'5C;W-E(&UO;FET;W)I;F<@<WES=&5M<R!O9@T*("`@
M(&EN9G)I;F=E;65N="!O9B!T=V\@<&%T96YT<R!R96QA=&5D('1O('1H92!U
M<V4@;V8@;6EC<F]E;&5C=')O9&4@<V5N<V]R<RX@26X@4V5P=&5M8F5R)B,Q
M-C`[,C`P.2P-"B`@("!,:69E4V-A;B!O8G1A:6YE9"!A(&9A=F]R86)L92!R
M=6QI;F<@;VX@8VQA:6T@8V]N<W1R=6-T:6]N('1H870@<')E8VQU9&5D(&$@
M9FEN9&EN9R!O9@T*("`@(&EN9G)I;F=E;65N="X@5&AE($-O=7)T(&5N=&5R
M960@:G5D9VUE;G0@86=A:6YS="!2;V-H92!I;B!*=6QY)B,Q-C`[,C`Q,"!A
M;F0@4F]C:&4@87!P96%L960N($)R:65F:6YG#0H@("`@;VX@87!P96%L(&ES
M<W5E<R!H87,@8F5E;B!C;VUP;&5T960N($]R86P@87)G=6UE;G0@=VEL;"!B
M92!H96QD(&EN#0H@("`@9F%L;"`R,#$Q+B!2;V-H92!I<R!S965K:6YG#0H@
M("`@;6]N971A<GD@9&%M86=E<R!A;F0@:6YJ=6YC=&EV92!R96QI968N#0H@
M("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E-T87)T:6YG(&EN($9E
M8G)U87)Y)B,Q-C`[,C`P."P@0V]R9&ES(&9I;&5D('!A=&5N="!I;F9R:6YG
M96UE;G0@;&%W<W5I=',@:6X@=&AE(%5N:71E9"!3=&%T97,@1&ES=')I8W0-
M"B`@("!#;W5R="!F;W(@=&AE($1I<W1R:6-T(&]F($YE=R!*97)S97D@86=A
M:6YS="!'=6ED86YT+"!!8F)O='0L($)O<W1O;B!38VEE;G1I9FEC(&%N9"!-
M961T<F]N:6,-"B`@("!A;&QE9VEN9R!T:&%T('1H92!8:65N8V4@5B8C.#0X
M,CL@*$%B8F]T="DL(%!R;VUU<R8C.#0X,CL@*$)O<W1O;B!38VEE;G1I9FEC
M*2!A;F0@16YD96%V;W(F(S$W-#L@*$UE9'1R;VYI8RD@9')U9PT*("`@(&5L
M=71I;F<@<W1E;G1S(&EN9G)I;F=E('-E=F5R86P@;V8@5WEE=&@F(S@R,3<[
M<R`H;F]W(%!F:7IE<B!);F,N*2!-;W)R:7,@<&%T96YT<RP@=VAI8V@@:&%V
M92!B965N#0H@("`@;&EC96YS960@=&\@0V]R9&ES+B!#;W)D:7,@:7,@<V5E
M:VEN9R!M;VYE=&%R>2!R96QI968N(%1R:6%L(&ES('-C:&5D=6QE9"!F;W(@
M4V5P=&5M8F5R)B,Q-C`[,C`Q,2X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT
M;W`Z(#9P="<^26X@2G5N928C,38P.S(P,#DL(%)E;6)R86YD="!6:7-I;VX@
M5&5C:&YO;&]G:65S+"!,+E`N("A296UB<F%N9'0I(&9I;&5D(&$@<&%T96YT
M(&EN9G)I;F=E;65N="!L87=S=6ET#0H@("`@86=A:6YS="!*;VAN<V]N("8C
M,#,X.R!*;VAN<V]N(%9I<VEO;B!#87)E+"!);F,N("A*2E9#*28C,38P.VEN
M('1H92!5;FET960@4W1A=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T:&4-"B`@
M("!%87-T97)N($1I<W1R:6-T(&]F(%1E>&%S(&%L;&5G:6YG('1H870@2DI6
M0R8C.#(Q-SMS(&UA;G5F86-T=7)E(&%N9"!S86QE(&]F(&ET<R!!0U56544@
M041604Y#128C,3<T.R!A;F0-"B`@("!!0U56544F(S$W-#L@3T%365,F(S@T
M.#([($A91%)/1T5,(&-O;G1A8W0@;&5N<V5S(&EN9G)I;F=E('1H96ER(%4N
M4RX@4&%T96YT($YO+B8C,38P.S4L-S$R+#,R-R`H=&AE($-H86YG('!A=&5N
M="DN#0H@("`@4F5M8G)A;F1T(&ES('-E96MI;F<@;6]N971A<GD@<F5L:65F
M+B!4:&4@8V%S92!I<R!S8VAE9'5L960@9F]R('1R:6%L(&EN($UA>28C,38P
M.S(P,3(N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY02$%2
M34%#155424-!3`T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY)
M;@T*("`@($%P<FEL)B,Q-C`[,C`P-RP@0V5N=&]C;W(L($EN8RX@*$-E;G1O
M8V]R*2`H;F]W($IA;G-S96X@0FEO=&5C:"P@26YC+B`H2D))*2D@9FEL960@
M82!P871E;G0@:6YF<FEN9V5M96YT(&QA=W-U:70@86=A:6YS="!!8F)O='0@
M3&%B;W)A=&]R:65S+`T*("`@($EN8RX@*$%B8F]T="D@:6X@=&AE(%5N:71E
M9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H92!%87-T97)N($1I<W1R
M:6-T(&]F(%1E>&%S(&%L;&5G:6YG('1H870-"B`@("!!8F)O='0F(S@R,3<[
M<R!(54U)4D$F(S$W-#L@86YT:2U43D8@86QP:&$@<')O9'5C="!I;F9R:6YG
M97,@0V5N=&]C;W(F(S@R,3<[<R!5+E,N(%!A=&5N="`W+#`W,"PW-S4N($EN
M($IU;F4F(S$V,#LR,#`Y+`T*("`@(&$@:G5R>2!R971U<FYE9"!A('9E<F1I
M8W0@9FEN9&EN9R!T:&4@<&%T96YT('9A;&ED(&%N9"!I;F9R:6YG960L(&%N
M9"!A=V%R9&5D($I"22!D86UA9V5S(&]F#0H@("`@87!P<F]X:6UA=&5L>2`F
M;F)S<#LD,2XW)B,Q-C`[8FEL;&EO;BX@26X@1F5B<G5A<GDF(S$V,#LR,#$Q
M+"!T:&4@0V]U<G0@;V8@07!P96%L<R!R979E<G-E9"!T:&4@2G5N928C,38P
M.S(P,#D@9&5C:7-I;VX-"B`@("!A;F0@=&AE(&IU9&=M96YT(&]F('1H92!$
M:7-T<FEC="!#;W5R="X@2D))('=I;&P@9FEL92!A('!E=&ET:6]N(&9O<@T*
M("`@(')E=FEE=R!O9B!T:&4@9&5C:7-I;VX@:6X@=&AE(%5N:71E9`T*("`@
M(%-T871E<R!3=7!R96UE($-O=7)T+@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@-G!T)SY);B!-87DF(S$V,#LR,#`Y+"!!8F)O='0@0FEO=&5C:&YO
M;&]G>2!,=&0N("A!8F)O='0I(&9I;&5D(&$@<&%T96YT(&EN9G)I;F=E;65N
M="!L87=S=6ET(&%G86EN<W0-"B`@("!#96YT;V-O<B`H;F]W($I"22D@:6X@
M=&AE(%5N:71E9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R#0H@("`@=&AE
M($1I<W1R:6-T(&]F($UA<W-A8VAU<V5T=',@86QL96=I;F<@=&AA="!324U0
M3TY))B,Q-S0[(&EN9G)I;F=E<R!!8F)O='0F(S@R,3<[<R!5+E,N(%!A=&5N
M="!.;W,N(#<L,C(S+#,Y-`T*("`@(&%N9"`W+#0U,2PP,S$@*'1H92!386QF
M96QD('!A=&5N=',I+B!!8F)O='0@:7,@<V5E:VEN9R!M;VYE=&%R>2!D86UA
M9V5S(&%N9"!I;FIU;F-T:79E(')E;&EE9BX@3F\-"B`@("!T<FEA;"!D871E
M(&AA<R!B965N('-E="X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P
M="<^26X@075G=7-T)B,Q-C`[,C`P.2P@06)B;W1T($=M8D@@)B,P,S@[($-O
M+B`H06)B;W1T($=M8D@I(&%N9"!!8F)O='0@0FEO<F5S96%R8V@@0V5N=&5R
M(&9I;&5D(&$@<&%T96YT#0H@("`@:6YF<FEN9V5M96YT(&QA=W-U:70@86=A
M:6YS="!#96YT;V-O<B`H;F]W($I"22D@:6X@=&AE(%5N:71E9"!3=&%T97,@
M1&ES=')I8W0@0V]U<G0@9F]R('1H90T*("`@($1I<W1R:6-T(&]F($UA<W-A
M8VAU<V5T=',@86QL96=I;F<@=&AA="!35$5,05)!)B,Q-S0[(&EN9G)I;F=E
M<R!T=V\@56YI=&5D(%-T871E<R!P871E;G1S(&%S<VEG;F5D('1O#0H@("`@
M06)B;W1T($=M8D@N($I"22!F:6QE9"!A(&-O;7!L86EN="!I;B!T:&4@56YI
M=&5D(%-T871E<R!$:7-T<FEC="!#;W5R="!F;W(@=&AE($1I<W1R:6-T(&]F
M($-O;'5M8FEA#0H@("`@9F]R(&$@9&5C;&%R871O<GD@:G5D9VUE;G0@;V8@
M;F]N+6EN9G)I;F=E;65N="!A;F0@:6YV86QI9&ET>2!O9B!T:&4@06)B;W1T
M($=M8D@@<&%T96YT<RP@87,@=V5L;`T*("`@(&%S(&$@0V]M<&QA:6YT(&9O
M<B!2979I97<@;V8@82!0871E;G0@26YT97)F97)E;F-E($1E8VES:6]N('1H
M870@9W)A;G1E9"!P<FEO<FET>2!O9B!I;G9E;G1I;VX@;VX-"B`@("!O;F4@
M;V8@=&AE('1W;R!A<W-E<G1E9"!P871E;G1S('1O($%B8F]T="!';6)(+B!4
M:&4-"B`@("!C87-E<R!H879E(&)E96X@=')A;G-F97)R960@9G)O;2!T:&4@
M1&ES=')I8W0-"B`@("!O9B!#;VQU;6)I82!T;R!T:&4@1&ES=')I8W0@;V8@
M36%S<V%C:'5S971T<RX@1&ES8V]V97)Y(&EN('1H97-E(&-A<V5S(&ES(&]N
M9V]I;F<N($YO('1R:6%L(&1A=&4-"B`@("!H87,@8F5E;B!S970N($%L<V\@
M:6X@075G=7-T)B,Q-C`[,C`P.2P@06)B;W1T($=M8D@@86YD($%B8F]T="!,
M86)O<F%T;W)I97,@3&EM:71E9"!B<F]U9VAT(&$@<&%T96YT#0H@("`@:6YF
M<FEN9V5M96YT(&QA=W-U:70@:6X@5&AE($9E9&5R86P@0V]U<G0@;V8@0V%N
M861A(&%L;&5G:6YG('1H870@4U1%3$%2028C,3<T.R!I;F9R:6YG97,@06)B
M;W1T($=M8D@F(S@R,3<[<PT*("`@($-A;F%D:6%N('!A=&5N="X@5&AE($-A
M;F%D:6%N(&-A<V4@:7,@<V-H961U;&5D('1O(&)E('1R:65D(&EN($]C=&]B
M97(F(S$V,#LR,#$R+B!);B!E86-H(&]F('1H97-E#0H@("`@8V%S97,L($%B
M8F]T="!I<R!S965K:6YG(&UO;F5T87)Y(&1A;6%G97,@86YD(&EN:G5N8W1I
M=F4@<F5L:65F+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY)
M;B!!=6=U<W0F(S$V,#LR,#`Y+"!"87EE<B!(96%L=&A#87)E($Q,0R`H0F%Y
M97(I(&9I;&5D(&$@<&%T96YT(&EN9G)I;F=E;65N="!L87=S=6ET(&%G86EN
M<W0@0V5N=&]C;W(-"B`@("!/<G1H;R!":6]T96-H($EN8RX@*&YO=R!*0DDI
M(&EN(%5N:71E9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H92!$:7-T
M<FEC="!O9B!-87-S86-H=7-E='1S#0H@("`@86QL96=I;F<@=&AA="!T:&4@
M;6%N=69A8W1U<F4@86YD('-A;&4@8GD@2D))(&]F(%-)35!/3DDF(S$W-#L@
M:6YF<FEN9V5S(&$@0F%Y97(@<&%T96YT(')E;&%T:6YG('1O#0H@("`@:'5M
M86X@86YT:2U43D8@86YT:6)O9&EE<RX@26X@2F%N=6%R>28C,38P.S(P,3$L
M('1H92!C;W5R="!I<W-U960@:G5D9VUE;G0@9&ES;6ES<VEN9R!"87EE<B8C
M.#(Q-SMS#0H@("`@:6YF<FEN9V5M96YT(&-L86EM<RX@0F%Y97(@87!P96%L
M960@=&AI<R!R=6QI;F<N($EN(&%D9&ET:6]N+"!I;B!.;W9E;6)E<B8C,38P
M.S(P,#DL($)A>65R(&9I;&5D(&$-"B`@("!L87=S=6ET('5N9&5R(&ET<R!%
M=7)O<&5A;B!C;W5N=&5R<&%R="!T;R!T:&5S92!P871E;G1S(&EN($=E<FUA
M;GD@86YD('1H92!.971H97)L86YD<RX@5&AE(&-O=7)T#0H@("`@:6X@=&AE
M($YE=&AE<FQA;F1S(&AE;&0@=&AE($1U=&-H('!A=&5N="!I;G9A;&ED(&%N
M9"!E;G1E<F5D(&IU9&=M96YT(&EN(&9A=F]R(&]F($I"228C.#(Q-SMS($5U
M<F]P96%N#0H@("`@869F:6QI871E+"!*86YS<V5N($)I;VQO9VEC<R!"+E8N
M($)A>65R(&%P<&5A;&5D('1H870@:G5D9VUE;G0@:6X@=&AE($YE=&AE<FQA
M;F1S+B!);B!A9&1I=&EO;BP-"B`@("!I;B!-87)C:"8C,38P.S(P,3`L($IA
M;G-S96XM0VEL86<@3E8@9FEL960@82!R979O8V%T:6]N(&%C=&EO;B!I;B!T
M:&4@2&EG:"!#;W5R="!I;B!,;VYD;VX@<V5E:VEN9R!T;PT*("`@(&EN=F%L
M:61A=&4@0F%Y97(F(S@R,3<[<R!52R!P871E;G0@<F5L871I;F<@=&\@:'5M
M86X@86YT:2U43D8@86YT:6)O9&EE<RX@26X@36%Y)B,Q-C`[,C`Q,2P@2D))
M('-E='1L960@86QL#0H@("`@;V8@=&AE<V4@8V%S97,@86YD(')E8V5I=F5D
M(&$@<&%I9"UU<"P@<F]Y86QT>2UF<F5E(&QI8V5N<V4@=&\@=&AE(&9A;6EL
M>2!O9B!P871E;G1S(&EN('-U:70N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM
M=&]P.B`Q,G!T)SX\=3Y,251)1T%424].($%'04E.4U0@1DE,15)3($]&($%"
M0E)%5DE!5$5$($Y%5R!$4E5'($%04$Q)0T%424].4R`H04Y$07,I/"]U/@T*
M("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9F]L;&]W:6YG
M('-U;6UA<FEZ97,@;&%W<W5I=',@<&5N9&EN9R!A9V%I;G-T(&=E;F5R:6,@
M8V]M<&%N:65S('1H870@9FEL960@06)B<F5V:6%T960@3F5W($1R=6<-"B`@
M("!!<'!L:6-A=&EO;G,@*$%.1$%S*2!S965K:6YG('1O(&UA<FME="!G96YE
M<FEC(&9O<FUS(&]F('!R;V1U8W1S('-O;&0@8GD@=F%R:6]U<R!S=6)S:61I
M87)I97,@;V8-"B`@("!T:&4@0V]M<&%N>2!P<FEO<B!T;R!E>'!I<F%T:6]N
M(&]F('1H92!A<'!L:6-A8FQE('!A=&5N=',@8V]V97)I;F<@=&AO<V4@<')O
M9'5C=',N(%1H97-E($%.1$%S#0H@("`@='EP:6-A;&QY(&EN8VQU9&4@86QL
M96=A=&EO;G,@;V8@;F]N+6EN9G)I;F=E;65N="P@:6YV86QI9&ET>2!A;F0@
M=6YE;F9O<F-E86)I;&ET>2!O9B!T:&5S90T*("`@('!A=&5N=',N($EN('1H
M92!E=F5N="!T:&4@0V]M<&%N>28C.#(Q-SMS('-U8G-I9&EA<FEE<R!A<F4@
M;F]T('-U8V-E<W-F=6P@:6X@=&AE<V4@86-T:6]N<RP@;W(@=&AE#0H@("`@
M<W1A='5T;W)Y(#,P+6UO;G1H('-T87ES(&5X<&ER92!B969O<F4@=&AE($1I
M<W1R:6-T($-O=7)T(')U;&EN9W,@87)E(&]B=&%I;F5D+"!T:&4@=&AI<F0M
M<&%R='D-"B`@("!C;VUP86YI97,@:6YV;VQV960@=VEL;"!H879E('1H92!A
M8FEL:71Y+"!U<&]N(&%P<')O=F%L(&]F('1H92!5;FET960@4W1A=&5S($9O
M;V0@86YD($1R=6<-"B`@("!!9&UI;FES=')A=&EO;B`H1D1!*2P@=&\@:6YT
M<F]D=6-E(&=E;F5R:6,@=F5R<VEO;G,@;V8@=&AE('!R;V1U8W1S(&%T(&ES
M<W5E(')E<W5L=&EN9R!I;B!V97)Y#0H@("`@<W5B<W1A;G1I86P@;6%R:V5T
M('-H87)E(&%N9"!R979E;G5E(&QO<W-E<R!F;W(@=&AO<V4@<')O9'5C=',N
M#0H@("`@/"]D:78^#0H@("`@/"$M+2!&;VQI;R`M+3X-"B`@("`\(2TM("]&
M;VQI;R`M+3X-"B`@("`\+V1I=CX-"B`@("`\(2TM(%!!1T5"4D5!2R`M+3X-
M"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY#3TY#
M15)4028C,3<T.PT*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY)
M;B!*86YU87)Y)B,Q-C`[,C`Q,"P@04Q:02!#;W)P;W)A=&EO;B`H04Q:02DF
M(S$V,#MA;F0@3W)T:&\M36-.96EL+4IA;G-S96X@4&AA<FUA8V5U=&EC86QS
M+"!);F,N("A/34I022D-"B`@("`H;F]W($IA;G-S96X@4&AA<FUA8V5U=&EC
M86QS+"!);F,N("A*4$DI*2!F:6QE9"!A('!A=&5N="!I;F9R:6YG96UE;G0@
M;&%W<W5I="!I;B!T:&4@56YI=&5D(%-T871E<PT*("`@($1I<W1R:6-T($-O
M=7)T(&9O<B!T:&4@1&ES=')I8W0@;V8@1&5L87=A<F4@86=A:6YS="!+<F5M
M97)S+55R8F%N+"!,3$,@86YD($M51$-/($ER96QA;F0L($QT9"X-"B`@("`H
M8V]L;&5C=&EV96QY+"!+541#3RD@:6X@<F5S<&]N<V4@=&\@2U5$0T\F(S@R
M,3<[<R!!3D1!('-E96MI;F<@87!P<F]V86P@=&\@;6%R:V5T(&$@9V5N97)I
M8R!V97)S:6]N(&]F#0H@("`@0T].0T525$$F(S$W-#L@8F5F;W)E('1H92!E
M>'!I<F%T:6]N(&]F('1W;R!O9B!!3%I!(&%N9"!*4$DF(S@R,3<[<R!P871E
M;G1S(')E;&%T:6YG('1O($-/3D-%4E1!)B,Q-S0[+B!+541#3R!F:6QE9`T*
M("`@(&-O=6YT97)C;&%I;7,@86QL96=I;F<@;F]N+6EN9G)I;F=E;65N="!A
M;F0@:6YV86QI9&ET>2X@04Q:02!A;F0@2E!)('-U8G-E<75E;G1L>2!R96UO
M=F5D(&]N92!O9@T*("`@('1H92!P871E;G1S(&9R;VT@=&AE(&QA=W-U:70N
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN($YO=F5M8F5R
M)B,Q-C`[,C`Q,"P@04Q:02!A;F0@3TU*4$D@*&YO=R!*4$DI(&9I;&5D(&$@
M<&%T96YT(&EN9G)I;F=E;65N="!L87=S=6ET(&EN('1H92!5;FET960@4W1A
M=&5S#0H@("`@1&ES=')I8W0@0V]U<G0@9F]R('1H92!$:7-T<FEC="!O9B!$
M96QA=V%R92!A9V%I;G-T($EM<&%X($QA8F]R871O<FEE<RP@26YC+B`H26UP
M87@I+"!4979A#0H@("`@4&AA<FUA8V5U=&EC86QS(%5302P@26YC+BP@86YD
M(%1E=F$@4&AA<FUA8V5U=&EC86P@26YD=7-T<FEE<R!,=&0N("AC;VQL96-T
M:79E;'DL(%1E=F$I(&EN(')E<W!O;G-E#0H@("`@=&\@26UP87@@86YD(%1E
M=F$F(S@R,3<[<R!F:6QI;F<@;V8@82!M86IO<B!A;65N9&UE;G0@=&\@:71S
M($%.1$$@<V5E:VEN9R!A<'!R;W9A;"!T;R!M87)K970@82!G96YE<FEC#0H@
M("`@=F5R<VEO;B!O9B!#3TY#15)4028C,3<T.R!B969O<F4@=&AE(&5X<&ER
M871I;VX@;V8@04Q:02!A;F0@2E!))B,X,C$W.W,@<&%T96YT(')E;&%T:6YG
M('1O($-/3D-%4E1!)B,Q-S0[+B!);7!A>`T*("`@(&%N9"!4979A(&9I;&5D
M(&-O=6YT97)C;&%I;7,@86QL96=I;F<@;F]N+6EN9G)I;F=E;65N="!A;F0@
M:6YV86QI9&ET>2X@26X@36%Y)B,Q-C`[,C`Q,2P@06QZ82!A;F0@2E!)#0H@
M("`@9FEL960@82!S96-O;F0@;&%W<W5I="!A9V%I;G-T(%1E=F$@:6X@<F5S
M<&]N<V4@=&\@5&5V828C.#(Q-SMS(&9I;&EN9R!O9B!A('-E8V]N9"!M86IO
M<B!A;65N9&UE;G0@=&\@:71S#0H@("`@04Y$02!S965K:6YG(&%P<')O=F%L
M('1O(&UA<FME="!A9&1I=&EO;F%L(&1O<V%G92!S=')E;F=T:',@;V8@:71S
M(&=E;F5R:6,@0T].0T525$$F(S$W-#L@<')O9'5C="!B969O<F4-"B`@("!T
M:&4@97AP:7)A=&EO;B!O9B!!;'IA(&%N9"!*4$DF(S@R,3<[<R!P871E;G0@
M<F5L871I;F<@=&\@0T].0T525$$F(S$W-#LN($EN(&5A8V@@;V8@=&AE(&%B
M;W9E(&-A<V5S+"!!3%I!(&%N9`T*("`@($I022!A<F4@<V5E:VEN9R!A;B!/
M<F1E<B!E;FIO:6YI;F<@=&AE(&1E9F5N9&%N=',@9G)O;2!M87)K971I;F<@
M:71S(&=E;F5R:6,@=F5R<VEO;B!O9B!#3TY#15)4028C,3<T.PT*("`@('!R
M:6]R('1O('1H92!E>'!I<F%T:6]N(&]F($%,6D$@86YD($I0228C.#(Q-SMS
M($-/3D-%4E1!)B,Q-S0[('!A=&5N="X-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#$R<'0G/D]25$A/(%1222U#64Q%3B8C,3<T.TQ/#0H@("`@/"]D
M:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN($]C=&]B97(F(S$V,#LR,#`X
M+"!/34I022`H;F]W($I022D@86YD($IO:&YS;VX@)B,P,S@[($IO:&YS;VX@
M4&AA<FUA8V5U=&EC86P@4F5S96%R8V@@)B,P,S@[($1E=F5L;W!M96YT+`T*
M("`@($PN3"Y#+B`H2DI04D0I)B,Q-C`[9FEL960@82!P871E;G0@:6YF<FEN
M9V5M96YT(&QA=W-U:70@86=A:6YS="!7871S;VX@3&%B;W)A=&]R:65S+"!)
M;F,N(&%N9"!7871S;VX-"B`@("!0:&%R;6%C975T:6-A;',L($EN8RX@*&-O
M;&QE8W1I=F5L>2P@5V%T<V]N*2!I;B!T:&4@56YI=&5D(%-T871E<R!$:7-T
M<FEC="!#;W5R="!F;W(@=&AE($1I<W1R:6-T#0H@("`@;V8@3F5W($IE<G-E
M>2!I;B!R97-P;VYS92!T;R!7871S;VXF(S@R,3<[<R!!3D1!('-E96MI;F<@
M87!P<F]V86P@=&\@;6%R:V5T(&$@9V5N97)I8R!V97)S:6]N(&]F($I0228C
M.#(Q-SMS#0H@("`@<')O9'5C="!P<FEO<B!T;R!T:&4@97AP:7)A=&EO;B!O
M9B!*4$DF(S@R,3<[<R!P871E;G0@<F5L871I;F<@=&\@3U)42$\@5%))+4-9
M0TQ%3B8C,3<T.R!,3R`H=&AE($]40TQ/#0H@("`@<&%T96YT*2X@5V%T<V]N
M(&9I;&5D(&$@8V]U;G1E<F-L86EM(&%L;&5G:6YG(&EN=F%L:61I='D@;V8@
M=&AE('!A=&5N="X@26X@861D:71I;VXL(&EN($IA;G5A<GD-"B`@("`R,#$P
M+"!*4$D@9FEL960@82!P871E;G0@:6YF<FEN9V5M96YT(&QA=W-U:70@86=A
M:6YS="!,=7!I;B!,=&0N(&%N9"!,=7!I;B!0:&%R;6%C975T:6-A;',L($EN
M8RX-"B`@("`H8V]L;&5C=&EV96QY+"!,=7!I;BD@:6X@=&AE(%5N:71E9"!3
M=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H92!$:7-T<FEC="!O9B!.97<@
M2F5R<V5Y(&EN#0H@("`@<F5S<&]N<V4@=&\@3'5P:6XF(S@R,3<[<R!!3D1!
M('-E96MI;F<@87!P<F]V86P@=&\@;6%R:V5T(&$@9V5N97)I8R!V97)S:6]N
M(&]F($]25$A/(%1222U#64-,14XF(S$W-#L@3$\@<')I;W(-"B`@("!T;R!T
M:&4@97AP:7)A=&EO;B!O9B!T:&4@3U1#3$\@<&%T96YT+B!,=7!I;B!F:6QE
M9"!A(&-O=6YT97)C;&%I;2!A;&QE9VEN9R!I;G9A;&ED:71Y(&]F('1H90T*
M("`@('!A=&5N="X@5&AE($QU<&EN(&%N9"!7871S;VX@8V%S97,@:&%V92!B
M965N(&-O;G-O;&ED871E9"X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#9P="<^26X@3F]V96UB97(F(S$V,#LR,#$P+"!/34I022`H;F]W($I022D@
M9FEL960@82!P871E;G0@:6YF<FEN9V5M96YT(&QA=W-U:70@86=A:6YS="!-
M>6QA;B!);F,N(&%N9"!->6QA;@T*("`@(%!H87)M86-E=71I8V%L<RP@26YC
M+B`H8V]L;&5C=&EV96QY+"!->6QA;BDL(&%N9"!&86UY($-A<F4L($QT9"X@
M*$9A;7D@0V%R92D@:6X@=&AE(%5N:71E9"!3=&%T97,-"B`@("!$:7-T<FEC
M="!#;W5R="!F;W(@=&AE($1I<W1R:6-T(&]F($YE=R!*97)S97D@:6X@<F5S
M<&]N<V4@=&\@1F%M>2!#87)E)B,X,C$W.W,@04Y$02!S965K:6YG(&%P<')O
M=F%L('1O#0H@("`@;6%R:V5T(&$@9V5N97)I8R!V97)S:6]N(&]F($]25$A/
M(%1222U#64-,14XF(S$W-#L@3$\@<')I;W(@=&\@=&AE(&5X<&ER871I;VX@
M;V8@=&AE($]40TQ/('!A=&5N="X-"B`@("!->6QA;B!A;F0@1F%M>2!#87)E
M(&9I;&5D(&-O=6YT97)C;&%I;7,@86QL96=I;F<-"B`@("!I;G9A;&ED:71Y
M(&]F('1H92!P871E;G0N($EN(&5A8V@@;V8@=&AE(&%B;W9E#0H@("`@8V%S
M97,L($I*4%)$(&%N9"]O<B!*4$D@87)E('-E96MI;F<@86X@3W)D97(@96YJ
M;VEN:6YG('1H92!D969E;F1A;G1S(&9R;VT@;6%R:V5T:6YG('1H96ER(&=E
M;F5R:6,-"B`@("!V97)S:6]N<R!O9B!/4E1(3R!44DDM0UE,0T5.)B,Q-S0[
M($Q/(&)E9F]R92!T:&4@97AP:7)A=&EO;B!O9B!T:&4@3U1#3$\@<&%T96YT
M+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@,3)P="<^4%)%6DE35$$F
M(S$W-#L-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@3F]V
M96UB97(F(S$V,#LR,#$P+"!4:6)O=&5C+"!);F,N(&%N9"!4:6)O=&5C(%!H
M87)M86-E=71I8V%L<RP@26YC+B`H8V]L;&5C=&EV96QY+"!4:6)O=&5C*2!F
M:6QE9"!A#0H@("`@<&%T96YT(&EN9G)I;F=E;65N="!L87=S=6ET(&%G86EN
M<W0@3'5P:6XL($QT9"XL($QU<&EN(%!H87)M86-E=71I8V%L<RP@26YC+B`H
M8V]L;&5C=&EV96QY+"!,=7!I;BDL#0H@("`@37EL86XL($EN8RX@86YD($UY
M;&%N(%!H87)M86-E=71I8V%L<RP@26YC+B`H8V]L;&5C=&EV96QY+"!->6QA
M;BD@:6X@=&AE(%5N:71E9"!3=&%T97,@1&ES=')I8W0-"B`@("!#;W5R="!F
M;W(@=&AE($1I<W1R:6-T(&]F($YE=R!*97)S97D@:6X@<F5S<&]N<V4@=&\@
M3'5P:6XF(S@R,3<[<R!A;F0@37EL86XF(S@R,3<[<R!R97-P96-T:79E($%.
M1$$F(S@R,3<[<R!S965K:6YG#0H@("`@87!P<F]V86P@=&\@;6%R:V5T(&=E
M;F5R:6,@=F5R<VEO;G,@;V8@5&EB;W1E8R8C.#(Q-SMS(%!215I)4U1!)B,Q
M-S0[('!R;V1U8W0@8F5F;W)E('1H92!E>'!I<F%T:6]N(&]F#0H@("`@5&EB
M;W1E8R8C.#(Q-SMS('!A=&5N="!R96QA=&EN9R!T;R!04D5:25-4028C,3<T
M.RX@3'5P:6X@86YD($UY;&%N(&5A8V@@9FEL960@8V]U;G1E<F-L86EM<R!A
M;&QE9VEN9PT*("`@(&YO;BUI;F9R:6YG96UE;G0@86YD(&EN=F%L:61I='DN
M#0H@("`@26X@2G5L>28C,38P.S(P,3$L#0H@("`@5&EB;W1E8R!F:6QE9"!A
M;F]T:&5R('!A=&5N="!I;F9R:6YG96UE;G0@;&%W<W5I="!A9V%I;G-T($QU
M<&EN(&EN('1H92!5;FET960@4W1A=&5S#0H@("`@1&ES=')I8W0@0V]U<G0@
M9F]R('1H92!$:7-T<FEC="!O9B!.97<@2F5R<V5Y(&EN(')E<W!O;G-E('1O
M($QU<&EN)B,X,C$W.W,@<W5P<&QE;65N="!T;R!I=',@04Y$02!T;R!A9&0-
M"B`@("!N97<@9&]S86=E('-T<F5N9W1H<R!F;W(@:71S('!R;W!O<V5D('!R
M;V1U8W0N#0H@("`@26X@075G=7-T)B,Q-C`[,C`Q,2P@5&EB;W1E8R!A;F0@
M1RY$+B!396%R;&4@)B,P,S@[($-O;7!A;GD@*$<N1"X@4V5A<FQE*0T*("`@
M(&9I;&5D(&$@<&%T96YT(&EN9G)I;F=E;65N="!L87=S=6ET(&%G86EN<W0@
M3'5P:6X@86YD($UY;&%N(&EN(')E<W!O;G-E('1O('1H96ER(&YO=&EC92!L
M971T97)S#0H@("`@861V:7-I;F<@=&AA="!T:&5I<B!!3D1!<R!A<F4@<V5E
M:VEN9R!A<'!R;W9A;"!T;R!M87)K970@9V5N97)I8R!V97)S:6]N<R!O9B!4
M:6)O=&5C)B,X,C$W.W,@4%)%6DE35$$F(S$W-#L-"B`@("!P<F]D=6-T(&)E
M9F]R92!T:&4@97AP:7)A=&EO;B!O9B!T=V\@<&%T96YT<R!R96QA=&EN9R!T
M;R!04D5:25-4028C,3<T.R!T:&%T(%1I8F]T96,@97AC;'5S:79E;'D-"B`@
M("!L:6-E;G-E<R!F<F]M($<N1"X@4V5A<FQE+@T*("`@(#PO9&EV/@T*("`@
M(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M;6%R9VEN+71O<#H@-G!T)SY);B!-87)C:"8C,38P.S(P,3$L(%1I8F]T96,@
M86YD($<N1"X@4V5A<FQE("!F:6QE9"!A('!A=&5N="!I;F9R:6YG96UE;G0@
M;&%W<W5I=`T*("`@(&%G86EN<W0@5&5V82!0:&%R;6%C975T:6-A;',@55-!
M+"!);F,N(&%N9"!4979A(%!H87)M86-E=71I8V%L<RP@3'1D+B`H8V]L;&5C
M=&EV96QY+"!4979A*2!I;B!T:&4-"B`@("!5;FET960@4W1A=&5S($1I<W1R
M:6-T($-O=7)T(&9O<B!T:&4@1&ES=')I8W0@;V8@3F5W($IE<G-E>2!I;B!R
M97-P;VYS92!T;R!4979A)B,X,C$W.W,@04Y$02!S965K:6YG#0H@("`@87!P
M<F]V86P@=&\@;6%R:V5T(&$@9V5N97)I8R!V97)S:6]N(&]F(%!215I)4U1!
M)B,Q-S0[(&)E9F]R92!T:&4@97AP:7)A=&EO;B!O9B!C97)T86EN('!A=&5N
M=',@<F5L871I;F<-"B`@("!T;R!04D5:25-4028C,3<T.R!T:&%T(%1I8F]T
M96,@96ET:&5R(&]W;G,@;W(@97AC;'5S:79E;'D@;&EC96YS97,@9G)O;2!'
M+D0N(%-E87)L92X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^
M26X@36%R8V@F(S$V,#LR,#$Q+"!4:6)O=&5C(&9I;&5D(&$@<&%T96YT(&EN
M9G)I;F=E;65N="!L87=S=6ET(&%G86EN<W0@2&5T97)O($1R=6=S+"!,=&0N
M(%5N:70@24E)(&%N9`T*("`@($AE=&5R;R!54T$@26YC+B`H8V]L;&5C=&EV
M96QY+"!(971E<F\I(&EN('1H92!5;FET960@4W1A=&5S($1I<W1R:6-T($-O
M=7)T(&9O<B!T:&4@1&ES=')I8W0@;V8@3F5W#0H@("`@2F5R<V5Y(&EN(')E
M<W!O;G-E('1O($AE=&5R;R8C.#(Q-SMS($%.1$$@<V5E:VEN9R!A<'!R;W9A
M;"!T;R!M87)K970@82!G96YE<FEC('9E<G-I;VX@;V8@4%)%6DE35$$F(S$W
M-#L-"B`@("!B969O<F4@=&AE(&5X<&ER871I;VX@;V8@8V5R=&%I;B!P871E
M;G1S(')E;&%T:6YG('1O(%!215I)4U1!)B,Q-S0[('1H870@5&EB;W1E8R!E
M>&-L=7-I=F5L>2!L:6-E;G-E<PT*("`@(&9R;VT@1RY$+B!396%R;&4N#0H@
M("`@26X@2G5L>2`R,#$Q+"!U<&]N(&%G<F5E;65N="!B>2!T:&4@<&%R=&EE
M<RP@=&AE($-O=7)T(&5N=&5R960@82!S=&%Y(&]F('1H92!L87=S=6ET('!E
M;F1I;F<@82!F:6YA;"!D96-I<VEO;@T*("`@(&EN('1H92!L87=S=6ET("!A
M9V%I;G-T(%1E=F$@=VET:"!R97-P96-T('1O('1H92!V86QI9&ET>2!A;F0O
M;W(@96YF;W)C96%B:6QI='D-"B`@("!O9B!T:&4@<&%T96YT<R!T:&%T(%1I
M8F]T96,@;&EC96YS97,@9G)O;2!'+D0N(%-E87)L92P@=VET:"!(971E<F\@
M86=R965I;F<@=&\@8F4@8F]U;F0@8GD@<W5C:"!F:6YA;"!D96-I<VEO;BX-
M"B`@("!);B!E86-H(&]F('1H92!A8F]V92!L87=S=6ET<RP@5&EB;W1E8R!I
M<R!S965K:6YG(&%N($]R9&5R(&5N:F]I;FEN9R!T:&4-"B`@("!D969E;F1A
M;G1S(&9R;VT@;6%R:V5T:6YG('1H96ER(&=E;F5R:6,@=F5R<VEO;G,@;V8@
M4%)%6DE35$$F(S$W-#L@8F5F;W)E('1H92!E>'!I<F%T:6]N(&]F('1H92!R
M96QE=F%N=`T*("`@('!A=&5N=',N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM
M=&]P.B`Q,G!T)SX\=3Y/5$A%4B!)3E1%3$Q%0U1504P@4%)/4$525%D@34%4
M5$524SPO=3X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@
M4V5P=&5M8F5R)B,Q-C`[,C`P.2P@0V5N=&]C;W(@3W)T:&\@0FEO=&5C:"!0
M<F]D=6-T<RP@3"Y0+B`H;F]W($IA;G-S96X@4')O9'5C=',L($Q0("A*4$Q0
M*2D-"B`@("!I;G1E<G9E;F5D(&EN(&%N(&EN=F5N=&]R<VAI<"!L87=S=6ET
M(&9I;&5D(&)Y('1H92!5;FEV97)S:71Y(&]F($MA;G-A<R!#96YT97(@9F]R
M(%)E<V5A<F-H+"!);F,N#0H@("`@*$M50U(I)B,Q-C`[86=A:6YS="!T:&4@
M56YI=&5D(%-T871E<R!O9B!!;65R:6-A("A54T$I)B,Q-C`[:6X@=&AE(%5N
M:71E9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H90T*("`@($1I<W1R
M:6-T(&]F($MA;G-A<RX@2U5#4B!A;&QE9V5S('1H870@='=O($M50U(@<V-I
M96YT:7-T<R!S:&]U;&0@8F4@861D960@87,@:6YV96YT;W)S(&]N('1W;PT*
M("`@(%5302UO=VYE9"!P871E;G1S(')E;&%T:6YG('1O(%9%3$-!1$4F(S$W
M-#LN(%1H92!54T$@;&EC96YS960@=&AE('!A=&5N=',-"B`@("`H86YD('1H
M96ER(&9O<F5I9VX-"B`@("!C;W5N=&5R<&%R=',I('1O($UI;&QE;FYI=6T@
M4&AA<FUA8V5U=&EC86QS+"!);F,N("A-4$DI+"!W:&\@:6X@='5R;B!S=6)L
M:6-E;G-E9"!T:&4@<&%T96YT<R`H86YD#0H@("`@=&AE:7(@9F]R96EG;B!C
M;W5N=&5R<&%R=',I('1O($I03%`@9F]R(&-O;6UE<F-I86P@;6%R:V5T:6YG
M(&]U='-I9&4@=&AE(%5N:71E9"!3=&%T97,N($EN($IU;'D-"B`@("`R,#$P
M+"!T:&4@<&%R=&EE<R!R96%C:&5D(&$@<V5T=&QE;65N="!A9W)E96UE;G0@
M=&\@<F5S;VQV92!T:&4@9&ES<'5T97,@:6X@=&AI<R!C87-E(&%N9"!W:6QL
M#0H@("`@<W5B;6ET('1H92!I;G9E;G1O<G-H:7`@:7-S=64@=&\@87)B:71R
M871I;VXN(%1H92!C87-E(&AA<R!B965N('-T87EE9"!P96YD:6YG('1H92!A
M<F)I=')A=&EO;BX@07,-"B`@("!A(')E<W5L="!O9B!T:&4@<V5T=&QE;65N
M="!A9W)E96UE;G0L('1H92!O=71C;VUE(&]F('1H92!A<F)I=')A=&EO;B!R
M96=A<F1I;F<@:6YV96YT;W)S:&EP('=I;&P-"B`@("!D971E<FUI;F4@=VAE
M=&AE<B!P<F4M<W!E8VEF:65D('!A>6UE;G1S('=I;&P@8F4@;6%D92!T;R!+
M54-2+"!B=70@=VEL;"!N;W0@869F96-T($I03%`F(S@R,3<[<R!R:6=H="!T
M;PT*("`@(&UA<FME="!614Q#041%)B,Q-S0[+@T*("`@(#PO9&EV/@T*("`@
M(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M;6%R9VEN+71O<#H@-G!T)SY);B!$96-E;6)E<B8C,38P.S(P,#DL('1H92!3
M=&%T92!O9B!)<W)A96P@9FEL960@82!L87=S=6ET(&EN('1H92!$:7-T<FEC
M="!#;W5R="!I;B!496P@079I=B!*869F80T*("`@(&%G86EN<W0@=F%R:6]U
M<R!A9F9I;&EA=&5S(&]F($]M<FEX($)I;W!H87)M86-E=71I8V%L<RP@26YC
M+B`H3VUR:7@I+B!);B!T:&4@;&%W<W5I="P@=&AE(%-T871E#0H@("`@8VQA
M:6US('1H870@86X@96UP;&]Y964@;V8@82!G;W9E<FYM96YT+6]W;F5D(&AO
M<W!I=&%L('=A<R!T:&4@:6YV96YT;W(@;VX@<V5V97)A;"!P871E;G1S(')E
M;&%T960-"B`@("!T;R!F:6)R:6X@9VQU92!T96-H;F]L;V=Y('1H870@=&AE
M(&5M<&QO>65E(&1E=F5L;W!E9"!W:&EL92!H92!W87,@82!G;W9E<FYM96YT
M(&5M<&QO>65E+B!4:&4@4W1A=&4-"B`@("!C;&%I;7,@=&AA="!H92!H860@
M;F\@<FEG:'0@=&\@=')A;G-F97(@86YY(&EN=&5L;&5C='5A;"!P<F]P97)T
M>2!T;R!/;7)I>"!B96-A=7-E(&ET(&)E;&]N9W,@=&\-"B`@("!T:&4@4W1A
M=&4N(%1H92!3=&%T92!I<R!S965K:6YG(&1A;6%G97,@<&QU<R!R;WEA;'1I
M97,@;VX@455)6$E,)B,X-#@R.R!A;F0@159)0T5,)B,X-#@R.R!O<BP@86QT
M97)N871I=F5L>2P-"B`@("!T<F%N<V9E<B!O9B!T:&4@<&%T96YT<R!T;R!T
M:&4@4W1A=&4N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN
M($IA;G5A<GDF(S$V,#LR,#$Q+"!'96YE;G1E8V@L($EN8RX@*$=E;F5N=&5C
M:"D@:6YI=&EA=&5D(&%N(&%R8FET<F%T:6]N(&%G86EN<W0@54-"($-E;&QT
M96-H#0H@("`@*$-E;&QT96-H*2!S965K:6YG(&1A;6%G97,@9F]R(&%L;&5G
M961L>2!C;V]P97)A=&EN9R!W:71H($-E;G1O8V]R("AN;W<@2D))*2!T;R!I
M;7!R;W!E<FQY#0H@("`@=&5R;6EN871E(&$@<')I;W(@86=R965M96YT(&EN
M('=H:6-H($I"22!W87,@<W5B;&EC96YS960@=6YD97(@1V5N96YT96-H)B,X
M,C$W.W,@0V%B:6QL>2!P871E;G1S+B!*0DD-"B`@("!H87,@86X@:6YD96UN
M:71Y(&%G<F5E;65N="!W:71H($-E;&QT96-H+"!A;F0@0V5L;'1E8V@@:&%S
M(&%S<V5R=&5D('1H870@2D))(&ES(&QI86)L92!F;W(@86YY#0H@("`@9&%M
M86=E<R!#96QL=&5C:"!M87D@8F4@<F5Q=6ER960@=&\@<&%Y($=E;F5N=&5C
M:"!I;B!T:&%T(&%R8FET<F%T:6]N+@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@,3)P="<^/'4^/&(^1T]615).345.5"!04D]#145$24Y'4SPO8CX\
M+W4^#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DQI:V4@;W1H
M97(@8V]M<&%N:65S(&EN('1H92!P:&%R;6%C975T:6-A;"!A;F0@;65D:6-A
M;"!D979I8V5S(&%N9"!D:6%G;F]S=&EC<R!I;F1U<W1R:65S+"!T:&4-"B`@
M("!#;VUP86YY(&%N9"!C97)T86EN(&]F(&ET<R!S=6)S:61I87)I97,@87)E
M('-U8FIE8W0@=&\@97AT96YS:79E(')E9W5L871I;VX@8GD@;F%T:6]N86PL
M('-T871E(&%N9`T*("`@(&QO8V%L(&=O=F5R;FUE;G0@86=E;F-I97,@:6X@
M=&AE(%5N:71E9"!3=&%T97,@86YD(&]T:&5R(&-O=6YT<FEE<R!I;B!W:&EC
M:"!T:&5Y(&]P97)A=&4N($%S(&$-"B`@("!R97-U;'0L(&EN=&5R86-T:6]N
M('=I=&@@9V]V97)N;65N="!A9V5N8VEE<R!I<R!O;F=O:6YG+B!4:&4@;6]S
M="!S:6=N:69I8V%N="!L:71I9V%T:6]N(&)R;W5G:'0-"B`@("!B>2P@86YD
M(&EN=F5S=&EG871I;VYS(&-O;F1U8W1E9"!B>2P@9V]V97)N;65N="!A9V5N
M8VEE<R!A<F4@;&ES=&5D(&)E;&]W+B!)="!I<R!P;W-S:6)L92!T:&%T#0H@
M("`@8W)I;6EN86P@8VAA<F=E<R!A;F0@<W5B<W1A;G1I86P@9FEN97,@86YD
M+V]R(&-I=FEL('!E;F%L=&EE<R!O<B!D86UA9V5S(&-O=6QD(')E<W5L="!F
M<F]M#0H@("`@9V]V97)N;65N="!I;G9E<W1I9V%T:6]N<R!O<B!L:71I9V%T
M:6]N+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@,3)P="<^/'4^059%
M4D%'12!72$],15-!3$4@4%))0T4@*$%74"DF(S$V,#M,251)1T%424]./"]U
M/@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@0V]M<&%N
M>2!A;F0@<V5V97)A;"!O9B!I=',@<&AA<FUA8V5U=&EC86P@<W5B<VED:6%R
M:65S("AT:&4@2B8C,#,X.TH@05=0(&1E9F5N9&%N=',I+"!A;&]N9R!W:71H
M#0H@("`@;G5M97)O=7,@;W1H97(@<&AA<FUA8V5U=&EC86P@8V]M<&%N:65S
M+"!A<F4@9&5F96YD86YT<R!I;B!A('-E<FEE<R!O9B!L87=S=6ET<R!I;B!S
M=&%T92!A;F0-"B`@("!F961E<F%L(&-O=7)T<R!I;G9O;'9I;F<@86QL96=A
M=&EO;G,@=&AA="!T:&4@<')I8VEN9R!A;F0@;6%R:V5T:6YG(&]F(&-E<G1A
M:6X@<&AA<FUA8V5U=&EC86P-"B`@("!P<F]D=6-T<R!A;6]U;G1E9"!T;R!F
M<F%U9'5L96YT(&%N9"!O=&AE<G=I<V4@86-T:6]N86)L92!C;VYD=6-T(&)E
M8V%U<V4L(&%M;VYG(&]T:&5R('1H:6YG<RP@=&AE#0H@("`@8V]M<&%N:65S
M(&%L;&5G961L>2!R97!O<G1E9"!A;B!I;F9L871E9"!!=F5R86=E(%=H;VQE
M<V%L92!0<FEC92`H05=0*28C,38P.V9O<B!T:&4@9')U9W,@870@:7-S=64N
M#0H@("`@4&%Y;W)S(&%L;&5G960@=&AA="!T:&5Y('5S960@=&AO<V4@05=0
M<R!I;B!C86QC=6QA=&EN9R!P<F]V:61E<B!R96EM8G5R<V5M96YT(&QE=F5L
M<RX-"B`@("!-86YY(&]F('1H97-E(&-A<V5S+"!B;W1H(&9E9&5R86P@86-T
M:6]N<R!A;F0@<W1A=&4@86-T:6]N<PT*("`@(')E;6]V960@=&\@9F5D97)A
M;"!C;W5R="P@=V5R90T*("`@(&-O;G-O;&ED871E9"!F;W(@<')E+71R:6%L
M('!U<G!O<V5S(&EN(&$@375L=&DM1&ES=')I8W0@3&ET:6=A=&EO;B`H341,
M*28C,38P.VEN('1H92!5;FET960@4W1A=&5S#0H@("`@1&ES=')I8W0@0V]U
M<G0@9F]R('1H92!$:7-T<FEC="!O9B!-87-S86-H=7-E='1S+@T*("`@(#PO
M9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@<&QA:6YT:69F<R!I;B!T
M:&5S92!C87-E<R!I;F-L=61E9"!T:')E92!C;&%S<V5S(&]F('!R:79A=&4@
M<&5R<V]N<R!O<B!E;G1I=&EE<R!T:&%T('!A:60@9F]R#0H@("`@86YY('!O
M<G1I;VX@;V8@=&AE('!U<F-H87-E(&]F('1H92!D<G5G<R!A="!I<W-U92!B
M87-E9"!O;B!!5U`L(&%N9"!S=&%T92!G;W9E<FYM96YT(&5N=&ET:65S('1H
M870-"B`@("!M861E($UE9&EC86ED('!A>6UE;G1S(&9O<B!T:&4@9')U9W,@
M870@:7-S=64@8F%S960@;VX@05=0+B!);B!*=6YE)B,Q-C`[,C`P-RP@869T
M97(@82!T<FEA;"!O;B!T:&4-"B`@("!M97)I=',L('1H92!-1$P@0V]U<G0@
M9&ES;6ES<V5D('1H92!C;&%I;7,@;V8@='=O(&]F('1H92!P;&%I;G1I9F8@
M8VQA<W-E<R!A9V%I;G-T('1H92!*)B,P,S@[2B!!5U`-"B`@("!D969E;F1A
M;G1S(&9R;VT@=&AE(&-A<V4@<F5G87)D:6YG(&%L;"!C;&%I;7,@;V8@0VQA
M<W-E<R`R(&%N9"`S+B!);B!-87)C:"8C,38P.S(P,3$L('1H92!#;W5R=`T*
M("`@(&1I<VUI<W-E9"!T:&4@8VQA:6US(&]F('1H92!T:&ER9"!C;&%S<R!A
M9V%I;G-T('1H92!*)B,P,S@[2B!!5U`@9&5F96YD86YT<R!W:71H;W5T('!R
M96IU9&EC92X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^05=0
M(&-A<V5S(&)R;W5G:'0@8GD@=F%R:6]U<R!!='1O<FYE>7,@1V5N97)A;"!H
M879E('!R;V-E961E9"!T;R!T<FEA;"!A9V%I;G-T(&]T:&5R(&UA;G5F86-T
M=7)E<G,N#0H@("`@5&AR964@<W1A=&4@8V%S97,@86=A:6YS="!C97)T86EN
M(&]F('1H92!#;VUP86YY)B,X,C$W.W,@<W5B<VED:6%R:65S(&AA=F4@8F5E
M;B!S970@9F]R('1R:6%L.B!)9&%H;R!I;@T*("`@($]C=&]B97(F(S$V,#LR
M,#$Q+"!+96YT=6-K>2!I;B!*86YU87)Y)B,Q-C`[,C`Q,B!A;F0@2V%N<V%S
M(&EN($UA<F-H)B,Q-C`[,C`Q,RX@3W1H97(@<W1A=&4@8V%S97,@87)E(&QI
M:V5L>2!T;PT*("`@(&)E('-E="!F;W(@=')I86PN($EN(&%D9&ET:6]N+"!A
M;B!!5U`@8V%S92!A9V%I;G-T('1H92!*)B,P,S@[2B!!5U`@9&5F96YD86YT
M<R!B<F]U9VAT(&)Y('1H90T*("`@($-O;6UO;G=E86QT:"!O9B!096YN<WEL
M=F%N:6$@=V%S('1R:65D(&EN($-O;6UO;G=E86QT:"!#;W5R="!I;B!/8W1O
M8F5R(&%N9"!.;W9E;6)E<B8C,38P.S(P,3`N(%1H90T*("`@($-O=7)T(&9O
M=6YD(&EN('1H92!#;VUM;VYW96%L=&@F(S@R,3<[<R!F879O<B!W:71H(')E
M9V%R9"!T;R!C97)T86EN(&]F(&ET<R!C;&%I;7,@=6YD97(@=&AE(%!E;FYS
M>6QV86YI80T*("`@(%5N9F%I<B!4<F%D92!0<F%C=&EC97,@86YD($-O;G-U
M;65R(%!R;W1E8W1I;VX@3&%W+"!E;G1E<F5D(&%N(&EN:G5N8W1I;VXL(&%N
M9"!A=V%R9&5D("9N8G-P.R0T-28C,38P.VUI;&QI;VX-"B`@("!I;B!R97-T
M:71U=&EO;B!A;F0@)FYB<W`[)#8N-28C,38P.VUI;&QI;VX@:6X@8VEV:6P@
M<&5N86QT:65S+B!4:&4@0V]U<G0@9F]U;F0@:6X@=&AE($HF(S`S.#M*($%7
M4"!D969E;F1A;G1S)B,X,C$W.PT*("`@(&9A=F]R(&]N('1H92!#;VUM;VYW
M96%L=&@F(S@R,3<[<R!C;&%I;7,@;V8@=6YJ=7-T(&5N<FEC:&UE;G0L(&UI
M<W)E<')E<V5N=&%T:6]N+V9R875D+"!C:79I;"!C;VYS<&ER86-Y+`T*("`@
M(&%N9"!O;B!C97)T86EN(&]F('1H92!#;VUM;VYW96%L=&@F(S@R,3<[<R!C
M;&%I;7,@=6YD97(@=&AE(%!E;FYS>6QV86YI82!5;F9A:7(@5')A9&4@4')A
M8W1I8V5S(&%N9`T*("`@($-O;G-U;65R(%!R;W1E8W1I;VX@3&%W+B!4:&4@
M<&%R=&EE<R!A<F4@8W5R<F5N=&QY(&%W86ET:6YG(&$@<G5L:6YG(&]N('!O
M<W0@=')I86P@;6]T:6]N<RP@=VAI8V@L#0H@("`@:68@;F5C97-S87)Y+"!W
M:6QL(&)E(&9O;&QO=V5D(&)Y(&%N(&%P<&5A;"!T;R!T:&4@4&5N;G-Y;'9A
M;FEA(%-U<')E;64@0V]U<G0N(%1H92!#;VUP86YY#0H@("`@8F5L:65V97,@
M=&AA="!I="!H87,@<W1R;VYG(&%R9W5M96YT<R!S=7!P;W)T:6YG(&%N(&%P
M<&5A;"X@0F5C875S92!T:&4@0V]M<&%N>2!B96QI979E<R!T:&%T('1H90T*
M("`@('!O=&5N=&EA;"!F;W(@86X@=6YF879O<F%B;&4@;W5T8V]M92!I<R!N
M;W0@<')O8F%B;&4L(&ET(&AA<R!N;W0@97-T86)L:7-H960@82!R97-E<G9E
M('=I=&@@<F5S<&5C=`T*("`@('1O('1H92!V97)D:6-T+@T*("`@(#PO9&EV
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@,3)P="<^/'4^4DE34$521$%,)B,Q-S0[/"]U
M/@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY);B!*86YU87)Y
M)B,Q-C`[,C`P-"P@2F%N<W-E;B!0:&%R;6%C975T:6-A($EN8RX@*$IA;G-S
M96XI("AN;W<@2F%N<W-E;B!0:&%R;6%C975T:6-A;',L($EN8RX@*$I022DI
M#0H@("`@<F5C96EV960@82!S=6)P;V5N82!F<F]M('1H92!/9F9I8V4@;V8@
M=&AE($EN<W!E8W1O<B!'96YE<F%L(&]F('1H92!5;FET960@4W1A=&5S($]F
M9FEC92!O9@T*("`@(%!E<G-O;FYE;"!-86YA9V5M96YT('-E96MI;F<@9&]C
M=6UE;G1S(&-O;F-E<FYI;F<@<V%L97,@86YD(&UA<FME=&EN9R!O9BP@86YY
M(&%N9"!A;&P@<&%Y;65N=',@=&\-"B`@("!P:'ES:6-I86YS(&EN(&-O;FYE
M8W1I;VX@=VET:"!S86QE<R!A;F0@;6%R:V5T:6YG(&]F+"!A;F0@8VQI;FEC
M86P@=')I86QS(&9O<BP@4DE34$521$%,)B,Q-S0[(&9R;VT@,3DY-PT*("`@
M('1O(#(P,#(N($1O8W5M96YT<R!S=6)S97%U96YT('1O(#(P,#(@:&%V92!A
M;'-O(&)E96X@<F5Q=65S=&5D(&)Y('1H92!$97!A<G1M96YT(&]F($IU<W1I
M8V4N($%N#0H@("`@861D:71I;VYA;"!S=6)P;V5N82!S965K:6YG(&EN9F]R
M;6%T:6]N(&%B;W5T(&UA<FME=&EN9R!O9BP@86YD(&%D=F5R<V4@<F5A8W1I
M;VYS('1O+"!225-015)$04PF(S$W-#L-"B`@("!W87,@<F5C96EV960@9G)O
M;2!T:&4@56YI=&5D(%-T871E<R!!='1O<FYE>28C.#(Q-SMS($]F9FEC92!F
M;W(@=&AE($5A<W1E<FX@1&ES=')I8W0@;V8@4&5N;G-Y;'9A;FEA(&EN#0H@
M("`@3F]V96UB97(F(S$V,#LR,#`U+B!.=6UE<F]U<R!S=6)P;V5N87,@<V5E
M:VEN9R!T97-T:6UO;GD@9G)O;2!V87)I;W5S('=I=&YE<W-E<R!B969O<F4@
M82!G<F%N9"!J=7)Y('=E<F4-"B`@("!A;'-O(')E8V5I=F5D+B!*4$D@8V]O
M<&5R871E9"!I;B!R97-P;VYD:6YG('1O('1H97-E(')E<75E<W1S(&9O<B!D
M;V-U;65N=',@86YD('=I=&YE<W-E<RX@5&AE#0H@("`@56YI=&5D(%-T871E
M<R!$97!A<G1M96YT(&]F($IU<W1I8V4@86YD('1H92!5;FET960@4W1A=&5S
M($%T=&]R;F5Y)B,X,C$W.W,@3V9F:6-E(&9O<B!T:&4@16%S=&5R;@T*("`@
M($1I<W1R:6-T(&]F(%!E;FYS>6QV86YI82`H=&AE($=O=F5R;FUE;G0I(&%R
M92!C;VYT:6YU:6YG('1O(&%C=&EV96QY('!U<G-U92!B;W1H(&-R:6UI;F%L
M(&%N9"!C:79I;`T*("`@(&%C=&EO;G,N($EN($9E8G)U87)Y)B,Q-C`[,C`Q
M,"P@=&AE($=O=F5R;FUE;G0@<V5R=F5D($-I=FEL($EN=F5S=&EG871I=F4@
M1&5M86YD<R!S965K:6YG(&%D9&ET:6]N86P-"B`@("!I;F9O<FUA=&EO;@T*
M("`@(')E;&%T:6YG('1O('-A;&5S(&%N9"!M87)K971I;F<@;V8@4DE34$52
M1$%,)B,Q-S0[(&%N9"!S86QE<R!A;F0@;6%R:V5T:6YG(&]F($E.5D5'028C
M,3<T.RX@5&AE#0H@("`@9F]C=7,@;V8@=&AE<V4@;6%T=&5R<R!I<R!T:&4@
M86QL96=E9"!P<F]M;W1I;VX@;V8@4DE34$521$%,)B,Q-S0[(&%N9"!)3E9%
M1T$F(S$W-#L@9F]R(&]F9BUL86)E;"!U<V5S+B!4:&4-"B`@("!';W9E<FYM
M96YT(&AA<R!N;W1I9FEE9"!*4$D@=&AA="!T:&5R92!A<F4@86QS;R!P96YD
M:6YG('%U:2!T86T@86-T:6]N<R!A;&QE9VEN9R!O9F8M;&%B96P-"B`@("!P
M<F]M;W1I;VX@;V8@4DE34$521$%,)B,Q-S0[+B!4:&4@1V]V97)N;65N="!I
M;F9O<FUE9"!*4$D@=&AA="!I="!W:6QL(&EN=&5R=F5N92!I;B!T:&5S92!Q
M=6D@=&%M#0H@("`@86-T:6]N<R!A;F0@9FEL92!A('-U<&5R<V5D:6YG(&-O
M;7!L86EN="X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^1&ES
M8W5S<VEO;G,@:&%V92!B965N(&]N9V]I;F<@:6X@86X@969F;W)T('1O(')E
M<V]L=F4@8W)I;6EN86P@<&5N86QT:65S('5N9&5R('1H92!&;V]D($1R=6<@
M86YD#0H@("`@0V]S;65T:6,@06-T(')E;&%T960@=&\@=&AE('!R;VUO=&EO
M;B!O9B!225-015)$04PF(S$W-#LN($%N#0H@("`@86=R965M96YT(&EN('!R
M:6YC:7!A;"!O;B!K97D@:7-S=65S(')E;&5V86YT#0H@("`@=&\@82!D:7-P
M;W-I=&EO;B!O9B!C<FEM:6YA;"!C:&%R9V5S('!U<G-U86YT('1O(&$@<VEN
M9VQE(&UI<V1E;65A;F]R('9I;VQA=&EO;B!O9B!T:&4@1F]O9"!$<G5G#0H@
M("`@86YD($-O<VUE=&EC($%C="!H87,@8F5E;B!R96%C:&5D+"!B=70@8V5R
M=&%I;B!I<W-U97,@<F5M86EN(&]P96X-"B`@("!B969O<F4@82!S971T;&5M
M96YT(&-A;B!B90T*("`@(&9I;F%L:7IE9"X@5&AE($-O;7!A;GD@:&%S(&%D
M:G5S=&5D('1H92!A8V-R=65D(&%M;W5N="!I;B!T:&4@<V5C;VYD#0H@("`@
M<75A<G1E<B!O9B`R,#$Q('1O(&-O=F5R('1H92!F:6YA;F-I86P@8V]M<&]N
M96YT(&]F('1H90T*("`@('!R;W!O<V5D(&-R:6UI;F%L('-E='1L96UE;G0N
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN#0H@("`@861D
M:71I;VXL(&1I<V-U<W-I;VYS('=I=&@@<W1A=&4@86YD(&9E9&5R86P@9V]V
M97)N;65N="!R97!R97-E;G1A=&EV97,@=&\@<F5S;VQV92!T:&4@<V5P87)A
M=&4-"B`@("!C:79I;"!C;&%I;7,@<F5L871E9"!T;R!T:&4@;6%R:V5T:6YG
M(&]F(%))4U!%4D1!3"8C,3<T.R!A;F0@24Y614=!)B,Q-S0[+"!I;F-L=61I
M;F<-"B`@("!T:&]S92!U;F1E<B!T:&4@1F%L<V4@0VQA:6US($%C="`H=&AE
M('%U:0T*("`@('1A;2!A8W1I;VYS*2P@:&%V92!B965N(&]N9V]I;F<N(%1H
M92!#;VUP86YY(&)E;&EE=F5S('1H97)E(&%R92!M97)I=&]R:6]U<R!D969E
M;G-E<R!T;R!T:&5S90T*("`@(&-L86EM<RP@86YD(&ET(')E;6%I;G,@=6YC
M;&5A<B!W:&5T:&5R(&$@<V5T=&QE;65N="!C86X@8F4@<F5A8VAE9"!A<R!D
M:7-C;W9E<GD@:7,@;F]T(&-O;7!L971E+`T*("`@('1H97)E(&%R92!S:6=N
M:69I8V%N="!F86-T<R!I;B!D:7-P=71E+"!T:&4@9&%M86=E<R!S;W5G:'0@
M:6X@=&AE(&-L86EM<R!A<F4@=6YS=6)S=&%N=&EA=&5D(&%N9`T*("`@(&EN
M9&5T97)M:6YA=&4L('1H97)E(&%R92!N=6UE<F]U<R!P87)T:65S(&EN=F]L
M=F5D+"!A;F0@<&]S<VEB;&4@;W5T8V]M97,@87)E('5N8V5R=&%I;BX@1F]R
M('1H97-E#0H@("`@<F5A<V]N<RP@=&AE($-O;7!A;GD@:7,@=6YA8FQE('1O
M(&5S=&EM871E(&$@<F%N9V4@;V8@;&]S<RX@2&]W979E<BP@9G5T=7)E(&YE
M9V]T:6%T:6]N<R!M87D@;&5A9`T*("`@('1O(&$@;F%R<F]W:6YG(&]F('1H
M92!A<F5A<R!O9B!D:7-A9W)E96UE;G0@86YD('1H92!L:6%B:6QI='D@;6%Y
M('1H96X@8F5C;VUE(')E87-O;F%B;'D@97-T:6UA8FQE#0H@("`@:6X@86-C
M;W)D86YC92!W:71H(&%P<&QI8V%B;&4@86-C;W5N=&EN9R!P<FEN8VEP;&5S
M+B!)9B!A(&YE9V]T:6%T960@<F5S;VQU=&EO;B!C86YN;W0@8F4@<F5A8VAE
M9"P-"B`@("!C:79I;"!L:71I9V%T:6]N(')E;&%T:6YG('1O('1H92!A;&QE
M9V%T:6]N<R!O9B!O9F8M;&%B96P@<')O;6]T:6]N(&]F(%))4U!%4D1!3"8C
M,3<T.R!A;F0O;W(@24Y614=!)B,Q-S0[(&ES#0H@("`@;&EK96QY+B!4:&4@
M=6QT:6UA=&4@<F5S;VQU=&EO;B!O9B!T:&4@86)O=F4@8W)I;6EN86P@86YD
M('1H97-E(&-I=FEL(&UA='1E<G,@:7,@;F]T(&5X<&5C=&5D('1O#0H@("`@
M:&%V92!A(&UA=&5R:6%L(&%D=F5R<V4@969F96-T(&]N('1H92!#;VUP86YY
M)B,X,C$W.W,@9FEN86YC:6%L('!O<VET:6]N+"!A;'1H;W5G:"!T:&4@<F5S
M;VQU=&EO;B!I;B!A;GD-"B`@("!R97!O<G1I;F<@<&5R:6]D(&-O=6QD(&AA
M=F4@82!M871E<FEA;"!I;7!A8W0@;VX@=&AE($-O;7!A;GDF(S@R,3<[<R!R
M97-U;'1S(&]F(&]P97)A=&EO;G,@86YD(&-A<V@@9FQO=W,-"B`@("!F;W(@
M=&AA="!P97)I;V0N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G
M/E1H90T*("`@($%T=&]R;F5Y<R!'96YE<F%L(&]F(&UU;'1I<&QE('-T871E
M<RP@:6YC;'5D:6YG($%L87-K82P@07)K86YS87,L#0H@("`@3&]U:7-I86YA
M+"!-87-S86-H=7-E='1S+"!-:7-S:7-S:7!P:2P@36]N=&%N82P@3F5W($UE
M>&EC;RP-"B`@("!096YN<WEL=F%N:6$L(%-O=71H($-A<F]L:6YA+"!497AA
M<R!A;F0@571A:"P@:&%V92!P96YD:6YG(&%C=&EO;G,@86=A:6YS="!*86YS
M<V5N("AN;W<@2E!)*2!S965K:6YG#0H@("`@;VYE(&]R(&UO<F4@;V8@=&AE
M(&9O;&QO=VEN9R!R96UE9&EE<SH-"B`@("!R96EM8G5R<V5M96YT(&]F($UE
M9&EC86ED(&]R(&]T:&5R#0H@("`@<'5B;&EC(&9U;F1S(&9O<B!225-015)$
M04PF(S$W-#L@<')E<V-R:7!T:6]N<R!W<FET=&5N(&9O<B!O9F8M;&%B96P@
M=7-E+"!C;VUP96YS871I;VX@9F]R('1R96%T:6YG#0H@("`@=&AE:7(@8VET
M:7IE;G,@9F]R(&%L;&5G960@861V97)S92!R96%C=&EO;G,@=&\@4DE34$52
M1$%,)B,Q-S0[+"!C:79I;"!F:6YE<R!O<B!P96YA;'1I97,L(&1A;6%G97,@
M9F]R#0H@("`@)B,X,C(P.V]V97)P87EM96YT<R8C.#(R,3L@8GD@=&AE('-T
M871E(&%N9"!O=&AE<G,L('!U;FET:79E(&1A;6%G97,L#0H@("`@;W(@;W1H
M97(@<F5L:65F(')E;&%T:6YG('1O(&%L;&5G960@=6YF86ER(&)U<VEN97-S
M('!R86-T:6-E<RX-"B`@("!#97)T86EN(&]F('1H97-E(&%C=&EO;G,@86QS
M;R!S965K(&EN:G5N8W1I=F4@<F5L:65F(')E;&%T:6YG('1O('1H90T*("`@
M('!R;VUO=&EO;B!O9B!225-015)$04PF(S$W-#LN($EN('1H92!497AA<R!M
M871T97(L('1H92!!='1O<FYE>2!'96YE<F%L(&]F#0H@("`@5&5X87,@:&%S
M(&IO:6YE9"!A('%U:2!T86T@86-T:6]N(&EN('1H870@<W1A=&4@<V5E:VEN
M9R!S:6UI;&%R#0H@("`@<F5L:65F+"!A;F0@=&AE('1R:6%L(&ES('-C:&5D
M=6QE9"!T;R!C;VUM96YC92!I;B!L871E($YO=F5M8F5R)B,Q-C`[,C`Q,2X-
M"B`@("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@+T9O
M;&EO("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM/@T*
M("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M
M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^5&AE($%T
M=&]R;F5Y($=E;F5R86P@;V8@5V5S="!6:7)G:6YI82!C;VUM96YC960@<W5I
M="!I;B`R,#`T(&%G86EN<W0@2F%N<W-E;B`H;F]W($I022D@8F%S960@;VX-
M"B`@("!C;&%I;7,@;V8@86QL96=E9"!C;VYS=6UE<B!F<F%U9"!A<R!T;R!$
M55)!1T5324,F(S$W-#LL(&%S('=E;&P@87,@4DE34$521$%,)B,Q-S0[+B!*
M4$D@=V%S(&9O=6YD(&QI86)L92!A;F0-"B`@("!D86UA9V5S('=E<F4@87-S
M97-S960@870@)FYB<W`[)#0N-28C,38P.VUI;&QI;VXN($I022!F:6QE9"!A
M;B!A<'!E86PL(&%N9"!I;B!.;W9E;6)E<B8C,38P.S(P,3`L('1H92!797-T
M#0H@("`@5FER9VEN:6$@4W5P<F5M92!#;W5R="!R979E<G-E9"!T:&4@=')I
M86P@8V]U<G0F(S@R,3<[<R!D96-I<VEO;BX@26X@1&5C96UB97(F(S$V,#LR
M,#$P+"!T:&4@071T;W)N97D@1V5N97)A;`T*("`@(&]F(%=E<W0@5FER9VEN
M:6$@9&ES;6ES<V5D('1H92!C87-E(&%S(&ET(')E;&%T960@=&\@4DE34$52
M1$%,)B,Q-S0[('=I=&AO=70@86YY('!A>6UE;G0N(%1H97)E869T97(L#0H@
M("`@2E!)('-E='1L960@=&AE(&-A<V4@:6YS;V9A<B!A<R!I="!R96QA=&5D
M('1O($154D%'15-)0R8C,3<T.RX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT
M;W`Z(#9P="<^26X@,C`P-"P@=&AE($%T=&]R;F5Y($=E;F5R86P@;V8@3&]U
M:7-I86YA(&9I;&5D(&$@;75L=&DM8V]U;G0@0V]M<&QA:6YT(&%G86EN<W0@
M2F%N<W-E;B`H;F]W($I022DN#0H@("`@5&AE($-O;7!A;GD@=V%S(&QA=&5R
M(&%D9&5D(&%S(&$@9&5F96YD86YT+B!4:&4@8V%S92!W87,@=')I960@:6X@
M3V-T;V)E<B8C,38P.S(P,3`N(%1H92!I<W-U92!T<FEE9`T*("`@('1O('1H
M92!J=7)Y('=A<R!W:&5T:&5R('1H92!#;VUP86YY(&]R($I022!H860@=FEO
M;&%T960@=&AE(%-T871E)B,X,C$W.W,@365D:6-A:60@1G)A=60@06-T("AT
M:&4@06-T*0T*("`@('1H<F]U9V@@;6ES<F5P<F5S96YT871I;VYS(&%L;&5G
M961L>2!M861E(&EN('1H92!M86EL:6YG(&]F(&$@3F]V96UB97(F(S$V,#LR
M,#`S($1E87(@2&5A;'1H($-A<F4-"B`@("!0<F]V:61E<B!L971T97(N(%1H
M92!J=7)Y(')E='5R;F5D(&$@=F5R9&EC="!T:&%T($I022!A;F0@=&AE($-O
M;7!A;GD@:&%D('9I;VQA=&5D('1H92!!8W0@86YD#0H@("`@87=A<F1E9"`F
M;F)S<#LD,C4W+C<F(S$V,#MM:6QL:6]N(&EN(&1A;6%G97,N(%1H92!T<FEA
M;"!J=61G92!S=6)S97%U96YT;'D@87=A<F1E9"!T:&4@071T;W)N97D@1V5N
M97)A;`T*("`@(&-O=6YS96P@9F5E<R!A;F0@97AP96YS97,@:6X@=&AE(&%M
M;W5N="!O9B`F;F)S<#LD-S,F(S$V,#MM:6QL:6]N+B!4:&4@0V]M<&%N>2!A
M;F0@2E!))B,X,C$W.W,@;6]T:6]N(&9O<B!A(&YE=PT*("`@('1R:6%L('=A
M<R!D96YI960N(%1H92!#;VUP86YY(&%N9"!*4$D@:&%V92!F:6QE9"!A;B!A
M<'!E86P@86YD(&)E;&EE=F4@=&AA="!T:&5Y(&AA=F4@<W1R;VYG#0H@("`@
M87)G=6UE;G1S('-U<'!O<G1I;F<@=&AE(&%P<&5A;"X@5&AE($-O;7!A;GD@
M8F5L:65V97,@=&AA="!T:&4@<&]T96YT:6%L(&9O<B!A;B!U;F9A=F]R86)L
M92!O=71C;VUE#0H@("`@:7,@;F]T('!R;V)A8FQE+"!A;F0@=&AE<F5F;W)E
M+"!T:&4@0V]M<&%N>2!H87,@;F]T(&5S=&%B;&ES:&5D(&$@<F5S97)V92!W
M:71H(')E<W!E8W0@=&\@=&AE#0H@("`@=F5R9&EC="X-"B`@("`\+V1I=CX-
M"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@,C`P-RP@5&AE($]F9FEC92!O9B!'
M96YE<F%L($-O=6YS96P@;V8@=&AE($-O;6UO;G=E86QT:"!O9B!096YN<WEL
M=F%N:6$@9FEL960@82!L87=S=6ET(&%G86EN<W0-"B`@("!*86YS<V5N("AN
M;W<@2E!)*2!O;B!A(&UU;'1I+4-O=6YT($-O;7!L86EN="!R96QA=&5D('1O
M($IA;G-S96XF(S@R,3<[<R!S86QE(&]F(%))4U!%4D1!3"8C,3<T.R!T;R!T
M:&4-"B`@("!#;VUM;VYW96%L=&@F(S@R,3<[<R!-961I8V%I9"!P<F]G<F%M
M+B!4:&4@=')I86P@;V-C=7)R960@:6X@2G5N928C,38P.S(P,3`N(%1H92!T
M<FEA;"!J=61G92!D:7-M:7-S960@=&AE#0H@("`@8V%S92!A9G1E<B!T:&4@
M8VQO<V4@;V8@=&AE('!L86EN=&EF9B8C.#(Q-SMS(&5V:61E;F-E+B!4:&4@
M0V]M;6]N=V5A;'1H)B,X,C$W.W,@<&]S="UT<FEA;"!M;W1I;VYS('=E<F4-
M"B`@("!D96YI960N(%1H92!#;VUM;VYW96%L=&@@9FEL960@86X@87!P96%L
M(&EN($%P<FEL)B,Q-C`[,C`Q,2X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT
M;W`Z(#9P="<^26X@,C`P-RP@=&AE($%T=&]R;F5Y($=E;F5R86P@;V8@4V]U
M=&@@0V%R;VQI;F$@9FEL960@82!L87=S=6ET(&%G86EN<W0@=&AE($-O;7!A
M;GD@86YD($IA;G-S96X-"B`@("`H;F]W($I022D@;VX@<V5V97)A;"!C;W5N
M=',N($EN($UA<F-H)B,Q-C`[,C`Q,2P@=&AE(&UA='1E<B!W87,@=')I960@
M;VX@;&EA8FEL:71Y(&]N;'DL(&%T('=H:6-H('1I;64-"B`@("!T:&4@;&%W
M<W5I="!W87,@;&EM:71E9"!T;R!C;&%I;7,@;V8@=FEO;&%T:6]N(&]F('1H
M92!3;W5T:"!#87)O;&EN82!5;F9A:7(@5')A9&4@4')A8W1I8V4@06-T+`T*
M("`@(&EN8VQU9&EN9RP@86UO;F<@;W1H97)S+"!Q=65S=&EO;G,@;V8@=VAE
M=&AE<B!T:&4@0V]M<&%N>2!O<B!*4$D@96YG86=E9"!I;B!U;F9A:7(@;W(@
M9&5C97!T:79E#0H@("`@86-T<R!O<B!P<F%C=&EC97,@:6X@=&AE(&-O;F1U
M8W0@;V8@86YY('1R861E(&]R(&-O;6UE<F-E(&)Y(&1I<W1R:6)U=&EN9R!T
M:&4@3F]V96UB97(F(S$V,#LR,#`S("8C.#(R,#M$96%R#0H@("`@1&]C=&]R
M)B,X,C(Q.R!L971T97(@;W(@:6X@=&AE:7(@=7-E(&]F('1H92!&1$$M87!P
M<F]V960@;&%B96PN(%1H92!J=7)Y(&9O=6YD(&EN(&9A=F]R(&]F('1H92!#
M;VUP86YY#0H@("`@86YD(&%G86EN<W0@2E!)+B!);B!*=6YE)B,Q-C`[,C`Q
M,2P@=&AE($-O=7)T(&%W87)D960@8VEV:6P@<&5N86QT:65S(&]F(&%P<')O
M>&EM871E;'D@)FYB<W`[)#,R-RXQ)B,Q-C`[;6EL;&EO;BX-"B`@("!0;W-T
M+71R:6%L(&)R:65F:6YG(&ES('5N9&5R=V%Y+"!A;F0@:68@<F5L:65F(&ES
M(&YO="!G<F%N=&5D+"!*4$D@:6YT96YD<R!T;R!A<'!E86P@=&AI<R!J=61G
M;65N="X-"B`@("!4:&4@0V]M<&%N>2!A;F0@2E!)(&)E;&EE=F4@=&AA="!*
M4$D@:&%S('-T<F]N9R!A<F=U;65N=',@<W5P<&]R=&EN9R!A;B!A<'!E86P@
M86YD('1H870@=&AE#0H@("`@<&]T96YT:6%L(&9O<B!A;B!U;F9A=F]R86)L
M92!O=71C;VUE(&ES(&YO="!P<F]B86)L92X@5&AE<F5F;W)E+"!T:&4@0V]M
M<&%N>2!H87,@;F]T(&5S=&%B;&ES:&5D(&$-"B`@("!R97-E<G9E('=I=&@@
M<F5S<&5C="!T;R!T:&4@=F5R9&EC="X-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#9P="<^5&AE($%T=&]R;F5Y<PT*("`@($=E;F5R86P@;V8@87!P
M<F]X:6UA=&5L>2`T,"!O=&AE<B!S=&%T97,@:&%V92!I;F1I8V%T960@82!P
M;W1E;G1I86P@:6YT97)E<W0@:6X@<'5R<W5I;F<@<VEM:6QA<@T*("`@(&QI
M=&EG871I;VX@86=A:6YS="!*4$DL(&%N9"!H879E(&]B=&%I;F5D(&$@=&]L
M;&EN9R!A9W)E96UE;G0@<W1A>6EN9R!T:&4@<G5N;FEN9R!O9B!T:&4@<W1A
M='5T92!O9@T*("`@(&QI;6ET871I;VYS('=H:6QE('1H97D@<'5R<W5E(&$@
M8V]O<F1I;F%T960@8VEV:6P@:6YV97-T:6=A=&EO;B!O9B!*4$D@<F5G87)D
M:6YG('!O=&5N=&EA;"!C;VYS=6UE<@T*("`@(&9R875D(&%C=&EO;G,@:6X@
M8V]N;F5C=&EO;B!W:71H('1H92!M87)K971I;F<@;V8-"B`@("!225-015)$
M04PF(S$W-#LN#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/CQU
M/DU#3D5)3"!#3TY354U%4B!(14%,5$A#05)%/"]U/@T*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@;6%R9VEN+71O<#H@-G!T)SY3=&%R=&EN9R!I;B!*=6YE)B,Q-C`[,C`Q
M,"P@36-.96EL($-O;G-U;65R($AE86QT:&-A<F4@1&EV:7-I;VX@;V8@36-.
M14E,+5!00RP@26YC+B`H36-.96EL($-O;G-U;65R#0H@("`@2&5A;'1H8V%R
M92DL(&%N9"!C97)T86EN#0H@("`@869F:6QI871E<RP@:6YC;'5D:6YG('1H
M92!#;VUP86YY("AT:&4@0V]M<&%N:65S*2P@<F5C96EV960@9W)A;F0@:G5R
M>0T*("`@('-U8G!O96YA<R!F<F]M('1H92!5;FET960@4W1A=&5S($%T=&]R
M;F5Y)B,X,C$W.W,@3V9F:6-E(&9O<B!T:&4@16%S=&5R;B!$:7-T<FEC="!O
M9B!096YN<WEL=F%N:6$-"B`@("!R97%U97-T:6YG(&1O8W5M96YT<R!B<F]A
M9&QY(')E;&%T:6YG('1O(')E8V5N="!R96-A;&QS(&]F('9A<FEO=7,@<')O
M9'5C=',@;V8@36-.96EL($-O;G-U;65R#0H@("`@2&5A;'1H8V%R92P@86YD
M('1H92!&1$$@:6YS<&5C=&EO;G,@;V8@=&AE($9O<G0@5V%S:&EN9W1O;BP@
M4&5N;G-Y;'9A;FEA(&%N9"!,86YC87-T97(L#0H@("`@4&5N;G-Y;'9A;FEA
M(&UA;G5F86-T=7)I;F<@9F%C:6QI=&EE<RX@26X@861D:71I;VXL(&EN($9E
M8G)U87)Y)B,Q-C`[,C`Q,2P@=&AE(&=O=F5R;FUE;G0@<V5R=F5D#0H@("`@
M36-.14E,+5!00RP@26YC+B`H36-.14E,+5!00RD@=VET:"!A($-I=FEL($EN
M=F5S=&EG871I=F4@1&5M86YD('-E96MI;F<@<F5C;W)D<R!R96QE=F%N="!T
M;R!I=',-"B`@("!I;G9E<W1I9V%T:6]N('1O(&1E=&5R;6EN92!I9B!T:&5R
M92!W87,@82!V:6]L871I;VX@;V8@=&AE($9A;'-E($-L86EM<R!!8W0N(%1H
M92!#;VUP86YI97,@87)E#0H@("`@8V]O<&5R871I;F<@=VET:"!T:&4@56YI
M=&5D(%-T871E<R!!='1O<FYE>28C.#(Q-SMS($]F9FEC92!I;B!R97-P;VYD
M:6YG('1O('1H97-E('-U8G!O96YA<RX-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#9P="<^5&AE($-O;7!A;FEE<R!H879E(&%L<V\@<F5C96EV960@
M0VEV:6P@26YV97-T:6=A=&EV92!$96UA;F1S(&9R;VT@;75L=&EP;&4@4W1A
M=&4@071T;W)N97ES($=E;F5R86P-"B`@("!/9F9I8V5S(&)R;V%D;'D@<F5L
M871I;F<@=&\@=&AE($UC3F5I;"!R96-A;&P@:7-S=65S+B!4:&4@0V]M<&%N
M:65S(&-O;G1I;G5E('1O(&-O;W!E<F%T92!W:71H#0H@("`@=&AE<V4@:6YQ
M=6ER:65S+B!);B!*86YU87)Y)B,Q-C`[,C`Q,2P@=&AE($]R96=O;B!!='1O
M<FYE>2!'96YE<F%L(&9I;&5D(&$@8VEV:6P@8V]M<&QA:6YT(&%G86EN<W0@
M=&AE#0H@("`@0V]M<&%N>2P@36-.14E,+5!00R!A;F0@36-.96EL($AE86QT
M:&-A<F4@3$Q#(&EN('-T871E(&-O=7)T(&%L;&5G:6YG(&-I=FEL('9I;VQA
M=&EO;G,@;V8@=&AE#0H@("`@3W)E9V]N('5N;&%W9G5L('1R861E('!R86-T
M:6-E<R!A8W0@<F5L871I;F<@=&\@86X@96%R;&EE<B!R96-A;&P@;V8@82!-
M8TYE:6P@3U1#('!R;V1U8W0N(%1H90T*("`@($-O;7!A;FEE<R!R96UO=F5D
M('1H:7,@8V%S92!T;R!F961E<F%L(&-O=7)T(&%N9"!H879E('-O=6=H="!T
M<F%N<V9E<B!O9B!T:&4@8V%S92!T;R!T:&4@56YI=&5D#0H@("`@4W1A=&5S
M($1I<W1R:6-T($-O=7)T(&9O<B!T:&4@16%S=&5R;B!$:7-T<FEC="!O9B!0
M96YN<WEL=F%N:6$N(%1H92!*=61I8VEA;"!086YE;"!O;@T*("`@($UU;'1I
M9&ES=')I8W0@3&ET:6=A=&EO;B!D96YI960@=&AE('1R86YS9F5R(')E<75E
M<W0L(&%N9"!T:&4@0V]M<&%N:65S(&UO=F5D(&9O<B!R96-O;G-I9&5R871I
M;VX-"B`@("!O9B!T:&4@4&%N96PF(S@R,3<[<R!D96-I<VEO;BX@0W5R<F5N
M=&QY+"!T:&4@8V%S92!H87,@8F5E;B!S=&%Y960@<&5N9&EN9R!A(&9I;F%L
M(&1E8VES:6]N(&]N('1R86YS9F5R+@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@-G!T)SY);B!-87)C:"8C,38P.S(P,3$L('1H92!5;FET960@4W1A
M=&5S(&9I;&5D(&$@8V]M<&QA:6YT(&9O<B!I;FIU;F-T:79E(')E;&EE9B!I
M;B!T:&4@56YI=&5D(%-T871E<PT*("`@($1I<W1R:6-T($-O=7)T(&9O<B!T
M:&4@16%S=&5R;B!$:7-T<FEC="!O9B!096YN<WEL=F%N:6$@86=A:6YS="!-
M8TY%24PM4%!#(&%N9"!T=V\@;V8@:71S#0H@("`@96UP;&]Y965S+"!A;&QE
M9VEN9R!T:&%T($UC3D5)3"U04$,@:7,@:6X@=FEO;&%T:6]N(&]F($9$02!R
M96=U;&%T:6]N<R!R96=A<F1I;F<@=&AE(&UA;G5F86-T=7)E(&]F#0H@("`@
M9')U9W,@870@=&AE(&9A8VEL:71I97,@:70@;W!E<F%T97,@:6X@3&%N8V%S
M=&5R+"!096YN<WEL=F%N:6$L($9O<G0@5V%S:&EN9W1O;BP@4&5N;G-Y;'9A
M;FEA+"!A;F0-"B`@("!,87,@4&EE9')A<RP@4'5E<G1O(%)I8V\N($]N('1H
M92!S86UE(&1A>2P@=&AE('!A<G1I97,@9FEL960@82!C;VYS96YT(&1E8W)E
M92!O9B!P97)M86YE;G0-"B`@("!I;FIU;F-T:6]N(')E<V]L=FEN9R!T:&4@
M8VQA:6US('-E="!F;W)T:"!I;B!T:&4@8V]M<&QA:6YT+B!4:&4@0V]U<G0@
M87!P<F]V960@86YD(&5N=&5R960@=&AE#0H@("`@8V]N<V5N="!D96-R964@
M;VX@36%R8V@F(S$V,#LQ-BP@,C`Q,2X-"B`@("`\+V1I=CX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I
M;BUT;W`Z(#9P="<^5&AE(&-O;G-E;G0@9&5C<F5E+"!W:&EC:"!I<R!S=6)J
M96-T('1O(&]N9V]I;F<@96YF;W)C96UE;G0@8GD@=&AE(&-O=7)T+"!R97%U
M:7)E<R!-8TY%24PM4%!#('1O#0H@("`@=&%K92!E;FAA;F-E9"!M96%S=7)E
M<R!T;R!R96UE9&EA=&4@=&AE('1H<F5E(&9A8VEL:71I97,N(%1H92!&;W)T
M(%=A<VAI;F=T;VX@9F%C:6QI='DL('=H:6-H('1H90T*("`@(&-O;7!A;GD@
M=F]L=6YT87)I;'D@<VAU="!D;W=N(&EN($%P<FEL)B,Q-C`[,C`Q,"P@=VEL
M;"!R96UA:6X@<VAU="!D;W=N('5N=&EL(&$@=&AI<F0M<&%R='D@8V]N<W5L
M=&%N=`T*("`@(&-E<G1I9FEE<R!T:&%T(&ET<R!O<&5R871I;VYS('=I;&P@
M8F4@:6X@8V]M<&QI86YC92!W:71H(&%P<&QI8V%B;&4@;&%W+"!A;F0@=&AE
M($9$02!C;VYC=7)S('=I=&@-"B`@("!T:&4@=&AI<F0@<&%R='D@8V5R=&EF
M:6-A=&EO;BX@5&AE($QA;F-A<W1E<B!A;F0@3&%S(%!I961R87,@9F%C:6QI
M=&EE<R!M87D@8V]N=&EN=64@=&\-"B`@("!M86YU9F%C='5R92!A;F0@9&ES
M=')I8G5T92!D<G5G<RP@<')O=FED960@=&AA="!A('1H:7)D('!A<G1Y(')E
M=FEE=W,@;6%N=69A8W1U<FEN9R!R96-O<F1S(&9O<@T*("`@('-E;&5C=&5D
M(&)A=&-H97,@;V8@9')U9W,@<F5L96%S960@9G)O;2!T:&4@9F%C:6QI=&EE
M<RP@86YD(&-E<G1I9FEE<R!T:&%T(&%N>2!D979I871I;VYS(')E=FEE=V5D
M#0H@("`@9&\@;F]T(&%D=F5R<V5L>2!A9F9E8W0@=&AE('%U86QI='D@;V8@
M=&AE('-E;&5C=&5D(&)A=&-H97,N#0H@("`@36-.14E,+5!00R!M=7-T(&9U
M<G1H97(@<W5B;6ET(&$@=V]R:W!L86X@*'=I=&@@9&5A9&QI;F5S*2!T;R!T
M:&4@1D1!(&9O<B!R96UE9&EA=&EO;B!O9B!T:&4-"B`@("!,86YC87-T97(@
M86YD($QA<R!0:65D<F%S(&9A8VEL:71I97,[('1H870@<&QA;B!I<R!S=6)J
M96-T('1O($9$02!A<'!R;W9A;"X@069T97(@8V]M<&QE=&EO;B!O9@T*("`@
M('1H92!W;W)K<&QA;BP@=&AI<F0M<&%R='D@8F%T8V@@<F5C;W)D(')E=FEE
M=R!M87D@8V5A<V4@:68@=&AE($9$02!H87,@<W1A=&5D('1H870@=&AE(&9A
M8VEL:71I97,-"B`@("!A<'!E87(@=&\@8F4@:6X@8V]M<&QI86YC92!W:71H
M(&%P<&QI8V%B;&4@;&%W+B!%86-H(&9A8VEL:71Y(&ES#0H@("`@<W5B:F5C
M="!T;R!A(&9I=F4M>65A<B!A=61I=`T*("`@('!E<FEO9"!B>2!A('1H:7)D
M('!A<G1Y(&%F=&5R('1H92!F86-I;&ET>2!H87,@8F5E;B!D965M960@8GD@
M=&AE($9$02!T;R!B92!I;B!A<'!A<F5N="!C;VUP;&EA;F-E#0H@("`@=VET
M:"!A<'!L:6-A8FQE(&QA=RX-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#$R<'0G/CQU/D]-3DE#05)%/"]U/@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@-G!T)SY);B!397!T96UB97(F(S$V,#LR,#`U+"!T:&4@0V]M<&%N
M>2!R96-E:79E9"!A('-U8G!O96YA(&9R;VT@=&AE(%5N:71E9"!3=&%T97,@
M071T;W)N97DF(S@R,3<[<R!/9F9I8V4L#0H@("`@1&ES=')I8W0@;V8@36%S
M<V%C:'5S971T<RP@<V5E:VEN9R!D;V-U;65N=',@<F5L871E9"!T;R!T:&4@
M<V%L97,@86YD(&UA<FME=&EN9R!O9B!E:6=H="!D<G5G<R!T;PT*("`@($]M
M;FEC87)E+"!);F,N("A/;6YI8V%R92DL(&$@;6%N86=E<B!O9B!P:&%R;6%C
M975T:6-A;"!B96YE9FET<R!F;W(@;&]N9RUT97)M(&-A<F4@9F%C:6QI=&EE
M<RX@26X-"B`@("!!<')I;"8C,38P.S(P,#DL('1H92!#;VUP86YY(&%N9"!C
M97)T86EN(&]F(&ET<R!P:&%R;6%C975T:6-A;"!S=6)S:61I87)I97,@=V5R
M92!S97)V960@:6X@='=O(&-I=FEL('%U:0T*("`@('1A;2!C87-E<R!A<W-E
M<G1I;F<@8VQA:6US('5N9&5R('1H92!&961E<F%L($9A;'-E($-L86EM<R!!
M8W0@86YD(')E;&%T960@<W1A=&4@;&%W(&-L86EM<R!A;&QE9VEN9PT*("`@
M('1H870@=&AE(&1E9F5N9&%N=',@<')O=FED960@3VUN:6-A<F4@=VET:"!R
M96)A=&5S(&%N9"!O=&AE<B!A;&QE9V5D(&MI8VMB86-K<RP@8V%U<VEN9R!/
M;6YI8V%R92!T;PT*("`@(&9I;&4@9F%L<V4@8VQA:6US('=I=&@@365D:6-A
M:60@86YD(&]T:&5R(&=O=F5R;FUE;G0@<')O9W)A;7,N($EN($IA;G5A<GDF
M(S$V,#LR,#$P+"!T:&4@9V]V97)N;65N=`T*("`@(&EN=&5R=F5N960@:6X@
M8F]T:"!O9B!T:&5S92!C87-E<RP@;F%M:6YG('1H92!#;VUP86YY+"!/<G1H
M;RU-8TYE:6PM2F%N<W-E;B!0:&%R;6%C975T:6-A;',L($EN8RX-"B`@("`H
M;F]W($IA;G-S96X@4&AA<FUA8V5U=&EC86QS+"!);F,N("A*4$DI*2P@86YD
M($IO:&YS;VX@)B,P,S@[($IO:&YS;VX@2&5A;'1H($-A<F4@4WES=&5M<R!)
M;F,N(&%S#0H@("`@9&5F96YD86YT<RX@4W5B<V5Q=65N=&QY+"!T:&4@0V]M
M;6]N=V5A;'1H(&]F($UA<W-A8VAU<V5T=',L(%9I<F=I;FEA+"!A;F0@2V5N
M='5C:WDL(&%N9"!T:&4-"B`@("!3=&%T97,@;V8@0V%L:69O<FYI82!A;F0@
M26YD:6%N82!I;G1E<G9E;F5D(&EN('1H92!A8W1I;VXN(%1H92!D969E;F1A
M;G1S(&UO=F5D('1O(&1I<VUI<W,@=&AE#0H@("`@0V]M<&QA:6YT<RP@86YD
M(&EN($9E8G)U87)Y)B,Q-C`[,C`Q,2P@=&AE(%5N:71E9"!3=&%T97,@1&ES
M=')I8W0@0V]U<G0@9F]R('1H92!$:7-T<FEC="!O9@T*("`@($UA<W-A8VAU
M<V5T=',@9&ES;6ES<V5D(&]N92!Q=6D@=&%M(&-A<V4@96YT:7)E;'D@86YD
M(&1I<VUI<W-E9"!T:&4@;W1H97(@8V%S92!I;B!P87)T+"!R96IE8W1I;F<-
M"B`@("!A;&QE9V%T:6]N<R!T:&%T('1H92!D969E;F1A;G1S(&AA9"!V:6]L
M871E9"!I=',@;V)L:6=A=&EO;B!T;R!R97!O<G0@:71S("8C.#(R,#MB97-T
M('!R:6-E)B,X,C(Q.R!T;R!H96%L=&@-"B`@("!C87)E('!R;V=R86T@;V9F
M:6-I86QS+B!4:&4@9&5F96YD86YT<R!S=6)S97%U96YT;'D@;6]V960@=&AE
M($-O=7)T('1O(')E8V]N<VED97(@:71S(&1E8VES:6]N(&YO=`T*("`@('1O
M(&1I<VUI<W,@=&AE('-E8V]N9"!C87-E(&EN(&ET<R!E;G1I<F5T>2P@=VAI
M8V@@=&AE($-O=7)T(&1E;FEE9"!I;B!-87DF(S$V,#LR,#$Q+B!4:&4@8VQA
M:6US(&]F('1H90T*("`@(%5N:71E9"!3=&%T97,@86YD(&EN9&EV:61U86P@
M<W1A=&5S(')E;6%I;B!P96YD:6YG+@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN
M+71O<#H@-G!T)SY);B!.;W9E;6)E<B8C,38P.S(P,#4L(&$@;&%W<W5I="!W
M87,@9FEL960@=6YD97(@<V5A;"!B>2!38V]T="!"87)T>BP@82!F;W)M97(@
M96UP;&]Y964L(&EN('1H92!5;FET960-"B`@("!3=&%T97,@1&ES=')I8W0@
M0V]U<G0@9F]R('1H92!%87-T97)N($1I<W1R:6-T(&]F(%!E;FYS>6QV86YI
M82!A9V%I;G-T('1H92!#;VUP86YY(&%N9"!C97)T86EN(&]F#0H@("`@:71S
M('!H87)M86-E=71I8V%L('-U8G-I9&EA<FEE<R`H=&AE($HF(S`S.#M*($1E
M9F5N9&%N=',I+"!A;&]N9R!W:71H(&-O+61E9F5N9&%N=',@36-+97-S;VX@
M0V]R<&]R871I;VX-"B`@("!A;F0@3VUN:6-A<F4L($EN8RX@5&AE($)A<G1Z
M(&-O;7!L86EN="!R86ES97,@;6%N>2!I<W-U97,@:6X@8V]M;6]N('=I=&@@
M=&AE($]M;FEC87)E+7)E;&%T960-"B`@("!L:71I9V%T:6]N(&1I<V-U<W-E
M9"!A8F]V92!A;')E861Y('!E;F1I;F<@8F5F;W)E('1H92!5;FET960@4W1A
M=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T:&4@1&ES=')I8W0-"B`@("!O9B!-
M87-S86-H=7-E='1S+"!S=6-H(&%S(&)E<W0@<')I8V4@86YD(&$@;G5M8F5R
M(&]F(&MI8VMB86-K(&%L;&5G871I;VYS+B!!9G1E<B!I;G9E<W1I9V%T:6]N
M+"!T:&4-"B`@("!5;FET960@4W1A=&5S(&1E8VQI;F5D('1O(&EN=&5R=F5N
M92X@5&AE(&-A<V4@=V%S('-U8G-E<75E;G1L>2!U;G-E86QE9"!I;B!*86YU
M87)Y)B,Q-C`[,C`Q,2X@26X-"B`@("!&96)R=6%R>28C,38P.S(P,3$L('1H
M92!P;&%I;G1I9F8@9FEL960@86X@86UE;F1E9"!C;VUP;&%I;G0L('=H:6-H
M('=A<R!P;&%C960@=6YD97(@<V5A;"X@5&AE<F5A9G1E<BP-"B`@("!O;B!T
M:&4@2B8C,#,X.TH@1&5F96YD86YT<R8C.#(Q-SL@;6]T:6]N+"!T:&4@8V%S
M92!W87,@=')A;G-F97)R960@=&\@=&AE(%5N:71E9"!3=&%T97,@1&ES=')I
M8W0@0V]U<G0@9F]R('1H90T*("`@($1I<W1R:6-T(&]F($UA<W-A8VAU<V5T
M=',L('=H97)E(&ET(&ES(&-U<G)E;G1L>2!P96YD:6YG+B!);B!!<')I;"8C
M,38P.S(P,3$L('1H92!A;65N9&5D(&-O;7!L86EN="!W87,-"B`@("!O<F1E
M<F5D('5N<V5A;&5D(&%N9"!A;&QE9V5S(&$@=F%R:65T>2!O9B!C875S97,@
M;V8@86-T:6]N('5N9&5R('1H92!F961E<F%L($9A;'-E($-L86EM<R!!8W0@
M86YD#0H@("`@8V]R<F5S<&]N9&EN9R!S=&%T92!A;F0@;&]C86P@<W1A='5T
M97,L(&EN8VQU9&EN9R!T:&%T('1H92!*)B,P,S@[2B!$969E;F1A;G1S(&5N
M9V%G960@:6X@=F%R:6]U<PT*("`@(&EM<')O<&5R('1R86YS86-T:6]N<R!T
M:&%T('=E<F4@86QL96=E9&QY(&1E<VEG;F5D('1O(')E<&]R="!F86QS92!P
M<F5S8W)I<'1I;VX@9')U9R!P<FEC97,@=&\@=&AE#0H@("`@9F5D97)A;"!G
M;W9E<FYM96YT(&EN(&]R9&5R('1O(')E9'5C92!T:&4@2B8C,#,X.TH@1&5F
M96YD86YT)B,X,C$W.W,@365D:6-A:60@<F5B871E(&]B;&EG871I;VYS+B!4
M:&4-"B`@("!C;VUP;&%I;G0@9G5R=&AE<B!A;&QE9V5S('1H870@=&AE($HF
M(S`S.#M*($1E9F5N9&%N=',@:6UP<F]P97)L>2!R971A;&EA=&5D(&%G86EN
M<W0@=&AE('!L86EN=&EF9B!F;W(-"B`@("!H879I;F<@<F%I<V5D('1H97-E
M(&%L;&5G871I;VYS(&EN=&5R;F%L;'DN($)A<G1Z('-E96MS(&UU;'1I<&QE
M(&9O<FUS(&]F#0H@("`@<F5L:65F+"!I;F-L=61I;F<@9&%M86=E<PT*("`@
M(&%N9"!R96EN<W1A=&5M96YT('1O(&$@<&]S:71I;VX@=VET:"!T:&4@<V%M
M92!S96YI;W)I='D@<W1A='5S+B!4:&4@2B8C,#,X.TH@1&5F96YD86YT<R!S
M=6)S97%U96YT;'D-"B`@("!M;W9E9"!T;R!D:7-M:7-S('1H92!C;VUP;&%I
M;G0@:6X@36%Y)B,Q-C`[,C`Q,2P@=VAI8V@@:7,@8W5R<F5N=&QY('-C:&5D
M=6QE9"!F;W(@87)G=6UE;G0@:6X@075G=7-T#0H@("`@,C`Q,2X-"B`@("`\
M+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#$R<'0G/CQU/D]42$52/"]U/@T*("`@
M(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY);B!*=6QY)B,Q-C`[,C`P
M,RP@0V5N=&]C;W(L($EN8RX@*&YO=R!*86YS<V5N($)I;W1E8V@L($EN8RX@
M*$I"22DI+"!R96-E:79E9"!A(')E<75E<W0@=&AA="!I=`T*("`@('9O;'5N
M=&%R:6QY('!R;W9I9&4@9&]C=6UE;G1S(&%N9"!I;F9O<FUA=&EO;B!T;R!T
M:&4@8W)I;6EN86P@9&EV:7-I;VX@;V8@=&AE(%5N:71E9"!3=&%T97,-"B`@
M("!!='1O<FYE>28C.#(Q-SMS($]F9FEC92P@1&ES=')I8W0@;V8@3F5W($IE
M<G-E>2P@:6X@8V]N;F5C=&EO;B!W:71H(&ET<R!I;G9E<W1I9V%T:6]N(&EN
M=&\@=F%R:6]U<R!*0DD-"B`@("!M87)K971I;F<@<')A8W1I8V5S+B!3=6)S
M97%U96YT(')E<75E<W1S(&9O<B!D;V-U;65N=',@:&%V92!B965N(')E8V5I
M=F5D(&9R;VT@=&AE(%5N:71E9"!3=&%T97,-"B`@("!!='1O<FYE>28C.#(Q
M-SMS($]F9FEC92X@0F]T:"!T:&4@0V]M<&%N>2!A;F0@2D))(&AA=F4@<F5S
M<&]N9&5D('1O('1H97-E(')E<75E<W1S(&9O<B!D;V-U;65N=',@86YD#0H@
M("`@:6YF;W)M871I;VXN#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V
M<'0G/DEN($IU;'DF(S$V,#LR,#`U+"!38VEO<R!);F,N("A38VEO<RD@<F5C
M96EV960@82!S=6)P;V5N82!F<F]M('1H92!5;FET960@4W1A=&5S($%T=&]R
M;F5Y)B,X,C$W.W,@3V9F:6-E#0H@("`@9F]R('1H92!$:7-T<FEC="!O9B!-
M87-S86-H=7-E='1S+"!S965K:6YG(&1O8W5M96YT<R!R96QA=&5D('1O('1H
M92!S86QE<R!A;F0@;6%R:V5T:6YG(&]F($Y!5%)%0T]2)B,Q-S0[+B!);@T*
M("`@($%U9W5S="8C,38P.S(P,#4L(%-C:6]S('=A<R!A9'9I<V5D('1H870@
M=&AE(&EN=F5S=&EG871I;VX@=V]U;&0@8F4@:&%N9&QE9"!B>2!T:&4@56YI
M=&5D(%-T871E<PT*("`@($%T=&]R;F5Y)B,X,C$W.W,@3V9F:6-E(&9O<B!T
M:&4@3F]R=&AE<FX@1&ES=')I8W0@;V8@0V%L:69O<FYI82!I;B!386X@1G)A
M;F-I<V-O+B!);B!&96)R=6%R>28C,38P.S(P,#DL('1W;PT*("`@('%U:2!T
M86T@8V]M<&QA:6YT<R!W97)E('5N<V5A;&5D(&EN('1H92!5;FET960@4W1A
M=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T:&4@3F]R=&AE<FX@1&ES=')I8W0@
M;V8-"B`@("!#86QI9F]R;FEA+"!A;&QE9VEN9RP@86UO;F<@;W1H97(@=&AI
M;F=S+"!I;7!R;W!E<B!A8W1I=FET:65S(&EN('1H92!P<F]M;W1I;VX@;V8@
M3D%44D5#3U(F(S$W-#LN($EN#0H@("`@2G5N928C,38P.S(P,#DL('1H92!5
M;FET960@4W1A=&5S(&=O=F5R;FUE;G0@:6YT97)V96YE9"!I;B!O;F4@;V8@
M=&AE('%U:2!T86T@86-T:6]N<RP@86YD(&9I;&5D(&$-"B`@("!C;VUP;&%I
M;G0@86=A:6YS="!38VEO<R!A;F0@=&AE($-O;7!A;GD@<V5E:VEN9R!R96QI
M968@=6YD97(@=&AE($9A;'-E($-L86EM<R!!8W0@86YD(&%S<V5R=&EN9R!A
M#0H@("`@8VQA:6T@;V8@=6YJ=7-T(&5N<FEC:&UE;G0N(%1H92!C:79I;"!C
M87-E(&ES('!R;V-E961I;F<@86YD(&1I<V-O=F5R>2!I<R!O;F=O:6YG+B!!
M;@T*("`@($EN9F]R;6%T:6]N(&-H87)G:6YG(%-C:6]S('=I=&@@82!M:7-D
M96UE86YO<B!V:6]L871I;VX@;V8@=&AE($9O;V0@1')U9R!A;F0@0V]S;65T
M:6,@06-T(&AA<R!B965N(&9I;&5D(&)Y('1H92!G;W9E<FYM96YT+@T*("`@
M($ET(&ES(&5X<&5C=&5D('1H870@82!P<F]P;W-E9"!S971T;&5M96YT(&]F
M('1H870@8VAA<F=E('=I;&P@8F4@<W5B;6ET=&5D('1O('1H92!C;W5R="!F
M;W(@87!P<F]V86PN#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G
M/DEN($9E8G)U87)Y)B,Q-C`[,C`P-RP@=&AE($-O;7!A;GD@=F]L=6YT87)I
M;'D@9&ES8VQO<V5D('1O('1H92!5;FET960@4W1A=&5S($1E<&%R=&UE;G0@
M;V8@2G5S=&EC90T*("`@("A$3THI)B,Q-C`[86YD('1H92!5;FET960@4W1A
M=&5S(%-E8W5R:71I97,@)B,P,S@[($5X8VAA;F=E($-O;6UI<W-I;VX@*%-%
M0RDF(S$V,#MT:&%T('-U8G-I9&EA<FEE<R!O=71S:61E('1H90T*("`@(%5N
M:71E9"!3=&%T97,@87)E(&)E;&EE=F5D('1O(&AA=F4@;6%D92!I;7!R;W!E
M<B!P87EM96YT<R!I;B!C;VYN96-T:6]N('=I=&@@=&AE('-A;&4@;V8@;65D
M:6-A;`T*("`@(&1E=FEC97,@:6X@='=O('-M86QL+6UA<FME="!C;W5N=')I
M97,L('=H:6-H('!A>6UE;G1S(&UA>2!F86QL('=I=&AI;B!T:&4@:G5R:7-D
M:6-T:6]N(&]F('1H90T*("`@($9O<F5I9VX@0V]R<G5P="!0<F%C=&EC97,@
M06-T("A&0U!!*2X@26X@=&AE(&-O=7)S92!O9B!C;VYT:6YU:6YG(&1I86QO
M9W5E<R!W:71H('1H92!A9V5N8VEE<RP-"B`@("!O=&AE<B!I<W-U97,@<&]T
M96YT:6%L;'D@<FES:6YG('1O('1H92!L979E;"!O9B!&0U!!('9I;VQA=&EO
M;G,@:6X@861D:71I;VYA;"!M87)K971S('=E<F4@8G)O=6=H=`T*("`@('1O
M('1H92!A='1E;G1I;VX@;V8@=&AE(&%G96YC:65S(&)Y('1H92!#;VUP86YY
M+B!,87<@96YF;W)C96UE;G0@86=E;F-I97,@;V8@82!N=6UB97(@;V8@;W1H
M97(-"B`@("!C;W5N=')I97,@87)E('!U<G-U:6YG(&EN=F5S=&EG871I;VYS
M(&]F(&UA='1E<G,@=F]L=6YT87)I;'D@9&ES8VQO<V5D(&)Y('1H92!#;VUP
M86YY('1O('1H92!$3TH-"B`@("!A;F0@4T5#+B!);B!A9&1I=&EO;BP@:6X@
M1F5B<G5A<GDF(S$V,#LR,#`V+"!T:&4@0V]M<&%N>2!R96-E:79E9"!A('-U
M8G!O96YA(&9R;VT@=&AE(%-%0R!R97%U97-T:6YG#0H@("`@9&]C=6UE;G1S
M(')E;&%T:6YG('1O('1H92!P87)T:6-I<&%T:6]N(&)Y('-E=F5R86P@0V]M
M<&%N>2!S=6)S:61I87)I97,@:6X@=&AE(%5N:71E9"!.871I;VYS($ER87$-
M"B`@("!/:6P@9F]R($9O;V0@4')O9W)A;2X@3VX@07!R:6PF(S$V,#LX+"`R
M,#$Q+"!T:&4@0V]M<&%N>2!R97-O;'9E9"!T:&4@1D-000T*("`@(&%N9"!/
M:6P@9F]R($9O;V0@;6%T=&5R<R!T:')O=6=H('-E='1L96UE;G1S('=I=&@@
M=&AE($1/2BP@4T5#(&%N9"!5;FET960@2VEN9V1O;2!397)I;W5S($9R875D
M#0H@("`@3V9F:6-E+B!4:&5S92!S971T;&5M96YT<R!R97%U:7)E9"!P87EM
M96YT<R!O9B!A<'!R;WAI;6%T96QY("9N8G-P.R0W."8C,38P.VUI;&QI;VX@
M:6X@9FEN86YC:6%L('!E;F%L=&EE<RX@07,-"B`@("!P87)T(&]F('1H92!S
M971T;&5M96YT('=I=&@@=&AE($1/2BP@=&AE($-O;7!A;GD@96YT97)E9"!I
M;G1O(&$@1&5F97)R960@4')O<V5C=71I;VX@06=R965M96YT('1H870-"B`@
M("!R97%U:7)E<R!T:&4@0V]M<&%N>2!T;R!C;VUP;&5T92!A('1H<F5E+7EE
M87(@=&5R;2!O9B!E;FAA;F-E9"!C;VUP;&EA;F-E('!R86-T:6-E<RX-"B`@
M("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@+T9O;&EO
M("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM/@T*("`@
M(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG
M+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@07!R:6PF
M(S$V,#LR,#`W+"!T:&4@0V]M<&%N>2!R96-E:79E9"!T=V\@<W5B<&]E;F%S
M(&9R;VT@=&AE($]F9FEC92!O9B!T:&4@071T;W)N97D@1V5N97)A;"!O9B!T
M:&4-"B`@("!3=&%T92!O9B!$96QA=V%R92X@5&AE('-U8G!O96YA<R!S965K
M(&1O8W5M96YT<R!A;F0@:6YF;W)M871I;VX@<F5L871I;F<@=&\@;F]M:6YA
M;"!P<FEC:6YG#0H@("`@86=R965M96YT<RX@1F]R('!U<G!O<V5S(&]F('1H
M92!S=6)P;V5N87,L(&YO;6EN86P@<')I8VEN9R!A9W)E96UE;G1S(&%R92!D
M969I;F5D(&%S(&%G<F5E;65N=',-"B`@("!U;F1E<B!W:&EC:"!T:&4@0V]M
M<&%N>2!A9W)E960@=&\@<')O=FED92!A('!H87)M86-E=71I8V%L('!R;V1U
M8W0@9F]R(&QE<W,@=&AA;B!T96X@<&5R8V5N="!O9B!T:&4-"B`@("!!=F5R
M86=E($UA;G5F86-T=7)E<B!0<FEC92!F;W(@=&AE('!R;V1U8W0N(%1H92!#
M;VUP86YY(')E<W!O;F1E9"!T;R!T:&5S92!R97%U97-T<RX-"B`@("`\+V1I
M=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@36%Y)B,Q-C`[,C`P-RP@=&AE
M($YE=R!9;W)K(%-T871E($%T=&]R;F5Y($=E;F5R86P@:7-S=65D(&$@<W5B
M<&]E;F$@=&\@=&AE($-O;7!A;GD@<V5E:VEN9PT*("`@(&EN9F]R;6%T:6]N
M(')E;&%T:6YG('1O('1H92!M87)K971I;F<L('-A;&4L(')E:6UB=7)S96UE
M;G0@86YD('-A9F5T>2!O9B!04D]#4DE4)B,Q-S0[+B!4:&4@0V]M<&%N>2!H
M87,-"B`@("!R97-P;VYD960@=&\@=&AE('-U8G!O96YA+@T*("`@(#PO9&EV
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY);B!*=6YE)B,Q-C`[,C`P."P@=&AE
M($-O;7!A;GD@<F5C96EV960@82!S=6)P;V5N82!F<F]M('1H92!5;FET960@
M4W1A=&5S($%T=&]R;F5Y)B,X,C$W.W,@3V9F:6-E(&9O<B!T:&4-"B`@("!$
M:7-T<FEC="!O9B!-87-S86-H=7-E='1S(')E;&%T:6YG('1O('1H92!M87)K
M971I;F<@;V8@8FEL:6%R>2!S=&5N=',@8GD@0V]R9&ES($-O<G!O<F%T:6]N
M#0H@("`@*$-O<F1I<RDN($-O<F1I<R!I<R!C=7)R96YT;'D@8V]O<&5R871I
M;F<@:6X@<F5S<&]N9&EN9R!T;R!T:&4@<W5B<&]E;F$N($EN(&%D9&ET:6]N
M+"!I;B!*86YU87)Y#0H@("`@,C`Q,"P@82!C;VUP;&%I;G0@=V%S('5N<V5A
M;&5D(&EN('1H92!5;FET960@4W1A=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T
M:&4@3F]R=&AE<FX@1&ES=')I8W0@;V8-"B`@("!497AA<R!S965K:6YG(&1A
M;6%G97,@86=A:6YS="!#;W)D:7,@9F]R(&%L;&5G960@=FEO;&%T:6]N<R!O
M9B!T:&4@9F5D97)A;"!&86QS92!#;&%I;7,@06-T(&%N9`T*("`@('-E=F5R
M86P@<VEM:6QA<B!S=&%T92!L87=S(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@
M;6%R:V5T:6YG(&]F(&)I;&EA<GD@<W1E;G1S+B!4:&4@56YI=&5D(%-T871E
M<PT*("`@($1E<&%R=&UE;G0@;V8@2G5S=&EC92!A;F0@<V5V97)A;"!S=&%T
M97,@:&%V92!D96-L:6YE9"!T;R!I;G1E<G9E;F4@870@=&AI<R!T:6UE+B!)
M;B!!<')I;"8C,38P.S(P,3$L#0H@("`@=&AE($1I<W1R:6-T($-O=7)T(&9O
M<B!T:&4@3F]R=&AE<FX@1&ES=')I8W0@;V8@5&5X87,@9&ES;6ES<V5D('1H
M92!C;VUP;&%I;G0@=VET:&]U="!P<F5J=61I8V4N#0H@("`@/"]D:78^#0H@
M("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!M87)G:6XM=&]P.B`V<'0G/DEN($UA>28C,38P.S(P,#DL('1H92!.97<@
M2F5R<V5Y($%T=&]R;F5Y($=E;F5R86P@:7-S=65D(&$@<W5B<&]E;F$@=&\@
M1&50=7D@3W)T:&]P865D:6-S+"!);F,N+"!S965K:6YG#0H@("`@:6YF;W)M
M871I;VX@<F5G87)D:6YG('1H92!F:6YA;F-I86P@:6YT97)E<W0@;V8@8VQI
M;FEC86P@:6YV97-T:6=A=&]R<R!W:&\@<&5R9F]R;65D(&-L:6YI8V%L#0H@
M("`@<W1U9&EE<R!F;W(@1&50=7D@3W)T:&]P865D:6-S+"!);F,N(&%N9"!$
M95!U>2!3<&EN92P@26YC+B!$95!U>2!/<G1H;W!A961I8W,L($EN8RX@:&%S
M(')E<W!O;F1E9`T*("`@('1O('1H97-E(')E<75E<W1S+@T*("`@(#PO9&EV
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY);B!R96-E;G0@>65A<G,@=&AE($-O
M;7!A;GD@:&%S(')E8V5I=F5D(&YU;65R;W5S(')E<75E<W1S(&9R;VT@82!V
M87)I971Y(&]F(%5N:71E9"!3=&%T97,-"B`@("!#;VYG<F5S<VEO;F%L($-O
M;6UI='1E97,@=&\@<')O9'5C92!I;F9O<FUA=&EO;B!R96QE=F%N="!T;R!O
M;F=O:6YG(&-O;F=R97-S:6]N86P@:6YQ=6ER:65S+B!)="!I<PT*("`@('1H
M92!#;VUP86YY)B,X,C$W.W,@<&]L:6-Y('1O(&-O;W!E<F%T92!W:71H('1H
M97-E(&EN<75I<FEE<R!B>2!P<F]D=6-I;F<@=&AE(')E<75E<W1E9"!I;F9O
M<FUA=&EO;BX-"B`@("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM/@T*("`@
M(#PA+2T@+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)2
M14%+("TM/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#$R
M<'0G/CQU/CQB/D=%3D5204P@3$E424=!5$E/3CPO8CX\+W4^#0H@("`@/"]D
M:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN(%-E<'1E;6)E<B8C,38P.S(P
M,#0L(%!L86EN=&EF9G,L(&EN(&%N(&5M<&QO>6UE;G0@9&ES8W)I;6EN871I
M;VX@;&ET:6=A=&EO;B!I;FET:6%T960@86=A:6YS="!T:&4-"B`@("!#;VUP
M86YY(&EN(#(P,#$@:6X@=&AE(%5N:71E9"!3=&%T97,@1&ES=')I8W0@0V]U
M<G0@9F]R('1H92!$:7-T<FEC="!O9B!.97<@2F5R<V5Y+"!M;W9E9"!T;PT*
M("`@(&-E<G1I9GD@82!C;&%S<R!O9B!A;&P@069R:6-A;B!!;65R:6-A;B!A
M;F0@2&ES<&%N:6,@<V%L87)I960@96UP;&]Y965S(&]F('1H92!#;VUP86YY
M(&%N9"!I=',-"B`@("!A9F9I;&EA=&5S(&EN('1H92!5;FET960@4W1A=&5S
M+"!W:&\@=V5R92!E;7!L;WEE9"!A="!A;GD@=&EM92!F<F]M($YO=F5M8F5R
M)B,Q-C`[,3DY-R!T;R!T:&4@<')E<V5N="X-"B`@("!0;&%I;G1I9F9S('-E
M96L@;6]N971A<GD@9&%M86=E<R!F;W(@=&AE('!E<FEO9"`Q.3DW('1H<F]U
M9V@@=&AE('!R97-E;G0@*&EN8VQU9&EN9R!P=6YI=&EV90T*("`@(&1A;6%G
M97,I(&%N9"!E<75I=&%B;&4@<F5L:65F+B!4:&4@0V]U<G0@9&5N:65D(%!L
M86EN=&EF9G,F(S@R,3<[(&-L87-S(&-E<G1I9FEC871I;VX@;6]T:6]N(&EN
M($1E8V5M8F5R#0H@("`@,C`P-B!A;F0@=&AE:7(@;6]T:6]N(&9O<B!R96-O
M;G-I9&5R871I;VX@:6X@07!R:6PF(S$V,#LR,#`W+B!0;&%I;G1I9F9S('-O
M=6=H="!T;R!A<'!E86P@=&AE<V4-"B`@("!D96-I<VEO;G,@86YD+"!I;B!!
M<')I;"8C,38P.S(P,#@L('1H92!#;W5R="!O9B!!<'!E86QS(')U;&5D('1H
M870@4&QA:6YT:69F<R8C.#(Q-SL@87!P96%L(&]F('1H92!D96YI86P@;V8-
M"B`@("!C;&%S<R!C97)T:69I8V%T:6]N('=A<R!U;G1I;65L>2X@26X@2G5L
M>28C,38P.S(P,#DL(%!L86EN=&EF9G,@9FEL960@82!M;W1I;VX@9F]R(&-E
M<G1I9FEC871I;VX@;V8@80T*("`@(&UO9&EF:65D(&-L87-S+"!W:&EC:"!T
M:&4@0V]M<&%N>2!O<'!O<V5D+B!4:&4@1&ES=')I8W0@0V]U<G0@9&5N:65D
M(%!L86EN=&EF9G,F(S@R,3<[(&UO=&EO;B!I;B!*=6QY#0H@("`@,C`Q,"P@
M86YD('1H92!#;W5R="!O9B!!<'!E86QS(&1E;FEE9"!0;&%I;G1I9F9S)B,X
M,C$W.R!R97%U97-T(&9O<B!L96%V92!T;R!A<'!E86P@=&AE(&1E;FEA;"!O
M9@T*("`@(&-E<G1I9FEC871I;VX@;V8@=&AE(&UO9&EF:65D(&-L87-S+B!)
M;B!-87DF(S$V,#LR,#$Q+"!T:&4@8V%S92!W87,@9&ES;6ES<V5D('=I=&@@
M<')E:G5D:6-E+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY3
M=&%R=&EN9R!I;B!*=6QY)B,Q-C`[,C`P-BP@9FEV92!L87=S=6ET<R!W97)E
M(&9I;&5D(&EN(%5N:71E9"!3=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H
M92!$:7-T<FEC="!O9@T*("`@($YE=R!*97)S97D@8GD@=F%R:6]U<R!E;7!L
M;WEE<G,@86YD(&5M<&QO>65E(&)E;F5F:70@<&QA;G,@86YD(&9U;F1S('-E
M96MI;F<@=&\@<F5C;W9E<B!A;6]U;G1S#0H@("`@=&AE>2!P86ED(&9O<B!2
M25-015)$04PF(S$W-#L@9F]R('!L86X@<&%R=&EC:7!A;G1S+B!);B!G96YE
M<F%L+"!0;&%I;G1I9F9S(&%L;&5G92!T:&%T('1H92!#;VUP86YY(&%N9`T*
M("`@(&-E<G1A:6X@;V8@:71S('!H87)M86-E=71I8V%L('-U8G-I9&EA<FEE
M<R!E;F=A9V5D(&EN(&]F9BUL86)E;"!M87)K971I;F<@;V8@4DE34$521$%,
M)B,Q-S0[(&EN#0H@("`@=FEO;&%T:6]N(&]F('1H92!F961E<F%L(&%N9"!.
M97<@2F5R<V5Y(%))0T\@<W1A='5T97,N($EN(&%D9&ET:6]N+"!0;&%I;G1I
M9F9S(&%S<V5R=&5D('9A<FEO=7,-"B`@("!S=&%T92!L87<@8VQA:6US+B!!
M;&P@;V8@=&AE(&-A<V5S('=E<F4@8V]N<V]L:61A=&5D(&EN=&\@;VYE(&-A
M<V4@<V5E:VEN9R!C;&%S<R!A8W1I;VX@<W1A='5S+"!B=70-"B`@("!S:&]R
M=&QY('1H97)E869T97(L(&]N92!A8W1I;VX@=V%S('9O;'5N=&%R:6QY(&1I
M<VUI<W-E9"X@26X@1&5C96UB97(F(S$V,#LR,#`X+"!T:&4@0V]U<G0@9&ES
M;6ES<V5D('1H90T*("`@(&%C=&EO;G,@;V8@=&AE(&9O=7(@<F5M86EN:6YG
M('!L86EN=&EF9G,N($EN($%P<FEL)B,Q-C`[,C`Q,"P@=&AO<V4@<&QA:6YT
M:69F<R!F:6QE9"!A(&YE=R!C;VYS;VQI9&%T960-"B`@("!C;&%S<R!A8W1I
M;VX@86=A:6YS="!T:&4@0V]M<&%N>2!A;F0@2F%N<W-E;BP@3"Y0+B`H;F]W
M($IA;G-S96X@4&AA<FUA8V5U=&EC86QS+"!);F,N("A*4$DI*3L@86YD#0H@
M("`@:6X@36%R8V@F(S$V,#LR,#$Q+"!T:&%T(&%C=&EO;B!W87,@9&ES;6ES
M<V5D+B!);B!!<')I;"8C,38P.S(P,3$L(&]N92!O9B!T:&]S92!P;&%I;G1I
M9F9S(&9I;&5D(&$@;F]T:6-E(&]F#0H@("`@87!P96%L('=I=&@@=&AE(%5N
M:71E9"!3=&%T97,@0V]U<G0@;V8@07!P96%L<R!F;W(@=&AE(%1H:7)D($-I
M<F-U:70N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DEN($%P
M<FEL)B,Q-C`[,C`P.2P@3W)T:&\M0VQI;FEC86P@1&EA9VYO<W1I8W,L($EN
M8RX@*$]#1"DF(S$V,#MR96-E:79E9"!A(&=R86YD(&IU<GD@<W5B<&]E;F$@
M9G)O;2!T:&4-"B`@("!5;FET960@4W1A=&5S($1E<&%R=&UE;G0@;V8@2G5S
M=&EC92P@06YT:71R=7-T($1I=FES:6]N+"!R97%U97-T:6YG(&1O8W5M96YT
M<R!A;F0@:6YF;W)M871I;VX@9F]R#0H@("`@=&AE('!E<FEO9"!B96=I;FYI
M;F<@4V5P=&5M8F5R)B,Q-C`[,2P@,C`P,"!T:')O=6=H('1H92!P<F5S96YT
M+"!P97)T86EN:6YG('1O(&%N(&EN=F5S=&EG871I;VX@;V8-"B`@("!A;&QE
M9V5D('9I;VQA=&EO;G,@;V8@=&AE(&%N=&ET<G5S="!L87=S(&EN('1H92!B
M;&]O9"!R96%G96YT<R!I;F1U<W1R>2X@3T-$(&-O;7!L:65D('=I=&@@=&AE
M#0H@("`@<W5B<&]E;F$N($EN($9E8G)U87)Y)B,Q-C`[,C`Q,2P@3T-$(')E
M8V5I=F5D(&$@;&5T=&5R(&9R;VT@=&AE($%N=&ET<G5S="!$:79I<VEO;B!I
M;F1I8V%T:6YG('1H870@:70-"B`@("!H860@8VQO<V5D(&ET<R!I;G9E<W1I
M9V%T:6]N(&EN($YO=F5M8F5R)B,Q-C`[,C`Q,"X@26X@2G5N928C,38P.S(P
M,#DL(&9O;&QO=VEN9R!T:&4@<'5B;&EC(&%N;F]U;F-E;65N=`T*("`@('1H
M870@3T-$(&AA9"!R96-E:79E9"!A(&=R86YD(&IU<GD@<W5B<&]E;F$L(&UU
M;'1I<&QE(&-L87-S(&%C=&EO;B!C;VUP;&%I;G1S('-E96MI;F<@9&%M86=E
M<R!F;W(-"B`@("!A;&QE9V5D('!R:6-E(&9I>&EN9R!W97)E(&9I;&5D(&%G
M86EN<W0@3T-$+B!4:&4@=F%R:6]U<R!C87-E<R!W97)E(&-O;G-O;&ED871E
M9"!F;W(@<')E+71R:6%L#0H@("`@<'5R<&]S97,@:6X@=&AE(%5N:71E9"!3
M=&%T97,@1&ES=')I8W0@0V]U<G0@9F]R('1H92!%87-T97)N($1I<W1R:6-T
M(&]F(%!E;FYS>6QV86YI82X@1&ES8V]V97)Y#0H@("`@:7,@;VYG;VEN9RX-
M"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X-"B`@("!-87DF
M(S$V,#LR,#`Y+"!#96YT;V-O<B!/<G1H;R!":6]T96-H($EN8RX@*&YO=R!*
M86YS<V5N($)I;W1E8V@L($EN8RX-"B`@("`H2D))*2D@8V]M;65N8V5D(&%N
M(&%R8FET<F%T:6]N#0H@("`@<')O8V5E9&EN9R!B969O<F4@=&AE($%M97)I
M8V%N($%R8FET<F%T:6]N($%S<V]C:6%T:6]N(&%G86EN<W0@4V-H97)I;F<M
M4&QO=6=H($-O<G!O<F%T:6]N(&%N9"!I=',-"B`@("!S=6)S:61I87)Y(%-C
M:&5R:6YG+5!L;W5G:"`H27)E;&%N9"D@0V]M<&%N>2`H8V]L;&5C=&EV96QY
M+"!38VAE<FEN9RU0;&]U9V@I+B!*0DD@86YD#0H@("`@4V-H97)I;F<M4&QO
M=6=H(&%R92!P87)T:65S('1O(&$@<V5R:65S(&]F(&%G<F5E;65N=',@*$1I
M<W1R:6)U=&EO;@T*("`@($%G<F5E;65N=',I('1H870@9W)A;G0@4V-H97)I
M;F<M4&QO=6=H('1H92!E>&-L=7-I=F4@<FEG:'0@=&\@9&ES=')I8G5T92!T
M:&4@9')U9W,@4D5-24-!1$4F(S$W-#L@86YD#0H@("`@4TE-4$].228C,3<T
M.R!W;W)L9'=I9&4L(&5X8V5P="!W:71H:6X@=&AE(%5N:71E9"!3=&%T97,L
M($IA<&%N+"!486EW86XL($EN9&]N97-I82P@86YD('1H92!096]P;&4F(S@R
M,3<[<PT*("`@(%)E<'5B;&EC(&]F($-H:6YA("AI;F-L=61I;F<@2&]N9R!+
M;VYG*2X@2D))(&1I<W1R:6)U=&5S(%)%34E#041%)B,Q-S0[(&%N9"!324U0
M3TY))B,Q-S0[+"!T:&4@;F5X=`T*("`@(&=E;F5R871I;VX@=')E871M96YT
M+"!W:71H:6X@=&AE(%5N:71E9"!3=&%T97,N($EN('1H92!A<F)I=')A=&EO
M;BP@2D))('-O=6=H="!A(&1E8VQA<F%T:6]N('1H870-"B`@("!T:&4@86=R
M965M96YT(&%N9"!M97)G97(@8F5T=V5E;B!-97)C:R`F(S`S.#L@0V\N+"!)
M;F,N("A-97)C:RD@86YD(%-C:&5R:6YG+5!L;W5G:"!C;VYS=&ET=71E9"!A
M(&-H86YG90T*("`@(&]F(&-O;G1R;VP@=6YD97(@=&AE('1E<FUS(&]F('1H
M92!$:7-T<FEB=71I;VX@06=R965M96YT<R!T:&%T('!E<FUI='1E9"!*0DD@
M=&\@=&5R;6EN871E('1H90T*("`@($%G<F5E;65N=',N($]N($%P<FEL)B,Q
M-C`[,34L(#(P,3$L('1H92!#;VUP86YY+"!*0DD@86YD($UE<F-K(&%N;F]U
M;F-E9"!A;B!A9W)E96UE;G0@=&\@86UE;F0@=&AE#0H@("`@1&ES=')I8G5T
M:6]N($%G<F5E;65N=',N(%1H:7,@86=R965M96YT(&-O;F-L=61E9"!T:&4@
M87)B:71R871I;VX@<')O8V5E9&EN9RX-"B`@("`\+V1I=CX-"B`@("`\(2TM
M($9O;&EO("TM/@T*("`@(#PA+2T@+T9O;&EO("TM/@T*("`@(#PO9&EV/@T*
M("`@(#PA+2T@4$%'14)214%+("TM/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&UA<F=I;BUT;W`Z(#9P="<^56YD97(@=&AE('1E<FUS(&]F('1H92!A;65N
M9&5D($1I<W1R:6)U=&EO;B!!9W)E96UE;G1S+"!E9F9E8W1I=F4@2G5L>28C
M,38P.S$L(#(P,3$L($UE<F-K)B,X,C$W.W,@<W5B<VED:6%R>2P-"B`@("!3
M8VAE<FEN9RU0;&]U9V@@*$ER96QA;F0I('=I;&P@<F5L:6YQ=6ES:"!E>&-L
M=7-I=F4@;6%R:V5T:6YG(')I9VAT<R!F;W(@4D5-24-!1$4F(S$W-#L@86YD
M(%-)35!/3DDF(S$W-#L@=&\-"B`@("!T:&4@0V]M<&%N>28C.#(Q-SMS($IA
M;G-S96X@<&AA<FUA8V5U=&EC86P@8V]M<&%N:65S(&EN('1E<G)I=&]R:65S
M(&EN8VQU9&EN9R!#86YA9&$L($-E;G1R86P@86YD(%-O=71H#0H@("`@06UE
M<FEC82P@=&AE($UI9&1L92!%87-T+"!!9G)I8V$@86YD($%S:6$@4&%C:69I
M8R`H<F5L:6YQ=6ES:&5D('1E<G)I=&]R:65S*2X@3F]T92P@:6X@2F%P86XL
M#0H@("`@26YD;VYE<VEA+"!A;F0@5&%I=V%N+"!*0DD@=VEL;"!C;VYT:6YU
M92!T;R!L:6-E;G-E(&1I<W1R:6)U=&EO;B!R:6=H=',@=&\@4D5-24-!1$4F
M(S$W-#L@86YD(%-)35!/3DDF(S$W-#L-"B`@("!T;R!-:71S=6)I<VAI(%1A
M;F%B92!0:&%R;6$@0V]R<&]R871I;VXN($UE<F-K('=I;&P@<F5T86EN(&5X
M8VQU<VEV92!M87)K971I;F<@<FEG:'1S('1H<F]U9VAO=70-"B`@("!%=7)O
M<&4L(%)U<W-I82!A;F0@5'5R:V5Y("AR971A:6YE9"!T97)R:71O<FEE<RDN
M(%1H92!R971A:6YE9"!T97)R:71O<FEE<R!R97!R97-E;G0@87!P<F]X:6UA
M=&5L>0T*("`@(#<P)B,Q-C`[<&5R8V5N="!O9B!-97)C:R8C.#(Q-SMS(#(P
M,3`@<F5V96YU92!O9B!A<'!R;WAI;6%T96QY("9N8G-P.R0R+C@F(S$V,#MB
M:6QL:6]N(&9R;VT@4D5-24-!1$4F(S$W-#L@86YD(%-)35!/3DDF(S$W-#LL
M('=H:6QE#0H@("`@=&AE(')E;&EN<75I<VAE9"!T97)R:71O<FEE<R!R97!R
M97-E;G0@87!P<F]X:6UA=&5L>2`S,"8C,38P.W!E<F-E;G0N($EN(&%D9&ET
M:6]N+"!B96=I;FYI;F<@2G5L>28C,38P.S$L#0H@("`@,C`Q,2P@86QL('!R
M;V9I="!D97)I=F5D(&9R;VT@365R8VLF(S@R,3<[<R!E>&-L=7-I=F4@9&ES
M=')I8G5T:6]N(&]F('1H92!T=V\@<')O9'5C=',@:6X@=&AE(')E=&%I;F5D
M#0H@("`@=&5R<FET;W)I97,@=VEL;"!B92!E<75A;&QY(&1I=FED960@8F5T
M=V5E;B!-97)C:R!A;F0@2D))+B!5;F1E<B!T:&4@<')I;W(@=&5R;7,@;V8@
M=&AE#0H@("`@1&ES=')I8G5T:6]N($%G<F5E;65N=',L('1H92!C;VYT<FEB
M=71I;VX@:6YC;VUE("AP<F]F:70I)B,Q-C`[<W!L:70L('=H:6-H('=A<R!A
M="`U."8C,38P.W!E<F-E;G0@=&\@365R8VL-"B`@("!A;F0@-#(F(S$V,#MP
M97)C96YT('1O($I"22P@=V]U;&0@:&%V92!D96-L:6YE9"!F;W(@365R8VL@
M86YD(&EN8W)E87-E9"!F;W(@2D))(&5A8V@@>65A<B!U;G1I;"`R,#$T+`T*
M("`@('=H96X@:70@=V]U;&0@:&%V92!B965N(&5Q=6%L;'D@9&EV:61E9"X@
M2D))(&%L<V\@<F5C96EV960@82!O;F4M=&EM92!P87EM96YT(&]F("9N8G-P
M.R0U,#`F(S$V,#MM:6QL:6]N(&EN#0H@("`@07!R:6PF(S$V,#LR,#$Q+"!W
M:&EC:"!W:6QL(&)E(&%M;W)T:7IE9"!O=F5R('1H92!P97)I;V0@;V8@=&AE
M(&%G<F5E;65N="X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^
M26X@07!R:6PF(S$V,#LR,#$P+"!A('!U=&%T:79E(&-L87-S(&%C=&EO;B!L
M87=S=6ET('=A<R!F:6QE9"!I;B!T:&4@56YI=&5D(%-T871E<R!$:7-T<FEC
M="!#;W5R="!F;W(-"B`@("!T:&4@3F]R=&AE<FX@1&ES=')I8W0@;V8@0V%L
M:69O<FYI82!B>2!R97!R97-E;G1A=&EV97,@;V8@;G5R<VEN9R!H;VUE(')E
M<VED96YT<R!O<B!T:&5I<B!E<W1A=&5S#0H@("`@86=A:6YS="!T:&4@0V]M
M<&%N>2P@3VUN:6-A<F4L($EN8RX@*$]M;FEC87)E*2P@86YD(&]T:&5R('5N
M:61E;G1I9FEE9"!C;VUP86YI97,@;W(@:6YD:79I9'5A;',N#0H@("`@26X@
M1F5B<G5A<GDF(S$V,#LR,#$Q+"!P;&%I;G1I9F9S(&9I;&5D(&$@<V5C;VYD
M(&%M96YD960@8V]M<&QA:6YT(&%S<V5R=&EN9R!T:&%T(&-E<G1A:6X@<F5B
M871E#0H@("`@86=R965M96YT<R!B971W965N('1H92!#;VUP86YY(&%N9"!/
M;6YI8V%R92!I;F-R96%S960@=&AE(&%M;W5N="!O9B!M;VYE>2!S<&5N="!O
M;B!P:&%R;6%C975T:6-A;',-"B`@("!B>2!T:&4@;G5R<VEN9R!H;VUE(')E
M<VED96YT<R!A;F0@=FEO;&%T960@=&AE(%-H97)M86X@06-T(&%N9"!T:&4@
M0V%L:69O<FYI82!"=7-I;F5S<R`F(S`S.#L-"B`@("!0<F]F97-S:6]N<R!#
M;V1E+B!4:&4@<V5C;VYD(&%M96YD960@8V]M<&QA:6YT(&%L<V\@87-S97)T
M<R!A(&-L86EM(&]F('5N:G5S="!E;G)I8VAM96YT+@T*("`@(%!L86EN=&EF
M9G,@<V5E:R!M=6QT:7!L92!F;W)M<R!O9B!M;VYE=&%R>2!A;F0@:6YJ=6YC
M=&EV92!R96QI968N(%1H92!#;VUP86YY(&UO=F5D('1O(&1I<VUI<W,@=&AE
M#0H@("`@<V5C;VYD(&%M96YD960@8V]M<&QA:6YT(&EN($UA<F-H)B,Q-C`[
M,C`Q,2X@02!H96%R:6YG(&ES('-E="!O;B!T:&4@;6]T:6]N('1O(&1I<VUI
M<W,@9F]R($%U9W5S="8C,38P.S(P,3$N#0H@("`@/"]D:78^#0H@("`@/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G
M:6XM=&]P.B`V<'0G/E-T87)T:6YG(&EN($%P<FEL)B,Q-C`[,C`Q,"P@82!N
M=6UB97(@;V8@<VAA<F5H;VQD97(@9&5R:79A=&EV92!L87=S=6ET<R!W97)E
M(&9I;&5D(&EN('1H92!5;FET960@4W1A=&5S#0H@("`@1&ES=')I8W0@0V]U
M<G0@9F]R('1H92!$:7-T<FEC="!O9B!.97<@2F5R<V5Y(&%G86EN<W0@8V5R
M=&%I;B!C=7)R96YT(&%N9"!F;W)M97(@9&ER96-T;W)S(&%N9`T*("`@(&]F
M9FEC97)S(&]F('1H92!#;VUP86YY+B!4:&4@0V]M<&%N>2!I<R!N86UE9"!A
M<R!A(&YO;6EN86P@9&5F96YD86YT+B!4:&5S92!A8W1I;VYS('=E<F4-"B`@
M("!C;VYS;VQI9&%T960@;VX@075G=7-T)B,Q-C`[,3<L(#(P,3`@:6YT;R!O
M;F4@;&%W<W5I=#H@/&D^26X@<F4@2F]H;G-O;B`F(S`S.#L@2F]H;G-O;B!3
M:&%R96AO;&1E<B!$97)I=F%T:79E#0H@("`@3&ET:6=A=&EO;CPO:3XN($%N
M(&%M96YD960@8V]N<V]L:61A=&5D(&-O;7!L86EN="!W87,@9FEL960@;VX@
M1&5C96UB97(F(S$V,#LQ-RP@,C`Q,"X@061D:71I;VYA;&QY+"!I;@T*("`@
M(%-E<'1E;6)E<B8C,38P.S(P,3`L(&%N;W1H97(@<VAA<F5H;VQD97(@9&5R
M:79A=&EV92!L87=S=6ET('=A<R!F:6QE9"!I;B!.97<@2F5R<V5Y(%-U<&5R
M:6]R($-O=7)T#0H@("`@86=A:6YS="!C97)T86EN(&-U<G)E;G0@86YD(&9O
M<FUE<B!D:7)E8W1O<G,@86YD(&]F9FEC97)S(&]F('1H92!#;VUP86YY+B!4
M:&4@0V]M<&%N>2!I<R!N86UE9"!A<R!A#0H@("`@;F]M:6YA;"!D969E;F1A
M;G0@:6X@=&AI<R!A8W1I;VX@87,@=V5L;"X@5&AE('!A<G1I97,@=&\@=&AI
M<R!A8W1I;VX@:&%V92!S=&EP=6QA=&5D('1H870@:70@<VAA;&P-"B`@("!B
M92!S=&%Y960@=6YT:6P@=&AE(#QI/DEN(')E($IO:&YS;VX@)B,P,S@[($IO
M:&YS;VX@4VAA<F5H;VQD97(@1&5R:79A=&EV92!,:71I9V%T:6]N(#PO:3YI
M<R!C;VUP;&5T96QY#0H@("`@<F5S;VQV960N#0H@("`@/"]D:78^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M
M87)G:6XM=&]P.B`V<'0G/E1H97-E('-H87)E:&]L9&5R(&1E<FEV871I=F4@
M86-T:6]N<R!A<F4@<VEM:6QA<B!I;B!T:&5I<B!C;&%I;7,@86YD(&-O;&QE
M8W1I=F5L>2!T:&5Y(&%S<V5R="!A#0H@("`@=F%R:65T>2!O9B!A;&QE9V5D
M(&)R96%C:&5S(&]F#0H@("`@9FED=6-I87)Y(&1U=&EE<RP@:6YC;'5D:6YG
M+"!A;6]N9R!O=&AE<B!T:&EN9W,L('1H870@=&AE(&1E9F5N9&%N=',-"B`@
M("!A;&QE9V5D;'D@96YG86=E9"!I;BP@87!P<F]V960@;V8L(&]R(&9A:6QE
M9"!T;R!R96UE9'D@;W(@<')E=F5N="!D969E8W1I=F4@;65D:6-A;"!D979I
M8V5S+`T*("`@(&EM<')O<&5R('!H87)M86-E=71I8V%L(')E8F%T97,L(&EM
M<')O<&5R(&]F9BUL86)E;"!M87)K971I;F<@;V8@<&AA<FUA8V5U=&EC86P@
M86YD(&UE9&EC86P@9&5V:6-E#0H@("`@<')O9'5C=',L('9I;VQA=&EO;G,@
M;V8@8W5R<F5N="!G;V]D(&UA;G5F86-T=7)I;F<@<')A8W1I8V4@<F5G=6QA
M=&EO;G,@=&AA="!R97-U;'1E9"!I;B!P<F]D=6-T#0H@("`@<F5C86QL<RP@
M86YD(&9A:6QE9"!T;R!D:7-C;&]S92!T:&4@869O<F5M96YT:6]N960@86QL
M96=E9"!M:7-C;VYD=6-T(&EN('1H92!#;VUP86YY)B,X,C$W.W,@9FEL:6YG
M<PT*("`@('5N9&5R('1H92!396-U<FET:65S($5X8VAA;F=E($%C="!O9B`Q
M.3,T+B!%86-H(&-O;7!L86EN="!S965K<R!A('9A<FEE='D@;V8@<F5L:65F
M+"!I;F-L=61I;F<-"B`@("!M;VYE=&%R>2!D86UA9V5S(&%N9"!C;W)P;W)A
M=&4@9V]V97)N86YC92!R969O<FUS+B!);B!&96)R=6%R>28C,38P.S(P,3$L
M('1H92!#;VUP86YY(&UO=F5D('1O(&1I<VUI<W,-"B`@("!T:&5S92!A8W1I
M;VYS(&]N('1H92!G<F]U;F1S+"`\:3YI;G1E<B!A;&EA/"]I/BP@=&AA="!T
M:&4@<&QA:6YT:69F<R!F86EL960@=&\@;6%K92!A(&1E;6%N9"!U<&]N('1H
M90T*("`@($)O87)D(&]F($1I<F5C=&]R<RX-"B`@("`\+V1I=CX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA
M<F=I;BUT;W`Z(#9P="<^26X@36%Y)B,Q-C`[,C`Q,2P@='=O(&%D9&ET:6]N
M86P@<VAA<F5H;VQD97(@9&5R:79A=&EV92!L87=S=6ET<R!W97)E(&9I;&5D
M(&EN('1H92!5;FET960@4W1A=&5S#0H@("`@1&ES=')I8W0@0V]U<G0@9F]R
M('1H92!$:7-T<FEC="!O9B!.97<@2F5R<V5Y(&%N9"!A;F]T:&5R('-H87)E
M:&]L9&5R(&1E<FEV871I=F4@;&%W<W5I="!W87,@9FEL960-"B`@("!I;B!.
M97<@2F5R<V5Y(%-U<&5R:6]R($-O=7)T+"!A;&P@;F%M:6YG('1H92!#;VUP
M86YY)B,X,C$W.W,@8W5R<F5N="!D:7)E8W1O<G,@87,@9&5F96YD86YT<R!A
M;F0@=&AE#0H@("`@0V]M<&%N>2!A<R!T:&4@;F]M:6YA;"!D969E;F1A;G0N
M(%1H92!C;VUP;&%I;G1S(&%L;&5G92!B<F5A8VAE<R!O9B!F:61U8VEA<GD@
M9'5T:65S(')E;&%T960@=&\-"B`@("!T:&4@0V]M<&%N>28C.#(Q-SMS(&-O
M;7!L:6%N8V4@=VET:"!T:&4@1F]R96EG;B!#;W)R=7!T(%!R86-T:6-E<R!!
M8W0@86YD('!A<G1I8VEP871I;VX@:6X@=&AE(%5N:71E9`T*("`@($YA=&EO
M;G,@27)A<2!/:6P@1F]R($9O;V0@4')O9W)A;2P@=&AA="!T:&4@0V]M<&%N
M>2!H87,@<W5F9F5R960@9&%M86=E<R!A<R!A(')E<W5L="!O9B!T:&]S90T*
M("`@(&%L;&5G960@8G)E86-H97,L(&%N9"!T:&%T('1H92!D969E;F1A;G1S
M(&9A:6QE9"!T;R!D:7-C;&]S92!T:&4@86QL96=E9"!M:7-C;VYD=6-T(&EN
M('1H90T*("`@($-O;7!A;GDF(S@R,3<[<R!F:6QI;F=S('5N9&5R('1H92!3
M96-U<FET:65S($5X8VAA;F=E($%C="!O9B`Q.3,T+B!0;&%I;G1I9F9S('-E
M96L@;6]N971A<GD@9&%M86=E<RP@86YD#0H@("`@;VYE('!L86EN=&EF9B!A
M;'-O('-E96MS(&-O<G!O<F%T92!G;W9E<FYA;F-E(')E9F]R;7,N(%1H92!#
M;VUP86YY(&EN=&5N9',@=&\@;6]V92!T;R!D:7-M:7-S('1H90T*("`@(&9E
M9&5R86P@;&%W<W5I=',@;VX@=&AE(&=R;W5N9',L(#QI/FEN=&5R(&%L:6$\
M+VD^+"!T:&%T('1H92!P;&%I;G1I9F9S(&9A:6QE9"!T;R!M86ME(&$@9&5M
M86YD('5P;VX@=&AE#0H@("`@0F]A<F0@;V8@1&ER96-T;W)S+B!4:&4@0V]M
M<&%N>2!I;G1E;F1S('1O(&UO=F4@=&\@9&ES;6ES<R!O<B!S=&%Y('1H92!S
M=&%T92!L87=S=6ET('!E;F1I;F<-"B`@("!R97-O;'5T:6]N(&]F('1H92!F
M961E<F%L(&QA=W-U:71S+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@
M-G!T)SY);B!*=6QY)B,Q-C`[(#(P,3$L(&EN('1H92`\:3Y);B!R92!*;VAN
M<V]N("8C,#,X.R!*;VAN<V]N(%-H87)E:&]L9&5R($1E<FEV871I=F4-"B`@
M("!,:71I9V%T:6]N(#PO:3YM871T97(L('1H92!#;VUP86YY(&9I;&5D(&$@
M<F5P;W)T('!R97!A<F5D(&)Y(&$@4W!E8VEA;"!#;VUM:71T964@;V8@=&AE
M($)O87)D(&]F($1I<F5C=&]R<RP@=VAI8V@@:6YV97-T:6=A=&5D#0H@("`@
M=&AE(&%L;&5G871I;VYS(&-O;G1A:6YE9"!I;B!T:&4@9&5R:79A=&EV92!A
M8W1I;VYS(&%N9"!I;B!A('-E<FEE<R!O9B!S:&%R96AO;&1E<B!L971T97)S
M('1H870@=&AE#0H@("`@0F]A<F0@<F5C96EV960@:6X@,C`Q,"!R86ES:6YG
M('-I;6EL87(@:7-S=65S+B!4:&4@4W!E8VEA;"!#;VUM:71T964@=V%S(&%S
M<VES=&5D(&EN(&ET<PT*("`@(&EN=F5S=&EG871I;VX@8GD@:6YD97!E;F1E
M;G0@8V]U;G-E;"X@5&AE(%-P96-I86P@0V]M;6ET=&5E)B,X,C$W.W,@<F5P
M;W)T(')E8V]M;65N9&5D.B!I*2!T:&%T('1H90T*("`@($-O;7!A;GD@<F5J
M96-T('1H92!S:&%R96AO;&1E<B!D96UA;F1S(&%N9"!T86ME('=H871E=F5R
M('-T97!S(&%R92!N96-E<W-A<GD@;W(@87!P<F]P<FEA=&4@=&\-"B`@("!S
M96-U<F4@9&ES;6ES<V%L(&]F('1H92!D97)I=F%T:79E(&QI=&EG871I;VX@
M86YD(&EI*2!T:&%T('1H92!";V%R9"!O9B!$:7)E8W1O<G,@8W)E871E(&$@
M;F5W#0H@("`@4F5G=6QA=&]R>2!A;F0@0V]M<&QI86YC92!#;VUM:71T964@
M8VAA<F=E9"!W:71H(')E<W!O;G-I8FEL:71Y#0H@("`@9F]R(&UO;FET;W)I
M;F<@86YD(&]V97)S:6=H="!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS($AE86QT
M:"!#87)E($-O;7!L:6%N8V4@86YD(%%U86QI='D@)B,P,S@[($-O;7!L:6%N
M8V4-"B`@("!S>7-T96US(&%N9"!I<W-U97,N(%1H92!#;VUP86YY)B,X,C$W
M.W,@0F]A<F0@;V8@1&ER96-T;W)S("!U;F%N:6UO=7-L>2!A9&]P=&5D('1H
M92!3<&5C:6%L($-O;6UI='1E928C.#(Q-SMS(')E8V]M;65N9&%T:6]N<RX-
M"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^4W1A<G1I;F<@:6X@
M36%Y)B,Q-C`[,C`Q,"P@;75L=&EP;&4@8V]M<&QA:6YT<R!S965K:6YG(&-L
M87-S(&%C=&EO;B!C97)T:69I8V%T:6]N(')E;&%T960@=&\@=&AE($UC3F5I
M;`T*("`@(')E8V%L;',@:&%V92!B965N(&9I;&5D(&%G86EN<W0@36-.96EL
M($-O;G-U;65R($AE86QT:&-A<F4@86YD(&-E<G1A:6X@869F:6QI871E<RP@
M:6YC;'5D:6YG('1H90T*("`@($-O;7!A;GDL(&EN('1H92!5;FET960@4W1A
M=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T:&4@16%S=&5R;B!$:7-T<FEC="!O
M9B!096YN<WEL=F%N:6$L('1H92!.;W)T:&5R;@T*("`@($1I<W1R:6-T(&]F
M#0H@("`@26QL:6YO:7,L('1H92!#96YT<F%L($1I<W1R:6-T(&]F($-A;&EF
M;W)N:6$L('1H92!3;W5T:&5R;B!$:7-T<FEC="!O9@T*("`@($]H:6\@86YD
M('1H90T*("`@($5A<W1E<FX@1&ES=')I8W0@;V8@36ES<V]U<FDN(%1H97-E
M(&-O;G-U;65R(&-O;7!L86EN=',@86QL96=E(&=E;F5R86QL>2!T:&%T('!U
M<F-H87-E<G,@;V8@=F%R:6]U<PT*("`@($UC3F5I;"!M961I8VEN97,@87)E
M(&]W960@;6]N971A<GD@9&%M86=E<R!A;F0@<&5N86QT:65S(&)E8V%U<V4@
M=&AE>2!P86ED('!R96UI=6T@<')I8V5S(&9O<@T*("`@(&1E9F5C=&EV92!M
M961I8V%T:6]N<R!R871H97(@=&AA;B!L97-S(&5X<&5N<VEV92!A;'1E<FYA
M=&EV92!M961I8V%T:6]N<RX@06QL(&)U="!O;F4@8V]M<&QA:6YT#0H@("`@
M<V5E:W,@8V5R=&EF:6-A=&EO;B!O9B!A(&YA=&EO;BUW:61E(&-L87-S(&]F
M('!U<F-H87-E<G,@;V8@=&AE<V4@;65D:6-I;F5S+"!W:&5R96%S(&]N92!C
M;VUP;&%I;G0L#0H@("`@=&AE($AA<G9E>2!C87-E+"!S965K<R!C97)T:69I
M8V%T:6]N(&]F(&$@8VQA<W,@;V8@36]T<FEN)B,Q-S0[($E"('!U<F-H87-E
M<G,@:6X@36ES<V]U<FDN($EN($]C=&]B97(-"B`@("`R,#$P+"!T:&4@2G5D
M:6-I86P@4&%N96P@;VX@375L=&ED:7-T<FEC="!,:71I9V%T:6]N("A*4$U,
M*28C,38P.V-O;G-O;&ED871E9"!A;&P@;V8@=&AE(&-O;G-U;65R#0H@("`@
M8V]M<&QA:6YT<RP@97AC97!T(&9O<B!T:&4@2&%R=F5Y(&-A<V4L('=H:6-H
M('=A<R!C;VYS;VQI9&%T960@:6X@36%R8V@F(S$V,#LR,#$Q+"!F;W(@<')E
M=')I86P-"B`@("!P<F]C965D:6YG<R!I;B!T:&4@56YI=&5D(%-T871E<R!$
M:7-T<FEC="!#;W5R="!F;W(@=&AE($5A<W1E<FX@1&ES=')I8W0@;V8@4&5N
M;G-Y;'9A;FEA+B!);@T*("`@($IA;G5A<GDF(S$V,#LR,#$Q+"!T:&4@<&QA
M:6YT:69F<R!I;B!A;&P@;V8@=&AE(&-A<V5S(&5X8V5P="!T:&4@2&%R=F5Y
M(&-A<V4@9FEL960@82`F(S@R,C`[0V]N<V]L:61A=&5D#0H@("`@06UE;F1E
M9"!#:79I;"!#;VYS=6UE<B!#;&%S<R8C,38P.T%C=&EO;B!#;VUP;&%I;G0F
M(S@R,C$[("A#04,I)B,Q-C`[;F%M:6YG(&%D9&ET:6]N86P@<&%R=&EE<R!A
M;F0@8VQA:6US+B!);B!*=6QY#0H@("`@,C`Q,2P@=&AE($-O=7)T(&=R86YT
M960@=&AE($-O;7!A;GDF(S@R,3<[<R!M;W1I;VX@=&\@9&ES;6ES<R!T:&4@
M0T%#('=I=&AO=70@<')E:G5D:6-E+"!B=70@<&5R;6ET=&5D#0H@("`@=&AE
M('!L86EN=&EF9G,@=&\@9FEL92!A;B!A;65N9&5D(&-O;7!L86EN="!W:71H
M:6X@=&AI<G1Y(&1A>7,@;V8@=&AE(&1I<VUI<W-A;"!O<F1E<BX-"B`@("`\
M+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^26X@4V5P=&5M8F5R)B,Q-C`[
M,C`Q,"P@82!S:&%R96AO;&1E<BP@4F]N86QD($UO;FLL(&9I;&5D(&$@;&%W
M<W5I="!I;B!T:&4@56YI=&5D(%-T871E<R!$:7-T<FEC="!#;W5R=`T*("`@
M(&9O<B!T:&4@1&ES=')I8W0@;V8@3F5W($IE<G-E>2!S965K:6YG(&-L87-S
M(&-E<G1I9FEC871I;VX@86YD(&%L;&5G:6YG('1H870@=&AE($-O;7!A;GD@
M86YD#0H@("`@8V5R=&%I;B!I;F1I=FED=6%L<RP@:6YC;'5D:6YG(&5X96-U
M=&EV92!O9F9I8V5R<R!A;F0@96UP;&]Y965S(&]F('1H92!#;VUP86YY+"!F
M86EL960@=&\@9&ES8VQO<V4-"B`@("!T:&%T(&$@;G5M8F5R(&]F(&UA;G5F
M86-T=7)I;F<@9F%C:6QI=&EE<R!W97)E(&9A:6QI;F<@=&\@;6%I;G1A:6X@
M8W5R<F5N="!G;V]D(&UA;G5F86-T=7)I;F<-"B`@("!P<F%C=&EC97,L(&%N
M9"!T:&%T(&%S(&$@<F5S=6QT+"!T:&4@<')I8V4@;V8@=&AE($-O;7!A;GDF
M(S@R,3<[<R!S=&]C:R!H87,@9&5C;&EN960@<VEG;FEF:6-A;G1L>2X-"B`@
M("!0;&%I;G1I9F8@<V5E:W,@=&\@<'5R<W5E(')E;65D:65S('5N9&5R('1H
M92!396-U<FET:65S($5X8VAA;F=E($%C="!O9B`Q.3,T('1O(')E8V]V97(@
M:&ES(&%L;&5G960-"B`@("!E8V]N;VUI8R!L;W-S97,N($EN($UA>28C,38P
M.S(P,3$L('1H92!#;VUP86YY(&9I;&5D(&$@;6]T:6]N('1O(&1I<VUI<W,L
M('=H:6-H(&ES('!E;F1I;F<@8F5F;W)E('1H90T*("`@($-O=7)T+@T*("`@
M(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY);B!!<')I;"8C,38P.S(P
M,3$L($]-2B!0:&%R;6%C975T:6-A;',L($EN8RX@*$]-2B!04BD@9FEL960@
M82!L87=S=6ET(&%G86EN<W0@=&AE(%5N:71E9"!3=&%T97,@:6X-"B`@("!5
M;FET960@4W1A=&5S($1I<W1R:6-T($-O=7)T(&9O<B!T:&4@1&ES=')I8W0@
M;V8@4'5E<G1O(%)I8V\@86QL96=I;F<@;W9E<G!A>6UE;G0@;V8@9F5D97)A
M;"!I;F-O;64-"B`@("!T87AE<R!F;W(@=&AE('1A>"!Y96%R<R!E;F1E9"!.
M;W9E;6)E<B8C,38P.S,P+"`Q.3DY(&%N9"!.;W9E;6)E<B8C,38P.S,P+"`R
M,#`P+B!/34H@4%(@86QL96=E<R!T:&%T('1H90T*("`@($EN=&5R;F%L(%)E
M=F5N=64@4V5R=FEC92!E<G)O;F5O=7-L>2!C86QC=6QA=&5D($]-2B!04B8C
M.#(Q-SMS('1A>"!C<F5D:71S('5N9&5R(%-E8W1I;VXF(S$V,#LY,S8@;V8@
M=&AE(%1A>`T*("`@($-O9&4N#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P
M.B`V<'0G/DEN($%U9W5S=`T*("`@(#(P,3$L(&%N(&%R8FET<F%T:6]N('!A
M;F5L(')U;&5D('1H870@36ET<W5B:7-H:2!486YA8F4@4&AA<FUA#0H@("`@
M0V]R<&]R871I;VX@*%1A;F%B92DL($I"228C.#(Q-SMS(&1I<W1R:6)U=&]R
M(&]F(%)%34E#041%/'-U<"!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R
M=&EC86PM86QI9VXZ('1E>'0M=&]P)SXF(S$W-#L@/"]S=7`^(&EN#0H@("`@
M2F%P86XL(&-O=6QD('-E96L@=&\@;6]D:69Y('1H92!P<F]P;W)T:6]N(&]F
M(&YE="!S86QE<R!R979E;G5E('1H870-"B`@("!486YA8F4@;75S="!R96UI
M="!T;R!*0DD@:6X@97AC:&%N9V4@9F]R(&1I<W1R:6)U=&EO;B!R:6=H=',@
M86YD#0H@("`@8V]M;65R8VEA;"!S=7!P;'D@;V8@4D5-24-!1$4\<W5P('-T
M>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T:6-A;"UA;&EG;CH@=&5X="UT
M;W`G/B8C,3<T.R`\+W-U<#X@*'1H92!3=7!P;'D@4')I8V4I+B!486YA8F4-
M"B`@("!C;VUM96YC960@=&AE(&%R8FET<F%T:6]N(&%G86EN<W0@2D))(&EN
M(#(P,#D@<'5R<W5A;G0@=&\@=&AE#0H@("`@<&%R=&EE<R8C.#(Q-SL@9&ES
M=')I8G5T:6]N(&%G<F5E;65N="P@=VAI8V@@9W)A;G1S(%1A;F%B92!T:&4@
M<FEG:'0-"B`@("!T;R!D:7-T<FEB=71E(%)%34E#041%/'-U<"!S='EL93TS
M1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M=&]P)SXF
M(S$W-#L@/"]S=7`^(&EN($IA<&%N(&%N9"!C97)T86EN(&]T:&5R('!A<G1S
M(&]F#0H@("`@07-I82X@2D))(&AA<R!C;W5N=&5R8VQA:6UE9"!F;W(@86X@
M:6YC<F5A<V4@:6X@=&AE(%-U<'!L>2!0<FEC92X@5&AE#0H@("`@87)B:71R
M871I;VX@:&5A<FEN9R!T;R!D971E<FUI;F4@=&AE(&%P<')O<')I871E('-P
M;&ET(&]F(')E=F5N=64@:7,-"B`@("!S8VAE9'5L960@9F]R($YO=F5M8F5R
M(#(P,3$L(&%N9"!A(&1E8VES:6]N(&ES(&%N=&EC:7!A=&5D(&EN(#(P,3(N
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!#;VUP86YY
M(&]R(&ET<R!S=6)S:61I87)I97,@87)E(&%L<V\@<&%R=&EE<R!T;R!A(&YU
M;6)E<B!O9B!P<F]C965D:6YG<R!B<F]U9VAT('5N9&5R('1H90T*("`@($-O
M;7!R96AE;G-I=F4@16YV:7)O;FUE;G1A;"!297-P;VYS92P@0V]M<&5N<V%T
M:6]N+"!A;F0@3&EA8FEL:71Y($%C="P@8V]M;6]N;'D@:VYO=VX@87,@4W5P
M97)F=6YD+`T*("`@(&%N9"!C;VUP87)A8FQE('-T871E+"!L;V-A;"!O<B!F
M;W)E:6=N(&QA=W,@:6X@=VAI8V@@=&AE('!R:6UA<GD@<F5L:65F('-O=6=H
M="!I<R!T:&4@8V]S="!O9B!P87-T#0H@("`@86YD+V]R(&9U='5R92!R96UE
M9&EA=&EO;BX-"B`@("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F
M7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S
M+U=O<FMS:&5E=',O4VAE970Q."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P139!04,^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4F5S=')U8W1U<FEN9SQB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E<W1R=6-T=7)I
M;F<@86YD(%)E;&%T960@06-T:79I=&EE<R!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)%4U1254-455))
M3D<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$
M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A
M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$
M5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G
M:6X@0FQO8VL@5&%G9V5D($YO=&4@,3(@+2!U<RUG86%P.E)E<W1R=6-T=7)I
M;F=!;F1296QA=&5D06-T:79I=&EE<T1I<V-L;W-U<F5497AT0FQO8VLM+3X-
M"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%
M(#$R("8C.#(Q,CL@4D535%)50U154DE.1PT*("`@(#PO9&EV/@T*("`@(#QD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R
M9VEN+71O<#H@-G!T)SY);B!T:&4@9FES8V%L('-E8V]N9"!Q=6%R=&5R(&]F
M(#(P,3$L($-O<F1I<R!#;W)P;W)A=&EO;BP@82!S=6)S:61I87)Y(&]F($IO
M:&YS;VX@)B,P,S@[($IO:&YS;VXL#0H@("`@86YN;W5N8V5D('1H92!D:7-C
M;VYT:6YU871I;VX@;V8@:71S(&-L:6YI8V%L(&1E=F5L;W!M96YT('!R;V=R
M86T@9F]R('1H92!.159/)B,X-#@R.R!3:7)O;&EM=7,M16QU=&EN9PT*("`@
M($-O<F]N87)Y(%-T96YT(&%N9"!C97-S871I;VX@;V8@=&AE(&UA;G5F86-T
M=7)E(&%N9"!M87)K971I;F<@;V8@0UE02$52)B,Q-S0[(&%N9"!#65!(15(-
M"B`@("!314Q%0U0\<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T
M:6-A;"UA;&EG;CH@=&5X="UT;W`G/B8C,3<T.R`\+W-U<#Y0;'5S(%-I<F]L
M:6UU<RU%;'5T:6YG($-O<F]N87)Y(%-T96YT<R!B>2!T:&4@96YD(&]F(#(P
M,3$N(%1H:7,@=VEL;"!A;&QO=R!T:&4-"B`@("!#;VUP86YY('1O(&9O8W5S
M(&]N(&]T:&5R(&-A<F1I;W9A<V-U;&%R('1H97)A<&EE<R!W:&5R92!S:6=N
M:69I8V%N="!P871I96YT(&YE961S(&5X:7-T+@T*("`@(#PO9&EV/@T*("`@
M(#PA+2T@1F]L:6\@+2T^#0H@("`@/"$M+2`O1F]L:6\@+2T^#0H@("`@/"]D
M:78^#0H@("`@/"$M+2!004=%0E)%04L@+2T^#0H@("`@/&1I=B!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY!<R!A#0H@("`@<F5S=6QT(&]F('1H
M92!A8F]V92!M96YT:6]N960@<F5S=')U8W1U<FEN9R!P;&%N(&%N;F]U;F-E
M9"!B>2!#;W)D:7,-"B`@("!#;W)P;W)A=&EO;BP@=&AE($-O;7!A;GD@<F5C
M;W)D960@)FYB<W`[)#8W-B8C,38P.VUI;&QI;VX@:6X@<F5L871E9"!P<F4M
M=&%X(&-H87)G97,L(&]F('=H:6-H(&%P<')O>&EM871E;'D-"B`@("`F;F)S
M<#LD,38T)B,Q-C`[;6EL;&EO;B!O9B!T:&4@<')E+71A>"!R97-T<G5C='5R
M:6YG(&-H87)G97,@<F5Q=6ER92!C87-H('!A>6UE;G1S+B!4:&4@)FYB<W`[
M)#8W-B8C,38P.VUI;&QI;VX@;V8-"B`@("!R97-T<G5C='5R:6YG(&-H87)G
M97,@8V]N<VES=',@;V8@87-S970@=W)I=&4M;V9F<R!O9B`F;F)S<#LD-3$R
M)B,Q-C`[;6EL;&EO;B!A;F0@)FYB<W`[)#$V-"8C,38P.VUI;&QI;VX@<F5L
M871E9"!T;PT*("`@(&QE87-E:&]L9"!A;F0@8V]N=')A8W0@;V)L:6=A=&EO
M;G,@86YD(&]T:&5R(&5X<&5N<V5S+B!4:&4@)FYB<W`[)#4Q,B8C,38P.VUI
M;&QI;VX@;V8@87-S970@=W)I=&4M;V9F<R!R96QA=&4-"B`@("!T;R!P<F]P
M97)T>2P@<&QA;G0@86YD(&5Q=6EP;65N="!O9B`F;F)S<#LD,C8U)B,Q-C`[
M;6EL;&EO;BP@:6YT86YG:6)L92!A<W-E=',@;V8@)FYB<W`[)#$V,"8C,38P
M.VUI;&QI;VX@86YD(&EN=F5N=&]R>0T*("`@(&]F("9N8G-P.R0X-R8C,38P
M.VUI;&QI;VX@*')E8V]R9&5D(&EN(&-O<W0@;V8@<')O9'5C=',@<V]L9"DN
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!F;VQL;W=I
M;F<@=&%B;&4@<W5M;6%R:7IE<R!T:&4@<V5V97)A;F-E(')E<V5R=F5S(&%S
M<V]C:6%T960@=VET:"!T:&4@<F5S=')U8W1U<FEN9R!P;&%N#0H@("`@<F5C
M;W)D960@:6X@=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,#DN#0H@("`@/"]D
M:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C96QL
M<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@("`\
M='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#@X)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@
M(S`P,#`P,"<^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P
M>"!S;VQI9"`C,#`P,#`P)SY3979E<F%N8V4\+W1D/@T*("`@(#PO='(^#0H@
M("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A
M8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M4F5S97)V92!B86QA;F-E(&%S(&]F.@T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY*86YU87)Y)B,Q-C`[,BP@,C`Q,0T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,S0U/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/D-A<V@@;W5T;&%Y<PT*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^*#<W/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^2G5L>28C,38P.S,L(#(P,3$J#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR-C@\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%
M;F0@5&%B;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*
M("`@(#QD:78@86QI9VX],T1L969T/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N
M="US:7IE.B`S<'0[(&UA<F=I;BUT;W`Z(#$V<'0[('=I9'1H.B`Q."4[(&)O
M<F1E<BUT;W`Z(#%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L-"B`@("`\+V1I
M=CX-"B`@("`\+V1I=CX-"B`@("`\=&%B;&4@=VED=&@],T0Q,#`E(&)O<F1E
M<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(#QT
M<CX-"B`@("`\=&0@=VED=&@],T0S)3X\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#$E/CPO=&0^#0H@("`@/'1D('=I9'1H/3-$.38E/CPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1L969T/BH\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#Y296UA:6YI;F<@8V%S:"!O=71L87ES(&9O<B!S979E<F%N
M8V4@87)E(&5X<&5C=&5D('1O(&)E('!A:60@;W5T(&EN(&%C8V]R9&%N8V4@
M=VET:"!T:&4@0V]M<&%N>28C.#(Q-SMS#0H@("`@<&QA;G,@86YD(&QO8V%L
M(&QA=W,N/"]T9#X-"B`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@("`@/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G
M:6XM=&]P.B`V<'0G/D]F('1H92`W+#4P,"!P;W-I=&EO;G,@=&AE($-O;7!A
M;GD@<&QA;FYE9"!T;R!E;&EM:6YA=&4@:6X@=&AE(#(P,#D@<F5S=')U8W1U
M<FEN9R!P;&%N+`T*("`@(&%P<')O>&EM871E;'D@-2PW,#`@<&]S:71I;VYS
M(&AA=F4@8F5E;B!E;&EM:6YA=&5D(&%S(&]F($IU;'DF(S$V,#LS+"`R,#$Q
M+@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A
M-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H
M965T<R]3:&5E=#$Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D%!0SX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY3=6)S97%U96YT($5V96YT<SQB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U8G-E<75E;G0@179E
M;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4U5"4T51545.5"!%5D5.5%,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#
M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT
M='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I
M;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO
M=&4@,3,@+2!U<RUG86%P.E-U8G-E<75E;G1%=F5N='-497AT0FQO8VLM+3X-
M"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY.3U1%
M(#$S("8C.#(Q,CL@4U5"4T51545.5"!%5D5.5%,-"B`@("`\+V1I=CX-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&UA<F=I;BUT;W`Z(#9P="<^3VX@2G5L>28C,38P.S<L(#(P,3$L('1H92!#
M;VUP86YY(&-O;7!L971E9"!T:&4@9&EV97-T:71U<F4@;V8@:71S($%N:6UA
M;"!(96%L=&@@8G5S:6YE<W,@=&\@16QA;F-O+"!A#0H@("`@1&EV:7-I;VX@
M;V8@16QI($QI;&QY+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T
M)SY/;B!*=6QY)B,Q-C`[,30L(#(P,3$L('1H92!#;VUP86YY(&-O;7!L971E
M9"!T:&4@86-Q=6ES:71I;VX@;V8@<V5V97)A;"!O=F5R+71H92UC;W5N=&5R
M(&-O=6=H(&%N9"!C;VQD#0H@("`@8G)A;F1S(&EN(%)U<W-I82!F<F]M($HN
M0BX@0VAE;6EC86QS(&%N9"!0:&%R;6%C975T:6-A;',@3'1D+@T*("`@(#PO
M9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY/;B!*=6QY)B,Q-C`[,34L(#(P
M,3$L('1H92!#;VUP86YY(&%N;F]U;F-E9"!T:&4@9&5F:6YI=&EV92!A9W)E
M96UE;G0@=&\@9&EV97-T('1H92!A<W-E=',@;V8@:71S($]R=&AO#0H@("`@
M1&5R;6%T;VQO9VEC<R!D:79I<VEO;B!I;B!T:&4@52Y3+B!T;R!S=6)S:61I
M87)I97,@;V8@5F%L96%N="!0:&%R;6%C975T:6-A;',@26YT97)N871I;VYA
M;"P@26YC+@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?
M-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O
M5V]R:W-H965T<R]3:&5E=#(P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4T9!0SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U
M;G1I;F<@4&]L:6-I97,@*%!O;&EC:65S*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF
M:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97-E;G1A=&EO
M;B!O9B!C;VUP<F5H96YS:79E(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U194$4@:'1M;"!054),24,@(BTO
M+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO
M+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L
M+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!";&]C:R!486=G960@06-C;W5N
M=&EN9R!0;VQI8WDZ($I.2BTR,#$Q,#<P,U]N;W1E,5]A8V-O=6YT:6YG7W!O
M;&EC>5]T86)L93$@+2!J;FHZ4F5Q=6ER96UE;G1S1F]R4')E<V5N=&%T:6]N
M3V9#;VUP<F5H96YS:79E26YC;VUE4&]L:6-Y5&5X=$)L;V-K+2T^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P
M.B`V<'0G/D1U<FEN9R!T:&4@9FES8V%L('-E8V]N9"!Q=6%R=&5R(&]F(#(P
M,3$L('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A<F0@
M*$9!4T(I(&ES<W5E9`T*("`@(&%M96YD;65N=',@=&\@=&AE(&1I<V-L;W-U
M<F4@<F5Q=6ER96UE;G1S(&9O<B!P<F5S96YT871I;VX@;V8@8V]M<')E:&5N
M<VEV92!I;F-O;64N(%1H92!A;65N9&UE;G0-"B`@("!R97%U:7)E<R!T:&%T
M(&%L;"!N;VXM;W=N97(@8VAA;F=E<R!I;B!S=&]C:VAO;&1E<G,F(S@R,3<[
M(&5Q=6ET>2!B92!P<F5S96YT960@96ET:&5R(&EN(&$@<VEN9VQE#0H@("`@
M8V]N=&EN=6]U<R!S=&%T96UE;G0@;V8@8V]M<')E:&5N<VEV92!I;F-O;64@
M;W(@:6X@='=O('-E<&%R871E(&)U="!C;VYS96-U=&EV92!S=&%T96UE;G1S
M+B!4:&ES#0H@("`@9W5I9&%N8V4@:7,@969F96-T:79E(')E=')O<W!E8W1I
M=F5L>2!F;W(@=&AE(&EN=&5R:6T@<&5R:6]D<R!A;F0@86YN=6%L('!E<FEO
M9',@8F5G:6YN:6YG(&%F=&5R#0H@("`@1&5C96UB97(F(S$V,#LQ-2P@,C`Q
M,2X@16%R;'D@861O<'1I;VX@:7,@<&5R;6ET=&5D+B!4:&4@861O<'1I;VX@
M;V8@=&AI<R!S=&%N9&%R9"!W:6QL(&YO="!H879E(&$-"B`@("!M871E<FEA
M;"!I;7!A8W0@;VX@=&AE($-O;7!A;GDF(S@R,3<[<R!R97-U;'1S(&]F(&]P
M97)A=&EO;G,L(&-A<V@@9FQO=W,@;W(@9FEN86YC:6%L('!O<VET:6]N+@T*
M("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<75I
M<F5M96YT<R!F;W(@8V]M;6]N(&9A:7(@=F%L=64@;65A<W5R96UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%
M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO
M;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT
M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO
M8VL@5&%G9V5D($%C8V]U;G1I;F<@4&]L:6-Y.B!*3DHM,C`Q,3`W,#-?;F]T
M93%?86-C;W5N=&EN9U]P;VQI8WE?=&%B;&4R("T@=7,M9V%A<#I&86ER5F%L
M=65/9D9I;F%N8VEA;$EN<W1R=6UE;G1S4&]L:6-Y+2T^#0H@("`@/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@
M3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G
M/D1U<FEN9R!T:&4@9FES8V%L('-E8V]N9"!Q=6%R=&5R(&]F(#(P,3$L('1H
M92!&05-"(&ES<W5E9"!A;65N9&UE;G1S('1O(&1I<V-L;W-U<F4@<F5Q=6ER
M96UE;G1S(&9O<@T*("`@(&-O;6UO;B!F86ER('9A;'5E(&UE87-U<F5M96YT
M+B!4:&5S92!A;65N9&UE;G1S(')E<W5L="!I;B!C;VYV97)G96YC92!O9B!F
M86ER('9A;'5E(&UE87-U<F5M96YT(&%N9`T*("`@(&1I<V-L;W-U<F4@<F5Q
M=6ER96UE;G1S(&)E='=E96X@52Y3+B!'04%0(&%N9"!)1E)3+B!4:&ES(&=U
M:61A;F-E(&ES(&5F9F5C=&EV92!P<F]S<&5C=&EV96QY(&9O<@T*("`@('1H
M92!I;G1E<FEM('!E<FEO9',@86YD(&%N;G5A;"!P97)I;V1S(&)E9VEN;FEN
M9R!A9G1E<B!$96-E;6)E<B8C,38P.S$U+"`R,#$Q+B!%87)L>2!A9&]P=&EO
M;B!I<PT*("`@('!R;VAI8FET960N(%1H92!A9&]P=&EO;B!O9B!T:&ES('-T
M86YD87)D(&ES(&YO="!E>'!E8W1E9"!T;R!H879E(&$@;6%T97)I86P@:6UP
M86-T(&]N('1H90T*("`@($-O;7!A;GDF(S@R,3<[<R!R97-U;'1S(&]F(&]P
M97)A=&EO;G,L(&-A<V@@9FQO=W,@;W(@9FEN86YC:6%L('!O<VET:6]N+@T*
M("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D;W!T
M:6]N(&]F('-T86YD87)D('5P9&%T92!R96QA=&5D('1O(')E=F5N=64@<F5C
M;V=N:71I;VX@=6YD97(@=&AE(&UI;&5S=&]N92!M971H;V0@86YD(&ET<R!I
M;7!A8W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA
M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@
M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL
M,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@
M0F5G:6X@0FQO8VL@5&%G9V5D($%C8V]U;G1I;F<@4&]L:6-Y.B!*3DHM,C`Q
M,3`W,#-?;F]T93%?86-C;W5N=&EN9U]P;VQI8WE?=&%B;&4S("T@=7,M9V%A
M<#I2979E;G5E4F5C;V=N:71I;VY0;VQI8WE497AT0FQO8VLM+3X-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@
M("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4
M:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#9P="<^1'5R:6YG('1H92!F:7-C86P@9FER<W0@<75A<G1E<B!O9B`R,#$Q
M+"!T:&4@0V]M<&%N>2!A9&]P=&5D('1H92!&05-"(&=U:61A;F-E(&%N9"!A
M;65N9&UE;G1S#0H@("`@:7-S=65D(')E;&%T960@=&\@<F5V96YU92!R96-O
M9VYI=&EO;B!U;F1E<B!T:&4@;6EL97-T;VYE(&UE=&AO9"X@5&AE(&]B:F5C
M=&EV92!O9B!T:&4@86-C;W5N=&EN9PT*("`@('-T86YD87)D('5P9&%T92!I
M<R!T;R!P<F]V:61E(&=U:61A;F-E(&]N(&1E9FEN:6YG(&$@;6EL97-T;VYE
M(&%N9"!D971E<FUI;FEN9R!W:&5N(&ET(&UA>2!B90T*("`@(&%P<')O<')I
M871E('1O(&%P<&QY('1H92!M:6QE<W1O;F4@;65T:&]D(&]F(')E=F5N=64@
M<F5C;V=N:71I;VX@9F]R(')E<V5A<F-H(&]R(&1E=F5L;W!M96YT#0H@("`@
M=')A;G-A8W1I;VYS+B!4:&ES('5P9&%T92!I<R!E9F9E8W1I=F4@;VX@82!P
M<F]S<&5C=&EV92!B87-I<R!F;W(@;6EL97-T;VYE<R!A8VAI979E9"!I;B!F
M:7-C86P-"B`@("!Y96%R<RP@86YD(&EN=&5R:6T@<&5R:6]D<R!W:71H:6X@
M=&AO<V4@>65A<G,L(&)E9VEN;FEN9R!O;B!O<B!A9G1E<B!*=6YE)B,Q-C`[
M,34L(#(P,3`N(%1H92!A9&]P=&EO;B!O9@T*("`@('1H:7,@<W1A;F1A<F0@
M9&ED(&YO="!H879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY
M)B,X,C$W.W,@<F5S=6QT<R!O9B!O<&5R871I;VYS+"!C87-H(&9L;W=S(&]R
M#0H@("`@9FEN86YC:6%L('!O<VET:6]N+@T*("`@(#PO9&EV/@T*("`@(#PO
M9&EV/@T*("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!H87)M86-E=71I8V%L(&9E97,@<&%I
M9"!T;R!T:&4@9V]V97)N;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^#0H@("`@/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O
M1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW
M,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@
M+2T^#0H@("`@/"$M+2!"96=I;B!";&]C:R!486=G960@06-C;W5N=&EN9R!0
M;VQI8WDZ($I.2BTR,#$Q,#<P,U]N;W1E,5]A8V-O=6YT:6YG7W!O;&EC>5]T
M86)L930@+2!J;FHZ4&AA<FUA8V5U=&EC86Q&965S4&%I9%1O1V]V97)N;65N
M=%!O;&EC>51E>'1";&]C:RTM/@T*("`@(#QD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.
M97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM
M97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY$=7)I;F<@=&AE(&9I
M<V-A;"!F:7)S="!Q=6%R=&5R(&]F(#(P,3$L('1H92!#;VUP86YY(&%D;W!T
M960@=&AE($9!4T(@9W5I9&%N8V4@;VX@:&]W#0H@("`@<&AA<FUA8V5U=&EC
M86P@8V]M<&%N:65S('-H;W5L9"!R96-O9VYI>F4@86YD(&-L87-S:69Y(&EN
M('1H92!#;VUP86YY)B,X,C$W.W,@9FEN86YC:6%L('-T871E;65N=',L('1H
M90T*("`@(&YO;BUD961U8W1I8FQE(&%N;G5A;"!F964@<&%I9"!T;R!T:&4@
M1V]V97)N;65N="!I;B!A8V-O<F1A;F-E('=I=&@@=&AE(%!A=&EE;G0@4')O
M=&5C=&EO;B!A;F0-"B`@("!!9F9O<F1A8FQE($-A<F4@06-T+"!A<R!A;65N
M9&5D(&)Y('1H92!(96%L=&@@0V%R92!A;F0@161U8V%T:6]N(%)E8V]N8VEL
M:6%T:6]N($%C="X@5&AI<R!F964@:7,-"B`@("!B87-E9"!O;B!A;B!A;&QO
M8V%T:6]N(&]F(&$@8V]M<&%N>28C.#(Q-SMS(&UA<FME="!S:&%R92!O9B!T
M;W1A;"!B<F%N9&5D('!R97-C<FEP=&EO;B!D<G5G('-A;&5S(&9R;VT-"B`@
M("!T:&4@<')I;W(@>65A<BX@5&AE(&5S=&EM871E9"!F964@=V%S(')E8V]R
M9&5D(&%S(&$@<V5L;&EN9RP@;6%R:V5T:6YG(&%N9"!A9&UI;FES=')A=&EV
M92!E>'!E;G-E#0H@("`@:6X@=&AE($-O;7!A;GDF(S@R,3<[<R!F:6YA;F-I
M86P@<W1A=&5M96YT(&%N9"!W:6QL(&)E(&%M;W)T:7IE9"!O;B!A('-T<F%I
M9VAT+6QI;F4@8F%S:7,@9F]R('1H92!Y96%R(&%S#0H@("`@<&5R('1H92!&
M05-"(&=U:61A;F-E+B!4:&4@861O<'1I;VX@;V8-"B`@("!T:&ES('-T86YD
M87)D(&1I9"!N;W0@:&%V92!A(&UA=&5R:6%L(&EM<&%C="!O;B!T:&4-"B`@
M("!#;VUP86YY)B,X,C$W.W,@<F5S=6QT<R!O9B!O<&5R871I;VYS+"!C87-H
M(&9L;W=S(&]R(&9I;F%N8VEA;"!P;W-I=&EO;BX-"B`@("`\+V1I=CX-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U
M,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V
M-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S+U=O<FMS:&5E=',O
M4VAE970R,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P139!04,^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^26YV96YT;W)I97,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G9E;G1O<FEE<R!;06)S
M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-U;6UA<GD@;V8@26YV96YT;W)I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M
M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z
M+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA
M;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@
M5&%B;&4Z($I.2BTR,#$Q,#<P,U]N;W1E,E]T86)L93$@+2!U<RUG86%P.E-C
M:&5D=6QE3V9);G9E;G1O<GE#=7)R96YT5&%B;&5497AT0FQO8VLM+3X-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^
M#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D
M97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M
M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D('=I9'1H/3-$-S8E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T
M>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$1O;&QA<G,@:6X@
M36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0@8V]L<W!A;CTS1#(^2G5L
M>2`S+"`R,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M<FEG:'0@8V]L<W!A;CTS1#(^2F%N=6%R>2`R+"`R,#$Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE
M($AE860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C
M965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E)A=R!M871E<FEA;',@86YD
M('-U<'!L:65S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1L969T/B9N8G-P.R0\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C$L,S@S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#`W,SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY';V]D<R!I;B!P<F]C97-S#0H@("`@
M/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#@Y-SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PT-C`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F
M)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1FEN:7-H960@9V]O9',-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L,3,S/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#@T-3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;"!I
M;G9E;G1O<FEE<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$;&5F=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XV+#0Q,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-2PS-S@\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@0F]D
M>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*
M("`@(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W
M,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F
M7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#(R+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%44-!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);G1A
M;F=I8FQE($%S<V5T<R!A;F0@1V]O9'=I;&P@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G1A;F=I
M8FQE($%S<V5T<R!A;F0@1V]O9'=I;&P@6T%B<W1R86-T73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1A;F=I8FQE(&%S
M<V5T<R!A;F0@1V]O9'=I;&P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14
M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM
M/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@5&%B;&4Z($I.
M2BTR,#$Q,#<P,U]N;W1E,U]T86)L93$@+2!U<RUG86%P.E-C:&5D=6QE3V9)
M;G1A;F=I8FQE07-S971S06YD1V]O9'=I;&Q486)L951E>'1";&]C:RTM/@T*
M("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF
M)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@
M86QI9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\
M(2TM($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0@=VED=&@],T0W-B4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2F%N
M=6%R>2`R+#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N
M="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$;&5F="!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`Q<'@@<V]L:60@(V9F9F9F9B<^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\(2TM($5N9"!486)L92!(96%D("TM/@T*("`@(#PA+2T@0F5G:6X@
M5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY);G1A;F=I8FQE(&%S<V5T<R!W:71H(&1E9FEN:71E(&QI=F5S.@T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY0871E;G1S(&%N9"!T<F%D96UA<FMS("8C.#(Q,CL@
M9W)O<W,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C<L-3(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XV+#8V,#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY,97-S(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;@T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPX,3D\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L-C(Y/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E!A=&5N=',@86YD
M('1R861E;6%R:W,@)B,X,C$R.R!N970-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C0L-S`Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XT+#`S,3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/CPA
M+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P
M.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY/=&AE<B!I;G1A;F=I8FQE<R`F(S@R,3([(&=R;W-S#0H@("`@/"]D
M:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XX+#8P.3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-RPV-S0\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^3&5S<R!A8V-U
M;75L871E9"!A;6]R=&EZ871I;VX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C,L,#0X/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR+#@X,#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY/=&AE<B!I;G1A;F=I8FQE<R`F(S@R,3([(&YE=`T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-2PU-C$\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0L-SDT/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1T;W`^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&%N9VEB;&4@87-S
M971S('=I=&@@:6YD969I;FET92!L:79E<SH-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5')A9&5M87)K<PT*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-BPP.#`\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4L.34T
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E!U<F-H
M87-E9"!I;BUP<F]C97-S(')E<V5A<F-H(&%N9"!D979E;&]P;65N=`T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPP,S8\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L.3,W
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F
M9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L(&EN=&%N9VEB;&4@87-S
M971S('=I=&@@:6YD969I;FET92!L:79E<PT*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^."PQ,38\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C<L.#DQ/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T;W`^
M/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q
M-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L(&EN=&%N9VEB;&4@87-S971S
M("8C.#(Q,CL@;F5T#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ."PS-S@\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$V+#<Q-CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L
M92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@/"]D
M:78^#0H@("`@/"]D:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&P\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#
M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT
M='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I
M;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO
M=&4@5&%B;&4Z($I.2BTR,#$Q,#<P,U]N;W1E,U]T86)L93(@+2!U<RUG86%P
M.E-C:&5D=6QE3V9';V]D=VEL;%1E>'1";&]C:RTM/@T*("`@(#QD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1C96YT
M97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@=&5X
M="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN(%1A
M8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0@=VED=&@],T0W-B4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS
M<&%N/3-$,SY-960@1&5V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G
M9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH1&]L;&%R<R!I;B!-:6QL:6]N
M<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0V]N<W5M97(\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^4&AA<FT\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^)B,P,S@[($1I86<\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^5&]T86P\+W1D/@T*("`@(#PO
M='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E
M9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^1V]O9'=I;&PL(&YE="!A="!*86YU87)Y)B,Q-C`[,BP@,C`Q,0T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^."PQ-#0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C$L,C(U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XU+#DR-3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,34L,CDT/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%C<75I<VET:6]N<PT*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3,X
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XU,S@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K
M9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0W5R<F5N
M8WD@=')A;G-L871I;VXO3W1H97(-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C,R,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-3(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C,Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT,3$\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1V]O9'=I;&PL(&YE="!A<R!O9B!*
M=6QY)B,Q-C`[,RP@,C`Q,0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^."PT-C0\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L.#$U/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#DV-#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,38L,C0S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F
M7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S
M+U=O<FMS:&5E=',O4VAE970R,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14)%04,^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^1F%I<B!686QU92!-96%S=7)E;65N=',@*%1A
M8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P
M,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT<R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U;6UA
M<GD@;V8@9&5S:6=N871E9"!D97)I=F%T:79E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U194$4@:'1M;"!054),24,@
M(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T
M<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO
M;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!";&]C:R!486=G960@3F]T
M92!486)L93H@2DY*+3(P,3$P-S`S7VYO=&4T7W1A8FQE,2`M('5S+6=A87`Z
M4V-H961U;&5/9D1E<FEV871I=F5);G-T<G5M96YT<T=A:6Y,;W-S26Y3=&%T
M96UE;G1/9D9I;F%N8VEA;%!E<F9O<FUA;F-E5&5X=$)L;V-K+2T^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*
M("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M
M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^5&AE(&9O
M;&QO=VEN9R!T86)L92!I<R!A('-U;6UA<GD@;V8@=&AE(&%C=&EV:71Y(')E
M;&%T960@=&\@9&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G97,@9F]R
M#0H@("`@=&AE(&9I<V-A;"!S96-O;F0@<75A<G1E<G,@:6X@,C`Q,2!A;F0@
M,C`Q,#H-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N=&5R/@T*
M("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI
M9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I;B!486)L92!(
M96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D('=I
M9'1H/3-$,C@E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/CQB/D=A:6XO("A,
M;W-S*3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^1V%I;B\@*$QO<W,I
M/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CYR96-L
M87-S:69I960\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W
M/CQB/D=A:6XO("A,;W-S*3PO8CX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M-SX\8CYR96-O9VYI>F5D(&EN/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C
M;VQS<&%N/3-$-SX\8CYF<F]M/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C
M;VQS<&%N/3-$-SX\8CYR96-O9VYI>F5D(&EN/"]B/CPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0W/CQB/D%C8W5M=6QA=&5D/"]B/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY!8V-U;75L871E9"!/0TD\+V(^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/CQB/F]T:&5R/"]B/CPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SX\8CY/0TD\+V(^/'-U<"!S='EL93TS
M1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M=&]P)SX\
M8CXH,2D\+V(^/"]S=7`^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F
M)SX\8CYI;G1O(&EN8V]M93PO8CX\<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@
M.#4E.R!V97)T:6-A;"UA;&EG;CH@=&5X="UT;W`G/CQB/B@Q*3PO8CX\+W-U
M<#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/CQB/FEN8V]M92]E
M>'!E;G-E/"]B/CQS=7`@<W1Y;&4],T0G9F]N="US:7IE.B`X-24[('9E<G1I
M8V%L+6%L:6=N.B!T97AT+71O<"<^*#(I/"]S=7`^/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$
M8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^1FES8V%L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/D9I<V-A;#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SY&:7-C86P\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^1FES
M8V%L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D9I<V-A;#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C86P\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SYS96-O;F0\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,^<V5C;VYD/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0S/G-E8V]N9#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SYS96-O;F0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^
M<V5C;VYD/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/G-E8V]N
M9#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE
M.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$;&5F="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@
M<V]L:60@(V9F9F9F9B<^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/G%U87)T97(\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^<75A<G1E<CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,SYQ=6%R=&5R/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/G%U87)T97(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^<75A<G1E<CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SYQ=6%R=&5R/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS
M1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/CQB/D-A<V@@1FQO=R!(961G
M97,\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SXR,#$P/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE
M($AE860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C
M965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D9O<F5I9VX@97AC:&%N9V4@
M8V]N=')A8W1S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^*#4S/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C
M.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH.3PO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/'-U8B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M8F]T=&]M)SXH02D\
M+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,C`\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@
M+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T
M.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X8VAA;F=E(&-O
M;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,3(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q,#(\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#0T/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@W-CPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/'-U8B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M8F]T=&]M)SXH0BD\
M+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/B@Q-#D\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U
M;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY&;W)E:6=N(&5X
M8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,C@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C0T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,C`\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[
M/'-U8B!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ
M('1E>'0M8F]T=&]M)SXH0RD\+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C$V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D-R;W-S(&-U<G)E;F-Y(&EN=&5R97-T
M(')A=&4@<W=A<',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@S,3PO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH.#(\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$V/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Q/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/B8C,38P.SQS=6(@<W1Y;&4],T0G
M9F]N="US:7IE.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O;2<^
M*$0I/"]S=6(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF
M(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@
M(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z
M+3$U<'@G/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH-SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS-3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<#XF(S$V,#L\<W5B('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E
M.R!V97)T:6-A;"UA;&EG;CH@=&5X="UB;W1T;VTG/BA%*3PO<W5B/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C`\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O
M='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^5&]T86P-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,34X/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XH-#`\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B@U-#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$S,SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#XI#0H@("`@/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@
M("`\+V1I=CX-"B`@("`\(2TM($9O;&EO("TM/@T*("`@(#PA+2T@+T9O;&EO
M("TM/@T*("`@(#PO9&EV/@T*("`@(#PA+2T@4$%'14)214%+("TM/@T*("`@
M(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG
M+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#!P="<^#0H@("`@06QL
M(&%M;W5N=',@<VAO=VX@:6X@=&AE('1A8FQE(&%B;W9E(&%R92!N970@;V8@
M=&%X+@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9F]L
M;&]W:6YG('1A8FQE(&ES(&$@<W5M;6%R>2!O9B!T:&4@86-T:79I='D@<F5L
M871E9"!T;R!D97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&AE9&=E<R!F;W(-
M"B`@("!T:&4@9FER<W0@9FES8V%L('-I>"!M;VYT:',@:6X@,C`Q,2!A;F0@
M,C`Q,#H-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N=&5R/@T*
M("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI
M9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I;B!486)L92!(
M96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D('=I
M9'1H/3-$,C@E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P
M.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/CQB/D=A:6XO("A,
M;W-S*3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<^/&(^1V%I;B\@*$QO<W,I
M/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CYR96-L
M87-S:69I960\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W
M/CQB/D=A:6XO("A,;W-S*3PO8CX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M-SX\8CYR96-O9VYI>F5D(&EN/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C
M;VQS<&%N/3-$-SX\8CYF<F]M/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C
M;VQS<&%N/3-$-SX\8CYR96-O9VYI>F5D(&EN/"]B/CPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0W/CQB/D%C8W5M=6QA=&5D/"]B/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$-SX\8CY!8V-U;75L871E9"!/0TD\+V(^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W/CQB/F]T:&5R/"]B/CPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SX\8CY/0TD\+V(^/'-U<"!S='EL93TS
M1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M=&]P)SX\
M8CXH,2D\+V(^/"]S=7`^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F
M)SX\8CYI;G1O(&EN8V]M93PO8CX\<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@
M.#4E.R!V97)T:6-A;"UA;&EG;CH@=&5X="UT;W`G/CQB/B@Q*3PO8CX\+W-U
M<#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#<@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/CQB/FEN8V]M92]E
M>'!E;G-E/"]B/CQS=7`@<W1Y;&4],T0G9F]N="US:7IE.B`X-24[('9E<G1I
M8V%L+6%L:6=N.B!T97AT+71O<"<^*#(I/"]S=7`^/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$
M8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^1FES8V%L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/D9I<V-A;#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SY&:7-C86P\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^1FES
M8V%L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D9I<V-A;#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY&:7-C86P\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SYS:7@\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^<VEX/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/G-I>#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYS:7@\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^<VEX/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/G-I>#PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^*$1O
M;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/FUO;G1H<SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SYM;VYT:',\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^;6]N
M=&AS/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/FUO;G1H<SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SYM;VYT:',\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^;6]N=&AS/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L
M969T/CQB/D-A<V@@1FQO=R!(961G97,\+V(^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^,C`Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$P/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#PA+2T@16YD(%1A8FQE($AE860@+2T^#0H@("`@/"$M+2!"96=I
M;B!486)L92!";V1Y("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR-SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@X-#PO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$P/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF;F)S
M<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,CD\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`^*3QS=6(@<W1Y;&4],T0G9F]N="US:7IE
M.B`X-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O;2<^*$$I/"]S=6(^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^*#(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/B@R,3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q
M-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D9O
M<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XY,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^*#(P-CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XH,3`V/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B@Y.#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI
M/'-U8B!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ
M('1E>'0M8F]T=&]M)SXH0BD\+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q-30\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^*#@\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-S,\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Y/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR,3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#XF(S$V,#L\<W5B('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V
M97)T:6-A;"UA;&EG;CH@=&5X="UB;W1T;VTG/BA#*3PO<W5B/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^*#(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^,38\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM($)L
M86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0W)O<W,@8W5R
M<F5N8WD@:6YT97)E<W0@<F%T92!S=V%P<PT*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^*#0P/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B@T.3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,3@\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,3$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[
M/'-U8B!S='EL93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ
M('1E>'0M8F]T=&]M)SXH1"D\+W-U8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM($)L
M86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C
M=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@U.3PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XX,3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#,\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`^*3QS=6(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M-24[('9E<G1I8V%L+6%L:6=N.B!T97AT+6)O='1O;2<^*$4I/"]S=6(^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XR/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR,#PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C
M,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4
M;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,3(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XH,3@U/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,3$X/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XH.38\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q,SD\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM
M($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^
M#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!M87)G:6XM=&]P.B`V<'0G/D%L;"!A;6]U;G1S('-H;W=N(&EN('1H
M92!T86)L92!A8F]V92!A<F4@;F5T(&]F('1A>"X-"B`@("`\+V1I=CX-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F=#X-"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,W!T.R!M87)G:6XM=&]P.B`Q-G!T.R!W:61T:#H@,3@E.R!B;W)D
M97(M=&]P.B`Q<'@@<V]L:60@(S`P,#`P,"<^)B,Q-C`[#0H@("`@/"]D:78^
M#0H@("`@/"]D:78^#0H@("`@/'1A8FQE('=I9'1H/3-$,3`P)2!B;W)D97(]
M,T0P(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`\='(^
M#0H@("`@/'1D('=I9'1H/3-$,R4^/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3X\+W1D/@T*("`@(#QT9"!W:61T:#TS1#DV)3X\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$;&5F=#XH,2D\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#Y%9F9E8W1I=F4@<&]R=&EO;CPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH,BD\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y);F5F9F5C=&EV92!P
M;W)T:6]N/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#-P="<^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1L969T/BA!*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/DEN8VQU9&5D(&EN(%-A;&5S('1O(&-U<W1O;65R<SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M;&5F=#XH0BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y)
M;F-L=61E9"!I;B!#;W-T(&]F('!R;V1U8W1S('-O;&0\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@,W!T)SX-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T
M;W`^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$,I
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^26YC;'5D960@
M:6X@4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&5X<&5N<V4\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@,W!T)SX-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1T;W`^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^
M*$0I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^26YC;'5D
M960@:6X@26YT97)E<W0@*&EN8V]M92DO26YT97)E<W0@97AP96YS92P@;F5T
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z
M(#-P="<^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1L969T/BA%*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/DEN8VQU9&5D(&EN($]T:&5R("AI;F-O;64I+V5X<&5N<V4L(&YE=#PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@
M(#PO9&EV/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9I;F%N8VEA;"!A<W-E=',@86YD(&QI86)I;&ET:65S
M(&%T(&9A:7(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!8
M2%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G
M+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*
M("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D($YO=&4@5&%B;&4Z($I.2BTR
M,#$Q,#<P,U]N;W1E-%]T86)L93(@+2!U<RUG86%P.E-C:&5D=6QE3V9$97)I
M=F%T:79E26YS=')U;65N='-);E-T871E;65N=$]F1FEN86YC:6%L4&]S:71I
M;VY&86ER5F%L=65497AT0FQO8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM
M97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@0V]M<&%N>28C.#(Q-SMS('-I
M9VYI9FEC86YT(&9I;F%N8VEA;"!A<W-E=',@86YD(&QI86)I;&ET:65S(&UE
M87-U<F5D(&%T(&9A:7(@=F%L=64@87,@;V8@2G5L>28C,38P.S,L#0H@("`@
M,C`Q,2!A;F0@2F%N=6%R>28C,38P.S(L(#(P,3$@=V5R92!A<R!F;VQL;W=S
M.@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1C96YT97(^#0H@("`@
M/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@=&5X="UA;&EG;CH@
M;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($AE860@
M+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@=VED=&@]
M,T0T,"4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0W('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#!P>"!S;VQI9"`C,#`P,#`P)SX\8CY*
M=6QY(#,L(#(P,3$\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/CQB
M/DIA;G5A<GD@,BP@,C`Q,3PO8CX\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@,'!X('-O;&ED(",P,#`P,#`G/BA$;VQL87)S(&EN
M($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,R!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(S`P,#`P,"<^/&(^
M3&5V96P@,3PO8CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED(",P,#`P,#`G/CQB
M/DQE=F5L(#(\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C,#`P,#`P)SX\
M8CY,979E;"`S/"]B/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(S`P,#`P,"<^
M/&(^5&]T86P\+V(^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C,#`P,#`P)SX\
M8CY4;W1A;#PO8CX\<W5P('-T>6QE/3-$)V9O;G0M<VEZ93H@.#4E.R!V97)T
M:6-A;"UA;&EG;CH@=&5X="UT;W`G/CQB/B@Q*3PO8CX\+W-U<#X\+W1D/@T*
M("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\
M(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^/&(^1&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G
M:6YG(&EN<W1R=6UE;G1S.CPO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^/&(^07-S971S.CPO8CX-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C
M=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q
M,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C0X-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-#@W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XS,C$\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^0W)O<W,@8W5R<F5N8WD@:6YT97)E<W0@
M<F%T92!S=V%P<SQS=7`@<W1Y;&4],T0G9F]N="US:7IE.B`X-24[('9E<G1I
M8V%L+6%L:6=N.B!T97AT+71O<"<^*#(I/"]S=7`^#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XQ-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SX\8CY4;W1A;#PO8CX-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0X
M.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^-#@Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XS,S@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X\(2TM($)L
M86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA
M<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXF(S$V,#L-"B`@
M("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@
M/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL
M93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^/&(^
M3&EA8FEL:71I97,Z/"]B/@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-C0V/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XV
M-#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C4X-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY#<F]S<R!C=7)R96YC>2!I;G1E<F5S="!R871E('-W87!S/'-U<"!S='EL
M93TS1"=F;VYT+7-I>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M=&]P
M)SXH,RD\+W-U<#X-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C0P-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#`T/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,#(\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^/&(^5&]T86P\+V(^#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+#`U,#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,2PP-3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$L,#@X/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C
M92`M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F
M=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/D1E<FEV871I
M=F5S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',Z/"]B
M/@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z
M("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SX\8CY!<W-E=',Z/"]B
M/@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<PT*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C@\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(X
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XQ.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY3=VES<R!&<F%N8R!/<'1I
M;VXJ#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R
M,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XU-CD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4V.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T
M.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3DW/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XU.3<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M
M+3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@
M/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X
M="UI;F1E;G0Z+3$U<'@G/CQB/DQI86)I;&ET:65S.CPO8CX-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^1F]R96EG;B!E
M>&-H86YG92!C;VYT<F%C=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C(W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR-SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,SD\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M/&(^3W1H97(@26YV97-T;65N=',\+V(^/'-U<"!S='EL93TS1"=F;VYT+7-I
M>F4Z(#@U)3L@=F5R=&EC86PM86QI9VXZ('1E>'0M=&]P)SX\8CXH-"D\+V(^
M/"]S=7`^#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ+#,W,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)B,X,C$R.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,2PS-S$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P
M.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L,38U/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A
M8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@("`\
M9&EV(&%L:6=N/3-$;&5F=#X-"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,W!T.R!M87)G:6XM=&]P.B`Q-G!T.R!W:61T:#H@,3@E.R!B;W)D97(M
M=&]P.B`Q<'@@<V]L:60@(S`P,#`P,"<^)B,Q-C`[#0H@("`@/"]D:78^#0H@
M("`@/"]D:78^#0H@("`@/'1A8FQE('=I9'1H/3-$,3`P)2!B;W)D97(],T0P
M(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)SX-"B`@("`\='(^#0H@
M("`@/'1D('=I9'1H/3-$,R4^/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3X\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#DV)3X\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$;&5F=#XJ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^0W5R<F5N8WD@;W!T:6]N(')E;&%T960@=&\@=&AE('!L86YN960@
M86-Q=6ES:71I;VX@;V8@4WEN=&AE<RP@26YC+CPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH,2D\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y!<R!O9B!*86YU87)Y
M)B,Q-C`[,BP@,C`Q,2P@=&AE<V4@87-S971S(&%N9"!L:6%B:6QI=&EE<R!A
M<F4@8VQA<W-I9FEE9"!A<R!,979E;"`R('=I=&@@=&AE(&5X8V5P=&EO;@T*
M("`@(&]F($]T:&5R($EN=F5S=&UE;G1S(&]F("9N8G-P.R0Q+#$V-2!W:&EC
M:"!A<F4@8VQA<W-I9FEE9"!A<R!,979E;"`Q+CPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH,BD\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#Y);F-L=61E<R`F;F)S
M<#LD,B8C,38P.VUI;&QI;VX@86YD("9N8G-P.R0Q-"8C,38P.VUI;&QI;VX@
M;V8@;F]N+6-U<G)E;G0@87-S971S(&9O<B!*=6QY)B,Q-C`[,RP@,C`Q,2!A
M;F0@2F%N=6%R>28C,38P.S(L(#(P,3$L#0H@("`@<F5S<&5C=&EV96QY+CPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`S
M<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$;&5F=#XH,RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#Y);F-L=61E<R`F;F)S<#LD-#`T)B,Q-C`[;6EL;&EO;B!A;F0@)FYB<W`[
M)#4P,B8C,38P.VUI;&QI;VX@;V8@;F]N+6-U<G)E;G0@;&EA8FEL:71I97,@
M9F]R($IU;'DF(S$V,#LS+"`R,#$Q(&%N9"!*86YU87)Y#0H@("`@,BP@,C`Q
M,2P@<F5S<&5C=&EV96QY+CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y
M;&4],T0G9F]N="US:7IE.B`S<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH-"D\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#Y#;&%S<VEF:65D(&%S(&YO;BUC=7)R96YT
M(&]T:&5R(&%S<V5T<RX\+W1D/@T*("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&:6YA;F-I86P@87-S971S
M(&%N9"!L:6%B:6QI=&EE<R!N;W0@;65A<W5R960@870@9F%I<B!V86QU93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!"
M;&]C:R!486=G960@3F]T92!486)L93H@2DY*+3(P,3$P-S`S7VYO=&4T7W1A
M8FQE,R`M('5S+6=A87`Z1F%I<E9A;'5E0GE"86QA;F-E4VAE971'<F]U<&EN
M9U1E>'1";&]C:RTM/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M
M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G
M:6XM=&]P.B`V<'0G/D9I;F%N8VEA;"!);G-T<G5M96YT<R!N;W0@;65A<W5R
M960@870@1F%I<B!686QU93H-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z
M(#9P="<^5&AE(&9O;&QO=VEN9R!F:6YA;F-I86P@87-S971S(&%N9"!L:6%B
M:6QI=&EE<R!A<F4@:&5L9"!A="!C87)R>6EN9R!A;6]U;G0@;VX@=&AE(&-O
M;G-O;&ED871E9`T*("`@(&)A;&%N8V4@<VAE970@87,@;V8@2G5L>28C,38P
M.S,L(#(P,3$Z#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E
M<CX-"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT
M+6%L:6=N.B!L969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL
M<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B
M;&4@2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT
M9"!W:61T:#TS1#<V)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CY#87)R>6EN9SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT(&-O;'-P86X]
M,T0R/D5S=&EM871E9#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG
M;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M;&5F=#XH1&]L;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M="!C;VQS<&%N/3-$,CY!;6]U;G0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CY&86ER(%9A;'5E/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD
M(%1A8FQE($AE860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N
M9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/D9I;F%N8VEA
M;"!!<W-E=',\+V(^#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/D-U<G)E;G0@26YV
M97-T;65N=',\+V(^#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@
M/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X
M="UI;F1E;G0Z+3$U<'@G/D-A<V@-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1&QE9G0^)FYB<W`[)#PO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPR.3D\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L,CDY/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D=O=F5R;FUE;G0@
M<V5C=7)I=&EE<R!A;F0@;V)L:6=A=&EO;G,-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C(S+#DU,3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C,L.34Q/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/D-O<G!O<F%T92!D96)T('-E8W5R:71I97,-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4Q-3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3$U/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DUO;F5Y(&UA<FME
M="!F=6YD<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,2PX,C`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$L.#(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R
M;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1I;64@9&5P
M;W-I=',-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L
M,#DW/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ+#`Y-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@
M+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY4;W1A;"!C87-H+"!C87-H(&5Q=6EV86QE;G1S(&%N9"!C=7)R96YT
M(&UA<FME=&%B;&4@<V5C=7)I=&EE<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$;&5F=#XF;F)S<#LD
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR.2PV.#(\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Y+#8X,CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9"!C;VQS<&%N/3-$.2!A;&EG;CTS1&QE9G0^1F%I<B!V86QU
M92!O9B!G;W9E<FYM96YT('-E8W5R:71I97,@86YD#0H@("`@;V)L:6=A=&EO
M;G,@86YD(&YO;BUC=7)R96YT(&UA<FME=&%B;&4-"B`@("!S96-U<FET:65S
M('=A<R!E<W1I;6%T960@=7-I;F<@<75O=&5D(&)R;VME<B!P<FEC97,-"B`@
M("!I;B!A8W1I=F4-"B`@("!M87)K971S+CPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SX\
M8CY&:6YA;F-I86P@3&EA8FEL:71I97,\+V(^#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/CQB/D-U<G)E;G0@1&5B
M=#PO8CX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1&QE9G0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^-2PP-#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4L,#0V/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/CQB/DYO;BU#=7)R96YT($1E8G0\+V(^#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G
M/C4N,34E($1E8F5N='5R97,@9'5E(#(P,3(-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C4Y.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-C,R/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C`N-S`E($YO=&5S(&1U92`R,#$S#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,#`\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4P,SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXS+C@P)2!$96)E;G1U<F5S(&1U92`R
M,#$S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,#`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C4R-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXS
M)B,Q-C`[;6]N=&@@3$E"3U(F(S`T,SLP)2!&4DX@9'5E(#(P,3,-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4P,#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3`P/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/C,F(S$V,#MM;VYT:"!,24)/4B8C,#0S.S`N
M,#DE($923B!D=64@,C`Q-`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^-S4P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XW-3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^,2XR,"4@3F]T97,@9'5E(#(P,30-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/CDY.3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PP,#8\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^,BXQ-24@3F]T97,@9'5E(#(P,38-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C@Y.#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^.3`S/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C4N-34E($1E8F5N='5R
M97,@9'5E(#(P,3<-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C$L,#`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ+#$V,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A
M8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXU+C$U
M)2!$96)E;G1U<F5S(&1U92`R,#$X#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XX.3@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C$L,#$U/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/C0N-S4E($YO=&5S(&1U92`R,#$Y("@Q0B!%
M=7)O(#$N-#0W-BD-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C$L-#0P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ+#4V.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A
M8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE
M/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXS)2!:
M97)O($-O=7!O;B!#;VYV97)T:6)L92!3=6)O<F1I;F%T960@1&5B96YT=7)E
M<R!D=64@:6X@,C`R,`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,3DW/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XR-#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^,BXY-24@1&5B96YT=7)E<R!D=64@,C`R,`T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-30Q/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU,C(\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^,RXU-24@3F]T97,@9'5E(#(P,C$-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0T-CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#4V/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C8N-S,E($1E8F5N='5R
M97,@9'5E(#(P,C,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C(U,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,S(S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R
M;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C4N-3`E($YO
M=&5S(&1U92`R,#(T("@U,#`@1T)0,2XV,#(U*0T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^-SDU/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XX-38\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^-BXY-24@3F]T97,@9'5E(#(P,CD-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Y-#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,S<U
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F
M9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C0N.34E($1E8F5N='5R97,@9'5E
M(#(P,S,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4P
M,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-3(S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G
M/C4N.34E($YO=&5S(&1U92`R,#,W#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XY.34\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C$L,3(P/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/C4N.#8E($1E8F5N='5R97,@9'5E(#(P,S@-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C<P,#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-S<S/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C0N-3`E($1E8F5N='5R97,@9'5E
M(#(P-#`-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4S
M.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^-#@Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/C0N.#4E($YO=&5S(&1U
M92`R,#0Q#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR
M.3@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C(Y,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY/=&AE<B`H26YC;'5D97,@26YD=7-T<FEA;"!2979E;G5E($)O;F1S*0T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-#$\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0Q/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT^/"$M+2!";&%N:R!3<&%C92`M+3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^)B,Q-C`[#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L($YO;BU#=7)R96YT($1E8G0-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1&QE9G0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,3,L-C@P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ-"PU.#$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@
M("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`@(#PO9&EV
M/@T*("`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D
M,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#(T+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%-D%!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY096YS:6]N<R!A;F0@
M3W1H97(@4&]S=')E=&ER96UE;G0@0F5N969I=',@*%1A8FQE<RD\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY096YS
M:6]N<R!A;F0@3W1H97(@0F5N969I="!0;&%N<R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;7!O;F5N
M=',@;V8@;F5T('!E<FEO9&EC(&)E;F5F:70@8V]S=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!";&]C:R!486=G960@
M3F]T92!486)L93H@2DY*+3(P,3$P-S`S7VYO=&4V7W1A8FQE,2`M('5S+6=A
M87`Z4V-H961U;&5/9DYE=$)E;F5F:71#;W-T<U1A8FQE5&5X=$)L;V-K+2T^
M#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R
M:68G/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.
M97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^
M0V]M<&]N96YT<R!O9B!.970@4&5R:6]D:6,@0F5N969I="!#;W-T#0H@("`@
M3F5T('!E<FEO9&EC(&)E;F5F:70@8V]S="!F;W(@=&AE($-O;7!A;GDF(S@R
M,3<[<R!D969I;F5D(&)E;F5F:70@<F5T:7)E;65N="!P;&%N<R!A;F0@;W1H
M97(@8F5N969I=`T*("`@('!L86YS(&9O<B!T:&4@9FES8V%L('-E8V]N9"!Q
M=6%R=&5R<R!O9B`R,#$Q(&%N9"`R,#$P(&EN8VQU9&4@=&AE(&9O;&QO=VEN
M9R!C;VUP;VYE;G1S.@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1C
M96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN
M(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0@=VED=&@],T0U,B4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T
M)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`Q<'@@<V]L:60@(V9F9F9F9B<^4F5T:7)E;65N="!0;&%N<SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^3W1H97(@0F5N969I="!0;&%N<SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P
M>"!S;VQI9"`C9F9F9F9F)SY&:7-C86P@475A<G1E<G,@16YD960\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^)B,Q-C`[/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,^2G5L>2`S+#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C
M;VQS<&%N/3-$,SY*=6QY(#0L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS
M1#,^2G5L>2`T+#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G
M9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F="!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^*$1O;&QA<G,@:6X@36EL;&EO;G,I
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%
M;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@
M+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O
M=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^4V5R=FEC92!C
M;W-T#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ-#0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C$R,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,S<\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,S/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R97-T(&-O<W0-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Q-#PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3DT/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT-CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-3`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F
M)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^17AP96-T960@<F5T=7)N(&]N('!L
M86X@87-S971S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,C<W/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@R-#@\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY!
M;6]R=&EZ871I;VX@;V8@<')I;W(@<V5R=FEC92!C;W-T+RAC<F5D:70I#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R
M,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3PO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C
M965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%M;W)T:7IA=&EO;B!O9B!N
M970@=')A;G-I=&EO;B!O8FQI9V%T:6]N#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E)E8V]G;FEZ960@
M86-T=6%R:6%L(&QO<W-E<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^.3@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C4Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XQ,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,3,\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^3F5T('!E<FEO9&EC(&)E;F5F:70@8V]S=`T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3@Q/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,S`\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/CDT/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XY-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@
M("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/DYE="!P97)I;V1I8R!B
M96YE9FET(&-O<W0@9F]R('1H92!#;VUP86YY)B,X,C$W.W,@9&5F:6YE9"!B
M96YE9FET(')E=&ER96UE;G0@<&QA;G,@86YD(&]T:&5R(&)E;F5F:70-"B`@
M("!P;&%N<R!F;W(@=&AE(&9I<G-T(&9I<V-A;"!S:7@@;6]N=&AS(&]F(#(P
M,3$@86YD(#(P,3`@:6YC;'5D92!T:&4@9F]L;&]W:6YG(&-O;7!O;F5N=',Z
M#0H@("`@/"]D:78^#0H@("`@/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\
M=&%B;&4@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L
M969T)R!C96QL<W!A8VEN9STS1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M
M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS
M1#4R)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C
M9F9F9F9F)SY2971I<F5M96YT(%!L86YS/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI
M9"`C9F9F9F9F)SY/=&AE<B!"96YE9FET(%!L86YS/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$
M8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#<@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F
M9F8G/D9I<V-A;"!3:7@@36]N=&AS($5N9&5D/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/DIU;'D@,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^
M2G5L>2`T+#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY
M(#,L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@
M.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O
M;&ED("-F9F9F9F8G/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SXR,#$P/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($AE
M860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F
M9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E-E<G9I8V4@8V]S=`T*("`@(#PO
M9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,C@W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XR-#<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C<T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XV-SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY);G1E<F5S="!C;W-T#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XT,C<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C,Y-#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^.30\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$P,#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY%>'!E8W1E9"!R971U<FX@;VX@<&QA;B!A<W-E=',-
M"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/B@U-34\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#4P,#PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3PO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%M;W)T:7IA=&EO
M;B!O9B!P<FEO<B!S97)V:6-E(&-O<W0O*&-R961I="D-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B@Q/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B@R/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@
M("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N
M=#HM,35P>"<^06UO<G1I>F%T:6]N(&]F(&YE="!T<F%N<VET:6]N(&]B;&EG
M871I;VX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^4F5C;V=N:7IE9"!A8W1U87)I86P@;&]S<V5S#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ.30\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Q-SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,C,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C(U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DYE="!P97)I;V1I8R!B
M96YE9FET(&-O<W0-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C,U.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,C8U/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ.#D\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$X.3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!4
M86)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@
M/"]D:78^#0H@("`@/"]D:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q
M-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y
M,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H
M965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$4V04%#/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/D%C8W5M=6QA=&5D($]T:&5R($-O;7!R96AE;G-I=F4@26YC;VUE("A4
M86)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@
M,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^06-C=6UU;&%T960@3W1H97(@0V]M<')E:&5N<VEV92!);F-O
M;64@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;VUP;VYE;G1S(&]F($%C8W5M=6QA=&5D($]T:&5R($-O
M;7!R96AE;G-I=F4@26YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X-"B`@("`\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$
M5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S
M+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M
M+3X-"B`@("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(%1A8FQE.B!*
M3DHM,C`Q,3`W,#-?;F]T93=?=&%B;&4Q("T@=7,M9V%A<#I38VAE9'5L94]F
M06-C=6UU;&%T961/=&AE<D-O;7!R96AE;G-I=F5);F-O;65,;W-S5&%B;&54
M97AT0FQO8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@
M86QI9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\
M(2TM($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0@=VED=&@],T0T,"4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X
M<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/E1O=&%L/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT
M+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L
M<W!A;CTS1#,^06-C=6T\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE
M/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<B!C;VQS<&%N/3-$,SY/=&AE<CPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/D9O<F5I9VX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^
M4V5C=7)I=&EE<SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY%
M;7!L;WEE93PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY$97)I
M=BX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^0V]M<"X\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T
M)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&QE9G0^1V%I;G,O*$QO<W-E<RD\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@8V]L<W!A;CTS1#,^0W5R<F5N8WD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^079A:6QA8FQE/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0S/D)E;F5F:70\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^)B,P,S@[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S
M/DEN8V]M92\\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O
M;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*$1O;&QA<G,@:6X@36EL;&EO;G,I
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E1R86YS;&%T:6]N
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/F9O<B!S86QE/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E!L86YS/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DAE9&=E<SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SXH3&]S<RD\+W1D/@T*("`@(#PO='(^#0H@
M("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A
M8FQE($)O9'D@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S
M='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^
M2F%N=6%R>28C,38P.S(L(#(P,3$-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH
M.38Y/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C(T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,BPV.#8\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3`P/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XH,RPU,S$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T
M.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SXR,#$Q('-I>"!M;VYT:',@8VAA
M;F=E#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N
M9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,S!P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E5N<F5A;&EZ960@
M9V%I;B`H;&]S<RD-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0S
M-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3(\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G
M:6XM;&5F=#HS,'!X.R!T97AT+6EN9&5N=#HM,35P>"<^3F5T(&%M;W5N="!R
M96-L87-S960@=&\@;F5T(&5A<FYI;F=S#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XF(S@R,3([/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XH,3,Y/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B8C.#(Q,CL\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C$Q-CPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<#XJ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/DYE="!S:7@@;6]N=&AS(&-H86YG90T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PW.#<\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(Y-CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3(X/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,C@\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C(L,S,Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G
M/DIU;'DF(S$V,#LS+"`R,#$Q#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XX,3@\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,R,#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^*#(L-34X/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(R.#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$L,3DR/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@
M/"$M+2!%;F0@5&%B;&4@0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO
M9&EV/@T*("`@(#QD:78@86QI9VX],T1L969T/@T*("`@(#QD:78@<W1Y;&4]
M,T0G9F]N="US:7IE.B`S<'0[(&UA<F=I;BUT;W`Z(#$V<'0[('=I9'1H.B`Q
M."4[(&)O<F1E<BUT;W`Z(#%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@("`\=&%B;&4@=VED=&@],T0Q,#`E
M(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*
M("`@(#QT<CX-"B`@("`\=&0@=VED=&@],T0S)3X\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/CPO=&0^#0H@("`@/'1D('=I9'1H/3-$.38E/CPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1L969T/BH\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#Y3=6)S=&%N=&EA;&QY(&]F9G-E="!I;B!N970@
M96%R;FEN9W,@8GD@8VAA;F=E<R!I;B!V86QU92!O9B!T:&4@=6YD97)L>6EN
M9R!T<F%N<V%C=&EO;G,N/"]T9#X-"B`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@("`@/"]D:78^#0H@("`@/"]D:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V
M9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE
M971S+U-H965T,C8N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V04%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D5A<FYI;F=S(%!E<B!3:&%R92`H5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5A<FYI
M;F=S(%!E<B!3:&%R92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E8V]N8VEL:6%T:6]N(&]F(&)A<VEC
M(&YE="!E87)N:6YG<R!P97(@<VAA<F4@=&\@9&EL=71E9"!N970@96%R;FEN
M9W,@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X-
M"B`@("`\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A4
M34P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]4
M4B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"B`@
M("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(%1A8FQE.B!*3DHM,C`Q
M,3`W,#-?;F]T93A?=&%B;&4Q("T@=7,M9V%A<#I38VAE9'5L94]F16%R;FEN
M9W-097)3:&%R95)E8V]N8VEL:6%T:6]N5&%B;&5497AT0FQO8VLM+3X-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^
M#0H@("`@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2
M;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@
M9F]L;&]W:6YG(&ES(&$@<F5C;VYC:6QI871I;VX@;V8@8F%S:6,@;F5T(&5A
M<FYI;F=S('!E<B!S:&%R92!T;R!D:6QU=&5D(&YE="!E87)N:6YG<R!P97(@
M<VAA<F4-"B`@("!F;W(@=&AE(&9I<V-A;"!S96-O;F0@<75A<G1E<G,@96YD
M960@2G5L>28C,38P.S,L(#(P,3$@86YD($IU;'DF(S$V,#LT+"`R,#$P+@T*
M("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1C96YT97(^#0H@("`@/'1A
M8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F
M="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P
M('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($AE860@+2T^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@=VED=&@],T0W
M-B4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0W('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(#%P>"!S;VQI9"`C9F9F9F9F)SY&:7-C86P@475A<G1E<G,@16YD960\+W1D
M/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T
M)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@,7!X('-O;&ED("-F9F9F9F8G/BA3:&%R
M97,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X]
M,T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q
M,#PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D("TM
M/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*
M("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[
M('1E>'0M:6YD96YT.BTQ-7!X)SY"87-I8R!N970@96%R;FEN9W,@<&5R('-H
M87)E#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XQ+C`Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S
M<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ+C(U/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX]
M,T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%V97)A9V4@<VAA<F5S
M(&]U='-T86YD:6YG("8C.#(Q,CL@8F%S:6,-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C(L-S0P+C4\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L-S4V+C8\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^4&]T96YT:6%L('-H87)E<R!E>&5R8VES86)L92!U
M;F1E<B!S=&]C:R!O<'1I;VX@<&QA;G,-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C$V."XY/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-S4N-3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY,97-S.B!S:&%R97,@=VAI8V@@8V]U
M;&0@8F4@<F5P=7)C:&%S960@=6YD97(@=')E87-U<GD@<W1O8VL@;65T:&]D
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,3,Q+C<\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#$S.2XW/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F
M)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^0V]N=F5R=&EB;&4@9&5B="!S:&%R
M97,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,N-CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,RXV/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@
M(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%V
M97)A9V4@<VAA<F5S(&]U='-T86YD:6YG("8C.#(Q,CL@9&EL=71E9`T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPW.#$N,SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPW
M.38N,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY$:6QU=&5D(&5A<FYI;F=S
M('!E<B!S:&%R90T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^,2XP,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2XR,SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM
M($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^
M#0H@("`@/"]D:78^#0H@("`@/"]D:78^#0H@("`@#0H@("`@/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!"
M;&]C:R!486=G960@3F]T92!486)L93H@2DY*+3(P,3$P-S`S7VYO=&4X7W1A
M8FQE,B`M(&IN:CI38VAE9'5L94]F16%R;FEN9W-097)3:&%R95)E8V]N8VEL
M:6%T:6]N5&%B;&5497AT0FQO8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM
M97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G
M/@T*("`@(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@;6%R9VEN+71O<#H@-G!T)SY4:&4@9F]L;&]W:6YG(&ES(&$@<F5C
M;VYC:6QI871I;VX@;V8@8F%S:6,@;F5T(&5A<FYI;F=S('!E<B!S:&%R92!T
M;R!D:6QU=&5D(&YE="!E87)N:6YG<R!P97(@<VAA<F4-"B`@("!F;W(@=&AE
M(&9I<V-A;"!S:7@@;6]N=&AS(&5N9&5D($IU;'DF(S$V,#LS+"`R,#$Q(&%N
M9"!*=6QY)B,Q-C`[-"P@,C`Q,"X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D
M97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M
M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D('=I9'1H/3-$-S8E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T
M>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$-R!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^1FES
M8V%L(%-I>"!-;VYT:',@16YD960\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$
M,SY*=6QY(#,L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU
M;'D@-"P\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M,7!X('-O;&ED("-F9F9F9F8G/BA3:&%R97,@:6X@36EL;&EO;G,I/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@("`@/"]T<CX-"B`@
M("`\(2TM($5N9"!486)L92!(96%D("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B
M;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY"
M87-I8R!N970@96%R;FEN9W,@<&5R('-H87)E#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF
M;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+C(X/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XR+C@Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/D%V97)A9V4@<VAA<F5S(&]U='-T86YD:6YG("8C.#(Q,CL@
M8F%S:6,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L
M-S,Y+C8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C(L-S4U+C<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K
M9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^4&]T96YT
M:6%L('-H87)E<R!E>&5R8VES86)L92!U;F1E<B!S=&]C:R!O<'1I;VX@<&QA
M;G,-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$V."XX
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XQ-S4N-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV
M('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X
M)SY,97-S.B!S:&%R97,@=VAI8V@@8V]U;&0@8F4@<F5P=7)C:&%S960@=6YD
M97(@=')E87-U<GD@<W1O8VL@;65T:&]D#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XH,3,S+CD\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^*#$S."XV/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^0V]N=F5R=&EB;&4@9&5B="!S:&%R97,-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C,N-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RXV/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D%V97)A9V4@<VAA<F5S(&]U='-T86YD
M:6YG("8C.#(Q,CL@9&EL=71E9`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,BPW-S@N,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPW.38N,3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY$:6QU=&5D(&5A<FYI;F=S('!E<B!S:&%R90T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BXR
M-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^,BXX-3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*
M("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@/"]D:78^#0H@("`@/"]D
M:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A
M-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,C<N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5"14%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-E9VUE;G1S(&]F
M($)U<VEN97-S(&%N9"!'96]G<F%P:&EC($%R96%S("A486)L97,I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V5G
M;65N=',@;V8@0G5S:6YE<W,@86YD($=E;V=R87!H:6,@07)E87,@6T%B<W1R
M86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y386QE<R!B>2!S96=M96YT(&]F(&)U<VEN97-S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X-"B`@("`\(2TM1$]#5%E012!H=&UL(%!50DQ)
M0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H
M='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET
M:6]N86PN9'1D(B`M+3X-"B`@("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.
M;W1E(%1A8FQE.B!*3DHM,C`Q,3`W,#-?;F]T93E?=&%B;&4Q("T@:FYJ.E-A
M;&5S0GE396=M96YT3V9"=7-I;F5S<U1A8FQE5&5X=$)L;V-K+2T^#0H@("`@
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*
M("`@(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M
M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&UA<F=I;BUT;W`Z(#9P="<^4T%,15,@
M0ED@4T5'345.5"!/1B!"55-)3D534PT*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\
M(2TM($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O
M='1O;3X-"B`@("`\=&0@=VED=&@],T0V-"4^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E
M/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T
M:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS
M1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#$Q('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SY&:7-C86P@
M475A<G1E<G,@16YD960\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE
M/3-$)V9O;G0M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY
M(#,L/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^4&5R8V5N=#PO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$;&5F=#XH1&]L;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!C;VQS<&%N/3-$,SXR,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P
M86X],T0S/D-H86YG93PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!4
M86)L92!(96%D("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z
M("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY#;VYS=6UE<@T*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XQ+#,S.3PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PT
M-C,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@X+C4\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^*24\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^26YT97)N871I;VYA;`T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPT-30\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L
M,3@T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XQ,BXT/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R
M/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/E1O=&%L#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XS+#<Y,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,RPV-#<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C0N,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA
M;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@
M(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG
M<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY0:&%R;6%C
M975T:6-A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*
M("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[
M('1E>'0M:6YD96YT.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XS+#(S.3PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPQ,3`\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0N,3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT
M9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M
M:6YD96YT.BTQ-7!X)SY);G1E<FYA=&EO;F%L#0H@("`@/"]D:78^/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XR+#DY-#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPT-#,\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C(R+C8\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG
M;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G
M:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8L,C,S/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#4U,SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M,3(N,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY-961I8V%L($1E=FEC97,@)B,P,S@[
M($1I86=N;W-T:6-S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E4N4RX-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C(L.#8Y/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#@V-3PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,"XQ/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@
M("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@
M=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R;F%T:6]N86P-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L-S`R/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#(V-3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3,N-#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;`T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-BPU-S$\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C8L
M,3,P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XW+C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD
M.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G
M:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5V]R;&1W:61E#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*
M("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E
M;G0Z+3$U<'@G/E4N4RX-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C<L-#0W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XW+#0S.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,"XQ/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/DEN=&5R;F%T:6]N86P-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/CDL,34P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XW+#@Y,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,34N.3PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,38L-3DW/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ-2PS,S`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C@N,SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XE/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@
M("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N
M=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E
M>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I;B!4
M86)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@
M/'1D('=I9'1H/3-$-C0E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED
M=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE
M.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0Q,2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^1FES8V%L(%-I>"!-;VYT:',@
M16YD960\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1C96YT97(@8V]L<W!A;CTS1#,^4&5R8V5N=#PO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F
M=#XH1&]L;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SXR,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D-H
M86YG93PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D
M("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY#;VYS=6UE<@T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T
M>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY5
M+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XR+#8X-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB
M<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPP,C,\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q,2XR/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/BDE/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/DEN=&5R;F%T:6]N86P-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C0L-SDQ/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XT+#,Y,#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^.2XQ
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT
M<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E1O=&%L
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XW+#0W-3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M-RPT,3,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C`N.#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@
M+2T^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C
M8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL
M969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY0:&%R;6%C975T:6-A;`T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XV+#8S,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&%L:6=N/3-$<FEG:'0^-BPS,38\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C4N,#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\
M9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ
M-7!X)SY);G1E<FYA=&EO;F%L#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XU+#8V,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^-"PX-S4\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$V+C$\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ
M-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^5&]T86P-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C$R+#(Y,CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3$L,3DQ/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XY+C@\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;3X\(2TM($)L86YK(%-P86-E("TM/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SXF(S$V,#L-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-"B`@("`\
M=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT
M+6EN9&5N=#HM,35P>"<^365D:6-A;"!$979I8V5S("8C,#,X.R!$:6%G;F]S
M=&EC<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XU+#<T,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^-2PW-3$\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/B@P+C(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY);G1E<FYA=&EO;F%L#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XW+#(V,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^-BPV,#8\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/CDN.3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T
M=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T
M.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3,L,#`S/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ,BPS-3<\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4N,CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY7;W)L9'=I9&4-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS
M1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^52Y3+@T*
M("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,34L,#4U/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ
M-2PP.3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@P+C(\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-
M"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z
M("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY);G1E<FYA=&EO;F%L
M#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-RPW,34\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C$U+#@W,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N
M/3-$<FEG:'0^,3$N-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,S(L-S<P/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS
M,"PY-C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4N.#PO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XE/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<&5R871I
M;F<@<')O9FET(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@4%5"
M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@
M(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS
M:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G9V5D
M($YO=&4@5&%B;&4Z($I.2BTR,#$Q,#<P,U]N;W1E.5]T86)L93(@+2!U<RUG
M86%P.E-C:&5D=6QE3V9396=M96YT4F5P;W)T:6YG26YF;W)M871I;VY">5-E
M9VUE;G1497AT0FQO8VLM+3X-"B`@("`\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<L5&EM97,L<V5R:68G/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@
M("`\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&UA<F=I;BUT;W`Z(#$R<'0G/D]015)!5$E.1R!04D]&250@0ED@4T5'345.
M5"!/1B!"55-)3D534PT*("`@(#PO9&EV/@T*("`@(#QD:78@86QI9VX],T1C
M96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E<CTS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM($)E9VEN
M(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@
M("`\=&0@=VED=&@],T0V-"4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I
M>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#$Q('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SY&:7-C86P@475A<G1E<G,@
M16YD960\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M
M<VEZ93H@.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1C96YT97(@8V]L<W!A;CTS1#,^4&5R8V5N=#PO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F
M=#XH1&]L;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SXR,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D-H
M86YG93PO=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D
M("TM/@T*("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G
M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U
M<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY#;VYS=6UE<@T*("`@(#PO9&EV/CPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG
M:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-30Y/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XV-CD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/B@Q-RXY/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BDE/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@
M/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X
M="UI;F1E;G0Z+3$U<'@G/E!H87)M86-E=71I8V%L("@Q*0T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PW,30\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C$L.#,S/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH-BXU/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C8V-E969F)SX-
M"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X
M.R!T97AT+6EN9&5N=#HM,35P>"<^365D:6-A;"!$979I8V5S("8C,#,X.R!$
M:6%G;F]S=&EC<R`H,BD-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$L,C<U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XQ+#@W-CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^*#,R+C`\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^*3PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY396=M96YT<R!O<&5R871I;F<@<')O9FET#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#4S.#PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-"PS
M-S@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B@Q.2XR/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^17AP96YS92!N;W0@86QL
M;V-A=&5D('1O('-E9VUE;G1S("@S*0T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M*#$Q-CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L
M:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XH,34X/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@
M/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM
M,35P>"<^5V]R;&1W:61E(&EN8V]M92!B969O<F4@=&%X97,-"B`@("`\+V1I
M=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L
M-#(R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@
M("`\=&0@86QI9VX],T1R:6=H=#XT+#(R,#PO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^*#$X+CD\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`^*24\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@0F]D
M>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#QD:78@86QI
M9VX],T1C96YT97(^#0H@("`@/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@=&5X="UA;&EG;CH@;&5F="<@8V5L;'-P86-I;F<],T0P(&)O<F1E
M<CTS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`@("`\(2TM
M($)E9VEN(%1A8FQE($AE860@+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0@=VED=&@],T0V-"4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W
M:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F
M;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#$Q('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C9F9F9F9F)SY&:7-C86P@4VEX
M($UO;G1H<R!%;F1E9#PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4]
M,T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@
M,RP\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`T+#PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY097)C96YT/"]T9#X-
M"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1L969T/BA$;VQL87)S(&EN($UI;&QI;VYS*3PO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!C;VQS<&%N/3-$,SXR,#$Q/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M(&-O;'-P86X],T0S/C(P,3`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^0VAA;F=E/"]T9#X-"B`@("`\+W1R/@T*("`@(#PA+2T@16YD(%1A
M8FQE($AE860@+2T^#0H@("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*
M("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F%C:V=R;W5N9#H@
M(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/D-O;G-U;65R#0H@("`@
M/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H
M=#XQ+#$R,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,2PT-30\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B@R,BXX/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/BDE/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B
M;W1T;VT^#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E!H87)M86-E=71I8V%L("@Q
M*0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,RPY,C,\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C,L.#`S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XS+C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO
M='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O
M=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^365D:6-A;"!$
M979I8V5S("8C,#,X.R!$:6%G;F]S=&EC<R`H,BD-"B`@("`\+V1I=CX\+W1D
M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L,C$Y/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#4W.#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^*#0R+C,\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`^*3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I
M;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY396=M96YT<R!O<&5R
M871I;F<@<')O9FET#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XX+#(V-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L
M:6=N/3-$<FEG:'0^,3`L.#,U/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R
M:6=H=#XH,C,N-SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD:78@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U<'@G
M/D5X<&5N<V4@;F]T(&%L;&]C871E9"!T;R!S96=M96YT<R`H,RD-"B`@("`\
M+V1I=CX\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B@S,S(\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`^*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@
M/'1D(&%L:6=N/3-$<FEG:'0^*#,S-3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^
M#0H@("`@/'1D/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P
M>#L@=&5X="UI;F1E;G0Z+3$U<'@G/E=O<FQD=VED92!I;F-O;64@8F5F;W)E
M('1A>&5S#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@
M86QI9VX],T1R:6=H=#XW+#DS,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3`L-3`P/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XH,C0N-3PO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#XI)3PO=&0^#0H@("`@/"]T<CX-"B`@("`\
M(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D
M:78^#0H@("`@/"$M+2!&;VQI;R`M+3X-"B`@("`\(2TM("]&;VQI;R`M+3X-
M"B`@("`\+V1I=CX-"B`@("`\(2TM(%!!1T5"4D5!2R`M+3X-"B`@("`\9&EV
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE
M<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0^#0H@("`@/&1I=B!S
M='EL93TS1"=F;VYT+7-I>F4Z(#-P=#L@;6%R9VEN+71O<#H@,39P=#L@=VED
M=&@Z(#$X)3L@8F]R9&5R+71O<#H@,7!X('-O;&ED(",P,#`P,#`G/B8C,38P
M.PT*("`@(#PO9&EV/@T*("`@(#PO9&EV/@T*("`@(#QT86)L92!W:61T:#TS
M1#$P,"4@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<]
M,T0P('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@=&5X="UA;&EG;CH@;&5F
M="<^#0H@("`@/'1R/@T*("`@(#QT9"!W:61T:#TS1#,E/CPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,24^/"]T9#X-"B`@("`\=&0@=VED=&@],T0Y-B4^/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1T;W`^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^*#$I/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^26YC;'5D97,@;&ET:6=A=&EO;B!E
M>'!E;G-E(&]F("9N8G-P.R0R.3`F(S$V,#MM:6QL:6]N(&%N9"`F;F)S<#LD
M-30P)B,Q-C`[;6EL;&EO;B!R96-O<F1E9"!I;B!T:&4@9FES8V%L('-E8V]N
M9`T*("`@('%U87)T97(@86YD('1H92!F:7)S="!F:7-C86P@<VEX(&UO;G1H
M<R!O9B`R,#$Q+"!R97-P96-T:79E;'DN(%1H92!F:7)S="!F:7-C86P@<VEX
M(&UO;G1H<R!O9B`R,#$Q#0H@("`@:6YC;'5D97,@82!G86EN(')E;&%T960@
M=&\@=&AE($-O;7!A;GDF(S@R,3<[<R!E87)L:65R(&EN=F5S=&UE;G0@:6X@
M0W)U8V5L;"!R96-O<F1E9"!I;B!T:&4@9FES8V%L(&9I<G-T#0H@("`@<75A
M<G1E<B!O9B`R,#$Q+B!4:&4@9FES8V%L('-E8V]N9"!Q=6%R=&5R(&%N9"!T
M:&4@9FER<W0@9FES8V%L('-I>`T*("`@(&UO;G1H<R!O9B`R,#$P+"!I;F-L
M=61E<R!N970@;&ET:6=A=&EO;B!E>'!E;G-E(&]F("9N8G-P.R0Q,34F(S$V
M,#MM:6QL:6]N(&%N9"`F;F)S<#LD,C`R)B,Q-C`[;6EL;&EO;BP@<F5S<&5C
M=&EV96QY+CPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N
M="US:7IE.B`S<'0G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1'1O<#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$;&5F=#XH,BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9#Y);F-L=61E<R!R97-T<G5C='5R:6YG(&5X<&5N<V4@;V8@
M)FYB<W`[)#8W-B8C,38P.VUI;&QI;VX@<F5C;W)D960@:6X@=&AE(&9I<V-A
M;"!S96-O;F0@<75A<G1E<B!A;F0@9FER<W0-"B`@("!F:7-C86P@<VEX(&UO
M;G1H<R!O9B`R,#$Q+B!);F-L=61E<R!L:71I9V%T:6]N(&5X<&5N<V4@86YD
M(&%D9&ET:6]N86P@1&50=7D@05-2)B,X-#@R.R!(:7`@<F5C86QL(&-O<W1S
M#0H@("`@;V8@)FYB<W`[)#$R-R8C,38P.VUI;&QI;VX@<F5C;W)D960@:6X@
M=&AE(&9I<V-A;"!S96-O;F0@<75A<G1E<B!O9B`R,#$Q+B!);F-L=61E<R!L
M:71I9V%T:6]N(&5X<&5N<V4@86YD#0H@("`@861D:71I;VYA;"!$95!U>2!!
M4U(F(S@T.#([($AI<"!R96-A;&P@8V]S=',@;V8@)FYB<W`[)#(R,R8C,38P
M.VUI;&QI;VX@<F5C;W)D960@:6X@=&AE(&9I<G-T(&9I<V-A;"!S:7@@;6]N
M=&AS(&]F#0H@("`@,C`Q,2X@26YC;'5D97,@;F5T(&QI=&EG871I;VX@97AP
M96YS92!O9B`F;F)S<#LD-#(F(S$V,#MM:6QL:6]N(&%N9"!I;F-O;64@;V8@
M)FYB<W`[)#$L-30R)B,Q-C`[;6EL;&EO;B!R96-O<F1E9"!I;B!T:&4-"B`@
M("!F:7-C86P@<V5C;VYD('%U87)T97(@86YD('1H92!F:7)S="!F:7-C86P@
M<VEX(&UO;G1H<R!O9B`R,#$P+"!R97-P96-T:79E;'DN/"]T9#X-"B`@("`\
M+W1R/@T*("`@(#QT<B!S='EL93TS1"=F;VYT+7-I>F4Z(#-P="<^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M=&]P/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1L969T/B@S
M*3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/D%M;W5N=',@
M;F]T(&%L;&]C871E9"!T;R!S96=M96YT<R!I;F-L=61E(&EN=&5R97-T(&EN
M8V]M92\H97AP96YS92DL(&YO;BUC;VYT<F]L;&EN9R!I;G1E<F5S=',-"B`@
M("!A;F0@9V5N97)A;"!C;W)P;W)A=&4@:6YC;VUE+RAE>'!E;G-E*2X\+W1D
M/@T*("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@("`\+V1I=CX-"B`@("`\
M+V1I=CX-"B`@/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y386QE<R!B>2!G96]G<F%P:&EC(&%R96$\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/@T*("`@(#PA+2U$3T-465!%(&AT;6P@
M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%
M3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R
M86YS:71I;VYA;"YD=&0B("TM/@T*("`@(#PA+2T@0F5G:6X@0FQO8VL@5&%G
M9V5D($YO=&4@5&%B;&4Z($I.2BTR,#$Q,#<P,U]N;W1E.5]T86)L93,@+2!J
M;FHZ4V%L94)Y1V5O9W)A<&AI8T%R96%486)L951E>'1";&]C:RTM/@T*("`@
M(#QD:78@86QI9VX],T1L969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-
M"B`@("`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)RQ4:6UE<RQS97)I9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!M87)G:6XM=&]P.B`Q,G!T)SY304Q%
M4R!"62!'14]'4D%02$E#($%214$-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L
M:6=N/3-$8V5N=&5R/@T*("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D
M97(],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M
M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T
M;VT^#0H@("`@/'1D('=I9'1H/3-$-C0E/B8C,38P.SPO=&0^#0H@("`@/'1D
M('=I9'1H/3-$-24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@
M("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@]
M,T0U)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO
M=&0^#0H@("`@/'1D('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C
M,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS
M1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G
M9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0Q,2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(V9F9F9F9B<^1FES8V%L(%%U
M87)T97)S($5N9&5D/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!S='EL93TS
M1"=F;VYT+7-I>F4Z(#AP="<@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A;CTS1#,^2G5L>2`S
M+#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#0L/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/E!E<F-E;G0\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@.'!T)R!V
M86QI9VX],T1B;W1T;VT^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1&QE9G0^*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R(&-O;'-P86X],T0S/C(P,3$\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M8V]L<W!A;CTS1#,^,C`Q,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N
M/3-$,SY#:&%N9V4\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B
M;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@+2T^#0H@
M("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O=6YD.B`C
M8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM
M;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^52Y3+@T*("`@(#PO9&EV
M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^)FYB<W`[)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^-RPT
M-#<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C<L-#,X/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI
M9VX],T1R:6=H=#XP+C$\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M)3PO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*
M("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[
M('1E>'0M:6YD96YT.BTQ-7!X)SY%=7)O<&4-"B`@("`\+V1I=CX\+W1D/@T*
M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!A;&EG;CTS1')I9VAT/C0L-30S/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS+#@S,CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3@N-CPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY797-T97)N($AE;6ES<&AE<F4L(&5X8VQU9&EN
M9R!5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ
M+#4T,SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$
M<FEG:'0^,2PS-S4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A
M;&EG;CTS1')I9VAT/C$R+C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#PO='(^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^
M#0H@("`@/&1I=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN
M9&5N=#HM,35P>"<^07-I82U086-I9FEC+"!!9G)I8V$-"B`@("`\+V1I=CX\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C,L,#8T/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#8X-3PO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,30N,3PO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D
M/@T*("`@(#QD:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI
M;F1E;G0Z+3$U<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[
M)#PO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,38L-3DW/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XQ-2PS,S`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT
M/C@N,SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XE/"]T9#X-"B`@
M("`\+W1R/@T*("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T
M86)L93X-"B`@("`\+V1I=CX-"B`@("`\9&EV(&%L:6=N/3-$8V5N=&5R/@T*
M("`@(#QT86)L92!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[('1E>'0M86QI
M9VXZ(&QE9G0G(&-E;&QS<&%C:6YG/3-$,"!B;W)D97(],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`@/"$M+2!"96=I;B!486)L92!(
M96%D("TM/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D('=I
M9'1H/3-$-C0E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$-24^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@
M(#QT9"!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H/3-$
M,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0U)3XF(S$V,#L\+W1D
M/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I
M9'1H/3-$,24^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0S)3XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@
M/'1D('=I9'1H/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q
M)3XF(S$V,#L\+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^
M#0H@("`@/"]T<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G
M('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0Q,2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B`Q<'@@<V]L:60@(V9F9F9F9B<^1FES8V%L(%-I>"!-;VYT:',@16YD960\
M+W1D/@T*("`@(#PO='(^#0H@("`@/'1R('-T>6QE/3-$)V9O;G0M<VEZ93H@
M.'!T)R!V86QI9VX],T1B;W1T;VT^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SY*=6QY(#,L/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R(&-O;'-P86X],T0S/DIU;'D@-"P\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C
M96YT97(@8V]L<W!A;CTS1#,^4&5R8V5N=#PO=&0^#0H@("`@/"]T<CX-"B`@
M("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS1&)O='1O
M;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F=#XH1&]L
M;&%R<R!I;B!-:6QL:6]N<RD\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L<W!A
M;CTS1#,^,C`Q,3PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!C;VQS<&%N/3-$,SXR
M,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0S/D-H86YG93PO
M=&0^#0H@("`@/"]T<CX-"B`@("`\(2TM($5N9"!486)L92!(96%D("TM/@T*
M("`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@
M(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E
M>'0M:6YD96YT.BTQ-7!X)SY5+E,N#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XQ-2PP-34\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/B9N8G-P.R0\+W1D/@T*("`@(#QT9"!A;&EG;CTS
M1')I9VAT/C$U+#`Y,#PO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^
M*#`N,CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XI)3PO=&0^#0H@
M("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-
M"B`@("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD
M96YT.BTQ-7!X)SY%=7)O<&4-"B`@("`\+V1I=CX\+W1D/@T*("`@(#QT9#XF
M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG
M;CTS1')I9VAT/C@L-S(V/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@86QI9VX],T1R:6=H=#XW+#DS-#PO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3`N,#PO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY797-T97)N($AE;6ES<&AE<F4L(&5X8VQU9&EN9R!5+E,N#0H@
M("`@/"]D:78^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR+#DW.3PO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,BPV
M-34\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\
M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I
M9VAT/C$R+C(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^07-I82U086-I9FEC+"!!9G)I8V$-"B`@("`\+V1I=CX\+W1D/@T*("`@
M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9"!A;&EG;CTS1')I9VAT/C8L,#$P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@86QI9VX],T1R:6=H=#XU+#(X,CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^,3,N.#PO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$
M8F]T=&]M/CPA+2T@0FQA;FL@4W!A8V4@+2T^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/B8C,38P.PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@
M("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@
M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)A8VMG<F]U;F0Z("-C8V5E9F8G/@T*("`@(#QT9#X-"B`@
M("`\9&EV('-T>6QE/3-$)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT
M.BTQ-7!X)SY4;W1A;`T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,S(L-S<P/"]T9#X-"B`@("`\=&0^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX]
M,T1R:6=H=#XF;F)S<#LD/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XS
M,"PY-C$\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V
M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#XF(S$V,#L\+W1D/@T*("`@(#QT9"!A;&EG;CTS1')I9VAT/C4N.#PO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#XE/"]T9#X-"B`@("`\+W1R/@T*
M("`@(#PA+2T@16YD(%1A8FQE($)O9'D@+2T^#0H@("`@/"]T86)L93X-"B`@
M("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@("`\+V1I=CX-"B`@/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F
M7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S
M+U=O<FMS:&5E=',O4VAE970R."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P139!04,^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4F5S=')U8W1U<FEN9R`H5&%B;&5S*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E
M<W1R=6-T=7)I;F<@86YD(%)E;&%T960@06-T:79I=&EE<R!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E
M=F5R86YC92!R97-E<G9E(&%N9"!T:&4@87-S;V-I871E9"!S<&5N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^#0H@("`@/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`@/"$M+2!"96=I;B!"
M;&]C:R!486=G960@3F]T92!486)L93H@2DY*+3(P,3$P-S`S7VYO=&4Q,E]T
M86)L93$@+2!U<RUG86%P.E-C:&5D=6QE3V9297-T<G5C='5R:6YG4F5S97)V
M94)Y5'EP94]F0V]S=%1E>'1";&]C:RTM/@T*("`@(#QD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=4
M:6UE<R!.97<@4F]M86XG+%1I;65S+'-E<FEF)SX-"B`@("`\9&EV('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RQ4:6UE<RQS97)I
M9B<^#0H@("`@/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!M87)G:6XM=&]P.B`V<'0G/E1H92!F;VQL;W=I;F<@=&%B;&4@
M<W5M;6%R:7IE<R!T:&4@<V5V97)A;F-E(')E<V5R=F5S(&%S<V]C:6%T960@
M=VET:"!T:&4@<F5S=')U8W1U<FEN9R!P;&%N#0H@("`@<F5C;W)D960@:6X@
M=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,#DN#0H@("`@/"]D:78^#0H@("`@
M/&1I=B!A;&EG;CTS1&-E;G1E<CX-"B`@("`\=&%B;&4@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!T97AT+6%L:6=N.B!L969T)R!C96QL<W!A8VEN9STS
M1#`@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*
M("`@(#PA+2T@0F5G:6X@5&%B;&4@2&5A9"`M+3X-"B`@("`\='(@=F%L:6=N
M/3-$8F]T=&]M/@T*("`@(#QT9"!W:61T:#TS1#@X)3XF(S$V,#L\+W1D/@T*
M("`@(#QT9"!W:61T:#TS1#4E/B8C,38P.SPO=&0^#0H@("`@/'1D('=I9'1H
M/3-$,R4^)B,Q-C`[/"]T9#X-"B`@("`\=&0@=VED=&@],T0Q)3XF(S$V,#L\
M+W1D/@T*("`@(#QT9"!W:61T:#TS1#,E/B8C,38P.SPO=&0^#0H@("`@/"]T
M<CX-"B`@("`\='(@<W1Y;&4],T0G9F]N="US:7IE.B`X<'0G('9A;&EG;CTS
M1&)O='1O;3X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`Q<'@@<V]L:60@(S`P,#`P,"<^
M*$1O;&QA<G,@:6X@36EL;&EO;G,I/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R(&-O
M;'-P86X],T0S('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(#%P>"!S;VQI9"`C
M,#`P,#`P)SY3979E<F%N8V4\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%
M;F0@5&%B;&4@2&5A9"`M+3X-"B`@("`\(2TM($)E9VEN(%1A8FQE($)O9'D@
M+2T^#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K9W)O
M=6YD.B`C8V-E969F)SX-"B`@("`\=&0^#0H@("`@/&1I=B!S='EL93TS1"=M
M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P>"<^4F5S97)V92!B
M86QA;F-E(&%S(&]F.@T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO
M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/"]T<CX-"B`@("`\='(@
M=F%L:6=N/3-$8F]T=&]M/@T*("`@(#QT9#X-"B`@("`\9&EV('-T>6QE/3-$
M)VUA<F=I;BUL969T.C$U<'@[('1E>'0M:6YD96YT.BTQ-7!X)SY*86YU87)Y
M)B,Q-C`[,BP@,C`Q,0T*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C,38P
M.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^)FYB<W`[)#PO=&0^#0H@
M("`@/'1D(&%L:6=N/3-$<FEG:'0^,S0U/"]T9#X-"B`@("`\=&0^)B,Q-C`[
M/"]T9#X-"B`@("`\+W1R/@T*("`@(#QT<B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F%C:V=R;W5N9#H@(V-C965F9B<^#0H@("`@/'1D/@T*("`@(#QD
M:78@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z,35P>#L@=&5X="UI;F1E;G0Z+3$U
M<'@G/D-A<V@@;W5T;&%Y<PT*("`@(#PO9&EV/CPO=&0^#0H@("`@/'1D/B8C
M,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I
M9VAT/B8C,38P.SPO=&0^#0H@("`@/'1D(&%L:6=N/3-$<FEG:'0^*#<W/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/@T*("`@(#PO='(^
M#0H@("`@/'1R('9A;&EG;CTS1&)O='1O;3X-"B`@("`\=&0^#0H@("`@/&1I
M=B!S='EL93TS1"=M87)G:6XM;&5F=#HQ-7!X.R!T97AT+6EN9&5N=#HM,35P
M>"<^2G5L>28C,38P.S,L(#(P,3$J#0H@("`@/"]D:78^/"]T9#X-"B`@("`\
M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XF;F)S<#LD
M/"]T9#X-"B`@("`\=&0@86QI9VX],T1R:6=H=#XR-C@\+W1D/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#PO='(^#0H@("`@/"$M+2!%;F0@5&%B;&4@
M0F]D>2`M+3X-"B`@("`\+W1A8FQE/@T*("`@(#PO9&EV/@T*("`@(#QD:78@
M86QI9VX],T1L969T/@T*("`@(#QD:78@<W1Y;&4],T0G9F]N="US:7IE.B`S
M<'0[(&UA<F=I;BUT;W`Z(#$V<'0[('=I9'1H.B`Q."4[(&)O<F1E<BUT;W`Z
M(#%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L-"B`@("`\+V1I=CX-"B`@("`\
M+V1I=CX-"B`@("`\=&%B;&4@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`@8V5L
M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[('1E>'0M86QI9VXZ(&QE9G0G/@T*("`@(#QT<CX-"B`@("`\
M=&0@=VED=&@],T0S)3X\+W1D/@T*("`@(#QT9"!W:61T:#TS1#$E/CPO=&0^
M#0H@("`@/'1D('=I9'1H/3-$.38E/CPO=&0^#0H@("`@/"]T<CX-"B`@("`\
M='(@=F%L:6=N/3-$=&]P/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1L969T/BH\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT
M9#Y296UA:6YI;F<@8V%S:"!O=71L87ES(&9O<B!S979E<F%N8V4@87)E(&5X
M<&5C=&5D('1O(&)E('!A:60@;W5T(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@
M0V]M<&%N>28C.#(Q-SMS#0H@("`@<&QA;G,@86YD(&QO8V%L(&QA=W,N/"]T
M9#X-"B`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@("`@/"]D:78^#0H@("`@
M/"]D:78^#0H@(#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W
M-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,CDN:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$4V2T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/DEN=F5N=&]R
M:65S("A$971A:6QS*2`H55-$("9N8G-P.R0I/&)R/DEN($UI;&QI;VYS/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#`R
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-U;6UA<GD@;V8@26YV96YT;W)I97,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F%W(&UA=&5R:6%L<R!A;F0@
M<W5P<&QI97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P
M.R0@,2PS.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XF;F)S<#LD(#$L,#<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y';V]D<R!I;B!P<F]C97-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@Y-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#8P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&:6YI<VAE
M9"!G;V]D<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPQ,S,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#@T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L(&EN=F5N=&]R:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XF;F)S<#LD(#8L-#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U+#,W.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q
M9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W
M,R]7;W)K<VAE971S+U-H965T,S`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R-4%'/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/DEN=&%N9VEB;&4@07-S971S(&%N9"!';V]D
M=VEL;"`H1&5T86EL<RD@*%531"`F;F)S<#LD*3QB<CY);B!-:6QL:6]N<SPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`P,BP@,C`Q,3QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G1A
M;F=I8FQE(&%S<V5T<R!W:71H(&1E9FEN:71E(&QI=F5S.CPO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0871E;G1S(&%N9"!T
M<F%D96UA<FMS("T@9W)O<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B9N8G-P.R0@-RPU,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#8L-C8P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S(&%C8W5M=6QA
M=&5D(&%M;W)T:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPX,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#8R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!A=&5N=',@86YD('1R861E;6%R:W,@+2!N970\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-S`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP,S$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T
M:&5R(&EN=&%N9VEB;&5S("T@9W)O<W,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@L-C`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-RPV-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE<W,@86-C=6UU;&%T960@86UO<G1I
M>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`T.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L
M.#@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W1H97(@:6YT86YG:6)L97,@+2!N970\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4L-38Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-"PW.30\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YT86YG:6)L
M92!A<W-E=',@=VET:"!I;F1E9FEN:71E(&QI=F5S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4<F%D96UA<FMS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#`X,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L.34T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S
M960@:6XM<')O8V5S<R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,#,V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY,S<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!I
M;G1A;F=I8FQE(&%S<V5T<R!W:71H(&EN9&5F:6YI=&4@;&EV97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L,3$V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPX.3$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!I
M;G1A;F=I8FQE(&%S<V5T<R`M(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3@L,S<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,38L-S$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D=O;V1W:6QL/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=O;V1W:6QL
M+"!"96=I;FYI;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,34L,CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8W%U:7-I=&EO;G,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0W5R<F5N8WD@=')A;G-L871I;VXO;W1H97(\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0Q,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&PL
M($5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-BPR-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-O;G-U;65R(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1V]O9'=I;&P\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&PL($)E9VEN
M;FEN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX
M+#$T-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0W5R<F5N8WD@=')A;G-L871I;VXO;W1H97(\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&PL($5N9&EN9R!"86QA
M;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#0V-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&AA
M<FUA8V5U=&EC86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY';V]D=VEL;#PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y';V]D=VEL;"P@0F5G:6YN:6YG($)A
M;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C(U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8W%U:7-I=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0W5R<F5N8WD@=')A;G-L871I;VXO;W1H97(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y';V]D=VEL;"P@16YD:6YG($)A;&%N8V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#$U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-961I8V%L
M($1E=FEC97,@86YD($1I86=N;W-T:6-S(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1V]O9'=I;&P\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&PL
M($)E9VEN;FEN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU+#DR-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0W5R<F5N8WD@=')A;G-L871I;VXO;W1H97(\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y';V]D=VEL;"P@16YD:6YG
M($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P
M.R0@-2PY-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?
M839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#,Q+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%3%!!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);G1A;F=I8FQE
M($%S<V5T<R!A;F0@1V]O9'=I;&P@*$1E=&%I;',@5&5X='5A;',I("A54T0@
M)FYB<W`[)"D\8G(^26X@36EL;&EO;G,\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G1A;F=I8FQE
M($%S<V5T<R!A;F0@1V]O9'=I;&P@*%1E>'1U86QS*3PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S960@:6X@<')O
M8V5S<R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0@=&\@86UO<G1I>F%B;&4@
M:6YT86YG:6)L97,@=&\@<F5F;&5C="!C;VUM97)C:6%L:7IA=&EO;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Y-S$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H
M=&5D(&%V97)A9V4@86UO<G1I>F%T:6]N('!E<FEO9',@9F]R('!A=&5N=',@
M86YD('1R861E;6%R:W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/C$W('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E(&%M;W)T:7IA=&EO;B!P97)I
M;V1S(&9O<B!O=&AE<B!);G1A;F=I8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^,C<@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!E>'!E
M;G-E(&]F(&%M;W)T:7IA8FQE(&EN=&%N9VEB;&4@87-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!A;6]R=&EZ
M871I;VX@97AP96YS92!P97(@>65A<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)FYB<W`[)"`X-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U
M8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C
M-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E
M=#,R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%6D-"23X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY&86ER(%9A;'5E($UE87-U<F5M96YT<R`H1&5T86EL<RD@*%531"`F;F)S
M<#LD*3QB<CY);B!-:6QL:6]N<SPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F
M(&1E<VEG;F%T960@9&5R:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G;FEZ960@
M:6X@06-C=6UU;&%T960@3T-)/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XF;F)S<#LD(#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B9N8G-P.R0@*#$U."D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XF;F)S<#LD("@Q
M.#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y'86EN+R`H3&]S<RD@<F5C;&%S<VEF:65D(&9R;VT@06-C=6UU;&%T
M960@3T-)(&EN=&\@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@T,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@U-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH.38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN+R`H3&]S<RD@<F5C;V=N:7IE9"!I
M;B!/=&AE<B!I;F-O;64O97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#$S,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3,Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C
M=',@6TUE;6)E<ET@?"!);F-L=61E9"!I;B!386QE<R!T;R!C=7-T;VUE<B!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E-U;6UA<GD@;V8@9&5S:6=N871E9"!D97)I=F%T:79E<SPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN+R`H3&]S
M<RD@<F5C;V=N:7IE9"!I;B!!8V-U;75L871E9"!/0TD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#4S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN+R`H3&]S<RD@<F5C
M;&%S<VEF:65D(&9R;VT@06-C=6UU;&%T960@3T-)(&EN=&\@:6YC;VUE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(Y*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG
M;B!E>&-H86YG92!C;VYT<F%C=',@6TUE;6)E<ET@?"!);F-L=61E9"!I;B!#
M;W-T(&]F('!R;V1U8W1S('-O;&0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(&1E<VEG;F%T
M960@9&5R:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G;FEZ960@:6X@06-C=6UU
M;&%T960@3T-)/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$P
M,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XY,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#(P-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D=A:6XO("A,;W-S*2!R96-L87-S:69I960@9G)O;2!!8V-U
M;75L871E9"!/0TD@:6YT;R!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#0T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#<V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$P-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Y."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F5I9VX@97AC:&%N9V4@8V]N
M=')A8W1S(%M-96UB97)=('P@26YC;'5D960@:6X@4F5S96%R8V@@86YD(&1E
M=F5L;W!M96YT(&5X<&5N<V4@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(&1E<VEG;F%T960@
M9&5R:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G;FEZ960@:6X@06-C=6UU;&%T
M960@3T-)/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1V%I;B\@*$QO<W,I(')E8VQA<W-I9FEE9"!F<F]M($%C8W5M=6QA=&5D
M($]#22!I;G1O(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S(%M-96UB
M97)=('P@26YC;'5D960@:6X@3W1H97(@*&EN8V]M92DO97AP96YS92P@;F5T
M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^4W5M;6%R>2!O9B!D97-I9VYA=&5D(&1E<FEV871I=F5S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=A:6XO("A,
M;W-S*2!R96-O9VYI>F5D(&EN($%C8W5M=6QA=&5D($]#23PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4Y*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN+R`H3&]S<RD@
M<F5C;&%S<VEF:65D(&9R;VT@06-C=6UU;&%T960@3T-)(&EN=&\@:6YC;VUE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG
M;B!E>&-H86YG92!C;VYT<F%C=',@6TUE;6)E<ET@?"!);F-L=61E9"!I;B!/
M=&AE<B`H26YC;VUE*2]%>'!E;G-E(%1Y<&4@5'=O+"!N970@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM
M87)Y(&]F(&1E<VEG;F%T960@9&5R:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G
M;FEZ960@:6X@3W1H97(@:6YC;VUE+V5X<&5N<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N(&5X8VAA;F=E(&-O
M;G1R86-T<R!;365M8F5R72!\($EN8VQU9&5D(&EN($]T:&5R("A);F-O;64I
M+T5X<&5N<V4@5'EP92!4:')E92P@;F5T(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!D97-I
M9VYA=&5D(&1E<FEV871I=F5S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D=A:6XO("A,;W-S*2!R96-O9VYI>F5D(&EN($]T
M:&5R(&EN8V]M92]E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,30Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q-30I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<R!;
M365M8F5R72!\($EN8VQU9&5D(&EN($]T:&5R("A);F-O;64I+T5X<&5N<V4@
M5'EP92!&;W5R+"!N970@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(&1E<VEG;F%T960@9&5R
M:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G;FEZ960@:6X@3W1H97(@:6YC;VUE
M+V5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<R!;365M8F5R72!\($]T
M:&5R($EN=&5R97-T($EN8V]M92!%>'!E;G-E(%1Y<&4@4VEX($YE="!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-U;6UA<GD@;V8@9&5S:6=N871E9"!D97)I=F%T:79E<SPO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN+R`H3&]S<RD@
M<F5C;V=N:7IE9"!I;B!/=&AE<B!I;F-O;64O97AP96YS93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-R;W-S(&-U<G)E;F-Y(&EN
M=&5R97-T(')A=&4@<W=A<',@6TUE;6)E<ET@?"!);F-L=61E9"!I;B!);G1E
M<F5S="`H:6YC;VUE*2]);G1E<F5S="!E>'!E;G-E+"!N970@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM
M87)Y(&]F(&1E<VEG;F%T960@9&5R:79A=&EV97,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V%I;B\@*$QO<W,I(')E8V]G
M;FEZ960@:6X@06-C=6UU;&%T960@3T-)/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@S,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@X,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@T,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=A:6XO("A,;W-S*2!R96-L87-S
M:69I960@9G)O;2!!8V-U;75L871E9"!/0TD@:6YT;R!I;F-O;64\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)FYB<W`[)"`H,38I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)FYB<W`[)"`H,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)FYB<W`[)"`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q
M-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y
M,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H
M965T,S,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$56,4))/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R
M;VYG/D9A:7(@5F%L=64@365A<W5R96UE;G1S("A$971A:6QS(#$I("A54T0@
M)FYB<W`[)"D\8G(^26X@36EL;&EO;G,\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@,#(L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6%L(&%S
M<V5T<R!A;F0@;&EA8FEL:71I97,@870@9F%I<B!V86QU93PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!D
M97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@.B!!<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-#@Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[
M)"`S,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1E<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T
M<G5M96YT<R`Z($QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#`U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,#@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N871E
M9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@;F]T(&1E
M<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($]T:&5R($EN=F5S
M=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,W,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<R!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9I;F%N8VEA
M;"!A<W-E=',@86YD(&QI86)I;&ET:65S(&%T(&9A:7(@=F%L=64\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV
M97,@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@07-S971S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.#<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,C$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV
M871I=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($QI
M86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#8\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M.#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E<FEV871I=F5S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS
M=')U;65N=',@.B!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D1E<FEV871I=F5S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=I
M;F<@:6YS=')U;65N=',@.B!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!E>&-H86YG92!C;VYT<F%C
M=',@6TUE;6)E<ET@?"!1=6]T960@<')I8V5S(&EN(&%C=&EV92!M87)K971S
M(&9O<B!I9&5N=&EC86P@87-S971S(&%N9"!L:6%B:6QI=&EE<R!,979E;"`Q
M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@870@9F%I
M<B!V86QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U
M;65N=',@.B!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M
M96YT<R`Z($QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N871E9"!A<R!H961G:6YG
M(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N871E9"!A<R!H961G
M:6YG(&EN<W1R=6UE;G1S(#H@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S
M(%M-96UB97)=('P@4VEG;FEF:6-A;G0@;W1H97(@;V)S97)V86)L92!I;G!U
M=',@3&5V96P@,B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D9I;F%N8VEA;"!A<W-E=',@86YD(&QI86)I;&ET
M:65S(&%T(&9A:7(@=F%L=64\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G
M:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D
M9VEN9R!I;G-T<G5M96YT<R`Z($QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S(&YO="!D97-I9VYA
M=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@.B!!<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S
M:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@3&EA8FEL:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N(&5X
M8VAA;F=E(&-O;G1R86-T<R!;365M8F5R72!\(%-I9VYI9FEC86YT('5N;V)S
M97)V86)L92!I;G!U=',@3&5V96P@,R!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9I;F%N8VEA;"!A<W-E=',@
M86YD(&QI86)I;&ET:65S(&%T(&9A:7(@=F%L=64\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@9&5S:6=N
M871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!D97-I9VYA
M=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@.B!,:6%B:6QI=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@;F]T
M(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@
M;F]T(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($QI86)I
M;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#<F]S
M<R!C=7)R96YC>2!I;G1E<F5S="!R871E('-W87!S(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6%L
M(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@870@9F%I<B!V86QU93PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E
M<R!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@.B!!<W-E=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV
M97,@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@3&EA8FEL
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0W)O<W,@8W5R<F5N8WD@:6YT97)E<W0@<F%T92!S=V%P<R!;365M8F5R72!\
M(%%U;W1E9"!P<FEC97,@:6X@86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A
M;"!A<W-E=',@86YD(&QI86)I;&ET:65S($QE=F5L(#$@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&:6YA;F-I
M86P@87-S971S(&%N9"!L:6%B:6QI=&EE<R!A="!F86ER('9A;'5E/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I
M=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV
M97,@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@3&EA8FEL
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-R;W-S
M(&-U<G)E;F-Y(&EN=&5R97-T(')A=&4@<W=A<',@6TUE;6)E<ET@?"!3:6=N
M:69I8V%N="!O=&AE<B!O8G-E<G9A8FQE(&EN<'5T<R!,979E;"`R(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@870@9F%I<B!V86QU
M93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@
M.B!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E
M<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z
M($QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-R;W-S(&-U<G)E;F-Y(&EN=&5R97-T(')A=&4@<W=A<',@6TUE;6)E
M<ET@?"!3:6=N:69I8V%N="!U;F]B<V5R=F%B;&4@:6YP=71S($QE=F5L(#,@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY&:6YA;F-I86P@87-S971S(&%N9"!L:6%B:6QI=&EE<R!A="!F86ER
M('9A;'5E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E<FEV871I=F5S(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M
M96YT<R`Z($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE
M;G1S(#H@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-W:7-S($9R86YC($]P=&EO;B!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9I;F%N8VEA;"!A<W-E
M=',@86YD(&QI86)I;&ET:65S(&%T(&9A:7(@=F%L=64\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@;F]T
M(&1E<VEG;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=VES<R!&<F%N
M8R!/<'1I;VX@6TUE;6)E<ET@?"!3:6=N:69I8V%N="!O=&AE<B!O8G-E<G9A
M8FQE(&EN<'5T<R!,979E;"`R(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6%L(&%S<V5T<R!A;F0@
M;&EA8FEL:71I97,@870@9F%I<B!V86QU93PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N
M871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-CD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E%U;W1E9"!P<FEC97,@:6X@
M86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@86YD(&QI86)I
M;&ET:65S($QE=F5L(#$@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&:6YA;F-I86P@87-S971S(&%N9"!L:6%B
M:6QI=&EE<R!A="!F86ER('9A;'5E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S(&1E<VEG;F%T960@87,@
M:&5D9VEN9R!I;G-T<G5M96YT<R`Z($QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N
M871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S
M:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@3W1H97(@26YV97-T
M;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S<Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M:6=N:69I8V%N="!O=&AE<B!O8G-E<G9A8FQE(&EN<'5T<R!,979E;"`R(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@870@9F%I<B!V
M86QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N
M=',@.B!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE
M;G1S(#H@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,#4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N;W0@9&5S:6=N871E9"!A<R!H961G
M:6YG(&EN<W1R=6UE;G1S(#H@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S(&YO="!D97-I9VYA=&5D(&%S
M(&AE9&=I;F<@:6YS=')U;65N=',@.B!/=&AE<B!);G9E<W1M96YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VEG;FEF:6-A;G0@=6YO
M8G-E<G9A8FQE(&EN<'5T<R!,979E;"`S(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6%L(&%S<V5T
M<R!A;F0@;&EA8FEL:71I97,@870@9F%I<B!V86QU93PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!D97-I
M9VYA=&5D(&%S(&AE9&=I;F<@:6YS=')U;65N=',@.B!!<W-E=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S(&1E<VEG
M;F%T960@87,@:&5D9VEN9R!I;G-T<G5M96YT<R`Z($QI86)I;&ET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!N
M;W0@9&5S:6=N871E9"!A<R!H961G:6YG(&EN<W1R=6UE;G1S(#H@3W1H97(@
M26YV97-T;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N
M8G-P.R0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A
M-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,S0N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5164=+/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D9A:7(@5F%L=64@
M365A<W5R96UE;G1S("A$971A:6QS(#(I("A54T0@)FYB<W`[)"D\8G(^26X@
M36EL;&EO;G,\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIA;BX@,#(L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6%L($QI86)I;&ET:65S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@
M1&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U
M+#`T-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B9N8G-P.R0@-RPV,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG
M+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L
M-C@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.2PQ-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@26YV97-T
M;65N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPR.3D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D=O=F5R;FUE;G0@<V5C=7)I=&EE<R!A;F0@;V)L:6=A=&EO;G,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#DU,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]R<&]R871E(&1E
M8G0@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-3$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y-;VYE>2!M87)K970@9G5N9',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L.#(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4:6UE(&1E<&]S:71S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#`Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-A<V@L(&-A<V@@97%U
M:79A;&5N=',@86YD(&-U<G)E;G0@;6%R:V5T86)L92!S96-U<FET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.2PV.#(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1FEN86YC:6%L($QI86)I;&ET:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@1&5B=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-2PP-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@
M1&5B=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y,;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3,L-C@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87)R>6EN9R!!;6]U;G0@6TUE;6)E<ET@?"`U+C$U)2!$
M96)E;G1U<F5S(&1U92`R,#$R(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E
M<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3DY/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M87)R>6EN9R!!;6]U;G0@6TUE;6)E<ET@?"`P+C<P)2!.;W1E<R!D=64@,C`Q
M,R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-
M96UB97)=('P@,RXX,"4@1&5B96YT=7)E<R!D=64@,C`Q,R!;365M8F5R73PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#
M=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=('P@,R!M
M;VYT:"!,24)/4BLP)2!&4DX@9'5E(#(P,3,@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$
M96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M8F5R72!\(#,@;6]N=&@@3$E"
M3U(K,"XP.24@1E).(&1U92`R,#$T(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG
M+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#87)R>6EN9R!!;6]U;G0@6TUE;6)E<ET@?"`Q+C(P)2!N;W1E<R!D=64@
M,C`Q-"!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDY.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT
M(%M-96UB97)=('P@,BXQ-24@3F]T97,@9'5E(#(P,38@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM0W5R
M<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M8F5R72!\(#4N-34E
M($1E8F5N='5R97,@9'5E(#(P,3<@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M
M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=('P@-2XQ-24@1&5B96YT=7)E
M<R!D=64@,C`Q."!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@Y.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@
M06UO=6YT(%M-96UB97)=('P@-"XW-24@3F]T97,@9'5E(#(P,3D@*#%"($5U
M<F\@,2XT-#<V*2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#0P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87)R>6EN
M9R!!;6]U;G0@6TUE;6)E<ET@?"`S)2!:97)O($-O=7!O;B!#;VYV97)T:6)L
M92!3=6)O<F1I;F%T960@1&5B96YT=7)E<R!D=64@:6X@,C`R,"!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO
M;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=('P@
M,BXY-24@1&5B96YT=7)E<R!D=64@,C`R,"!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E
M8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=('P@,RXU-24@3F]T97,@
M9'5E(#(P,C$@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<G)Y:6YG($%M
M;W5N="!;365M8F5R72!\(#8N-S,E($1E8F5N='5R97,@9'5E(#(P,C,@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M8F5R
M72!\(#4N-3`E($YO=&5S(&1U92`R,#(T("@U,#`@1T)0(#$N-C`R-2D@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M8F5R
M72!\(#8N.34E($YO=&5S(&1U92`R,#(Y(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B
M=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#87)R>6EN9R!!;6]U;G0@6TUE;6)E<ET@?"`T+CDU)2!$96)E;G1U
M<F5S(&1U92`R,#,S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87)R>6EN
M9R!!;6]U;G0@6TUE;6)E<ET@?"`U+CDU)2!.;W1E<R!D=64@,C`S-R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDY-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=
M('P@-2XX-B4@1&5B96YT=7)E<R!D=64@,C`S."!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT
M($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V%R<GEI;F<@06UO=6YT(%M-96UB97)=('P@-"XU,"4@1&5B
M96YT=7)E<R!D=64@,C`T,"!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M
M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%R
M<GEI;F<@06UO=6YT(%M-96UB97)=('P@-"XX-24@3F]T97,@9'5E(#(P-#$@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<G)Y:6YG($%M;W5N="!;365M
M8F5R72!\($]T:&5R("A);F-L=61E<R!);F1U<W1R:6%L(%)E=F5N=64@0F]N
M9',I(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A
M;'5E(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^0W5R<F5N="!);G9E<W1M96YT<SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#(Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]V97)N;65N="!S96-U<FET:65S
M(&%N9"!O8FQI9V%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C,L.34Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;W)P;W)A=&4@9&5B="!S96-U<FET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO;F5Y(&UA<FME="!F=6YD
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PX,C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1I;64@
M9&5P;W-I=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#DW
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@8V%S:"P@8V%S:"!E<75I=F%L96YT<R!A;F0@8W5R<F5N="!M
M87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(Y+#8X,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&:6YA;F-I86P@3&EA8FEL:71I97,\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R
M<F5N="!$96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`T
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PU.#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&
M86ER(%9A;'5E(%M-96UB97)=('P@-2XQ-24@1&5B96YT=7)E<R!D=64@,C`Q
M,B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8S,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L
M=64@6TUE;6)E<ET@?"`P+C<P)2!.;W1E<R!D=64@,C`Q,R!;365M8F5R73PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#
M=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64@6TUE;6)E<ET@
M?"`S+C@P)2!$96)E;G1U<F5S(&1U92`R,#$S(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@
M1&5B=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y,;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-3(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%<W1I;6%T960@1F%I<B!686QU92!;365M8F5R72!\(#,@;6]N
M=&@@3$E"3U(K,"4@1E).(&1U92`R,#$S(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B
M=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%<W1I;6%T960@1F%I<B!686QU92!;365M8F5R72!\(#,@;6]N=&@@
M3$E"3U(K,"XP.24@1E).(&1U92`R,#$T(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B
M=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-S4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%<W1I;6%T960@1F%I<B!686QU92!;365M8F5R72!\(#$N,C`E(&YO
M=&5S(&1U92`R,#$T(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP,#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM
M871E9"!&86ER(%9A;'5E(%M-96UB97)=('P@,BXQ-24@3F]T97,@9'5E(#(P
M,38@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,#,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A
M;'5E(%M-96UB97)=('P@-2XU-24@1&5B96YT=7)E<R!D=64@,C`Q-R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,38Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@1F%I<B!686QU92!;
M365M8F5R72!\(#4N,34E($1E8F5N='5R97,@9'5E(#(P,3@@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM
M0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#`Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64@6TUE;6)E
M<ET@?"`T+C<U)2!.;W1E<R!D=64@,C`Q.2`H,4(@175R;R`Q+C0T-S8I(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PU-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A;'5E
M(%M-96UB97)=('P@,R4@6F5R;R!#;W5P;VX@0V]N=F5R=&EB;&4@4W5B;W)D
M:6YA=&5D($1E8F5N='5R97,@9'5E(&EN(#(P,C`@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N
M="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A;'5E(%M-96UB97)=('P@,BXY
M-24@1&5B96YT=7)E<R!D=64@,C`R,"!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N
M9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^17-T:6UA=&5D($9A:7(@5F%L=64@6TUE;6)E<ET@?"`S+C4U)2!.;W1E
M<R!D=64@,C`R,2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0U-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D
M($9A:7(@5F%L=64@6TUE;6)E<ET@?"`V+C<S)2!$96)E;G1U<F5S(&1U92`R
M,#(S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^3F]N+4-U<G)E;G0@1&5B=#PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@9&5B=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S(S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@1F%I<B!6
M86QU92!;365M8F5R72!\(#4N-3`E($YO=&5S(&1U92`R,#(T("@U,#`@1T)0
M(#$N-C`R-2D@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&
M86ER(%9A;'5E(%M-96UB97)=('P@-BXY-24@3F]T97,@9'5E(#(P,CD@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;VXM0W5R<F5N="!$96)T/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A;'5E(%M-
M96UB97)=('P@-"XY-24@1&5B96YT=7)E<R!D=64@,C`S,R!;365M8F5R73PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#
M=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64@6TUE;6)E<ET@
M?"`U+CDU)2!.;W1E<R!D=64@,C`S-R!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N
M9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%<W1I;6%T960@1F%I<B!686QU92!;365M8F5R72!\(#4N.#8E($1E
M8F5N='5R97,@9'5E(#(P,S@@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VXM0W5R<F5N="!$96)T/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R
M;2!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S
M=&EM871E9"!&86ER(%9A;'5E(%M-96UB97)=('P@-"XU,"4@1&5B96YT=7)E
M<R!D=64@,C`T,"!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D
M($9A:7(@5F%L=64@6TUE;6)E<ET@?"`T+C@U)2!.;W1E<R!D=64@,C`T,2!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64@
M6TUE;6)E<ET@?"!/=&AE<B`H26YC;'5D97,@26YD=7-T<FEA;"!2979E;G5E
M($)O;F1S*2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/DYO;BU#=7)R96YT($1E8G0\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&1E8G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V
M,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X
M-S,O5V]R:W-H965T<R]3:&5E=#,U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-C1!1SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT<R`H
M1&5T86EL<R!497AT=6%L<RD@*%531"`F;F)S<#LD*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#0L(#(P
M,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`P,BP@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT<R`H5&5X='5A;',I/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E86QI>F5D
M(&=A:6X@;VX@;W!T:6]N(&YO="!D97-I9VYA=&5D(&%S(&AE9&=E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$P,BPP,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$969E<G)E9"!N970@9V%I;G,@;VX@9&5R:79A=&EV97,@:6YC;'5D960@
M:6X@86-C=6UU;&%T960@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(R."PP,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(X+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5C;&%S<VEF:6-A=&EO;B!O9B!F;W)E:6=N
M(&5X8VAA;F=E(&-O;G1R86-T<R!I;G1O(&5A<FYI;F=S+"!P97)I;V0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DYE>'0@,3(@;6]N=&AS/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-
M87AI;75M(&QE;F=T:"!O9B!T:6UE(&9O<B!H961G:6YG('1R86YS86-T:6]N
M(&5X<&]S=7)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ."!-
M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]T:&5R(&EN8V]M92\H97AP96YS92DL(&YE="P@<F5L871E9"!T
M;R!F;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T<RP@;F]N(&AE9&=I;F<\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<L,#`P+#`P,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,2PP,#`L
M,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#8Y+#`P,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!I;G9E<W1M96YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-S$L,#`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,S<Q+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#$V-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E(')A
M=&4@;VX@;F]N+6-U<G)E;G0@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"XP."4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9O<F5I9VX@97AC:&%N9V4@8V]N=')A8W1S(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1&5R:79A=&EV92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]T:6]N86P@86UO=6YT<R!O=71S
M=&%N9&EN9R!F;W(@9F]R=V%R9"!F;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,L,#`P+#`P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR,RPP,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0W)O<W,@8W5R<F5N8WD@:6YT97)E<W0@<F%T
M92!S=V%P<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D1E<FEV871I=F4@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&EO;F%L(&%M
M;W5N=',@;W5T<W1A;F1I;F<@9F]R(&-R;W-S(&-U<G)E;F-Y(&EN=&5R97-T
M(')A=&4@<W=A<',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L
M,#`P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#`P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM8W5R<F5N="!A<W-E=',@
M:6YC;'5D960@:6YT;R!C<F]S<R!C=7)R96YC>2!I;G1E<F5S="!R871E('-W
M87!S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM8W5R<F5N="!L:6%B:6QI=&EE<R!I
M;F-L=61E9"!I;G1O(&-R;W-S(&-U<G)E;F-Y(&EN=&5R97-T(')A=&4@<W=A
M<',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-#`T
M+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XF;F)S<#LD(#0P-"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U,#(L,#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V
M-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S
M,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,S8N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,
M2$%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DEN8V]M92!487AE<R`H1&5T
M86EL<R!497AT=6%L<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!487@@*%1E>'1U86QS*2!;06)S
M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5F9F5C=&EV92!T87@@<F%T97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(Q+C(P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(T+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q
M-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y
M,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H
M965T,S<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5#24%'/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/E!E;G-I;VYS(&%N9"!/=&AE<B!0;W-T<F5T:7)E;65N="!"96YE9FET
M<R`H1&5T86EL<RD@*%531"`F;F)S<#LD*3QB<CY);B!-:6QL:6]N<SPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`T
M+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@
M,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L
M+B`P-"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4F5T:7)E;65N="!0;&%N<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;7!O;F5N=',@;V8@;F5T('!E
M<FEO9&EC(&)E;F5F:70@8V]S=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y397)V:6-E(&-O<W0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,30T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q,C$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD
M(#(X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B9N8G-P.R0@,C0W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S="!C;W-T/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.30\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(')E='5R
M;B!O;B!P;&%N(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,C<W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(T."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@U-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-3`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N(&]F('!R:6]R('-E
M<G9I8V4@8V]S="\@*&-R961I="D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!O9B!N970@=')A;G-I=&EO;B!O
M8FQI9V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y296-O9VYI>F5D(&%C='5A<FEA;"!L;W-S97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@<&5R:6]D:6,@8F5N
M969I="!C;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D]T:&5R($)E;F5F:70@4&QA;G,@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VUP;VYE;G1S
M(&]F(&YE="!P97)I;V1I8R!B96YE9FET(&-O<W0\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5R=FEC92!C;W-T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@
M8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDT/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%>'!E8W1E9"!R971U<FX@;VX@<&QA;B!A<W-E=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@;V8@
M<')I;W(@<V5R=FEC92!C;W-T+R`H8W)E9&ET*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-O9VYI>F5D(&%C='5A<FEA;"!L
M;W-S97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T('!E<FEO9&EC(&)E;F5F:70@8V]S=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@.30\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$X
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B9N8G-P.R0@,3@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T
M83<T7V$V9#%?-3,Q-#5B,64P.#<S+U=O<FMS:&5E=',O4VAE970S."YH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P15I)04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4&5N<VEO
M;G,@86YD($]T:&5R(%!O<W1R971I<F5M96YT($)E;F5F:70@*$1E=&%I;',@
M5&5X='5A;',I("A54T0@)FYB<W`[)"D\8G(^26X@36EL;&EO;G,\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5+E,N(')E=&ER96UE;G0@
M<&QA;G,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY096YS:6]N<R!A;F0@3W1H97(@0F5N969I="!0;&%N<R`H
M5&5X='5A;',I/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;G1R:6)U=&EO;B!T;R!P96YS:6]N('!L86YS/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$Q.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)N871I
M;VYA;"!R971I<F5M96YT('!L86YS(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4&5N<VEO;G,@86YD($]T:&5R
M($)E;F5F:70@4&QA;G,@*%1E>'1U86QS*3PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYT<FEB=71I;VX@=&\@<&5N<VEO
M;B!P;&%N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[
M)"`Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q
M7S4S,30U8C%E,#@W,R]7;W)K<VAE971S+U-H965T,SDN:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$534T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D%C8W5M=6QA=&5D($]T
M:&5R($-O;7!R96AE;G-I=F4@26YC;VUE("A$971A:6QS*2`H55-$("9N8G-P
M.R0I/&)R/DEN($UI;&QI;VYS/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY&;W)E:6=N($-U<G)E;F-Y(%1R86YS;&%T:6]N
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DIA
M;G5A<GD@,BP@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XF
M;F)S<#LD("@Y-CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@<VEX(&UO;G1H<R!C:&%N9V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S@W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y*=6QY(#,L(#(P,3$\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@Q.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY396-U
M<FET:65S($%V86EL86)L92!F;W(@<V%L93PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y*86YU87)Y(#(L(#(P,3$\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D(&=A:6X@
M*&QO<W,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE
M="!A;6]U;G0@<F5C;&%S<V5D('1O(&YE="!E87)N:6YG<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3,Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!S:7@@;6]N=&AS(&-H
M86YG93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CDV/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y*=6QY
M(#,L(#(P,3$\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,R,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY%;7!L;WEE92!"96YE9FET(%!L86YS/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DIA;G5A<GD@,BP@,C`Q,3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPV.#8I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@<VEX
M(&UO;G1H<R!C:&%N9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^2G5L>2`S+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@R+#4U."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5R:79A=&EV97,@)F%M<#L@2&5D9V5S
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DIA
M;G5A<GD@,BP@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y5;G)E86QI>F5D(&=A:6X@*&QO<W,I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&%M;W5N="!R96-L87-S:69I960@=&\@
M;F5T(&5A<FYI;F=S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@4VEX(&UO;G1H<R!C:&%N9V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^2G5L>2`S+"`R,#$Q/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR,C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5&]T86P@06-C=6UU;&%T
M960@3W1H97(@0V]M<')E:&5N<VEV92!);F-O;64O*$QO<W,I/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DIA;G5A<GD@,BP@
M,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPU,S$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5T(%-I>"!M;VYT:',@8VAA;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#,S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^2G5L>2`S+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B9N8G-P.R0@*#$L,3DR*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V
M9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K<VAE
M971S+U-H965T-#`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5%14%%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D%C8W5M=6QA=&5D($]T:&5R($-O;7!R96AE;G-I=F4@26YC
M;VUE("A$971A:6QS(%1E>'1U86QS*2`H55-$("9N8G-P.R0I/&)R/DEN($)I
M;&QI;VYS/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;"X@,#0L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%C8W5M=6QA=&5D($]T:&5R($-O;7!R
M96AE;G-I=F4@26YC;VUE("A497AT=6%L<RD@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C;VUP
M<F5H96YS:79E(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)FYB<W`[)"`S+C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$N-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@."XV/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U
M+C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A
M-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U
M,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#0Q+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M659!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%87)N:6YG<R!097(@4VAA
M<F4@*$1E=&%I;',I("A54T0@)FYB<W`[)"D\8G(^26X@36EL;&EO;G,L(&5X
M8V5P="!097(@4VAA<F4@9&%T83PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY296-O;F-I;&EA
M=&EO;B!O9B!B87-I8R!N970@96%R;FEN9W,@<&5R('-H87)E('1O(&1I;'5T
M960@;F5T(&5A<FYI;F=S('!E<B!S:&%R93PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!N970@96%R;FEN9W,@<&5R
M('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD
M(#$N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XF;F)S<#LD(#$N,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(N,C@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(N.#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%V
M97)A9V4@<VAA<F5S(&]U='-T86YD:6YG("T@8F%S:6,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-S0P+C4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<U-BXV/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW,SDN-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S4U
M+C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!O=&5N=&EA;"!S:&%R97,@97AE<F-I<V%B;&4@=6YD97(@<W1O8VL@
M;W!T:6]N('!L86YS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-C@N.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$W-2XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,38X+C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-S4N-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&5S<SH@<VAA<F5S('=H:6-H(&-O=6QD
M(&)E(')E<'5R8VAA<V5D('5N9&5R('1R96%S=7)Y('-T;V-K(&UE=&AO9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,Q+C<I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,Y+C<I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,S
M+CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3,X+C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!D96)T('-H87)E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,RXV/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXV/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXV/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXV/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^079E<F%G92!S
M:&%R97,@;W5T<W1A;F1I;F<@+2!D:6QU=&5D/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#<X,2XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW.38\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<W."XQ/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW.38N,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&EL
M=71E9"!N970@96%R;FEN9W,@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$N,C,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(N
M,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XF;F)S<#LD(#(N.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W
M,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F
M7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E=#0R+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%145!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%87)N
M:6YG<R!097(@4VAA<F4@*$1E=&%I;',@5&5X='5A;',I/&)R/DEN($UI;&QI
M;VYS/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*
M=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;"X@,#0L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D5A<FYI;F=S(%!E<B!3:&%R92`H5&5X='5A
M;',I(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06YT:61I;'5T:79E('-H87)E<R!E>&-L=61E9"!F<F]M
M(&-O;7!U=&%T:6]N(&]F(&5A<FYI;F=S('!E<B!S:&%R93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A
M-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H
M965T<R]3:&5E=#0S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4U-#23X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY396=M96YT<R!O9B!"=7-I;F5S<R!A;F0@1V5O9W)A<&AI
M8R!!<F5A<R`H1&5T86EL<RD@*%531"`F;F)S<#LD*3QB<CY);B!-:6QL:6]N
M<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#0L(#(P,3`\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4V%L97,@8GD@<V5G;65N="!O9B!B=7-I;F5S<SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q-BPU.3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$U+#,S
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B9N8G-P.R0@,S(L-S<P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`S,"PY-C$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A9V4@0VAA
M;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+C,P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4N.#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VYS=6UE<B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-A;&5S(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-SDS/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPV-#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M+#0W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<L-#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y097)C96YT86=E($-H86YG93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N<W5M97(@6TUE;6)E<ET@
M?"!5+E,N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4V%L97,@8GD@<V5G;65N="!O9B!B=7-I;F5S<SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,SD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0V,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-C@T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,RPP,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!E<F-E;G1A9V4@0VAA;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@X+C4P)2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q,2XR,"4I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYS=6UE<B!;365M8F5R72!\
M($EN=&5R;F%T:6]N86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY386QE<R!B>2!S96=M96YT(&]F(&)U<VEN
M97-S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0U-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L
M,3@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PW.3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+#,Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!#:&%N9V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R+C0P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDN,3`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0:&%R;6%C975T:6-A
M;"!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-A;&5S(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L,C,S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PU-3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPR.3(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PQ
M.3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!E<F-E;G1A9V4@0VAA;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,BXR,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XY+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4&AA<FUA8V5U=&EC86P@6TUE;6)E<ET@
M?"!5+E,N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4V%L97,@8GD@<V5G;65N="!O9B!B=7-I;F5S<SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPR,SD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#$Q,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L-C,P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-BPS,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!E<F-E;G1A9V4@0VAA;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+C$P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0:&%R;6%C975T:6-A;"!;365M8F5R
M72!\($EN=&5R;F%T:6]N86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY386QE<R!B>2!S96=M96YT(&]F(&)U
M<VEN97-S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DY
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L-#0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-2PV-C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#@W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!#:&%N9V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(R+C8P)3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+C$P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^365D:6-A;"!$
M979I8V5S(&%N9"!$:6%G;F]S=&EC<R!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-A;&5S(&)Y('-E9VUE;G0@
M;V8@8G5S:6YE<W,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8L-3<Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-BPQ,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,RPP,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,BPS-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A9V4@0VAA;F=E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+C(P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4N,C`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-961I
M8V%L($1E=FEC97,@86YD($1I86=N;W-T:6-S(%M-96UB97)=('P@52Y3+B!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E-A;&5S(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.#8Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX-C4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#<T,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-S4Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M97)C96YT86=E($-H86YG93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,"XQ,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@P+C(P)2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DUE9&EC86P@1&5V:6-E<R!A;F0@1&EA9VYO<W1I
M8W,@6TUE;6)E<ET@?"!);G1E<FYA=&EO;F%L(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V%L97,@8GD@<V5G
M;65N="!O9B!B=7-I;F5S<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPW,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#(V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<L,C8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-BPV,#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A9V4@0VAA;F=E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RXT,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+CDP)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M52Y3+B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-A;&5S(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L-#0W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPT,S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PP-34\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-2PP.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!E<F-E;G1A9V4@0VAA;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XP+C$P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#`N,C`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)N871I;VYA;"!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-A
M;&5S(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@.2PQ-3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#<L.#DR/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB
M<W`[)"`Q-RPW,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XF;F)S<#LD(#$U+#@W,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!#:&%N9V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+CDP)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+C8P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR
M8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U
M8C%E,#@W,R]7;W)K<VAE971S+U-H965T-#0N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R-$%'
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-E9VUE;G1S(&]F($)U<VEN97-S
M(&%N9"!'96]G<F%P:&EC($%R96%S("A$971A:6QS(#$I("A54T0@)FYB<W`[
M)"D\8G(^26X@36EL;&EO;G,L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN
M(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;"X@,#0L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN9R!P<F]F:70@8GD@<V5G;65N="!O
M9B!B=7-I;F5S<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y396=M96YT<R!O<&5R871I;F<@<')O9FET/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#,L-3,X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`T+#,W
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B9N8G-P.R0@."PR-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$P+#@S-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N="!#:&%N9V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Y+C(P)2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,RXW,"4I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%>'!E;G-E(&YO="!A;&QO8V%T960@=&\@<V5G;65N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$Q-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-3@I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S,R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,S-2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=O<FQD
M=VED92!I;F-O;64@8F5F;W)E('1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#0R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0L,C(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-RPY,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PU,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=O<FQD=VED92!T
M;W1A;"P@<&5R8V5N="!T;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3@N.3`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#(T+C4P)2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G-U;65R(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG
M('!R;V9I="!B>2!S96=M96YT(&]F(&)U<VEN97-S/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E9VUE;G1S(&]P97)A=&EN
M9R!P<F]F:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4T.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8V
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L,3(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PT-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!E<F-E;G0@0VAA;F=E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q-RXY,"4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C(N.#`E*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&AA<FUA8V5U=&EC86P@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY/<&5R871I;F<@<')O9FET(&)Y('-E9VUE;G0@;V8@8G5S:6YE<W,\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5G
M;65N=',@;W!E<F%T:6YG('!R;V9I=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PW,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#@S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L.3(S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPX,#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G0@0VAA;F=E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+C4P)2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C(P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M365D:6-A;"!$979I8V5S(&%N9"!$:6%G;F]S=&EC<R!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN
M9R!P<F]F:70@8GD@<V5G;65N="!O9B!B=7-I;F5S<SPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y396=M96YT<R!O<&5R871I
M;F<@<')O9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S
M<#LD(#$L,C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)FYB<W`[)"`Q+#@W-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,RPR,3D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#4L
M-3<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y097)C96YT($-H86YG93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,S(N,#`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#0R+C,P)2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U
M8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W838V.3)C
M-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,O5V]R:W-H965T<R]3:&5E
M=#0U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%3$5"1SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY396=M96YT<R!O9B!"=7-I;F5S<R!A;F0@1V5O9W)A<&AI8R!!<F5A<R`H
M1&5T86EL<R`R*2`H55-$("9N8G-P.R0I/&)R/DEN($UI;&QI;VYS+"!U;FQE
M<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY386QE<R!B
M>2!G96]G<F%P:&EC(&%R96$\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B9N8G-P.R0@,38L-3DW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q-2PS,S`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#,R
M+#<W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B9N8G-P.R0@,S`L.38Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT($-H86YG93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^."XS,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+C@P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^52Y3+B!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-A
M;&5S(&)Y(&=E;V=R87!H:6,@87)E83PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-RPT-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW+#0S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#`U-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#`Y,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N="!#
M:&%N9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,3`E/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,"XR
M,"4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%=7)O<&4@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY386QE<R!B>2!G96]G<F%P:&EC(&%R96$\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-30S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPX,S(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#<R
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<L.3,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y097)C96YT($-H86YG93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3@N-C`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y797-T97)N($AE;6ES<&AE<F4L(&5X
M8VQU9&EN9R!5+E,N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4V%L97,@8GD@9V5O9W)A<&AI8R!A<F5A/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4T,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S<U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY
M-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+#8U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4&5R8V5N="!#:&%N9V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R+C(P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$R+C(P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-I82U086-I9FEC+"!!9G)I8V$@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY386QE<R!B>2!G96]G<F%P:&EC(&%R96$\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,RPP-C0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(L-C@U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)FYB<W`[)"`V+#`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B9N8G-P.R0@-2PR.#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G0@0VAA;F=E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"XQ,"4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RXX,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=A-C8Y,F,T
M7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,PT*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q
M93`X-S,O5V]R:W-H965T<R]3:&5E=#0V+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,5A!13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY396=M96YT<R!O9B!"=7-I;F5S<R!A
M;F0@1V5O9W)A<&AI8R!!<F5A<R`H1&5T86EL<R!497AT=6%L<RD@*%531"`F
M;F)S<#LD*3QB<CY);B!-:6QL:6]N<SPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`T+"`R,#$P/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P-"P@,C`Q,#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY396=M96YT
M(&]F($)U<VEN97-S(&%N9"!'96]G<F%P:&EC($%R96%S("A497AT=6%L<RD@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y297-T<G5C='5R:6YG(&5X<&5N<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-3@Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U.#D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!H87)M
M86-E=71I8V%L(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^4V5G;65N="!O9B!"=7-I;F5S<R!A;F0@1V5O9W)A
M<&AI8R!!<F5A<R`H5&5X='5A;',I(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&ET:6=A=&EO;B!%>'!E
M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,34\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUE9&EC86P@1&5V:6-E<R!A;F0@1&EA9VYO<W1I8W,@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY396=M
M96YT(&]F($)U<VEN97-S(&%N9"!'96]G<F%P:&EC($%R96%S("A497AT=6%L
M<RD@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y,:71I9V%T:6]N($5X<&5N<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PU-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R=6-T=7)I;F<@97AP96YS
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C<V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C<V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,:71I
M9V%T:6]N(&%N9"!A9&1I=&EO;F%L($1E4'5Y($%34B!(:7`@<F5C86QL(&-O
M<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$R
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B9N8G-P.R0@,C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?839D,5\U,S$T-6(Q93`X-S,-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V$V-CDR8S1?,38Q9E\T
M83<T7V$V9#%?-3,Q-#5B,64P.#<S+U=O<FMS:&5E=',O4VAE970T-RYH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P1490044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0G5S:6YE
M<W,@0V]M8FEN871I;VYS(&%N9"!$:79E<W1I='5R97,@*$1E=&%I;',I("A5
M4T0@)FYB<W`[)"D\8G(^26X@0FEL;&EO;G,L('5N;&5S<R!O=&AE<G=I<V4@
M<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5L+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y!<'(N(#`S+"`R,#$Q/&)R/D-R=6-E;&P@+DXN(%8@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`P-"P@,C`Q
M,#QB<CY!8V-L87)E;G0@26YC(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^4WEN=&AE<RP@26YC
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D)U<VEN97-S($-O;6)I;F%T:6]N<R!A;F0@1&EV97-T:71U
M<F5S("A497AT=6%L<RD@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8W%U:7-I=&EO;B!P<FEC92!A;&QO
M8V%T960@=&\@86UO<G1I>F%B;&4@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,"XW/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`P
M+C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D)U<VEN97-S(&%C<75I<VET:6]N(&-O<W0@;V8@86-Q=6ER960@96YT
M:71Y('!U<F-H87-E('!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,"XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.;VX@86UO<G1I>F%B;&4@:6YT86YG:6)L92!A<W-E=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)U<VEN97-S($%C
M<75I<VET:6]N+"!0=7)C:&%S92!0<FEC92!!;&QO8V%T:6]N+"!';V]D=VEL
M;"!!;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0G5S:6YE<W,@06-Q=6ES:71I;VX@0V]S="!O9B!!8W%U:7)E9"!%;G1I='D@
M0V%S:"!086ED(%!E<F-E;G1A9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0G5S:6YE<W,@86-Q=6ES:71I;VX@8V]S="!O9B!A
M8W%U:7)E9"!E;G1I='D@<W1O8VL@:7-S=65D('!E<F-E;G1A9V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06=R965M96YT('1O
M($%C<75I<F4@4WEN=&AE<VES/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,2XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!8W%U:7-I=&EO;B!C87-H('!A:60\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,3DN,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T
M7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K
M<VAE971S+U-H965T-#@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5'24)'/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/DQE9V%L(%!R;V-E961I;F=S("A$971A:6QS*2`H55-$
M("9N8G-P.R0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^07!R+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DIU;BX@,C@L(#(P,#D\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&]S<R!#;VYT:6YG96YC:65S(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y,:71I9V%T:6]N($QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B9N8G-P.R0@-3DS+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L:71I9V%T:6]N
M(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<S+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^3&5G86P@4')O8V5E9&EN9R`H5&5X='5A;',I(%M!
M8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06UO=6YT(&=I=F5N('1O('!L86EN=&EF9B!B>2!J=7)Y/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.#(L,#`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F5R9&EC
M="!I;B!F879O<B!O9B!T:&4@4W1A=&4G<R!!='1O<FYE>2!'96YE<F%L(&%N
M9"!A9V%I;G-T($IA;G-S96X@86YD('1H92!#;VUP86YY/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-3<L-S`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&ET:6=A=&EO;B!S
M971T;&5M96YT('!R92!J=61G;65N="!I;G1E<F5S=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$Q+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%P<')O>&EM871E(&1A
M;6%G97,@:6YI=&EA;&QY(&%W87)D960@=&\@0V5N=&]C;W(L('1H96X@<W5B
M<V5Q=65N=&QY(')E=F5R<V5D(&)Y('1H92!#;W5R="!O9B!!<'!E86QS/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<P,"PP,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M<W-E<W-E9"!D86UA9V5S(&9O<B!A;&QE9V5D(&-O;G-U;65R(&9R875D(&%S
M('1O($154D%'15-)0R!A;F0@4DE34$521$%,/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E='1L96UE;G0@<&%Y;65N="!R
M96QA=&5D(&9I;F5S(&1I<V=O<F=E;65N="!A;F0@:6YT97)E<W0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A
M9V4@;V8@<F5V96YU92!R97!R97-E;G1E9"!B>2!R96QI;G%U:7-H960@=&5R
M<FET;W)I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3VYE('1I;64@<&%Y;65N="!R96-E:79E9"!B>2!#;VUP86YY/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^365R8VL@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY,;W-S($-O;G1I;F=E;F-I97,@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A9V4@
M;V8@8V]N=')I8G5T:6]N('1O(&EN8V]M92!P<F]F:70@<W!L:70\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4X+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O
M9B!R979E;G5E(')E<')E<V5N=&5D(&)Y(')E=&%I;F5D('1E<G)I=&]R:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,"XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N
M="!O9B!R979E;G5E(')E<')E<V5N=&5D(&)Y(')E=&%I;F5D('1E<G)I=&]R
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#@P,"PP,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#3T))(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^3&]S<R!#;VYT:6YG96YC:65S(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M97)C96YT86=E(&]F(&-O;G1R:6)U=&EO;B!T;R!I;F-O;64@<')O9FET('-P
M;&ET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,BXP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%V
M97)A9V4@5VAO;&5S86QE(%!R:6-E($QI=&EG871I;VX@6TUE;6)E<ET@?"!#
M:79I;"!P96YA;'1I97,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY,;W-S($-O;G1I;F=E;F-I97,@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQI=&EG871I;VX@3&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y2:7-P97)D86P@6TUE;6)E<ET@?"!#:79I;"!P
M96YA;'1I97,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY,;W-S($-O;G1I;F=E;F-I97,@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQI
M=&EG871I;VX@3&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S(W+#$P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E<W1I='5T:6]N(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&]S<R!#;VYT:6YG96YC
M:65S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,:71I9V%T:6]N($QO<W,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-#4L,#`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T
M83<T7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7
M;W)K<VAE971S+U-H965T-#DN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5714%#/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/E)E<W1R=6-T=7)I;F<@*$1E=&%I;',I("A3979E
M<F%N8V4@6TUE;6)E<ETL(%531"`F;F)S<#LD*3QB<CY);B!-:6QL:6]N<SPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;"X@,#,L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E=F5R86YC92!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E-E=F5R86YC92!297-E<G9E(&)A;&%N8V4@87,@;V8Z/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)E9VEN;FEN9R!"
M86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD
M(#,T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0W5R<F5N="!Y96%R(&%C=&EV:71Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@W-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#(V.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V$V-CDR8S1?,38Q9E\T83<T
M7V$V9#%?-3,Q-#5B,64P.#<S#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S=A-C8Y,F,T7S$V,69?-&$W-%]A-F0Q7S4S,30U8C%E,#@W,R]7;W)K
M<VAE971S+U-H965T-3`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$51-$%%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E)E<W1R=6-T=7)I;F<@*$1E=&%I;',@5&5X='5A;',I
M("A54T0@)FYB<W`[)"D\8G(^26X@36EL;&EO;G,L('5N;&5S<R!O=&AE<G=I
M<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XR,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L
M+B`P,RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*
M=6PN(#`S+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;"X@,#,L(#(P,3$\8G(^0V]R9&ES(%)E<W1R=6-T=7)I;F<@6TUE;6)E
M<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`P,RP@
M,C`Q,3QB<CY#;W)D:7,@4F5S=')U8W1U<FEN9R!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#`S+"`R,#$Q/&)R/C(P
M,#D@4F5S=')U8W1U<FEN9R!0;&%N(%M-96UB97)=/&)R/E!O<VET:6]N<SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2
M97-T<G5C='5R:6YG($-O<W0@86YD(%)E<V5R=F4@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R
M=6-T=7)I;F<@8VAA<F=E<RP@<')E('1A>#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)FYB<W`[)"`U.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#4X.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-C<V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y297-T<G5C='5R:6YG(&-H87)G97,@<F5Q=6ER960@=&\@8F4@<&%I9"!I
M;B!C87-H+"!P<F4@=&%X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%S<V5T('=R:71E+6]F9G,@:6YC;'5D960@:6X@<F5S=')U8W1U
M<FEN9R!C:&%R9V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQE87-E:&]L9"!A;F0@8V]N=')A8W0@;V)L:6=A=&EO;G,@:6YC;'5D
M960@:6X@<F5S=')U8W1U<FEN9R!C:&%R9V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%S<V5T('=R:71E+6]F9G,@<F5L871E9"!T
M;R!P<F]P97)T>2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!<W-E="!W<FET92UO9F9S(')E;&%T
M960@=&\@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^07-S970@=W)I=&4M;V9F<R!R96QA=&5D('1O(&EN
M=F5N=&]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[
M)"`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17AP96-T960@;G5M8F5R(&]F('!O<VET:6]N<R!T;R!B92!E;&EM
M:6YA=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#4P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3G5M8F5R(&]F('!O<VET:6]N<R!E;&EM:6YA=&5D('1O(&1A=&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-S`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W838V.3)C-%\Q-C%F7S1A-S1?
M839D,5\U,S$T-6(Q93`X-S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
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M9CTS1")3:&5E=#`Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,#8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970Q-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,3@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,"YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,RYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C0N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#(U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970R-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C<N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(X+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970R.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,Q+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,S,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#,T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S8N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#,W+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970S."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,SDN
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0P+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970T,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0S
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T-"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T-#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#0V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T
M-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#@N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0Y+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970U,"YH=&UL(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A
K<G1?-V$V-CDR8S1?,38Q9E\T83<T7V$V9#%?-3,Q-#5B,64P.#<S+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EWEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Restructuring (Details) (Severance [Member], USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Severance [Member]</div>
        </td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Severance Reserve balance as of:</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
        <td class="nump">$ 345<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithCash', window );">Current year activity</a></td>
        <td class="num">(77)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
        <td class="nump">$ 268<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 95-3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserve</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserveRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b) (2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Emerging Issues Task Force (EITF)<br> -Number 95-3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 146<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserveSettledWithCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ELEBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Details 2) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">$ 16,597<span></span></td>
        <td class="nump">$ 15,330<span></span></td>
        <td class="nump">$ 32,770<span></span></td>
        <td class="nump">$ 30,961<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percent Change</a></td>
        <td class="nump">8.30%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">5.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">7,447<span></span></td>
        <td class="nump">7,438<span></span></td>
        <td class="nump">15,055<span></span></td>
        <td class="nump">15,090<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percent Change</a></td>
        <td class="nump">0.10%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="num">(0.20%)<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Europe [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">4,543<span></span></td>
        <td class="nump">3,832<span></span></td>
        <td class="nump">8,726<span></span></td>
        <td class="nump">7,934<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percent Change</a></td>
        <td class="nump">18.60%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Western Hemisphere, excluding U.S. [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">1,543<span></span></td>
        <td class="nump">1,375<span></span></td>
        <td class="nump">2,979<span></span></td>
        <td class="nump">2,655<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percent Change</a></td>
        <td class="nump">12.20%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">12.20%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Asia-Pacific, Africa [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Total</a></td>
        <td class="nump">$ 3,064<span></span></td>
        <td class="nump">$ 2,685<span></span></td>
        <td class="nump">$ 6,010<span></span></td>
        <td class="nump">$ 5,282<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percent Change</a></td>
        <td class="nump">14.10%<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">13.80%<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesByGeographicArea">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage change in sales by geographic area.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_PercentageChangeInSalesByGeographicArea</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueGoodsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentsGeographicalAreasAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E1XAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Details Textuals) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract', window );"><strong>Segment of Business and Geographic Areas (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expense</a></td>
        <td class="nump">$ 589<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 589<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Pharmaceutical [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract', window );"><strong>Segment of Business and Geographic Areas (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationExpense', window );">Litigation Expense</a></td>
        <td class="nump">290<span></span></td>
        <td class="nump">115<span></span></td>
        <td class="nump">540<span></span></td>
        <td class="nump">202<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Medical Devices and Diagnostics [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract', window );"><strong>Segment of Business and Geographic Areas (Textuals) [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationExpense', window );">Litigation Expense</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">42<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">1,542<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring expense</a></td>
        <td class="nump">676<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">676<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LitigationAndRecallExpense', window );">Litigation and additional DePuy ASR Hip recall costs</a></td>
        <td class="nump">$ 127<span></span></td>
        <td class="text"> <span></span></td>
        <td class="nump">$ 223<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LitigationAndRecallExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Litigation And Recall Expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_LitigationAndRecallExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LitigationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Litigation expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_LitigationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Segment Of Business And Geographic Areas.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>jnj_SegmentOfBusinessAndGeographicAreasTextualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>jnj</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394695&amp;loc=d3e140864-122747<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ECIAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Pensions and Other Postretirement Benefits (Details) (USD $)<br>In Millions</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
        <th class="th">
          <div>Jul. 03, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 04, 2010</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Retirement Plans [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
        <td class="nump">$ 144<span></span></td>
        <td class="nump">$ 121<span></span></td>
        <td class="nump">$ 287<span></span></td>
        <td class="nump">$ 247<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
        <td class="nump">214<span></span></td>
        <td class="nump">194<span></span></td>
        <td class="nump">427<span></span></td>
        <td class="nump">394<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
        <td class="num">(277)<span></span></td>
        <td class="num">(248)<span></span></td>
        <td class="num">(555)<span></span></td>
        <td class="num">(500)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/ (credit)</a></td>
        <td class="nump">1<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">4<span></span></td>
        <td class="nump">6<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets', window );">Amortization of net transition obligation</a></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="nump">1<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
        <td class="nump">98<span></span></td>
        <td class="nump">59<span></span></td>
        <td class="nump">194<span></span></td>
        <td class="nump">117<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
        <td class="nump">181<span></span></td>
        <td class="nump">130<span></span></td>
        <td class="nump">358<span></span></td>
        <td class="nump">265<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Other Benefit Plans [Member]</div>
        </td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
        <td class="nump">37<span></span></td>
        <td class="nump">33<span></span></td>
        <td class="nump">74<span></span></td>
        <td class="nump">67<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
        <td class="nump">46<span></span></td>
        <td class="nump">50<span></span></td>
        <td class="nump">94<span></span></td>
        <td class="nump">100<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/ (credit)</a></td>
        <td class="text"> <span></span></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(2)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
        <td class="nump">12<span></span></td>
        <td class="nump">13<span></span></td>
        <td class="nump">23<span></span></td>
        <td class="nump">25<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
        <td class="nump">$ 94<span></span></td>
        <td class="nump">$ 94<span></span></td>
        <td class="nump">$ 189<span></span></td>
        <td class="nump">$ 189<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of gains or losses recognized in net periodic benefit cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the prior service cost or credit recognized in net periodic benefit cost relating to benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the transition obligation or asset recognized in net periodic benefit cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanAmortizationOfTransitionObligationsAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512136<br> -Topic 715<br> -SubTopic 30<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512171<br> -Topic 715<br> -SubTopic 60<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 106<br> -Paragraph 518<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 87<br> -Paragraph 264<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 106<br> -Paragraph 518<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 87<br> -Paragraph 264<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph a, h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanInterestCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6962843&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 106<br> -Paragraph 518<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Service Cost (Component of Net Periodic Pension Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6525008<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 87<br> -Paragraph 264<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 132R<br> -Paragraph 5<br> -Subparagraph a, h<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanServiceCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
